doc49 era-edta congress - ERA
download 
Report Transcription
49 era-edta congress - ERA
eraedta2012.org www. MAY 24-27, 2012 49th ERA-EDTA CONGRESS PARIS, France Final Programme AMGEN is dedicated to creating a better future in nephrology. Come and see how at stand 2.48 level 2 MN-IHQ-AMG-317-2012- April-P MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N CONTENTS page Welcome Address 4 ERA-EDTA Council 6 Organising and Scientific Committees 7 Paper Selection Committee 8 ERA-EDTA Information 16 Congress Information 18 Press/Media Information 22 Accepted Abstracts 24 ERA-EDTA Awards and Grants 26 CME Credits 36 Social Programme - Tours and Excursions 38 Paris General Information 39 Renal Run 43 SCIENTIFIC PROGRAMME Thursday, May 24, 2012 45 Friday, May 25, 2012 59 Friday, May 25, 2012 - posters 105 Saturday, May 26, 2012 207 Saturday, May 26, 2012 - posters 249 Sunday, May 27, 2012 349 Industry Sponsored Symposia 373 Industry Exhibition 391 Cover: Les Nymphéas, Claude Monet, Musée de l’Orangerie, Paris photograph by Edoardo Terzolo w w w. e r a e d t a 2 01 2 . o r g 3 49th ERA-EDTA CONGRESS W E L C O M E A D D R E S S Dear Colleagues and Friends, We are very glad to welcome you to Paris for the 49th congress of ERA-EDTA. We hope that the wonderful “Ville lumière” will charm you with its unique flavour of modernity and history. Paris is a megalopolis, with more than ten million inhabitants, a city as populated as some European States, full of contradictions and doubts, as well as potential and treasures. Twenty years after the last ERA-EDTA congress in Paris chaired by Prof. Claude Jacobs, this Congress inaugurates the 50th year of European Nephrology while taking place in a moment of global crisis of the European and World economy; as difficult as they are, the moments of crisis are also opportunities to reflect on the motivations of our present to build our future. Past and present, keys for the future, will accompany you both during the Congress and the time that we hope you’ll be able to enjoy in our beautiful city. The scientific programme, carefully prepared by Prof. Jürgen Floege and his Scientific Committee, was built with particular attention towards the clinics, a major strength of European medicine, and to the integration of basic science into the clinical context. The three plenary lectures that deal with cutting-edge topics of major interest to all nephrologists and the late breaking clinical trial session will be highlights of the congress. The intense activities of the different ERA-EDTA working groups will be presented on the day of the official opening together with CME sessions dedicated to diverse aspects of daily nephrology. The scientific congress further includes 46 symposia and 17 mini-lectures covering all major areas of nephrology within eight main themes. Overall, a record-breaking number of 2672 abstracts were submitted, from 77 Countries all over the world. We warmly thank Prof. Markus Ketteler and the whole Paper Selection Committee and external referees for their hard work. The choice was more difficult than ever. We hope that the Authors of the oral communications and of the posters will be proud of their achievement, while those who could not be included in the programme due to the space constraints, will find a stimulating atmosphere for their future studies. Past and future will accompany us starting from the Opening Ceremony, as illustrated by the three prizes that will be awarded. Two will recognize the outstanding achievements of two great Masters of our discipline, Prof J. Stewart Cameron, the innovative, non-conventional genius of the early days of Nephrology, and Prof. Vincenzo Cambi, to whom we owe major contributions to 4 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France W E L C O M E A D D R E S S ERA-EDTA as well as the concept of “short dialysis”. Dr. Giovana Seno di Marco will be the recipient of the young investigator’s award. Memory is the refrain of the Opening Ceremony: memory in biology, through the lecture presented by Prof. Alain Prochiantz, and memory in the moving pictures of the Pioneers of Nephrology, who remind us of the adagio stating that only the one who knows the history does not risk reproducing its errors. The enlightened quotes on patient-physician relationship, on the sense of Medicine and Science, the wishes to the young physicians, in a kaleidoscope of languages, gain a special importance in this context of redefining our profession. We hope that the strength of the Masters will follow us as a most powerful wish. Paris is also joy, la joie de vivre. The young artists of the Ecole Nationale du Cirque will take you by the hand in the collective memory of the Circus, playing at the cosmopolitan music of Gilberto Richiero, merging artists and children, opera and rap. The search for perfection links science and art. The symbol of our Congress, the water lily, photographed in the marvelous pond of the Orangerie, is just one among thousands of water lilies, in over 250 oil paintings by Claude Monet. This simple flower, paradigm of the Impressionism, painted in all hues and nuances, may reflect the same research for perfection that is at the basis of the progress of our discipline. We hope that, in these days dedicated to the art of medicine, you’ll find some time not only for the great museums, as the Louvre and the Musée d’Orsay, but also for discovering some less known jewels, such as the Musée Marmottan, to see the small and marvelous painting which gave Impressionism its name, for living the experience out of time of the home-museum of Gustave Moreau, or for reflecting on the interactions between nature and art, looking at the inspiring water lilies in the oasis of Giverny, or for discovering the ever moving borders of the future in the City of Science. It is with great pleasure that we welcome you to this meeting in Paris, wishing that the search for perfection in Nephrology will never end. Raymond Vanholder ERA-EDTA President w w w. e r a e d t a 2 01 2 . o r g Pierre Ronco 49th Congress President 5 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N Registered Charity No. 1060134 President Raymond Vanholder, Belgium Secretary-Treasurer Andrzej Więcek, Poland Chairperson of the Administrative Offices Rosanna Coppo, Italy Editor-in-Chief of “Nephrology Dialysis Transplantation” Carmine Zoccali, Italy Chairperson of the Registry Christoph Wanner, Germany Ordinary Council Members Peter Barany, Sweden Peter J. Blankestijn, The Netherlands Jonathan G. Fox, United Kingdom Markus Ketteler, Germany (Chairperson of the Paper Selection Committee) Marian Klinger, Poland Ziad Massy, France Kostas Siamopoulous, Greece Vladimir Tesar, Czech Republic Congress Presidents (Paris - France) Pierre Ronco, France Raymond Vanholder, Belgium 6 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N ORGANISING COMMITTEE ERA-EDTA President Raymond Vanholder, Belgium Congress President Pierre Ronco, France Congress Secretary Dominique Chauveau, France LOCAL COMMITTEE Maurice Laville President of Société de Néphrologie, France Thierry Hannedouche President of Société Francophone de Dialyse, France Jean-Paul Squifflet President of Société Francophone de Transplantation, Belgium Georges Deschênes President of Société de Néphrologie Pédiatrique, France SCIENTIFIC COMMITTEE Chair: Jürgen Floege, Germany Raymond Vanholder, Belgium Mustafa Arici, Turkey Bernard Canaud, France Giovambattista Capasso, Italy Pierre Cochat, France John Feehally, UK Bengt Fellstrom, Sweden Sandrine Florquin, Netherlands João M. Frazão, Portugal Markus Ketteler, Germany Nine Knoers, Netherlands Armin Kurtz, Germany Johannes Mann, Germany Patrick Maxwell, UK Klaus Olgaard, Denmark Manuel Praga, Spain Pierre Ronco, France Laszlo Rosivall, Hungary Francesco Paolo Schena, Italy Nicholas Topley, UK w w w. e r a e d t a 2 01 2 . o r g 7 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N PAPER SELECTION COMMITTEE ERA-EDTA is grateful to the following physicians for the work done in reviewing the abstracts submitted to this year’s congress. Chair Markus Ketteler, Germany Core group Dominique Chauveau, France Jürgen Floege, Germany Pierre Ronco, France Section Chairs Acid-base/Na, K, Cl. Proteins and cell physiology Carsten Wagner, Switzerland Cell signalling. Cell growth control and related alterations (hypertrophy, hyperplasia and apoptosis) including neoplasia Jesus Egido, Spain Renal development and cystic diseases Adrian S. Woolf, UK Genetic diseases and molecular genetics Olivier Devuyst, Switzerland Hormones Peter Gross, Germany Basic and clinical hypertension research and renal haemodynamics Roland E. Schmieder, Germany Acute Renal Failure - Human studies Norbert Lameire, Belgium Acute Renal Failure - Experimental models Andreas Kribben, Germany Lab methods, progression & risk factors for CKD, nutrition in CKD, renal diseases (except GNs and cystic diseases) Danilo Fliser, Germany 8 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N General and Clinical Epidemiology and CKD 1-5 Bénédicte Stengel, France Anaemia in CKD 1-5 Goce Spasovski, F.Y.R. of Macedonia Bone disease in CKD 1-5 Pieter Evenepoel, Belgium Pathophysiology and clinical studies in CKD 1-5 Ivan Rychlik, Czech Republic Nutrition, inflammation and oxidative stress in CKD 1-5 Denis Fouque, France Diabetes - Basic research Erwin Schleicher, Germany Diabetes - Clinical studies Peter Rossing, Denmark Acid Base and N/K related diseases, nephrolithiasis, divalent ions and divalent ions disorders Giovanni Gambaro, Italy Clinical Nephrology, primary and secondary glomerulonephritis Claudio Ponticelli, Italy Experimental pathology Peter Mathieson, UK Immune and inflammatory mechanisms Hans-Joachim Anders, Germany Renal histopathology Jan J. Weening, Netherlands Extracorporeal dialysis: techniques and adequacy Martin K. Kuhlmann, Germany Peritoneal dialysis Olof Heimbürger, Sweden Cardiovascular complications in CKD 5D Carmine Zoccali, Italy Vascular access in extracorporeal dialysis Pietro Ravani, Italy/Canada Anemia in CKD 5D Kai-Uwe Eckardt, Germany w w w. e r a e d t a 2 01 2 . o r g 9 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N Bone disease in dialysis patients João M. Frazão, Portugal Pathophysiology and clinical studies in CKD 5D patients Raymond Vanholder, Belgium Epidemiology, outcome research, health services research in CKD 5D Friedo W. Dekker, Netherlands Protein-energy wasting, inflammation and oxidative stress in CKD 5D Peter Barany, Sweden Transplantation basic science and immunetolerance of allogenic and xenogenic transplants Bruno Watschinger, Austria Clinical epidemiology of renal transplantation Anders Hartmann, Norway Paediatric nephrology Christer Holmberg, Finland Reviewers Dwomoa Adu, Ghana/UK Alberto Albertazzi, Italy Kerstin Amann, Germany Alessandro Amore, Italy Björn Anderstam, Sweden Michele Andreucci, Italy Vittorio E. Andreucci, Italy Anders Åsberg, Norway Jan Aten, Netherlands Per-Ola Attman, Sweden Jonas Axelsson, Sweden Bert Bammens, Belgium Bernhard Banas, Germany Ali Basci, Turkey Carlo Basile, Italy Laurent Baud, France Joachim Beige, Germany Ariela Benigni, Italy Thomas Benzing, Germany Patrick Biggar, Germany Peter J. Blankestijn, Netherlands 10 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N Carsten Boeger, Germany Elisabeth W. Boeschoten, Netherlands Alessandra Boletta, Italy Jürgen Bommer, Germany Annette Bruchfeld, Sweden Philippe Brunet, France Klemens Budde, Germany Leonardo Cagnoli, Italy Bernard Canaud, France Giovanni Cancarini, Italy Jorge B. Cannata-Andía, Spain Giovambattista Capasso, Italy Cristina Stela Capusa, Romania Fernando Carrera, Portugal Juan Jesus Carrero, Sweden Francesco G. Casino, Italy Fergus Caskey, UK Michal Chmielewski, Poland Erik Ilsø Christensen, Denmark Jerzy Chudek, Poland Pierre Cochat, France Clemens D. Cohen, Switzerland Gerald Cohen, Austria Peter Joseph Conlon, Ireland Rosanna Coppo, Italy Maria Covic, Romania Mario Cozzolino, Italy Stanislaw Czekalski, Poland Andrew Davenport, UK Marc E. De Broe, Belgium Moniek de Goeij, Netherlands Dinanda J. de Jager, Netherlands Dick De Zeeuw, Netherlands Guy Decaux, Belgium Ljubica Djukanovic, Serbia Joerg Doetsch, Germany Michel Dracon, France Tilman B. Drueke, France Soner Duman, Turkey Tevfik Ecder, Turkey Frank Eitner, Germany Henrik Ekberg, Sweden Ekrem Erek, Turkey F. Fevzi Ersoy, Turkey Vincent L.M. Esnault, France Christopher K.T. Farmer, UK John Feehally, UK Bo Feldt-Rasmussen, Denmark w w w. e r a e d t a 2 01 2 . o r g 11 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N Robert Fenton, Denmark Franco Ferrario, Italy Anibal Ferreira, Portugal Patrick Finne, Finland Michael Fischereder, Germany Sandrine Florquin, Netherlands Joan Fort, Spain Ulrich Frei, Germany Gérard Friedlander, France Jan Galle, Germany Maurizio Gallieni, Italy Loreto Gesualdo, Italy Matthias Girndt, Germany Eric Goffin, Belgium Matthew D. Griffin, Ireland Megan Griffith, UK Josep M. Grinyó, Spain Hermann-Josef Groene, Germany Oliver Gross, Germany Paul Gusbeth-Tatomir, Romania Valsamakis E. Hadjiconstantinou, Greece Dieter Haffner, Germany Nynke Halbesma, Netherlands Hermann Haller, Germany Kevin Harris, UK Marion Haubitz, Germany Ingeborg A. Hauser, Germany James Heaf, Denmark Uwe Heemann, Germany Luuk Hilbrands, Netherlands Rachel Hilton, UK Eero Olavi Honkanen, Finland Eric Hoste, Belgium Tobias Huber, Germany Alastair James Hutchison, UK Helena Isoniemi, Finland Stefan Jacobson, Sweden Christian Jacquot, France Michel Jadoul, Belgium Philippe Jaeger, UK Alan Jardine, UK AnnCatherine Johansson, Sweden Achim Joerres, Germany Dontscho Kerjaschki, Austria Marian Klinger, Poland Anneke Kramer, Netherlands Bernhard K. Krämer, Germany Raymond T. Krediet, Netherlands 12 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N Matthias Kretzler, USA Wolfgang Kühn, Germany Ulrich Kunzendorf, Germany Armin Kurtz, Germany Maurice Laville, France Christophe Legendre, France Jens Leipziger, Denmark Ewa Lewin, Denmark Orfeas Liangos, Germany Carlo Lomonte, Italy Gérard M. London, France Merike Luman, Estonia Iain C. Macdougall, UK David Makanjuola, UK Francesca Mallamaci, Italy Marko Malovrh, Slovenia Jacek Manitius, Poland Johannes F.E. Mann, Germany Alejandro Martin-Malo, Spain Ziad Massy, France Patrick Maxwell, UK Gert Mayer, Austria Christopher W. McIntyre, UK Otto Mehls, Germany Paolo Mene’, Italy Peter Mertens, Germany Piergiorgio Messa, Italy Quentin Meulders, France Karsten Midtvedt, Norway Gabriel Mircescu, Romania Marcus Moeller, Germany Carl Erik Mogensen, Denmark Leo A.H. Monnens, Netherlands Daniela Monova, Bulgaria Eugen Mota, Romania Heini Murer, Switzerland Judit Nagy, Hungary Guy Nield, UK Hans Hellmut Neumayer, Germany Marlies Noordzij, Netherlands Marina Noris, Italy Michal Nowicki, Poland Gurbey Ocak, Turkey Klaus Olgaard, Denmark Michel Olmer, France Yvonne O’Meara, Ireland Ingrid Os, Norway Mai Ots-Rosenberg, Estonia w w w. e r a e d t a 2 01 2 . o r g 13 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N Antonello Pani, Italy Vincenzo Panichi, Italy Ulf Panzer, Germany Andreas Pasch, Switzerland Sonia Pasquali, Italy Hermann Pavenstädt, Germany E.B. Pedersen, Denmark Norberto Perico, Italy Manuel Pestana, Portugal Harm Peters, Germany Thierry Petitclerc, France Luis Piera, Spain Yves Pirson, Belgium Momir Polenakovic, F.Y.R. of Macedonia Claudio Pozzi, Italy Uwe Querfeld, Germany Abdul Rashid Qureshi, Sweden Ton J. Rabelink, Netherlands Maria Pia Rastaldi, Italy Helmut Reichel, Germany Bengt Rippe, Sweden Eberhard Ritz, Germany Ian Roberts, UK Paul Roderick, UK Anabela Soares Rodrigues, Portugal Mariano Rodriguez-Portillo, Spain Alexander Rosenkranz, Austria Joanna Rowinska Matrow, Poland Luis Ruilope, Spain Alan Salama, UK Moin A. Saleem, UK Kaija Salmela, Finland Antonio Santoro, Italy Francesco Paolo Schena, Italy Adalbert Schiller, Romania Ralf Schindler, Germany Georg Schlieper, Germany Vedat Schwenger, Germany Astrid Seeberger, Sweden Rafael Selgas, Spain Mehmet Sükrü Sever, Turkey Neil Sheerin, UK Kostas C. Siamopoulos, Greece João Manuel Graça Silva, Portugal Justin Silver, Israel Sandor Sonkodi, Hungary Søren Schwarz Sørensen, Denmark Jean-Paul Squifflet, Belgium 14 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N Coen Stehouwer, Netherlands Peter Stenvinkel, Sweden Dirk Struijk, Germany Frank Strutz, Germany Gultekin Süleymanlar, Turkey Wladyslaw Sulowicz, Poland Gere Sunder-Plassmann, Austria Maria Svensson, Sweden My Svensson, Denmark Pieter M. ter Wee, Netherlands Vladimir Tesar, Czech Republic Nicola Tessitore, Italy Daniel Teta, Switzerland Friedrich Thaiss, Germany Christian Tielemans, Belgium Burkhard Toenshoff, Germany Natalja Tomilina, Russia Rezan Topaloglu, Turkey Nicholas Topley, UK Dimitrios J. Tsakiris, Greece Photini-Effie C. Tsilibary, Greece Gunnar Tufveson, Sweden Robert Unwin, UK Cengiz Utas, Turkey Wim Van Biesen, Belgium Tessa van den Beukel, Netherlands Frank M. van der Sande, Netherlands Cees Van Kooten, Netherlands Karlijn van Stralen, Netherlands Roland Veelken, Germany Volker Vielhauer, Germany Andreas Vychytil, Austria Zofia Wankowicz, Poland Christoph Wanner, Germany Stefanie Weber, Germany Willem Weimar, Netherlands Ulrich O. Wenzel, Germany Ralf Westenfeld, Germany David Wheeler, UK Andrzej J. Wiecek, Poland Martin Wilkie, UK Christopher G. Winearls, UK Ralph Witzgall, Germany Rainer P. Woitas, Germany Rudolf Peter Wüthrich, Switzerland Mahmut Ilker Yilmaz, Turkey Martin Zeier, Germany w w w. e r a e d t a 2 01 2 . o r g 15 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N Registered Charity No. 1060134 ERA-EDTA Membership Office You will find the ERA-EDTA Membership Office in the Registration Area of the Palais des Congrès. It is possible to pay membership fees and become a new ERA-EDTA member. How to vote for the new Ordinary Council Members All Full members of the ERA-EDTA will be able to vote for a maximum of three (3) candidates. Also this year, electronic voting online was possible (April 16th – May 16th). Only members who have not already voted online will be able to vote on-site. The voting station, next to the ERAEDTA Membership Office, in the Registration Area will be open from 14:00 to 18:00 on May 24, 2012 (Thursday), from 7:00 to 19:00 on May 25, 2012 (Friday), from 7:00 to 19:00 on May 26, 2012 (Saturday) and also before the start of the General Assembly on May 27, 2012 (Sunday) starting at 7:00 up to 10.00. A valid identification document (i.e. passport of national identity card) of the Full member who wishes to vote must be personally shown in order to vote. Vote by proxy is NOT possible. Only paper ballot voting will be possible. Candidates for Ordinary Council Membership (in alphabetical order according to last name): - Denis Fouque, France - Loreto Gesualdo, Italy - Gert Mayer, Austria - Alberto Ortiz, Spain - Mehmet Sever, Turkey A short curriculum for each candidate will be on display at the voting station and is also on the ERA-EDTA’s website (www.era-edta.org, section “About ERA-EDTA”, click on “Council Candidates”). General Assembly The General Assembly will be held on Sunday, May 27, 2012 starting at 10:30 am, in the “Amphitheatre Havane” on the 3rd floor of the Palais de Congrès. The admission to the General Assembly is strictly reserved to ERA- 16 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N EDTA Members only. Members should have their ERAEDTA membership cards to show in order to enter the room for the General Assembly. Reasons to become an ERA-EDTA member 1. Free paper and/or online subscription to the journals “Nephrology Dialysis Transplantation” (NDT) and “CKJ” (former NDT-Plus). 2. Free password to access the Directory of ERA-EDTA Members on Internet. 3. Discounted registration fees at the annual ERA-EDTA Congresses. 4. Presentations of the ERA-EDTA CME Courses. 5. 25% or more discount on Oxford University Press medical publications. Both lists of books and order forms are available at the ERA-EDTA Membership Office Desk or at the OUP booth in the exhibition area. Go and check out all the latest initiatives of the ERAEDTA (including educational activities, grants, etc) on our website www.era-edta.org: 1. Membership information 2. Directory of all ERA-EDTA members 3. Annual ERA-EDTA Congresses 4. NDT and CKJ Journals 5. ERA-EDTA Fellowship Programme 6. ERA-EDTA Grant Programme 7. ERA-EDTA Research Programme 8. European Renal Best Practice (ERBP) 9. ERA-EDTA CME Courses 10. ERA-EDTA Registry 11. NDT-Educational 12. European National Societies 13. ERA-EDTA Working Groups To find out more about the ERA-EDTA (more advantages, educational initiatives, CME Courses, grants, etc. ) visit the society’s website www.era-edta.org w w w. e r a e d t a 2 01 2 . o r g 17 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N CONGRESS INFORMATION Abstract CD-ROM and Abstract Book A CD-ROM, with all the accepted abstracts, is in all delegates’ bags. Only a few Abstract Books have been printed. Should you wish to receive one you can collect it at booth 1.102 NDT-ERBP-NDT-Educational located on Level 1/Paris. Certificate of attendance All regularly registered delegates can collect their certificate of attendance at the appropriate desk (“Certificate of Attendance”) located in the Registration Area starting May 25, 2012 after 15.00 hours. To obtain the certificate of attendance, it is mandatory to go to this desk and show the badge. A personalized certificate will be printed and will state exactly, and only, the days of the participation in the congress. For example, if you registered as a full congress member on May 24 and you request the certificate on May 25, you will receive it for May 24 and 25. If you ask for it on May 27, you will receive it for May 24, 25, 26 and 27. If you are not able to go to this desk to collect your certificate due to other commitments, you can send a written request to the ERA-EDTA Congress Office after the congress (e-mail: registrations@era-edta.org), it will then be sent to you by e-mail. Children The participation to the ERA-EDTA Congress is not open to non healthcare professionals, particularly children. Children under 12 years of age are not admitted within the Congress limits, children who are at least 12 years old can be admitted but only to the Opening Ceremony and only if accompanied by regularly registered adults. Their number cannot exceed one child per registered adult. The accompanying adult will be responsible for the child’s safety and behaviour at all times. Access for non healthcare professionals, in particular children, to the exhibition/poster/session halls will be prohibited at all times. Coffee and tea break Complimentary coffee and tea will be served to registered delegates only in exchange of the coffee tickets received together with the congress badge, in the catering areas of the Exhibition Hall of the Palais des Congrès, during all coffee breaks. Congress membership Regularly registered participants are entitled to attend all Scientific and Poster Sessions, Opening Ceremony with Welcome Reception and Industrial Exhibition. On- 18 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N site they will also receive a congress kit (including Final Programme and Abstract CD-ROM). Accompanying guest registration is not available; however, all participants can take part, with their accompanying guests, in the Opening Ceremony and Welcome Reception on May 24, 2012. All participants must wear their name badge when attending any congress or social event. Please note that only attendants wearing delegate badges are entitled to attend lecture and poster sessions. The information printed on the badges is exactly the one provided by participants when registering Recycle your badge! You will find special bins at the exit of the congress centre (registration area) where you can throw your badge as you leave the congress. A “Reprint desk” for lost or forgotten delegate badges will be available in the Registration Area. A personal picture ID (passport, driver’s licence, etc.) must be shown in order to receive a replacement delegate badge. CME Courses In order to participate in the CME Courses held on May 24, 2012, all regularly registered congress members must go to the session halls and have their badge scanned by the hostesses at the entrance (at participant’s own responsibility). Please note that the seat capacity of the conference rooms is limited, therefore participation in these courses will be on a “first come first served” basis. The courses are reserved to regularly registered congress members and are included in the registration fee. Facilities at the Palais des Congrès A Cloak Room is located on the mezzanine (Service Area) of the Grand Amphitheatre, between Level 1 and 2; this service will be available for the entire duration of the congress. An internet point is available on the mezzanine (Service Area); there are also free wi-fi spots around the congress centre. Snack bars are available in the main Exhibition Area located on Level 1 and 2; there is another bar on Level 3 between Amphitheatre Havane and Amphitheatre Bordeaux. On Level 0 and on the basement level there is a nice shopping mall. Grant policy All ERA-EDTA travel grants had to be applied for in advance and have already been assigned. No additional travel grants, reduced fees or financial support of any kind can be given to participants. w w w. e r a e d t a 2 01 2 . o r g 19 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N Insurance / Liability Participation in this Congress implies that persons/participants agree that the organizers do not assume any liability whatsoever. Upon registration, the participant accepts this proviso. Language of the Congress The official language of the Congress is English. No simultaneous translation will be provided. Lunch Snack bars and catering areas will offer light food for purchase; they are located in the main Exhibition Area on Level 1 and 2; the same applies for the Bar located on Level 3. Most of the Companies that have arranged the Industry Sponsored Symposia will offer lunch to the participants. Post-Congress Correspondence If you wish to contact the ERA-EDTA after the Congress, the address is: ERA-EDTA Congress Office, Via I. Spolverini 2, 43126 Parma (Italy). Telephone: +39-0521989078, fax: +39-0521-959242, e-mail: congress@era-edta. org or registrations@era-edta.org Programme changes The organisers cannot assume liability for changes in the programme due to external or unforeseen circumstances. Registration / Information A confirmation letter and congress materials (badge and coffee tickets) have been sent by post to regularly preregistered participants. The registration and information desks are situated in the Registration Area of the Palais des Congrès. The desks will be open at the following times: Thursday, May 24 07:00-18:00 hours Friday, May 25 07:00-18:45 hours Saturday, May 26 07:00-18:45 hours Sunday, May 27 07:00-13:45 hours Receipts Pre-registered delegates may request the receipt of the payment by personally giving their full address to the ERA-EDTA Congress Office or by sending a request to registrations@era-edta.org. Receipts will be sent upon request and only after the congress. On-site registered delegates may request the receipt of the payment by ticking the appropriate box in the onsite form or personally giving their full address to the ERA-EDTA Congress Office or by sending a request to 20 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N registrations@era-edta.org. Receipts will be sent after the congress. UEMS CME Credits The 49th ERA-EDTA Congress has been designated for a maximum of 21 hours of European external CME credits. Please refer to page 36 for further accreditation details. ERA-EDTA cannot be deemed responsible for forgotten, lost or stolen personal belongings and Congress materials. SPEAKERS INFORMATION The Speakers’ Preview Room is located on the second floor of the Palais des Congrès. All presentations need to be prepared as PowerPoint files and will be loaded on a central server in the Speakers’ Preview Room. All speakers should bring their presentations stored on a CD-ROM, DVD or USB memory stick to this room no later than 2 hours before the start of their session (or the afternoon of the day before if the slides refer to the first morning session). The use of laptop computers and traditional slides will not be possible. The transparency declarations of all Invited Speakers and Chairs will be made available at the beginning of the sessions. Moreover, they have been posted on the Paris Congress website www.eraedta2012.org, under a special section. w w w. e r a e d t a 2 01 2 . o r g 21 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N INFORMATION FOR PRESS/MEDIA REPRESENTATIVES Media registration Pre-registered journalists can pick up their press passes in the press lounge (Room 135M, Level 1 Mezzanine/ Neuilly). The press pass provides access to all sessions and symposia of this congress. Also for onsite registration, media representatives are kindly asked to come to the press room. The following identification will be required: press identification/press card and a letter of assignment from the news organization being represented. Please note: public relations personnel and exhibitors cannot register as Press! Press room ERA-EDTA will be providing a fully-equipped press lounge (computers with internet access/printer) in Room 135M, Level 1 Mezzanine/Neuilly. Press folders and other materials will be available. Opening hours: Thursday, May 24: 12:30-18:00 Friday, May 25 and Saturday, May 26: 09:00-18:00 Sunday, May 27: 09:00-12:30 ERA-EDTA press events Main press conference: Friday, May 25, 11:45-12:45 Room 134M, Level 1 Mezzanine/Neuilly Topics will be: 1. Organ donation: how the kidney transplantation changed the life of a young man 2. The often overlooked burden of kidney disease: when diagnosis comes too late for patients 3. Born to be uremic? The research of the ERA-EDTA Working Group on Inherited Kidney Diseases LBCT press briefing: Saturday, May 26, 11:00-12:00 Room 134M, Level 1 Mezzanine/Neuilly Several late breaking clinical trials (LBCT) are to be presented at the ERA-EDTA congress in Paris. One press briefing featuring these late breaking trials will be held. Journalists will be informed ������������������������������������ about latest research findings and will have the opportunity to speak to the principal investigators of the LBCT. Embargo policy All LBCT are confidential until officially released by ERA-EDTA in the LBCT sessions of the scientific programme. Unless otherwise noted, all abstracts presented at the ERA-EDTA are embargoed until the date and time of their presentation. 22 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N Press Office ERA-EDTA 2012 albersconcept Dr. Bettina Albers Jakobstrasse 38 - 99423 Weimar, Germany Phone +49 3643/ 7764-23, Fax +49 3643/ 7764-52 info@albersconcept.de w w w. e r a e d t a 2 01 2 . o r g 23 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N ACCEPTED ABSTRACTS Free Communications The presentation time for all free communication sessions is 10 minutes, followed by 5 minutes of discussion. The free communications which will be presented in the symposia, instead, will last 8 minutes and will be followed by a 4 minute discussion. All speakers are requested to keep to their allotted time. Please ensure that you are in your session hall at least 10 minutes before the session starts, and remain until the end of the session. All presentations need to be prepared in PowerPoint. All speakers should bring their presentations stored on a CD-ROM, DVD or USB memory stick to the Speakers’ Preview Room no later than 2 hours before the start of their session. The use of laptop computers and traditional slides will not be possible. Posters Posters will be displayed in the Poster Area located in the Hall Neuilly and Paris, level 1 of the Palais ��������������� des Congrès. There will be two poster sessions, with the following timetable: Friday, May 25 09:30-10:45 Saturday, May 26 09:30-10:45 Authors should mount their poster on the day of their session starting at 07:30 and dismantle it after 17:00 hrs the same day. The poster panel measures 90 cm width x 200 cm height (portrait/vertical). The organisers will provide suitable fixing material during this period (07:30-17:00). The code number of each poster indicates both the position of the display board as well as the abstract number in the Abstract CD-ROM. Presenting authors are kindly requested to be present throughout the official poster viewing time (both timeslots) in order to explain their research and to answer questions from the delegates. There will be no guided formal discussion. ERA-EDTA cannot be deemed responsible for lost or stolen posters. Posters which are not dismounted by the end of each day will automatically be disposed of. 24 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N Abstract numbering system e.g. SAP313 = Satuday, poster number 313 F = Friday SA = Saturday SU = Sunday O = free communication P = poster Number: Abstract number and reference number for the Abstract CD-ROM Publication All submitted abstracts which have been accepted for presentation will be published in NDT Volume 27, Supplement 2, 2012, as well as in the Abstract CD-ROM included in the delegates’ congress bags. In addition, authors are encouraged to submit their final manuscript to be peer reviewed for publication in Nephrology Dialysis Transplantation. All manuscripts should be submitted online at: http://mc.manuscriptcentral.com/ndt Poster service online ERA-EDTA will offer all delegates the chance of consulting the posters from the Poster Virtual Gallery stations located in the booth 1.04 of the Exhibition Level 1 - where 10 computers will be provided for this viewing. This online service will start from Thursday, May 24 and will remain available online for twelve months. w w w. e r a e d t a 2 01 2 . o r g 25 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N ERA-EDTA AWARDS AND GRANTS Also this year the ERA-EDTA has decided to give up to 90 travel grants for young nephrologists (under 40 years of age) to attend the Paris Congress. The total sum – EUR 50,000 - has thus been allocated to the best rated abstracts in the various categories. All winners will receive: a) Free Congress Registration; b) A grant for EUR 500, except for the Presenting Authors of the best abstracts of each category whose grant will be of EUR 1,000. The Presenting Authors of the two best abstracts of each category will also receive a diploma, independently of age. The Paper Selection Committee has also selected the 8 best abstracts overall, the authors of which will receive a diploma. How to receive your grant In case of free communications, a voucher will be given to the winner of the grant directly from the Chairpersons of his/her session. Instead, poster presenters will have to go directly to the Grant Desk in the Registration Hall of the Palais des Congrès. Congress awards will be given only to the presenting author of the successful abstract, who must show a valid identification picture ID, together with the voucher (if applicable), to the ERA-EDTA staff at the ERA-EDTA Grant Desk after the presentation. Awards will not be given to co-authors/colleagues/ friends/relatives; no exceptions will be made. No other grants or financial support of any kind, besides the grants mentioned above, will be given to Congress participants. ¯Eight Best Abstracts 26 t Eight Best Abstracts presented by young Authors «Best Abstracts presented by young Authors w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N Eight Best Abstracts The authors of the abstracts below will receive a diploma. FO005 MICROVESICLES DERIVED FROM ENDOTHELIAL PROGENITOR CELLS PROTECT KIDNEY FROM CISPLATIN-INDUCED ACUTE TOXIC INJURY BY MICRORNA-DEPENDENT REPROGRAMMING AND INHIBITION OF APOPTOSIS OF TUBULAR CELLS Vincenzo Cantaluppi, Italy FO011 MIR-148B UPREGULATION MODULATING CORE 1, Β1,3GALACTOSYLTRANSFERASE 1 EXPRESSION EXPLAINS THE ABNORMAL GLYCOSYLATION PROCESS OF IGA1 IN IGA NEPHROPATHY Grazia Serino, Italy FO053 GENOME-WIDE ASSOCIATION STUDY (GWAS) OF INCIDENT CKD AND EGFR CHANGE: THE CKDGEN CONSORTIUM Carsten Böger, Germany SAO052 GLUT9-MEDIATED RENAL URIC ACID HANDLING Muriel Auberson, Switzerland SAO055 PARATHYROID HORMONE (PTH) LEVELS ROSE OVER TIME IN HEMODIALYSIS (HD) PATIENTS: RESULTS FROM THE DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS) Francesca Tentori, USA SAO062 10-YEAR CARDIOVASCULAR RISK IN TYPE 2 DIABETES IS PREDICTED BY MEASURABLE URINARY ALBUMIN EVEN IN THE NORMOALBUMINURIC RANGE Esteban Porrini, Spain SAP179 BEST SUPPORTIVE CARE AND THERAPEUTIC PLASMA EXCHANGE Jan Kielstein, Germany SAP719 UK PAEDIATRIC RENAL TRANSPLANTATION: A REVIEW OF CHANGING PRACTICE AND IMPROVED OUTCOMES OVER 20 YEARS Lisa Mumford, UK SUO017 ANGIOMYOLIPOMA RESPONSE TO EVEROLIMUS TREATMENT IN PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX OR SPORADIC LYMPHANGIOLEIOMYOMATOSIS: RESULTS FROM EXIST-2 Bernard Zonnenberg, Netherlands w w w. e r a e d t a 2 01 2 . o r g 27 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N Eight Best Abstracts presented by Young Authors The authors of the abstracts below will receive a grant of EUR 1,000, free congress registration and a diploma. FO005 MICROVESICLES DERIVED FROM ENDOTHELIAL PROGENITOR CELLS PROTECT KIDNEY FROM CISPLATIN-INDUCED ACUTE TOXIC INJURY BY MICRORNA-DEPENDENT REPROGRAMMING AND INHIBITION OF APOPTOSIS OF TUBULAR CELLS Vincenzo Cantaluppi, Italy FO011 miR-148b UPREGULATION MODULATING CORE 1, β1,3GALACTOSYLTRANSFERASE 1 EXPRESSION EXPLAINS THE ABNORMAL GLYCOSYLATION PROCESS OF IgA1 IN IgA NEPHROPATHY Grazia Serino, Italy SAO028 NFAT5 CONTRIBUTES TO OSMOLALITY-INDUCED MCP-1 EXPRESSION IN MESOTHELIAL CELLS Christoph Küper, Germany SAO029 INTERLEUKIN L-17A: A NOVEL PLAYER IN PERITONEAL INJURY BY DIALYSIS Raquel Rodrigues-Díez, Spain SAO052 GLUT9-MEDIATED RENAL URIC ACID HANDLING Muriel Auberson, Switzerland SAO062 10-YEAR CARDIOVASCULAR RISK IN TYPE 2 DIABETES IS PREDICTED BY MEASURABLE URINARY ALBUMIN EVEN IN THE NORMOALBUMINURIC RANGE Esteban Porrini, Spain SAP719 UK PAEDIATRIC RENAL TRANSPLANTATION: A REVIEW OF CHANGING PRACTICE AND IMPROVED OUTCOMES OVER 20 YEARS Lisa Mumford, UK SUO023 ECULIZUMAB FOR AHUS RECURRENCE IN RENAL TRANSPLANTATION Julien Zuber, France 28 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N Best Abstracts presented by Young Authors The authors of the abstracts below will receive a grant of EUR 500, free congress registration and a certificate. FO001 BMP-2 INDUCES A PRO-FIBROTIC PHENOTYPE IN ADULT RENAL PROGENITOR CELLS THROUGH NOX4 ACTIVATION Simona Simone, Italy FO002 ENDOTHELIAL-TO-MESENCHYMAL TRANSITION IN SWINE RENAL ISCHEMIA REPERFUSION INJURY IS MEDIATED BY COMPLEMENT AND AKT PATHWAY Giuseppe Castellano, Italy FO006 H,K-ATPASE TYPE 2 IS REQUIRED FOR RENAL ADAPTATION TO PREGNANCY Gilles Crambert, France FO012 SOLUBLE CD89-IGA1 COMPLEXES AGGRAVATE IGAN DEVELOPMENT IN A MOUSE MODEL Christina Papista, France FO018 CTGF: A LIGAND OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR). OPENING NOVEL POTENTIAL THERAPEUTIC TARGETS FOR RENAL DISEASES Sandra Rayego-Mateos, Spain FO021 DEF-6 EXPRESSION AND LOCALIZATION IS CHANGED IN PKCΛ/Ι DEFICIENT MICE AND PODOCYTES Kirstin Worthmann, Germany FO030 EPIDEMIOLOGY OF THE IDIOPATHIC NEPHROTIC SYNDROME IN CHILDREN: ENDEMIC OR EPIDEMIC? Claire Dossier, France FO039 BIRTHWEIGHT PREDICTS GLOMERULAR FILTRATION RATE Issa Salmi, Oman FO040 SERUM URIC ACID AND RISK OF CHRONIC KIDNEY DISEASE: THE ROTTERDAM STUDY AND META-ANALYSIS Sanaz Sedaghat, Netherlands FO041 RELATIVE ENERGY BALANCE, CHRONIC KIDNEY DISEASE AND RISK OF CARDIOVASCULAR AND ALL-CAUSE MORTALITY Samuel Iff, Australia w w w. e r a e d t a 2 01 2 . o r g 29 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N FO043 FGF23 AND ASYMMETRICAL DIMETHYLARGININE (ADMA) ARE INTERACTIVE FACTORS IN THE HIGH RISK FOR CKD PROGRESSION IN STAGE 2-5 CKD PATIENTS Giovanni Tripepi, Italy FO044 INTACT FIBROBLAST GROWTH FACTOR 23 LEVELS PREDICT INCIDENT CARDIOVASCULAR EVENT BEFORE BUT NOT AFTER THE START OF DIALYSIS Sayoko Yonemoto, Japan FO050 HIGHER THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR LEVELS ARE ASSOCIATED WITH INFLAMMATION AND GENETIC MUTATIONS IN ATTACK-FREE FAMILIAL MEDITERRANEAN FEVER PATIENTS Nuket Bavbek Ruzgaresen, Turkey FO052 LINKAGE ANALYSIS DETECTES TWO ADDITIONAL REGIONS IN FAMILIAL IGA NEPHROPATHY Francesco Pesce, United Kingdom FO056 DETERMINANTS OF THE COMMON CAROTID ARTERY SUBCLINICAL LESIONS IN HYPERTENSIVE SUBJECTS WITH RENAL FIBROMUSCULAR DYSPLASIA Luca Zanoli, France FP030 ENDOTHELIAL DYSFUNCTION PROMOTES THE TRANSITION FROM COMPENSATORY RENAL HYPERTROPHY TO KIDNEY INJURY AFTER UNILATERAL NEPHRECTOMY IN MICE Hiroyuki Kadoya, Japan FP039 ANGIOTENSIN II-INDUCED MITOCHONDRIAL NOX4 IS A MAJOR ENDOGENOUS SOURCE OF OXIDATIVE STRESS IN KIDNEY PROXIMAL TUBUALR CELLS Ju-Young Moon, Korea FP053 COMPARATIVE EFFECTIVENESS OF VARIOUS ANTIHYPERTENSIVE AGENTS IN DIABETIC PATIENTS: A SYSTEMATIC REVIEW AND BAYESIAN NETWORK METAANALYSIS Hon-Yen Wu, Taiwan FP109 REDUCED Γ-CARBOXYLASE ACTIVITY IN UREMIA- A POSSIBLE MECHANISM OF UREMIC VASCULAR CALCIFICATION Nadine Kaesler, Germany FP150 META-ANALYSIS: STATIN THERAPY TO PREVENT DEATH AND MAJOR CARDIOVASCULAR EVENTS IN PEOPLE WITH CHRONIC KIDNEY DISEASE Suetonia Palmer, New Zealand 30 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N FP166 OSTEOPROTEGERIN REPLACES CORONARY ARTERY CALCIFICATION SCORE AS A PREDICTOR OF INCIDENT CARDIOVASCULAR EVENTS IN DIABETIC CHRONIC KIDNEY DISEASE Chikako Nakano, Japan FP212 EARLY RECOMBINANT HUMAN ERYTHROPOIETIN TREATMENT PROMOTES CARDIORENAL CYTOPROTECTION IN A RAT MODEL OF CHRONIC RENAL FAILURE Patrícia Garrido, Portugal FP259 INVOLVEMENT OF IFN-Γ IN THE PATHOGENESIS OF TYPE2 DIABETIC NEPHROPATHY Miho Kimachi, Japan FP264 PRESERVATION OF ENDOTHELIAL GTP CYCLOHYDROLASE I ACTIVITY AND IMPROVEMENT OF RENAL NITRIC OXIDE AVAILABILITY PREVENT THE DEVELOPMENT OF DIABETIC NEPHROPATHY Kengo Kidokoro, Japan FP353 ACE INSERTION(I)/DELETION(D) POLYMORPHISM PREDICTED RENOPROTECTIVE EFFECTIVENESS OF RENINANGIOTENSIN SYSTEM (RAS) BLOCKADE IN PATIENTS WITH IGA NEPHROPATHY Junya Teranishi, Japan FP375 ASSESSMENT OF PODOCYTE DYSFUNCTION AND URINARY PODOCYTE LOSS IN CHRONIC GLOMERULONEPHRITIS (CGN): SIGNIFICANCE FOR ESTIMATION OF CLOMERULAR DAMAGE AND GLOMERULOSCLEROSIS RISK Natalia Tchebotareva, Russian Federation FP476 TRENDS IN THE INCIDENCE OF ATRIAL FIBRILLATION IN OLDER PATIENTS INITIATING DIALYSIS IN THE USA Benjamin Goldstein, USA FP485 WHAT IS THE EFFECT OF A/V FISTULA FLOW ON RIGHT VENTRICULAR PERFORMANCE INDEX IN PATIENTS WITH ESRD; A THREE MONTH FOLLOW UP TISSUE DOPPLER ECHOCARDIOGRAPHIC STUDY? Bahaa El-Din Zayed, Egypt FP508 HYPERPHOSPHATAEMIA AND MICROVESICLE FORMATION: A NOVEL MECHANISM FOR CARDIOVASCULAR RISK IN CHRONIC KIDNEY DISEASE Nima Abbasian, United Kingdom FP594 HIGHER DIALYSATE SODIUM IS ASSOCIATED WITH BETTER HEMODIALYSIS PATIENT-REPORTED OUTCOMES: RESULTS FROM THE DOPPS Angelo Karaboyas, USA w w w. e r a e d t a 2 01 2 . o r g 31 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N FP714 PERFORMANCE, LIMITATIONS AND UTILITY OF CYSTATIN C AS AN ENDOGENOUS GFR MARKER IN RENAL TRANSPLANTATION Ingrid Masson, France FP715 SURVIVAL AFTER RENAL TRANSPLANT FAILURE: A UK RENAL REGISTRY ANALYSIS Lynsey Webb, United Kingdom FP718 URINARY TRACT INFECTIONS DURING FIRST YEAR AFTER RENAL TRANSPLANTATION Justyna Gołębiewska, Poland SAO004 MTORC1 CONTRIBUTES TO THE PATHOGENESIS OF FSGS Stefan Zschiedrich, Germany SAO011 THE SOLUBLE GUANYLATE CYCLASE ACTIVATOR CINACIGUAT ATTENUATES NEPHROPATHY IN DIABETIC RATS Gabor Kokeny, Hungary SAO015 EFFECTS OF PHOSPHATE ON VASCULATURE CAN BE CORRECTED WITH A PHOSPHODIESTERASE 5 INHIBITOR Kathryn Stevens, United Kingdom SAO023 THROMBIN MODULATE T CELLS RESPONSE INDUCED BY DENDRITIC CELLS (DC) IN KIDNEY TRANSPLANT RECIPIENTS WITH DELAYED GRAFT FUNCTION (DGF) Paola Pontrelli, Italy SAO025 A SPECIFIC B-CELL SUBSET AND FUNCTIONAL PROFILE IN THE CHRONIC HUMORAL REJECTION! Isabelle Segalen, France SAO030 REFUTING A TABOO: OVERHYDRATION PREVALENCE DOES NOT INCREASE IN PERITONEAL DIALYSIS PATIENTS - A PROSPECTIVE LONGITUDINAL STUDY Aguiar Pedro Ventura, Portugal SAO031 PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS IN AUSTRIA: EPIDEMIOLOGY, RISK FACTORS, AND THE ROLE OF ORAL ACTIVE VITAMIN D Julia Kerschbaum, Austria SAO032 A DUTCH GUIDELINE FOR THE MANAGEMENT OF ENCAPSULATING PERITONEAL SCLEROSIS Meelad Habib, Netherlands 32 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N SAO033 ENCAPSULATING PERITONEAL SCLEROSIS IN PEDIATRIC PERITONEAL DIALYSIS PATIENTS: THE EXPERIENCE OF THE ITALIAN REGISTRY OF PEDIATRIC CHRONIC DIALYSIS Enrico Vidal, Italy SAO042 PKD1 MUTATION INFLUENCES RENAL OUTCOME IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: RESULTS FROM THE GENKYST REGISTRY Emilie Cornec Le Gall, France SAO044 A LOOK BEYOND BLOOD IN THE UREMIC SYNDROME: COMPARATIVE ANALYSIS OF INTERSTITIAL FLUID AND PLASMA IN KIDNEY DISEASE Leonard Ebah, United Kingdom SAO053 ENTERIC HYPEROXALURIA PREDISPOSING TO NEPHROLITHIASIS IS A COMPLICATION OF BARIATRIC SURGERY Leila Froeder, Brazil SAO056 EFFECTIVENESS OF A MG-BASED PHOSPHATE BINDER ON THE DEVELOPMENT OF VASCULAR CALCIFICATIONS IN UREMIC RATS Tineke De Schutter, Belgium SAO059 SEVELAMER ATTENUATES CV MORTALITY IN INCIDENT HEMODIALYSIS PATIENTS: OPEN LABEL, RANDOMIZED CLINICAL TRIAL OF EFFICACY AND SAFETY (INDEPENDENT STUDY) Antonio Bellasi, Italy SAP026 THE JAK/STAT SIGNALING PATHWAY MODIFICATIONS BY GLUCOCORTICOSTEROIDS IN THE LEUKOCYTES OF CHILDREN WITH NEPHROTIC SYNDROME Katarzyna Lipkowska, Poland SAP053 IS VASCULAR SMOOTH MUSCLE CELLS MINERALOCORTICOID RECEPTOR INVOLVED IN CYCLOSPORINE A NEPHROTOXICITY? Jean-Philippe Bertocchio, France SAP068 CALCIUM-OXALATE CRYSTALS INDUCE RENAL INFLAMMATION AND ACUTE KIDNEY INJURY BY ACTIVATING NLRP3 INFLAMMASOME-MEDIATED INTERLEUKIN-1Β SECRETION IN RENAL DENDRITIC CELLS Shrikant R. Mulay, Germany SAP073 HYPOXIC RESPONSE IN MACROPHAGES IN RENAL ISCHEMIA REPERFUSION INJURY Alexander Weidemann, Germany w w w. e r a e d t a 2 01 2 . o r g 33 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N SAP100 EFFECT OF ERYTHROPOIETIN ON SHORT TERM I/R REPERFUSION INJURY IN RATS Massimo Torreggiani, Italy SAP184 LUNG CONGESTION BY ULTRASOUND PREDICTS DEATH AND CARDIOVASCULAR COMPLICATIONS IN HEMODIALYSIS (HD) PATIENTS: A MULTICENTRE COHORT STUDY Claudia Torino, Italy SAP232 GEOGRAPHIC DISTRIBUTION OF SERVICES MAY BE A BARRIER TO HOME DIALYSIS IN THE USA Suma Prakash, USA SAP316 DECREASING INCIDENCE IN RENAL AMYLOIDOSIS. DATA FROM LARGE REGISTRY OF KIDNEY BIOPSIES Nayara Panizo, Spain SAP429 EFFECTS OF TRANSPLANTED MESOTHELIAL CELLS DURING PERITONEAL REPAIR USING TEMPERATURE-SENSITIVE SV40 LARGE T ANTIGEN GENE TRANSGENIC RAT MESOTHELIAL CELLS Reo Kanda, Japan SAP476 THE EFFECT OF HMG-COA REDUCTASE INHIBITOR ON INSULIN RESISTANCE IN PATIENTS UNDERGOING PERITONEAL DIALYSIS Tae Ik Chang, Korea SAP563 ACTIVATED VITAMIN D ALTERS THE T CELL DIFFERENTIATION IN CHRONIC HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM Cheng-Lin Lang, Taiwan SAP621 “PROPE TOLERANCE” THE POSSIBILITY OF DONOR INTERLEUKIN-10-TRANSDUCTED FOETAL LIVER STEM CELLS IN MICE HEART ALLOGRAFT Masahide Matsuyama, Japan SAP625 IMMUNOMODULATORY EFFECTS OF TNFΑ / TNF RECEPTOR SYSTEM DEPENDENT ON ACTIVATION OF VIRAL RECEPTORS OF THE INNATE IMMUNE SYSTEM IN POLYOMAVIRUS BK ASSOCIATED NEPHROPATHY Markus Wörnle, Germany SAP632 MOLECULAR PREDICTORS OF DELAYED GRAFT FUNCTION OF KIDNEY ALLOGRAFT Mariana Wohlfahrtova, Czech Republic 34 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N SAP641 SYSTEMATIC HISTOLOGICAL ANALYSIS OF THROMBOTIC MICROANGIOPATHY IN A PORCINE XENO-KIDNEYTRANSPLANT-MODEL Clemens Bockmeyer, Germany SAP667 SHORT-TERM EFFECTS OF AN Ω-3 (N-3) RICH DIET ON METABOLIC AND INFLAMMATORY MARKERS IN RENAL TRANSPLANT RECIPIENTS Luca Apicella, Italy SAP675 ANALYSIS OF CHARACTERISTICS AND OUTCOMES OF A SINGLE CENTRE CLUSTER OF PNEUMOCYSTIS JIROVECII PNEUMONIA IN THE UK Sajeda Youssouf, United Kingdom SAP710 CARPEDIEM: CARDIO-RENAL PEDIATRIC DIALYSIS EMERGENCY MACHINE. A NEW HOPE FOR INFANTS Francesco Garzotto, Italy SUO024 UK STUDY OF LIVING KIDNEY DONOR-RECIPIENT RELATIONSHIPS: GENDER AND ETHNIC VARIATIONS Rishi Pruthi, United Kingdom SUO025 EVIDENCE FOR A CAUSAL RELATIONSHIP BETWEEN NERVE DYSFUNCTION AND HYPERKALAEMIA IN ENDSTAGE KIDNEY DISEASE Ria Arnold, Australia SUO027 PREDICTING ERYTHROPOIETIN RESISTANCE IN HEMODIALYSIS PATIENTS: POST HOC ANALYSES FROM THE 4D STUDY Andreas Schneider, Germany SUO029 PATTERNS OF SYSTOLIC BLOOD PRESSURE, ALBUMIN, AND INTERDIALYTIC WEIGHT GAIN IN CHRONIC HEMODIALYSIS PATIENTS BEFORE HOSPITAL ADMISSION Len A Usvyat, USA SUO030 RENAL CENTRE CHARACTERISTICS AND PRACTICE PATTERNS ASSOCIATED WITH RRT INCIDENCE IN THE UK Clare Castledine, United Kingdom w w w. e r a e d t a 2 01 2 . o r g 35 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N EUROPEAN UNION OF MEDICAL SPECIALISTS (UEMS) CME CREDITS The 49th ERA-EDTA Congress (scientific sessions held between Friday, May 25, 2012 and Sunday, May 27, 2012) has been designated for a maximum of 21 hours of European external CME credits. The 49th ERA-EDTA Congress and pre-congress CME Courses are accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS). EACCME credits Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event. Delegates attending only the 49th ERA-EDTA Congress (scientific sessions held between Friday, May 25, 2012 and Sunday, May 27, 2012), will receive a maximum of 21 ECMECs credits. ECMECs credits are recognised in the following countries: Armenia, Austria, Croatia, Czech Republic, Denmark, Estonia, Finland, Georgia, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and United Kingdom. Delegates receiving certificates for ECMEC credits must contact their National Accreditation Authority to have the credits recognised (or converted) in their country of practice. EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). To convert EACCME credit to AMA PRA category 1 credit, contact the AMA. For more information, visit www.uems.net. HOW TO RECEIVE UEMS CME CREDITS ERA-EDTA will track attendance of congress members during the congress in the Palais des Congrès each day. All regularly registered congress members must go to the session halls and have their badge scanned 36 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N by the hostesses at the entrance (at participant’s own responsibility). Congress members will then be awarded the number of credits towards the hours actually spent participating in the sessions of the congress. ERA-EDTA will send UEMS CME Certificate only upon specific request. Regularly registered congress members can either request to receive it by post or e-mail at the UEMS CME desk (starting May 24, 2012) during the congress or in writing to cmecredits@era-edta.org. The certificate will be then sent after the congress. w w w. e r a e d t a 2 01 2 . o r g 37 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N SOCIAL PROGRAMME Thursday, May 24 - 18:00-19:30 hrs. Palais des Congrès Grand Amphitheatre Opening Ceremony (see page 58) Welcome Cocktail in the Exhibition Level 1 and 2 TOURS AND EXCURSIONS WIP - Colloquium will be available for booking tours and excursions to the most beautiful places of interest in Paris and surrounding areas. Desks are located on the mezzanine of the Palais des Congrès, near the entrance of the Grand Amphitheatre. 38 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N PARIS GENERAL INFORMATION Currency EUR (€) is the official currency in France. Money can be changed at the main train stations, international airports, major banks, exchange bureau, most large hotels and the post office. All major credit cards are accepted in most hotels, restaurants and shops. Restaurants Paris offers plenty of fine restaurants serving the traditional dishes that guarantee the reputation of French cuisine throughout the world. Dining in Paris is a culinary adventure and almost instantly connected with the famous “petits fours”, “foie gras”, “grenouilles” and “escargot”, but there is a range of other possibilities that start from traditional cuisine and go towards every gastronomic delight from all over the world. Paris has also a long tradition of brasseries and wine cellars. Parisians do not dine before 20:00. Prior to that, time is set aside for “l’apéritif”. But in very popular tourist areas, restaurants are open from 19:00 onwards. At the Palais des Congrès a choice of restaurants is available with something for every taste, such as Sushi, Sandwiches, and Mediterranean food. Tipping Tipping is optional, but normally 10% is customary in taxis and restaurants. Transports Travelling to the Palais des Congrès de Paris (Porte Maillot) The Porte Maillot is located in western Paris, easily accessible from the airport and railway station (“Porte Maillot” station) by underground, bus and RER. • Arriving by plane Paris has two international airports. Most international flights use the larger Roissy Charles de Gaulle Airport (airport code CDG), 30 km north-east of Paris. The other one is the Orly Airport (airport code ORY), 18 km south of the city. Most international airlines have direct connections to Paris from their respective hubs. Roissy Charles de Gaulle Airport and Orly Airport are both well connected by public transport to central Paris. From Roissy-Charles de Gaulle Airport: (approximate travel time: 75 minutes) - RER B, stop at “Chatelet Les Halles” - then take RER A to “Charles de Gaulle/Etoile” - then line 1 of the metro to “Porte Maillot/Palais des Congrès” By Air France or ADP shuttle bus: take line 2 (buses go directly to “Porte Maillot/Palais des Congrès” or to the w w w. e r a e d t a 2 01 2 . o r g 39 49th ERA-EDTA CONGRESS C O N G R E S S I N F O R M A T I O N “Opéra” in the city centre). Departure every 15 minutes from 05:45 to 23:00. Approximate travel time: 1 hour. Cost: € 15.00. From Orly Airport: (approximate travel time: 60 minutes) - High speed shuttle (Orlyval) to “Antony” - RER B, stop at “Chatelet Les Halles” - then take RER A to “Charles de Gaulle/Etoile” - then line 1 of the metro to “Porte Maillot/Palais des Congrès” By the “Cars Air France”: - go to “Terminus Etoile” - then line 1 of the metro to “Porte Maillot/Palais des Congrès” Departure every 30 minutes from 06:00 to 23:00. Approximate travel time: 40 minutes to 1 hour. Cost: € 11.50. By taxi: approximate travel time to central Paris is 40 minutes to 1 hour depending on traffic. Cost: approximately € 50.00/60.00. • Arriving by car To Reach “Porte Maillot”, you need to drive on the inner/ outer ring road and you should exit at “Boulevard Periphérique Ouest” (west beltway). Direct access to the underground parking of the Palais des Congrès via Porte Maillot. Open 24 hours a day. • Arriving by train Line C of the RER Commuter train provides direct access to the “Porte Maillot” station. Public transportation • Metro The metro is probably the best way to travel within the city. The Palais des Congrès is close to the “Porte Maillot” metro station. It runs from 05:30 to 01:00. You should keep your ticket until you leave the metro as you may need to show it /have it with you at some exit doors and in case of controls. Line 1 of the metro (La Défense-Château de Vincennes) crosses the city from east to west and provides direct access to the Palais des Congrès “Porte Maillot” station. • Bus They are slower than the metro at certain hours of the day depending on traffic, but the bus services are frequent during the day even if more irregular after 20:00 on some lines. Lines to “Porte Maillot”: 82 (LuxembourgNeuilly), 73 (Concorde-La Défense), and PC1, PC2, PC3 (beltway lines). • Public transport tickets Paris public transport is operated by the RATP and includes the metro subway system, RER trains, buses, night buses, Montmartre bus, and the Montmartre funicular railway, all of which accept the same tickets and passes. You can purchase individual tickets, or a Paris Visite Metro Pass, available for 2, 3 or 5 consecutive days of unli- 40 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France C O N G R E S S I N F O R M A T I O N mited travelling: these tickets were created especially for visitors they also include special offers and discounts of up to 35% at a variety of attractions in the Paris area. This makes travelling around the city very easy. Single tickets cost € 1.80. Tickets for public transport are available at subway stations, some bus terminals and registered retailers, usually tobacconists and bookshops, displaying the RATP sign. • Taxis There are approximately 500 taxi stations on the city’s major avenues and boulevards. There is an initial fee for each ride. The average fare from downtown to the Palais des Congrès is € 15.00. For your ride back, there is a taxi station located on the Avenue de la Grande Armée, right next to the Palais des Congrès: +33 (0)1 45 72 61 84. The Airports’ specialist is: +33 (0)6 08 57 75 83 available 24 hours and 7/7 days (major credit cards accepted). Useful telephone numbers • Paris airports (Roissy CDG and Orly): 3950 • Air France: 3654 • SNCF (French National Railways): 3635 • Taxi services: - Taxis G7: +33 (0)1 47 39 47 39 - Taxis Bleus: +33 (0)1 49 36 10 10 • Emergency: 15 or 112 Useful websites • Venue: www.viparis.fr • Tourism: www.paris-touristoffice.com • Air France: www.airfrance.fr • National train network (SNCF): www.sncf.fr • Metro, bus in Paris (loadable map): www.ratp.fr w w w. e r a e d t a 2 01 2 . o r g 41 49th ERA-EDTA CONGRESS 42 w w w. e r a e d t a 2 01 2 . o r g nephrollogists ists in motion 2nd ERA-EDTA Renal Run 2012 The organizing committee is very pleased to announce the second ERA-EDTA Renal Run, which will take place on Saturday, May 26, 2012 at 16.30. This year runners will enjoy a 6.5 km run (4 miles) through the Bois de Boulogne, West of Paris, within walking distance from the Palais des Congrès. The Bois de Boulogne is a part of what used to be the Forest of Rouvray that surrounded the Gallo-Roman city of Lutetia. You will admire its impressive variety of trees, including very old oaks. The race will loop the upper and lower lakes. Runners will definitely enjoy this part of the woods during this time of the year. The participation in the race is intended for Congress participants. They will be divided into categories according to age and gender. Registration is free, but must still be done for administrative purposes. On-site registration is possible at the Colloquium Desk in the Service Area of the Palais des Congrès. Registration to the Renal Run can be done up to Friday, May 25, 2011, at 15.00. Each participant will receive a number and a T-shirt. Refreshments and cloakrooms will be available. For further details, please see the Congress website eraedta2012.org We are looking forward to your participation and wish you a very enjoyable and fun experience! 49th ERA-EDTA CONGRESS 4 MAY 24-27, 2012 PARIS, France M 49th ERA-EDTA CONGRESS Next Congresses of the ERA-EDTA Istanbul, Turkey May 18-21, 2013 Amsterdam, Netherlands May 31-June 3, 2014 44 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E 08:30 - 12:30 CME Courses Rheumatology for nephrologists Peritoneal Dialysis Workshop THURSDAY, MAY 24 DAY AT A GLANCE page 46 47 10:15 - 11.45 ERA-EDTA Working Group Symposium EURECA-m 48 12:00 - 13.30 ERA-EDTA Working Group Symposium EUTox 49 13:00 - 17:00 CME Courses Clinical questions for managing Nephrolithiasis Renal Pathology 50 51 13:45 - 15.15 ERA-EDTA Working Group Symposia Inherited Kidney Disorders 52 Immunonephrology 53 15.00 - 17.00 Special Symposium Drug-induced renal injury: the quest for sensitive biomarkers 54 15:30 - 17.00 ERA-EDTA Working Group Symposium EuDial 56 Educational Symposium The Soft-Skill Masterclass 57 18:00 - 19:30 Opening Ceremony 58 Guest Lecture Alain Prochiantz “Building adaptive memories through evolution and development” Film: Pioneers of the European Nephrology Creation: Deep-Light-Light-Deep 19:30 - 21:00 Welcome Cocktail in the Exhibition Level 1 and 2 w w w. e r a e d t a 2 01 2 . o r g 45 49th ERA-EDTA CONGRESS THURSDAY, MAY 24 S C I E N T I F I C P R O G R A M M E CME COURSE 1 ROOM 252AB 08:30 - 12:30 Rheumatology for nephrologists Chair: Hans-Joachim Anders, Munich, Germany David Jayne, Cambridge, UK Welcome and introduction Hans-Joachim Anders, Munich, Germany David Jayne, Cambridge, UK Joint pain in CKD patients: When do we need a joint aspirate? Hendrik Schulze-Koops, Munich, Germany Proteinuria in the patient with arthritis Volker Vielhauer, Munich, Germany The 2012 “standard of care” in lupus nephritis – referral, drugs and monitoring Frédéric A. Houssiau, Brussels, Belgium Non-renal flares in lupus nephritis patients – new options Falk Hiepe, Berlin, Germany Antiphospholipid antibodies and the kidney Ricard Cervera, Barcelona, Spain B cell targeted therapy in nephritis, all hype and no substance? David Jayne, Cambridge, UK ANCA-associated vasculitis - an update on therapeutic strategies Alan Salama, London, UK 46 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM 352AB THURSDAY, MAY 24 CME COURSE 2 08:30 - 12:30 Peritoneal Dialysis Workshop in cooperation with EuroPD Chair: Nicholas Topley, Cardiff, UK New insights in pharmacokinetics and pharmacodynamics of antibiotics: implications for the treatment of peritonitis An De Vriese, Bruges, Belgium Survival on PD and HD: what do we know? James Heaf, Herlev, Denmark Catheter placement: do’s and dont’s Alain Slingeneyer, Montpellier, France Optimal and individualised PD prescription: the ERBP viewpoint Wim Van Biesen, Ghent, Belgium Biocompatibility revisited: is it relevant in 2012? Nicholas Topley, Cardiff, UK Membrane pathophysiology, EMT and MicroRNA’s as potential therapeutic targets Donald Fraser, Cardiff, UK Animal models revisited: what do they really tell us about the peritoneum Olivier Devuyst, Zurich, Switzerland Peritoneal membrane physiology and function: insights from cohort studies Simon Davies, Stoke-on-Trent, UK w w w. e r a e d t a 2 01 2 . o r g 47 49th ERA-EDTA CONGRESS THURSDAY, MAY 24 S C I E N T I F I C P R O G R A M M E ERA-EDTA WORKING GROUP SYMPOSIUM 1 ROOM 351 10:15 - 11:45 EURECA-m (EUropean REnal and CArdiovascular Medicine) Chair: Gérard M. London, Fleury-Mérogis, France Carmine Zoccali, Reggio Calabria, Italy Ultrafiltration in heart failure: experience or evidencebased? Enrico Fiaccadori, Parma, Italy The new dimension of hypertension: short term and visit to visit BP variability Gianfranco Parati, Milan, Italy Coronary calcium quantification: a useful surrogate in clinical research? A reasonable biomarker in clinical practice? Gérard M. London, Fleury-Mérogis, France Pulmonary hypertension in CKD: a neglected complication? Alan G. Jardine, Glasgow, UK 48 w w w. e r a e d t a 2 01 2 . o r g ERA-EDTA WORKING GROUP SYMPOSIUM 2 ROOM 351 12:00 - 13:30 EUTox Handling the patient with CKD: can we do more than dialyse? Chair: Angel Argiles, Montpellier, France Goce Spasovski, Skopje, F.Y.R. of Macedonia Improve early screening. CKD markers Harald Mischak, Hannover, Germany Prevent fibrosis and CKD progression. New pathways and putative therapeutic targets Alberto Ortiz, Madrid, Spain Alternative treatments in CKD Raymond Vanholder, Ghent, Belgium New methods to treat CKD: the application of hydrophobic media in extracorporeal systems for removal of uremic toxins Joachim Jankowski, Berlin, Germany Endothelial markers after transplantation Henri Vacher-Coponat, Marseille, France w w w. e r a e d t a 2 01 2 . o r g 49 THURSDAY, MAY 24 MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E 49th ERA-EDTA CONGRESS THURSDAY, MAY 24 S C I E N T I F I C P R O G R A M M E CME COURSE 3 ROOM 252AB 13:00 - 17:00 Clinical questions for managing Nephrolithiasis in cooperation with the EAU Section of Urolithiasis (EULIS) Chair: Noor Buchholz, London, UK Giovanni Gambaro, Rome, Italy What do we ask the radiologist? - What can the radiologist tell us? Kim Hovgaard Andreassen, Fredericia, Denmark What do we learn from the stone’s analysis? Michel Daudon, Paris, France When and why do we suspect a genetic disorder in a patient with stones? Giovanni Gambaro, Rome, Italy When and why do we suspect a tubular disorder in a patient with stones? Robert Unwin, London, UK How do we interpret and manage hypercalciuria? Philippe Jaeger, London, UK How do we interpret the results of urine analysis? Martino Marangella, Turin, Italy How do we manage patients’ diet? Alberto Trinchieri, Lecco, Italy What does the urologist ask the nephrologist? Noor Buchholz, London, UK 50 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM 253 THURSDAY, MAY 24 CME COURSE 4 13:00 - 17:00 Renal Pathology Chair: Kerstin Amann, Erlangen, Germany Sandrine Florquin, Amsterdam, Netherlands New insights in C3 glomerulopathy Terry Cook, London, UK Critical review of the ISN/RPS classification of lupus nephritis Ian Roberts, Oxford, UK Update in renal transplantation Heinz Regele, Vienna, Austria Monoclonal deposit diseases Eric Steenbergen, Nijmegen, Netherlands w w w. e r a e d t a 2 01 2 . o r g 51 49th ERA-EDTA CONGRESS THURSDAY, MAY 24 S C I E N T I F I C P R O G R A M M E ERA-EDTA WORKING GROUP SYMPOSIUM 3 ROOM 351 13:45 - 15:15 Inherited Kidney Disorders Chair: Olivier Devuyst, Zurich, Switzerland Remi Salomon, Paris, France New insights into inherited renal Fanconi syndrome Detlef Bockenhauer, London, UK Mendalian disorders of membrane trafficking Maria Antonietta De Matteis, Naples, Italy Uric acid: from GWAS to mendelian disorders Olivier Bonny, Lausanne, Switzerland The EuroCYST initiative Andreas Serra, Zurich, Switzerland 52 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 2 THURSDAY, MAY 24 ERA-EDTA WORKING GROUP SYMPOSIUM 4 13:45 - 15:15 Immunonephrology Chair: Rosanna Coppo, Turin, Italy Mohamed Daha, Leiden, Netherlands Introduction Mohamed Daha, Leiden, Netherlands Update on the ongoing programme: VALIGA Rosanna Coppo, Turin, Italy A multicentre trial for the treatment of membranous nephropathy: sequential therapy of tacrolimus and rituximab Manuel Praga, Madrid, Spain A European Registry for recurrent glomerular diseases after transplantation Jürgen Floege, Aachen, Germany ERA-EDTA/RPS immunopathology projects Loreto Gesualdo, Bari, Italy New prospectives for IWG Mohamed Daha, Leiden, Netherlands w w w. e r a e d t a 2 01 2 . o r g 53 49th ERA-EDTA CONGRESS THURSDAY, MAY 24 S C I E N T I F I C P R O G R A M M E SPECIAL SYMPOSIUM ROOM 352AB 15:00 - 17:00 Drug-induced renal injury: the quest for sensitive biomarkers Organized in collaboration with Innovative Medicines Initiative (IMI) Chair: Michel Goldman, Brussels, Belgium Keynote introduction: Why do we need new biomarkers for drug-kidney interaction? Raymond Vanholder, Ghent, Belgium Preclinical approaches by the PSTC consortium to support translational drug-induced kidney injury monitoring in drug development Jonathan Phillips, Boehringer Ingelheim, Ridgefield, U.S.A. The Biomarkers Consortium: Prospective clinical trial design to qualify biomarkers for drug development Irene Nunes, Merck, West Point, USA Acute kidney injury biomarkers in clinical practice: current status Ralf Schindler, Berlin, Germany IMI project - SAFE-T: an European consortium approach to renal safety biomarkers Stefan Sultana, Novartis, UK Panel Discussion Moderator: Jean-Marc Vidal, European Medicines Agency, London, UK Nephrotoxicity is a serious problem for drug development and current clinical standards used for the detection of acute kidney injury, serum creatinine (sCr) and blood urea nitrogen (BUN), are suboptimal. Drugs can cause histopathological lesions and functional impairment in the kidney at doses and times where no measureable changes in sCR and BUN can be detected. This has important consequences both for patient care and the development of safe and innovative drugs. To address this issue, three public-private partnerships 54 w w w. e r a e d t a 2 01 2 . o r g have been formed: the Predictive Safety Testing Consortium Nephrotoxicity Working Group, the Drug Induced Kidney Injury (DIKI) working group of the Innovative Medicines Initiative (IMI) SAFE-T consortium and the Biomarkers Consortium Kidney Safety Project Team. All three partnerships conduct research designed to define thresholds and characterize the performance of the new DIKI biomarkers in order to enhance decision making in drug development. The research focuses on the various regions of the kidney, including injury to the proximal kidney tubule and the glomerulus. Clinical studies are being conducted in patients receiving standard of care treatment known to cause injuries to the kidney via different mechanisms. The data generated will be submitted to global health authorities for regulatory qualification of new biomarkers for monitoring early onset and reversal of drug-induced kidney injury. During this session, achievements and ongoing activities of the three partnerships will be presented and the complementary scope of their approaches will be discussed. w w w. e r a e d t a 2 01 2 . o r g 55 THURSDAY, MAY 24 MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E 49th ERA-EDTA CONGRESS THURSDAY, MAY 24 S C I E N T I F I C P R O G R A M M E ERA-EDTA WORKING GROUP SYMPOSIUM 5 ROOM 351 15:30 - 17:00 EuDial (European Dialysis Working Group) Recommendations based on available evidence for hemodiafiltration therapy. Report of EuDial working meeting of October 2011. Chair: Peter Blankestijn, Utrecht, Netherlands Bernard Canaud, Montpellier, France Opening / welcome Bernard Canaud, Montpellier, France How to define and quantify hemodiafiltration? James Tattersall, Leeds, UK How to apply HDF in a safe way? Current safety standards, regulations and guidelines Richard Ward, Louisville, USA Available clinical evidence for HDF Peter Blankestijn, Utrecht, Netherlands Menso Nube, Amsterdam, Netherlands EuDial, where do we go from here? Bernard Canaud, Montpellier, France 56 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 2 THURSDAY, MAY 24 EDUCATIONAL SYMPOSIUM 15:30 - 17:00 The Soft-Skill Masterclass Chair: Jürgen Floege, Aachen, Germany Why did my grant application fail? Common mistakes you should avoid Frédéric Jaisser, Paris, France Common pitfalls in writing a paper Frank Eitner, Aachen, Germany Collaborations, intellectual property and patents - curse or blessing Steve Harper, Bristol, UK How to ruin your presentation? Jürgen Floege, Aachen, Germany w w w. e r a e d t a 2 01 2 . o r g 57 49th ERA-EDTA CONGRESS THURSDAY, MAY 24 S C I E N T I F I C P R O G R A M M E OPENING CEREMONY Since 17:30 live performances by the young artists of the Ecole Nationale du Cirque GRAND AMPHITHEATRE 18:00 - 19:30 Welcome address Gabriel Richet and Pierre Ronco, Congress President Introductory remarks Raymond Vanholder, ERA-EDTA President Presentation of the ERA-EDTA Award for outstanding scientific merits to John Stewart Cameron Presentation of the ERA-EDTA Award for outstanding contributions to the Society to Vincenzo Cambi Presentation of the ERA-EDTA young investigator Award to Giovana Seno di Marco Opening Lecture Building adaptive memories through evolution and development Alain Prochiantz (intr. Pierre Ronco) Professor at Collège de France (Chair of morphogenetic processes) Film: Pioneers of the European Nephrology Presented by Giorgina B. Piccoli Creation: Deep-Light-Light-Deep With the contribution of the Ecole Nationale du Cirque, the Corou de Berra (Provençal choir), Nadia Kuprina (opera singer). Music and videos: Gilberto Richiero Stage directors: Luc Richard and David Jauzion-Graverolles Welcome Cocktail in the Exhibition Level 1 and 2, accompanied by the artists of the Ecole Nationale du Cirque 58 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E DAY AT A GLANCE page 09:30 - 10:45 Poster session 10:45 - 11:30 Plenary Lecture G. Karsenty The novel endocrinology of bone 11:45 - 13:15 Symposia Sepsis and AKI What is “good dialysis”? Polycystic kidney disease Bone and mineral metabolism after tx Leukocytes and pro-inflammatory mediators in renal injury Free Communications + Mini Lectures Mechanisms and targets of glom. damage HUS and diabetic nephropathy Paediatric nephrology 13:15 - 15:15 Industry Symposia 15:15 - 16:45 Symposia Thrombotic microangiopathies and complement disorders Prehypertensive kidney Calcium sensing and PTH secretion Peritoneal dialysis Renal fibrosis Free Communications + Mini Lectures Vascular damage and access in CKD Clinical epidemiology and CKD 1-5 AKI clinical studies 17:00 - 18:30 Symposia DOPPS Vascular calcifications in CKD Paraneoplastic GN, monoclonal-IgG related disorders and amyloid Literature Updates Clinical nephrology Transplantation Free Communications + Mini Lectures Genetic studies in renal diseases Hypertension Anaemia w w w. e r a e d t a 2 01 2 . o r g 60 61 62 63 64 65 67 69 FRIDAY, MAY 25 08:00 - 09:30 Symposia Late breaking clinical trials ERA-EDTA Registry CKD-mineral bone disorders Diagnostic approaches to tx kidney Renin-angiotensin system Free Communications + Mini Lectures AKI and stem cells Renal physiology IgA Nephropathy and urinary proteomics 105 71 72 73 74 75 76 77 79 81 373 83 84 85 86 87 88 90 92 93 94 95 96 97 98 100 102 59 49th ERA-EDTA CONGRESS S C I E N T I F I C GRAND AMPHITHEATRE P R O G R A M M E 08:00 - 09:30 Symposium 1 FRIDAY, MAY 25 Late breaking clinical trials Chair:Johannes Mann, Munich, Germany Giuseppe Remuzzi, Bergamo, Italy Effect of dual blockade of the renin angiotensin system on the progression of type 2 diabetic nephropathy José Luño, Madrid, Spain Olmesartan in dialysis patients: results of the OCTOPUS study Kunitoshi Iseki, Nishihara, Japan The impact of a low glucose peritoneal dialysis solution regimen on metabolic control in diabetic patients: the IMPENDIA and EDEN randomized, controlled clinical trials Joanne M. Bargman, Toronto, Canada The use of phosphate binding agents is associated with lower mortality: results from the COSMOS study Jorge B. Cannata-Andía, Oviedo, Spain 60 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 1 08:00 - 09:30 Symposium 2 Chair:Raymond Vanholder, Ghent, Belgium Christoph Wanner, Würzburg, Germany The Registry in 2012: a source for research and collaboration Christoph Wanner, Würzburg, Germany European nephrologists’ experience with the decision not to start RRT Moniek van de Luijtgaarden, Amsterdam, Netherlands EQUAL study - an international study in Stage 4 CKD Kitty Jager, Amsterdam, Netherlands Policies and practices of paediatric kidney transplantation across Europe Jérome Harambat, Bordeaux, France Pregnancy in chronic dialysis patients - a systematic review Marlies Noordzij, Amsterdam, Netherlands Timing and outcome of RRT in patients with congenital malformations of the kidney and the urinary tract Elke Wühl, Heidelberg, Germany w w w. e r a e d t a 2 01 2 . o r g 61 FRIDAY, MAY 25 ERA-EDTA Registry 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE BLEU P R O G R A M M E 08:00 - 09:30 Symposium 3 FRIDAY, MAY 25 Current aspects of CKD-mineral bone disorders Chair:Marc De Broe, Antwerp, Belgium Marc Vervloet, Amsterdam, Netherlands Cardiovascular disease related mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals Michal Nowicki, Lodz, Poland Not all phosphate is created equal: phosphate toxicity by food supplements? Markus Ketteler, Coburg, Germany Interaction between FGF23, PTH, P and calcitriol in CKD-MBD, which comes first? Justin Silver, Jerusalem, Israel Vitamin D, FGF23 and innate immunity in CKD Justine Bacchetta, Bron, France 62 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E AMPHITHEATRE BORDEAUX 08:00 - 09:30 Symposium 4 Chair:Maryvonne Hourmant, Nantes, France Francesco Paolo Schena, Bari, Italy Molecular phenotypes of renal allograft rejection Ondrej Viklicky, Prague, Czech Republic Towards personalized medicine in transplantation / Biomarkers in transplantation Josep M. Grinyó, Barcelona, Spain Antibodies against vascular receptors in transplant recipients Duska Dragun, Berlin, Germany The clinical relevance of HLA antibody detection Frans H.J. Claas, Leiden, Netherlands w w w. e r a e d t a 2 01 2 . o r g 63 FRIDAY, MAY 25 Diagnostic approaches to the transplant kidney 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE HAVANE P R O G R A M M E 08:00 - 09:30 Symposium 5 FRIDAY, MAY 25 Advances in understanding the renin-angiotensin system Chair:Armin Kurtz, Regensburg, Germany Laszlo Rosivall, Budapest, Hungary Aldosterone synthase inhibition Michel Azizi, Paris, France Prorenin receptor function in the kidney Geneviève Nguyen, Paris, France Renin-Inhibitors: What is their current place in therapy? Jan Danser, Rotterdam, Netherlands 64 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM 352AB 08:00 - 09:30 Free Communication Session 1 + Mini Lecture Chair:Uta Kunter, Aachen, Germany Masaomi Nangaku, Tokyo, Japan FREE COMMUNICATIONS « FO001 BMP-2 INDUCES A PRO-FIBROTIC PHENOTYPE IN ADULT RENAL PROGENITOR CELLS THROUGH Nox4 ACTIVATION Simona Simone | Marica Cariello | Carmela Cosola | Fabio Sallustio | Antonia Loverre | Francesco Paolo Schena | G Grandaliano | Loreto Gesualdo | Giovanni Pertosa Nephrology, Dialysis and Transpl Unit, DETO, Univ Bari, Italy| Dept Emergency and Organ Transpl, Univ Bari, Bari, Italy | Nephrology, Dialysis and Transpl Unit, Dept Biomedical Sciences, Univ Foggia, Italy « FO002 ENDOTHELIAL-TO-MESENCHYMAL TRANSITION IN SWINE RENAL ISCHEMIA REPERFUSION INJURY IS MEDIATED BY COMPLEMENT AND AKT PATHWAY Giuseppe Castellano | Claudia Curci | Antonia Loverre | Alessandra Stasi | Simona Simone | Marica Cariello | Vincenzo Montinaro | Pasquale Ditonno | Michele Battaglia | Francesco Staffieri | Antonio Crovace | Beatrijs Oortwjin | Edwin van Amersfoort | Francesco Paolo Schena | Loreto Gesualdo | Giuseppe Grandaliano Dept Emergency and Organ Transpl, Univ Bari, Bari, Italy | Pharming Group NV, Leiden, Netherlands | Renal, Dialysis and Transpl Unit, Dept Biomedical Sciences, Univ Foggia, Foggia, Italy FO003 RENOPROTECTIVE EFFECTS OF IN VIVO TREATMENT WITH DNASE IN A RAT MODEL OF ISCHEMIA-REPERFUSION-INDUCED ACUTE KIDNEY INJURY Joshuah Weissgarten | Shai Efrati | Sylvia Berman | Ramzia Abu Hamad Assaf Harofeh Medical Center FO004 THE EFFECT OF BONE MARROW MESENCHYMAL STEM CELLS (BMSC) OR CONDITIONED MEDIUM (CM) IN RATS WITH ACUTE KIDNEY INJURY (AKI) INDUCED BY LIPOPOLYSACCHARIDE (LPS) Joelma Santina Christo | Luciana Aparecida Reis | Fernanda Borges | Manuel de Jesus Simões | Nestor Schor w w w. e r a e d t a 2 01 2 . o r g 65 FRIDAY, MAY 25 AKI and stem cells 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E FRIDAY, MAY 25 Nephrology Division, Morphology Dept | Federal Univ São Paulo (UNIFESP), São Paulo, Brazil ¯ t FO005 MICROVESICLES DERIVED FROM ENDOTHELIAL PROGENITOR CELLS PROTECT KIDNEY FROM CISPLATIN-INDUCED ACUTE TOXIC INJURY BY MICRORNA-DEPENDENT REPROGRAMMING AND INHIBITION OF APOPTOSIS OF TUBULAR CELLS Vincenzo Cantaluppi | Stefania Bruno | Federico Figliolini | Davide Medica | Ciro Tetta | Giovanni Camussi Univ Turin, Italy | Fresenius Medical Care, Bad Homburg, Germany Mini Lecture Stem cell therapy using MSC from human adipose tissues Shoichi Maruyama, Nagoya, Japan 66 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM 342AB 08:00 - 09:30 Free Communication Session 2 + Mini Lecture Chair:Giovambattista Capasso, Naples, Italy Pascal Houillier, Paris, France FREE COMMUNICATIONS « FO006 H,K-ATPase TYPE 2 IS REQUIRED FOR RENAL ADAPTATION TO PREGNANCY Salhi Amel | Gilles Crambert | Doucet Alain INSERM-Cordelier Research Center, Paris, France FO007 UNMASKING A CONSTITUTIVELY ACTIVE SALT-ABSORBING PATHWAY IN THE KIDNEY: A NOVEL TARGET FOR DIURETIC THERAPY Manoocher Soleimani | Hassane Amlal | Sharon Barone | Jie Xu | Kamyar Zahedi Univ Cincinnati, Cincinnati, USA FO008 UP4A AFFECTING THE GLOMERULAR FILTRATION RATE Zidek Walter | Jankowski Joachim | Jankowski Vera Charité, Berlin, Germany Mini Lecture ATP and the kidney Robert Unwin, London, UK FREE COMMUNICATIONS FO009 RENAL UPTAKE OF 99MTC-DMSA IS DEPENDENT ON ENDOCYTOSIS BY THE MEGALIN/CUBILIN RECEPTOR COMPLEX Kathrin Weyer | Rikke Nielsen | Erik Christensen | Michael Rehling | Henrik Birn Dept Biomedicine, Aarhus Univ | Dept Clinical Physiology and Nuclear Medicine, Aarhus Univ Hosp, Skejby, Aarhus, Denmark w w w. e r a e d t a 2 01 2 . o r g 67 FRIDAY, MAY 25 Renal physiology 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E FRIDAY, MAY 25 FO010 EXOSOME ISOLATION, COUNT AND CHARACTERIZATION FROM NORMAL URINE Veronica Dimuccio | Andrea Ranghino | Giovanni Camussi | Benedetta Bussolati Dept Internal Medicine, Univ Torino | Dept Internal Medicine, Torino, Italy 68 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 2 08:00 - 09:30 Free Communication Session 3 + Mini Lecture Chair:Rosanna Coppo, Turin, Italy Christophe Mariat, Saint-Etienne, France FREE COMMUNICATIONS ¯ t FO011 miR-148b UPREGULATION MODULATING CORE 1, β1,3GALACTOSYLTRANSFERASE 1 EXPRESSION EXPLAINS THE ABNORMAL GLYCOSYLATION PROCESS OF IgA1 IN IgA NEPHROPATHY Grazia Serino | Fabio Sallustio | Sharon Natasha Cox | Francesco Pesce | Francesco Paolo Schena Dept Emergency and Organ Transpl, Nephrology Dialysis and Transpl Unit, Univ Bari, Bari, Italy « FO012 SOLUBLE CD89-IGA1 COMPLEXES AGGRAVATE IGAN DEVELOPMENT IN A MOUSE MODEL Christina Papista | Laureline Berthelot | Thiago T. Maciel | Martine Biarnes-Pelicot | Emilie Tissandie | Pamela H.M. Wang | Houda Tamouza | Agnès Jamin | Julie Bex-Coudrat | Aurelie Gestin | Ahmed Boumediene | Michelle Arcos-Fajardo| Patrick England | Evangéline Pillebout | Francine Walker| Eric Daugas | François Vrtosvnik | Marc Benhamou | Michel Cogné | Ivan C. Moura | Renato C Monteiro INSERM U699, Paris, France | CNRS UMR6101, Univ Limoges, Limoges, France | Inst Pasteur, Proteopole, Paris, France | Serv Anatomo-Pathologie, Hôp Bichat-Claude Bernard, Paris, France FO013 WHAT ARE THE MOST IMPORTANT PROGNOSTIC FACTORS FOR RENAL SURVIVAL IN IgA NEPHROPATHY? Cristina Sarcina | Carmine Tinelli | Francesca Ferrario | Bianca Visciano | Veronica Terraneo | Antonello Pani | Giovanni Battista Fogazzi | Silvia Furiani | Elena Alberghini | Laura Buzzi | Claudio Pozzi Bassini Hosp, Cinisello Balsamo, Milan, Italy | S. Matteo Hosp, Pavia, Italy | Brotzu Hosp, Cagliari, Italy | Maggiore Hosp, Milan, Italy Mini Lecture Will urinary proteomics make the renal tissue biopsy redundant? Loreto Gesualdo, Bari, Italy w w w. e r a e d t a 2 01 2 . o r g 69 FRIDAY, MAY 25 IgA Nephropathy and urinary proteomics 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E FRIDAY, MAY 25 FREE COMMUNICATIONS FO014 IGA NEPHROPATHY: ASSOCIATION BETWEEN HISTOLOGICAL LESIONS AND BLOOD AND URINE PEPTIDE PROFILE Fredzzia Graterol | Maribel Navarro-Muñoz | Dolores López| Meritxell Ibernon | Maruja Navarro | Maribel Troya | Vanessa Pérez| Neus Sala | Assumpta Serra | Josep Bonet | Ramón Romero Hosp Univ Germans Trias i Pujol, Badalona, Spain FO015 COMPLETE REMISSION PREDICTS A GOOD PROGNOSIS AFTER METHYLPREDNISOLONE PULSE THERAPY IN PATIENTS WITH IGA NEPHROPATHY Miho Tatematsu | Yoshinari Yasuda | Waichi Sato | Naotake Tsuboi | Shoichi Maruyama | Enyu Imai | Seiichi Matsuo Nagoya Univ Graduate School of Medicine, Nagoya, Japan 70 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E GRAND AMPHITHEATRE 10:45 - 11:30 Plenary Lecture 1 Chair:Pierre Ronco, Paris, France Raymond Vanholder, Ghent, Belgium FRIDAY, MAY 25 The novel endocrinology of bone Gerard Karsenty, New York, USA w w w. e r a e d t a 2 01 2 . o r g 71 49th ERA-EDTA CONGRESS S C I E N T I F I C GRAND AMPHITHEATRE P R O G R A M M E 11:45 - 13:15 Symposium 6 FRIDAY, MAY 25 Sepsis and AKI Chair:Norbert Lameire, Ghent, Belgium Mehmet Sukru Sever, Istanbul, Turkey Diagnosis and treatment of hyponatremia in the ICU the ERBP guideline Evi Nagler, Ghent, Belgium General, non-renal management of septic shock Eric Hoste, Ghent, Belgium CRRT in sepsis, does the anticogulant matter? Heleen M. Oudemans-van Straaten, Amsterdam, Netherlands SLED vs CRRT vs IHD in sepsis Achim Jörres, Berlin, Germany 72 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 1 11:45 - 13:15 Symposium 7 Chair:Mustafa Arici, Ankara, Turkey Bernard Canaud, Montpellier, France What is early start and why it should not be systematic? Christian Combe, Bordeaux, France What is late start and why is it harmful? Charles Tomson, Bristol, UK When to start of dialysis: guideline and reality James Tattersal, Leeds, UK Target blood pressure in hemodialysis patients Thierry Hannedouche, Strasbourg, France Long dialysis sessions (daily, nocturnal etc) Ercan Ok, Izmir, Turkey w w w. e r a e d t a 2 01 2 . o r g 73 FRIDAY, MAY 25 What is “good dialysis”? 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE BLEU P R O G R A M M E 11:45 - 13:15 Symposium 8 FRIDAY, MAY 25 Polycystic kidney disease: clinical studies Chair:Yves Pirson, Brussels, Belgium Andreas Serra, Zurich, Swizerland Vaptans in ADPKD Vicente Torres, Rochester, USA Somatostatin analogues in polycystic liver disease Joost P.H. Drenth, Nijmegen, Netherlands What is a reasonable endpoint in clinical PKD studies? Giuseppe Remuzzi, Bergamo, Italy The many masks of HNF1beta-related (kidney) diseases Dominique Chauveau, Toulouse, France 74 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E AMPHITHEATRE BORDEAUX 11:45 - 13:15 Symposium 9 Bone and mineral metabolism after transplantation FRIDAY, MAY 25 Chair:João M. Frazão, Porto, Portugal Rudolf Wüthrich, Zurich, Swizerland The use of cinacalcet after renal transplantation Andries Hoitsma, Nijmegen, Netherlands Bone metabolism in renal transplanted patients Pieter Evenepoel, Leuven, Belgium Post-transplant hypophosphatemia Wilfried Gwinner, Hanover, Germany FREE COMMUNICATIONS FO016 A PROSPECTIVE COHORT STUDY OF PERSISTENT HYPERPARATHYROIDISM IN KIDNEY TRANSPLANT RECIPIENTS F Vincenti | M Weir | J Von Visger | N Kopyt | RB Mannon | S Tseng | W Goodman | M Wolf UCSF Kidney Transplant Serv, San Francisco, USA | U Maryland, USA | Ohio State U Medical Center, USA | Lehigh Valley Hosp, USA | U Alabama Birmingham, USA | Amgen, San Francisco USA | Amgen, Thousand Oaks USA | U Miami Miller School of Medicine, USA FO017 CHOLECALCIFEROL SUPPLEMENTATION REDUCES PROTEINURIA AND PARATHORMONE IN KIDNEY TRANSPLANT PATIENTS Ines Aires | Anibal Ferreira | Cecilia Silva | Francisco Remedio| Fernando Nolasco HCC, Lisbon, Portugal w w w. e r a e d t a 2 01 2 . o r g 75 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE HAVANE P R O G R A M M E 11:45 - 13:15 Symposium 10 FRIDAY, MAY 25 Leukocytes and pro-inflammatory mediators in renal injury Chair:Hans-Joachim Anders, Munich, Germany Loreto Gesualdo, Bari, Italy Genetic loci modulate macrophage activity in glomerulonephritis Terry Cook, London, UK Kidney dendritic cells in acute and chronic renal disease Christian Kurts, Bonn, Germany Kinase inhibitors in experimental glomerulonephritis Charles Pusey, London, UK NFκB in renal inflammation Alberto Ortiz, Madrid, Spain 76 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM 352AB 11:45 - 13:15 Free Communication Session 4 + Mini Lecture Chair:Jesus Egido, Madrid, Spain Maria Pia Rastaldi, Milan, Italy FREE COMMUNICATIONS « FO018 CTGF: A LIGAND OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR). OPENING NOVEL POTENTIAL THERAPEUTIC TARGETS FOR RENAL DISEASES Sandra Rayego-Mateos | Raquel Rodrigues-Díez | Raul R. Rodrigues-Díez | Carolina Lavoz-Barria | Matilde Alique | Sebastian Mas | Janos Pato | Gyorgy Keri | Jesus Egido | Alberto Ortiz | Marta Ruiz-Ortega Cellular Biology Renal Diseases Lab Univ Autónoma Madrid, Spain | Renal Research Lab Fund Jiménez Díaz, Univ Autónoma Madrid, Spain | Vichem Chemie Ltd. Budapest, Hungary | Dialysis Unit, Fund Jiménez Díaz, Madrid Spain FO019 BLOCKADE OF THE PROTEOGLYCAN SYNDECAN 4 AMELIORATES PROTEINURIC KIDNEY DISEASE Liu Ying | Martin Tepel | Echtermeyer Frank | Thilo Florian | Theilmeier Gregor | Jensen Boye | Gollasch Maik SDU IMM Odense Denmark | MHH Hannover Germany | Charite Berlin Germany FO020 DYNAMIN ACTIVATION RESCUES PKCe DEFICIENCY INDUCED ACTIN DYSREGULATION IN PODOCYTES Beina Teng | Changkyu Gu | Hermann Haller | Sanja Sever | Mario Schiffer Medical School Hannover | Nephrology Div, Dept Medicine, Massachusetts Gerneral Hosp, Charlestown, Massachusetts, USA « FO021 DEF-6 EXPRESSION AND LOCALIZATION IS CHANGED IN PKCλ/ι DEFICIENT MICE AND PODOCYTES Kirstin Worthmann | Michael Leitges | Oliver DittrichBreiholz | Michael Kracht | Hermann Haller | Mario Schiffer Medical School Hannover, Hannover, Germany | Biotechnology Centre Oslo, Oslo, Norway FO022 PROTEINURIA IMPAIRS PODOCYTE REGENERATION IN GLOMERULAR DISORDERS Anna Peired | Maria Lucia Angelotti | Elisa Ronconi | Elena w w w. e r a e d t a 2 01 2 . o r g 77 FRIDAY, MAY 25 Mechanisms and targets of glomerular damage 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E Lazzeri | Alessandro Sisti | Laura Lasagni | Paola Romagnani Univ Florence, Florence, Italy FRIDAY, MAY 25 Mini Lecture Podocyte cell communication through glutamate receptors and co Maria Pia Rastaldi, Milan, Italy 78 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM 342AB 11:45 - 13:15 Free Communication Session 5 + Mini Lecture Chair:Ivan Rychlik, Prague, Czech Republic Franz Schaefer, Heidelberg, Germany FREE COMMUNICATIONS FO023 aHUS SUPERIMPOSED TO UNDERLYING GLOMERULOPATHY: AN UNDERPINNED ASSOCIATION? Lucio Manenti | Marco Allinovi | Augusto Vaglio | Lando Allegri | Elisa Gnappi Dept Nephrology, Univ Parma FO024 EFFICACY AND SAFETY OF ECULIZUMAB TREATMENT FOR ATYPICAL HAEMOLYTIC UREMIC SYNDROME (aHUS) IN PAEDIATRIC PATIENTS: SUBGROUP ANALYSIS OF A RETROSPECTIVE STUDY Giacomo Simonetti | Ramon Vilalta | Anne-Laure Lapeyraque| Ralph Gruppo | Julius Sherwinter | Jodi Smith | Courtney Thornburg | Therese Jungraithmayr | Elke Wuehl | Samhar Al-Akash | J.C. Davin | Marie Alice Macher | Craig Langman | Juan Antonio Camacho Diaz Bern Univ Hosp, Bern, Switzerland | Hosp Vall d’Hebron, Barcelona, Spain | CHU Sainte-Justine, Montréal, Canada | Cincinnati Children’s Hosp Medical Center, Cincinnati, USA| Children’s Healthcare Atlanta, Atlanta, USA | Children’s Hosp and Regional Medical Center, Seattle, USA | Duke Univ Medical Center, Durham, USA | Innsbruck Medical Univ, Innsbruck, Austria | Center Pediatric and Adolescent Medicine, Univ Heidelberg, Heidelberg, Germany | Driscoll Children’s Kidney Center, Corpus Christi, USA | Emma Children’s Hosp, Amsterdam, Netherlands | Hôp Robert Debré, Paris, France | Children’s Memorial Hosp, Chicago, USA | Hosp Infantil Sant Joan de Déu, Barcelona, Spain FO025 BARDOXOLONE METHYL ACUTELY REDUCES SERUM MAGNESIUM IN STAGE 3B AND 4 CKD PATIENTS WITH TYPE 2 DIABETES WITHOUT ANY ADVERSE EFFECT ON QT INTERVAL Melanie Chin | Angie Goldsberry, MS | Sudarshan Hebbar | Colin Meyer | Paul Audhya | Robert Toto | David Warnock Reata Pharmaceuticals, Irving TX, USA | Univ Texas Southwestern, Dallas TX, USA | Univ Alabama Birmingham, Birmingham, AL USA w w w. e r a e d t a 2 01 2 . o r g 79 FRIDAY, MAY 25 HUS and diabetic nephropathy 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E FRIDAY, MAY 25 FO026 WEIGHT LOSS IN OBESE, STAGE 3B AND 4 CKD PATIENTS WITH TYPE 2 DIABETES GIVEN BARDOXOLONE METHYL Pablo Pergola | Melanie Chin | Angie Goldsberry, MS | Sudarshan Hebbar | Colin Meyer | Paul Audhya Renal Associates, San Antonio TX, USA | Reata Pharmaceuticals, Irving TX, USA FO027 PROTEINURIA IS A THERAPEUTIC TARGET FOR RENOPROTECTION IN PATIENTS WITH TYPE 2 DIABETES WITH OVERT NEPHROPATHY: A SUB-ANALYSIS OF ORIENT STUDY Enyu Imai | Masakazu Haneda | Sadayoshi Ito | Fumiaki Kobayashi | Tetsu Yamasaki | Juliana Chan | Hirofumi Makino Nagoya Univ, Nagoya, Japan | Asahikawa Medical Univ, Asahikawa, Japan | Tohoku Univ, Sendai, Japan | Daiichi-Sankyo Co.Ltd. Tokyo Japan | Chinese Univ Hong Kong, Hong Kong, China | Okayama Univ, Okayama, Japan Mini Lecture An analysis of the worldwide output in Nephrology research 2002-2010 Marc de Broe, Antwerp, Belgium 80 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 2 11:45 - 13:15 Free Communication Session 6 Chair:Georges Deschênes, Paris, France Markus J. Kemper, Hamburg, Germany FREE COMMUNICATIONS FO028 IDENTIFICATION OF PROGNOSTIC MARKERS OF POSTNATAL RENAL FUNCTION IN BILATERAL OBSTRUCTIVE NEPHROPATHY BY FOETAL URINE PROTEOME ANALYSIS Julie Klein | Chrystelle Lacroix | Cécile Caubet | Justyna Siwy| Françoise Muller | Jean-Loup Bascands | Stéphane Decramer | Joost Schanstra Inserm U1048 | CNRS, IPBS (Inst Pharmacologie et Biologie Structurale)| Mosaiques Diagnostics | Néphrologie Pédiatrique, Hôp Robert Debré AP-HP| Inst Cardiovascular and Metabolic Disease FO029 SWITCH FROM PROTEASOME TO IMMUNOPROTEASOME IN CHILDREN WITH IDIOPATHIC NEPHROTIC SYNDROME Roberta Camilla | Elisa Loiacono | Licia Peruzzi | Rachele Gallo | Maria Elena Donadio | Luca Vergano | Federica Campolo | Laura Morando | Alessandro Amore | Rosanna Coppo Nephrology, Dialysis, Transpl, R.Margherita Hosp, Turin « FO030 EPIDEMIOLOGY OF THE IDIOPATHIC NEPHROTIC SYNDROME IN CHILDREN: ENDEMIC OR EPIDEMIC? Claire Dossier | Anne-Laure Leclerc | Nathanael Lapidus | Alexandra Rousseau | Marina Charbit | Helene Sarda | Fouad Madhi | Fabrice Carrat | Georges Deschenes Hop Robert Debré | Hop Trousseau | Unité Biostatistiques, Saint Antoine | URC-Est , Saint Antoine | Hop Necker Enfant Malade | Hop René Dubos | CH Intercommunal Creteil | Serv Néphrologie Pédiatique, Hôp Robert Debré, Paris, France FO031 THERAPEUTIC DRUG MONITORING OF MYCOPHENOLATE MOFETIL IN CHILDREN WITH STEROID-DEPENDENT IDIOPATHIC NEPHROTIC SYNDROME Jerome Harambat | Aymeric Dallocchio | Vincent Guigonis | Lydia Ichay | Lucie Bessenay | Françoise Broux | Arnaud Garnier | Denis Morin | Brigitte Llanas | Frank Saint-Marcoux | Stéphane Decramer ESPN/ERA-EDTA Registry, Academic Medical Center, Amsterdam, Netherlands | Children’s Univ Hosp | Children’s w w w. e r a e d t a 2 01 2 . o r g 81 FRIDAY, MAY 25 Paediatric nephrology 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E FRIDAY, MAY 25 Univ Hosp, Limoges, France | Children’s Univ Hosp, Montpelier, France | Children’s Univ Hosp, Clermond-Ferrand, France | Children’s Univ Hosp, Rouen, France | Children’s Univ Hosp, Toulouse, France | Children’s Univ Hosp, Bordeaux, France | Pharmacology, Univ Hosp, Limoges, France FO032 POST-TRANSPLANT DISEASE RECURRENCE AND GRAFT LOSS; STILL A MAJOR PROBLEM IN PEDIATRIC TRANSPLANTATION Karlijn van Stralen | Enrico Verrina | Mirco Belingheri | Jiri Dusek | Jan Dudley | Ryszard Grenda | Jacek Rubik | Sarunas Rudaitis | Christoph Rudin | Franz Schaefer | Kitty Jager AMC | G. Gaslini | Clinica Pediatrica De Marchi, Milano, Italy| Charles Univ Prague, Prague, Czech Republic | Bristol Royal Hosp Children, Bristol, UK | Children’s Memorial Health Inst, Warsaw, Poland | Hosp Lithuanian Univ Health Sciences Kaunas Clinics, Kaunas, Lithuania | Univ Children’s Hosp, Basel, Switzerland | Univ Heidelberg, Heidelberg, Germany | AMC, Amsterdam, Netherlands FO033 AN OUTBREAK OF SHIGA-TOXIN PRODUCING E. COLI O104:H4 HEMOLYTIC UREMIC SYNDROME (STEC-HUS) IN GERMANY: PRESENTATION AND SHORT TERM OUTCOME IN CHILDREN. A REPORT OF THE GERMAN PEDIATRIC HUS REGISTRY Sebastian Loos | Markus J Kemper Pediatric Nephrology, Hamburg, Germany 82 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E GRAND AMPHITHEATRE 15:15 - 16:45 Symposium 11 Thrombotic microangiopathies and complement disorders FRIDAY, MAY 25 Chair:Terry Cook, London, UK Marina Noris, Bergamo, Italy EHEC: the German 2011 epidemic Jan T. Kielstein, Hanover, Germany Atypical HUS and the complement system Véronique Fremeaux-Bacchi, Paris, France The biology of ADAMs in renal diseases Harry Van Goor, Groningen, Netherlands C3 glomerulonephritis and CFHR5 nephropathy Patrick Maxwell, London, UK w w w. e r a e d t a 2 01 2 . o r g 83 49th ERA-EDTA CONGRESS S C I E N T I F I C ROOM CONCORDE 1 P R O G R A M M E 15:15 - 16:45 Symposium 12 FRIDAY, MAY 25 The prehypertensive kidney Chair:Kerstin Amann, Erlangen, Germany Jean-Jacques Boffa, Paris, France Pathophysiological renal characteristics of prehypertension Peter W. de Leeuw, Maastricht, Netherlands Early markers of renal dysfunction in prehypertension Alexander Rosenkranz, Graz, Austria Tubulo-interstitial changes in early hypertension and its relation to natriuresis Jacek Manitius, Bydgoszcz, Poland Renal dysfunction and chronic abnormalities in prehypertension Luis Ruilope, Madrid, Spain 84 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E AMPHITHEATRE BLEU 15:15 - 16:45 Symposium 13 Chair:Klaus Olgaard, Copenhagen, Denmark Justin Silver, Jerusalem, Israel Physiology and pathophysiology of the calcium sensing receptor in the kidney Daniela Riccardi, Cardiff, UK microRNAs and RNA binding proteins in the regulation of PTH synthesis Tally Naveh-Many, Jerusalem, Israel Calcium sensing receptor: extrarenal effects Dominique Prié, Paris, France Modulation of calcium sensing by calcimimetics J. Mariano Rodriguez, Cordoba, Spain w w w. e r a e d t a 2 01 2 . o r g 85 FRIDAY, MAY 25 Calcium sensing and PTH secretion 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE BORDEAUX P R O G R A M M E 15:15 - 16:45 Symposium 14 FRIDAY, MAY 25 Peritoneal dialysis Chair:Olof Heimbürger, Stockholm, Sweden Nicholas Topley, Cardiff, UK The biology of the peritoneum, what’s emerging in the 21st century. Lessons to be learnt by EuTRiPD Christoph Aufricht, Vienna, Austria Mechanisms of fibrosis/sclerosis and impact of PD solutions Vedat Schwenger, Heidelberg, Germany Peritoneal sclerosis and clinical membrane changes when do we need to worry? Simon Davies, Stoke-on-Trent, UK Encapsulating Peritoneal Sclerosis: clinical insights and treatments options Martin Wilkie, Sheffield, UK 86 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 2 15:15 - 16:45 Symposium 15 Renal fibrosis FRIDAY, MAY 25 Chair:Christos Chatziantoniou, Paris, France Katalin Susztak, Bronx, USA The development of tubulo-interstitial fibrosis Wilhelm Kriz, Mannheim, Germany Lipocalin-2 and progression of CKD Fabiola Terzi, Paris, France EGF receptor pathway and progression of glomerular disease Pierre-Louis Tharaux, Paris, France Methylation determines fibroblast activation and fibrogenesis in the kidney Michael Zeisberg, Göttingen, Germany w w w. e r a e d t a 2 01 2 . o r g 87 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE HAVANE P R O G R A M M E 15:15 - 16:45 Free Communication Session 7 + Mini Lecture FRIDAY, MAY 25 Vascular damage and access in CKD Chair:Giorgina B. Piccoli, Turin, Italy Dimitrios Tsakiris, Thessaloniki, Greece FREE COMMUNICATIONS FO034 KRÜPPEL-LIKE FACTOR 4 CONTRIBUTES TO HIGH PHOSPHATE-INDUCED PHENOTYPIC SWITCHING OF VASCULAR SMOOTH MUSCLE CELLS INTO OSTEOGENIC CELLS Tadashi Yoshida | Maho Yamashita | Matsuhiko Hayashi Apheresis and Dialysis Center, School Medicine, Keio Univ, Tokyo Japan FO035 IN VIVO EFFECTS OF THE PROTEIN-BOUND UREMIC TOXINS P-CRESYLSULFATE, P-CRESYLGLUCURONIDE AND INDOXYLSULFATE ON THE CROSS-TALK BETWEEN LEUKOCYTES AND THE VESSEL WALL Anneleen Pletinck | Griet Glorieux | Eva Schepers | Maria Van Landschoot | Johan Van de Voorde | Wim Van Biesen | Raymond Vanholder Ghent Univ Hosp, Ghent, Belgium FO036 INDOXYL SULFATE ENHACES NEOINTIMA FORMATION VIA INDUCTION OF LY6CHIGH INFLAMMATORY MONOCYTE Yoko Yagi | Shunsuke Ito | Sumie Goto | Mizuko Osaka | Masayuki Yoshida Biomedical Research Laboratories, Kureha Corp, Tokyo, Japan| Tokyo Medical and Dental Univ, Tokyo, Japan Mini Lecture The vascular access unit: surgeons, nephrologists, nurses or all of them together? Carlo Basile, Taranto, Italy FREE COMMUNICATIONS FO037 RECENT INTERNATIONAL TRENDS FROM THE DOPPS IN VASCULAR ACCESS USE IN HEMODIALYSIS PA- 88 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E FO038 AN EVALUATION OF VASCULAR ACCESS AND MORTALITY IN THE IMPACT™ PROGRAM Steven Wilson | John Robertson | Grace Chen | Pooja Goel| Deborah Benner | Mahesh Krishnan | Tracy Mayne | Allen Nissenson DaVita, Inc | DaVita, Washington, D.C, US | DaVita, El Segundo, US w w w. e r a e d t a 2 01 2 . o r g 89 FRIDAY, MAY 25 TIENTS: SUBSTANTIAL RISE IN CATHETER USE IN SOME COUNTRIES Ronald Pisoni | Douglas Fuller | Richard Fluck | Joan Fort| Francesco Locatelli | Lawrence Spergel | David Goodkin | Friedrich Port | Bruce Robinson Arbor Research Collaborative for Health, Ann Arbor, USA | Derby City General Hosp, Derby, UK | Hosp Vall d’Hebron, Barcelona, Spain | Osp A. Manzoni, Lecco, Italy | Dialysis Management Medical Group 49th ERA-EDTA CONGRESS S C I E N T I F I C ROOM 352AB P R O G R A M M E 15:15 - 16:45 Free Communication Session 8 FRIDAY, MAY 25 Clinical epidemiology and CKD 1-5 Chair:Luc Frimat, Nancy, France Francesca Mallamaci, Reggio Calabria, Italy FREE COMMUNICATIONS « FO039 BIRTHWEIGHT PREDICTS GLOMERULAR FILTRATION RATE Suad Hannawi | Issa Salmi | Helen Healy | Robert Atkins | Jonathan Shaw Al Baraha Hosp, Muscat, Oman | Royal Hosp | Royal Brisbane Hosp | Baker IDI Heart and Diabetes Inst, Brisbane, Australia « FO040 SERUM URIC ACID AND RISK OF CHRONIC KIDNEY DISEASE: THE ROTTERDAM STUDY AND META-ANALYSIS Sanaz Sedaghat | Ewout Hoorn | Frank van Rooij | Albert Hofman | Oscar H. Franco | Jacqueline Witteman | Abbas Dehghan Dept Epidemiology, Dept Internal Medicine—Nephrology, Erasmus Medical Center, Rotterdam, Netherlands « FO041 RELATIVE ENERGY BALANCE, CHRONIC KIDNEY DISEASE AND RISK OF CARDIOVASCULAR AND ALL-CAUSE MORTALITY Samuel Iff | Wong Germaine | Angela C Webster | Jie-Jin Wang | Paul Mitchell | Jonathan Craig Centre Kidney Research, Westmead, Australia | Centre Vision Research, Westmead, Australia FO042 IS THERE AN ASSOCIATION BETWEEN SHORT TERM CHANGES IN KIDNEY FUNCTION AND MORTALITY? Christopher Farmer | Jean Irving | Brenda Hemmelgarn | Josef Coresh | Paul Stevens East Kent Univ Hosp NHS Foundation Trust, UK | East Kent Hosp Univ NHS Foundation Trust, UK | Univ Calgary, Calgary, Alberta, Canada| Johns Hopkins Bloomberg School Public Health, Baltimore, USA « FO043 FGF23 AND ASYMMETRICAL DIMETHYLARGININE (ADMA) ARE INTERACTIVE FACTORS IN THE HIGH RISK FOR CKD PROGRESSION IN STAGE 2-5 CKD PATIENTS Giovanni Tripepi | Daniela Leonardis | Maurizio Postorino | Giuseppe Enia | Carmine Zoccali | Francesca Mallamaci | The 90 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E « FO044 INTACT FIBROBLAST GROWTH FACTOR 23 LEVELS PREDICT INCIDENT CARDIOVASCULAR EVENT BEFORE BUT NOT AFTER THE START OF DIALYSIS Sayoko Yonemoto | Takayuki Hamano | Naohiko Fujii | Yoshitugu Obi | Isao Matsui | Satoshi Mikami | Chikako Nakano| Kazunori Inoue | Akihiro Shimomura | Noriyuki Okada| Yoshiharu Tsubakihara | Hiromi Rakugi | Yoshitaka Isaka | Masaya Katayama Hyogo Prefectural Nishinomiya Hosp, Hyogo, Japan | Center Clinical Epidemiology and Biostatistics, Univ Pennsylvania Perelman School Medicine, Pennsylvania, USA | Dept Internal Medicine, Hyogo Prefectural Nishinomiya Hosp, Hyogo, Japan| Dept Geriatric Medicine and Nephrology, Osaka Univ Graduate School Medicine, Osaka, Japan | Dept Internal Medicine, Higashi-Kohri Hosp, Osaka, Japan | Dept Nephrology and Hypertension, Osaka General Medical Center, Osaka, Japan | Tokushima Second Clinic, Tokushima, Japan w w w. e r a e d t a 2 01 2 . o r g 91 FRIDAY, MAY 25 MAURO Working Group CNR-IBIM, Reggio Calabria | CNR IBIM and Osp Riuniti, Reggio Calabria, Italy 49th ERA-EDTA CONGRESS S C I E N T I F I C ROOM 342AB P R O G R A M M E 15:15 - 16:45 Free Communication Session 9 + Mini Lectures FRIDAY, MAY 25 AKI clinical studies Chair:Fatma Ben Moussa, Tunis, Tunisia Petar Kes, Zagreb, Croatia Mini Lecture Epidemiology of AKI in the ICU Fernando Liano, Madrid, Spain FREE COMMUNICATIONS FO045 DOES ACUTE KIDNEY INJURY MANAGED ENTIRELY IN THE COMMUNITY HAVE SIMILAR MORTALITY OUTCOMES TO HOSP ACQUIRED ACUTE KIDNEY INJURY? Michael Bedford | Helen Hobbs | Jean Irving | Toby Wheeler| Paul Stevens | Christopher Farmer East Kent Hosp Univ NHS Foundation Trust FO046 RENAL HYPOPERFUSION, RATHER THAN TUBULAR DAMAGE IS THE MAIN INITIAL EVENT IN AKI DURING EARLY SEPSIS Jill Vanmassenhove | Wim Van Biesen | Griet Glorieux | Raymond Vanholder Ghent Univ Hosp, Nephrology, Gent, Belgium FO047 ACUTE KIDNEY INJURY IN PATIENTS WITH FALCIPARUM MALARIA. AN ASSESSMENT OF THE RIFLE CRITERIA João Brandão | Joao Egidio Romao Jr Clinica Multiperfil | Hosp Beneficencia Portuguesa, Sao Paulo, Brazil Mini Lecture Disaster nephrology Mehmet Sukru Sever, Istanbul, Turkey 92 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E GRAND AMPHITHEATRE 17:00 - 18:30 Symposium 16 Chair:Friedrich Port, Ann Arbor, USA Bruce Robinson, Ann Arbor, USA Benefits of studying differences in practice and outcomes Bruce Robinson, Ann Arbor, USA Practices before and after policy changes Werner Kleophas, Düsseldorf, Germany Transitions from CKD to dialysis Christian Combe, Bordeaux, France Indicators related to Mineral Bone Disease Francesca Tentori, Ann Arbor, USA Vascular access: Achieving better outcomes Richard Fluck, Derby, UK Panel Discussion w w w. e r a e d t a 2 01 2 . o r g 93 FRIDAY, MAY 25 Correlating international hemodialysis practice differences with outcomes: the Dialysis Outcomes and Practice Patterns Study (DOPPS) 49th ERA-EDTA CONGRESS S C I E N T I F I C ROOM CONCORDE 1 P R O G R A M M E 17:00 - 18:30 Symposium 17 FRIDAY, MAY 25 Vascular calcification in CKD Chair:Tilman Drueke, Amiens, France J. Mariano Rodriguez, Cordoba, Spain Vascular calcifications – lessons from animal studies Patrick D’Haese, Antwerp, Belgium Magnesium and cardiovascular disease in CKD Fatih Kircelli, Yozgat, Turkey The mysterious effects of sodium thiosulfate on extraosseous calcifications Andreas Pasch, Bern, Switzerland Vascular calcification in patients with CKD. Outcomes and therapy Teresa Adragão, Cascais, Portugal 94 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E AMPHITHEATRE HAVANE 17:00 - 18:30 Symposium 18 Chair:Fernando Fervenza, Rochester, USA Dario Roccatello, Turin, Italy Glomerulonephritis with monoclonal immunoglobulin deposits: the expanding spectrum Alexandre Karras, Paris, France Recent diagnostic and therapeutic advances in ALamyloidosis Frank Bridoux, Poitiers, France New strategies for the treatment of amyloidosis Mark B. Pepys, London, UK w w w. e r a e d t a 2 01 2 . o r g 95 FRIDAY, MAY 25 Paraneoplastic GN, monoclonal-IgG related disorders and amyloid 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE BLEU P R O G R A M M E 17:00 - 18:30 Literature Update 1 FRIDAY, MAY 25 Clinical nephrology Chair:Jacques Bernheim, Kfar-Saba, Israel Momir Polenakovic, Skopje, F.Y.R. of Macedonia Dominique Joly, Paris, France Eberhard Ritz, Heidelberg, Germany 96 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E AMPHITHEATRE BORDEAUX 17:00 - 18:30 Literature Update 2 Transplantation FRIDAY, MAY 25 Chair:François Berthoux, Saint-Etienne, France Rainer Oberbauer, Linz, Austria Daniel Abramowicz, Brussels, Belgium Denis Glotz, Paris, France w w w. e r a e d t a 2 01 2 . o r g 97 49th ERA-EDTA CONGRESS S C I E N T I F I C ROOM 352AB P R O G R A M M E 17:00 - 18:30 Free Communication Session 10 FRIDAY, MAY 25 Genetic studies in renal diseases Chair:Dominique Chauveau, Toulouse, France Roser Torra, Barcelona, Spain FREE COMMUNICATIONS FO048 THE COMPLEXITY OF THE 5’UTR REGION OF CLCN5 GENE: TEN 5’UTR ENDS ARE DIFFERENTIALLY EXPRESSED IN THE HUMAN KIDNEY Enrica Tosetto | Alberto Casarin | Rosalba Cristofaro | Leonardo Salviati | Franca Anglani Lab Clinical and Epidemiological Genetics, Dept Pediatrics, Univ Padua, Padua Italy | Lab Histomorphology and Molecular Biology Kidney, Div Nephrology, Dept Medicine, Univ Padua, Italy FO049 CYSTINURIA: PHENOTYPE AND OUTCOMES IN A LARGE FRENCH COHORT OF 426 PATIENTS Caroline Prot Bertoye | Said Lebbah | Michel Daudon | Camille Couffignal | Caroline Elie | Isabelle Tostivint | Olivier Traxer | Bertrand Knebelmann | Marie Courbebaisse Necker Hosp, Paris, France | Tenon Hosp, Paris, France | PitieSalpetriere Hosp, Paris, France | Europeen Georges Pompidou Hosp, Paris, France « FO050 HIGHER THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR LEVELS ARE ASSOCIATED WITH INFLAMMATION AND GENETIC MUTATIONS IN ATTACK-FREE FAMILIAL MEDITERRANEAN FEVER PATIENTS Nuket Bavbek Ruzgaresen | Mevlut Ceri | Ayse Kargili | Derya Akdeniz | Ali Akcay | Murat Duranay | Galip Guz Fatih Univ Medical School, Dept Nephrology, Ankara, Turkey| Ankara Education and Research Hosp, Dept Nephrology, Ankara, Turkey | Fatih Univ Medical School Dept Internal Medicine, Ankara, Turkey | Gazi Univ Medical School Dept Nephrology, Ankara, Turkey FO051 CAUSAL ROLE OF URIC ACID IN HYPERTENSION AND ATHEROSCLEROSIS: NEW EVIDENCE BY A MENDELIAN RANDOMIZATION APPROACH Alessandra Testa | Belinda Spoto | Maria Cristina Sanguedolce | Vincenzo Panuccio | Daniela Leonardis | Rocco Tripepi | Angela Mafrica | Giovanni Tripepi | Carmine Zoccali | Fran- 98 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E « FO052 LINKAGE ANALYSIS DETECTS TWO ADDITIONAL REGIONS IN FAMILIAL IGA NEPHROPATHY Francesco Pesce | Sharon Natasha Cox | Grazia Serino | Fabio Sallustio | Philippe Froguel | Francesco Paolo Schena | Mario Falchi Dept Genomics of Common Disease - School Public Health - Imperial College London | Dept Emergency and Organ Transpl (DETO) - Univ Bari-Italy | Nephrology Dialysis and Transpl Unit ¯ FO053 GENOME-WIDE ASSOCIATION STUDY (GWAS) OF INCIDENT CKD AND EGFR CHANGE: THE CKDGEN CONSORTIUM Carsten Böger on behalf of the CKDGen CKD Progression Writing Group Univ Medical Center Regensburg, Germany | CKDGen Consortium w w w. e r a e d t a 2 01 2 . o r g 99 FRIDAY, MAY 25 cesca Mallamaci CNR-IBIM, Reggio Calabria | CNR IBIM and Osp Riuniti, Reggio Calabria 49th ERA-EDTA CONGRESS S C I E N T I F I C ROOM 342AB P R O G R A M M E 17:00 - 18:30 Free Communication Session 11 + Mini Lecture FRIDAY, MAY 25 Hypertension Chair:Michel Godin, Rouen, France Gérard M. London, Fleury-Mérogis, France FREE COMMUNICATION FO054 MESENCHYMAL STEM CELLS (MSC) PREVENT THE RENOVASCULAR HYPERTENSION, IMPROVE RENAL FUNCTION AND REDUCE THE RAS MARKERS IN THE RAT KIDNEY Elizabeth Oliveira Sales | Mirian Boim | Edgar Maquigussa| Patricia Semedo | Luciana Pereira | Niels Camara | Cassia Bergamaschi | Ruy Campos Federal Univ São Paulo, São Paulo, Brazil Mini Lecture Intrarenal Renin Angiotensin System Laszlo Rosivall, Budapest, Hungary FREE COMMUNICATIONS FO055 ALISKIREN EFFECT IN REVERSING HYPERTENSION-INDUCED CHRONIC KIDNEY DISEASE Lise Weis | Jean-Claude Dussaule | David Feldman | Christos Chatziantoniou | Panagiotis Kavvadas INSERM UMR S702, Paris, France | Novartis Pharamaceuticals Corp., East Hanover, New Jersey, USA « FO056 DETERMINANTS OF THE COMMON CAROTID ARTERY SUBCLINICAL LESIONS IN HYPERTENSIVE SUBJECTS WITH RENAL FIBROMUSCULAR DYSPLASIA S Savard | Luca Zanoli | G Bobrie | X Jeunemaitre | M Azizi | M Frank | PF Plouin | S Laurent | P Boutouyrie Dept Nephrology, Dept Pharmacology, HEGP, AP-HP, INSERM U970 and Univ Paris-Descartes, Paris, France 100 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E FO058 COMPARISON OF BLOOD PRESSURE PATTERNS IN INCIDENT HEMODIALYSIS PATIENTS: EVALUATION OF DIALYSIS DATA FROM 24 COUNTRIES Adrian Guinsburg | Inga Bayh | Michael Etter | Gero von Gersdorff | Aileen Grassmann | Jeroen Kooman | Maggie Lam | Daniele Marcelli | Cristina Marelli | Laura Scatizzi | Mathias Schaller | Adam Tashman | Stephan Thijssen | Ted Toffelmire| Len A Usvyat | Frank M. van der Sande | Yuedong Wang | Claudia barth | Nathan W Levin | Peter Kotanko Fresenius Medical Care Latin America | Fresenius Medical Care Europe | Fresenius Medical Care Asia Pacific | Univ Hosp Cologne, Cologne, Germany | Maastricht Univ Hosp | Renal Research Inst, New York, New York, USA | Fresenius Medical Care Canada | Univ California Santa Barbara | Curatorium Dialysis and Kidney Transpl (KfH), Germany w w w. e r a e d t a 2 01 2 . o r g 101 FRIDAY, MAY 25 FO057 ENDOTHELIAL DYSFUNCTION IN SALT SENSITIVE PEOPLE Fernando Margulis | Veronica Golglid | Ruben Schiavelli Unidad Nefrologia y Trasplante Renal, Hosp Cosme Argerich, Buenos Aires, Argentina 49th ERA-EDTA CONGRESS S C I E N T I F I C ROOM CONCORDE 2 P R O G R A M M E 17:00 - 18:30 Free Communication Session 12 FRIDAY, MAY 25 Anaemia Chair:Patrick Biggar, Coburg, Germany Goce Spasovski, Skopje, F.Y.R. of Macedonia FREE COMMUNICATIONS FO059 CROSS-SPECIES EVALUATION OF PEGINESATIDE PHARMACOKINETICS, ERYTHROPOIETIC ACTIVITY, AND ERYTHROPOIETIN RECEPTOR (EPOR) BINDING Jennifer M. Green | Richard B. Mortensen | K-L Fong | Qing Fan | Karen Leu | Peter J. Schatz | Kathryn Woodburn Affymax, Inc., Palo Alto, USA | Affymax, Inc. | Accellient Partners LLC, USA FO060 PROTEIN CARBAMYLATION AND ERYTHROPOIETIN RESISTANCE IN END STAGE KIDNEY DISEASE Sahir Kalim | Hector Tamez | Julia Wenger | Elizabeth Ankers | Anders Berg | Ananth Karumanchi | Ravi Thadhani Massachusetts General Hosp, Boston, USA | Beth Israel Deaconess Medical Center, Boston, USA FO061 HEMOSIDEROSIS DURING HEMODIALYSIS: AN MRI STUDY BASES ON 119 PATIENTS Rostoker Guy | Griuncelli Mireille | Loridon Christelle | Roy Myriam | Cohen Yves | Janklewicz Philipppe Hôp Privé Claude Galien, Quincy sous Senart, France FO062 HEPCIDIN ISOFORMS AND THERAPEUTIC EFFECTS OF RECOMBINANT HUMAN ERYTHROPOIETIN IN PATIENTS UNDERGOING MAINTENANCE HEMODIALYSIS Takashi Yokoyama | Yasushi Shimonaka | Yusuke Sasaki | Yuichi Yoshida | Kenro Yamazaki Dept Nephrology and Dialysis, Sapporo Higashi-Tokushukai Hosp, Sapporo, Japan | Product Research Dept, Chugai Pharmaceutical Co., Led, Kamakura, Japan | Dept Nephrology and Dialysis, Sapporo Higashinaebo Hosp, Sapporo, Japan FO063 HEPCIDIN-25 IS ASSOCIATED WITH PROGRESSION TO END STAGE RENAL DISEASE BUT NOT WITH MORTALITY IN DIABETIC CHRONIC KIDNEY DISEASE Martin Wagner | Ahsan Alam | Mark Busbridge | Caroline Kurtz | Josef Zimmermann | Peter Heuschmann | Christoph 102 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E FO064 VITAMIN D AS A NEW REGULATOR OF IRON METABOLISM: VITAMIN D SUPPRESSES HEPCIDIN IN VITRO AND IN VIVO Justine Bacchetta | Joshua J Zaritsky | Thomas S Lisse | Jessica L Sea | Rene F Chun | Elizabeta Nemeth | Thomas Ganz | Mark Westerman | Isidro B Salusky | Martin Hewison Centre Reference Maladies Rénales Rares | UCLA, Los Angeles, USA | Intrinsic LifeSciences, La Jolla, USA w w w. e r a e d t a 2 01 2 . o r g 103 FRIDAY, MAY 25 Wanner | Damien Ashby | Lothar Schramm Div Nephrology, Univ Hosp Würzburg, Germany | Div Nephrology, McGill Univ, Montreal, Canada | Dept Clinical Chemistry, Imperial College London, UK |Inst Clinical Epidemiology and Biometry, Univ Würzburg, Germany| Kidney and Transplant Inst, Imperial College, London, UK 49th ERA-EDTA CONGRESS P R O G R A M M E FRIDAY, MAY 25 S C I E N T I F I C 104 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Acid-base / Electrolytes FP001-FP013 Cell signalling / Pathophysiology FP014-FP043 Hypertension FP044-FP077 Clinical Nephrology Lab methods and other markers FP078-FP147 Clinical Nephrology - Epidemiology I FP148-FP182 Renal anaemia - CKD 1-5 FP183-FP217 Mineral and bone disease - CKD 1-5 FP218-FP254 Diabetes - Experimental FP255-FP282 Diabetes - Clinical FP283-FP318 Electrolyte disorders / Nephrolithiasis FP319-FP330 Primary and secondary glomerulonephritis I FP331-FP377 Extracorporeal dialysis: techniques and adequacy FP378-FP460 Cardiovascular complications in CKD 5D FP461-FP537 Vascular access FP538-FP585 Epidemiology and outcome research in CKD 5D FP586-FP663 FRIDAY, MAY 25 POSTER SESSION Poster Area 09:30 - 10:45 Nutrition, inflammation and oxidative stress CKD 5D FP664-FP687 Transplantation - Clinical I w w w. e r a e d t a 2 01 2 . o r g FP688-FP729 105 49th ERA-EDTA CONGRESS P O S T E R S ACID-BASE / ELECTROLYTES FRIDAY, MAY 25 FP001 SEVERE HYPERKALEMIA REQUIRING HOSPITALIZATION; PREDICTORS OF MORTALITY AND IMPROVEMENT Jung Nam An | Jung Pyo Lee | Yun Kyu Oh | Chun Soo Lim Seoul National Univ Hosp | Boramae Medical Center | Seoul National Univ FP002 PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL TOLVAPTAN TABLETS IN SUBJECTS WITH VARYING DEGREES OF RENAL FUNCTION Susan Shoaf | Patricia Bricmont | Suresh Mallikaarjun Otsuka Pharmaceutical Development & Commercialization, Inc, Rockville, MD, USA | Otsuka Pharmaceutical Res & Commercialization, inc. FP003 N-ACETYLCYSTEINE ATTENUATES RENAL AND LUNG ALTERATIONS INDUCED BY SENESCENCE IN THE RAT Rildo Aparecido Volpini | Ana Carolina de Braganca | Daniele Canale | Janaina Garcia Gonçalves | Thais Prevital Bastos Brandão | Lucia Andrade | Antonio Carlos Seguro | Maria Heloisa Massola Shimizu Hosp Clínicas Fac Medicina Univ São Paulo, Brasil | Fac Medicina da Univ São Paulo FP004 WITH-NO-LYSINE KINASEs (WNKs) IN ALDOSTERONE ESCAPE PHENOMENON Jeonghwan Lee | Kwon Wook Joo | Yun Kyu Oh | Yoon Chul Jung | Jae-Ho Earm | Jin Suk Han Internal Medicine, Seoul National Univ Hosp, Seoul, Korea | Internal Medicine, Seoul National Univ Boramae Hosp, Seoul, Korea | Internal Medicine, Pundang Jesaeng General Hosp, Sungnam, Korea | Earm Jae-Ho Dialysis Center, Chungju, Korea | Seoul National Univ College of Medicine, Seoul, Korea FP005 HYPONATREMIA IN THE HOSP SETTING: INTERIM RESULTS FROM A PROSPECTIVE, OBSERVATIONAL, MULTI-CENTER, GLOBAL REGISTRY Esteban Poch | Volker Burst | Arthur Greenberg | Andrew Makin | Sandra Chase Hosp Clínic Barcelona | Univsklinik Köln | Duke Univ | Otsuka Pharmaceuticals Europe Ltd. | Otsuka America Pharmaceutical, Inc. FP006 HIGH INCIDENCE OF ASYMPTOMATIC HYPONATREMIA IN FEMALE RAVERS USING ECSTASY Boer Walther | R.E. Blom | G.D. Van Dijken | R.J. Hené Dept Nephrology, Univ Medical Center, Utrecht, Netherlands FP007 COORDINATED CONTROL OF BASOLATERAL NA,K-ATPASE AND TIGHTJUNCTIONS IN REPSONSE TO APICAL SODIUM ENTRY IN COLLECTING DUCT CELLS Wang Yu-Bao | Leroy Valerie | Ernandez Thomas | Maunsbach Arvid | Doucet Alain | Martin Pierre-Yves | Eric Feraille Univ Geneva | CHRU Lille | Univ Aarhus | INSERM-Cordelier Res CenterParis-France FP008 IN ACIDOTIC HEMODIALYSIS (HD) PATIENTS, HIGH DIALYSATE BICARBONATE CONCENTRATION CORRECTS PRE-HD ACIDOSIS BUT INDUCES POST-HD ALKALEMIA, ASSOCIATED WITH ATTENUATED PCO2 INCREASE WITH ITS PARTIAL DECREASE TOWARD END OF HD David Tovbin | Luna Avnon | Debora Bloch | Moshe Zlotnik | Amir AbdElkadir | Shimon Storch Soroka Medical Center, Beer-Sheva, Israel | Medical School for International Health, Ber-Sheva, Israel | Biomedical Engineering, Ben-Gurion Univ, Beer-Sheva, Israel | Nephrology, Bnai-Zion Medical Center, Haifa, Israel 106 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP010 DIFFERENT TRANSPORT MODE OF NPT1 AND NPT4 FOR ORGANIC ANIONS Naohiko Anzai | Promsuk Jutabha Dokkyo Medical Univ School of Medicine, Tochigi, Japan FP011 ISOLATION AND IDENTIFICATION OF THE STRONGEST MAS-AGONIST Markus Tölle | Vera Jankowski | Axel Kretschmer | Robson A. S. Santos | Walter Zidek | Joachim Jankowski | Michael Bader Charite | Bayer | Univ Minas Gerais, Belo Horizonte, Minas Gerais | Max-Delbrück-Center Molecular Medicine, Berlin FP012 IDENTIFICATION OF URINARY EXOSOMAL PROTEINS BY MASS SPECTROMETRY Matthieu Bourderioux | Guerrera Ida Chiara | Nguyen-Khoa Thao | Jeanson Ludovic | Chhuon Cerina | Planelles Gabrielle | Knebelmann Bertrand | Escudier Estelle | Escudier Bernard | Edelman Aleksander INSERM U845 | INSERM | AP-HP | INSERM U933 | Inst Gustave Roussy FP013 DISTAL CONVOLUTED TUBULE (DCT) SPECIFIC TRANSCRIPTS IDENTIFIED USING DCT LARGE SCALE SAMPLING Nicolas Picard | Johannes Loffing INSERM UMRS 872, Paris, France | Anatomisches Inst, Zurich, Switzerland w w w. e r a e d t a 2 01 2 . o r g 107 FRIDAY, MAY 25 FP009 DISRUPTED CHRONOBIOLOGY OF WATER EXCRETION, BUT NOT Na EXCRETION, IS ASSOCIATED WITH REDUCED INSULINOSECRETION IN THE METABOLIC SYNDROME Leopold Fezeu | Lise Bankir | Boris Hansel | Dominique Guerrot INSERM Unit 872-E2 | Serv Endocrinologie, Hôp Pitié-Salpetrière, Paris, France| Nephrology Dept, Rouen Univ Hosp, Rouen, France 49th ERA-EDTA CONGRESS P O S T E R S CELL SIGNALLING / PATHOPHYSIOLOGY FRIDAY, MAY 25 FP014 ROLE OF INDOLE-DERIVED UREMIC SOLUTES ON TISSUE FACTOR PRODUCTION VIA ARYL HYDROCARBON RECEPTOR PATHWAY Claire Cerini | Bertrand Gondouin | Laetitia Dou | Ariane Duval-Sabatier | Philippe Brunet | Francoise Dignat- George | Stephane Burtey INSERM U 1076, Univ Aix Marseille, Marseille, France FP015 IL-13 HAS AN INHIBITORY EFFECT ON TYPE I COLLAGEN EXPRESSION BY SUPPRESSION OF SMAD3 ACTIVITIES IN TGF-BETA1-STIMULATED RENAL TUBULOEPITHELIAL CELLS Kazuhiro Okano | Tomihito Iwasaki | Hikohiro Jinnai | Asako Hibi | Naoko Miwa | Naoki Kimata | Kosaku Nitta | Takashi Akiba Dept Blood Purification and Dept Medicine, Kidney Center, Tokyo Women’s Medical Univ, Tokyo, Japan FP016 TELMISARTAN POTENTIATES ANTIANGIOGENIC EFFECTS OF SUNITINIB IN A XENOGRAFT MODEL OF RENAL CELL CARCINOMA Thibault Dolley-Hitze | Grégory Verhoest | Florence Jouan | Yannick ArlotBonnemains | Audrey Lavenu | Marc-Antoine Belaud-Rotureau | Nathalie Rioux-Leclercq | Cécile Vigneau CNRS UMR6061 / IFR 140, Fac Médecine, Univ Rennes 1 | Dept Pharmacologie Expérimentale et Clinique, Univ Rennes 1 FP017 ALTERED ANTIGEN HANDLING AND INVOLVEMENT OF THE CX3CR1FKN AXIS IN PROMOTING HEMATURIA IN IgA NEPHROPATHY PATIENTS Sharon Natasha Cox | Fabio Sallustio | Grazia Serino | Antonia Loverre | Francesco Pesce | Margherita Gigante | Gianluigi Zaza | Patrizia Stifanelli | Nicola Ancona | Francesco Paolo Schena Dept Emergency and Organ Transpl, Univ Bari, Bari, Italy | Dept Biomedical Sciences, Univ Foggia, Foggia, Italy | Nephrology and Dialysis Unit, Dept Medicine, Univ Verona, Verona, Italy | ISSIA, CNR, Bari, Italy | Nephrology Dialysis and Transpl Unit, Dept Emergency and Organ Transpl (D.E.T.O.), Univ Bari, Italy FP018 ARACHIDONIC ACID STIMULATES CA2+ ENTRY INTO MOUSE TAL CELLS THROUGH AN APICAL TRPM7-LIKE CA2+-PERMEABLE NON-SELECTIVE CATION CHANNEL Paulais Marc | Teulon Jacques UMRS872 - ERL7226 FP019 EXTENDED FUNCTIONAL LIFESPAN OF THE ERYTHROPOIETIN RECEPTOR (EPOR) FOLLOWING STIMULATION WITH PEGINESATIDE Jennifer M. Green | Richard B. Mortensen | Rakesh Verma | Karen Leu | Peter J. Schatz | Don M. Wojchowski Affymax, Inc., Palo Alto, USA | Maine Medical Center Res Inst FP020 SIGNAL TRANSDUCTION PATHWAY AND DIRECT ACTION ON VASCULAR ENDOTHELIAL CELLS BY ERYTHROPOIESIS-STIMULATING AGENT Chieko Ihoriya | Minoru Satoh | Tamaki Sasaki | Naoki Kashihara Kawasaki Medical School, Kurashiki, Japan FP021 SIRT1 OVEREXPRESSION MITIGATES CISPLATIN-INDUCED ACETYLATES OF NF-KB P65 SUBUNIT AND CYTOTOXICITY Yu Jin Jung | Ae Sin Lee | Jung Eun Lee | Sik Lee | Sung Kwang Park | Won Kim | Kyung Pyo Kang Dept Internal Medicine, Res Inst Clinical Medicine, Chonbuk National Univ Medical School, Jeonju 108 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP022 CYSTEINE RESIDUES REGULATE TRANSIENT RECEPTOR POTENTIAL CANONICAL TYPE 6 CHANNEL PROTEIN EXPRESSION Thilo Florian | Martin Tepel | Liu Ying | Krueger Katharina | Förste Nora | Wittstock Antje | Scholze Alexandra Charite Berlin Germany|SDU IMM Odense Denmark|SDU KI Odense Denmark FP024 MICRORNA-146A DOWNREGULATES TOLL-LIKE RECEPTOR SIGNALING PATHWAY MEDIATING PUROMYCIN AMINONUCLEOSIDE INDUCED PODOCYTE INJURY Zhi-Hong Liu | Yaojun Liang | Chun-Xia Zheng | Zhao-Hong Chen | Cai-Hong Zeng Res Inst Nephrology, Jinling Hosp, Nanjing Univ School Medicine, Nanjing, China FP025 NANOTUBULAR CONNECTIONS BETWEEN HUMAN PERITONEAL MESOTHELIAL CELLS Julia Ranzinger | Amin Rustom | Lars Kihm | Danijela Heide | Peter Scheurich| Martin Zeier | Vedat Schwenger Nephrology, Univ Heidelberg, Germany | Max-Planck Inst Intelligent Systems, Stuttgart, Germany | Univ Stuttgart, Stuttgart, Germany FP026 ROLE OF DNA METHYLATION IN RENAL APOPTOSIS Jian Liu | Fang Zhong | Lili Xu | Qiao Zhou | Xu Hao | Weiming Wang | Nan Chen Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School of Medicine FP027 1H NMR SPECTROSCOPY ANALYSIS OF METABOLITES IN THE KIDNEYS PROVIDES NEW INSIGHT INTO PATHOPHYSIOLOGICAL MECHANISMS: APPLICATIONS FOR TREATMENT WITH CORDYCEPS SINENSIS Fang Zhong | Xia Liu | Qiao Zhou | Xu Hao | Ying Lu | Shanmai Guo | Weiming Wang | Donghai Lin | Nan Chen Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School Medicine FP028 PHOSPHOPROTEOMIC ANALYSIS OF THE P2X7 SIGNALLING CASCADE IN MACROPHAGES: A PUTATIVE ROLE IN GLOMERULONEPHRITIS Annalisa Vilasi | Simona Deplano | Pedro Cutillas | Robert Unwin | Frederick W.K. Tam Centre Nephrology, Univ College London Medical School, Royal Free Hosp, London, UK | Renal Medicine, Imperial College Kidney and Transpl Inst, Hammersmith Hosp, London, UK | Centre Cell Signalling, Barts Cancer Inst, Bart's and London School of Medicine, Queen Mary Univ London, London, UK FP029 TWEAK UP-REGULATES ENDOTHELIN-1 SYSTEM IN HUMAN ENDOTHELIAL CELLS Diana Medrano-Andres | Vanesa Lopez-Martinez | Patricia Martinez-Miguel | Jose Luis Cano | Ignacio Arribas | Manuel Rodiguez-Puyol | Susana LopezOngil Fund Investigacion Biomedica Hosp Principe de Asturias, Alcala de Henares, Madrid, Spain | Univ Alcala, Alcala de Henares, Madrid, Spain « FP030 ENDOTHELIAL DYSFUNCTION PROMOTES THE TRANSITION FROM COMPENSATORY RENAL HYPERTROPHY TO KIDNEY INJURY AFTER UNILATERAL NEPHRECTOMY IN MICE Hiroyuki Kadoya | Hajime Nagasu | Minoru Satoh | Tamaki Sasaki | Naoki w w w. e r a e d t a 2 01 2 . o r g 109 FRIDAY, MAY 25 FP023 RAPAMYCIN PROMOTES PODOCYTE MIGRATION THROUGH THE UPREGULATION OF UROKINASE RECEPTOR Yung-Tsung Chiu | Ming-Ju Wu Taichung Veterans General Hosp, Taichung, Taiwan 49th ERA-EDTA CONGRESS P O S T E R S Kashihara Kawasaki Medical School FRIDAY, MAY 25 FP031 CITRATE REDUCES CALCIUM PRECIPITATION FORMATION AND PARTICLE INDUCED INFLAMMATION Emma Lindeberg | Gunilla Grundström Gambro Res, Lund, Sweden FP032 SUPEROXIDE DISMUTASE 1 (SOD1) IN CHRONIC KIDNEY DISEASE Scholze Alexandra | Krueger Katharina | Maier Alexandra | Martin Tepel SDU KI Odense Denmark | Charite Berlin Germany FP033 SIMVASTATIN INHIBITS ANGIOPOIETIN-2 RELEASE AND PRODUCTION – A NOVEL PLEIOTROPIC EFFECT? Chandra C Ghosh | Sascha David | Aditit Mukherjee | Steven G John | Christopher W McIntyre | Hermann Haller | Samir M Parikh Beth Israel Deaconess Medical Center and Harvard Medical School | Royal Derby Hosp, Renal Medicine | Nephrology FP034 INTEGRIN-LINKED KINASE (ILK) MODULATES CELLULAR SENESCENCE REGULATING THE EXPRESSION OF ANTI-AGING GENES Nuria Troyano | Maria Del Nogal | Gemma Olmos | Ines Mora | Sergio De Frutos | Manuel Rodriguez-Puyol | Maria Piedad Ruiz Physiology Dept, Alcala Univ, Alcala de Henares, Madrid, Spain | Univ Alcala, Fac Medicina, Alcala de Henares, Madrid, Spain FP035 DIMERIZATION OF THE CALCIUM-SENSING RECEPTOR AND RESPONSE TO CINACALCET HCL Hansjörg Rothe | Warren Shapiro | Markus Ketteler Klinikum Coburg, Coburg, Germany | Brookdale Univ Hosp & Medical Center FP036 THE CALCIUM RECEPTOR CASR AND PARATHYROID HORMONE DETERMINE THE PARACELLULAR PATHWAY PERMEABILITY TO CALCIUM IN THE THICK ASCENDING LIMB Suresh Krishna Ramakrishnan | Alexandre Loupy | Pascal Houillier Cordeliers Res Centre FP037 INTRACELLULAR BLOCKADE OF AT1 RECEPTORS DOWNREGULATES THE (PRO)RENIN RECEPTOR (PRR) GENE EXPRESSION IN MESANGIAL CELLS Luciana Guilhermino Pereira | Mirian Boim | Danielle Aragão | Dulce Casarini Federal Univ São Paulo, São Paulo, Brazil FP038 THE ROLE OF INTERLEUKIN-10 IN THE FIBROSIS AND INFLAMMATION OF UNILATERAL URETERAL OBSTRUCTION IN MICE Yuanmeng Jin | Nan Chen Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ, School Medicine « FP039 ANGIOTENSIN II-INDUCED MITOCHONDRIAL NOX4 IS A MAJOR ENDOGENOUS SOURCE OF OXIDATIVE STRESS IN KIDNEY PROXIMAL TUBUALR CELLS Ju-Young Moon | Yang-Gyun Kim | Sang-Ho Lee | Tae-Won Lee | Chun-Gyoo Ihm | Eun-Young Kim | Hong-Ju Lee | Jeong-Guk Wi | Kyung-Hwan Jeong Kyung Hee Univ Hosp Gangdong, College Medicine, Kyung Hee Univ | Kyung Hee Univ FP040 STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CLEAVAGEACTIVATING PROTEIN (SCAP) MEDIATES THE INFLAMMATORY STRESS 110 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France IN RENAL PROXIMAL TUBULE CELLS Xiong Zhong Ruan | Lung-Chih Li | Zac Varghese | Jin-Bor Chen | Chien-Te Lee | John Moorhead Centre Nephrology, UCL Medical School, Royal Free Campus | Div Nephrology, Dept Internal Medicine | Kaohsiung Chang-Gung Memorial Hosp FP042 ROLE OF CAVEOLIN-3 IN ALTERED PI3K/Akt SIGNALING IN SKELETAL MUSCLE OF PATIENTS WITH CKD Alice Bonanni | Daniela Verzola | Davide Maggi | Giuliano Brunori | Antonella Sofia | Irene Mannucci | Sara Maffioli | Barbara Salani | Elena D'Amato| Stefano Saffioti | Alessandro Laudon | Renzo Cordera | Giacomo Garibotto Dept Internal Medicine, Nephrology Section, Genoa Univ, Genoa, Italy | Dept Internal Medicin, Endocrinology Section, Genoa Univ, Genoa, Italy | Nephrology Section Osp Santa Chiara, Trento, Italy FP043 POTENTIAL RENOPROTECTIVE EFFECT OF CALCITRIOL IN TUBULOINTERSTITIAL FIBROSIS INDUCED BY A PROTEINURIC NEPHROPATHY MODEL Edgar Maquigussa | Mirian Boim | Carine Arnoni | Luciana Guilhermino Pereira Federal Univ São Paulo, São Paulo, Brazil w w w. e r a e d t a 2 01 2 . o r g 111 FRIDAY, MAY 25 FP041 THE UREMIC TOXIN INDOLE-3-ACETIC ACID INDUCES ENDOTHELIAL COX-2 EXPRESSION BY INCREASING OXIDATIVE STRESS Laetitia Dou | Bertrand Gondouin | Claire Cerini | Stephane Poitevin | Philippe Brunet | Francoise Dignat-George | Burtey Stephane INSERM U 1076, Marseille, France 49th ERA-EDTA CONGRESS P O S T E R S HYPERTENSION FRIDAY, MAY 25 FP044 THE UNIQUE RESPONSE OF RENIN AND ALDOSTERONE ACCORDING TO THE AMOUNT OF SODIUM INTAKE IN SODIUM SENSITIVITY Sung Joon Shin | Moo-Yong Rhee | ChiYeon Lim Dongguk Univ Ilsan Hosp FP045 DIFFERENTIAL REGULATION BY ANGIOTENSIN II AND TGF-B1 OF NOTCH SIGNALING IN THE KIDNEY Carolina Lavoz | Raquel Rodrigues-Díez | Sandra Rayego-Mateos | Alberto Benito-Martin | Raul Rodrigues-Diez | Matilde Alique | Alberto Ortiz | Sergio Mezzano | Marta Ruiz-Ortega Cellular Biology in Renal Diseases Lab. Univ Autónoma Madrid, Spain | Dialysis Unit, Fund Jiménez Díaz, Madrid, Spain | Nephrology Div, Univ Austral Chile, Valdivia Chile FP046 ANGIOTENSIN II (ANGII) INDUCES RAPID, PRONOUNCED INCREASES IN GLOMERULAR PERMEABILITY IN VIVO INDEPENDENT OF ITS HEMODYNAMIC ACTIONS Josefin Axelsson | Anna Rippe | Kristinn Sverrisson | Bengt Rippe Lund Univ, Lund, Sweden FP047 CALCITONIN GENE RELATED PEPTIDE, HEME OXYGENASE-1, ENDOTHELIAL PROGENITOR CELLS AND NITRIC OXIDE-DEPENDENT VASODILATION RELATIONSHIPS IN A HUMAN MODEL OF ANGIOTENSIN II TYPE-1 RECEPTOR ANTAGONISM Lorenzo Calò | Lucia Dal Maso | Elisa Pagnin | Paola Caielli Univ Padova, Padova, Italy FP048 SIRT-1, HEME-OXYGENASE-1 AND NO-MEDIATED VASODILATION IN A HUMAN MODEL OF BLUNTED ANGIOTENSIN II TYPE 1 RECEPTOR SIGNALING. IMPLICATION WITH HYPERTENSION Lorenzo Calò | Elisa Pagnin | Lucia Dal Maso | Paola Caielli Univ Padova, Padova, Italy FP049 CAN RENIN INHIBITOR ALISKIREN KEEP ITS EFFECT ON AN EVERY OTHER DAY ADMINISTRATION? George Spanos | Rigas Kalaitzidis | Despina Karasavvidou | Kosmas Pappas | Olga Balafa | Kostas Siamopoulos Dept Nephrology, Univ Hosp Ioannina | Div Nephrology, Dept Internal Medicine, Medical School, Univ Ioannina FP050 ALISKIREN PREVENTS AND AMELIORATES INSULIN RESISTANCE AND AORTIC ENDOTHELIAL FUNCTION AND REMODELING IN FRUCTOSEFED HYPERTENSIVE RATS Te-Chao Fang | Tony J.F. Lee Buddhist Tzu Chi General Hosp, Hualien, Taiwan | Dept Pharmacology, Southern Illinois Univ School Medicine, Springfield, IL, USA FP051 A RANDOMIZED PARALLEL GROUP STUDY OF ALISKIREN VERSUS VALSARTAN IN HYPERTENSIVE PATIENTS WITH ALBUMINURIA George Spanos | Rigas Kalaitzidis | Efthymios Pappas | Eleni Ermeidi | Athina Tatsioni | Kostas Siamopoulos Dept Nephrology, Univ Hosp Ioannina | Div Nephrology, Dept Internal Medicine, Medical School, Univ Ioannina FP052 URINARY EXCRETION OF KLK9 IS ASSOCIATED TO SUSTAINED HYPERTENSION, CARDIAC HYPERTROPHY AND AORTA WALL THICKENING 112 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France « FP053 COMPARATIVE EFFECTIVENESS OF VARIOUS ANTIHYPERTENSIVE AGENTS IN DIABETIC PATIENTS: A SYSTEMATIC REVIEW AND BAYESIAN NETWORK META-ANALYSIS Hon-Yen Wu | Yu-Sen Peng | Kuan-Yu Hung | Tun-Jun Tsai | Yu-Kang Tu | Kuo-Liong Chien Internal Medicine, Far Eastern Memorial Hosp, New Taipei City, Taiwan | Internal Medicine, National Taiwan Univ Hosp, Taipei, Taiwan| Div Biostatistics, Leeds Inst Genetics, Health & Therapeutics, Univ Leeds, Leeds, UK | Grad Inst Epidemiology and Preventive Medicine, National Taiwan Univ, Taipei, Taiwan FP054 ANTIHYPERTENSIVE EFFECT OF CHOLECALCIFEROL DURING WINTER MONTHS IN PATIENTS WITH HYPERTENSION Thomas Larsen | Frank H Mose | Annebirthe B Hansen | Erling B Pedersen Dept Medical Res, Holstebro Hosp | Dept Clinical Biochemistry, Holstebro Hosp FP055 EFFECT OF PARICALCITOL IN HYPERTENSION AND RENAL DAMAGE INDUCED BY INHIBITION OF NITRIC OXIDE SYNTHASE IN RATS Yasmir Quiroz | Maria Rivero | Keila Yaguas | Bernardo Rodriguez-Iturbe Inst Venezolano Investigaciones Científicas, IVIC, Maracaibo, Venezuela | Hosp Univ Maracaibo FP056 MARKERS OF ENDOTHELIAL CELL DYSFUNCTION MIGHT PREDICT THE PROGRESSION TO OVERT PREECLAMPSIA IN WOMEN WITH GESTATIONAL HYPERTENSION Dimitris Xydakis | Marita Sfakianaki | Christina Petra | Eleftheria Maragaki| Ergini Antonaki | Eleni Krasoudaki | Konstantinos Kostakis | Konstantinos Stylianou | Apostolos Papadogiannakis Internal Medicine, Venizeleio Hosp, Greece | Nephrology Dept, Venizleio Hosp, Greece FP057 IS IT A PROMISING MIRACLEOUS THERAPY? HIGH-TONE EXTERNAL MUSCLE STIMULATION ELECTROTHERAPHY IN THE TREATMENTS OF RESISTANT AND IRREVERSIBLE SYMPTOMATIC PERIPHERIC POLYNEUROPATHY WITH DIABETES MELLITUS, CHRONIC KIDNEY DISEASE AND PRIMARY HYPERTENSIVES Yahya Sagliker | Nuray Paylar | A Heidland | A Keck | R Erek | P Kolasin | P S Ozkaynak | H S Sagliker | I Gokcay Cukurova Univ | Sagliker Hypertension Unit | Nephrology, Würzburg Univ| Neurology, Private Adana Hosp | Duzen Labs|Nephrology-Hypertension, Cukurova Univ FP058 EXCESSIVE MATERNAL SALT INTAKE INCREASES PLASMA MARINOBUFAGENIN CONCENTRATION AS WELL AS CAUSES DELAYED HYPERTENSION AND ALBUMINURIA IN MALE OFFSPRING Eberhard Ritz | Nadezda Koleganova | Marie-Luise Gross-Weissmann | Grzegorz Piecha Internal Medicine Div Nephrology, Heidelberg, Germany | Pathology, Heidelberg, Germany | Dept Nephrology, Endocrinology and Metabolic Diseases, Medical Univ Silesia, Katowice, Poland FP059 IMPAIRED EXERCISE-INDUCED PRODUCTION OF ENDOTHELIAL NITRIC OXIDE IN YOUNG ADULT PATIENTS WITH EARLY AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) Natalia Reinecke | Thulio Marquez Cunha | Elisa M . S. Higa | Ita Pfeferman w w w. e r a e d t a 2 01 2 . o r g 113 FRIDAY, MAY 25 Ana Blázquez-Medela | Omar Garcia-Sanchez | Yaremi Quiros | Francisco J. Lopez-Hernandez | Jose M. Lopez-Novoa | Carlos Martinez-Salgado Unidad Fisiopatología Renal y Cardiovascular, Inst Reina Sofía Investigación Nefrológica, Univ Salamanca, Spain | Inst Estudios Ciencias Salud Castilla y León (IECSCYL), Hosp Univ Salamanca, Spain | Univ Salamanca, Salamanca, Spain, | Unidad Investigacion, Hosp Univ Salamanca, Spain 49th ERA-EDTA CONGRESS P O S T E R S Heilberg | Jose Alberto Neder | José Luiz Nishiura | Waldemar Silva Almeida| Nestor Schor UNIFESP, São Paulo, Brazil FRIDAY, MAY 25 FP060 INHIBITION OF URICASE CONCOMITANT TO PHYSIOLOGICAL AMOUNTS OF GLUCOSE-FRUCTOSE HAS A SYNERGISTIC EFFECT ON INCREASING SYSTEMIC AND GLOMERULAR PRESSURES IN RATS Edilia Tapia | Laura G Sanchez-Lozada | Magdalena Cristóbal | Virgilia Soto| Fernando García-Arroyo | Fabiola Monroy-Sánchez | Magdalena Madero | Richard Johnson INC Ignacio Chávez | Univ Colorado FP061 RENOPROTECTIVE EFFECT OF ROSUVASTATIN IN DAHL SALT-SENSITIVE HYPERTENSIVE RATS Sun Moon Kim | Seung Hee Yang | Yon Su Kim Chungbuk National Univ Hosp, Cheongju, Korea | Kidney Res Inst, Seoul, Korea | Seoul National Univ FP062 TUBULAR PROTEINURIA AS AN EARLY SIGN OF RENAL DAMAGE IN PREHYPERTENSION? Sandra Karanović | Margareta Fištrek | Jelena Kos | Ivan Pećin | Vedran Premužić | Mirta Abramović | Vesna Matijević | Dubravka Čvorišćec | Ante Cvitković | Matej Knežević | Milan Bitunjac | Mario Laganović | Bojan Jelaković School Medicine Univ Zagreb, Dept Nephrology, Hypertension and Dialysis, UHC Zagreb, Zagreb, Croatia | Outpatient Clinic Bebrina, Bebrina, Croatia | Outpatient Clinic Slavonski Kobaš, Sl.Kobaš, Croatia | School Medicine Univ Zagreb, Lab Clinical Diagnosis, UHC Zagreb, Zagreb, Croatia | Inst Public Health Brodsko-posavska County, Slavonski Brod, Croatia | General Hosp Dr. Josip Benčević, Slavonski Brod, Croatia FP063 GLYCAEMIC CONTROL INFLUENCES SHORT-TERM BLOOD PRESSURE VARIABILITY IN TYPE 2 DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY Fang Liu | Min Wu | Ping Fu West China Hosp Sichuan Univ FP064 EFFECT OF AMILORIDE AND SPIRONOLACTONE ON RENAL TUBULAR FUNCTION Solveig Klok Matthesen | Thomas Larsen | Thomas Guldager Lauridsen | Henrik Vase | Pia Gjørup Holland | Karen Marie Nykjær | Søren Nielsen | Erling Bjerregaard Pedersen Depts Medical Res and Medicine | Water and Salt Res Center, Aarhus FP065 URINARY NGAL EXCRETION IN HYPERTENSIVE DIABETIC RATS IS THE CONSEQUENCE OF ITS ALTERED TUBULAR HANDLING Ana Blázquez-Medela | Francisco J. Lopez-Hernandez | Omar Garcia-Sanchez| Yaremi Quiros | Maria J. Montero | Jose M. Lopez-Novoa | Carlos MartinezSalgado Unidad Fisiopatología Renal y Cardiovascular, Inst Reina Sofía Investigación Nefrológica, Univ Salamanca, Spain | Univ Salamanca | Inst Estudios Ciencias Salud Castilla y León (IECSCYL), Unidad Investigacion, Hosp Univ Salamanca, Spain FP066 THE EFFECT OF RENAL SYMPATHETIC DENERVATION ON BLOOD PRESSURE; DATA OF 6 AND 12 MONTHS FOLLOW UP Eva Vink | Verloop Willemien | Voskuil Michiel | Spiering Wilko | Vonken Evert-Jan | PJ Blankestijn UMC Utrecht, Utrecht, Netherlands 114 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP068 RENALASE AND CATECHOLAMINES: CAUSATIVE FACTORS OR INNOCENT BYSTANDERS OF HYPERTENSION IN HAEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS Edyta Zbroch | Jolanta Malyszko | Jacek Malyszko | Ewa Koc-Zorawska | Michal Mysliwiec Dept Nephrology, Medical Univ, Bialystok, Poland FP069 EFFECTS OF RECOMBINANT RENALASE ON RENAL DOPAMINE ACTIVITY IN THE RENALASE KNOCKOUT MOUSE MODEL Janete Quelhas-Santos | Paula Serrão | Isabel Soares-Silva | Lieqi Tang | Benedita Sampaio-Maia | Gary Desir | Manuel Pestana Nephrology Res and Development Unit, Fac Medicine, Porto, Portugal | Inst Pharmacology and Therapeutics, Fac Medicine, Univ Porto, Portugal | Dept Medicine, Yale Univ School Medicine, New Haven, Connecticut, USA | Fac Dental Medicine, Univ Porto, Portugal FP070 THE RELATIONSHIP BETWEEN GAMMA-GLUTAMYL TRANSPEPTIDASE AND PULSE WAVE ANALYSIS IN HYPERTENSIVE PATIENT POPULATION Rengin Elsurer | Tarik Demir | Gulperi Celik | Melek Yavas | Ozlem Yavas Dept Internal Medicine, Div Nephrology, Selçuklu Medical Fac, Selçuk Univ, Selçuklu, Konya | Dept Internal Medicine, Selçuklu Fac Medicine, Selcuk Univ, Konya, Turkey FP071 INFORMING PATIENTS ABOUT DIALYSIS - A CALL TO ACTION (RESULTS OF THE 2011 EUROPEAN KIDNEY PATIENTS FEDERATION SURVEY) Mark Murphy Irish Kidney Association FP072 LUMINAL PROTEOLYTIC ACTIVATION OF THE COLLECTING DUCT EPITHELIAL SODIUM CHANNEL (ENAC) AND ITS POTENTIAL ROLE IN RENAL SODIUM REABSORPTION IN VIVO Gregory Jacquillet | Robert J Unwin | Havovi Chichger | David G Shirley UCL Centre Nephrology Royal Free FP073 THE VALUE OF INTRARENAL RESISTIVE INDEX ON RENAL OUTCOMES IN BENIGN NEPHROANGIOSCLEROSIS Alexandru Caraba | Munteanu Andreea | Serban Corina | Romosan Ioan Univ Medicine and Pharmacy Victor Babes Timisoara, Romania FP074 CLINICAL INERTIA IN THE TREATMENT OF HYPERTENSION IN CHRONIC KIDNEY DISEASE Michal Nowicki | Monika Bobik | Agnieszka Pawelec | Joanna Łacisz | Anna Zapała | Katarzyna Bryc Medical Univ Łódź FP075 PRE-PARTUM PROTEINURIA IS A RISK FACTOR FOR SHORT-TERMI HIGH BLOOD PRESSURE PERSISTENCE AFTER DELIVERY Ciro Esposito | Maria Lucia Scaramuzzi | Alessandra Manini | Massimo Torreggiani | Fausta Beneventi | Arsenio Spinillo | Fabrizio Grosjean | Gianluca Fasoli | Antonio Dal Canton Unit Nephrology and Hemodialysis, IRCCS Fond Salvatore Maugeri, Univ Pavia, Pavia, Italy | Unit Nephrology, Dialysis and Transpl, Fond IRCCS Policlinico San Matteo, Univ Pavia, Pavia, Italy | Unit Gynecology and Obstetrics, Fond IRCCS Policlinico San Matteo, Univ Pavia, Pavia, Italy w w w. e r a e d t a 2 01 2 . o r g 115 FRIDAY, MAY 25 FP067 SERIOUS COMPLICATIONS RELATED TO IMPROPER RENAL SYMPATHETIC DENERVATION: A CASE STUDY Simona Zerbi | Luciano A Pedrini AO Bolognini-NephroCare, Seriate, Italy 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FP076 NEWLY DIAGNOSED HYPERTENSION IN ADULT PATIENTS WITH EHEC Chatzykirkou Christos | Schmidt Bernhard M.W. | Nitschke Martin | Kielstein Jan | Michael Claus | Ramazan Leyla | Beneke Jan | Kunzendorf Ulrich | Haller Hermann | Jan Menne Medical School Hannover | Univ Hosp Schleswig-Holstein | Dept Nephrology & Hypertension, Medical School Hannover, Germany FP077 ARTERIAL HYPERTENSION FREQUENCY IN URBAN AND RURAL POPULATION OF SCHOOL CHILDREN Mirjana Pavicevic | Slavica Markovic | Zoran Igrutinovic Univ Clinic Center Kragujevac, Serbia 116 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP078 IMPLEMENTATION AND FIRST RESULTS OF A GERMAN CHRONIC KIDNEY DISEASE REGISTRY Werner Kleophas | B Bieber | BM Robinson | J Duttlinger | D Fliser | G Lonneman | LC Rump | RL Pisoni | FK Port | H Reichel Dialysezentrum Karlstrasse | Arbor Res Collaborative for Health, Ann Arbor, Michigan, USA | Nephrologisches Zentrum Offenburg, Germany | Uniklinik Saarland, Homburg/Saar, Germany | Gemeinschaftspraxis Eickenhof, Langenhagen, Germany | Heinrich-Heine-Univ, Düsseldorf, Germany | Nephrologisches Zentrum Schwennigen, Germany FP079 CKD PROGRESSION IN ELDERLY Radulescu Daniela | Alexandru Ciocalteu | Ionel Alexandru Checherita | Ileana Peride | Daniela Margareta Spataru | Andrei Niculae Saint John Emergency Hosp, Bucharest, Romania | Carol Davila Medicine Univ, Bucharest, Romania FP080 A NEW SIMPLIFIED CKD-EPI EQUATION FOR ELDERLY PEOPLE Koppe Laetitia | Klich Amna | Dubourd Laurence | Hadj-aissa Aoumeur HCL, Hôp E. Herriot Lyon France | Hospices Civils Lyon, Serv Biostatistique, Lyon, France | Univ Claude Bernard Lyon1, Villeurbanne France FP081 ESTIMATION OF GFR IN THE ELDERLY: WHICH FORMULA SHOULD BE USED? Martin Flamant | Jean-Philippe Haymann | Emmanuel Letavernier | Emmanuelle Vidal-Petiot | Jean-Jacques Boffa | Francois Vrtovsnik APHP, Paris, France | INSERM UMR_S 702 | Univ Pierre et Marie Curie, Paris, France | Hôp Bichat, AP-HP FP082 SUPPLEMENTED VERY LOW PROTEIN DIET (S-VLPD) IN ELDERLY UREMIC PATIENTS WITH MULTIPLE COMORBIDITIES Francesco Bianco | Giuseppina Pessolano | Michele Carraro | Giovanni Oliviero Panzetta Azienda Osp Univ Osp Riuniti, Trieste, Italy | Azienda Osp Univ Osp Riuniti, Verona , Italy FP083 ASSESSING GFR IN OLDER ADULTS: COMPARISON OF CURRENT EGFR EQUATIONS WITH MEASURED IOHEXOL-GFR IN A POPULATION BASED SAMPLE Natalie Ebert | Jens Gaedeke | Olga Jakob | Martin Kuhlmann | Peter Martus | Markus van der Giet | Elke Schäffner Charité Univ Medicine Campus Virchow | Charité Univ Medicine Berlin | Vivantes Klinikum im Friedrichshain, Berlin FP084 DIALYSIS IN OCTOGENARIANS: IMPROVED SURVIVAL IN LAST DECADE Izhar Khan | Yvonne Law Renal Unit Aberdeen FP085 COMMUNITY-ACQUIRED HYPONATREMIA IN THE ELDERLY AND VERY ELDERLY PATIENTS: ASSESSMENT OF CLINICAL FEATURES, OUTCOMES AND COSTS Kenan Turgutalp | Onur Ozhan | Ebru Gok Oguz | Ahmet Kiykim Mersin Univ Dept Internal Medicine Mersin, Turkey | Div Endocrinology and Metabolism, Dept Internal Medicine, School of Medicine, Mersin Univ, Mersin, Turkey | Div Nephrology Sanliurfa Hosp, Sanliurfa Turkey | Div Nephrology, Dept Internal Medicine, School of Medicine, Mersin Univ, Mersin, Turkey w w w. e r a e d t a 2 01 2 . o r g 117 FRIDAY, MAY 25 CLINICAL NEPHROLOGY LAB METHODS AND OTHER MARKERS 49th ERA-EDTA CONGRESS P O S T E R S FP086 PREDICTION OF GFR IN AGED PATIENTS FROM BODY ELECTRICAL IMPEDANCE AND SERUM CREATININE Carlo Donadio Dept Internal Medicine, Pisa, Italy FRIDAY, MAY 25 FP087 DOES MEDICAL MANAGEMENT PROGRAM FOR CKD PATIENTS POSTPONE RRT? A 5-YEAR-COHORT Zinat Nadia Hatmi | Mitra Mahdavi-Mazdeh Dept Social Medicine, Tehran Univ Medical Sciences FP088 RENOPROTECTIVE EFFECTS OF SPIRONOLACTONE IN PATIENTS WITH PROTEINURIC KIDNEY DISEASES Enrique Morales | Victor Gutierrez-Millet | Jorge Rojas-Rivera | Ana Huerta| Eduardo Gutierrez | Elena Gutierrez-Solis | Natalia Polanco | Jara Caro | Esther González | Manuel Praga Nephrology Dept Hosp 12 de Octubre | Inst Investigación Hosp 12 de Octubre, Madrid, Spain FP089 ESTIMATION OF PROTENURIA WITH THE PROTEIN TO CREATININE RATIO SHOULD BE ADJUSTED FOR MUSCLE MASS María Paz Marco Mayayo | José Manuel Valdivielso | Montserrat Martínez | Elvira Fernández Giráldez Hosp Univ Arnau Vilanova | IRB Lleida | Univ Lleida FP090 VALIDATION OF SERUM CREATININE (SCr) MEASUREMENT WITH THE POINT-OF-CARE TESTING (POCT) DEVICE i-STAT IN A MEXICAN GOVERNMENT SPONSORED-CHRONIC KIDNEY DISEASE (CKD) SCREENING PROGRAM Gregorio Obrador | Nadia Olvera | Daniela Ortiz de la Peña | Verónica Gutiérrez | Antonio Villa Univ Panamericana School of Medicine, Mexico City, Mexico | Mexican Kidney Foundation, Mexico City, Mexico | Univ Panamericana School of Nursing & Mexican Kidney Foundation, Mexico City, Mexico FP091 THE USE OF ABSOLUTE GLOMERULAR FILTRATION RATE VALUES IMPROVES PERFORMANCE OF CKD-EPI FORMULA Belén Redal-Baigorri Roskilde Univ Hosp, Roskilde, Denmark FP092 ARE MDRD AND COCKROFT GAULT DIFFERENT? THE GREEK EXPERIENCE FROM THE PRESTAR STUDY Konstantinos Sombolos | Dimitris Tsakiris | John Boletis | Dimitrios Vlahakos| Konstantinos Siamopoulos | Vassilios Vargiemezis | Pavlos Nikolaidis | Christos Iatrou | Evgenios Dafnis | Christos Argyropoulos | Konstantinos Xynos Nephrology Clinic, Papanikolaou Hosp, Thessaloniki | Nephrology Clinic, Papageorgiou Hosp, Thessaloniki | Nephrology Clinic, Laiko Hosp, Athens | Nephrology Clinic, Attiko Hosp, Athens | Nephrology Clinic, Ioannina Univ Hosp, Ioannina | Nephrology Clinic, Alexandroupoli Univ Hosp, Alexandroupoli| Nephrology Clinic, AHEPA Hosp, Thessaloniki | Nephrology Clinic, Nikea Hosp, Athens | Nephrology Clinic, PE.PA.G.N.I, Crete Univ Hosp, Iraklio Crete| Abbott Laboratories Hellas FP093 TRANSCUTANEOUS ASSESSMENT OF GLOMERULAR FILTRATION RATE IN CONSCIOUS MICE Daniel Schock-Kusch | Yury Shulhevich | Stefania Geraci | Juergen Hesser | Dzmitry Stsepankou | Sabine Neudecker | Stefan Koenig| Friederike Hoecklin| Johannes Pill | Norbert Gretz | Frank Schweda | Andrea Schreiber Medical Res Center, Medical Fac Mannheim, Univ Heidelberg, Germany | Experimental Radiation Oncology, Medical Fac Mannheim, Univ Heidelberg, Mannheim, Germany | Freudenberg Forschungsdienste KG Weinheim, Ger- 118 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France many | Mektec Europe GmbH Weinheim, Germany | Dept Physiology, Univ Regensburg, Germany FP094 THE RELATIONSHIP BETWEEN KIDNEY DAMAGE AND STROKE TYPES Kosuke Kudo | Tsuneo Konta Yamagata Univ, Yamagata, Japan FP096 DETECTION OF DECREASED GLOMERULAR FILTRATION RATE IN INTENSIVE CARE UNITS: INTEREST OF CYSTATIN C Pierre Delanaye | Etienne Cavalier | Ingrid Masson | Manolie Mehdi | Maillard Nicolas | Bernard Lambermont | Bernard Dubois | Pierre Damas | Jean-Marie Krzesinski | Jerome Morel | Alexandre Lautrette | Mariat Christophe Univ Liège | Serv Nephrologie Dialyse Transpl rénale CHU Saint Etienne, SaintEtienne, France | Saint-Etienne | Serv Néphrologie, Dialyse, Transpl Rénale, Lab Explorations Fonctionnelles Rénales, Hôp Nord, CHU Saint-Etienne | Univ Clermont Ferrand FP097 CREATININE AND/OR CYSTATIN C-BASED GFR ESTIMATION IN HIVINFECTED PATIENTS Amandine Gagneux-Brunon | Pierre Delanaye | Fresard Anne | Lucht Frédéric| Mariat Christophe Serv Néphrologie, Dialyse, Hypertension et Transpl, CHU Saint-Etienne France| Univ Liège | Serv Maladies Infectieuses et Tropicales, CHU de Saint-Etienne | Serv Néphrologie, Dialyse, Transpl Rénale, Lab Explorations Fonctionnelles Rénales, Hôp Nord, CHU Saint-Etienne, FP098 IMPACT OF OBESITY ON SIMPLE CYSTATIN C eGFR IN PATIENTS WITH CHRONIC KIDNEY DISEASE Sebastjan Bevc | Robert Ekart | Radovan Hojs | Maksimiljan Gorenjak | Ludvik Puklavec Dept Nephrology, Dept Dialysis, Clinic for Internal Medicine, Dept Clinical Chemistry, Dept Nuclear Medicine, Univ Medical Center Maribor, Slovenia FP099 URINARY PROCOLLAGEN TYPE III AMINOTERMINAL PROPEPTIDE PREDICTS THE DECLINE OF RENAL FUNCTION IN PRE-DIALYSIS CKD PATIENTS Norihiro Hashimoto | Akira Suzuki | Kensuke Mitsumoto | Morihiro Shimizu| Kakuya Niihata | Akihiro Kawabata | Yusuke Sakaguchi | Terumasa Hayashi | Tatsuya Shoji | Noriyuki Okada | Yoshiharu Tsubakihara Osaka General Medical Center, Osaka, Japan FP100 FIBROBLAST GROWTH FACTOR 23 AND 25-HYDROXYVITAMIN D PREDICT ANNUALIZED ESTIMATED GFR DECLINE Takayuki Hamano | Chikako Nakano | Naohiko Fujii | Yoshitugu Obi | Satoshi Mikami | Kazunori Inoue | Isao Matsui | Noriyuki Okada | Yoshiharu Tsubakihara | Yoshitaka Isaka | Hiromi Rakugi Osaka Univ Grad School of Medicine, Suita, Japan | Dept Geriatric Medicine and Nephrology, Osaka Univ Grad School of Medicine, Osaka, Japan | Dept Internal Medicine, Hyogo Prefectural Nishinomiya Hosp, Hyogo, Japan | Dept Internal Medicine, Higashi-Kohri Hosp, Osaka, Japan | Dept Nephrology and Hypertension, Osaka General Medical Center, Osaka, Japan FP101 RAPID DETERMINATION OF URINARY 2,8-DIHYDROXYADENINE WITH LIQUID CHROMATAOGRAPHY - ELECTROSPRAY TANDEM MASS SPECTROMETRY Vidar Edvardsson | Baldur Sigurðsson | Margret Thorsteinsdottir | Runolfur w w w. e r a e d t a 2 01 2 . o r g 119 FRIDAY, MAY 25 FP095 THE EFFECTS OF GLOBULINURIA ON URINARY CYSTATIN C Seung Ok Choi | Jae Seok Kim | Min Keun Kim | Jae Won Yang | Byoung Geun Han Yonsei Univ Wonju College of Medicine, Wonju, Korea 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 Palsson Landspitali - National Univ Hosp Iceland, Reykjavik, Iceland | Arcticmass, Reykjavik, Iceland FP102 TRADITIONAL INDIRECT-MOXIBUSTION THERMAL THERAPY DECREASE THE RENAL ARTERIAL RESISTIVE INDEX IN HEALTHY VOLUNTEERS Jun Matsumoto | Nagisa Miyazaki | Ichijiro Murata | Gakuro Yoshida | Kentaro Morishita | Hiroaki Ushikoshi | Kazuhiko Nishigaki | Shinji Ogura | Shinya Minatoguchi Div Cardiology, Gifu Univ Grad School of Medicine | Dept Cardiology, Respirology & Nephrology, Gifu Univ Grad School of Medicine, Gifu, Japan | Advanced Critical Care Centre, Gifu Univ Hosp, Gifu, Japan FP103 LONG-TERM LITHIUM TREATMENT AND THE RISK OF RENAL FAILURE: A DECISION ANALYSIS Ursula Werneke | Michael Ott | Ellinor Salander-Renberg | David Taylor | Bernd Stegmayr Dept Clinical Sciences Div Psychiatry, Umeå Univ, Umeå, Sweden | Pharmacy Dept South London and Maudsley NHS Foundation Trust and Inst Pharmaceutical Sciences, King’s College, London, UK | Inst Public Health and Clinical Medicine, Umeå Univ, Umeå, Sweden FP104 A FRENCH CONNECTION BETWEEN MICROHEMATURIA AND URETHRITIS Stanislav Surel | Martina Wenzlova Nephrology Brno, Czech Republic FP105 RENAL ABNORMALITIES AMONG PATIENTS WITH SICKLE CELL DISEASE – A COHORT OF 21 PATIENTS IN BRAZIL Geraldo Silva Junior | Ana Patricia Vieira | Amanda Couto Bem | Marilia Alves | Alba Torres | Gdayllon Meneses | Alice Martins | Alexandre Liborio | Elizabeth Daher School of Medicine, Univ Fortaleza, Fortaleza, Brazil | School of Medicine, Federal Univ Ceara, Fortaleza, Brazil | Dept Clinical Analysis and Toxicology, Federal Univ Ceara, Fortaleza, Brazil FP106 MOLECULAR EVIDENCE OF EXPOSURE TO ARISTOLOCHIC ACID (AA) IN THE BALKAN ENDEMIC NEPHROPATHY (BEN) REGION MEHEDINTI IN ROMANIA Gheorghe Gluhovschi | Mirela Modilca | Liviu Daminescu | Cristina Gluhovschi | Silvia Velciov | Ligia Petrica | Florica Gadalean | Cristian Balgradean | Heinz H. Schmeiser Univ Medicine and Pharmacy Timisoara, Romania | Renamed Dialysis Center, Drobeta Turnu Severin, Mehedinti, Romania | Emergency Clinical County Hosp Timisoara, Romania | Victor Babes Univ Medicine and Pharmacy Timisoara, Romania | German Cancer Res Center (DKFZ), Res Group Genetic Alterations in Carcinogensis, Heidelberg, Germany FP107 EFFECT OF HYPEROXALURIA ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE IN WOMEN WITH RECURRENT UNCOMPLICATED PYELONEPHRITIS Mykola Kolesnyk | Natalia Stepanova | Liudmyla Surzhko | Natalia Stashevska State Inst Nephrology National Academy of Medical Sciences, Kyiv, Ukraine FP108 EFFICACY AND SAFETY OF ORAL FEBUXOSTAT IN SUBJECTS WITH MODERATE-TO-SEVERE CHRONIC KIDNEY DISEASE (CKD): A PILOT STUDY Vassilis Filiopoulos | Dimitrios Hadjiyannakos | Dimitrios Arvanitis | Konstantinos Panagiotopoulos | Dimosthenis Vlassopoulos Amalia Fleming General Hosp, Athens, Greece | Nephrology Dept, Amalia Fleming General Hosp, Athens, Greece | Biochemistry Dept, Amalia Fleming General Hosp, Athens, Greece 120 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP110 PREVALENCE AND CHARACTERISTICS OF NEPHROCALCINOSIS IN A NEW LARGE OUTPATIENTS UNIT: RARE BUT NOT SO RARE..... Olga Randone | Martina Ferraresi | Emiliano Aroasio | Agostino Depascale | Stefania Scognamiglio | Valentina Consiglio | Giorgina Barbara Piccoli Nephrology, Lab, Radiology, ASOU San Luigi, Univ Torino, Italy FP111 VALIDATION OF ABRAHAMS FORMULA ESTIMATING EXTRACELLULAR VOLUME Belén Redal-Baigorri | Line Vedel Jensen Roskilde Univ Hosp, Roskilde, Denmark | Copenhagen Univ, Copenhagen, Denmark FP112 THE EFFECT OF VARIOUS TYPES OF THE RENIN-ANGIOTENSIN-ALDOSTERON SYSTEM BLOCKADE ON PROTEINURIA IN CHRONIC NON-DIABETIC KIDNEY DISEASE: A DOUBLE-BLIND CROSS-OVER RANDOMISED CONTROLLED TRIAL Slawomir Lizakowski | Leszek Tylicki | Przemyslaw Rutkowski | Marcin Renke| Beata Sulikowska | Rafal Donderski | Rafal Bednarski| Zbigniew Heleniak| Milena Przybylska | Jacek Manitius | Boleslaw Rutkowski Dept Nephrology, Transpl and Internal Medicine, Medical Univ Gdansk | Dept General Nursing, Medical Univ Gdansk | Dept Nephrology, Hypertension and Internal Medicine, Nicolaus Copernicus Univ Toruń, Collegium Medicum Bydgoszcz, Poland FP113 HEREDITARY THROMBOPHILIA AS A CAUSE OF RENAL TMA NOT ASSOCIATED WITH ANTIPHOSPHOLIPID SYNDROME Larisa Bobrova | Natalia Kozlovskaya I.M. Sechenov First Moscow State Medical Univ FP114 PROGNOSTIC VALUE OF URINARY CONCENTRATION OF LIVER-TYPE FATTY ACID-BINDING PROTEIN IN CHRONIC KIDNEY DISEASE Kyoko Kanayama | Midori Hasegawa | Fumihiko Kitagawa | Jyunichi Ishii | Yukio Yuzawa Fujita Health Univ School of Medicine, Toyoake, Japan | Lab Clinical Medicine, Fujita Health Univ, Toyoake, Japan | Joint Res Lab Clinical Medicine, Fujita Health Univ School of Medicine, Toyoake, Japan FP115 FACTORS CONTRIBUTING TO RESPONSE TO ORAL SODIUM BICARBONATE IN PATIENTS WITH CHRONIC KIDNEY DISEASE: CRITICAL LEVEL IDENTIFIED BY RECEIVER OPERATOR CHARACTERISTICS CURVE IN SLOWING CHRONIC KIDNEY DISEASE PROGRESSION Kentaro Tanaka | Ken Sakai | Shigeko Hara | Yasunori Suzuki | Yoshihide Tanaka | Atsushi Aikawa Dept Nephrology, Toho Univ School of Medicine FP116 PROGRESSION OF CKD IN HIV-INFECTED PATIENTS: A SURVEY AT A SINGLE MAJOR CENTER HOSPITAL IN TOKYO Fumihiko Hinoshita | Naoto Hamano | Emi Sasaki | Asami Kato | Takashi Katsuki | Ai Katsuma | Eri Imai | Maki Shibata | Manami Tada | Takuro Shimbo | w w w. e r a e d t a 2 01 2 . o r g 121 FRIDAY, MAY 25 « FP109 REDUCED Γ-CARBOXYLASE ACTIVITY IN UREMIA- A POSSIBLE MECHANISM OF UREMIC VASCULAR CALCIFICATION Nadine Kaesler | Thomas Schettgen | Elke Magdeleyns | Vincent Brandenburg| Cees Vermeer | Jürgen Floege | Thilo Krüger Medical Clinic II, Nephrology, Univ Clinic RWTH Aachen, Germany | Inst and Out-patient Clinic Occupational Medicine , Univ Clinic RWTH Aachen, Germany | VitaK BV, Univ Maastricht, Netherlands | Medical Clinic I, Cardiology, Univ Clinic RWTH Aachen, Germany| VitaK BV, Univ Maastricht, Netherlands| Medical Clinic II, Nephrology, Univ Clinic RWTH Aachen, Germany | Medical Clinic II, Nephrology, Univ Clinic RWTH Aachen, Germany 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 Yoshimi Kikuchi | Shinichi Oka Dept Nephrology, Dept Clinical Res and Informatics, Res Inst, AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan FP117 CLASSIFICATION OF HIV-INFECTED PATIENTS WITH CHRONIC KIDNEY DISEASE BY A COMBINATION OF ALBUMINURIA AND ESTIMATED GLOMERULAR FILTRATION RATE Takashi Muramatsu | Naoki Yanagisawa | Katsuyuki Fukutake | Yasuyuki Yamamoto | Atsushi Ajisawa | Ken Tsuchiya | Kosaku Nitta| Minoru Ando Dept Lab Medicine, Tokyo Medical Univ, Tokyo, Japan | Dept Infectious Diseases and Nephrology, Tokyo Metropolitan Komagome Hosp, Tokyo, Japan | Dept IV Internal Medicine, Tokyo Women's Medical Univ, Tokyo, Japan FP118 THE ROLE OF HYPOXIA INDUCIBLE FACTOR 1Α IN THE PATHOGENESIS OF TUBULAR EPITHELIAL CELLS APOPTOSIS INDUCED BY ALBUMIN OVERLOAD Xianhui Liang | Pei Wang | Zhangsuo Liu | Zhanzheng Zhao First Affiliated Hosp Zhengzhou Univ FP119 ASSOCIATION OF BIRTH WEIGHT WITH RISK FACTORS FOR CHRONIC KIDNEY DISEASE IN RURAL CAUCASIAN AND ABORIGINAL CANADIANS Valerie Luyckx | Samantha Bowker | Alison Miekle | Ellen Toth Univ Alberta, Edmonton, Canada FP120 THE RENAL RESPONSE TO A PROTEIN CHALLENGE IS IMPAIRED IN INDIVIDUALS WITH PROMINENT TUBULO-INTERSTITIAL INVOLVEMENT Ricardo Heguilen | Ana Malvar | Ricardo Hermes | Lilian Cohen | Graciela Muguerza | Bruno Lococo | Amelia Bernasconi Hosp Juan A Fernández FP121 EFFECTS OF ANTIOXIDANTS IN CHRONIC KIDNEY DISEASE: 12-MONTHLY SUPERVISION Olena Loboda | Iryna Dudar | Viktor Krot | Viktoria Alekseeva Inst Nephrology NAMS of Ukraine, Kyiv, Ukraine | Dept Efferesis Technology, Inst Nephrology NAMS of Ukraine, Kyiv, Ukraine FP122 PROTEIN C AND PROTEIN S DEFICIENCIES ARE POTENTIAL RISK FACTORS FOR HEMODAILYSIS PATIENTS Mayuri Ichinose | Naru Sasagawa | Katstuhide Toyama | Akira Saito | Yuzo Kayamori | Dongchon Kang Yokohama Dai-ichi Hosp, Yokohama | Dept Clinical Chemistry and Lab Medicine, Kyushu Univ FP123 RELATIVE LYMPHOCYTE COUNT TO PREDICT RENAL PROGRESSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE Hyun Woo Kim Jeju National Univ Hosp FP124 PREVALENCE AND MORTALITY OF CHRONIC KIDNEY DISEASE IN MYELOMA PATIENTS: AN ASSESSMENT BY RISK CATEGORY SYSTEM COMBINED PROTEINURIA WITH KIDNEY FUNCTION Kosuke Yoshioka | Minoru Ando | Masaki Hara | Kazuteru Ohashi | Ken Tsuchiya | Kosaku Nitta Dept Nephrology and Hematology, Tokyo Metropolitan Komagome Hosp, Tokyo, Japan | Dept Nephrology, Dept Hematology, Tokyo Metropolitan Komagome Hosp, Tokyo, Japan | Dept IV Internal Medicine, Tokyo Women's Medical Univ, Tokyo, Japan FP125 VALIDITY OF URIC ACID TEST IN DIAGNOSIS OF GOUT NEPHROPATHY 122 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Adelya Maksudova | Tamila Khalfina Kazan Medical Univ, Kazan, Russia FP127 INCREASED LEVELS OF INDOLEAMINE 2,3-DIOXYGENASE (IDO) ACTIVITY AND REGULATORY T CELLS IN HENOCH-SCHOENLEIN PURPURA Elisa Loiacono | Roberta Camilla | Valentina Daprà | Laura Morando | Rachele Gallo | Licia Peruzzi | Margherita Conrieri | Manuela Bianciotto | Francesca M. Bosetti | Rosannna Coppo Nephrology, Dialysis, Transpl, R. Margherita Hosp, Turin | Emergency Pediatric Dept, R. Margherita Hosp, Turin FP128 CLINICAL BENEFITS ON SECONDARY HYPERPARATHYROIDISM AND CHRONIC KIDNEY DISEASE PROGRESSION OF SEVELAMER TREATMENT ON PRE-DIALYSIS PATIENTS: TWO YEARS FOLLOW - UP Luca Di Lullo | Fulvio Floccari | Rodolfo Rivera | Antonio Granata | Rossella Faiola | Cherubino Feliziani | Annalisa Villani | Moreno Malaguti | Alberto Santoboni Dept Nephrology and Dialysis - L. Parodi Delfino Hop - Colleferro (Roma) - Italy| Dept Nephrology and Dialysis S.Paolo Hosp - Civitavecchia (Roma) Italy| Dept Nephrology - S. Gerardo Hosp - Monza (Italy) | Dept Nephrology and Dialysis S.Giovanni di Dio Hosp - Agrigento (Italy) | Post-Grad School Nephrology Tor Vergata Univ (Roma) - Italy FP129 CARDIOVASCULAR ROLE OF PARACALCITOL IN NON DIALYSIS CKD PATIENTS Kollia Kyriaki | John Droulias Renal Unit, General Hosp Livadia Greece FP130 AA-AMYLOIDOSIS RISK FACTORS IN PATIENTS WITH DIFFERENT GENETIC VARIANTS OF FAMILIAL MEDITERRANEAN FEVER Marina Bogdanova | Vilen Vilevich Rameev | Armine Hachaturovna Simonyan| Lidia Vladimirovna Kozlovskaya Lomonosov Moscow State Univ, Moscow, Russian Federation | I.M. Sechenov First Moscow State Medical Univ, Moscow, Russian Federation | Yerevan State Medical Univ after M. Heratsi, Yerevan, Armenia FP131 ATHEROSCLEROSIS IN PATIENTS WITH SECONDARY AMYLOIDOSIS DUE TO FAMILIAL MEDITERRANEAN FEVER Mehmet Rıza Altıparmak | Sinan Trabulus | Nilgül Akalın | Ayşe Serap Yalın | Asım Esenkaya | Serkan Feyyaz Yalın | Kamil Serdengeçti Istanbul Univ Cerrahpasa Medical Fac Dept Internal Medicine, Istanbul, Turkey| Istanbul Univ Cerrahpasa Medical Fac Dept Radiodiagnostic, Istanbul, Turkey FP132 DYSFUNCTION OF RENAL SYSTEM COULD MODULATE ACE AND ACE2 PROFILE IN CHRONIC KIDNEY DISEASE PATIENTS Danielle Arita | Tatiana Cunha | Juliana Perez | Maísa Sakata | Lilian Arita | Marie Nogueira | Zaira Jara | Nádia Souza | Dulce Casarini Federal Univ São Paulo, São Paulo, Brazil FP133 URINARY AMMONIUM EXCRETION, METABOLIC ACIDOSIS AND PROGRESSION TOWARD END-STAGE RENAL DISEASE Marie Metzger | Marion Vallet | Jean-Philippe Haymann | Martin Flamant | François Vrtovsnik | Jean-Jacques Boffa | Alexandre Karras| Marc Froissart | w w w. e r a e d t a 2 01 2 . o r g 123 FRIDAY, MAY 25 FP126 QUANTIFICATION OF P-CRESOL SULPHATE IN HUMAN PLASMA OF UREMIC PATIENTS BY MRM Aurora Cuoghi | Elisa Bellei | Marialuisa Caiazzo | Stefania Bergamini | Giuseppe Palladino | Emanuela Monari | Aldo Tomasi Univ Modena and Reggio Emilia, Modena, Italy | Scientifc Affairs, Bellco, Mirandola, Italy 49th ERA-EDTA CONGRESS P O S T E R S Bénédicte Stengel | Pascal Houillier Inserm U1018, Villejuif, France | Hôp Tenon, Paris, France | Hôp Bichat, Paris, France | HEGP, Paris , France FRIDAY, MAY 25 FP134 DECREASE IN CIRCULATING DENDRITIC CELL PRECURSORS - A NEW BIOMARKER OF CARDIOVASCULAR DISEASE IN CHRONIC KIDNEY DISEASE? Katharina Paul | Daniel Kretzschmar | Atilla Yilmaz | Barbara Bärthlein | Stephanie Titze | Hans-Reiner Figulla | Gunter Wolf | Martin Busch Univ Hosp Jena, Germany | Univ Erlangen-Nürnberg, Germany FP135 IL-6 LEVEL IN THE SERUM AND URINE AS MARKER OF CRYOGLOBULINAEMIC GLOMERULONEPHRITIS ACTIVITY IN PATIENTS WITH CHRONIC HEPATITIS C Yulia Korotchaeva | Nadezda Gordovskaya | Lidia Kozlovskaya I.M. Sechenov First Moscow State Medical Univ FP136 SEVERITY OF PERIODONTITIS IS ASSOCIATED WITH INCREASED ARTERIAL STIFFNESS IN PROGRESSIVE CHRONIC KIDNEY DISEASE (CKD) PATIENTS Khai Ping Ng | Praveen Sharma | Stephanie Stringer | Mark Jesky | Mary Dutton | Charles Ferro | Paul Cockwell Univ Hosp Birmingham, Birmingham, UK | Birmingham Dental Hosp, Birmingham, UK | Univ Bimingham, UK | Queen Elizabeth Hosp Birmingham, UK FP137 THE ASSOCIATION OF CHEMERIN LEVELS WITH CHANGES OF GLOMERULAR FILTRATION RATE IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS Sung Jin Moon | Sang Cheol Lee | Soo Young Yoon | Jung Eun Lee | Seung Jin Han Myongji Hosp, Kwandong Univ College of Medicine, Goyang, Korea | Yongin Severance Hosp | Ajou Univ Hosp, Ajou Univ School of Medicine, Suwon, Korea FP138 ADAM17 IS AN ACTIVITY MARKER OF GRANULOMATOSIS WITH POLYANGIITIS Bertram Anna | Torsten Kirsch | Lovric Svjetlana | Park Joon-Keun | Becker Jan| Kegel Johanna | Hermann Haller | Marion Haubitz Hannover Medical School, Hannover, Germany | Nephrology | Klinikum Fulda, Germany FP139 USE OF ACEI OR ANGIOTENSIN BLOCKERS IS ASSOCIATED WITH HIGHER EGFR BUT NOT PRIOR RENAL DECLINE IN A HIGH RISK CKD SECONDARY CARE COHORT Stephanie Stringer | Mark Jesky | Khai Ping Ng | Mary Dutton | Charles Ferro| Paul Cockwell Univ Bimingham, UK | Univ Hosp Birmingham, Birmingham, UK | Queen Elizabeth Hosp Birmingham, UK FP140 LEFT VENTRICLE HYPERTROPHY AND GLOMERULAR FILTRATION RATE IN PATIENTS WITH CHRONIC KIDNEY DISEASE Alexey Smirnov | Ivan Kayukov | Nowel Rafrafi | Olga Degtereva | Vladimir Dobronravov St.-Petersburg State Medical Univ n.a. I.P. Pavlov FP141 ANEMIA CONTROL IN CHRONIC KIDNEY DISEASE PATIENTS WITH ONCE MONTHLY C.E.R.A. AND IMPACT ON THE PROGRESSION OF THE RENAL DISEASE Michael Koch | Heidenreich Stefan Nephrologisches Zentrum, Mettmann | KfH-Nierenzentrum, Aachen 124 w w w. e r a e d t a 2 01 2 . o r g PARIS, France FP142 IS URINARY ACTIVE TGF-BETA A POTENTIAL DIAGNOSTIC MARKER IN ENDEMIC NEPHROPATHY? Živka Dika | Marie-Hélène Antoine | Cécile Husson | Jelena Kos | Maja Mišić| Mirjana Fuček | Dubravka Čvorišćec | Marie-Françoise Bourgeade | Joëlle L. Nortier | Bojan Jelaković School of Medicine Univ Zagreb, UHC Zagreb, Dept Nephrology, Hypertension and Dialysis, Zagreb, Croatia | Experimental Nephrology Unit, Fac Medicine, Univ Libre de Bruxelles, Belgium | General Hosp Dr. Josip Benčević, Slavonski Brod, Croatia | School of Medicine Univ Zagreb, UHC Zagreb, Lab for Clinical Diagnosis, Zagreb, Croatia | INSERM U785, Centre Hépato-biliaire, Hôp Paul Brousse, Villejuif, France | Dept Nephrology, Dialysis and Renal Transpl, Erasme Hosp, Univ Libre de Bruxelles, Brussels, Belgium FP143 EVALUATION OF THE ABSOLUTE RENAL RISK DIALYSIS / DEATH IN PRIMARY IGA NEPHROPATHY: EXPERIENCE OF THE NEPHROLOGY DEPT THE UNIV HOSP CASABLANCA El Hafid Nawal | Mtioui Naoufal | Mifdal Nabila | El Mountahi Fadwa | El Khyat Salma | Bennani Nisrine | Zamd Mohamed | Medkouri Guislaine | Benghanem Mohamed Gharbi | Ramdani Benyounes Dept Nephrology Uh Ibn Rochd Casablanca Morocco FP144 NEW BIOMARKERS FOR EARLY DETECTION ON RENAL INJURY IN HIV INFECTED PATIENTS Gianina Gabriela Sotila | Rugina Sorin | Dumitru Irina Magdalena | Cernat Roxana | Rugina Claudia Clinical Infectious Diseases Hosp, Centre Excellence Res Hiv Clinic Nephrology, Ovidius Univ, Constanta, Romania FP145 NEED FOR EXERCISE AMONG PATIENTS WITH HYPERTENSION AND RENAL DISEASE (NEPHROS TRIAL): RANDOMIZED CONTROLLED TRIAL: PRELIMINARY RESULTS Franklin Correa Barcellos | Pedro Hallal Hallal | Maristela Bohlke | Fabricio Boscolo Del Vechio | Annelise Reges | Ina Santos | Grégore Mielke | Milena Fortes | Bruno Antunez PostGrad Program Epidemiology, Federal Univ Pelotas, Brazil | Catholic Univ Pelotas | Superior School Physical Education | Catholic Univ Pelotas FP146 RENAL SHAPE AND FUNCTION IN YOUNG ADULT MEN BORN AFTER INTRAUTERINE GROWTH RETARDATION AND PRETERM BIRTH Mario Laganović | Ivana Vuković Lela | Sandra Karanović | Jadranka Serić| Vedran Premužić | Jelena Kos | Margareta Fištrek | Živka Dika | Ljiljana Fodor| Tajana Željković Vrkić | Bojan Jelaković Dept Nephrology, Arterial Hypertension and Dialysis Univ Hosp Center Zagreb, Zagreb, Croatia | School of Medicine Univ Zagreb, Zagreb, Croatia | Lab Clinical Diagnosis Univ Hosp Center Zagreb, Zagreb, Croatia FP147 VARIATIONS IN THE PREVALENCE OF HIT ANTIBODIES DURING THE PERIOD 2004-2012. RELEVANCE TO HEPARIN CONTAMINANTS Vinod Bansal | Debra Hoppensteadt | Jawed Fareed Loyola Univ Medical Center w w w. e r a e d t a 2 01 2 . o r g 125 FRIDAY, MAY 25 MAY 24-27, 2012 P O S T E R S 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 CLINICAL NEPHROLOGY EPIDEMIOLOGY I FP148 PLASMA RENIN ACTIVITY AND ALDOSTERONE-TO-RENIN RATIO ARE ASSOCIATED WITH THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE: THE OHASAMA STUDY Michihiro Satoh | Shiho Terata | Masahiro Kikuya | Takayoshi Ohkubo | Takanao Hashimoto | Azusa Hara | Takuo Hirose | Taku Obara | Hirohito Metoki| Ryusuke Inoue | Kei Asayama | Masaaki Nakayama | Atsuhiro Kanno | Kazuhito Totsune | Haruhisa Hoshi | Hiroshi Satoh | Hiroshi Sato | Yutaka Imai Tohoku Univ Grad School Pharmaceutical Sciences, Sendai, Japan | Shiga Univ Medical Science, Otsu City, Japan | Res Center Cancer Prevention and Screening National Cancer Center, Tokyo, Japan | College de France, Paris, France | Leuven Studies Coordinating Centre, Leuven, Belgium | Fukushima Medical Univ, Fukushima, Japan | Tohoku Fukushi Univ, Sendai, Japan | Ohasama Hosp, Iwate, Japan | Tohoku Univ Grad School of Medicine and Pharmaceutical Sciences, Sendai, Japan FP149 DAILY WATER INTAKE AND RISK OF MORTALITY: LONGITUDINAL COHORT STUDY Suetonia Palmer | Wong Germaine | Samuel Iff | Jonathan Craig | Paul Mitchell| Jie Jin Wang | Giovanni Strippoli Univ Otago Christchurch, New Zealand | Centre Kidney Res, Westmead, Australia | Univ Sydney, Australia | Cochrane Renal Group, Sydney, Australia « FP150 META-ANALYSIS: STATIN THERAPY TO PREVENT DEATH AND MAJOR CARDIOVASCULAR EVENTS IN PEOPLE WITH CHRONIC KIDNEY DISEASE Suetonia Palmer | Jonathan Craig | Sankar Navaneethan | Marcello Tonelli | Fabio Pellegrini | Giovanni Strippoli Univ Otago Christchurch, New Zealand | Univ Sydney | Cleveland Clinic | Univ Alberta, Edmonton, Alberta | Consorzio Mario Negri Sud | Cochrane Renal Group, Sydney, Australia FP151 SERUM CREATININE IS ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS IN MALES: RESULTS OF A POPULATION-BASED STUDY (SHIP) Sylvia Stracke | Friedlinde Ernst | Daniel Robinson | Christian Schwahn | Ulrich John | Stephan B. Felix | Henry Völzke Nephrology, Greifswald, Germany | Cardiology, Epidemiology, Univ Medicine Greifswald, Germany | Ernst-Moritz-Arndt Univ Greifswald FP152 CAROTID ARTERY REMODELING AND ENDOTHELIAL DYSFUNCTION IN PREDIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE Ihor Mysula | Anatoliy Gozhenko | Oleksandr Susla I.Ya. Horbachevsky Ternopil State Medical Univ, Ternopil, Ukraine | Ukrainian Scientific-Res Inst Transport Medicine, Odesa, Ukraine | Ternopil Univ Hosp, Ternopil, Ukraine FP153 AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION (RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICATIONS IN NON-DIALYSIS CKD Roberto Minutolo | Francis B. Gabbai | Rajiv Agarwal | Vincenzo Bellizzi | Felice Nappi | Giuseppe Conte | Luca De Nicola Div Nephrology, Second Univ Naples, Naples, Italy | VA San Diego Healthcare System and Univ California San Diego, CA, USA | Dept Medicine, Indiana Univ, and Richard L. Roudebush Veterans Affairs Medical Center, IN, USA | Nephrology Unit, County Hosp, Salerno | Nephrology Unit, County Hosp, Nola FP154 ELASTIN DEGRADATION IS ASSOCIATED WITH PROGRESSIVE AORTIC STIFFENING AND ALL-CAUSE MORTALITY IN PRE-DIALYSIS CKD Edward Smith | Laurie Tomlinson | Martin Ford | Lawrence McMahon | Cha- 126 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France kravarthi Rajkumar | Stephen Holt Monash Univ | Dept Clinical Pharmacology, Addenbrooke’s Hosp | Brighton and Sussex Medical School FP156 HEIGHT AS NORMALISATION INDEX OF GLOMERULAR FILTRATION RATE IN PATIENTS WITH EXTREME BODY SIZES Belén Redal-Baigorri | Knud Rasmusen | James Goya Heaf Roskilde Univ Hosp, Roskilde, Denmark | Roskilde Univ Hosp, Roskilde, Denmark | Herlev Univ Hosp, Herlev, Denmark FP157 HOW ARE EARLY CKD PATIENTS REFERRED TO NEPHROLOGISTS BY OTHER SPECIALTIES? Konstantinos Sombolos | Dimitrios Tsakiris | Boletis John | Dimitrios Vlahakos| Konstantinos Siamopoulos | Vassilios Vargiemezis | Pavlos Nikolaidis| Christos Iatrou | Evgenios Dafnis | Christos Argyropoulos | Konstantinos Xynos Director Nephrology Clinic, Papanikolaou Hosp, Thessaloniki | Director Nephrology Clinic, Papageorgiou Hosp, Thessaloniki | Director Nephrology Clinic, Laiko Hosp, Athens | Nephrology Clinic, Attiko Hosp, Athens | Nephrology Clinic, Ioannina Univ Hosp, Ioannina | Nephrology Clinic, Alexanroupoli Univ Hosp, Alexandroupoli | Nephrology Clinic, AHEPA Hosp, Thessaloniki| Nikea Hosp, Athens | Director Nephrology Clinic, PE.PA.G.N.I, Crete Univ Hosp, Iraklio Crete | Abbott Laboratories Hellas S.A. FP158 OXIDATIVE STRESS AND KIDNEY EFFECTS IN WORKERS WITH LOW OCCUPATIONAL EXPOSURE TO CADMIUM Hambach Ramona | Droste Jos | François Guido | D'Haese Patrick | Lison Dominique | Manuel-Y-Keenoy Begona | De Schryver Antoon| van Sprundel Marc Univ Antwerp, Antwerp, Belgium | Catholic Univ Louvain FP159 PHYSICAL FUNCTION AT START OF RENAL REPLACEMENT THERAPY INDEPENDENT PREDICTOR OF SURVIVAL Matthias Hellberg | Eva Maria Wiberg | Peter Höglund | Ole Simonsen | Naomi Clyne Dept Nephrology and Transpl Lund, Skane Univ Hosp | Competence Centre Clinical Res Lund, Skane Univ Hosp FP160 LOW INTENSITY, HOME-BASED EXERCISE IMPROVES PHYSICAL CAPACITY IN DIALYSIS PATIENTS: THE EXCITE STUDY (EXcercise Introduction To Enhance performance in dialysis) Fabio Manfredini | Davide Bolignano | Stefania Rastelli | Antonio Barillà | Silvio Bertoli | Daniele Ciurlino | Piergiorgio Messa | Fabrizio Fabrizi | Alessandro Zuccalà | Renato Rapanà | Pasquale Fatuzzo | Francesco Rapisarda | Graziella Bonanno | Luigi Lombardi | Luciano De Paola | Adamasco Cupisti| Giorgio Fuiano | Gaetano Lucisano | Giovanni Tripepi | Luigi Catizone | Carmine Zoccali | Francesca Mallamaci EXCITE Working Group | CNR IBIM and Osp Riuniti, Reggio Cal. FP161 ASSOCIATION BETWEEN LIVER ENZYMES AND PROTEINURIA STRATIFIED ON DRINKING STATUS: A NATIONWIDE CROSS-SECTIONAL STUDY Toshihiro Ishigami | Ryohei Yamamoto | Yasuyuki Nagasawa | Yoshitaka Isaka| Tsuneo Konta | Kunitoshi Iseki | Toshiki Moriyama | Kunihiro Yamagata| Kazuhiko Tsuruya | Hideaki Yoshida | Shouichi Fujimoto | Koichi Asahi | Tsu- w w w. e r a e d t a 2 01 2 . o r g 127 FRIDAY, MAY 25 FP155 SERUM HOMOCYSTEIN, SERUM CYSTATIN C, AND GLOMERULAR FILTRATION RATE ARE INDEPENDENTLY ASSOCIATED WITH ARTERIAL STIFFNESS IN CHRONIC KIDNEY DISEASE PATIENTS Soobong Lee | Ilyoung Kim | Dongwon Lee | Harin Rhee | Sangheon Song | Eunyoung Seong | Ihmsoo Kwak Pusan National Univ School Medicine | Pusan National Univ Hosp, Busan, South Korea 49th ERA-EDTA CONGRESS P O S T E R S yoshi Watanabe Dept Geriatric Medicine & Nephrology, Osaka Univ Grad School of Medicine | Steering committee for the 'Research on the positioning of chronic kidney disease (CKD) in specific health check and guidance in Japan' FRIDAY, MAY 25 FP162 RENAL DYSFUNCTION IN A COHORT OF MARFAN SYNDROME PATIENTS Enrique Morales | Eduardo Gutiérrez | Alberto Forteza | Raquel Bellot | Violeta Sánchez | M. Paz Sanz | Arturo Evangelista | Jose Cortina | Manuel Praga Nephrology Dept Hosp 12 de Octubre, Madrid, Spain | Marfan Center H. 12 Octubre, Madrid, Spain | Marfan Center Vall'de Hebrón. Barcelona, Spain FP163 DIPYRIDAMOLE IMPROVES PATIENT AND RENAL SURVIVAL IN CHRONIC KIDNEY DISEASE STAGE 3-5 PATIENTS Chi-Chih Hung | Mei-Li Yang | Shang-Jyh Hwang | Hung-Chen Chen Kaohsiung Medical Univ Hosp FP164 SYSTEMATIC REVIEW AND META-ANALYSIS: EFFECTS OF TARGETS FOR SERUM PHOSPHORUS, PARATHYROID HORMONE AND CALCIUM ON CLINICAL OUTCOMES IN CHRONIC KIDNEY DISEASE Valeria Maria Saglimbene | Suetonia Palmer | Jonathan Craig | Fabio Pellegrini| Mariacristina Vecchio | Marinella Ruospo | Giorgia De Berardis | Giovanni Strippoli Consorzio Mario Negri Sud | Univ Otago Christchurch, New Zealand | Univ Sydney | Diaverum Medical Scientific Office | Cochrane Renal Group, Sydney, Australia FP165 EFFECT OF PHOSPHATE BINDER THERAPY ON MORTALITY IN PREDIALYSIS PATIENTS Biagio Di Iorio | Antonio Bellasi | Andrea Pota | Luigi Russo | Domenico Russo Osp Landolfo, Solofra, Avellino, Italia | Osp Sant'Anna, Como | Univ Federico II, Naples « FP166 OSTEOPROTEGERIN REPLACES CORONARY ARTERY CALCIFICATION SCORE AS A PREDICTOR OF INCIDENT CARDIOVASCULAR EVENTS IN DIABETIC CHRONIC KIDNEY DISEASE Chikako Nakano | Takayuki Hamano | Naohiko Fujii | Yoshitsugu Obi | Isao Matsui | Satoshi Mikami | Kazunori Inoue | Akihiro Shimomura | Hiromi Rakugi | Yoshitaka Isaka Dept Geriatric Medicine and Nephrology, Osaka Univ Grad School of Medicine, Osaka, Japan | Center Clinical Epidemiology and Biostatistics, Univ Pennsylvania Perelman School of Medicine, Pennsylvania, USA | Dept Internal Medicine, Hyogo Prefectural Nishinomiya Hosp, Hyogo, Japan | Dept Internal Medicine, Higashi-Kohri Hosp, Osaka, Japan FP167 HEMATURIA IS A RISK FACTOR FOR END STAGE RENAL DISEASE IN CHRONIC KIDNEY DISEASE PATIENTS Chun-Yu Yen | Hsiao-Han Wang | Chi-Chih Hung | Shang-Jyh Hwang | Hung-Chen Chen Div Nephrology, Kaohsiung Medical Univ Hosp, Taiwan FP168 INDICES OF INSULIN RESISTANCE AND RISK OF TOTAL AND CARDIOVASCULAR MORTALITY IN DIALYSIS PATIENTS Maurizio Postorino | Sebastiano Cutrupi | Patrizia Pizzini | Carmela Marino| Graziella D'Arrigo | Giovanni Tripepi | Carmine Zoccali | on behalf of the Calabrian Registry of Dialysis and Transpl Working Group* CNR-IBIM & Nephrology Unit Reggio Calabria, Italy | CNR-IBIM, Reggio Calabria | CNR IBIM and Osp Riuniti, Reggio Cal. | Calabrian Registry of Dialysis and Transpl Working Group FP169 MONITORING OF INTRA OCULAR PRESSURE CHANGES IN HEMODIALY- 128 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP170 EVALUATION OF AN INSTRUMENT FOR SCREENING PATIENTS AT RISK FOR CHRONIC KIDNEY DISEASE: TESTING SCORED (SCREENING FOR OCCULT RENAL DISEASE) IN PORTUGUESE POPULATION Edgar Almeida | Carlota Lavinas | Catarina Teixeira | Mário Raimundo | Cristina Nogueira | Martina Ferreira | António Sampaio | Inês Henriques | Cecília Teixeira | António Gomes da Costa | Miguel Leal Dept Nephrology and Renal Transpl, Hosp Santa Maria, Lisbon, Portugal | Fac Medicine, Univ Lisbon, Portugal | Diaverum Portugal, Torres Vedras Unit, Portugal FP171 SUBENDOCARDIAL VIABILITY RATIO AND ALBUMINURIA IN CKD PATIENTS Robert Ekart | Nina Hojs | Breda Pečovnik Balon | Sebastjan Bevc | Benjamin Dvoršak | Tina Stropnik Galuf | Radovan Hojs Univ Clinical Centre Maribor, Clinic Internal Medicine, Dept Dialysis, Maribor, Slovenia | Univ Clinical Centre Maribor, Clinic for Internal Medicine, Dept Nephrology, Maribor, Slovenia FP172 FROM NEWLY DIAGNOSED SYSTEMIC LUPUS ERYTHEMATOSUS TO DIALYSIS AND THEN ALL-CAUSE MORTALITY: A NATIONWIDE COHORT STUDY IN TAIWAN Wei-Hung Lin | Chao-Yu Guo | Wei-Ming Wang | Deng-Chi Yang | Te-Hui Kuo | Ming-Fei Liu | Ming-Cheng Wang Tainan | Taipei FP173 THE SIGNIFICANCE OF HYPERURICEMIA ON NEPHROCALCINOSIS BY ULTRASONOGRAPHY IN NON-PROTEIURIC CKD OF GENERAL POPULATION Shigeko Hara | Kentaro Tanaka | Hiroshi Tsuji | Yukiko Ohmoto | Kazuhisa Amaka | Yoshifumi Ubara | Kouji Arase Dept Nephrology, Toho Univ School of Medicine | Health Management Center, Kidney Center, Toranomon Hosp FP174 PLATELET TO LYMPHOCYTE RATIO INDEPENDENTLY PREDICTS CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE Mahmut Ilker Yilmaz | Yalcin Solak | Mutlu Saglam | Halil Yaman | Hilmi Umut Unal | Mahmut Gok | Hakki Cetinkaya | Zeynep Biyik | Abduzhappar Gaipov | Kayser Caglar | Halil Zeki Tonbul | Suleyman Turk Gulhane School of Medicine, Ankara, Turkey | Konya Univ Meram School of Medicine, Konya, Turkey FP175 THE ASSOCIATION BETWEEN SERUM POTASSIUM AND CLINICAL OUTCOMES IN CHRONIC KIDNEY DISEASE STAGE 1-4 PATIENTS Hsiao-Han Wang | Chun-Yu Yen | Chi-Chih Hung | Shang-Jyh Hwang | HungChen Chen Kaohsiung Medical Univ Hosp | Div Nephrology, Kaohsiung Medical Univ Hosp, Taiwan FP176 SCREENING FOR CHRONIC KIDNEY DISEASES IN ROMA PEOPLE IN BULGARIA Stefan Krivoshiev | Anna Koteva | Zdravko Kraev | Georgi Mihaylov | Petar Shikov Medical Univ, Sofia, Bulgaria | District Hosp, Pazardjik, Bulgaria FP177 RDX5791, A NON-SYSTEMIC NHE3 INHIBITOR FOR THE TREATMENT OF w w w. e r a e d t a 2 01 2 . o r g 129 FRIDAY, MAY 25 SIS PATIENTS Hassan Ghasemi | Reza Afshar | Hoda Shabpirai | Ali Davati | Nikan Zerafatjou | Saeid Abdi | Mani Khorsand Askari Shahed Univ, Tehran, Iran | Shahid Beheshti Medical Univ, Tehran, Iran 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FLUID AND SODIUM OVERLOAD, SHIFTS SODIUM EXCRETION FROM URINE TO FECES IN HEALTHY SUBJECTS Rosenbaum David | Jacobs Jeffrey | Spencer Andrew | Raab Michael | Dominique Charmot Ardelyx Inc. FP178 PULMONARY HYPERTENSION IN CHRONIC KIDNEY DISEASE PATIENTS ON CONSERVATIVE TREATMENT AND ON DIALYSIS. RELATION TO NITRIC OXIDE Ragai Fouda | Yasser Abdelhamid | Dina Alsayed | Sheren Salah | Dawlat Belal| Mohammed Salem | Hamdy Ahmed Fac Medicine, Cairo Univ, Cairo, Egypt | Student Hosp, Cairo Univ, Cairo, Egypt| Ministry of Health | Dept Biochemistry, National Res Centre, Cairo, Egypt FP179 DEPRESSION IN PEOPLE WITH CHRONIC KIDNEY DISEASE: A METAANALYIS OF PREVALENCE AND ASSOCIATIONS WITH CLINICAL OUTCOMES Mariacristina Vecchio | Suetonia Palmer | Valeria Maria Saglimbene | Marinella Ruospo | Letizia Gargano | Fabio Pellegrini | Giovanni Strippoli Consorzio Mario Negri Sud, Italy | Univ Otago Christchurch, New Zealand | Diaverum Medical Scientific Office | Diaverum | Cochrane Renal Group, Sydney, Australia FP180 RENAL BIOPSY REGISTRY FROM CROATIAN UNIV HOSP: A 15 YEARS OF EXPERIENCE WITH REVIEW OF EPIDEMIOLOGICAL DATA Miroslav Tisljar | Ivica Horvatic | Borka Bozic | Jasenka Crnjakovic Palmovic | Jasna Bacalja | Stela Bulimbasic | Danica Galesic Ljubanovic | Kresimir Galesic Univ Hosp Dubrava, Dept Nephrology, Zagreb, Croatia | Univ Hosp Dubrava, Dept Pathology, Zagreb, Croatia FP181 RENAL DYSFUNCTION AS A RISK FACTOR FOR PAINLESS MYOCARDIAL INFARCTION: RESULTS FROM KOREA ACUTE MYOCARDIAL INFARCTION REGISTRY Joon seok Choi | Chang Seong Kim | Jeong Woo Park | Eun Hui Bae | Seong Kwon Ma | Soo Wan Kim Dept Internal Medicine, Chonnam National Univ Medical School, Gwangju, Korea FP182 SUBOPTIMAL MEDICAL CARE IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH RENAL DYSFUNCTION Joon seok Choi | Chang Seong Kim | Jeong Woo Park | Eun Hui Bae | Seong Kwon Ma | Soo Wan Kim Dept Internal Medicine, Chonnam National Univ Medical School, Gwangju, Korea 130 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France RENAL ANAEMIA - CKD 1-5 FP184 RELATIONSHIP BETWEEN CARDIOVASCULAR (CV) EVENTS AND HEMOGLOBIN (HB) LEVEL OR HB RATE OF CHANGE IN HEMODIALYSIS (HD) PATIENTS ON PEGINESATIDE Adrian Covic | Anatole Besarab | Robert Provenzano | Anne-Marie Duliege | Minjia Chen | Sandra Tong | Carol Francisco | Hong-Ye Gao | Krishna Polu | Angel LM de Francisco Univ Medicine Gr. T. Popa Iasi | Henry Ford Hosp, Detroit, MI, USA | Saint Claire Specialty Physicians, PC, Detroit, MI, USA | Affymax, Inc., Palo Alto, CA, USA | Hosp Univ Valdecilla, Santander, Spain FP185 HIGHER DOSING REQUIREMENTS OF PEGINESATIDE AND EPOETIN FOR TREATMENT OF ANEMIA IN US VS NON-US HEMODIALYSIS (HD) PATIENTS Iain Macdougall | Brigitte Schiller | Francesco Locatelli | Andrzej Więcek | Carol Francisco | Helen Tang | Sandra Tong | Minjia Chen | Anne-Marie Duliege| Krishna Polu | Martha Mayo | Adrian Covic King's College Hosp, London, UK | Satellite Healthcare, Inc., San Jose, CA, USA| Osp A. Manzoni, Lecco, Italy | Dept Nephrology, Endocrinology and Metabolic Diseases, Medical Univ Silesia | Affymax, Inc., Palo Alto, CA, USA | Univ Medicine Gr. T. Popa Iasi FP186 LONG-TERM RESULTS FROM A STUDY OF PEGINESATIDE IN PATIENTS WITH ANTIBODY-MEDIATED PURE RED CELL APLASIA (AB+PRCA) Iain Macdougall | Nicole Casadevall | Richard Stead | Maarten Taal | Bernadette Faller | Alexandre Karras | Minjia Chen | Sandra Tong| Anne-Marie Duliege| Richard Rowell | Krishna Polu | Kai-Uwe Eckardt King's College Hosp, London, UK | Hôp Saint Antoine, Paris, France | BioPharma Consulting Serv, Bellevue, WA, USA | Royal Derby Hosp, Derby, UK | Hôp Civils, Colmar, France | Néphrologie, HEGP, Paris, France | Univ ErlangenNuremberg, Erlangen, Germany FP187 CHARACTERISTICS OF PATIENTS WITH CHRONIC KIDNEY DISEASE ON DIALYSIS WITH A POOR RESPONSE TO CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR (C.E.R.A.) ONCE MONTHLY: AN ANALYSIS OF 10 INTERNATIONAL TRIALS Francesco Locatelli | Sylvie Dusilova Sulkova Dept Nephrology, Dialysis and Renal Transpl, Alessandro Manzoni Hosp | Dept Nephrology, Inst Clinical and Experimental Medicine FP188 IMPACT OF ON-LINE HAEMODIAFILTRATION ON THE MANAGEMENT OF ANAEMIA BY CERA: HDFHD STUDY, INTERIM ANALYSIS Stolz Arnaud | Paris Bruno | Guérard Arnaud | Visanica Dorina | Azoulay Eric | Mangenot Gérard Saint André Private Hosp Metz, France FP189 PROSPECTIVE OBSERVATIONAL MULTICENTER STUDY TO EVALUATE THE EFFECTIVENESS AND SAFETY OF METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (MIRCERA®) IN PATIENTS WITH ANAEMIA SECONDARY TO CHRONIC KIDNEY DISEASE. MINERVA STUDY Aleix Cases | J.M. Portolés | J. Calls | A. Martínez Castelao | D. Sánchez-Gui- w w w. e r a e d t a 2 01 2 . o r g 131 FRIDAY, MAY 25 FP183 CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR (C.E.R.A.) ONCE MONTHLY MAINTAINS STABLE HEMOGLOBIN VALUES IN HIGH-RISK PATIENTS WITH CHRONIC KIDNEY DISEASE ON DIALYSIS: AN ANALYSIS OF 10 INTERNATIONAL TRIALS Danilo Fliser | Valery Shilo Dept Internal Medicine IV, Saarland Univ Hosp | Dept Nephrology for PostGrad, Moscow Univ Medicine and Dentistry 49th ERA-EDTA CONGRESS P O S T E R S sande | A. Segarra Nephrology and Transpl Unit, Hosp Clínic, Barcelona, Spain | Hosp Univ Puerta de Hierro, Madrid, Spain | Hosp Manacor, Palma de Mallorca, Spain | Hosp Bellvitge, Barcelona, Spain | Hosp Barbanza, A Coruña, Spain | Hosp Vall d'Hebron, Barcelona, Spain FRIDAY, MAY 25 FP190 EFFICACY AND SAFETY OF PEGINESATIDE IN JAPANESE CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS Yoshiharu Tsubakihara | Akira Saito | AF37702/CCT-001 Study Group Dept Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan | Yokohama Dai-ichi Hosp, Yokohama, Japan FP191 EFFICACY AND SAFETY OF PEGINESATIDE IN JAPANESE CHRONIC KIDNEY DISEASE PATIENTS ON HEMODIALYSIS Akira Saito | Yoshiharu Tsubakihara | AF37702/CCT-101 Study Group Yokohama Dai-ichi Hosp, Yokohama, Japan | Dept Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan FP192 MANAGEMENT OF RENAL ANAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGES 3, 4 AND 5 NOT ON DIALYSIS TREATED WITH C.E.R.A. IN CATALONIAN NEPHROLOGY UNITS (THE MICENAS II STUDY) A. Martínez-Castelao | A. Cases | J. Fort | J. Bonal | X. Fulladosa | J.M. Galcerán| V. Torregrosa | E. Coll Nephrology Unit, Hosp Bellvitge, Barcelona, Spain | Nephrology and Transpl Unit, Hosp Clínic, Barcelona, Spain | Nephrology Unit, Hosp Vall d'Hebron, Barcelona, Spain | Nephrology Unit, Hosp Germans Trias i Pujol, Badalona, Spain | Nephrology Unit, Fund Althaia, Manresa, Spain | Nephrology Unit, Fund Puigvert, Barcelona, Spain FP193 SWITCH TO LOW DOSE C.E.R.A. MAINTAINS HEMOGLOBIN (Hb) LEVELS IN NON DIALYSIS CHRONIC KIDNEY DISEASE (CKD): A MULTICENTRIC PROSPECTIVE STUDY IN ITALY Roberto Minutolo | Mario Cozzolino | Biagio Di Iorio | Pasquale Polito | Domenico Santoro | Flavia Manenti | Felice Nappi | Sandro Feriozzi | Giuseppe Conte | Luca De Nicola Div Nephrology, Second Univ Naples, Naples, Italy | DMCO, Univ Milan, Renal Div, San Paolo Hosp, Milan, Italy | County Hosp Solofra| County Hosp Tivoli| Univ Messina | San Salvatore Hosp, Pesaro | County Hosp Nola | Belcolle Hosp Viterbo FP194 DOSE RELATIONSHIP BETWEEN PEGINESATIDE AND EPOETIN FOR PATIENTS ON DIALYSIS Ashraf Mikhail | Robert Provenzano | Brigitte Schiller | Anatole Besarab | Carol Francisco | Hong-Ye Gao | Richard Daley | Sandra Tong | Martha Mayo | Alex Yang | Krishna Polu | Iain Macdougall Renal Unit, Morriston Hosp, Swansea, UK | Saint Claire Specialty Physicians, PC, Detroit, MI, USA | Satellite Healthcare, Inc., San Jose, CA, USA | Henry Ford Hosp, Detroit, MI, USA | Affymax, Inc., Palo Alto, CA, USA | King's College Hosp, London, UK FP195 RELATIONSHIP BETWEEN CARDIOVASCULAR (CV) EVENTS, MORTALITY AND DOSES OF PEGINESATIDE VS EPOETIN IN HEMODIALYSIS (HD) PATIENTS Andrzej Więcek | Brigitte Schiller | Bernard Canaud | Francesco Locatelli | Alex Yang | Minjia Chen | Krishna Polu | Carol Francisco | Hong-Ye Gao | Sandra Tong | Anne-Marie Duliege | Robert Provenzano Dept Nephrology, Endocrinology and Metabolic Diseases, Medical Univ Silesia| Satellite Healthcare, Inc., San Jose, CA, USA | Univ Montpellier, Hôp Lapeyronie, Dept Nephrology, Montpellier, France | Osp A. Manzoni, Lecco, Italy | Affymax, Inc., Palo Alto, CA, USA | Saint Claire Specialty Physicians, PC, Detroit, MI, USA 132 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP197 EFFECT OF METHOXY POLYETHYLENE GLYCOL – EPOETIN BETA ON POLYMORPHONUCLEAR (PMN) CELLS APOPTOSIS IN PREDIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) Piotr Bartnicki | Zbigniew Baj | Ewa Majewska | Jacek Rysz Dept Nephrology Hypertension and Family Medicine | Medical Univ | WAM Univ Hosp FP198 FUNCTIONAL IRON DEFICIENCY IS A FACTOR LIMITING THE USE OF HIGH DOSES OF INTRAVENOUS IRON IN PREDIALYSIS Patrick Fievet | Maryam Assem | François Brazier | Xiaoli Xu | Oumeria Nadia Soltani | Renato Demontis Serv Néphrologie Hémodialyse, CH Laennec, CREIL FP199 IS HEPCIDIN-25 A CLINICALLY RELEVANT PARAMETER FOR THE IRON STATUS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS? Liliana Barsan | Simona Stancu | Ana Stanciu | Cristina Capusa | Ligia Petrescu| Adrian Zugravu | Gabriel Mircescu Dr Carol Davila Teaching Hosp Nephrology, Bucharest, Romania | Nephrology Dept, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania FP200 IRON METABOLISM IN HEMODIALYSIS PATIENTS - STILL A MYSTERY? Jolanta Malyszko Malyszko | Nomy Levin-Iaina | Jacek Malyszko | Irena Głowińska | Ewa Koc-Zorawska | Itzachk Slotki | Michal Mysliwiec Dept Nephrology and Transpl, Medical Univ, Bialystok Poland | Shaare Zedek Medical Center, Jerusalem, Israel FP201 ACUTE RENAL AND VASCULAR EFFECTS OF INTRAVENOUS IRON Gabriel Mircescu | Cristina Capusa | Simona Stancu | Liliana Barsan | Doina Grabowski | Violeta Blaga | Daniela Dumitru Nephrology Dept, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania | Dr Carol Davila Teaching Hosp Nephrology, Bucharest, Romania FP202 SYSTEMIC INFLAMMATION AS A FACTOR OF ANEMIA DEVELOPMENT IN PATIENTS WITH EARLY STAGES OF DIABETIC NEPHROPATHY Ivan Pchelin | Alexander Shishkin St.Petersburg Univ, St. Petersburg, Russia FP203 EVALUATION OF RELATIONSHIP BETWEEN HEMOGLOBIN VARIABILITY AND OXIDATIVE STRESS AND INFLAMMATION IN CHRONIC RENAL FAILURE Tulay Kus | Celalettin Usalan | Ozlem Tiryaki Gaziantep Univ School of Medicine, Dept Internal Medicine | Gaziantep Univ School of Medicine, Dept Nephrology, Turkey FP204 NUMBER OF RED BLOOD CELLS AS A RESPONSE OF INNATE ERYTHROPOIETIN IS AN IMPORTANT RISK FACTOR Ho Jun Chin | Dong-Wan Chae | Suhnggwon Kim Seoul National Univ Bundang Hosp Seongnam Korea | SNUBH | SNUH w w w. e r a e d t a 2 01 2 . o r g 133 FRIDAY, MAY 25 FP196 IRON UTILIZATION IN US HEMODIALYSIS (HD) PATIENTS TREATED WITH PEGINESATIDE VS EPOETIN FOR ANEMIA OF CHRONIC KIDNEY DISEASE (CKD) Francesco Locatelli | Robert Provenzano | Anatole Besarab | Thomas Rath | Alex Yang | Martha Mayo | Carol Francisco | Iain Macdougall Osp A. Manzoni, Lecco, Italy | Saint Claire Specialty Physicians, PC, Detroit, MI, USA | Henry Ford Hosp, Detroit, MI, USA | Westpfalz-Klinikum Kaiserslautern Medizinische Klinik III Abteilung für Nephrologie und Transpl, Kaiserslautern, Germany | Affymax, Inc., Palo Alto, CA, USA | King's College Hosp, London, UK 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FP205 A PHARMACODYNAMIC VIEW ON THE TREAT TRIAL – THE DARBEPOETIN THRESHOLD AND CEILING CONCENTRATIONS Hartmann Bertram | Frieder Keller Nephrology, Center for Internal Medicine, Univ Hosp, Ulm, Germany FP206 MINIMISATION OF ESA THERAPY POST-TREAT STUDY: ONE-YEAR EXPERIENCE Adam Rumjon | Cheryl Wood | Paul Wilson | Shammim Khakoo | Mee Onn Chai | Iain C. Macdougall King's College Hosp NHS Foundation Trust, London, UK | Renal Unit, King's College Hosp FP207 USE OF PENTOXIFYLLINE IN HEMODIALYSIS PATIENTS WITH ERYTHROPOIESIS-STIMULATING AGENT (ESA) RESISTANCE: A CASE-CONTROL STUDY Garcia-Fernandez Nuria | Ferrer Maria Asuncion | Mora-Gutierrez Jose Maria| Calderon Carmen | Martin-Moreno Paloma Leticia | Lavilla Francisco Javier Clinica Univ Navarra, Pamplona, Spain FP208 HEMOGLOBIN AND QUALITY OF LIFE IN PATIENTS ON PRE-DIALYSIS CARE de Goeij Moniek | Meuleman Yvette | Grootendorst Diana | Dekker Friedo | Halbesma Nynke Leiden Univ Medical Center, Dept Clinical Epidemiology, Leiden, Netherlands| Leiden Univ Medical Center, Dept Medical Psychology, Leiden, Netherlands | Kennemer Gasthuis, Linnaeus Inst, Haarlem, Netherlands FP209 PHARMACOKINETICS OF ERYTHROPOIETIN IN BALKAN ENDEMIC NEPHROPATHY PATIENTS Visnja Lezaic | Branislava Miljkovic | Nenad Petkovic | Ivko Maric | Katarina Vučićević | Sanja Simic Ogrizovic | Ljubica Djukanovic Medical Fac, Belgrade, Serbia | Fac Pharmacy, Univ Belgrade, Serbia | FMC Center Šamac, BH | Special Hosp for Endemic Nephropathy, Lazarevac, Serbia FP210 PREVALENCE OF ANAEMIA AND ITS MANAGEMENT IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGES 3, 4 AND 5 NOT ON DIALYSIS AT NEPHROLOGY UNITS IN CATALONIA (THE MICENAS I STUDY) Aleix Cases | A. Martínez-Castelao | A. Fort | J. Bonal | X. Fulladosa | J.M. Galcerán | V. Torregrosa | E. Coll Nephrology and Transpl Unit, Hosp Clínic, Barcelona, Spain | Nephrology Unit, Hosp Bellvitge, Barcelona, Spain | Nephrology Unit, Hosp Vall d'Hebron, Barcelona, Spain | Nephrology Unit, Hosp Germans Trias i Pujol, Badalona, Spain | Nephrology Unit, Fund Althaia, Manresa, Spain | Nephrology Unit, Fund Puigvert, Barcelona, Spain FP211 THE ASSOCIATION OF KIDNEY TRANSPL STATUS WITH ESA DOSE REQUIREMENT: INTERIM ANALYSIS OF THE EXTEND STUDY S Di Giulio | J Galle | I Kiss | H Herlitz | G Wirnsberger | K Claes | M Suranyi| A Guerin | C Winearls | J Addison | M D’Souza | M Froissart Osp San Camillo Forlanini, Rome, Italy | Klinikum Luedenscheid, Luedenscheid, Germany | Fov. Onk. Szent Imre Korhaz, Budapest, Hungary | Dept Molecular and Clinical Medicine/Nephrology, Inst Medicine, Sahlgrenska Academy Univ Gothenburg, Göteborg, Sweden | Dept Internal Medicine, Medical Univ Graz, Graz, Austria | UZ Gasthuisberg, Leuven, Belgium | Renal Unit, Liverpool Hosp, Sydney, Australia | Clinique Mont Loius, Paris, France | Oxford Kidney Unit, Churchill Hosp, Oxford, UK | Amgen Limited, Cambridge, UK | Contract statistician on behalf of Amgen Limited, Cambridge, UK | Amgen (Europe) GmbH, Zug 134 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP213 TRENDS IN CKD ANAEMIA MANAGEMENT: THE IMPACT OF A CHANGING ENVIRONMENT (AN INTERIM ANALYSIS OF THE EXTEND STUDY) C Winearls | S Di Giulio | J Galle | I Kiss | H Herlitz | G Wirnsberger | K Claes| M Suranyi | A Guerin | J Addison | M D’Souza | B Fouqueray Oxford Kidney Unit, Churchill Hosp, Oxford, UK | Osp San Camillo Forlanini, Rome, Italy | Klinikum Luedenscheid, Luedenscheid, Germany | Fov. Onk. Szent Imre Korhaz, Budapest, Hungary | Dept Molecular and Clinical Medicine/ Nephrology, Inst Medicine, Sahlgrenska Academy Univ Gothenburg, Göteborg, Sweden | Dept Internal Medicine, Medical Univ Graz, Graz, Austria | UZ Gasthuisberg, Leuven, Belgium | Renal Unit, Liverpool Hosp, Sydney, Australia| Clinique Mont Louis, Paris, France | Amgen Limited, Cambridge, UK | Contract statistician on behalf of Amgen Limited, Cambridge, UK | Amgen (Europe) GmbH, Zug, Switzerland FP214 CARDIORENAL SYNDROME TYPE 4 (CRS 4) ASSOCIATED WITH ANAEMIA LONG TERM SURVIVAL ANALYSIS Matteo Floris | Maura Conti | Riccardo Cao | Gianfranco Pili | Patrizia Melis| Valeria Matta | Efisio Murgia | Alice Atzeni | Valentina Binda | Andrea Angioi| Marcella Peri | Antonello Pani Nephrology, Brotzu Hosp, Cagliari | Pediatry, Univ Cagliari FP215 EVALUATION OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR FG-4592 FOR HEMOGLOBIN CORRECTION AND MAINTENANCE IN NONDIALYSIS CHRONIC KIDNEY DISEASE PATIENTS FOR 16 AND 24 WEEKS Anatole Besarab | Diogo Belo | Susan Diamond | Edouard Martin | Chao Sun| Tyson Lee | Khalil Saikali | Marietta Franco | Robert Leong | Thomas Neff | Kin-Hung Peony Yu Henry Ford Hosp, Detroit, USA | California Inst Renal Res, Chula Vista, USA| San Antonio Kidney Disease Center, San Antonio, USA | South Florida Res Inst, Lauderdale Lakes, USA | Apex Res, Riverside, USA | FibroGen, Inc., San Francisco, USA FP216 RECHALLENGE WITH INTRAVENOUS RECOMBINANT HUMAN ERYTHROPOIETIN (r-HuEpo) CAN SUCCESSFULLY TREAT ANTI-RECOMBINANT ERYTHROPOIETIN ASSOCIATED PRCA Khajohn Tiranathanagul | Pisut Katavetin | Talerngsak Kanjanabuch | Yingyos Avihingsanon | Kriang Tungsanga | Somchai Eiam-Ong Chulalongkorn Univ, Bangkok, Thailand FP217 A PROSPECTIVE, IMMUNOGENICITY SURVEILLANCE REGISTRY (PRIMS) TO ESTIMATE THE INCIDENCE OF ERYTHROPOIETIN ANTIBODY-MEDIATED PURE RED CELL APLASIA AMONG SUBJECTS WITH CHRONIC RENAL FAILURE AND SUBCUTANEOUS EXPOSURE TO RECOMBINANT ERYTHROPOIETIN PRODUCTS Iain C. Macdougall | Nicole Casadevall | Paul Percheson | Anna Potamianou | Arnaud Foucher | Daniel Fife | Els Vercammen | PRIMS Study Group Renal Unit, King's College Hosp | Sce d'Immunologie et Hématologie Biologiques, Hôp Saint Antoine, Paris, France | Janssen, Pharmaceutical Companies of Johnson & Johnson w w w. e r a e d t a 2 01 2 . o r g 135 FRIDAY, MAY 25 « FP212 EARLY RECOMBINANT HUMAN ERYTHROPOIETIN TREATMENT PROMOTES CARDIORENAL CYTOPROTECTION IN A RAT MODEL OF CHRONIC RENAL FAILURE Patrícia Garrido | Margarida Teixeira | Elísio Costa | Paulo Rodrigues-Santos| Belmiro Parada | Luís Belo | Rui Alves | Frederico Teixeira | Alice SantosSilva| Flávio Reis Pharmacology & Experimental Therapeutics, IBILI, Medicine Fac, Coimbra Univ, Coimbra| Inst Health Sciences of Univ Catholic, Porto | Group of Immunology and Oncology, CNC, Coimbra | Inst Molecular and Cellular Biology, Porto Univ, Porto | Serv Nephrology, HUC, Coimbra 49th ERA-EDTA CONGRESS P O S T E R S MINERAL AND BONE DISEASE - CKD 1-5 FRIDAY, MAY 25 FP218 CLINICAL AND DEMOGRAPHIC PREDICTORS FOR VITAMIN D DEFICIENCY IN MULTI-ETHNIC ASIAN PATIENTS WITH CHRONIC KIDNEY DISEASE Zhong Yi Loh | Chun Wei Yap | Vathsala Anantharaman | Priscilla How National Univ Singapore, Singapore | National Univ Health System, Singapore FP219 22-OXACALCITRIOL PREVENTS PROGRESSION OF ENDOTHELIAL DYSFUNCTION THROUGH ANTI-OXIDATIVE EFFECTS IN RATS WITH TYPE 2 DIABETES Michinori Hirata | Ken Aizawa | Kenji Yogo | Yoshihito Tashiro | Satoshi Takeda | Koichi Endo | Masafumi Fukagawa | Ken-ich Serizawa Chugai Pharmaceutical Co., Ltd. | Div Nephrology, Endocrinology and Metabolism, Tokai Univ School of Medicine, Isehara, Japan FP220 EFFECT OF VITAMIN D ON VASCULAR LESIONS AND OXIDATIVE STRESS AT EARLY STAGE OF DIABETIC NEPHROPATHY Hideki Fujii | Keiji Kono | Kentaro Nakai | Shunsuke Goto | Michinori Hirata| Masami Shinohara | Riko Kitazawa | Sohei Kitazawa | Masafumi Fukagawa | Shinichi Nishi Div Nephrology and Kidney Center, Kobe Univ Grad School of Medicine, Kobe, Japan | Fuji Gotemba Res Labs, Chugi pharmaceutical Co., Ltd, Shizuoka, Japan| CLEA Japan, Inc., Tokyo, Japan | Div Molecular Pathology, Dept Biomedical Informatics, Kobe Univ Grad School of Medicine, Kobe, Japan | Div Molecular Pathology, Ehime Univ Grad School of Medicine, Japan | Div Nephrology, Endocrinology and Metabolism, Tokai Univ School of Medicine, Isehara, Japan FP221 VITAMIN D RECEPTOR ACTIVATORS PRESERVE VASCULAR CALCIFICATION BY REDUCING OSTEOPROTEGERIN LEVELS IN HEMODIALYSIS PATIENTS Aysegul Oruc | Serhat Korkmaz | Oznur Bal | Arzu Yilmaztepe Oral | Alparslan Ersoy | Mustafa Gullulu Uludag Univ, Nephrology Dept, Bursa, Turkey | Uludag University, Biochemistry Dept, Bursa, Turkey FP222 IMPROVED iPTH LOWERING OF PARICALCITOL VS. CINACALCET IN SUBJECTS ON HEMODIALYSIS: ANALYSIS OF THE IMPACT STUDY Markus Ketteler | Kevin Martin | Michael Amdahl | Mario Cozzolino | David Goldsmith | Amit Sharma | Samina Khan Klinikum Coburg, Coburg Germany | Dept Internal Medicine, Div Nephrology, Saint Louis Univ, St. Louis, USA | Abbott Laboratories, Abbott Park, USA| DMCO, Univ Milan, Renal Div, San Paolo Hosp, Milan, Italy | Guy’s Hosp, London, UK | Boise Kidney and Hypertension Inst, Boise, USA | Abbott Laboratories, Abbott Park, USA FP223 EFFECTS OF THE SELECTIVE VITAMIN D RECEPTOR (VDR) AGONIST, PARICALCITOL, COMPARED TO CINACALCET ON CALCIUM, PHOSPHOROUS AND iPTH: RESULTS FROM THE IMPACT SHPT STUDY Markus Ketteler | Kevin Martin | Michael Amdahl | Mario Cozzolino | David Goldsmith | Amit Sharma | Samina Khan Klinikum Coburg, Coburg Germany | Dept Internal Medicine, Div Nephrology, Saint Louis Univ, St. Louis, USA | Abbott Laboratories, Abbott Park, USA| DMCO, Univ Milan, Renal Div, San Paolo Hosp, Milan, Italy | Guy’s Hosp, London, UK | Boise Kidney and Hypertension Inst, Boise, USA | Abbott Laboratories, Abbott Park, USA FP224 VITAMIN D IS LINKED WITH ANTI-INFLAMMATORY CYTOKINES IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD Nihil Chitalia | Behdad Afzali | Francis Edozie | Padmini Manghat | Anthony Wierzbicki | Geeta Hampson | David Goldsmith 136 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP225 CALCITRIOL DIRECTLY INFLUENCES FETUIN-A SYNTHESIS THROUGH ITS ACTION ON HEPATOCYTE VDR Mattia Corradini | Francesco Iannuzzella | Lucio Manenti | Alessia Ciarrocchi | Laura Albertazzi | Danio Somenzi | Sonia Pasquali Nephrology and Dialysis Unit Arcisp Santa Maria Nuova, Reggio Emilia , Italy| Dept Clinical Medicine Nephrology and Health Sciences, Univ Parma Medical School, Parma, Italy | Molecular Biology Lab, Arcisp Santa Maria Nuova, Reggio Emilia, Italy | Chemical and Clinical Lab, Arcisp Santa Maria Nuova, Reggio Emilia, Italy FP226 BODY FAT IS A PREDICTOR OF HYPOVITAMINOSIS D IN RENAL TRANSPL PATIENTS Alessandra Calábria Baxmann | Viviane Barcellos Menon | Leila Froeder | José Osmar Medina-Pestana | Aluizio Barbosa Carvalho | Ita Pfeferman Heilberg Univ Federal de São Paulo FP227 IS A 25 VITAMIN D DEFICIENCY A RISK FACTOR FOR ANEMIA IN CHRONIC KIDNEY DISEASE PATIENTS? Laura Solá | Nancy De Souza | Jaquelin Flores | Norberto Perico Preventive Medicine, Univ Republic, Montevideo, Uruguay | Hosp Maciel | Mario Negri Inst FP228 THE EFFECT OF CHOLECALCIFEROL SUPPLEMENTATION IN CHRONIC KIDNEY DISEASE Claudia Yuste | Maria Soledad Garcia De Vinuesa | Jose Luno | Maria Angeles Goicoechea | Daniel Barraca | Nayara Panizo | Borja Quiroga Hosp Gregorio Marañón, Madrid, Spain FP229 THE EFFECT OF ORAL VITAMIN D SUPPLEMENTATION IN CKD PATIENTS Sun Moon Kim | Soon Kil Kwon | Hye-Young Kim Chungbuk National Univ Hosp, Cheongju, Korea FP230 FIVE YEARS FOLLOW UP OF 25 OH VITAMIN D REMPLACEMENT THERAPY IN 165 CANADIAN DIALYSIS PATIENTS WITH CHOLECALCIFEROL 10000 UNITS ONCE A WEEK Serge Cournoyer | Robert Bell | Djamal Berbiche | Lorraine Ménard Serv Néphrologie Charles LeMoyne Hosp, Greenfield Park Canada | Dept Pharmacie, Maisonneuve-Rosemont Hosp Montréal Canada | Div Statistics, Fac Medecine Univ Sherbrooke Greenfield Park Canada | Charles Lemoyne Hosp Greenfield Park Canada FP231 UREMIA SUPPRESSES IMMUNE SIGNAL-INDUCED CYP27B1 EXPRESSION IN HUMAN MONOCYTES, WHILE INCREASING BACKGROUND EXPRESSION Liesbeth Viaene | Pieter Evenepoel | Björn Meijers | Lut Overbergh | Chantal Mathieu KULeuven, Nephrology, Leuven| KULeuven, Clinical and Experimental Endocrinology FP232 1,25D/25D RATIO TO ASSESS THE OVERALL BALANCE OF VITAMIN D HYDROXYLASES (OH-ase) Marzia Pasquali | Silverio Rotondi | Carmina Conte | Giuliana Pirrò | Sandro Mazzaferro | Aurora Frasheri | Martino Marangella | Lida Tartaglione Dept Cardiovascular, Respiratory, Nephrologic and Geriatric Sciences, Sapienza Univ Rome | Nephrology and Dialysis Unit, ASO Ordine Mauriziano, Turin w w w. e r a e d t a 2 01 2 . o r g 137 FRIDAY, MAY 25 King's Health Partners (AHSC) | MRC Centre for Transpl, Kings college London| Guy's and St Thomas' NHS Foundation Hosp 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FP233 IMPACT OF 1,25-DIHYDROXYVITAMIN D ON RENAL FUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS Joon-Sung Park | Tai Yeon Koo | Gheun-Ho Kim | Chong Myung Kang | Chang-Hwa Lee Depts Internal Medicine, Hanyang Univ College Medicine, Seoul | Hanyang Univ College Medicine, Seoul, Korea FP234 PLASMA EXCHANGE INDUCES VITAMIN D DEFICIENCY Thomas F Hiemstra | Alina Casian | Paul Boraks | David Jayne | Inez Schoenmakers Univ Cambridge | Lupus and Vasculitis Clinic | Apheresis Unit | Addenbrookes Hosp, UK | MRC Human Nutrition Res FP235 VITAMIN D DEFICIENCY IN FABRY DISEASE Benjamin Schmiedeke | Markus Niemann | Daniel Schmiedeke | Irina Davydenko | Andrea Emmert | Stefan Pilz | Barbara Obermayer-Pietsch | Frank Weidemann | Frank Breunig | Christoph Wanner | Christiane Drechsler Univ Würzburg, Germany | Univ Graz, Austria FP236 TREATMENT OF EXPERIMENTAL RENAL OSTEODYSTROPHY WITH RISEDRONATE Kazuhiro Shiizaki | Chiharu Ito | Akira Onishi | Eiko Nakazawa | Manabu Ogura | Eiji Kusano Univ Texas Southwestern Medical Center, Dallas, USA | Jichi Medical Univ School of Medicine, Shimotsuke, Japan FP237 ORAL NITROGEN-CONTAINING BISPHOSPHONATES USE IN TREATMENT OF MINERAL AND BONE DISORDERS (MBD) OF PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) STAGES 3 AND 4 Valentin Ermolenko | Natalia Mikhaylova | Karen Vartanjan | Dmitry Levchuk| Eleonora Dobrina Russian Medical Academy of PostGrad Education, Moscow, Russia FP238 IS ALKALINE PHOSPHATASE A USEFUL TOOL FOR CHRONIC KIDNEY DISEASE - MINERAL AND BONE DISORDER ASSESSMENT IN NON-DIALYSIS PATIENTS? Cristina Capusa | Simona Stancu | Daniela Maria | Iulia Vladu | Liliana Barsan| Liliana Garneata | Eugen Mota | Gabriel Mircescu Nephrology Dept, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania | Nephrology Dept, Emergency County Hosp, Craiova, Romania | Dr Carol Davila Teaching Hosp Nephrology, Bucharest, Romania FP239 ARE MINERAL METABOLISM ABNORMALITIES PREDICTORS OF VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE? Cristina Capusa | Simona Stancu | Liliana Barsan | Andrea Ilyes | Nicoleta Dorobantu | Ligia Petrescu | Gabriel Mircescu Nephrology Dept, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania | Dr Carol Davila Teaching Hosp Nephrology, Bucharest, Romania FP240 INCREASED SERUM PHOSPHATE CONCENTRATIONS IN PATIENTS WITH CHRONIC KIDNEY DISEASE TREATED WITH DIURETICS Rocio Martínez-Gallardo | Flavio Ferreira | Guadalupe García-Pino | Enrique Luna | Francisco Caravaca Hosp Infanta Cristina, Badajoz, Spain FP241 COMPLIANCE WITH KDOQI AND KDIGO GUIDELINES FOR SERUM PHOSPHORUS AND SERUM CALCIUM IN RELATION TO DISEASE PROGRESSION IN PRE-DIALYSIS PATIENTS Dinanda J. de Jager | Diana C Grootendorst | Iris Postmus | Moniek C.M. de 138 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Goeij | Els W. Boeschoten | Yvo W.J. Sijpkens | Friedo W. Dekker | Nynke Halbesma Dept Clinical Epidemiology, Leiden Univ Medical Center, Leiden, Netherlands | Hans Mak Inst, Naarden, Netherlands | Dept Nephrology, Leiden Univ Medical Center, Leiden, Netherlands FP243 MAGNESIUM PREVENTS PHOSPHATE-INDUCED CALCIFICATION IN PRIMARY HUMAN AORTIC VASCULAR SMOOTH MUSCLE CELLS (HAVSMC) Loïc Louvet | Janine Büchel | Sonja Steppan | Jutta Passlick-Deetjen | Ziad A. Massy INSERM U 1088, Amiens, France | Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany | Dept Nephrology, Univ Dusseldorf, Dusseldorf, Germany FP244 METABOLIC BONE DISEASE, ATHEROSCLEROSIS AND FIBROBLAST GROWTH FACTOR-23 IN PERITONEAL DIALYSIS PATIENTS Nilgül Akalın | Mehmet Rıza Altıparmak | Sinan Trabulus | Ayşe Serap Yalın| Nurhan Seyahi | Rezzan Ataman | Kamil Serdengeçti Istanbul Univ Cerrahpasa Medical Fac Dept Internal Medicine, Istanbul, Turkey FP245 EXPRESSION OF FGF23/KLOTHO SYSTEM IN HUMAN VASCULAR TISSUE Javier Donate-Correa | Rafael Martínez-Sanz | Mercedes Muros-de-Fuentes | Javier García | P García | Violeta Cazaña | Carmen Mora-Fernández | Juan Francisco Navarro-González Res Unit, Univ Hosp Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain | Hosp Univ Canarias, Canary Islands, Spain | Hosp Univ Nuestra Señora de Candelaria, Canary Islands, Spain FP246 SERUM FGF-23 IS LINKED WITH INCREASED INFLAMMATORY CYTOKINES IN CKD STAGE 3-5. IS THIS THE EXPLANATION FOR ITS ADVERSE CV EFFECTS? Nihil Chitalia | Behdad Afzali | Francis Edozie | Padmini Manghat | Anthony Wierzbicki | Geeta Hampson | David Goldsmith King's Health Partners (AHSC) | MRC Centre Transpl, Kings College London| Guy's and St Thomas' NHS Foundation Hosp FP247 PTH: WHAT ARE WE MEASURING? CLINICAL IMPLICATIONS OF A THIRD GENERATION ASSAY FOR THE DETERMINATION OF PTH LEVELS Silvia Berutti | Diega Marranca | Giorgio Soragna | Laura Erroi | Marco Migliardi | Martino Marangella Osp Mauriziano, Turin, Italy FP248 TOTAL SERUM CALCIUM CORRECTION FORMULAS IN HYPOALBUMINEMIA: WHICH WORKS BETTER? Mattia Corradini | Francesco Iannuzzella | Lucia Belloni | Danio Somenzi | Maria Parmeggiani | Sonia Pasquali Nephrology and Dialysis Unit, Arcisp Santa Maria Nuova, Reggio Emilia, Italy | Lab Autoimmunity, Allergology and Biotechnology, Arcisp Santa Maria Nuova, Reggio Emilia, Italy FP249 PREVALENCE AND PROGRESSION OF AORTIC VASCULAR CALCIFICATIONS IN CHRONIC KIDNEY DESEASE STAGE II, III AND IV Corrado Camerini | Mauro Pezzotta | Roberta Zani | Ezio Movilli | Giovanni Cancarini Univ Brescia w w w. e r a e d t a 2 01 2 . o r g 139 FRIDAY, MAY 25 FP242 PA21: AN EFFECTIVE AND WELL TOLERATED IRON-BASED PHOSPHATE BINDER FOR HEAMODIALYSIS PATIENTS, INCLUDING THOSE WITH DIABETES Rudolf P. Wüthrich | Adrian Covic | Sylvain Gaillard | Viatcheslav Rakov Div Nephrology | Univ Medicine Gr. T. Popa Iasi | Vifor Pharma Ltd 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FP250 HYPERCALCEMIA A RISK FACTOR FOR RENAL TRANSPL DYSFUNCTION siddiq Anwar | Rishi Pruthi | Shivkumar Kenchayikoppad Dept Renal Medicine Kent and Canterbury Hosp | Guys and St Thomas NHS Trust, London FP251 AUTONOMOUS HYPERPARARHYROIDISM IN CKD STAGES 3-4 TREATED WITH CINACALCET Joselyn Reyes | Iara DaSilva | Monica Furlano | Francesca Calero | Rosario Montañés | Nadia Ayasreh | Maitane Del Pozo | M Estorch | Ferran Rousaud | Jose A. Ballarin | Jordi Bover Fundacio Puigvert FP252 BONE DISEASE IN NEWLY DIAGNOSED LUPUS NEPHRITIS PATIENTS Aline Resende | Cristiane Bitencourt Dias | Luciene Dos Reis | Vanda Jorgetti| Viktoria Woronik São Paulo Univ, São Paulo, Brazil | Hosp das Clínicas, Univ São Paulo FP253 PRO-INFLAMMATORY CYTOKINES AND BONE FRACTURES IN CKD PATIENTS. A PROSPECTIVE SINGLE CENTRE STUDY Vincenzo Panuccio | Giuseppe Enia | Rocco Tripepi | Sebastiano Cutrupi | Patrizia Pizzini | Roberta Aliotta | Carmine Zoccali CNR IBIM Reggio Calabria Italy FP254 STRIKING AND PROMISING MIS-SENSE MUTATIONS ON THE GNAS1 GENE EXONS’ 1,4,10 AND 4 IN SAGLIKER SYNDROME (SS). A UNIQUE CATASTROPHIC ENTITY. CYTOGENETIC STUDIES FOR CHROMOSOMAL ABNORMALITIES, CASR GENES AND GNAS 1 MUTATIONS. INTERNATIONAL EVALUATION OF UNRECOGNIZABLY UGLYFYING HUMAN FACES IN LATE AND SEVERE SH IN CKD I Yildiz | Yahya Sagliker | O Demirhan | E Tunç | N Inandiklioglu | D Tasdemir | V Acharya | L Zhang | O Golea | A Sabry | D Ookalkar | C Capusa | D Radulescu | L Garneata | G Mircescu | H Ben Maiz | C Hsu Chen | J Prado Rome | M Benzegoutta | N Paylar | K Eyupoglu | E Karatepe | M Esenturk| O Yavascan | A Grzegorzevska | V Shilo | M M-Mazdeh | R C Francesco | Z Gouda | S M Adam | I Emir | F Ocal | E Usta | N Kıralp | C Sagliker | P S Ozkaynak | H.S Sagliker | M Bassuoni | H.S El-Wakil | H Akar | Y Yenicerioglu| E Kose | O Sekin Div Nephrology, Baskent Univ | Cukurova Univ | NKF, Mumbai | China-Japan Hosp | Timisoara Hosp | Mansoura Univ | Nagpur Dialysis Center | Bucharest Univ | Charles Nichole Hosp | Taichung Hosp | DF Nacional Siglo XX1 Hosp| Mila Hosp | Sagliker Hypertension Unit | Duzce State Hosp | Corum Dialysis Center | Malatya Hosp | Tepecik Hosp | Poznan Univ | Moscow Dialysis Center | Tehran Univ Medical Sciences | Damanhur Kidney Center | Fresenius Centers | Emir Dialysis | Bingol Dialysis | Alexandria Univ | Adnan Menderes Univ | Ata Dialysis Center 140 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France DIABETES - EXPERIMENTAL FP256 IMPACT OF FRUCTOSE ON PANCREATIC ISLET INSULIN SECRETION IN EXPERIMENTAL MODEL OF CHRONIC KIDNEY DISEASE Marta Pokrywczynska | Arkadiusz Jundzill | Sandra Krzyzanowska | Mariusz Flisinski | Andrzej Brymora | Magdalena Bodnar | Aleksander Deptula | Andrzej Marszalek | Jacek Manitius | Tomasz Drewa | Tomasz Kloskowski Dept Tissue Engineering, Nicolaus Copernicus Univ, Bydgoszcz, Poland | Chair and Dept Nephrology and Hypertension, Nicolaus Copernicus Univ, Bydgoszcz, Poland | Dept Clinical Pathomorphology, Nicolaus Copernicus Univ, Bydgoszcz, Poland | Chair and Dept Microbiology, Nicolaus Copernicus Univ, Bydgoszcz, Poland FP257 TREATMENT WITH PYRIDOXAMINE (PYR), PENTOSAN POLYSULFATE (PPS) AND ENALAPRIL (EN) REDUCES KIDNEY ALTERATIONS IN A MOUSE MODEL OF PROGRESSIVE DIABETIC NEPHROPATHY (DN) Fabrizio Grosjean | Vittoria Esposito | Massimo Torreggiani | Ciro Esposito | Feng Zheng | Helen Vlassara | Gary Striker Fond Salvatore Maugeri | Unit Nephrology and Hemodialysis, IRCCS Fond Salvatore Maugeri, Univ Pavia, Pavia, Italy | Unit Nephrology and Hemodialysis, IRCCS Fond Salvatore Maugeri, Univ Pavia, Pavia, Italy | Dept Geriatrics, Div Experimental Diabetes and Aging, MSSM, NY FP258 INSULIN RESISTANCE MEDIATED PATHOLOGICAL CHANGES IN THE KIDNEY OF STREPTOZOTOCIN- INDUCED CHRONIC DIABETIC RATS Shiju Michael | Pragasam Viswanathan | Rajesh Ganesh VIT Univ, Vellore and India | JIPMER, Puducherry and India « FP259 INVOLVEMENT OF IFN-Γ IN THE PATHOGENESIS OF TYPE2 DIABETIC NEPHROPATHY Miho Kimachi | Saori Nishio | Daigo Nakazawa | Yasunobu Ishikawa | Takayuki Toyoyama | Akiko Satou | Tasuku Nakagaki | Sekiya Shibasaki | Tatuya Atumi Internal Medicine II, Hokkaido Univ Grad School Medicine, Sapporo, Hokkaido, Japan FP260 DIABETIC NEPHROPATHY IN THE ZDSD RAT Vincent Gattone | Richard Peterson | Karen Zimmerman Indiana Univ School Medicine | Preclinomics Inc., Indianapolis, IN, USA FP261 NEPHROPATHY EVOLUTION IS PREVENTED BY THE DIPEPTIDYL PEPTIDASE-4 INHIBITOR, SITAGLIPTIN, IN A RAT MODEL OF TYPE 2 DIABETES Cristina Mega | Edite Teixeira de Lemos | Helena Vala | Rosa Fernandes | Jorge Oliveira | Frederico Teixeira | Flávio Reis Lab Pharmacology & Experimental Therapeutics, IBILI, Medicine Fac, Coimbra Univ, Coimbra, Portugal | ESAV, Polytechnic Inst Viseu, Viseu, Portugal FP262 THE ROLE OF IFN GAMMA ASSOCIATED WITH OXIDATIVE STRESS REDUCTION IN PREVENTING DIABETIC NEPHROPATHY IN RODENTS WITH TYPE II DIABETES AND OBESITY Andrei Niculae | Ionel-Alexandru Checherita | Alexandru Ciocalteu St. John Emergency Clinical Hosp, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania | Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania w w w. e r a e d t a 2 01 2 . o r g 141 FRIDAY, MAY 25 FP255 METFORMIN DECREASES OBESITY-INDUCED RENAL INJURY VIA ACTIVATION OF AMP-ACTIVATED PROTEIN KINASE Kyung Pyo Kang | Jung Eun Lee | Ae Sin Lee | Yu Jin Jung | Sik Lee | Sung Kwang Park | Won Kim Chonbuk National Univ Medical School, Jeonju, Korea 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FP263 PHYSIOLOGICAL LEVELS OF ENDOSTATIN SUPPRESS RENAL INJURY IN DIABETIC NEPHROPATHY Yuki Hamano | Yuki Udagawa | Yoshihiko Ueda | Osamu Yokosuka | Makoto Ogawa Dept Clinical Education and Res, Grad School of Pharmaceutical Sciences, Chiba Univ, Chiba, Japan | Dept Pathology, Dokkyo Medical Univ Koshigaya Hosp, Koshigaya, Japan | Dept Medicine and Clinical Oncology, Grad School of Medicine, Chiba Univ, Chiba, Japan | Dept Nephrology, Chiba Univ Hosp, Chiba, Japan « FP264 PRESERVATION OF ENDOTHELIAL GTP CYCLOHYDROLASE I ACTIVITY AND IMPROVEMENT OF RENAL NITRIC OXIDE AVAILABILITY PREVENT THE DEVELOPMENT OF DIABETIC NEPHROPATHY Minoru Satoh | Kengo Kidokoro | Hajime Nagasu | Yuko Nishi | Chieko Ihoriya | Hiroyuki Kadoya | Toyotaka Yada | Keith M Channon | Tamaki Sasaki| Naoki Kashihara Kawasaki Medical School | Univ Oxford, John Radcliffe Hosp FP265 ENHANCED DOWN REGULATION OF AT1B RECEPTORS ON AFFERENT AND EFFERENT ARTERIOLES IN STZ-INDUCED DIABETIC RAT KIDNEY Jens Randel Nyengaard | Zsolt Razga Stereology and Electron Microscopy Lab, Univ Aarhus, Denmark FP266 NEPHROPATHY IS ACCELERATED IN DIABETIC MICE WITH RENOVASCULAR HYPERTENSION Stella Hartono | Bruce Knudsen | Joseph Grande Mayo Clinic, Rochester MN, USA FP267 AGGRAVATION OF DIABETIC NEPHROPATHY IN OLETF RATS WITH THY1 NEPHROTIS Maho Watanabe | Kenji Ito | Yasuhiro Abe | Satoru Ogahara | Hitoshi Nakashima | Toshinobu Sato | Takao Saito Fukuoka Univ, Fukuoka, Japan | Sendai Shakai Hoken Hosp, Sendai, Japan FP268 MITOCHONDRIAL INSTABILITY OF PODOCYTE AGGRAVATES DIABETIC NEPHROPATHY IN STREPTOZOTOCIN INDUCED DIABETIC MICE Young Tai Shin | Dae Eun Choi | Ki-Ryang Na | Yoon Kyung Chang | Seong Suk Kim | Kang Wook Lee Renal Div, Chungnam National Univ Hosp, Daejeon, South Korea | Dept Internal Medicine, Daejeon Saint Mary Hosp, Daejeon, South Korea | Internal Medicine, Sun Hosp, Daejeon, South Korea | Renal Div, Dept Internal medicine, Chungnam National Univ Hosp. Daejeon, South Korea FP269 NOVEL THERAPEUTICS IN DIABETIC NEPHROPATHY: SIALIC ACID PRECURSORS REDUCE PROTEINURIA IN EXPERIMENTAL DIABETIC NEPHROPATHY Camille Mace | Sumant Chugh | Lionel Clement Univ Alabama Birmingham, Alabama, USA FP270 ROLES OF INSULIN RECEPTOR SUBSTRATES (IRS) IN RENAL FUNCTION AND RENAL HEMODYNAMICS Maoka Tomochika | Hashimoto Seiji | Mochizuki Toshio | Kawata Tetsuya | Koike Takao NTT East Japan Sapporo Hosp | Hokkaido Univ Grad School Medicine, Internal Medicine II FP271 CCR2 INHIBITION IN DIABETIC BKS db/db MICE RESULTS IN A RAPID AND ROBUST IMPROVEMENT OF RENAL INFLAMMATION AND RENAL FUNCTION 142 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Juan C. Jaen | Timothy J. Sullivan | Zhenhua Miao | Niky Zhao | Rob Berahovich | Antoni Krasinski | Jay P. Powers | Linda Ertl | Thomas J. Schall ChemoCentryx Inc., Mountain View (CA), USA FP273 SCAI CONTROLS TGF-β1 INDUCED α-SMOOTH MUSCLE ACTIN EXPRESSION DURING EPITHELIAL-MESENCHYMAL TRANSITION AND IS DOWNREGULATED IN DIABETIC NEPHROPATHY Gabor Kokeny | Akos Gasparics | Lilla Fang | Laszlo Rosivall | Attila Sebe Semmelweis Univ, Budapest, Hungary FP274 ALDOSTERONE ANTAGONISTS IN MONOTHERAPY ARE PROTECTIVE AGAINST STZ-INDUCED DIABETIC NEPHROPATHY Nora F Banki | Andrea Fekete | Laszlo Wagner | Agota Ver | Peter Degrell | Agnes Prokai | Reusz George | Attila Szabo | Chris Baylis| Adam Vannay | Tivadar Tulassay Semmelweis Univ First Dept Pediatrics, Hungary | Dept Transpl and Surgery, Semmelweis Univ, Budapest, Hungary | Semmelweis Univ, Dept Medical Chemistry, Molecular Biology and Pathobiochemistry, Budapest, Hungary | Second Dept Medicine and Nephrological Center, Pécs, Hungary | Dept Physiology and Functional Genomics and Medicine, Univ Florida | Res Lab Pediatrics and Nephrology, Hungarian Academy of Sciences and Semmelweis Univ, Budapest, Hungary FP275 ANGIOTENSIN 1 CONVERTING ENZYME AND RENAL VASCULAR REACTIVITY. STUDY IN NORMAL AND DIABETIC MOUSE Catherine Chollet | Annette Hus-Citharel | Nathalie Caron | Nadine Bouby INSERM U872, Paris, France | INSERM U1050, CIRB, Collège de France, Paris, France | FUNDP, Namur, Belgium FP276 RELATIONSHIP BETWEEN DIABETIC NEPHROPATHY AND CARDIAC FUNCTION: ROLE OF PREVIOUS EXERCISE TRAINING Kleiton Silva | Rodolfo Rampaso | Rafael Luiz | Kátia De Angelis | Cristiano Teixeira Mostarda | Nayda Abreu | Maria Claudia Irigoyen| Nestor Schor Federal Univ São Paulo | Nove de Julho Univ | São Paulo Univ - Hypertension Unit FP277 ROLE OF HIGH-INTENSITY AEROBIC EXERCISE (HIAE) ON THE CARDIOVASCULAR AND RENAL FUNCTIONS IN DIABETIC RATS BY STZ Rodolfo Rampaso | Rafael Luiz | Kleiton Silva | Jairo Montemor | Elisa M. S. Higa | Nestor Schor Federal Univ São Paulo FP278 ENDOTHELIAL CELL INTERACTED WITH PODOCYTE AND MESANGIAL CELLS VIA NAD(P)H OXIDASE Hajime Nagasu | Minoru Satoh | Kengo Kidokoro | Naoki Kashihara Kawasaki Medical School FP279 LANTHANUM SUPPRESSES AGES-INDUCED OSTEOBLASTIC DIFFERENTIATION VIA INHIBITION OF RAGE-NF-KAPPAB SIGNALING IN RAT VASCULAR SMOOTH MUSCLE CELLS Yosuke Nakayama | Kei Fukami | Nana Obara | Ryotaro Ando | Yusuke Kaida| Seiji Ueda | Sho-ichi Yamagishi | Seiya Okuda Div Nephrology, Dept Medicine, Kurume Univ, School Medicine | Dept Pathophysiology and Therapeutics Diabetic Vascular Complications, Kurume Univ School of Medicine w w w. e r a e d t a 2 01 2 . o r g 143 FRIDAY, MAY 25 FP272 PHOSPHODIESTERASE INHIBITOR IMPROVES RENAL TUBULOINTERSTITIAL HYPOXIA OF DIABETIC RAT KIDNEY Sang Youb Han | Hui-Kyoung Sun | Kum Hyun Han | Han-Seong Kim | SeonHo Ahn Dept Medicine, Inju Univ Ilsan-Paik Hosp | Dept Medicine, Wonkwang Univ 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FP280 HEPARANASE INDUCED BY ADVANCED GLYATION END PRODUCTS MEDIATES MACROPHAGE MIGRATION INVOLVING RAGE AND PI3K/AKT PATHWAY Qiaojing Qin | Zhaoxia Wang | Jianying Niu | Wangjie Xu | Zhongdong Qiao| Weiwei Qi | Yong Gu Dept Nephrology, Shanghai Fifth People’s Hosp, Fudan Univ, Shanghai, China| School Life Science and Biotechnology, Shanghai Jiaotong Univ, Shanghai, China| Dept Nephrology, Shanghai Fifth People’s Hosp/Huashan Hosp, Fudan Univ, Shanghai, China FP281 GENE EXPRESSION ANALYSIS OF THE THERAPEUTIC EFFECTS OF VITAMIN D ON DIABETIC-LIKE CONDITIONS IN VASCULAR SMOOTH MUSCLE CELLS Tali Zitman-Gal | Eliezer Golan | Janice Green | Metsada Pasmanik-Chor | Varda Oron-Karni | Jacques Bernheim | Sydney Benchetrit Renal Physiology Lab, Dept Nephrology and Hypertension, Meir Medical Center | Dept Nephrology and Hypertension, Meir Medical Center | Bioinformatics Unit, G. S. Wise Fac Life Sciences, Tel Aviv Univ FP282 HIGH GLUCOSE MEDIATES ENDOTHELIAL-TO-CHRONDROCYTE TRANSITION IN HUMAN AORTIC ENDOTHELIAL CELL Ri-Ning Tang | Min Wu | Min Gao | Hong Liu | Xiao-Liang Zhang | Bi Cheng Liu Inst Nephrology, ZhongDa Hosp, Medical School, Southeast Univ, Nanjing, China 144 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France DIABETES - CLINICAL FP284 COMPARATIVE EFFICACY OF VARIOUS RENIN-ANGIOTENSIN SYSTEM BLOCKERS AND OTHER ANTIHYPERTENSIVE DRUGS IN DIABETIC NEPHROPATHY: A SYSTEMATIC REVIEW AND BAYESIAN NETWORK METAANALYSIS Hon-Yen Wu | Yu-Sen Peng | Jenq-Wen Huang | Kwan-Dun Wu | Yu-Kang Tu | Kuo-Liong Chien Internal Medicine, Far Eastern Memorial Hosp, New Taipei City, Taiwan | Div Biostatistics, Leeds Inst Genetics, Health & Therapeutics, Univ Leeds, Leeds, UK| Grad Inst Epidemiology and Preventive Medicine, National Taiwan Univ, Taipei, Taiwan FP285 PLASMA ADIPONECTIN IS RELATED TO PROGRESSION OF KIDNEY DISEASE IN TYPE 2 DIABETES PATIENTS Ina Maria Kacso | Diana Moldovan | Alina Lenghel | Crina Claudia Rusu | Mirela Gherman Caprioara Univ Medicine and Pharmacy Iuliu Hatieganu Cluj, Cluj Napoca, Romania FP286 ADIPONECTIN: ASSOCIATION WITH NON-TRADITIONAL RISK FACTORS AND CARDIOVASCULAR MORTALITY IN TYPE 2 DIABETICS WITH MILD TO MODERATE KIDNEY DISEASE Ana Paula Silva | André Fragoso | Ana Pinho | Cláudia Silva | Nélio Santos | Nelson Tavares | Marilia Faísca | Ana Camacho | Fernanda Mesquita | Pedro Leao Nephrology Dept, Hosp Faro, Faro, Portugal | Serv Patologia clinica- Hosp Faro| Gnóstica Lab | Serv Cardiologia- Hosp Faro E.P.E | Inst Superior Ciências da Saúde Egas Moniz FP287 ADIPOKINES, OXIDATIVE STRESS, INFLAMMATION, MINERAL METABOLISM, AND INSULIN RESISTANCE: NEW PREDICTORS OF CAROTID ARTERY INTIMA-MEDIA THICKNESS Ana Paula Silva | Cláudia Silva | Nélio Santos | Fatima Rato | André Fragoso | Ana Pinho | Marilia Faísca | Fernanda Mesquita | Pedro Leao Serv Nefrologia Hosp Faro E.P.E | Serv Patologia clinica- Hosp Faro | Gnóstica Lab | Inst Superior Ciências da Saúde Egas Moniz FP288 DIABETIC NEPHROPATHY AND CARDIOVASCULAR RISK: POTENTIAL ROLE OF ADIPOKINES, OXIDATIVE STRESS, INFLAMMATION AND MINERAL METABOLISM Ana Paula Silva | Cláudia Silva | Nélio Santos | Fatima Rato | André Fragoso | Ana Pinho | Marilia Faísca | Fernanda Mesquita | Pedro Leao Serv Nefrologia Hosp Faro E.P.E | Serv Patologia Clinica, Hosp Faro E.P.E | Gnóstica Lab | Inst Superior Ciências da Saúde Egas Moniz FP289 ROLE OF HUMAN BETA DEFENSINS IN PATIENTS WITH CHRONIC KIDNEY DISEASE Dong-Jin Oh | Hye-Ryoun Kim | Su-Hyun Kim Chung-Ang Univ Hosp, Seoul, Korea FP290 TLR4 GENE EXPRESSION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS w w w. e r a e d t a 2 01 2 . o r g 145 FRIDAY, MAY 25 FP283 MEAN PLATELET VOLUME AND RELATED FACTORS IN PATIENTS AT DIFFERENT STAGES OF DIABETIC NEPHROPATHY Kenan Turgutalp | Onur Ozhan | Esen Akbay | Naci Tiftik | Turkay Ozcan | Sercan Yılmaz | Ahmet Kiykim Div Endocrinology and Metabolism, Div Hematology, Dept Cardiology, Div Nephrology, Dept Internal Medicine, School Medicine, Mersin Univ, Mersin, Turkey 49th ERA-EDTA CONGRESS P O S T E R S AND NEPHROPATHY Kamal Okasha | Mohammad Sweilam | Hala Nagy | Marwa Hassan Rizk Tanta Univ Hosp, Dept Internal Medicine, Div Nephrology, Fac Medicine, Tanta, Egypt | Clinical pathology-Fac Medicine-Tanta Univ, Tanta, Egypt | Clinical pathology-Fac Medicine-Tanta Univ,Tanta, Egypt FRIDAY, MAY 25 FP291 BASELINE DEMOGRAPHIC, CLINICAL AND LAB PARAMETERS RELATED WITH 24 HOUR URINARY SODIUM EXCRETION IN NEWLY DIAGNOSED PATIENTS WITH TYPE 2 DIABETES Alper Kirkpantur | Baris Afsar FP292 CLINICAL IMPLICATIONS OF PATHOLOGIC DIAGNOSIS AND CLASSIFICATION FOR DIABETIC NEPHROPATHY Dong-Wan Chae | Ho Jun Chin | Suhnggwon Kim SNUBH | Seoul National Univ Bundang Hosp Seongnam Korea | SNUH FP293 ADDITION OF SILYMARIN TO RENNIN-ANGIOTENSIN SYSTEM INHIBITORS ATTENUATES PROTEINURIA IN TYPE 2 DIABETIC PATIENTS WITH OVERT NEPHROPATHY: A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL Mohammad Kazem Fallahzadeh Abarghouei | Banafshe Dormanesh | Jamshid Roozbeh | Eskandar Kamali-Sarvestani | Ghazal Vessal | Maryam Pakfetrat | Mohammad Mahdi Sagheb Health Policy Res Center, Shiraz Univ Medical Sciences, Shiraz, Iran | AJA Univ Medical Sciences, Tehran, Iran | Shiraz Nephro-Urology Res Center, Shiraz Univ Medical Sciences, Shiraz, Iran | Autoimmune Diseases Res Center, Shiraz Univ Medical Sciences, Shiraz, Iran | Dept Clinical Pharmacy, Shiraz Univ Medical Sciences, Shiraz, Iran FP294 PREDICTION OF THE PROGNOSIS IN TYPE 2 DIABETIC NEPHROPATHY BY RENAL PATHOLOGICAL FINDINGS Toshiyuki Imasawa | Motonobu Nishimura | Takehiko Kawaguchi | Ryoichi Ishibashi | Hiroshi Kitamura Chiba-East National Hosp FP295 GLYCATED ALBUMIN IS TOXIC FOR THE PROXIMAL TUBULE BUT SPARES THE GLOMERULAR ENDOTHELIUM IN NORMOALBUMINURIC PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL STUDY Adrian Vlad | Ligia Petrica | Maxim Petrica | Dragos Catalin Jianu | Gheorghe Gluhovschi | Calina Ianculescu | Mioara Negru | Victor Dumitrascu | Florica Gadalean | Alina Zamfir | Cristina Popescu | Sorin Giju | Cristina Gluhovschi| Silvia Velciov | Oana Milas | Cristian Balgradean | Sorin Ursoniu Victor Babes Univ Medicine and Pharmacy Timisoara, Romania | Inst Chemistry Timisoara, Romania | V. Goldis Univ, Dept Molecular Chemistry | Univ Medicine and Pharmacy Timisoara Romania FP296 THE RELATIONSHIP BETWEEN DAYTIME, NIGHTTIME AND TOTAL HEART RATE WITH ALBUMIN AND PROTEIN EXCRETION IN NEWLY DIAGNOSED TYPE 2 DIABETIC PATIENTS Baris Afsar Konya Numune State Hosp FP297 IS VITAMIN D A RISK FACTOR OR A BIOMARKER OF RENAL DISEASE IN TYPE 2 DIABETICS? Ana Paula Silva | Ana Pinho | André Fragoso | Cláudia Silva | Nélio Santos | Marilia Faísca | Fernanda Mesquita | Pedro Leao Serv Nefrologia Hosp Faro E.P.E | Serv Patologia clinica- Hosp Faro | Gnóstica Laboratório | Inst Superior Ciências Saúde Egas Moniz FP298 NEUTROPHIL GELATINASE-ASSOCIATED LIPOKALIN AND CATHEPSIN 146 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP299 PREVALENCE AND CLINICAL CHARACTERISTIC OF PATIENTS WITH CLINICALLY DEFINED MANIFEST DIABETIC NEPHROPATHY IN A GENERAL TYPE 2 DIABETES POPULATION Hanri Afghahi Dept Renal Medicin, Skövde, Sweden FP300 PREVALENCE AND OUTCOMES OF NON-DIABETIC KIDNEY DISEASE IN TYPE 2 DIABETES MELLITUS PATIENTS Narayan Prasad | Dharmender Bhadauria | Anurag Gupta | Raj Kumar Sharma| Amit Gupta | Anupama Kaul | Manoj Jain Sanjay Gandhi PostGrad Inst Medical Sciences,Lucknow, India FP301 POSSIBILITIES OF INFLUENCE ON OXIDATIVE STRESS MARKERS AT DIABETIC NEPHROPATHY Olena Loboda | Iryna Dudar | Lesya Korol | Iryna Shifris Inst Nephrology NAMS of Ukraine, Kyiv, Ukraine | Dept Efferesis Technology, Inst Nephrology NAMS of Ukraine, Kyiv, Ukraine FP302 CLINICAL PREDICTORS FOR RENAL BIOPSY IN PATIENTS WITH CONCOMITANT DIABETES MELLITUS AND RENAL DISEASE Kenji Ito | Yasuhiro Abe | Satoru Ogahara | Tetsuhiko Yasuno | Maho Watanabe | Yoshie Sasatomi | Satoshi Hisano | Hitoshi Nakashima | Takao Saito Fukuoka Univ School of Medicine, Fukuoka, Japan FP303 C-PEPTIDE AND MARKERS OF KIDNEY DAMAGE CORRELATIONS IN PATIENTS WITH DIABETES MELLITUS TYPE 1 Assem Nogaibayeva | Saltanat Tuganbekova | Zhannat Taubaldiyeva | Bolat Bekishev | Rakhat Trimova National Scientific Medical Centre FP304 SERUM MONOCYTE CHEMOATTRACTANT PROTEIN-1 AND CD16+ MONOCYTES IN TYPE 2 DIABETIC PATIENTS WITH NEPHROPATHY Ivan Topchii | Polina Semenovykh | Valentina Galchiskaya | Natalia Efimova| Tatyana Scherban Inst Therapy named after L.T. Malaya of NAMS of Ukraine FP305 THE PATHOLOGIC CLASSIFICATION OF DIABETIC NEPHROPATHY IS CORRELATED WITH THE CLINICAL CHARACTERISTICS OF DIABETES MELLITUS Fumihiko Yasuda | Akira Shimizu | Akiko Mii | Megumi Fukui Nippon Medical School, Tokyo, Japan | Internal Medicine (Div Neurology, Nephrology, and Reumatology) FP306 RELATIONSHIP BETWEEN CHRONIC KIDNEY DISEASE AND ANEMIA IN PATIENTS WITH TYPE 2 DIABETES M. Postorino | E. Alessi | E. Dal Moro | S. Postorino | G. Mannino | A. Giandalia | D. Mannino Diabetology and Endocrinology Unit Reggio Calabria FP307 HYPERGLYCEMIA STIMULATES UBIQUITIN-CONJUGATING ENZYME E2 w w w. e r a e d t a 2 01 2 . o r g 147 FRIDAY, MAY 25 AS AN EARLY PREDICTORS OF KIDNEY DYSFUNCTION IN CHILDREN WITH DIABETES Jolanta Soltysiak | Jacek Zachwieja | Piotr Fichna | Katarzyna Lipkowska | Bogda Skowronska | Witold Stankiewicz | Maria Stachowiak-Lewandowska | Agnieszka Kluska-Jozwiak Dept Pediatric Cardiology and Nephrology, Poznan Univ Medical Science, Poznan, Poland | Dept Pediatric Diabetes and Obesity, Poznan Univ Medical Science, Poznan, Poland 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 VARIANT 1 (UBE2V1) MEDIATED LYSINE 63 UBIQUITINATION IN DIABETIC NEPHROPATHY (DN) Paola Pontrelli | Francesca Conserva | Matteo Accetturo | Massimo Papale | Anna Maria Di Palma | Giorgia Cordisco | G Grandaliano | Loreto Gesualdo DETO, Univ Bari, Italy | Dept Emergency and Organ Transpl, Univ Bari, Italy | Policlinic Hosp Bari, Nephrology, Dyalisis and Transpl Unit, Italy | Nephrology, Dialysis and Transpl Unit, Dept Biomedical Sciences, Univ Foggia FP308 REMNANT LIPOPROTEIN AND STEROL ABSORPTION IN DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE Eiji Kimoto | Tetsuo Shoji | Mika Sonoda | Hideaki Shima | Shoko Tsuchikura | Katsuhito Mori | Masanori Emoto | Eiji Ishimura | Yoshiki Nishizawa | Masaaki Inaba Dept Metabolism, Endocrinology and Molecular Medicine, Dept Nephrology, Osaka City Univ Grad School Medicine, Osaka, Japan FP309 DYNAMIC COLOR DOPPLER SONOGRAPHIC CORTICAL PERFUSION MEASUREMENT DETECTS DIABETIC NEPHROPATHY BEFORE THE OCCURENCE OF MICROALBUMINURIA Christian Vogel | Thomas Scholbach | Nils Bergner Hosp Children and Adolescents, Chemnitz, Germany FP310 PODOCYTOURIA AS AN EARLIER MARKER OF DIABETIC NEPHROPATHY Eirini Lioudaki | Konstantinos Stylianou | Eleutheria Maragkaki | Stavros Stratakis | Maria Panteri | Christianna Choulaki | Eleutheria Vardaki | Emmanuel Ganotakis | Eugene Daphnis Lab Experimental Nephrology and Dept Internal Medicine, Fac Medicine, Univ Crete, Heraklion, Greece | Lab Experimental Nephrology and Dept Nephrology, Fac Medicine, Univ Crete, Heraklion, Greece | Dept Nephrology, Univ Crete, Greece | Dept Internal Medicine, Univ Crete, Greece | Lab Rheumatology, Clinical Immunology and Allergy, Univ Crete, Greece FP311 ASSOCIATION OF TRADITIONAL RISK FACTORS WITH RENAL FUNCTIONAL VARIATIONS IN TYPE 2 DIABETIC SUBJECTS WITHOUT NEPHROPATHY – OBSERVATIONS FROM BNDC TRIAL IN BIRDEM, BANGLADESH MM Iqbal | Z Ahmed | MA Mansur | S Iqbal | S Choudhury | N Nahar | S Ali| T Ahmed | AKMS Alam | Z Rahman | MN Islam | AK Azad Khan NIKDU | BIRDEM | UHL FP312 SIGNIFICANT INCREASE IN THE RENAL RESISTIVE INDEX IN PATIENTS WITH TYPE 2 DIABETIC NEPHROPATHY WITH OVERT PROTEINURIA Ayu Ogawa | Hitoshi Sugiyama | Masashi Kitagawa | Hiroshi Morinaga | Tatsuyuki Inoue | Keiichi Takiue | Yoko Kikumoto | Haruhito Adam Uchida | Shinji Kitamura | Yohei Maeshima | Yoshinori Tsuchiyama | Hirofumi Makino Okayama Univ Grad School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan | Kyoto Univ, Kyoto, Japan | Kochi Health Sciences Center, Kochi, Japan FP313 INVESTIGATION ON THE VALIDITY OF FASTING BLOOD SUGAR AND GLUCOSE TOLERANCE TEST IN THE FIFTH DAY AFTER KIDNEY TRANSPL FOR ANTICIPATING DIABETES MELLITUS Fatemeh Nazemian | Mostafa Jafari | Narges o Sadat Zahed | Reza Javidi Dasht Bayaz Mahhad Univ Nedical Sciences. Mashhad, Iran | Shahid Beheshti Univ Medical Sciences | Tehran Univ Medical Sciences FP314 CLINICAL SIGNIFICANCE OF INCREASED URINARY β2-MICROGLOBULIN IN DIABETIC NEPHROPATHY (DN) Massimo Papale | Salvatore Di Paolo | Grazia Vocino | Annamaria Di Palma| Cataneo Federica | Maria Teresa Rocchetti | Giuseppe Grandaliano | Loreto 148 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Gesualdo D.E.T.O. Univ Bari, Italy | Nephrology and Dialysis Unit, Hosp Dimiccoli , ASL BAT, Barletta, Italy | InterDept Res Center Bioagromed, Univ Foggia, Italy | Nephrology, Dialysis and Transpl Unit, Dept Emergency and Transpl, A. Moro Univ, Bari | Nephrology, Dialysis and Transpl Unit, Dept Biomedical Sciences, Univ Foggia FP316 SECOND HARMONIC MICROSCOPY TO QUANTIFY RENAL INTERSTITIAL FIBROSIS IN ADULT PATIENTS WITH DIABETIC NEPHROPATHY Gener Ismail | Alexe Ditoiu | Stefan Stanciu | Vlad Herlea | Otilia Motoi Fundeni Clinical Inst, Dept Nephrology, Bucharest, Romania | Center Microscopy-Microanalysis and Information Processing, Univ Politehnica Bucharest, Bucharest, Romania | Dept Pathology, Fundeni Hosp, Bucharest, Romania | Dept Internal Medicine, Fundeni Clinical Inst, Bucharest, Romania FP317 DOSE DEPENDENT REDUCTION OF CYTOTOXIC ADVANCED GLYCATION ENDPRODUCTS BY SEVELAMER CARBONATE Gary Striker | Jaime Uribarri | Helen Vlassara Mount Sinai School of Medicine FP318 RELATIONSHIP VITAMIN D LEVELS AND MICROALBUMINURIA IN TYPE 2 DIABETIC PATIENTS Bulent Gul | Ozen Oz Gul | Abdulmecit Yildiz | Ayca Eroglu | Nermin Keni | Canan Ersoy | Alparslan Ersoy | Sazi İmamoglu | Mustafa Yurtkuran Uludag Univ Medical School Dept Nephrology, Bursa, Turkey | Cekirge State Hosp, Bursa, Turkey | Uludag Univ Medical School Dept Internal Medicine | Uludag Univ Medical School Dept Endocrinology w w w. e r a e d t a 2 01 2 . o r g 149 FRIDAY, MAY 25 FP315 PATTERN OF DIABETIC RETINOPATHY PATIENTS ON CHRONIC DIALYSIS Candra Wibowo Prajitno Nephrology and Hypertension Div Internal Medicine Dept Trisakti Univ Jakarta 49th ERA-EDTA CONGRESS P O S T E R S ELECTROLYTE DISORDERS / NEPHROLITHIASIS FRIDAY, MAY 25 FP319 MANAGEMENT OF HYPERNATREMIA IN EMERGENCY DEPT Baralla Camille | Buffat Christophe | Berland Yvon | Vacher-Coponat Henri | Michelet Pierre | Torro Dominique | Stanislas Bataille Univ Aix-Marseille, AP-HM, Marseille, France | Hôp Conception FP320 THIAZIDE INDUCED SEVERE HYPONATREMIA AND OSMOTIC DEMYELINATION SYNDROME - A CASE STUDY AND LITERATURE REVIEW Satish Chondolu | Tyler An | Shaza Khan | Supratik* Rayamajhi Michigan State Univ, East Lansing, USA FP321 CICLETANINE-INDUCED HYPONATREMIA AND HYPOKALEMIA IN PATIENTS WITH KIDNEY TRANSPLANTATION Gheun-Ho Kim | Young Wook Roh | Chang Hwa Lee | Chong Myung Kang Hanyang Univ College of Medicine, Seoul, Korea FP322 HYPOPHOSPHATEMIA: A SIGNIFICANT PROBLEM IN HOSPITALIZED PATIENTS Ravi Bansal | Kailash Nath Singh | Sanjiv Saxena | KK Malhotra Pushpawati Singhania Res Inst, New Delhi, India FP323 THE ASSOCIATION BETWEEN HYPOMAGNESEMIA AND PROTON PUMP INHIBITOR USE IN CHRONIC KIDNEY DISEASE Steven Van Laecke | Evi Nagler | Wim Van Biesen | Michel Jadoul | Raymond Vanholder Renal Div Ghent Univ Hosp, Ghent, Belgium | Ghent Univ Hosp | Cliniques Univ Saint-Luc, Univ Catholique Louvain, Brussels, Belgium FP324 WHAT YOU WOULD NOT EXPECT FROM A RENINOMA: METASTASIS AND SYNDROME OF INAPPROPRIATE SECRETION OF ANTIDIURETIC HORMONE (SIADH) David Cucchiari | Claudio Angelini | Marco Mirani | Paola Arosio | Giorgio Graziani | Salvatore Badalamenti Ist Clin Humanitas IRCCS - Rozzano, Milano - Italy FP325 CT SCAN EVALUATION OF PAPILLARY DENSITY IN HYPERCALCIURIC AND NON-HYPERCALCIURIC STONE FORMERS Daniela Girfoglio | Darren Allen | Alex Kirkham | Nikhil Johri | David C. Wheeler | Simon Choong | Shabbir Moochhala | Robert Unwin Centre Nephrology, Royal Free Campus UCL Medical School, London UK | Royal Free Hampstead NHS Trust, London, Uk | Univ College Hosp, London UK FP326 ABNORMAL ARTERIAL STIFFNESS AND BONE DENSITY IN CALCIUM RENAL STONE FORMERS PATIENTS Antonia Fabris | Antonio Lupo | Francesco Fantin | Pietro Manuel Ferraro | Chiara Caletti | Gabrielle Comellato | Michele Messa | Giovanni Gambaro Nephrology Univ Verona | Section Nephrology, Dept Medicine | Section Geriatic Depts Medicine | Neprhology Catholic Univ Rome | Catholic Univ Rome FP327 PREVALENCE OF HYPOKALAEMIA IN OUTPATIENTS Hiroshi Tanaka | Narihito Tatsumoto | Shoji Tsuneyoshi | Yasunori Daijo Hiroshima Red Cross Hosp and Atomic-bomb Survivors Hosp, Hiroshima, Japan FP328 MAGNESIUM LEVELS IN PATIENTS WITH ADPKD TREATED WITH ANTI EGF-R, NIMOTUZUMAB Raymed A. Bacallao Méndez | Tania Crombet | José M. Dávalos | Betsy Llere- 150 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France na| Christian Leyva | Reynaldo Manalich Inst Nefrología | Centro Inmunología Molecular FP330 THE ENDOUROLOGICAL TREATMENT OF RENAL MATRIX STONES Paolo Beltrami | Lorenzo Ruggera | Andrea Guttilla | Alessandro Iannetti | Fabio Zattoni | Francesca Gigli | Filiberto Zattoni Urology Clinic, Univ Padova, Padova, Italy | Dept Urology, S. Maria degli Angeli Hosp, Pordenone, Italy w w w. e r a e d t a 2 01 2 . o r g 151 FRIDAY, MAY 25 FP329 RETROGRADE INTRA RENAL SURGERY FOR RENAL STONES Paolo Beltrami | Lorenzo Ruggera | Alessandro Iannetti | Massimo Iafrate | Andrea Guttilla | Fabio Zattoni | Marcello Arancio | Filiberto Zattoni Urology Clinic, Univ Padova, Padova, Italy | Dept Urology, S. Maria degli Angeli Hosp, Pordenone, Italy 49th ERA-EDTA CONGRESS P O S T E R S PRIMARY AND SECONDARY GLOMERULONEPHRITIS I FRIDAY, MAY 25 FP331 TRADITIONAL THERMAL THERAPY WITH INDIRECT-MOXIBUSTION REDUCES RESISTIVE INDEX OF RENAL SEGMENTAL ARTERY IN CKD PATIENTS. A RANDOMIZED CROSS-OVER CONTROLLED TRIAL Nagisa Miyazaki | Jun Matsumoto Dept Cardiology, Respirology & Nephrology, Gifu Univ Grad School Medicine, Gifu, Japan | Div Cardiology, Gifu Univ Grad School Medicine FP332 METHOTREXATE PLUS PREDNISONE IN PATIENTS WITH RELAPSING IDIOPATHIC RETROPERITONEAL FIBROSIS Federico Alberici | Alessandra Palmisano | Federica Maritati | Elena Oliva | Carlo Buzio | Augusto Vaglio Nephrology Unit, Univ Parma, Italy FP333 OUTCOME IN BIOPSY-PROVEN LUPUS NEPHRITIS Geir Mjoen | Gudrun E Norby | Bjorn Egil Vikse | Einar Svarstad | Bjoerneklett Rune | Aasaroed Knut Oslo Univ Hosp, RiksHosp | Haukeland Univ Hosp | St Olavs Hosp FP334 HEPARANASE AS A NOVEL MARKER OF LUPUS NEPHRITIS ACTIVITY Maciej Szymczak | Jakub Kuźniar | Wacław Kopeć | Zofia Marchewka | Marian Klinger Dept Nephrology and Transpl Medicine, Wrocław, Poland | Dept Toxicology, Wroclaw Medical Univ FP335 ANTIPHOSPHOLIPID SYNDROME-ASSOCIATED NEPHROPATHY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: PREVALENCE, CLINICAL MANIFESTATIONS AND RENAL FUNCTIONAL OUTCOME Pilar Arrizabalaga | Ricardo Silvariño | Francesc Sant | Gerard Espinosa | Manel Solé | Ricard Cervera Hosp Clínic | Autoimmune Diseases. Hosp Clínic | Pathology. Fund Althaia FP336 CLINICOPATHOLOGICAL PROFILE OF PATIENTS WITH BIOPSY PROVEN LUPUS NEPHRITIS AT A TERTIARY CARE HOSP Dilip Gude | Sashidhar Chennamsetty Medwin Hosp, Nampally, Hyderabad FP337 HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPL FOR SEVERE REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS WITH LUPUS NEPHRITIS: REMOTE OUTCOMES Alexander Demin | Vladimir Kozlov | Igor Lisukov | Olga Kotova | Aleksey Sizikov | Vera Sergeevicheva | Larissa Demina Novosibirak State Medical Univ | Clinical Immunology Inst Russian Medical Sciences Academy, Novosibirsk, Russian Federation | Internal Medicine and SLE Centre, Novosibirsk State Medical Univ, Novosibirsk, Russian Federation | Nephrology and Dialysis City Centre, Novosibirsk, Russian Federation FP338 MACROPHAGE INHIBITORY FACTOR (MIF) AND EUTHYROID SICK SYNDROME IN ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS Ola Börjesson | Mårten Wendt | Aune Avik | Abdul R Qureshi | Johan Bratt | Edmund J Miller | Iva Gunnarsson | Annette Bruchfeld Unit Rheumatology, Dept Medicine, Karolinska Univ Hosp, Karolinska Inst, Stockholm, Sweden | Baxter Novum, CLINTEC, Karolinska Inst, Stockholm, Sweden | Feinstein Inst Medical Res, Manhasset, New York, USA | Dept Renal Medicine, Karolinska Univ Hosp, CLINTEC, Karolinska Inst, Stockholm, Sweden 152 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP340 THE DEMOGRAPHY OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS Steven Yew | David Jayne | Kerstin Westman | Peter Hoglund | Oliver Flossman | Alfred Mahr | Raashid Luqmani | Jo Robson Addenbrookes Hosp, UK | Malmo Univ Hosp, Malmo Sweden | Univ Lund, Skane Univ Hosp, Sweden | Reading Hosp, Reading, UK | Hosp Cochin, Paris, France | Nufflield Hosp, Oxford, UK FP341 NON RAPIDLY-PROGRESSIVE GLOMERULONEPHRITIS: A FREQUENT CLINICAL PRESENTATION OF ANCA-ASSOCIATED VASCULITIS WITH RENAL INVOLVEMENT Eric Thervet | Charlène Levi | Elsa Guiard | Mélanie Roland | Dominique Nochy | Cristina Daniliuc | Loïc Guillevin | Luc Mouthon | Christian Jacquot | Alexandre Karras Néphrologie, HEGP, Paris, France | Renal Pathology, HEGP, Paris, France | Médecine Interne, Cochin, Paris, France FP342 CIRCULATING ANTIBODIES SPECIFIC FOR -ENOLASE AND PHOSPHOLIPASE A2 RECEPTOR IN JAPANESE PATIENTS WITH PRIMARY OR SECONDARY MEMBRANOUS NEPHROPATHY Yukihiro Kimura | Hiroyuki Morita | Hanna Debiec | Harutaka Yamada | Naoto Miura | Shogo Banno | Pierre Ronco | Hirokazu Imai Div Nephrology and Rheumatology, Dept Internal Medicine, Aichi Medical Univ School Medicine | Univ Pierre et Marie Curie, Paris 6, Assist Publique–Hôp Paris (AP-HP), Tenon Hosp | Kawana Hosp FP343 PRESERVATION OF RENAL FUNCTION BY GLUCOCORTICOIDS ALONE OR WITH CYCLOSPORINE IN KOREAN PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY Dong Ho Shin | Hyang Mo Koo | Seung Hyeok Han | Kyu Hun Choi | TaeHyun Yoo | Shin-Wook Kang Dept Internal Medicine, College Medicine, Yonsei Univ, Seoul, Korea FP344 MEMBRANOUS NEPHROPATHY AND MALIGNANCIES Claudia Fofi | Luca Scabbia | Francescaromana Festuccia | Antonella Stoppacciaro | Paolo Mene’ U.O. Nefrologia, Azienda Osp S. Andrea, Univ Roma Sapienza, Rome, Italy| U.O. Istologia ed Anatomia Patologica, Azienda Osp S. Andrea, Univ Roma Sapienza, Rome, Italy FP345 THE MECHANISM OF THE DEVELOPMENT OF SEGMENTAL GLOMERULAR SCLEROSIS IN IDIOPATHIC MEMBRANOUS NEPHROPATHY Akira Shimizu | Akiko Mii | Tomohiro Kaneko | Yukinari Masuda | Yasuhiko Iino | Yasuo Katayama | Yuh Fukuda Pathology, Internal Medicine (Div Neurology, Nephrology, and Reumatology), Nippon Medical School, Tokyo, Japan FP346 ANTIGEN NON-SPECIFIC ACTIVATION OF CD8 T CELLS TRIGGERS AUTOIMMUNE RESPONSE IN IDIOPATHIC MEMBRANOUS NEPHROPATHY Aki Kuroki | Kei Matsumoto | Tadao Akizawa Div Nephrology, Dept Medicine, Showa Univ, Tokyo, Japan w w w. e r a e d t a 2 01 2 . o r g 153 FRIDAY, MAY 25 FP339 CLINICAL FEATURES, TREATMENT DIVERSITY AND OUTCOME OF MPOANCA-ASSOCIATED VASCULITIS – EXPERIENCE FROM THE DEPTS RHEUMATOLOGY AND NEPHROLOGY OF A SINGLE JAPANESE CENTER Kazuhiro Sugiyama | Midori Hasegawa | Koichiro Yamamoto | Hiroki Hayashi| Shigehisa Koide | Kazutaka Murakami | Makoto Tomita | Shunji Yoshida | Yukio Yuzawa Fujita Health Univ Scool of Medicine, Dept Nephrology | Fujita Health Univ Scool Medicine, Dept Rheumatology 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FP347 EFFICACY AND SAFETY OF TRIPLE THERAPY WITH MMF, CYCLOSPORINE AND PREDNISOLONE VERSUS CYCLOSPORINE AND PREDNISOLONE IN ADULT PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY AND PERSISTENT HEAVY PROTEINURIA Roxana Jurubita | Gener Ismail | Raluca Bobeica | Elena Rusu | Diana Zilisteanu | Andreea Andronesi | Otilia Motoi | Valerian Ditoiu | Ionel Copaci | Mihai Voiculescu Fundeni Clinical Inst, Dept Nephrology, Bucharest, Romania FP348 LOW AND HIGH MOLECULAR WEIGHT URINARY PROTEINS AS PREDICTORS OF RESPONSE TO RITUXIMAB IN PATIENTS WITH MEMBRANOUS NEPHROPATHY: A PROSPECTIVE STUDY Maria V. Irazabal | Alfonso Eirin | John C. Lieske | Laurence H. Beck | John J. Dillon | Patrick H. Nachman | Sanjeev Sethi | Stephen B. Erickson | Daniel C. Cattran | Fernando C. Fervenza Mayo Clinic | Boston Univ | Univ North Carolina | Toronto General Hosp FP349 MEASUREMENT OF ANTI-PLA2R ANTIBODIES IN A CZECH COHORT OF PATIENTS WITH MEMBRANOUS NEPHROPATHY Barbora Svobodova | Zdenka Hruskova | Ivana Janatkova | Eva Jancova | Vladimir Tesar Dept Nephrology, General Univ Hosp, Prague, Czech Republic | Inst Clinical Biochemistry and Lab Diagnostics , General Univ Hosp, Prague, Czech Republic FP350 EFFECT OF TREATMENT ON URINARY KIDNEY INJURY MOLECULE-1 IN IGA NEPHROPATHY Mi Seon Seo | Eun Bin Lee | Jin Young You | Yu Kyung Hyun | Sung Ae Woo| Moo Young Park | Soo Jung Choi | Jin Seok Jeon | Hyunjin Noh | Jin Gook Kim | Dong Cheol Han | Seung Duk Hwang | Tae Youn Choi | So young Jin | Soon Hyo Kwo Dept Internal Medicine, Dept Lab Medicine, Dept Pathology, Soon Chun Hyang Univ Hosp, Korea FP351 REGULATORY T CELLS (TREG) AND TRYPTOPHAN/KYNURENINE PATHWAY IN IgA NEPHROPATHY Elisa Loiacono | Davide Defedele | M. Paola Puccinelli | Roberta Camilla | Rachele Gallo | Licia Peruzzi | Cristiana Rollino | Giulietta Beltrame | Michela Ferro | Luca Vergano | Federica Campolo | Alessandro Amore | Rosanna Coppo Nephrology, Dialysis, Transpl, R.Margherita Hosp, Turin | Diagnostic Servs, Diagnostic Dept, R.Margherita Hosp, Turin | Nephrology and Dialysis, G.Bosco Hosp, Turin FP352 STANDARDIZED MORTALITY RATE IN IGA NEPHROPATHY PATIENTS Thomas Knoop | Bjørn Egil Vikse | Einar Svarstad | Leif Bostad | Torbjørn Leivestad | Rune Bjørneklett Medical Dept, Haukeland Univ Hosp, Bergen, Norway | Dept Pathology, Haukeland Univ Hosp, Bergen, Norway | Medical Dept, Oslo Univ Hosp, RiksHosp, Oslo, Norway « FP353 ACE INSERTION(I)/DELETION(D) POLYMORPHISM PREDICTED RENOPROTECTIVE EFFECTIVENESS OF RENIN-ANGIOTENSIN SYSTEM (RAS) BLOCKADE IN PATIENTS WITH IGA NEPHROPATHY Junya Teranishi | Ryohei Yamamoto | Yasuyuki Nagasawa | Tatsuya Shoji | Hirotsugu Iwatani | Noriyuki Okada | Toshiki Moriyama | Atsushi Yamauchi | Yoshiharu Tsubakihara | Enyu Imai | Hiromi Rakugi | Yoshitaka Isaka Dept Geriatric Medicine & Nephrology, Osaka Univ Grad School of Medicine, Suita, Japan | Dept Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan | Clinical Lab Medicine, Osaka General Medical Center, Osaka, Japan | Osaka Univ Healthcare Center, Toyonaka, Japan | Dept Nephrology, Osaka Rosai Hosp, Sakai, Japan | Nagoya Univ, Nagoya, Japan 154 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP355 GALACTOSE-DEFICIENT IGA1 AND IGA-IGG IMMUNE COMPLEX AS NOVEL NONINVASIVE BIOMARKERS FOR DISEASE ACTIVITY OF IGA NEPHROPATHY (IGAN) Yusuke Suzuki | Keiichi Matsuzaki | Hitoshi Suzuki | Keiko Okazaki | Hiroyuki Yanagawa | Masayuki Maiguma | Masahiro Muto | Toshinobu Sato | Satoshi Horikoshi | Jan Novak | Osamu Hotta | Yasuhiko Tomino Div Nephrology, Dept Internal Medicine, Juntendo Univ Fac Medicine | Dept Nephrology, Sendai Shakaihoken Hosp, Sendai, Miyagi, Japan | Univ Alabama Birmingham, Birmingham, AL FP356 LONG-TERM OUTCOME OF BIOPSY-PROVEN IgA NEPHROPATHY PRESENTING WITH NORMAL RENAL FUNCTION AND MINIMAL OR NEGATIVE PROTEINURIA Eduardo Gutierrez | Isabel Zamora | José Ballarín | Yolanda Arce | Sara Jiménez | Carlos Quereda | Teresa Olea | Jorge Martínez-Ara | Alfons Segarra| Carmen Bernis | Asunción García | Marian Goicoechea | Soledad García de Vinuesa| Jorge Rojas | Manuel Praga Hosp Univ 12 de Octubre, Madrid, Spain | Hosp Univ La Fe, Valencia, Spain | Fund Puigvert, Barcelona, Spain | Hosp Univ Ramón y Cajal, Madrid, Spain | Hosp Univ La Paz, Madrid, Spain | Hosp Univ Vall d´Hebrón, Barcelona, Spain| Hosp Univ La Princesa, Madrid, Spain | Hosp Univ Gregorio Marañón, Madrid, Spain | por Grupo Estudio Enfermedades Glomerulares Sociedad Española Nefrología (GLOSEN). FP357 LONG-TERM EFFECTS OF STEROIDS AND MYCOPHENOLATE MOFETIL IN NEPHROTIC IGA NEPHROPATHY PATIENTS WITH SCLEROTIC AND ENDOCAPILLARY PROLIFERATIVE CHANGES Vesna Ristovska | Gordana Petrushevska | Ladislava Grcevska Dept Nephrology, Skopje | Inst Pathology Skopje FP358 VALIDATION OF FRENCH MODEL TO PREDICT ESRD AND DEATH IN IGA NEPHROPATHY PATIENTS Thomas Knoop | Bjørn Egil Vikse | Einar Svarstad | Leif Bostad | Torbjørn Leivestad | Rune Bjørneklett Medical Dept, Haukeland Univ Hosp, Bergen, Norway | Medical Dept, Oslo Univ Hosp, RiksHosp, Oslo, Norway FP359 POLYMERIC IGA1 FOR THE SELECTIVE ANALYSIS OF O-GLYCOSYLATION IN PATIENTS WITH IGA NEPHROPATHY Kenji Satake | Yoshio Shimizu | Nozomi Mugitani | Hitoshi Suzuki | Yusuke Suzuki | Satoshi Horikoshi | Shinichiro Honda | Kazuko Shibuya | Akira Shibuya | Yasuhiko Tomino Juntendo Univ, Tokyo, Japan | Univ Tsukuba, Tsukuba, Japan FP360 DECREASE OF PERLECAN LG3 PEPTIDE AND FREE K-LIGHT CHAINS URINE EXCRETION IN IgA NEPHROPATHY: NEW INSIGHTS FOR A NONINVASIVE DIAGNOSIS OF IgAN? Massimo Papale | Maria Teresa Rocchetti | Salvatore Di Paolo | Ida Valentina Suriano | Annamaria D'Apollo | Grazia Vocino | Eustacchio Montemurno | Leonarda Varraso | Giuseppe Grandaliano | Loreto Gesualdo Proteomics Core Facility, Res Center BioAgroMed Univ Foggia, Italy | 2Div Nephrology and Dialysis, Hosp Dimiccoli, Barletta, Italy | Res Center Bioagromed Univ Foggia, Italy | Res Center Bioagromed Univ Foggia, Italy | Nephrology Dialysis and Transpl Unit, DETO, Univ Bari, Italy w w w. e r a e d t a 2 01 2 . o r g 155 FRIDAY, MAY 25 FP354 HYPOCOMPLEMENTEMIA AND MESANGIAL C3 DEPOSITION PREDICT RENAL OUTCOME IN PATIENTS WITH IGA NEPHROPATHY Hyang Mo Koo | Fa Mee Doh | Seung Jun Kim | Shin-Wook Kang | Kyu Hun Choi | Dae Suk Han | Seung Hyeok Han College of Medicine, Yonsei Univ, Seoul, Korea 49th ERA-EDTA CONGRESS P O S T E R S FP361 IgA NEPHROPATHY - CLINICAL AND HISTOLOGICAL PROGNOSTIC FACTORS Ana Huerta | Andrew S. Bomback | Pietro A. Canetta | Jai Radhakrishnan | Leal Herlitz | Barry Stokes | Vivette D´Agati | Glen Markowitz | Gerald B. Appel Hosp 12 de Octubre, Madrid, Spain | Columbia Univ College Physicians and Surgeons, New York, U.S. FRIDAY, MAY 25 FP362 TREATMENT OF PRIMARY AMYLOIDOSIS Vesna Ristovska | Ladislava Grcevska Dept Nephrology, Skopje FP363 ACUTE POSTINFECTIOUS GLOMERULONEPHRITIS IN ADULTS Hamouda Mouna | Ben Dhia Nasr | Imen Mrabet | Letaif Ahmed | Aloui Sabra| Frih Mohamed Ammeur | Elmay Mezri | Skhiri Habib Dept of Nephrology, Fattouma Bourguiba Hosp, Monastir, Tunisia FP364 CHRONIC AUTOIMMUNE THYROIDITIS AND GLOMERULONEPHRITIS: A TRULY RARE ASSOCIATION? Maurizio Innocenti | Antonio Pasquariello | Giovanna Pasquariello | Paola Mattei | Anna Bottai | Giordano Fumagalli | Laura Bozzoli | Sara Samoni | Adamasco Cupisti Medical Area, U.O. Nefrologia 2 SSN, AOUP, Pisa, Tuscany, Italy | Medical Area, U.O. Nefrologia 1 Univ, AOUP, Pisa, Tuscany, Italy FP365 KIDNEY BIOPSIES IN HIV PATIENTS: A FIFTEEN-YEAR SINGLE CENTER EXPERIENCE IN BRAZIL Bruno Caldin | James Hung | Liliany Repizo | Denise M. Malheiros | Rui Barros| Viktoria Woronik Univ São Paulo | Hosp Clínicas, Univ São Paulo | Dept Pathology, Univ São Paulo FP366 PREGNANCY IN PATIENTS WITH CRYOGLOBULINEMIC VASCULITIS TREATED WITH PLASMAPHERESIS AND MYCOPHENOLATE MOFETIL (MMF). A CASE REPORT Carlo Giammarresi | Luisa Bono | Angelo Ferrantelli | Calogera Tortorici | Gioacchino Licavoli | Ugo Rotolo ARNAS Civico U.O: Nefrologia e Dialisi, Palermo, Italy FP367 THE INDUCTION THERAPY WITH BORTEZOMIB AND DEXAMETHASONE FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPL CAN IMPROVE BOTH THE HEMATOLOGICAL AND ORGAN RESPONSE RATE IN AL AMYLOIDOSIS Xianghua Huang | Qingwen Wang | Mingjun Shi | Wencui Chen | Zhihong Liu Res Inst Nephrology, Jinling Hosp, Nanjing Univ School of Medicine, Nanjing, China FP368 INTERLEUKIN-1-RECEPTOR ANTAGONIST CANAKINUMAB MAY AMELIORATE RENAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND SECONDARY AMYLOIDOSIS (AA) IN THE MUCKLE-WELLS SYNDROME Roberto Scarpioni | Luca Cantarini | Antonio Lazzaro | Marco Ricardi | Vittorio Albertazzi | Luigi Melfa | Claudia Concesi | Daniele Vallisa | Luigi Cavanna Nephrology and Dialysis Unit, Dept Speciality, Guglielmo da Saliceto Hosp AUSL Piacenza, Italy | Rheumatology Unit, Dept Clinical Medicine and Immunologic Sciences, Univ Siena, Italy | Haematology Unit, Dept Oncohematology, Guglielmo da Saliceto Hosp AUSL Piacenza, Italy | Dept Oncohematology, Guglielmo da Saliceto Hosp AUSL Piacenza, Italy FP369 SERUM AND URINE NGAL LEVELS IN PATIENTS WITH CIRRHOSIS AND 156 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP370 HIGH PREVALENCE OF OCCULT HCV INFECTION IN PATIENTS WITH PRIMARY AND SECONDARY GLOMERULAR NEPHROPATHIES Jorge Martinez-Ara | Inmaculada Castillo | Vicente Carreño | Ana Aguilar | Rosario Madero | Eduardo Hernandez | Carmen Bernis | Javier Bartolomé | Francisco Gea | Rafael Selgas Hosp Univ La Paz, Madrid, Spain | Fund Estudio Hepatitis Virales, Madrid, Spain | Serv Nefrología, Serv Bioestadística, Hosp Univ La Paz, Madrid, Spain| Serv Nefrología, Hosp Univ 12 de Octubre, Madrid | Serv Nefrología, Hosp la Princesa, Madrid, Spain | Serv Gastroenterología, Hosp Univ La Paz, Madrid FP371 RENAL TUBULAR FUNCTION AND ITS RELATIONSHIP TO ADIPONECTIN AND OXIDATIVE STRESS IN OBESE SUBJECTS WITH AND WITHOUT EVIDENCE OF NEPHROPATHY Hayam Abdel Meguid El Aggan | Hisham Salah El Banawy | Eman Wagdy Fac Medicine, Alexandria, Egypt | Medical Res Inst, Alexandria, Egypt FP372 EXTRAVASCULAR EFFECTS OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 (PAI-1) IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS (CGN): IMPORTANT MECHANISM OF THE RENAL TUBULOINTERSTITIONAL FIBROSIS (TIF) AND POTENTIAL TARGET FOR ITS TREATMENT Natalia Tchebotareva | Olga Li | Irina Bobkova | Lidiya Kozlovskaya | Vladimir Varshavskiy | Ekaterina Golicina I.M. Sechenov First Moscow State Medical Univ, Russia | First Moscow State Medical Univ, Nephrology Dept, Russia FP373 THE EFFICACY AND SAFETY OF ABELMOSCHUS MOSCHATUS (A TRADITIONAL CHINESE MEDICINE) FOR CHRONIC KIDNEY DISEASE: A METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS AND OBSERVATIONAL TRIALS Yizhi Chen | Zhixiang Gong | Xiangmei Chen | Li Tang | Jianhui Zhou | Xueying Cao | Ribao Wei PLA General Hosp (301 Hosp), Beijing, China | Chinese PLA 532 Hosp, Anhui, China FP374 URINARY ANGIOTENSINOGEN ORIGINATES FROM KIDNEY AND REFLECTS KIDNEY INJURY REGARDLESS OF THE EXTENT OF PROTEINURIA Eun Hee Koo | Ji Hyeon Park | Hyun Kyung Kim | Min Su Kim | Hye Ryoun Jang | Jung Eun Lee | Wooseong Huh | Dae Joong Kim | Ha Young Oh | Yoon-Goo Kim Samsung Medical Center, Seoul, Korea « FP375 ASSESSMENT OF PODOCYTE DYSFUNCTION AND URINARY PODOCYTE LOSS IN CHRONIC GLOMERULONEPHRITIS (CGN): SIGNIFICANCE FOR ESTIMATION OF CLOMERULAR DAMAGE AND GLOMERULOSCLEROSIS RISK Natalia Tchebotareva | Irina Bobkova | Lidiya Kozlovskaya | Olga Li | Olga Eskova | Mikhail Shvetsov | Ekaterina Golytsina | Vladimir Varshavskiy | Olga Popova I.M. Sechenov First Moscow State Medical Univ, Russia FP376 OSTEOPONTIN AND SOLUBLE UROKINASE-LIKE PLASMINOGEN ACTIVATOR RECEPTOR PLASMA LEVELS ARE ASSOCIATED WITH PROTEINURIA IN IMMUNOLOGICAL DISORDERS: A NEW RATIONALE FOR ACEINHIBITORS? Marco Quaglia | Sara Monti | Roberta Fenoglio | Alberto Menegotto | Andrea w w w. e r a e d t a 2 01 2 . o r g 157 FRIDAY, MAY 25 HEPATO-RENAL SYNDROME Gökhan Güngör | Hüseyin Ataseven | Ali Demir | Yalcin Solak | Murat Biyik| Bahadır Öztürk | İlker Polat | Aysel Kıyıcı | Özlem Özer Çakır | Hakkı Polat Konya Univ Meram School of Medicine, Konya, Turkey | Selcuk Univ Selcuklu School of Medicine, Konya, Turkey 49th ERA-EDTA CONGRESS P O S T E R S Airoldi | Cristina Izzo | Maria Antonietta Rizzo | Umberto Dianzani | Piero Stratta Amedeo Avogadro Univ; Maggiore della Carità Hosp, Novara FRIDAY, MAY 25 FP377 A PILOT TRIAL OF SIROLIMUS PLUS PREDNISONE FOR THE TREATMENT OF ERDHEIM-CHESTER DISEASE Augusto Vaglio | Federico Alberici | Davide Gianfreda | Carlo Buzio Nephrology Unit, Univ Hosp Parma, Italy 158 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France EXTRACORPOREAL DIALYSIS: TECHNIQUES AND ADEQUACY FP379 SPKT/V MEASUREMENT THROUGH ULTRAVIOLET ABSORPTIOMETRY Adoración Martín-Gómez | Sergio Garcia | MEugenia Palacios-Gómez Agencia Sanitaria Hosp Poniente FP380 SPECTROPHOTOMETRIC AND SPECTROFLUORIMETRIC ANALYSIS OF SPENT DIALYSATE SHOULD ALLOW MONITORING OF DIALYSIS ADEQUACY EVEN IF UREA CONCENTRATIONS CANNOT BE DETERMINED BY THESE METHODS Carlo Donadio | Dario Calia | Elisa Colombini | Fabio Di Francesco | Silvia Ghimenti | Angeliki Kanaki | Massimo Onor | Danika Tognotti | Roger Fuoco Dept Internal Medicine, Pisa, Italy | Dept Chemistry & Industrial Chemistry, Univ Pisa, Pisa | Dept Internal Medicine – Nephrology, Univ Pisa, Pisa | ICCOM, CNR, Pis FP381 RELATIONSHIP OF KT/VM AND PROTEIN CATABOLIC RATE WITH HYPERPHOSPHATEMIA IN PATIENTS UNDER CHRONIC HEMODIALYSIS Edwin Marka-Castro | Manuel Ignacio Torres Zamora | Juan Giron-Mino | Maria Angelica Jaime-Solis | Luis Mauro Arteaga | Hector Romero | Edwin Marka-Castro Hosp Dalinde | Hosp San Rafael FP382 NOVEL COMPOSITE DIALYSIS ADEQUACY INDEX: COMPARISON WITH UREA STANDARD KT/V (STDKT/V) Alp Akonur | Markku Asola | Bruce Culleton Baxter Healthcare Corporation FP383 KT/V IS A POOR PREDICTOR OF CONCENTRATION OF A BROAD RANGE OF UREMIC TOXINS Sunny Eloot | Griet Glorieux | Neirynck Nathalie | Raymond Vanholder Hemodialysis 1P8, Ghent Univ Hosp | Ghent Univ Hosp, Ghent, Belgium | Nephrology - Gent - Belgium FP384 MORBIDITY OF METABOLIC SYNDROME IN HAEMODIALYSIS PATIENTS Ana Pérez de José | Ursula Verdalles Guzman | Soraya Abad Esttebanez | Almudena Vega Martinez | Daniel Barraca | Claudia Yuste | Laura Bucalo | Abraham Rincon | Juan Manuel López-Gómez Spain, Madrid, Hosp Gregorio Marañón FP385 EFFECTS ON NUTRITIONAL MARKERS OF HAEMODIAFILTRATION WITH REGENERATION OF ULTRAFILTRATE (HFR) VERSUS HIGH FLUX DIALYSIS: A CROSS-OVER RANDOMIZED TRIAL MULTICENTRE TRIAL Pierre Bataille | Pierkarski Celine | Azar Raymond | Glowacki Francois | Lemonies Hervé | Dracon Michel | Renaux Jean Louis Hôp Docteur Duchenne | Bellco | Hôp Dunkerque | CHRU Lille | Hôp Roubaix FP386 PREDICTION OF INTRADIALYTIC MORBID EVENTS BY CHANGES IN THE SLOPE OF RELATIVE BLOOD VOLUME IN HEMODIALYSIS PATIENTS Fansan Zhu | Peter Kotanko | Stephan Thijssen | Nathan W Levin Renal Res Inst, New York USA w w w. e r a e d t a 2 01 2 . o r g 159 FRIDAY, MAY 25 FP378 DIRECT CALCULATION OF Kt/V AS TOTAL BLOOD CLEARANCE OF UREA OVER TOTAL BODY WATER VOLUME Carlo Donadio | Angeliki Kanaki Dept Internal Medicine, Pisa, Italy | Dept Internal Medicine, Nephrology, Univ Pisa, Italy 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FP387 THE ELEVATED FILLING PRESSURES OF THE LEFT VENTRICLE DETERMINE THE DYSFUNCTION OF CORONARY MICROCIRCULATION IN HEMODIALYSIS PATIENTS Nickos Papamichail | Maria Bougiakli | Chara Gouva | Sophie Antoniou | Sophie Gianitsi | Afroditi Vlachopanou | Spiridon Chachalos | Katherina Naka | Despina Kaarsavvidou | Kostantinos Katopodis | lampros Michalis Cardiology Dept General Hosp Artas | Cardiology Dept, Michaelidion Center | Nephrology Dept, Artas General Hosp FP388 INFLUENCE OF INTRADIALYSIS HEART RATE AT INITIATION OF HAEMODIALYSIS ON LONG-TERM OUTCOME Koichi Sasaki | Keiko Yasuda | Masaya Yamato Rinku General Medical Center, Izumisano, Japan FP389 METHOD FOR CLUSTERING HEMODIALYSIS (HD) PATIENTS BASED ON THE ESTIMATED WATER REFILLING INDEX (WRI) Alessandro Surace | Paolo Rovatti | Denis Steckiph | Roberta Bandini | Stefano Severi | Alberto Dellacasa Bellingegni | Antonio Santoro Gambro Dasco S.p.A., Medolla, Italy | Gambro Hospal S.p.A., Bologna, Italy| Univ Bologna, Cesena, Italy | DEIS Bologna Univ, Cesena, Italy | Malpighi Hosp, Bologna, Italy FP390 COMBINING BLOOD VOLUME MONITORITING AND BIOELECTRICAL IMPEDANCE FOR HYPOTENSION PREVENTION AND ADJUSTMENT OF DRY WEIGHT Marta Arias | Alexis Sentis | Nuria Perez | Nestor Fontsere | Manel Vera | Nestor Rodriguez | Carola Arcal | Nancy Ortega | Fernando Uriza | Aleix Cases| Francisco Maduell Hosp Clinic Barcelona FP391 COMPARISON OF ULTRAFILTRATION VOLUME AND CHANGES IN INTRADIALYTIC EXTRACELLULAR FLUID VOLUME ESTIMATED BY MULTIFREQUENCY AND SINGLE FREQUENCY BIOIMPEDANCE TECHNIQUES IN HEMODIALYSIS PATIENTS Samer R. Abbas | Fansan Zhu | Peter Kotanko | Nathan W Levin Renal Res Inst, NY, USA FP392 LONG INTERDIALYTIC INTERVAL IS ASSOCIATED WITH GREATER CENTRAL AORTIC PRESSURE AUGMENTATION THAN A REGULAR 2-DAY INTERDIALYTIC INTERVAL ON MAINTENANCE HEMODIALYSIS PATIENTS Panagiotis Georgianos | Pantelis Sarafidis | Pavlos Nikolaidis | Anastasios Lasaridis Section Nephrology and Hypertension, 1st Dept Medicine, AHEPA Univ Hosp, Thessaloniki, Greece | Academic Dept Renal Medicine, King’s College Hosp FP393 A MODEL TO CALCULATE CARDIAC OUTPUT IN HAEMODIALYSIS PATIENTS BY THERMODILUTION Alayoud Ahmed | Hassani Kaoutar | Benyahya Mohammed | Oualim Zouhir Serv Nephrology, Hemodialysis and Kidney Transpl, Military Hosp Instruction, Mohammed V. Rabat, Morocco FP394 IN INCIDENT HEMODIALYSIS PATIENTS A HIGHER ULTRAFILTRATION RATE AND CHANGES IN ULTRAFILTRATION RATE ARE ASSOCIATED WITH POORER OUTCOMES Paul Balter | Nancy Ginsberg | Patrice Taylor | Terry Sullivan | Len A Usvyat | Nathan W Levin | Peter Kotanko | Paul Zabetakis Renal Res Inst, New York, USA FP395 GUIDED FLUID STATUS OPTIMIZATION IN HYPERHYDRATED CHRONIC 160 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France HD PATIENTS Ulrich Moissl | Manuela Ferrario | Francesco Garzotto | Peter Wabel | Dinna Cruz | Ciro Tetta | Maria Gabriella Signorini | Sergio Cerutti | Alessandra Brendolan | Claudio Ronco Fresenius Medical Care D GmbH | Politecnico Milano | Nephrology Dept, St. Bortolo Hosp, Vicenza. Italy FP397 PLASMA REFILLING DURING DIALYSIS Alayoud Ahmed | Hamzi Amine | Zouhir Oualim Serv Nephrology, Hemodialysis and Kidney Transpl, Military Hosp Instruction, Mohammed V. Rabat, Morocco FP398 PRE AND POST DIALYSIS ECHOCARDIOGRAPHY PERFORMED BY A NEPHROLOGIST. AN USEFUL TOOL FOR HEMODYNAMIC EVALUATION OF CHRONIC HEMODIALYSIS PATIENTS Adriano Luiz Ammirati | Nadia Karina Guimarães de Souza | Thais Nemoto Matsui | Marcelo Luiz Vieira | Wercules Antonio Alves de Oliveira | Cláudio Henrique Fischer | Fabiana Dias Carneiro | Ilson Jorge IIzuka | Marisa Aparecida de Souza | Ana Claudia Mallet | Maria Claudia Cruz Andreoli | Bento Fortunato Cardoso dos Santos Hosp Israelita Albert Einstein, São Paulo, Brazil FP399 HEMODYNAMIC STABILITY DURING SORBENT-BASED DIALYSIS WITH THE 2008 SORBENT HEMODIALYSIS SYSTEM Laura Rosales | Yanna Dou | Mary Carter | Stephan Thijssen | Peter Kotanko Renal Res Inst; Beth Israel Medical Cener, New York, USA | Sustainable Kidney Care Foundation, New York, USA | Renal Res Inst, New York, USA FP400 FREE LIGHT CHAIN CLEARANCE ON IMMUNE AND INFLAMMATORY RESPONSE IN CKD PATIENTS (FIREFLIES STUDY) Angelo Testa | Laura Sottini | Bruno Giacon | Elisabetta Prati | Carmelo Loschiavo | Mario Brognoli | Cosimo Marseglia | Adalberto Tommasi | Luisa Sereni | Giuseppe Palladino | Sergio Bove E.C.H.O. Nantes France | U.O. Nefrologia e Dialisi P.O. Montichiari | U.O. Nefrologia e Dialisi, Bolzano | Dialysis Center, Osp Desenzano | Nephrology and Dialysis Legnago (VR) Italy | U.O. Nefrologia e Dialisi, Manerbio | U.O. Nefrologia e Dialisi, Mantova | U.O. Nefrologia e Dialisi, Vimercate | Scientific Affairs Dept Bellco Mirandola FP401 CALCIUM AND CITRATE MASS-BALANCES IN REGIONAL CITRATE ANTICOAGULATION DIALYSIS FOR ACUTE KIDNEY INJURY Gianmario Bosticardo | Enrico Schillaci | Paolo Detoma | Roberto Bergia Nephrology Unit ASLBI, Biella, Italy | Lab Unit ASLBI - Biella FP402 HEPARIN REDUCTION AND CLINICAL EFFICACY USING CITRATE-BASED DIALYSATE Jong Won Park | Sung Jin Moon | Hoon Young Choi | Sung Kyu Ha | HyeongCheon Park Gangnam Severance Hosp, YUMC, Seoul, Korea | Myongji Hosp, Kwandong Univ College Medicine, Gyeonggido, Korea FP403 SIMPLIFIED REGIONAL CITRATE ANTICOAGULATION USING A CALCIUM-CONTAINING REPLACEMENT SOLUTION FOR CONTINUOUS VENOVENOUS HEMOFILTRATION Yujie Liao | Ling Zhang | Ping Fu West China Hosp Sichuan Univ, Chengdu, China w w w. e r a e d t a 2 01 2 . o r g 161 FRIDAY, MAY 25 FP396 MULTIPASS HAEMODIALYSIS: A NOVEL DIALYSIS MODALTIY James Heaf | Mette Axelsen | Robert Smith Pedersen Univ Copenhagen, Herlev Hosp, Copenhagen, Denmark | Aarhus Univ, Aarhus, Denmark | Flexdiaysis ApS, Copenhagen, Denmark 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FP404 ETRF PERFORMANCE SUSTAINABILITY IN THE PREPARATION OF ULTRAPURE DIALYSIS FLUID AND ON-LINE HDF IN THE CENTRAL DIALYSIS FLUID DELIVERY SYSTEM Hiroyuki Igarashi | Norio Suzuki | Shiho Esashi | Ikuto Masakane Yabuki-shima Clinic FP405 COMPARISON OF ON-LINE HDF MODES AUTOMATED TMP CONTROL VS. VOLUME CONTROL ON ACHIEVED CONVECTIVE VOLUME AND MIDDLE MOLECULE CLEARANCE Vincenzo Panichi | Giacomo De Ferrari | Stefano Saffiotti | Antonio Sidoti | Marina Biagioli | Stefano Bianchi | Patrizio Imperiali | Claudio Gabrielli | Paolo Conti | Pietro Patrone | Giuseppe Rombolà | Valeria Falqui | Carlo Mura | Andrea Icardi | Alberto Rosati | Francesco Santori | Antonio Mannarino | Andrea Bertucci | Denis Steckiph Versilia's Hosp | Nephrology and Dialysis, Univ Genova | Dialysis and Nephrology Unit, Alta Val d’Elsa Hosp | Dialysis and Nephrology Unit, San Donato Hosp | Dialysis and Nephrology Unit, della Misericordia Hosp | Dialysis and Nephrology Unit, Osp Civile Hosp | Dialysis and Nephrology Unit, S. Andrea Hosp | Dialysis and Nephrology Unit, S.Maria della Gruccia Hosp | Dialysis and Nephrology Unit, La Colletta Hosp | Dialysis and Nephrology Unit, Campo di Marte | Dialysis and Nephrology Unit, Osp Riuniti Val di Chiana Hosp | Dialysis and Nephrology Unit, San Giovanni di Dio Hosp | Gambro Hospal SpA FP406 SAFETY AND EFFICACY OF ON-LINE HEMODIAFILTRATION; SEQUENTIAL INCREMENT METHOD OF REPLACEMENT FLUID Jimin Jeong | Ok Ki Kim | Nam Ho Kim Chonnam National Univ Hosp FP407 THE EFFECT OF ONLINE HEMODIAFILTRATION ON SYSTEMIC INFLAMMATION IN A RANDOMIZED CONTROLLED TRIAL: RESULTS FROM THE CONVECTIVE TRANSPORT STUDY (CONTRAST) ML Bots | Claire den Hoedt | Muriel PC Grooteman | Neelke C. van der Weerd| Albert H.A. Mazairac | Renée Lévesque | Pieter M. ter Wee | Menso J. Nubé | PJ Blankestijn | Marinus A van den Dorpel Univ Medical Center Utrecht | VU Medical Center, Amsterdam | St. Luc Hosp, Montréal, Canada | Maasstad Hosp, Rotterdam FP408 DIALYSATE CONSUMPTION AND DIALYSIS DOSE IN ON-LINE HEMODIAFILTRATION WITH AUTOMATED COUPLING DIALYSATE/BLOOD FLOW FUNCTION (AUTOFLOW FUNCTION) Yongki Park | Jimin Jeon Dongrae BongSaeng Hosp FP409 EFFECT OF A SINGLE HEMODIALYSIS SESSION BY HFR AND LOW-FLUX BICARBONATE DIALYSIS ON SERUM HEPCIDIN-25 LEVELS: A RANDOMIZED CROSS-OVER STUDY Nicola Tessitore | Valeria Bedogna | Domenico Girelli | Luca Corazza Nephrology and Dialysis dpt., Borgo Roma Univ Hosp, Verona, Italy | Internal Medicine B dpt., Borgo Roma Univ Hosp, Verona, Italy | Bellco srl FP410 INSTRUCTION FOR USE OF DIALYZERS IN POST DILUTION ON LINE HEMODIAFILTRATION Potier Jacky | Queffeulou Guillaume | Bouet Julien CHPC Cherbourg France FP411 THE RESULTS OF MULTICENTER STUDY COMPARING EFFECTS OF DIFFERENT RENAL REPLACEMENT THERAPY MODALITIES (ONLINE HEMODIAFILTRATION VS. LOW-FLUX HEMODIALYSIS) Wojciech Marcinkowski | Maciej Drozdz | Andrzej Milkowski | Teresa Rydzynska | Tomasz Prystacki | Ryszard August | Ewa Benedyk-Lorens | 162 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP412 ON-LINE MONITORING OF URIC ACID CONCENTRATION IN SPENT DIALYSATE DURING HEMODIALYSIS ACCOMPANIED BY GRADD PHYSICAL EXERCISES WITH THE BISPECTRAL OPTICAL SENSOR Aleksandr Vasilevsky | Georgy Konoplev | Oksana Lopatenko | Artemy Komashnya | Konstantin Visnevsky | Roman Gerasimchuk | Indrek Neivelt | Aleksandr Frorip St. Petersburg Electrotechnical Univ, St. Petersburg, Russia | St. Petersburg Pavlov State Medical Univ, St. Petersburg, Russia | Mariinsky Hosp, St. Petersburg, Russia | LDIAMON AS, Tallinn, Estonia FP413 LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN HAEMODIALYSIS PATIENTS AND ITS RELATION TO THEIR PROGNOSIS AND OTHER RISK FACTORS OF CARDIOVASCULAR DISEASES Michal Vostrý | Jaroslav Racek | Daniel Rajdl | Jaromír Eiselt | Lada Malánová Fac Hosp, Pilsen, Czech Republic | Dialysis Centre B. Braun Avitum, Pilsen, Czech Republic FP414 EPIDEMIOLOGY PROFILE AND SURVIVAL OF RENAL REPLACEMENT THERAPY PATIENTS Ülle Pechter | Anne Selart | Mai Ots-Rosenberg Tartu Univ FP415 PLATELET ACTIVATION DURING HEMODIALYSIS AND HEMODIAFILTRATION WITH E-BEAM STERILIZED POLYETHERSULFONE DIALYZERS Detlef H. Krieter | Sebastian Seidel | Karin Merget | Horst-Dieter Lemke | Christoph Wanner Univ Würzburg, Dept Medicine, Div Nephrology, Würzburg, Germany | EXcorLab GmbH, Obernburg, Germany FP416 BISPHENOL A IN CHRONIC KIDNEY DIESEASE Detlef H. Krieter | Bernard Canaud | Horst-Dieter Lemke | Annie Rodriguez| Andreas Morgenroth | Kai von Appen | Gerd-Peter Dragoun | Christoph Wanner Univ Würzburg, Dept Medicine, Div Nephrology, Würzburg, Germany | Univ Montpellier, Hôp Lapeyronie, Dept Nephrology, Montpellier, France | Membrana GmbH, R & D, Wuppertal, Germany | Dialysis Center, Elsenfeld, Germany| Hamburger Dialyse Lohbrügge, Hamburg, Germany | KfH Center, Aschaffenburg, Germany FP417 NEPHROLOGISTS’ PERSPECTIVES ON DIALYSIS TREATMENT: RESULTS OF AN INTERNATIONAL SURVEY Richard Fluck | Denis Fouque | Robert Lockridge Royal Derby Hosp, Derby, UK | Hôp Edouard Herriot, Lyon, France | Univ Virginia Health System, Charlottesville, Virginia, USA FP418 A CONFORMATIONAL CHANGE OF AN INTERMEDIATE ß2-MICROGLOBULIN ASSOCIATED WITH HAEMODIALYSIS Yoshihiro Motomiya | Yoshinori Uji | Tadashi Hiramatsu | Yukio Ando Suiyukai Clinic | Toyama Univ Hosp | Grad School Medical Sciences, Kumamoto Univ FP419 THE SYNERGY EFFECT ON INFLAMMATORY CYTOKINES OF ADSORBENT COLUMN FOR Β2-MICROGLOBULIN AND AN69 MEMBRANE Minoru Furuta | Takahiro Kuragano | Aritohi Kida | Mana Yahiro | Yoshinaga Otaki | Yukiko Hasuike | Hiroshi Nonoguchi | Takeshi Nakanishi Hyogo College Medicine w w w. e r a e d t a 2 01 2 . o r g 163 FRIDAY, MAY 25 Katarzyna Bladek | Jan Cina | Grazyna Janiszewska | Andrzej Kaczmarek | Teresa Lewinska | Malgorzata Mendel | Mariusz Paszkot | Ewa Trafidlo | Malgorzata Trzciniecka-Kloczkowska Fresenius Nephrocare Polska, Poland 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FP420 WHAT ARE THE LOWEST DOSES OF LOW MOLECULAR WEIGHT HEPARIN IN DIFFERENT SUBGROUPS OF HD PATIENTS? Milenka Sain | Vedran Kovacic | Dragan Ljutic | Josipa Radic | Ivo Jelicic Dept Nephrology and Dialysis, Univ Split School Medicine, Split, Croatia | Univ Hosp Split FP421 FACTORS ASSOCIATED WITH MORTALITY IN PATIENTS UNDERWENT EMERGENCY HEMODIALYSIS Serkan Feyyaz Yalın | Sinan Trabulus | Ayşe Serap Yalın | Mehmet Rıza Altıparmak | Kamil Serdengeçti Istanbul Univ Cerrahpaşa Medical Fac Dept Internal Medicine Nephrology Unit, Istanbul, Turkey FP422 DIFFERENTIAL EFFECTS OF POLYSULFONE MEMBRANE DIALYZER ON BIO-INCOMPATIBILITY AND HMGB-1-SRAGE SYSTEM IN HEMODIALYSIS PATIENTS Aki Ohtsuka | Kei Fukami | Kazuhiro Ishikawa | Ryotaro Ando | Yusuke Kaida| Takeki Adachi | Kenzo Sugi | Seiya Okuda Sugi Cardiovascular Medicine Hosp | Div Nephrology, Dept Medicine, Kurume Univ School Medicine FP423 THE FIRST EXPERIENCE OF HEMODIALYSIS WITH SUCCINATE-CONTAINING DIALYSIS FLUID: A CROSS-OVER STUDY Oxana Borisovna Nesterova | Elena Dmitrievna Suglobova | Roman Vladimirovitch Golubev | Alexandr Nicolaevitch Vasiliev | Valentina Alexandrovna Lazeba | Alexej Vladimirivitch Smirnov St Petersburg Pavlov State Medical Univ | NPO Nephron, St Petersburg, Russia FP424 A SUPER HIGH-FLUX DIALYZER (PS: APS-EA) ELIMINATES 40% OF INJECTED RECOMBINANT HUMAN (rh) ERITHROPOIETIN (EPO) DURING 4-HOUR HEMODIALYSIS (HD) Kazuko Arita | Emi Kihara | Katsutoshi Maeda | Hiroaki Oda | Shigehiro Doi| Takao Masaki Oda Medical Clinic, Hiroshima, Japan | Hiroshima Univ Hosp | Dept Nephrology, Hiroshima Univ Hosp, Hiroshima, Japan FP425 DIFFERENCES IN BIOCOMPATIBILITY EXERTED ON ENDOTHELIAL FUNCTION BY DIFFERENT TYPES OF POLYSULFONE HEMODIALYSIS MEMBRANE Sumi Hidaka | Kunihiro Ishioka | Machiko Oka | Hidekazu Moriya | Takayasu Ohtake | Shosaku Nomura | Shuzo Kobayashi Dept Nephrology, Immunology, and Vascular Medicine Shonan Kamakura General Hosp, Kamakura, Japan | First Dept Internal Medicine, Kansai Medical Univ, Moriguchi, Japan FP426 INCREASED REMOVAL OF SMALL AND MIDDLE MOLECULES BY USE OF MEMBRANES WITH LARGER SURFACE AND HIGHER ULTRAFILTRATION COEFFICIENT Stephan Wagner | Andreas Gmerek | Juergen Wagner | Volker Wizemann Georg-Haas Dialysezentrum, Gießen, Germany | B. Braun Avitum AG, Melsungen, Germany FP427 IMPACT OF LOW-CALCIUM DIALYSATE ON THE LENGTH OF QT INTERVAL DURING HEMODIALYSIS SESSION Natasha Eftimovska-Otovic | Katerina Spaseska-Gjurovska | Sudanka Bogdanovska | Elena Babalj-Banskolieva | Maja Milovanceva | Risto Grozdanovski Dialysis Center Diamed, Skopje, Macedonia FP428 PROTECTIV EFFECTS OF A NEW ISOFORM OF HUMAN RECOMBINANT 164 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP429 KLOTHO AS A PROGNOSTIC MARKER IN PATIENTS ON MAINTENANCE HEMODIALYSIS Patrice Ambühl | Starke Astrid | Pavik Ivana | Hersberger Martin | Kistler Thomas | Räz Hans-Rudolf | Aerne Daniel | Kiss Denes | Miozzari Marco | Rudolf P. Wüthrich | Serra Andreas Renal Div, Stadtspital Waid Zurich, Switzerland | Renal Div, Univ Hosp, Zurich, Switzerland | Clinical Chemistry, Children's Univ Hosp, Zurich, Switzerland | Renal Div, Kantonsspital, Winterthur, Switzerland | Renal Div, Kantonsspital, Baden, Switzerland | Renal Div, Spital Lachen, Switzerland | Renal Div, Kantonsspital, Liestal, Switzerland | Renal Div, Kantonsspital, Schaffhausen, Switzerland | Div Nephrology | Renal Div, Univ Hosp, Zurich FP430 PREDICTORS OF HAEMOGLOBIN LEVELS AND RESISTANCE TO ERYTHROPOIESIS-STIMULATING AGENTS IN PATIENTS TREATED WITH LOW FLUX HEMODIALYSIS, HEMOFILTRATION AND HEMODIAFILTRATION: RESULTS OF A MULTICENTRE, RANDOMIZED AND CONTROLLED TRIAL Simeone Andrulli | Paolo Altieri | Giovanna Sau | Piergiorgio Bolasco | Luciano Alberto Pedrini | Carlo Basile | Salvatore David | Mariano Feriani | Pier Eugenio Nebiolo | Rocco Ferrara | Domenica Casu | Francesco Logias | Renzo Tarchini | Francesco Cadinu | Mario Passaghe | Gianfranco Fundoni | Giuseppe Villa | Biagio Raffaele Di Iorio | Carmine Zoccali | Francesco Locatelli A. Manzoni Hosp, Lecco, Italy | Azienda Osp G. Brotzu, Cagliari, Italy| Dip Territoriale ASL 8, Cagliari, Italy | Osp Bolognini, Seriate, Italy | Osp F. Miulli, Acquaviva delle Fonti, Italy | Osp Maggiore, Parma, Italy | Osp dell'Angelo, Mestre, Italy | Osp Regionale Aosta, Italy | Osp SS. Trinità ASL 8, Cagliari, Italy| Osp Civile, Alghero, Italy | Osp San Camillo, Sorgono, Italy | Azienda Osp Carlo Poma, Mantova, Italy | Osp S. Francesco, Nuoro, Italy | ASL 2 Olbia - P.O. P. Dettori, Tempio Pausania, Italy | Osp S. Giovanni di Dio, Olbia, Italy | Fond Maugeri IRCCS, Pavia, Italy | Osp Agostino Landolfi, Solofra, Italy | Azienda Osp Bianchi Melacrino Morelli Reggio Calabria, Italy | Azienda Osp Provincia Lecco, Osp Alessandro Manzoni Lecco, Italy FP431 PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) HETERODIMERS REDUCE SERUM LDL-CHOLESTEROL (LDL-C) LEVELS IN MAINTENANCE HEMODIALYSIS (HD) PATIENTS ASSOCIATED WITH DYSLIPIDEMIA CHARACTERIZED BY INCREASED TRIGLYCERIDE-RICH LIPOPROTEINS Emi Kihara | Kazuko Arita | Misuzu Hamamoto | Katsutoshi Maeda | Hiroaki Oda | Shigehiro Doi | Takao Masaki Oda Medical Clinic, Hiroshima, Japan | Dept Nephrology, Hiroshima Univ Hosp FP432 THE EFFECT OF LOWERING DIALYSATE SODIUM CONCENTRATION ON THE INTERDIALYTIC WEIGHT GAIN AND BLOOD PRESSURE IN ANURIC HEMODIALYSIS PATIENTS Dong-Young Lee | Beom Kim | Kyoung Hyoub Moon Seoul Veteran Hosp, Seoul, Korea FP433 EFFECT OF ELEVATING CALCIUM CONCENTRATION OF DIALYSATE TO TREAT INTRA-DIALYTIC HYPOTENSION: A CROSS-OVER SELF-CONTROL TRIAL Zi Li | Ping Fu West China Hosp, Sichuan Univ FP434 HEPARIN REDUCTION AND IMPROVED BIOCOMPATIBILITY USING CITRATE ENRICHED DIALYSATE IN HIGH FLUX DIALYSIS w w w. e r a e d t a 2 01 2 . o r g 165 FRIDAY, MAY 25 MNSOD ON HAEMODIALYSIS-INDUCED REACTIVE OXYGEN SPECIES AND PRO-INFLAMMATORY CYTOKINES Antonio Pisani | Eleonora Riccio | Aldo Mancini Chair Nephrology Univ Naples | Molecular Biology & Viral Oncogenesis Dept National Cancer 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 Peter Ahrenholz | Roland E. Winkler | Grit Waitz | Hartmut Wolf BioArtProducts GmbH, Rostock, Germany | Praxisverbund Dialyse und Apherese, Rostock, Germany | Biomedical Consulting, Hohen Neuendorf, Germany FP435 IMPROVED ACID-BASE STATUS BY A NOVEL SAFE CITRATE CONTAINING ACETATE-FREE HEMODIALYSIS FLUID Gunilla Grundström | Maria Alquist | Madeleine Holmquist | Anders Christensson | Peter Björk | Mohamed AbdGawad | Lars Ekholm | Mårten Segelmark Gambro Res, Lund, Sweden | Gambro Medical Safety Office, Lund, Sweden | Skåne Univ Hosp, Malmoe, Sweden | Skåne Univ Hosp, Malmoe, Sweden | Skåne Univ Hosp, Lund, Sweden | Ljungby Hosp, Ljungby, Sweden | Dept Medicine and Health, Linköping Univ, Sweden FP436 A NOVEL METHOD FOR NONINVASIVE BLOOD POTASSIUM ASSESSEMENT DURING HEMODIALYSIS Cristiana Corsi | Johan De Bie | Emanuele Mambelli | David Mortara | Antonio Santoro | Stefano Severi Univ Bologna, Cesena, Italy | Mortara Instrument Inc, Milwaukee, USA | Malpighi Hosp, Bologna, Italy FP437 POLYMYXIN B HEMOPERFUSION FOR THE TREATMENT OF SEVERE SEPTIC SHOCK David Arroyo | Nayara Panizo | Borja Quiroga | Javier Reque | Rosa Melero| Marisa Rodriguez-Ferrero | Patrocinio Rodriguez-Benitez | Fernando Anaya | Jose Luno Hosp General Univ Gregorio Maranon, Madrid, Spain FP438 MICROBIOLOGICAL QUALITY CONTROL OF DIALYSIS FLUIDS FOR ONLINE HEMODIAFILTRATION: 4 YEARS EXPERIENCE IN A PUBLIC HOSP DIALYSIS UNIT Alain Ragon | Anthony James | Philippe Brunet Lab Pôle Uro-Néphrologie | Serv Hémodialyse - Pôle Uro-Néphrologie FP439 ERYTHROCYTE MEMBRANE PROTEIN COMPOSITION AND BAND 3 PROFILE IN CHRONIC KIDNEY DISEASE PATIENTS UNDER ON-LINE HEMODIAFILTRATION Sandra Ribeiro | M. Sameiro Faria | S. Rocha | S. Rodrigues | C. Catarino | F. Reis | H. Nascimento | J. Fernandes | V. Miranda | A. Quintanilha | L. Belo | E. Costa | A. Santos-Silva Fac Farmácia, Univ Porto; Inst Biologia Molecular e Celular (IBMC) | FMC, Dinefro – Diálises e Nefrologia, SA; Inst Ciências Biomédicas Abel Salazar, Univ Porto | Inst Farmacologia e Terapêutica Experimental, IBILI, Fac Medicina, Univ Coimbra | Fac Farmácia, Univ Porto; Inst Farmacologia e Terapêutica Experimental, IBILI, Fac Medicina, Univ Coimbra | FMC, Dinefro – Diálises e Nefrologia, SA | Inst Biologia Molecular e Celular (IBMC), Univ Porto; Inst Ciências Biomédicas Abel Salazar| Inst Biologia Molecular e Celular (IBMC), Univ Porto; Inst Ciências Saúde Univ Católica Portuguesa FP440 IMPACT OF PARACETAMOL ON OPTICAL ON-LINE DIALYSIS MONITORING AND ON URICEMIA Jürgen Arund | Risto Tanner | Ivo Fridolin | Merike Luman Inst Biomedical Engineering Technomedicum Tallinn Univ Technology | Tallinn Univ Technology | North-Estonian Medical Centre, Tallinn, Estonia FP441 PROSPECTIVE LONGITUDINAL EVALUATION OF IN-CENTER CONVERSION FROM CONVENTIONAL TO INTENSIFIED NOCTURNAL HEMODIALYSIS Christian Clajus | Jan T Kielstein | Hermann Haller | Sascha David Medical School Hannover, Nephrology 166 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP443 MUDPIT ANALYSIS AS A PROTEOMIC TOOL FOR NOVEL POTENTIAL UREMIC TOXIN IDENTIFICATION IN HAEMODIALYSIS FILTRATES Christoph Krisp | Andreas Gmerek | Juergen Wagner | Dirk A. Wolters | Luciano A. Pedrini Analytical Chemistry, Ruhr Univ Bochum, Bochum, Germany | B. Braun Avitum AG, Melsungen, Germany | Nephrology and Dialysis Unit, Bolognini Hosp, Seriate, Italy FP444 BLOOD CONTACT CHARACTERISTICS OF SYNTHETIC DIALYSIS MEMBRANE Makoto Matsuyama | Kaede Ishida | Kazuhiro Matsuyama | Takeshi Nakata| Junichi Kadota Oita Univ, Fac Medicine, Dept Internal Medicine, Yufu-city, Oita-Pref, Japan FP445 STEPS STUDY: SUPERHIGHFLUX THERAPIES FOR HEMODIALYSIS. A PROTEOMIC APPROACH Marialuisa Caiazzo | Emanuela Monari | Aurora Cuoghi | Elisa Bellei | Stefania Bergamini | Giuseppe Palladino | Aldo Tomasi Univ Modena and Reggio Emilia, Modena, Italy | Scientifc Affairs, Bellco, Mirandola, Italy FP446 IMPROVEMENT OF THE REMOVAL OF MEDIUM-SIZED MOLECULES IN PRE-DILUTIONAL HEMODIAFILTRATION BY THE USE OF A VERY HIGH PERMEABILITY DIALYZER: STUDY ON 16 PATIENTS Thierry Baranger | Piotr Seniuta | Frank Berge | Valerie Drouillat | Carlos Frangie | Emmanuelle Rosier PBNA FP447 PULMONARY HYPERTENSION IN PATIENTS UNDERGOING HEMODIALYSIS Walter Labonia | Adrián Lescano | Débora Rubio Diaverum Paternal, Buenos Aires, Argentina | Hosp Santojanni, Buenos Aires, Argentina FP448 GENDER DIFFERENCES IN HRQOL IN PATIENTS RESUMING DIALYSIS AFTER GRAFT LOSS Nanna von der Lippe | Jakob Anker Jørgensen | Tone Brit Østhus | Bård Waldum | Ingrid Os Oslo Univ Hosp Ullevål FP449 QUALITIES OF FATIGUE IN CHRONIC HEMODIALYSIS PATIENTS Maurizio Bossola | Enrico Di Stasio | Manuela Antocicco | Luigi Tazza Catholic Univ FP450 HEAT-SHOCK PROTEIN 27 KINETICS IN END STAGE RENAL DISEASE PATIENTS Ioannis Griveas | Andreas Karameris | Ploumis Pasadakis 401 Army Hosp Athens | 417 Veterans Army Hosp Athens | Thrace Univ Medical School FP451 INCREASED LEVELS OF INTERLEUKIN-22 IN END STAGE RENAL DISEASE w w w. e r a e d t a 2 01 2 . o r g 167 FRIDAY, MAY 25 FP442 SODIUM SETPOINT AND SODIUM GRADIENT IN BICARBONATE HAEMODIALYSIS Carlo Basile | Pasquale Libutti | Piero Lisi | Luigi Vernaglione | Francesco Casucci | Nicola Losurdo | Annalisa Teutonico | Carlo Lomonte Miulli General Hosp Acquaviva delle Fonti Italy | Giannuzzi Hosp Manduria Italy 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 AND PATIENTS AND ROLE OF DIALYSIS Vincenzo Savica | Domenico Santoro | Salvatore Saitta | Valeria Tigano | Guido Bellinghieri | Sebastiano Gangemi Unit Nephrology and Dialysis, Univ Messina | Unit Allergy and Clinical Immunology, Univ Messina FP452 COMPARISSON BETWEEN HEMODIALYSIS AND PERITONEAL DIALYSIS IN ELDERLY PATIENTS Radulescu Daniela | Ionel Alexandru Checherita | Alexandru Ciocalteu | Ileana Adela Vacaroiu | Andrei Niculae Saint John Emergency Hosp, Bucharest, Romania | Carol Davila Medicine Univ, Bucharest, Romania FP453 BODY COMPOSITION MONITORING TO ADJUST DRY WEIGHT IN ON-LINE HEMODIAFILTRATION PATIENTS Katarzyna Błądek | Ewa Stefaniak| Irena Pietrzak | Dariusz Krupa FNC Poznań Poland | Fresenius Nephrocare FP454 CLINICAL VALIDATION OF A MATHEMATICAL MODEL OF CONVECTION IN MID-DILUTION HEMODIAFLTRATION Laurie Garred | Antonio Santoro | Elena Mancini | Luca Corrazza | Mauro Atti Lakehead Univ | Malpighi Hosp, Bologna, Italy | Bellco S.r.l., Mirandola, Italy FP455 SOCIODEMOGRAPHIC, CLINICAL AND LAB PARAMETERS RELATED WITH PRESENCE OF REGULAR TOOTH BRUSHING IN HEMODIALYSIS PATIENTS Baris Afsar Konya Numune State Hosp FP456 CRYSTALLIZATION OF ELECTROLYTES OF THE REPLACEMENT MEDIUM AT THE PERIPHERY OF RED BLOOD CELLS IN THERAPEUTIC PLASMA EXCHANGE: AN INVESTIGATION WITH SCANNING-ELECTRON AND ATOMIC-FORCE MICROSCOPES Dimosthenis Stamopoulos | Nerantzoula Mpakirtzi | Basiliki Gogola | Manos Zeibekis | Dora Stivarou | Maria Panagiotou | Eirini Grapsa Inst Materials Science, National Center Scientific Res Demokritos, Athens, Greece| Dept Nephrology, National Hosp Athens G. Gennimatas | Dept Experimental Pathology and Oncology, Univ Florence | Dept Nephrology, General Hosp Athens Alexandras, Athens, Greece FP457 EFFECTS OF A REDUCED INNER DIAMETER OF HOLLOW FIBERS IN DIALYZERS IN ON-LINE HEMODIAFILTRATION Olynka Vega Vega | Daniel Barraca Nuñez | Soraya Abad Esttebanez | Laura Bucalo | Claudia Yuste | Juan Manuel López-Gómez National Inst Nutrition. Mexico, Mexico | Hosp General Univ Gregorio Marañón FP458 MEGESTROL ACETATE AS A TREATMENT FOR UREMIC ANOREXIA: ANALYSIS OF BODY COMPOSITION BY BIOELECTRICAL IMPEDANCE Milagros Fernández-Lucas | Antonio Gomis | José Luis Teruel | Sandra Elías| Carlos Quereda Hosp Ramón y Cajal, Madrid, Spain FP459 HAEMODIALYSIS: DIALYSIS TO LIVE RATHER THAN LIVING TO DIALYSE. UK EXPERIENCE WITH THE NX STAGE SYSTEM ONE Laura Hignell | Sheila Humphrey | Nicola Pacy Wessex Renal and Transpl Serv FP460 EXTRACORPOREAL BLOOD CIRCULATION THERAPIES: A COMPARATIVE STUDY ON RED BLOOD CELLS OF HAEMODIALYSIS PATIENTS, THERA- 168 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FRIDAY, MAY 25 PEUTIC PLASMA EXCHANGE PATIENTS AND HEALTHY DONORS WITH ADVANCED MICROSCOPES Dimosthenis Stamopoulos | Nerantzoula Mpakirtzi | Nikolaos Afentakis | Eirini Grapsa Inst Materials Science, National Center Scientific Res Demokritos, Athens, Greece| Dept Nephrology, National Hosp Athens G. Gennimatas | Dept Nephrology, General Hosp Athens G. Gennimatas, Athens, Greece | Dept Nephrology, General Hosp Athens Aretaieion, Athens, Greece w w w. e r a e d t a 2 01 2 . o r g 169 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 CARDIOVASCULAR COMPLICATIONS IN CKD 5D FP461 CHRONIC PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED WITH AN INCREASED RISK OF VASCULAR CALCIFICATIONS IN CHRONIC KIDNEY DISEASE Maria Fusaro | Marianna Noale | Giovanni Tripepi | Angela D'Angelo | Davide Miozzo | Maurizio Gallieni | PPI-VC (Protein Pump Inhibitors – Vascular Calcification) Study Group Consiglio Nazionale delle Ricerche (CNR) - Inst Neuroscience, Aging Section, Padua, Italy | Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension, CNR - Ist Biometeorologia, Reggio Calabria, Italy | Nephrology Unit, Univ Padua, Italy FP462 INFLAMMATION AND SERUM FETUIN-A LEVELS ARE ASSOCIATED WITH CARDIOVASCULAR CALCIFICATIONS IN CHRONIC HEMODIALYSIS PATIENTS Mzia Tsamelesvili | Chrysostomos Dimitriadis | Aikaterini Papagianni | Christos Raidis | Georgios Efstratiadis | Dimitrios Memmos Dept Nephrology, Hippokration General Hosp, Thessaloniki, Greece FP463 ASSOCIATIONS BETWEEN OSTEOPONTIN, INTERLEUKIN-6 AND HOMOCYSTEIN LEVELS AND MALNUTRITION, CALCIFICATION AND CAROTID INTIMA-MEDIA THICKNESS IN DIALYSIS PATIENTS Ruya Mutluay | Ceyla Konca Degertekin | Ülver Derici | Serpil Müge Değer| Ferda Akkıyal | Serap Gültekin | Sevim Gönen | Gülten Taçoy | Turgay Arınsoy | Şükrü Sindel Gazi Univ Fac Medicine, Dept Nephrology, Ankara, Turkey | Gazi Univ Fac Medicine, Dept Endocrinology, Ankara, Turkey | Gazi Univ Fac Medicine, Dept Radiology, Ankara, Turkey | Gazi Univ Fac Medicine, Dept Cardiology, Ankara, Turkey FP464 VALVULAR CALCIFICATION PREDICTS ATRIAL FIBRILLATION ON CHRONIC DIALYSIS PATIENTS Carmen Sánchez-Perales | Eduardo Vázquez | Enoc Merino | Pilar Pérez del Barrio | Francisco José Borrego | M. José Borrego | Antonio Liébana Serv Cardiología, C.H Jaén | Serv Nefrología, C.H. Jaén FP465 CALCIUM SCORING (CASC) AS A LONG TERM PREDICTOR OF CARDIOVASCULAR MORTALITY IN A POPULATION OF DIALYSIS PATIENTS Marcin Krzanowski | Katarzyna Janda | Paulina Dumnicka | Andrzej Kraśniak| Władysław Sułowicz Chair and Dept Nephrology Clinic, Jagiellonian Univ Collegium Medicum, Cracow | Dept Medical Diagnostics, Jagiellonian Univ Collegium Medicum, Cracow FP466 RADIAL ARTERY MICRO-CALCIFICATION IS ASSOCIATED WITH CORONARY ARTERY CALCIUM SCORE IN HEMODIALYSIS PATIENTS Young-Ok Kim | Sun-Ae Yoon | Yu-Seon Yun | Ho-Cheol Song | Byung-Soo Kim | Myeong A Cheong Uijeongbu St. Mary's Hosp, Catholic Univ Korea | Bucheon St. Mary's Hosp, Catholic Univ Korea | St. Paul's Hosp, Catholic Univ Korea | Korean Cancer Center Hosp FP467 A NANOPARTICLE-BASED SERUM TEST MEASURING OVERALL CALCIFICATION INHIBITION Andreas Pasch | Stefan Farese | Jürgen Floege | Willi Jahnen-Dechent Univ Hosp Bern, Bern, Switzerland | RWTH Univ Aachen, Aachen, Germany FP468 LANTHANUM CARBONATE DELAYS THE PROGRESSION OF CORONARY 170 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP469 DETERMINANTS OF VALVULAR CALCIFICATIONS IN PREVALENT HEMODIALYSIS PATIENTS Anabela Guedes | Ana Pinho | André Fragoso | Andreia Cruz | Patrícia Mendes | Elsa Morgado | Isilda Bexiga | Ana Paula Silva | Pedro Neves Nephrocare, Faro, Portugal FP470 THE DIFFERENCES IN THE RISK FACTORS FOR PROGRESSIVE CALCIFICATION OF CORONARY ARTERY, AORTIC VALVE AND MITRAL ANNULUS Nobuyuki Oyake | Keiko Suzuki | Saki Itoh | Shozo Yano Otsuka Clinic | Shimane Univ Fac Medicine FP471 THE RELATIONSHIP BETWEEN BONE MINERAL DENSITOMETRY AND VASCULAR CALCIFICATION IN PATIENTS WITH END-STAGE RENAL DISEASE Kultigin Turkmen | Hatice Kayikcioglu | Orhan Ozbek | Mustafa Saglam | Aysun Toker | Halil Zeki Tonbul Konya Univ, Meram School Medicine, Konya, Turkey | Konya Univ, Dept Biochemistry, Konya, Turkey FP472 THE RELATIONSHIP BETWEEN CARDIAC VALVЕ CALCIFICATION PRESENCE AND QT INTERVAL (ECG) PROLONGATION IN HEMODIALYSIS PATIENTS Saso Gelev | Lada Trajceska | Elizabeta Srbinovska | Svetlana Pavleska | Vili Amitov | Gjulsen Selim | Pavlina Dzekova | Aleksandar Sikole Univ Clinic Nephrology, Skopje, FYR Macedonia | Univ Clinic Cardiology, Skopje, FYR Macedonia FP473 DO CORONARY CALCIFICATIONS PREDICT CARDIOVASCULAR EVENTS AND MORTALITY IN ADVANCED CKD PATIENTS? Hanane Bouarich | Susana Lopez | Concepcion Alvarez | Ignacio Arribas | Patricia De Sequera | Diego Rodriguez Hosp Univ Principe Asturias, Madrid, Spain | Hosp Infanta Leonor, Madrid, Spain FP474 WARFARIN USE IS ASSOCIATED WITH HIGHER PREVALENCE VERTEBRAL FRACTURES, VASCULAR CALCIFICATIONS AND INCREASED MORTALITY IN CHRONIC KIDNEY DISEASE Maria Fusaro | Marianna Noale | Giovanni Tripepi | Angela D'Angelo | Davide Miozzo | Maurizio Gallieni | PPI-VC (Protein Pump Inhibitors – Vascular Calcification) Study Group Consiglio Nazionale delle Ricerche (CNR) - Inst Neuroscience, Aging Section, Padua, Italy | Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension, CNR - Ist Biometeorologia, Reggio Calabria, Italy | Nephrology Unit, Univ Padua, Italy FP475 SILENT MYOCARDIAL ISCHEMIA IN HEMODIALYSIS PATIENTS WITH CORONARY ARTERY DISEASE Shinji Tanaka | Takafumi Kanemitsu | Mai Sugahara | Masafumi Kobayashi | Lisa Uchida | Yu Ishimoto | Nagaaki Kotera | Shuzou Tanimoto | Kengo Tanabe | Kazuhiro Hara | Tokuichiro Sugimoto | Naobumi Mise Dept Nephrology, Dept Cardiology, Mitsui Memorial Hosp, Tokyo, Japan « FP476 TRENDS IN THE INCIDENCE OF ATRIAL FIBRILLATION IN OLDER PAw w w. e r a e d t a 2 01 2 . o r g 171 FRIDAY, MAY 25 ARTERY CALCIFICATION COMPARED WITH CALCIUM-BASED PHOSPHATE BINDER IN PATIENTS ON HEMODIALYSIS Takayasu Ohtake | Rei Furuya | Masao Iwagami | Daimu Tsutsumi | Yasuhiro Mochida | Kunihiro Ishioka | Machiko Oka | Kyoko Maesato | Hidekazu Moriya | Sumi Hidaka | Shuzo Kobayashi Shonan Kamakura General Hosp 49th ERA-EDTA CONGRESS P O S T E R S TIENTS INITIATING DIALYSIS IN THE USA Benjamin Goldstein | Mintu Turakhia | Cristina Arce | Wolfgang Winkelmayer Stanford Univ, Palo Alto, USA | Veterans Affairs Palo Alto Health Care System, Palo Alto, USA FRIDAY, MAY 25 FP477 RIGHT VENTRICULAR FUNCTION IN CKD STAGE 5 PATIENTS WITH ENDSTAGE RENAL DISEASE STARTING DIALYSIS THERAPY. A TISSUE DOPPLER IMAGING STUDY Bahaa El-Din Zayed | Kareem Said Nephrology Dept Kasr Al-Aini School Medicine, Cairo Univ Egypt | Cardiolgy Dept Kasr Alaini, Cairo Univ FP478 PREDICTION OF CARDIOVASCULAR EVENTS IN HEMODIALYSIS PATIENTS BY AMINOTERMINAL PROPEPTIDE OF TYPE III PROCOLLAGEN CIRCULATING LEVELS Masato Nishimura | Yu Okamoto | Toshiko Tokoro | Masashi Nishida | Tetsuya Hashimoto | Noriyuki Iwamoto | Hakuo Takahashi | Toshihiko Ono Toujinkai Hosp, Kyoto, Japan. | Kansai Medical Univ, Osaka, Japan FP479 ORAL NICORANDIL TO REDUCE SUDDEN CARDIAC DEATH OF HEMODIALYSIS PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY Masato Nishimura | Yu Okamoto | Toshiko Tokoro | Nodoka Sato | Masashi Nishida | Tetsuya Hashimoto | Noriyuki Iwamoto | Hakuo Takahashi | Toshihiko Ono Toujinkai Hosp, Kyoto, Japan | Kansai Medical Univ FP480 LOWER MAGNESIUM LEVELS PREDICT PULSE PRESSURE IN PREVALENT HEMODIALYSIS PATIENTS Anabela Guedes | Andreia Cruz | Elsa Morgado | Ana Pinho | André Fragoso | Patrícia Mendes | Isilda Bexiga | Ana Paula Silva | Pedro Neves Nephrocare, Faro, Portugal FP481 SERUM MAGNESIUM CONCENTRATION RELATES TO INTRADIALYTIC HYPOTENSIVE EVENTS IN CHRONIC HEMODIALYSIS PATIENTS Jochen Raimann | Len A Usvyat | Jeffrey Sands | Nathan W Levin | Peter Kotanko Renal Res Inst, New York, USA | Fresenius Medical Care NA FP482 EEFFICACY OF DIGIT NUMBER OF NT-proBNP FOR SCREENING OF CARDIOVASCULAR DISEASE IN NEW HEMODIALYSIS PATIENTS Masaki Iwasaki | Nobuhiko Joki | Yuri Tanaka | Nobutaka Ikeda | Toshihide Hayashi | Shun Kubo | Taka-aki Imamura | Yasunori Takahashi | Koichi Hirahata | Yoshihiko Imamura | Hiroki Hase Toho Univ Ohashi Medical Center | Nissan Tamagawa Hosp | Hirahata Clinic FP483 PLASMA LEVELS OF ADMA AND SDMA REMAIN STABLE IN INCIDENT PD PATIENTS DESPITE A DECLINING RESIDUAL RENAL FUNCTION: A PROSPECTIVE STUDY Kathleen Claes | Björn Meijers | Bert Bammens | Dirk Kuypers | Maarten Naesens | Yves Vanrenterghem | Pieter Evenepoel Univ Hosp Gasthuisberg, Leuven | KULeuven, Nephrology | Univ Hosp, Leuven, Belgium FP484 DYSLIPIDEMIA, CHOLESTEROL ESTERIFICATION AND HIGH DENSITY LIPOPROTEINS IN DIALYSIS PATIENTS Giuliano Boscutti | Laura Calabresi | Manuela Bosco | Sara Simonelli | Emanuela Boer | Cecilia Vitali | Massimiliano Martone | Piero Luigi Mattei | Guido Franceschini ASS2 Isontina, Gorizia Italy | Center E. Grossi Paoletti Univ Milan 172 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP486 PLASMA ADIPONECTIN LEVELS FOR PREDICTION OF CARDIOVASCULAR RISK AMONG HEMODIALYSIS PATIENTS Eid El-Shafey | Amal Ezaat Internal Medicine Dept, Fac Medicine, Tanta Univ | Clinical Pathology Dept, Fac Medicine, Tanta Univ FP487 DNA METHYLATION PROFILING REVEALS DYSREGULATION OF ATHEROSCLEROSIS-RELATED GENES IN DIALYSIS PATIENTS Adam Zawada | Kyrill Rogacev | Björn Hummel | Oliver Grün | Annika Friedrich | Björn Rotter | Peter Winter | Jürgen Geisel | Danilo Fliser | Gunnar Henrik Heine Dept Internal Medicine IV, Saarland Univ Medical Center, Homburg, Germany | Clinical Chemistry and Lab Medicine/Central Lab, Saarland Univ Medical Center, Homburg, Germany | GenXPro GmbH, Frankfurt, Germany FP488 HYPER-BETA 2 MICROGLOBULINEMIA SEEMS TO BE A RISK FACTOR FOR VENTRICULAR ABNORMAL RELAXATION WITH NORMAL SYSTOLIC FUNCTION OF THE HEART IN HEMODIALYSIS PATIENTS Jun-ichi Makino | Kuni-shiro Makino | Takahito Ito Makino clinic | National Hosp Organization Osaka National Hosp FP489 ITALIAN SURVEY ON HEMORRHAGIC AND THROMBOEMOLIC RISK AND ORAL ANTICOAGULANT THERAPY IN A LARGE POPULATION OF HEMODALYSIS PATIENTS WITH ATRIAL FIBRILLATION Simonetta Genovesi | Paolo Fabbrini | Emanuela Rossi | Daniela Pogliani | Andrea Stella | Giuseppe Bonforte | Giuseppe Remuzzi | Silvio Bertoli | Claudio Pozzi | Maurizio Gallieni | Sonia Pasquali | Leonardo Cagnoli | Ferruccio Conte | Antonio Santoro Italian Study Group Atrial Fibrillation in Hemodialysis | Clinica Nefrologica, AO San Gerardo, Monza Italy FP490 POLYMORPHISMS OF ANGIOTESIN CONVERTING ENZYME AND MATRIX METALLOPROTEINASE 3 GENES IN HAEMODIALYSIS PATIENTS – ASSOCIATION WITH CARDIOVASCULAR MORBIDITY AND MORTALITY Ivana Buzadzic | Jelena Tosic | Nada Dimkovic | Zivka Djuric | Jovan Popovic| Ivana Pejin Grubisa | Nada Barjaktarevic Zvezdara Univ Hosp, Dept Human Genetics and Prenatal Diagnostic | Zvezdara Univ Hosp, Nefrology Dept, Belgrade, Serbia FP491 “DE NOVO” CARDIOVASCULAR DISEASES ONSET DURING CHRONIC DIALYSIS: AN EPIDEMIOLOGYC STUDY Anteo Di Napoli | Domenico Di Lallo | Maria Flora Salvatori | Francesco Franco| Serena Chicca | Gabriella Guasticchi Agency Public Health Lazio Region, Rome, Italy FP492 STRICT VOLUME CONTROL GUIDED BY BIOIMPEDANCE ANALYSIS AND THE EFFECT ON ARTERIAL STIFFNESS IN HEMODIALYSIS PATIENTS - A RANDOMIZED TRIAL Mihai Onofriescu | Simona Hogas | Voroneanu Luminita | Apetrii Mugurel | Veisa Gabriel | Florea Laura | Mititiuc Irina | Covic Adrian Parhon Hosp, Univ Medicine and Farmacy Gr.T.Popa, Iasi, Romania | Univ Medicine and Pharmacy Gr.T.Popa Iasi, Romania w w w. e r a e d t a 2 01 2 . o r g 173 FRIDAY, MAY 25 « FP485 WHAT IS THE EFFECT OF A/V FISTULA FLOW ON RIGHT VENTRICULAR PERFORMANCE INDEX IN PATIENTS WITH ESRD; A THREE MONTH FOLLOW UP TISSUE DOPPLER ECHOCARDIOGRAPHIC STUDY? Essam Baligh | Bahaa El-Din Zayed | Karim Said Cardiology Dept, Kasr Al-Aini School of Medicine, Cairo Univ, Egypt | Nephrology Dept Kasr Al-Aini School of Medicine, Cairo Univ, Egypt 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FP493 CHANGES IN LEFT VENTRICULAR STRUCTURE AFTER PARICALCITOL THERAPY IN CHRONIC HEMODIALYSIS PATIENTS Elvira Bosch | Eduardo Baamonde | Carlos Culebras | German Perez | Bilal El Hayek | Jose Ignacio Ramirez | Ana Ramirez | Cesar Garcia | Mar Lago | Agustín Toledo | Maria Dolores Checa Centro Hemodiálisis Avericum, Las Palmas de Gran Canaria, Spain | Dept Cardiology, Las Palmas, Spain | Dept Nephrology, Hosp Univ Insular Gran Canaria FP494 CILOSTAZOL INCREASES HDL2 CHOLESTEROL LEVELS IN CHRONIC HEMODIALYSIS PATIENTS Takayasu Taira | Tsutomu Hirano | Kyoko Nohtomi | Toru Hyodo | Tetsuo Chiba | Akira Saito Yokohama Daichi Hosp | Dept Diabetes, Metabolism, and Endocrinology, Showa Univ School of Medicine | Dept Urology, Kitasato Univ School of Medicine, Sagamihara, Japan | Dept Nephrology, Yokohama Daiichi Hosp, Yokohama, Japan FP495 RELATIONSHIP BETWEEN ERYTHROPOIETIN RESISTANCE INDEX AND LEFT VENTRICULAR MASS AND FUNCTION AND CARDIOVASCULAR EVENTS IN PATIENTS ON CHRONIC HEMODIALYSIS Yong Kyun Kim | Ho-Cheol Song | Euy Jin Choi | Chul Woo Yang | Yong-Soo Kim Dept Internal Medicine, Bucheon Saint Mary’s Hosp | Bucheon St. Mary's Hosp, Catholic Univ Korea | Dept Internal Medicine, Seoul Saint Mary’s Hosp, Catholic Univ Korea FP496 THE REDOX STATE OF SERUM ALBUMIN AND MORTALITY IN HEMODIALYSIS PATIENTS Paik Seong Lim | Wu Ming Ying | Jeng Ya-Chung Providence Univ, Taiwan | Tungs Taichung Metroharbours Hosp FP497 RENIN ANGIOTENSIN ALDOSTERONE SYSTEM BLOCHADE AND LEFT VENTRICULAR HYPERTROPHY IN MAINTENANCE HEMODIALYSIS PATIENTS Inna Zaripova | Ivan Kayukov | Ashot Essaian | Aysa Nimgirova St.Petersburg State Medical Univ named after I.P.Pavlov, St.Petersburg, Russian Federation FP498 EXERCISE IN END STAGE RENAL FAILURE: PATIENT PERCEIVED BARRIERS AND MOTIVATORS Hannah Young | Maurice Dungey | Emma L Watson | Richard Baines | James O Burton | Alice C Smith John Walls Renal Unit, Leicester General Hosp, Leicester | School of Sport, Exercise and Health Science, Loughborough Univ | Dept Infection, Immunity and Inflammation, Univ Leicester, UK FP499 THE BEST CUT-OFF VALUE FOR DIAGNOSING OF ACUTE CORONARY SYNDROME AT EMERGENCY ROOM IN PATIENTS WITH END STAGE KIDNEY DISEASE Nobuhiko Joki | Masaki Iwasaki | Yuri Tanaka | Shun Kubo | Toshihide Hayashi | Nobutaka Ikeda | Kenji Yamazaki | Hiroki Hase Toho Univ Ohashi Medical Center | National Center Global Health And Medicine FP500 REACTIVE OXYGEN METABOLITES (ROMS) ARE ASSOCIATED WITH CARDIOVASCULAR DISEASE AND NEW CARDIOVASCULAR EVENTS IN CHRONIC HEMODIALYSIS PATIENTS Maurizio Bossola | Luigi Colacicco | Donata Scribano | Carlo Vulpio | Luigi Tazza Catholic Univ, Rome, Italy 174 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP502 POOR PATIENT SURVIVAL AFTER EARLY DIALYSIS INITIATION MAY BE EXPLAINED BY ADVANCED AGE Nuria Montero | MªJosé Soler | MºJosé Pascual | Clara Barrios | Eva Márquez| Eva Rodríguez | Mª Antonia Orfila | Higini Cao | Emma Arcos | Jordi Comas| Julio Pascual Hosp Mar, Barcelona Spain | Registre Malalts Renals Catalunya, Barcelona Spain FP503 ANALYSIS OF QT PROLONGATION IN ESRD PATIENTS DURING HEMODIALYSIS TREATMENT Manuela Ferrario | Tommaso Sironi | Simone Monacizzo | Flavio Basso | Francesco Garzotto | Dinna N. Cruz | Ulrich Moissl | Ciro Tetta | Maria G. Signorini| Sergio Cerutti | Claudio Ronco Politecnico Milano | San Bortolo Hosp, Vicenza | Fresenius Medical Care, R&D, Bad Homburg FP504 BETA 2-MICROGLOBULIN IS A PREDICTOR OF LEFT VENTRICULAR MASS INDEX IN HEMODIALYSIS PATIENTS Irina Mostovaya | Muriel Grooteman | Marinus van den Dorpel | Lars Penne | Neelke van der Weerd | Albert Mazairac | Claire den Hoedt | Renee Levesque | Menso Nube | Piet ter Wee | Michiel Bots | Peter Blankestijn Univ Medical Centre Utrecht, Utrecht, Netherlands | VU Univ Medical Center, Amsterdam, Netherlands | Maasstad Hosp, Rotterdam, Netherlands | Centre Hosp Univ Montréal, St-Luc Hosp, Montreal, Canada FP505 THE ACTIVATION OF MTOR PATHWAY INDUCED BY INFLAMMATION ACCELERATES THE PROGRESSION OF ATHEROSCLEROSIS IN HEMODIALYSIS PATIENTS Jing Liu | Kun Ling Ma | Xiaoliang Zhang | Bi Cheng Liu Inst Nephrology, Southeast Univ, Nanjing China | Zhong Da Hosp, School of Medicine, Southeast Univ, Nanjing, China FP506 CLINICAL RES OF RELATIONSHIP BETWEEN CAROTID INTIMA-MEDIA THICKNESS AND CARDIOVASCULAR RISK FACTORS IN HEMODIALYSIS PATIENTS Iulia-Daniela Vladu | Roxana Mustafa | Daniela Cana-Ruiu | Cristina Vaduva | Corina Grauntanu | Eugen Mota Nephrology Dept, Emergency County Hosp, Craiova, Romania | Cardiology Dept, Emergency County Hosp, Craiova, Romania FP507 PRO-INFLAMMATORY AND PRO-COAGULANT CHARACTERISTICS OF PLATELET DERIVED MICROVESICLES IN HAEMODIALYSIS PATIENTS Ruchir Singh | Nima Abbasian | Cordula Stover | Nigel Brunskill | James Burton Univ Leicester, Dept Infection, Immunity, and Inflammation, Leicester, UK « FP508 HYPERPHOSPHATAEMIA AND MICROVESICLE FORMATION: A NOVEL MECHANISM FOR CARDIOVASCULAR RISK IN CHRONIC KIDNEY DISEASE Nima Abbasian | Karl Herbert | Alan Bevington | Nigel Brunskill | James Burton Dept Infection, Immunity, and Inflammation, Univ Leicester, Leicester, UK | Dept Cardiovascular Sciences, Univ Leicester, Leicester, UK FP509 PARATHYROID HORMONE INDUCES ENDOTHELIAL-TO-MESENCHYMAL TRANSITION IN HUMAN AORTIC ENDOTHELIAL CELLS Min Wu | Ri-Ning Tang | Min Gao | Hong Liu | Long Chen | Lin-Li Lv | Bi- w w w. e r a e d t a 2 01 2 . o r g 175 FRIDAY, MAY 25 FP501 EFFECT OF LOW DOSE ASPIRIN ON PREVENTION OF FOOT ULCERS IN HEMODIALYSIS PATIENTS WITH DIABETES: A RETROSPECTIVE COHORT STUDY Tadashi Okada | Noriyuki Okada | Iwao Michibata | Takafumi Yura Hakuyu Chiyoda Clinic | Hakuyu Chiyoda Clinic | Hakuyu Clinic 49th ERA-EDTA CONGRESS P O S T E R S Cheng Liu Inst Nephrology, Zhong Da Hosp, Southeast Univ, NanJing, China FRIDAY, MAY 25 FP510 ALFACALCIDOL AND PARICALCITOL HAVE SIMILAR EFFECTS ON LEFT VENTRICULAR HYPERTROPHY Maria Nikodimopoulou | Spyridon Liakos | Stergios Kapoulas | Charalampos Karvounis Renal Unit AHEPA, Aristotelian Univ Thessalonik, Greece | Aristotelian Univ Thessaloniki FP511 THE RELATIONSHIP BETWEEN TNF-RELATED APOPTOSIS INDUCING LIGAND CONCENTRATION AND INFLAMMATORY MARKERS Danuta Fedak | Marek Kuzniewski | Dumnicka Paulina | Beata Kusnierz-Cabala | Maria Kapusta | Bogdan Solnica | Wladyslaw Sulowicz Dept Clinical Biochemistry, Jagiellonian Univ Collegium Medicum, Krakow, Poland | Dept Medical Diagnostics Fac Pharmacy, UJCM, Krakow, Poland | Dept Nephrology, Jagiellonian Univ Collegium Medicum, Krakow, Poland FP512 BENEFITS OF AN ENDURANCE TRAINING PROGRAM IN PATIENTS ON HEMODIALYSIS: A CASE-CONTROL STUDY Anna Junqué | Esteve Simo Vicent | Lidia Moreno | Miquel Fulquet | Veronica Duarte | Anna Saurina | Monica Pou | Javier Macías | Marisa Lavado | Manel Ramírez de Arellano Hosp Terrassa, Consorci Sanitari Terrassa, Barcelona FP513 SEASONAL AND WEEKLY VARIABILITY OF HOME BLOOD PRESSURE EVALUATED WITH TELEMEDECINE SYSTEM USING CELLULAR PHONE IN HEMODIALYSIS PATIENTS Munekazu Ryuzaki | Hidetomo Nakamoto | Shyunsuke Kinoshita | Emi Kobayashi | Chie Takimoto | Takashi Shishido Dept Internal Medecine, Kawasaki Municipal Ida Hosp, Kanagawa, Japan | Dept Internal Medecine, Saitama Medical School, Morohongo, Japan FP514 PULMONARY CONGESTION AND PHYSICAL FUNCTIONING IN CKD-5 HD PATIENTS Giuseppe Enia | C. Torino | R. Tripepi | V. Panuccio | M. Postorino | A. Clementi | M. Garozzo | G. Bonanno | R. Boito | G. Natale | T. Cicchetti | A. Chippari | D. Logozzo | G. Alati | S. Cassani | A. Sellaro | Carmine Zoccali CNR IBIM Reggio Calabria Italy | Lung Comets Cohort (LCC) working group FP515 INCIDENCE AND MORTALITY RISK FACTORS ASSOCIATED WITH NONOCCLUSIVE MESENTERIC ISCHAEMIA IN PATIENTS UNDERGOING HEMODIALYSIS Borja Quiroga | Eduardo Verde | Soraya Abad | Almudena Vega | Marian Goicoechea | Javier Reque | Juan Manuel López-Gómez | José Luño Hosp Gregorio Marañón FP516 COGNITIVE DYSFUNCTION AND WHITE MATTER LESIONS IN MAINTENANCE HAEMODIALYSIS PATIENTS Carmen Cabre Menendez | Veronica Moles | Joan Pere Vives | Diasol Villa | Jaume Viñas | Teresa Compte | Mercedes Arruche | Carlos Diaz | Jordi Soler | Josep Aguilera | Alberto Martinez Vea Joan XXIII Univ Hosp, Tarragona, Spain | Dept Diagnostic Imaging, Joan XXIII Univ Hosp, Tarragona, Spain | Dept Neurology, Joan XXIII Univ Hosp, Tarragona, Spain | Nephrology Unit Tortosa, Spain | Dialysis Center Reus Medical, Reus, Spain | Dialysis Center Llevant, Tarragona, Spain | Dept Nephrology, Joan XXIII Univ Hosp, Tarragona, Spain FP517 UREMIC FOOT: THE EMERGENT ROLE OF VITAMIN K-ANTAGONISTS Andreana De Mauri | Paola David | Maria Maddalena Conte | Doriana Chiari- 176 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP518 VITAMIN E-COATED POLYSULFONE MEMBRANE IMPROVED RED BLOOD CELL ANTIOXIDANT STATUS: A PROSPECTIVE MULTICENTER STUDY Anne-Sophie Bargnoux | Marion Morena | Isabelle Jaussent | Lotfi Chalabi | Pierre Bories | Jean-Jacques Dion | Patrick Henri | Martine Delage | Anne-Marie Dupuy | Stéphanie Badiou | Bernard Canaud | Jean-Paul Cristol Lab Biochimie, CHRU Montpellier | INSERM, U1061 | AIDER | Serv Néphrologie, CHU, Toulouse | Serv Néphrologie, CH Manchester | Serv Néphrologie, CHU Caen | Serv Néphrologie-Hémodialyse et Soins Intensifs, CHRU Montpellier FP519 P WAVE DURATION, ATRIAL DIMENSION AND ATRIAL FIBRILLATION IN HEMODIALYSIS PATIENTS Paolo Fabbrini | Elisabetta Sironi | Federico Pieruzzi | Eleonora Galbiati | Maria Rosa Viganò | Andrea Stella | Simonetta Genovesi Clinica Nefrologica, AO San Gerardo, Monza Italy FP520 ROLE OF PRE-TRANSPL ECHOCARDIOGRAPHY IN PREDICTING OUTCOME IN PATIENTS WAITING FOR KIDNEY TRANSPL Sheela Anpalakhan | Sofia Rocha | Nihil Chitalia | Rajan Sharma | Juan Carlos Kaski | John Chambers | David Goldsmith | Debasish Banerjee St George's, Univ London | St Georges Healthcare NHS Trust | Guys Hosp NHS Foundation Trust FP521 CHANGES IN RELAXIN’S SERUM LEVELS DURING ACETATE-FREE BIOFILTRATION: WHAT MEANINGS? Valeria Cernaro | Antonio Lacquaniti | Rosaria Lupica | Silvia Lucisano | Maria Rosaria Fazio | Valentina Donato | Michele Buemi Polyclinic Messina, Dept Internal Medicine, Div Nephrology FP522 RISK OF SUDDEN CARDIAC DEATH IN HEMODIALYSIS PATIENTS Isabelle Segalen | Ulrich Vinsonneau | Tugdual Tanquerel | Gilles Quiniou | Yannick Le Meur Nephrology, CHRU Brest, France | Dept Cardiology, Clermont Tonnerre Hosp, Brest, France | Dept Cardiology, Pasteur Clinic, Brest, France FP523 AUTONOMIC NERVOUS DYSFUNCTION AND INFLAMMATION IN HAEMODIALYSIS PATIENTS Eric Seibert | Matthias Girndt | Kristina Zohles | Christof Ulrich | Alexander Kluttig | Sebastian Nuding | CA Swenne | JA Kors | Karl Werdan | Roman Fiedler Dept Internal Medicine II | Inst Medical Epidemiology | Dept Internal Medicine III | Dept Cardiology, Leiden Univ Medical Center | Dept Medical Informatics, Erasmus Univ Medical Center Rotterdam | Martin-Luther-Univ Halle-Wittenberg FP524 HEPCIDIN-25 IS RELATED TO CARDIOVASCULAR EVENTS IN CHRONIC HEMODIALYSIS PATIENTS Neelke C. van der Weerd | Muriel PC Grooteman | ML Bots | Marinus A van den Dorpel | Claire den Hoedt | Menso J. Nubé | JFM Wetzels | Dorine W. Swinkels | PJ Blankestijn | Pieter M. ter Wee VU Medical Center, Amsterdam | Univ Medical Center Utrecht | Maasstad Hosp, Rotterdam| Radboud Univ Nijmegen Medical Center | Dept Lab Medicine, Lab Genetic, Endocrine and Metabolic Diseases, Radboud Univ Medical Center, Nijmegen FP525 INCIDENCE OF CARDIOVASCULAR DISEASE (CVD) IN CHRONIC KIDNEY DISEASE SUBJECTS (PRE-DIALYSIS): THE ROLE OF PLASMA HIGH SENSITI- w w w. e r a e d t a 2 01 2 . o r g 177 FRIDAY, MAY 25 notti | Carlo Edoardo Ruva | Martino De Leo Nephrology Dept, Univ Hosp Maggiore della Carità 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 VITY C-REACTIVE PROTEIN (HS-CRP), HOMOCYSTEINE (HCY), CAROTID INTIMA MEDIA THICKNESS (CIMT) AND LEFT VENTRICULAR HYPERTROPHY (LVH) Ashwini Khandekar | Jitendra Khandge Bhabha Atomic Res Centre Hosp, Anushaktinagar, Mumbai FP526 NONINVASIVE DETECTION OF CORONARY ARTERY STENOSIS WITH MULTIDETECTOR ROW COMPUTED TOMOGRAPHY IN CHRONIC KIDNEY DISEASE PATIENTS AT THE INITIATION OF RENAL REPLACEMENT THERAPY Jung Eun Lee | Sung Jin Moon | Kyu Hun Choi | Ho Yung Lee | Beom Seok Kim Yongin Severance Hosp | Myongji Hosp, Kwandong Univ College of Medicine, Goyang, Korea | Dept Nephrology, Inst Kidney Disease, Yonsei Univ College Medicine, Seoul, Korea | Severance Hosp, Seoul, Korea FP527 IMPAIRMENT IN ENDOTHELIAL PROGENITOR CELLS MOBILIZATION AS A COMPONENT OF MALNUTRITION INFLAMMATION COMPLEX SYNDROME: WHICH ROLE FOR DIALYSIS MODALITIES? Marion Morena | Edouard Tuaillon | Isabelle Jaussent | Annie Rodriguez | Leila Chenine | Jean-Pierre Vendrell | Jean-Paul Cristol | Bernard Canaud IRFD, CHRU, Montpellier, France | CHRU, Lab Virologie, Montpellier, France | INSERM U1061, Montpellier, France | CHRU, Serv Néphrologie, Hémodialyse et Soins Intensifs, Montpellier, France | Univ Montpellier, Hôp Lapeyronie, Dept Nephrology, Montpellier, France FP528 CARDIOPROTECTIVE DRUGS PROLONG HEART FAILURE SURVIVAL IN LONG-TERM HEMODIALYSIS PATIENTS Yuh-Mou Sue | Chao-Hsiun Tang | Yen-Chen Chen Wan-Fang Hosp, Taipei City, Taiwan | School of Health Care Administration, Taipei Medical Univ, Taipei, Taiwan FP529 ACUTE MYOCARDIAL INFARCTION IN INCIDENT DIALYSIS PATIENTS Carmen Sánchez-Perales | Eduardo Vázquez | Pilar Segura | M. José García Cortés | Jose Manuel Gil | M. Mar Biechy | Antonio Liébana Serv Cardiología, C.H. Jaén | Serv Nefrología, C.H. Jaén FP530 SAFETY AND EFFICACY OF BETA BLOCKERS IN HAEMODIALYSIS Dimitrios Poulikakos | Apeksha Shah | Mattias Persson | Debasish Banerjee St George's Hosp NHS Trust, London, UK | St Georges Healthcare NHS Trust, London UK FP531 VARIABILITY IN ESA DOSING AND NOT IN HAEMOGLOBIN LEVELS IS A STRONG PREDICTOR OF DEATH RISK IN HAEMODIALYSIS PATIENTS Pietro Dattolo | Marco Amidone | Stefano Michelassi | Luigi Moriconi | Giancarlo Betti | Paolo Conti | Alberto Rosati | Antonio Mannarino | Vincenzo Panichi | Francesco Pizzarelli S M Annunziata Hosp, Florence, Italy | ASL 11 | ASL 1 | ASL 9 | ASL 4 | ASL 10 | ASL 12 FP532 AGE AND GENDER PREDICT OPG LEVEL AND OPG/SRANKL RATIO IN MAINTENANCE HEMODIALYSED PATIENTS Katarzyna Klejna | Beata Naumnik | Ewa Koc-Zorawska | Michal Mysliwiec Dept Nephrology and Transpl with Dialysis Unit, Medical Univ, Bialystok, Poland | Medical Univ Bialystok, Bialystok, Poland FP533 EVALUATION OF LUNG WATER BY ULTRASOUND AND ITS RELATION WITH CARDIAC PARAMETERS AND BIOIMPEDANCE-DERIVED BODY WATER IN HAEMODIALYSIS PATIENTS Siriopol Dimitrie | Hogas Simona | Oleniuc Mihaela | Apetrii Mugurel | Onode Gabriela | Sascau Radu | Prisada Octavian | Covic Adrian 178 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Parhon Hosp, Univ Medicine and Farmacy Gr.T. Popa, Iasi, Romania | Cardiology Center, Univ Medicine and Farmacy Gr.T. Popa, Iasi, Romania FP535 CIRCULATING SCLEROSTIN AND DICKKOPF-1 (DKK1) IN PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD): RELATIONSHIP WITH BONE DENSITY AND ARTERIAL STIFFNESS David Goldsmith | S Thambiah | R Roplekar | P Manghat | P Manghat | I Fogelman | W Fraser | G Hampson King's Health Partners FP536 ABI TO EVALUATE PERIPHERAL ARTERIAL DAMAGE IN HEMODIALYSIS PATIENTS Erjola Likaj | Gentian Caco | Saimir Seferi | Merita Rroji | Myftar Barbullushi| Nestor Thereska UHC Mother Theresa, Tirana, Albania FP537 A RANDOMIZED TRIAL OF BIOIMPEDANCE VS. CLINICAL METHODS FOR EVALUATING “DRY WEIGHT” IN HEMODIALYSIS AND THE EFFECT ON HYDRATION STATUS, BLOOD PRESSURE AND MORTALITY Mihai Onofriescu | Simona Hogas | Voroneanu Luminita | Apetrii Mugurel| Ardeleanu Serban | Volovat Carmen | Stoicescu Cristian | Lungu Silvia | Adrian Covic Univ Medicine and Pharmacy Gr.T. Popa Iasi, Romania | Parhon Hosp, Univ Medicine and Farmacy Gr.T. Popa, Iasi, Romania | Dr C.I. Parhon Hosp, Iasi, Romania w w w. e r a e d t a 2 01 2 . o r g 179 FRIDAY, MAY 25 FP534 THE EVALUATION OF ARTERIAL STIFFNESS AND VOLUME STATUS IN CHRONIC KIDNEY DISEASE PATIENTS Hakan Akdam | Harun Akar | Yavuz Yenicerioglu | Özgül Küçük | İmran Kurt Ömürlü Div Nephrology, Adnan Menderes Univ Medical School, Aydın, Turkey 49th ERA-EDTA CONGRESS P O S T E R S VASCULAR ACCESS FRIDAY, MAY 25 FP538 ESTABLISHMENT AND MAINTENANCE OF VASCULAR AND PERITONEAL ACCESSES IN INCIDENT DIALYSIS PATIENTS: A COST-EFFECTIVENESS ANALYSIS Luis Coentrao | Carlos Ribeiro | Carla Santos-Araujo | Ricardo Neto | Manuel Pestana Nephrology Res and Development Unit, Fac Medicine, Univ Porto, Sao Jao Hosp Centre, Porto, Portugal | Financial Management Unit, São João Hosp Centre, Porto, Portugal FP539 THREE YEARS PROSPECTIVE SINGLE CENTER OBSERVATION OF NATURAL HISTORY OF TRANSHEPATIC PERMCATHETER IN HEMODIALYSIS PATIENTS Ebadur Rahman | Habibur Rahman | Dildar Ahmed | Dujanah Mousa | Mohamed El Bishlawi Riyadh Military Hosp | KKUH | RMH FP540 HISTOLOGICAL FINDINGS OF CLINICALLY DIAGNOSED EXIT-SITE INFECTIONS OF TUNNELED CUFFED CATHETERS Hiroshi Shibahara | Nami Shibahara | Susumu Takahashi Sagamihara Kyodo Hosp, Kanagawa, Japan | Nihon Univ Grad School, Tokyo, Japan FP541 TRISODIUM CITRATE 46.7% VERSUS HEPARIN CATHETER LOCKS FOR TUNNELED CENTRAL VENOUS CATHETERS: A SINGLE-CENTER STUDY Emmanuel Dupuis | Xavier Duval | Quentin Dornic | C Bonnal | Jean-Christophe Lucet | Olivier Cerceau | Christine Randoux | Cellou Balde | Frederic Besson | France Mentre | Francois Vrtovsnik Nephrology, CHU Bichat Paris France | Hop Bichat, AP-HP | Inserm UMR-S738 FP542 THE CHOICE BETWEEN TUNNELED OR NOT CENTRAL VEIN HEMODIALYSIS CATHETERS FOR SHORT PERIODS OF TIME George Koutroubas | Pavlos Malindretos | George Zagotsis | Panagiota Makri| Christos Syrganis General Hosp Volos Achillopoulion, Volos, Greece | Nephrology Dept, General Hosp Volos Achillopoulion, Volos, Greece FP543 HAEMOCATCH®: A NEW DEVICE FOR THE MANAGEMENT OF CVC (CENTRAL VENOUS CATHETERS) FOR HEMODIALYSIS Emanuele Mambelli | Elena Mancini | Cinzia Elia | Vincenza Guadagno | Maria Grazia Facchini | Annalisa Zucchelli | Michele Grazia | Laura Patregnani | Antonio Santoro Nefrologia, Dialisi Ipertensione, Policlinico S.Orsola-Malpighi, Bologna, Italy FP544 CATHETER-RELATED INFECTIONS IN CHRONIC HEMODIALYSIS – A CLINICAL AND ECONOMIC PERSPECTIVE Gabriel Stefan | Simona Stancu | Cristina Capusa | Oana Ramaiana Ailioaiei | Gabriel Mircescu Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania | Nephrology Dept, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania | Dr Carol Davila Teaching Hosp Nephrology, Bucharest, Romania FP545 LINE STRIPPING: AN UNDERUSED, SAFE AND EFFECTIVE OPTION FOR BLOCKED TUNNELLED HAEMODIALYSIS CATHETERS Siddiq Anwar | Callum Little | Richard Kingston | Previn Diwakar | Robert Kaikini Dept Renal Medicine Kent and Canterbury Hosp | Dept Interventional Radiology, Kent and Canterbury Hosp 180 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP547 THE LECEL OF C REACTIVE PROTIEN IN CHRONIC HEMODIALYSIS PATIENTS WITH NON INFECTED HEMODIALYSIS ACTHETER COMPARED TO AVF IN A LARGE SAUDI HEMODIALYSIS CENTER Alaa Sabry | Khalid AlSaran | Sherrine Al Sherbeiny | Mohamed Abdulkader1 Mansoura Urology and Nephrology Center | Prince Salman Center For Kidney Diseases FP548 BACTERIAL COLONIZATION OF TUNNELED CUFFED CATHETER IN PATIENTS WITH HEMODIALYSIS Ihmsoo Kwak | Sangheon Song | Eunyoung Seong | Soobong Lee | Dongwon Lee | Ilyoung Kim | Harin Rhee Pusan National Univ Hosp | Pusan National Univ School of Medicine | Pusan National Univ Yangsan Hosp FP549 PREDICTORS OF STEAL SYNDROME IN HEMODIALYSIS PATIENTS Fernanda Silva | José Queirós | Jorge Malheiro | António Cabrita | Ana Rocha Centro Hosp Porto, Portugal FP550 SOUND INTENSITY ANALYSIS OF ARTERIOVENOUS FISTULA (AVF) IN HEMODIALYSIS PATIENTS Panagiotis Bamidis | Christos Liaskos | Ioannis Chryssogonidis | Christos Frantzidis | Andreas Papagiannis | Dionisis Vrochides | Anastasios Lasaridis | Pavlos Nikolaidis | Pavlos Malindretos Lab Medical Informatics, Aristotle Univ Thessaloniki | Radiology Dept, Aristotle Univ, Thessaloniki, Greece | Organ Transpl Unit, Aristotle Univ, Thessaloniki, Greece | Nephrology Dept, 1st Medical Dept, AHEPA Univ Hosp | Nephrology Dept, Acillopoulion General Hosp, Volos, Greece FP551 BUTTONHOLE VERSUS SHARPNEEDLE CANNULATION: SERVLIVERY AND CLINICAL OUTCOMES Sradha Kotwal | Christopher Muir | Carmel Hawley | Paul Snelling | Martin Gallagher | Meg Jardine George Inst Global Health | Univ Sydney, Sydney, Australia | Princess Alexandria Hosp, Brisbane, Australia | Statewide Renal Servs, Sydney, Australia FP552 BUTTONHOLE NEEDLING OF HEMODIALYSIS ARTERIOVENOUS FISTULAE RESULTS IN LESS PAIN AND STRESS COMPARING TO THE ROPELADDER PUNCTURE TECHNIQUE Kazuhiko Shibata | Yoshiyuki Toya | Satoshi Umemura | Tamio Iwamoto | Syuji Ono | Eri Ikeda | Atsushi Kitazawa | Tadashi Kuji | Naoaki Koguchi | Hidehisa Satta | Masahiro Nishihara | Seiichi Kawata | Tomoko Kaneda | Yukiko Yamada | Tomoyuki Murakami | Mai Yanagi | Gen Yasuda Yokohama Minami Clinic | Yokohama City Univ, Yokohama, Japan | Saiseikai Yokohamashi Nanbu Hosp | Yokodai Central Clinic, Yokohama, Japan | Toshin Clinic | Yokohama City Univ Medical Center FP553 PER HEMODIALYSIS VASCULAR ACCESS BLOOD FLOW MEASURMENT BY DOPPLER ULTRASOUND: TECHNIC DESCRIPTION AND VALIDATION Sacquépée Mathieu | Doussy Yves | Tivollier Jean-Michel | Quirin Nicolas | Cantin Jean-François ATIR NC, Noumea, New Caledonia | CHT, BPJ9, Nouméa, New Calédonia FP554 PROGNOSTIC VALUE OF B2 GLYCOPROTEIN I ANTIBODIES IN w w w. e r a e d t a 2 01 2 . o r g 181 FRIDAY, MAY 25 FP546 INFECTIONS RELATED TO CENTRAL VEIN DIALYSIS CATHETERS - 11 YEARS EXPERIENCE Christos Syrganis | George Koutroubas | George Zagotsis | Pavlos Malindretos| Panagiota Makri | Evdokia Nikolaou | George Loukas General Hosp Volos Achillopoulion, Volos, Greece 49th ERA-EDTA CONGRESS P O S T E R S Mohamed Ibrahim | Mona Abdel Salam | Ahmed Awadalla | Walid Bichari | Shaimaa Zaki Ain Shams Univ, Cairo, Egypt | Benha Univ, Cairo, Egypt FRIDAY, MAY 25 FP555 INCIDENCE AND ETIOLOGY OF VASCULAR ACCESS (VA) THROMBOSIS IN PREVALENT PATIENTS UNDER VA SURVEILLANCE FOR STENOSIS BY BLOOD FLOW RATE (QA) MEASUREMENTS Ramon Roca-Tey | Rosa Samon | Omar Ibrik | Amparo Roda | Juan Carlos González-Oliva | Román Martínez-Cercós | Jordi Viladoms Dept Nephrology, Hosp Mollet, Mollet del Vallès, Barcelona, Spain FP556 FAR INFRARED THERAPY IMPROVES ENDOTHELIAL FUNCTION AND ACCESS FLOW OF NEWLY-CREATED AV FISTULA IN PATIENTS WITH STAGE 5 CHRONIC KIDNEY DISEASE Chih-Ching Lin | Wu-Chang Yang School Medicine, National Yang-Ming Univ, Taipei, Taiwan | Div Nephrology, Taipei Veterans General Hosp, Taipei, Taiwan FP557 THE IMPACT OF VASCULAR MICRO-CALCIFICATION OF RADIAL ARTERY ON CARDIOVASCULAR MORTALITY IN HEMODIALYSIS PATIENTS Young-Ok Kim | Sun-Ae Yoon | Yu-Seon Yun | Ho-Cheol Song | Byung-Soo Kim | Myeong-A Cheong Uijeongbu St. Mary's Hosp, Catholic Univ Korea | Bucheon St. Mary's Hosp, Catholic Univ Korea | St. Paul's Hosp, Catholic Univ Korea | Korea Cancer Center Hosp FP558 STUDY ON PREDICTION OF ARTERIOVENOUS FISTULA PATENCY DURATION AFTER PTA PROCEDURE Tomonari Ogawa | Tota Kiba | Shinpei Okazaki | Minoru Hatano | Mizuki Iwanaga | Chie Noiri | Akihiko Matsuda | Hajime Hasegawa | Tetsuya Mitarai Dept Nephrology and Blood Purification, Saitama Medical Center, Saitama Medical Univ FP559 EPIDEMIOLOGY OF HEMODIALYSIS VASCULAR ACCESS IN AN ITALIAN REGION: PREVALENCE, INCIDENCE, DETERMINANTS, SURVIVAL Anteo Di Napoli | Domenico Di Lallo | Luigi Tazza | Carmine De Cicco | Maria Flora Salvatori | Serena Chicca | Gabriella Guasticchi Agency Public Health Lazio Region, Rome, Italy | Catholic Univ | Ars Medica Dialysis Unit, Rome, Italy FP560 IS THERE AN ASSOCIATION BETWEEN ARTERIOVENOUS FISTULA THROMBOSIS AND PRESENCE OF THE CARDIAC VALVE CALCIFICATION IN NON-DIABETIC HEMODIALYSIS PATIENTS Saso Gelev | Lada Trajceska | Elizabeta Srbinovska | Svetlana Pavleska | Angel Oncevski | Petar Dejanov | Vesna Gerasomovska | Gjulsen Selim | Aleksandar Sikole Univ Clinic Nephrology, Skopje, FYR Macedonia | Univ Clinic Cardiology, Skopje, FYR Macedonia FP561 CATHAWAY FISTULA VASCULAR ACCESS PROGRAM ACHIEVES IMPROVED OUTCOMES AND SETS A NEW STANDARD OF TREATMENT FOR END-STAGE RENAL DISEASE Steven Wilson | Tracy Mayne | Mahesh Krishnan | Janet Holland | Abbe Volz| Lori Good | Allen Nissenson DaVita, Inc, Denver, USA FP562 CREATION OF UPPER EXTREMITY VASCULAR ACCESS IN DIALYSIS PATIENTS WITH SUPERIOR VENA CAVA STENOSIS Aristeidis Stavroulopoulos | Vasiliki Aresti | Georgios Maragkakis | Stelios Kyriakides 182 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Neprology Dept, Radiology Dept, Surgery Dept, IASIO Hosp, General Clinic Kallithea, Athens, Greece FP564 CREATION OF ARTERIOVENOUS FISTULAE IN DIALYSIS NESTORS ABOVE 85 YEARS OLD Tomasz Golebiowski | Ewa Watorek | Mariusz Kusztal | Krzysztof Letachowicz| Waldemar Letachowicz | Katarzyna Madziarska | Hanna Augustyniak Bartosik | Magdalena Krajewska | Wacław Weyde | Marian Klinger Dept Nephrology and Transpl Medicine Wroclaw Medical Univ Poland FP565 PAINFUL SHOULDER IN HEMODIALYSIS: THE ROLE OF VASCULAR ACCESS Alessandro Capitanini | Sara Lange | Adamasco Cupisti Dept Nephrology, Civil Hosp Pescia | Rehabilitation Medicine Unit, Pescia Hosp, Pescia - Italy | Div Nephrology, Dept Internal Medicine, Univ Pisa FP566 INCIDENCE OF AV FISTULA CLOSURE DUE TO HIGH OUTPUT CARDIAC FAILURE IN KIDNEY TRANSPLED PATIENTS Tabea Schier | Georg Göbel | Claudia Bösmüller | Ingrid Gruber | Martin Tiefenthaler Medical Univ Innsbruck, Dept Internal Medicine IV (Nephrology and Hypertension) | Dept Medical Statistics and Computer Science, Medical Univ Innsbruck| Dept Visceral, Transpl and Thoracic Surgery, Medical Univ Innsbruck | Dept Vascular Surgery, Medical Univ Innsbruck FP567 DOES FAR INFRARED THERAPY AID AV FISTULA MATURATION AND MAINTENANCE? Timothy Shipley | Jennifer Adam | Deborah Sweeney | Sean Fenwick | Hatem Mansy | Saeed Ahmed | Iain Moore City Hosp Sunderland FP568 RANDOMIZED TRIAL COMPARING NEW CHITOSAN-BASED BANDAGE WITH KALTOSTAT HEMOSTATIC DRESSING TO CONTROL BLEEDING FROM HEMODIALYSIS PUNCTURE SITE Tamio Iwamoto | Kazuhiko Shibata | Gen Yasuda | Tomoko Kaneda | Tomoyuki Murakami | Tadashi Kuji | Naoaki Koguchi | Hidehisa Satta | Masahiro Nishihara | Seiichi Kawata | Mai Yanagi | Yukiko Yamada | Syuji Ono | Eri Ikeda| Atsushi Kitazawa | Yoshiyuki Toya | Satoshi Umemura Saiseikai Yokohamashi Nanbu Hosp | Yokohama City Univ Medical Center | Yokodai Central Clinic, Yokohama, Japan | Toshin Clinic | Yokohama Minami Clinic | Yokohama City Univ, Yokohama, Japan FP569 POST-PUNCTURE BLEEDING TIME OF ARTERIO-VENOUS FISTULAE IS SHORTENED BY THE USE OF ‘IRIS’ BANDAGE Philippe Vigeral | Salima Saksi | Martin Flamant | Henri Boulanger Serv Nephro-dialyse Clinique Lambert | Clinique Estree Stains | CHU Bichat FP570 CLINICAL SIGNIFICANCE OF EARLY POST-OPERATIVE VENOGRAPHY OF VASCULAR ACCESS BEFORE FIRST NEEDLING IN HEMODIALYSIS PATIENTS Young-Ok Kim | Sun-Ae Yoon | Yu-Seon Yun | Ho-Cheol Song | Byung-Soo Kim | Won-Do Park | Myeong A Cheong w w w. e r a e d t a 2 01 2 . o r g 183 FRIDAY, MAY 25 FP563 CHANGES IN ACCESS BLOOD FLOW RATE AND BLOOD PRESSURE DURING HEMODIALYSIS Csaba Rikker | Edina Juhász | László Tornóci | Szilveszter Tóvárosi | Judit Greguschik | Otília Mag | László Rosivall FMC Dialysis Center, Péterfy Hosp, Budapest, Hungary | Inst Pathophysiology, Hungarian Academy of Sciences, Semmelweis Univ, Res Group for Pediatrics and Nephrology, Budapest, Hungary | FMC Hungary, Budapest, Hungary 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 Uijeongbu St. Mary's Hosp, Catholic Univ Korea | Bucheon St. Mary's Hosp, Catholic Univ Korea | St. Paul's Hosp, Catholic Univ Korea | Sanggye Paik Hosp, Inje Univ | Korea Cancer Center Hosp FP571 OPTIFLOWTM DEVICE – A NOVEL TECHNOLOGY FOR CREATION OF ARTERIOVENOUS FISTULAE FOR HAEMODIALYSIS: EARLY CLINICAL EXPERIENCE, SAFETY AND EFFICACY Milind Nikam | Afshin Tavakoli | Eric Chemla | Jackie Evans | Hazel Malete | Lajos Matyas | Istvan Mogan | Miltos Lazarides | Adrian Ebner Manchester Royal Infirmary, Manchester, UK | Central Manchester Foundation Trust, Manchester, UK | St Georges Healthcare NHS trust, London, UK | B.A.Z. Megyei KH., Miskolc, Hungary | Szent Imre, Budapest, Hungary | Demokritos Univ, Alexandroupolis, Greece | French Hosp, Paraguay FP572 ANATOMICAL FACTOR FOR THE LEFT BRACHIOCEPHALIC VEIN STENOSIS IN HEMODIALYSIS PATIENTS Yaxue Shi | Jiwei Zhang | Jiejun Cheng Dept Vascular Surgery, Dept Radiology, RenJi Hosp, Shanghai, China FP573 COMPARISON OF HEMODIALYSIS BLOOD ACCESS FLOW RATES USING 3 ON-LINE TECHNIQUES AND ULTRASOUND DILUTION Le Roy Frank | Hanoy Mélanie | Bertrand Dominique | Godin Michel Rouen Universitary Hosp, Rouen, France FP574 THE IMPORTANCE OF LOW-PRESSURE DILATION TO CONTROL LINING MEMBRANE DAMAGE IN VAIVT Kiyoshi Ikeda | Toru Yasuda | Hideki Yotueda Ikeda Vascular Access, Dialysis, and Internal Medicine Clinic| Fukuoka Red Cross Hosp FP575 VASCULAR ACCESS IN HOME HAEMODIALYSIS: TRENDS AND OUTCOMES Milind Nikam | Leonard Ebah | Anuradha Jayanti | Jackie Evans | Durga Kanigicherla | Angela Summers | Grace Manley | Gillian Dutton | Nicholas Chalmers | Sandip Mitra Manchester Royal Infirmary, Manchester, UK | Central Manchester Found Trust, Manchester, UK FP576 INFLUENCE OF CKD ETIOLOGY AND HbA1C ON ACHIEVING A MATURE AVF Ionel-Alexandru Checherita | Andrei Niculae | Daniela Radulescu | Cristiana David | Flavia Liliana Turcu | Alexandru Ciocalteu Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania | Saint John Emergency Hosp, Bucharest, Romania FP577 ARTERIOVENOUS FISTULA FOR HEMODIALYSIS IN ELDERLY PATIENTS Vanja Persic | Jadranka Buturovic-Ponikvar | Rafael Ponikvar Univ Medical Center, Ljubljana, Slovenia FP578 PLASMA BNP LEVELS AND AVF FLOW IN HEMODIALYSIS (HD) PATIENTS Malik Touam | Victorio Menoyo | Tilman Drüeke | Mohamed Rifaat | Carmina Muresan | Mehdi Abtahi | Zineb Koochakipour | Dominique Joly AURA, Paris | ECHO, Vannes | Inserm ERI 12, Amiens | Hôp Necker FP579 RETROSPECTIVE SURVEY OF VASCULAR ACCESS PROVISION FOR PATIENTS STARTING ON HAEMODIALYSIS AT BIRMINGHAM HEARTLANDS HOSP IN 2007 AND 2009/2010 Jyoti Baharani | Sara Rizvi | Khai Ping Ng Birmingham Heartlands Hosp | Univ Hosp Birmingham, Birmingham, UK 184 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP581 VALIDATION OF A NEW FISTULA (AVF) MONITORING SYSTEM BY TIME PATTERN DATA ANALYSIS Massimo Adorati Menegato | Rossella Mortellaro | Antonina Locicero | Alessandra Romano | Pier Paolo Manzini | Denis Steckiph San Antonio's Hosp | Gambro Hospal Spa, Italy FP582 EXPERIENCE WITH THE MILLER BANDING PROCEDURE FOR HEMODIALYSIS PATIENTS WITH HIGH FLOW ACCESS OR STEAL SYNDROME Sadanori Shintaku | Hideki Kawanishi| Misaki Moriishi | Masataka Bansyodani | Syunpei Nakamura | Masafumi Saito | Shinichiro Tsuchiya Tsuchiya General Hosp, Hiroshima, Japan FP583 ALTERNATIVE VASCULAR ACCESS FOR HEMODIALYSIS – A DEPT'S EXPERIENCE Francisca Barros | Raquel Vaz | Berta Carvalho | Ricardo Neto | Patrícia Martins | Manuel Pestana Nephrology Dept, Hosp São João, Porto, Portugal FP584 VASCULAR ACCESS: HAVE THE ALBANIAN NEPHROLOGISTS "DONE THE HOMEWORKS" LEFT BY THE INTERNATIONAL GUIDELINES Erjola Likaj | Saimir Seferi | Merita Rroji | Alma Idrizi | Ahmet Duraku | Myftar Barbullushi | Nestor Thereska UHC Mother Theresa, Tirana, Albania FP585 FLOW VOLUME AND RESISTANCE INDEX PREDICT EARLY ACCESS FAILURE IN ARTERIOVENOUS FAILURE Sadanori Shintaku | Hideki Kawanishi| Misaki Moriishi | Masataka Bansyodani | Syunpei Nakamura | Masafumi Saito | Shinichiro Tsuchiya Tsuchiya General Hosp, Hiroshima, Japan w w w. e r a e d t a 2 01 2 . o r g 185 FRIDAY, MAY 25 FP580 ENDOVASCULAR RECANALIZATION OF AN ACUTE DISTAL AVF THROMBOSIS WITH EKOS® SYSTEM Laura Buzzi | Elena Alberghini | Francesca Ferrario | Ivano Baragetti | Gaia Santagostino | Silvia Furiani | Enzo Corghi | Cristina Sarcina | Veronica Terraneo | Francesco Rastelli | Giuseppe Bacchini | Claudio Pozzi Bassini Hosp, Cinisello Balsamo, Milan, Italy | A. Manzoni Hosp, Lecco, Italy 49th ERA-EDTA CONGRESS P O S T E R S EPIDEMIOLOGY AND OUTCOME RESEARCH IN CKD 5D FRIDAY, MAY 25 FP586 BUNDLED PAYMENT FOR RENAL DIALYSIS IN A PORTUGUESE SETTING: ECONOMIC IMPLICATIONS Luis Coentrao | Carlos Ribeiro | Carla Santos-Araujo | Ricardo Neto | Manuel Pestana Nephrology Res and Development Unit, Fac Medicine, Univ Porto, Sao Jao Hosp Centre, Porto, Portugal | Financial Management Unit, São João Hosp Centre, Porto, Portugal FP587 TRENDS BEFORE AND AFTER THE INTRODUCTION OF A REIMBURSEMENT FLAT RATE AND A QUALITY MONITORING PROGRAM: EXPERIENCE FROM THE DOPPS IN GERMANY Werner Kleophas | Angelo Karaboyas | Yun Li | Juergen Bommer | Ronald Pisoni | Bruce Robinson | Friedrich Port Gemeinschaftspraxis Karlstrasse, Dusseldorf, Germany | Arbor Res Collaborative for Health, Ann Arbor, USA | Dialysezentrum Heidelberg, Germany FP588 IS SLEEP AND LIFE QUALITY OF CAREGIVERS AFFECTED AS MUCH AS THAT OF HEMODIALYSIS PATIENTS? Gülperi Çelik | Bilge Burcak Annagur | Mümtaz Yılmaz | Tarık Demir | Fatih Kara Dept Internal Medicine, Div Nephrology, Selçuklu Fac Medicine, Selcuk Univ, Konya, Turkey | Dept Psychiatry, Selçuklu Fac Medicine, Selcuk Univ, Konya, Turkey | Dept Internal Medicine, Div Nephrology, Kütahya State Hosp, Kütahya, Turkey | Dept Public Health, Selçuklu Fac Medicine, Selcuk Univ, Konya, Turkey FP589 SLEEP QUALITY, DAYTIME ACTIVITY AND RESTLESS LEGS SYNDROME IN PATIENTS UNDERGOING HEMODIALYSIS AND HEMODIAFILTRATION: A SINGLE CENTRE EXPERIENCE Konstantina Trigka | Periklis Dousdampanis | Nikolaos Vaitsis | Stamatina Aggelakou-Vaitsi Kyanous Stayros Patron FP590 HEALTH RELATED QUALITY OF LIFE, SLEEP QUALITY AND DEPRESSION IN ELDERLY HEMODIALYSIS PATIENTS Kultigin Turkmen | Ibrahim Guney | Faruk Turgut | Lutfullah Altintepe | Halil Zeki Tonbul | Emaad Abdel-Rahman Konya Univ, Meram School of Medicine, Konya, Turkey | Meram Training and Reseach Hosp | Iskenderun Training and Res Hosp, Iskenderun, Turkey | Univ Virginia, Health System, Div Nephrology, Virginia, USA FP591 ASSESSING QUALITY OF LIFE IN DIALYSIS PATIENTS: A ROLE FOR COMPNENTS OF FRAILTY Paola Sclauzero | Giovanni Galli | Giulia Barbati | Michele Carraro | Giovanni Oliviero Panzetta Nephrology and Dialisis Unit AOUTS, Trieste - Italy | Cardiology Unit AOUTS, Trieste - Italy FP592 PREDICTING MORTALITY IN DIABETIC INCIDENT DIALYSIS PATIENTS Merel van Diepen | Marielle Schroijen | Olaf Dekkers | Friedo Dekker Leiden Univ Medical Center, Leiden, Netherlands FP593 DOES THE DAILY SODIUM INTAKE INFLUENCE MORTALITY IN DIALYSIS PATIENTS? Aleksandar Sikole | Galina Severova- Andreevska | Lada Trajceska | Saso Gelev| Vili Amitov | Svetlana Pavleska- Kuzmanovska Univ Clinic of Nefrology 186 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP595 LONGITUDINAL EVALUATION OF SYMPTOM BURDEN IN HEMODIALYSIS PATIENTS Beverly Jung | Marianna Leung | Fong Huynh | Tinnie Chung | Stan Marchuk | Mercedeh Kiaii | Lee Er | Ronald Werb | Clifford Chan-Yan | Monica Beaulieu St. Paul's Hosp, Vancouver, Canada | BC Renal Agency FP596 SUBJECTIVE GLOBAL ASSESSMENT, NUTRITIONAL STATUS AND HEALTH RELATED QUALITY OF LIFE IN HEMODIALYSIS PATIENT Pavlos Malindretos | P Makri | G Zagkotsis | G Koutroumbas | G Loukas | E Nikolaou | M Pavlou | E Gourgoulianni | M Paparizou | M Markou | E Syrgani| Ch Syrganis Nephrology Dept, Acillopoulion General Hosp, Volos, Greece | Biochemistry Dept, Achillopoulion General Hosp, Volos, Greece | Statistician, Volos, Greece | 1st Dept Internal Medicine, Achillopoulion General Hosp FP597 DIFFERENCES IN SELF-REPORTED PHYSICAL AND MENTAL WELL-BEING BETWEEN DIABETIC AND NON-DIABETIC US HEMODIALYSIS PATIENTS Jochen Raimann | Len A Usvyat | Viraj Bhalani | Nathan W Levin | Peter Kotanko Renal Res Inst, New York, USA FP598 ESTIMATED HEPATIC AND ADIPOSE TISSUE STEAROYL-COA DESATURASE-1 ACTIVITIES ARE ASSOCIATED WITH INFLAMMATION AND ALLCAUSE MORTALITY IN DIALYSIS PATIENTS Xiaoyan Huang | Peter Stenvinkel | Abdul Rashid Qureshi | Ulf Riserus | Tommy Cederholm | Peter Barany | Olof Heimburger | Bengt Lindholm | Juan Jesus Carrero Karolinska Inst | Uppsala Univ | Div Renal Medicine and Baxter Novum, Dept Clinical Science, Intervention and Technology, Karolinska Inst, Stockholm, Sweden | Renal Medicine and Baxter Novum, Karolinska Inst FP599 MORTALITY COMPARISON OF DIALYSIS MODALITY IN INCIDENT PATIENTS WITH END STAGE RENAL DISEASE: A PROPENSITY SCORE APPROACH Jae Hyun Chang | Ji Yoon Sung | Ji Yong Jung | Hyun Hee Lee | Wookyung Chung | Sejoong Kim Dept Internal Medicine, Gachon Univ School Medicine, Incheon, Korea | Dept Internal Medicine, Seoul National Univ Bundang Hosp, Seongnam, Korea FP600 EFFECT OF TIMING OF DIALYSIS INITIATION ON MORTALITY IN ESRD PATIENTS Jin Suk Han | Sejoong Kim | Jae Hyun Chang | Ji Yong Jung | Wookyung Chung | Ki Young Na Seoul National Univ College Medicine, Seoul, Korea | Gachon Univ Gil Hosp, Incheon, Korea | Seoul National Univ Bundang Hosp, Seongnam, Korea FP601 RELATIONSHIP BETWEEN VARIABILITY OF PRE DIALYSIS SERUM SODIUM AND MORTALITY RISK IN INCIDENT HEMODIALYSIS PATIENTS Jochen Raimann | Len A Usvyat | Peter Kotanko | Nathan W Levin Renal Res Inst, New York, USA FP602 CHARLSON COMORBIDITY INDEX INDEPENDENTLY PREDICTS VASCU- w w w. e r a e d t a 2 01 2 . o r g 187 FRIDAY, MAY 25 « FP594 HIGHER DIALYSATE SODIUM IS ASSOCIATED WITH BETTER HEMODIALYSIS PATIENT-REPORTED OUTCOMES: RESULTS FROM THE DOPPS Angelo Karaboyas | Hugh Rayner | Yun Li | Raymond Vanholder | Ronald Pisoni | Bruce Robinson | Friedrich Port | Manfred Hecking Arbor Res Collaborative for Health, Ann Arbor, USA | Birmingham Heartlands Hosp, UK | Ghent Univ Hosp, Belgium | Medical Univ Vienna, Austria 49th ERA-EDTA CONGRESS P O S T E R S LAR CALCIFICATION IN HEMODIALYSIS PATIENTS André Fragoso | Ana Pinho | Anabela Malho | Ana Paula Silva | Elsa Morgado| Pedro Leão Neves Nephrology Dept, Hosp Faro, Faro, Portugal FRIDAY, MAY 25 FP603 THE TRANSITION OF PREVALENCE OF CORONARY ARTERY DISEASE AT THE INITIATION OF DIALYSIS OVER THE LAST TWO DECADES Nobuhiko Joki | Yuri Tanaka | Masaki Iwasaki | Shun Kubo | Toshihide Hayashi | Yasunori Takahashi | Koichi Hirahata | Yoshihiko Imamura | Hiroki Hase Toho Univ Ohashi Medical Center | Nissan Tamagawa Hosp | Hirahata Clinic FP604 FACTORS AFFECTING THE NUMBER OF PATIENTS TREATED WITH EITHER PERITONEAL OR HOME HAEMODIALYSIS IN THE UK Clare Castledine | Julie Gilg | Chris Rogers | Yoav Ben-Shlomo | Fergus Caskey UK Renal Registry, Bristol, UK | Univ Bristol | School Social and Community Medicine, Bristol Univ, UK | NHS North Bristol, Bristol, UK FP605 LOW RESISTIN LEVELS IS ASSOCIATED WITH POOR HOSPITALIZATIONFREE SURVIVAL IN HEMODIALYSIS PATIENTS Ki Young Na | Sejoong Kim | Wookyung Chung | Ji Yong Jung | Jae Hyun Chang | Hyun Hee Lee SNUBH | Gachon Univ Gil Hosp, Incheon, Korea FP606 OCULAR CHANGES IN PATIENTS OF CHRONIC KIDNEY DISEASE AND RENAL ALLOGRAFT RECIPIENTS Jasvinder Singh Sandhu | G S Bajwa | Shyna Kansal | Jashan Sandhu Dayanand Medical College, Ludhiana, India FP607 TECHNIQUE FAILURE IN HOME HAEMODIALYSIS- A PROSPECTIVE SINGLE CENTRE EXPERIENCE Anuradha Jayanti | Milind Nikam | Leonard Ebah | Angela Summers | Sandip Mitra Manchester Royal Infirmary, Manchester, UK FP608 AN AFFORDABLE MODEL FOR SOLAR-ASSISTED HOME HAEMODIALYSIS John Agar | Anthony Perkins | Rosemary Simmonds | Alwie Tjipto Geelong Hosp, Barwon Health FP609 PREVALENCE OF NEPHROGENIC SYSTEMIC FIBROSIS (NSF) IN DIALYSIS PATIENTS: FINAL RESULTS OF THE PRO-FINEST STUDY Sabine Amet | Vincent Launay-Vacher | Maurice Laville | Aurore Tricotel | Camille Frances | Benedicte Stengel | Jean-Yves Gauvrit | Nicolas Grenier | Genevieve Reinhardt | Olivier Clement | Nicolas Janus | Laurence Rouillon | Gabriel Choukroun | Gilbert Deray Serv ICAR, Nephrology Dept, Pitie-Salpetriere Hosp, Paris, France | Nephrology Dept, Edouard Herriot Hosp, Lyon, France | Drug Monitoring, Afssaps, Saint-Denis, France | Dermatology Dept, Tenon Hosp, Paris, France | Inserm U1018, Paul Brousse Hosp, Villejuif, France | Radiology Dept, Pontchaillou Hosp, Rennes, France | Radiology Dept, Pellegrin Hosp, Bordeaux, France | Radiology Dept, Haguenau Hosp, Haguenau, France | Radiology Dept, G. Pompidou Hosp, Paris, France | Nephrology Dept, South Hosp, Amiens, France | Nephrology Dept, Pitie-Salpetriere Hosp, Paris, France FP610 CAN A REDUCED RENAL RESPONSE TO A PROTEIN CHALLENGE IN PREGNANT WOMEN SUFFERING FROM CHRONIC RENAL DISEASE PRECLUDE THE INITIATION OF RENAL IMPAIRMENT? Amelia Bernasconi | Rosa Waisman | Ana Patricia Montoya | Amador Andrés Liste | Ricardo Hermes | Graciela Muguerza | Ricardo Heguilen Hosp J.A. Fernandez 188 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP612 EVALUATION OF CHRONIC PAIN IN CKD PATIENTS Valentina Martina | Maria Antonietta Rizzo | Paolo Magenta | Lorenzo Lubatt| Giuseppe Rombolà | Maurizio Gallieni Nephrology and Dialysis Unit, San Carlo Borromeo Hosp, Milano, Italy | Pain Therapy Unit, San Carlo Borromeo Hosp, Milano, Italy | Nephrology and Dialysis Unit, Osp Sant'Andrea, La Spezia, Italy FP613 SOCIOPROFESSIONAL OUTCOME AT ADULT AGE OF CHILDREN AFTER KIDNEY TRANSPL Chantal Loirat | Hélène Mellerio | Marylène Labèguerie | Béatrice Andriss | Emilie Savoye | Mathilde Lassale | Christian Jacquelinet | Corinne Alberti Pediatric Nephrology, Hôp Robert Debré, Paris, France | Inserm, CIC-EC, CIE 5, Hôp Robert Debré, Paris, France | Agence Biomédecine, Saint Denis La Plaine, France FP614 END OF LIFE DECISION-MAKING: WITHDRAWING FROM DIALYSIS – A 10 YEAR RETROSPECTIVE SINGLE CENTRE EXPERIENCE FROM THE UK Yogita Aggarwal | Jyoti Baharani Birmingham Heartlands Hosp FP615 DRUG COMPLIANCE IN HEMODIALYSIS PATIENTS- CORRELATION WITH DEPRESSION AND PARACLINICAL FINDINGS Shiva Tabrizian | Shahrzad Ossareh | Marjan Zebarjadi Hasheminejad Clinical Res Development Center, Tehran Univ Medical Sciences FP616 UNDERSTANDING A NEW ERA FOR DEPRESSION AND ANXIETY IN HEMODIALYSIS PATIENTS Pedro Azevedo | Francisco Travassos | Inês Frade | Manuela Almeida | José Queirós | Fernanda Silva | António Cabrita | Rosária Rodrigues Centro Hosp Porto | Mirandela Hemodialysis Center FP617 CLUSTERING COUNTRIES BY RENAL SERV CHARACTERISTICS: RESULTS FROM THE EVEREST STUDY Cécile Couchoud | Jager Kitty | Stengel Bénédicte | Caskey Fergus Agence Biomédecine | AMC, Amsterdam, Netherlands | Inserm/Univ Paris Sud, Villejuif, France | Southmead Hosp, Bristol, UK FP618 A NEW APPROACH FOR MEASURING GENDER DISPARITY IN ACCES TO RENAL TRANSPL Couchoud Cécile | Bayat Sahar | Villar Emmanuel | Jacquelinet Christian | Ecochard René Agence Biomédecine, France | School Public Health, Rennes, France | Hospices Civils Lyon, France FP619 INTEGRATION OF CHRONIC KIDNEY DISEASE SCREENING IN NATIONAL PRIMARY HEALTH CARE NETWORK , PILOT STUDY, IRAN Hamid Barahimi | Mitra Mahdavi-Mazdeh | Mohsen Nafar Ministry Health, Transpl and Specific Disease Office | Iranian Tissue Bank & Res Center, TUMS | Labbafinejad Hosp; Tehran; Iran FP620 THIRST AND ORAL SYMPTOMS IN PEOPLE ON HEMODIALYSIS: A MULTINATIONAL PROSPECTIVE COHORT STUDY Massimo Petruzzi | Michele De Benedittis | Michela Sciancalepore | Letizia Gar- w w w. e r a e d t a 2 01 2 . o r g 189 FRIDAY, MAY 25 FP611 CROSS SECTIONAL EPIDEMIOLOGICAL STUDY IN HEMODIALYSIS PATIENTS Elena Laura Iliescu Fundeni Clinical Inst, Bucharest, Romania 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 gano | Patrizia Natale | Maria Cristina Vecchio | Valeria Saglimbene | Fabio Pellegrini | Giorgio Gentile | Paul Stroumza | Luc Frantzen | Miguel Leal | Marietta Torok | Anna Bednarek | Jan Dulawa | Eduardo Celia | Ruben Gelfman| Jorgen Hegbrant | Charlotta Wollheim | Suetonia Palmer | David W Johnson | Pauline J Ford | Jonathan C Craig | Giovanni FM Strippoli | Marinella Ruospo Univ Bari, School Dentistry and Surgery, Italy | Diaverum Italy | Consorzio Mario Negri Sud, Italy | Univ Perugia, Italy | Diaverum France | Diaverum Portugal| Diaverum Hungary | Diaverum Poland | Diaverum Argentina | Diaverum Medical Scientific Office, Sweden | Univ Otago Christchurch, New Zealand| Univ Queensland, Princess Alexandra Hosp, Australia | Univ Queensland, School Dentistry, Australia | School Public Health, Univ Sydney, Australia FP621 GENERALIZED ANXIETY DISORDER (GAD) IN PREVALENT PATIENTS ON HEMODIALYSIS Bilal El Hayek | Eduardo Baamonde | Elvira Bosch | Jose I Ramirez | German Perez | Ana Ramirez | Agustin Toledo | Maria M Lago | Cesar Garcia-Canton| M Dolores Checa Avericum Hemodialysis Center, Las Palmas, Spain | Centro Hemodiálisis Avericum | Serv Nefrología FP622 A SIMPLIFIED FORMULA TO CALCULATE THE CREATININE INDEX IN HEMODIALYSIS PATIENTS: STRONG ASSOCIATION WITH PATIENT CHARACTERISTICS AND MORTALITY IN THE DOPPS Bernard Canaud | Brett Lantz | Ronald Pisoni | Alexandre Granger-Vallée | Paungpaga Lertdumrongluk | Nicolas Molinari | Jean Ethier | Michel Jadoul | Brenda Gillespie | Friedrich Port Lapeyronie Univ Hosp, Montpellier, France | Arbor Res Collaborative for Health, Ann Arbor, USA | Montpellier Regional Univ Hosp, Montpellier, France | Srinakharinwirot Univ, Pakkret, Nonthaburi, Thailand | INSERM, Montpellier, France | Centre Hosp Univ Montréal, Montreal, Quebec, Canada | Cliniques Univ St-Luc, Brussels, Belgium | Univ Michigan, Ann Arbor, USA FP623 PILL BURDEN AND ITS ASSOCIATION WITH MEDICATION POSSESSION RATIO AMONG HEMODIALYSIS PATIENTS WITH HYPERPHOSPHATEMIA Christopher Bond | Steven Wang | Thomas Alfieri | Peter Braunhofer | Britt Newsome DaVita Inc, Denver, CO, USA | Vifor Pharma, Glattbrugg, Switzerland, EU | Denver Nephrology, Denver, CO, USA FP624 DIALYSIS TREATMENT TIME, DIALYSIS FREQUENCY, AND DELIVERED SINGLE POOL KT/V AMONG HEMODIALYSIS PATIENTS IN THE CHINA DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS) M Wang | M Guidinger | B Bieber | M Wang | L Zuo | RL Pisoni | X Yu | X Yang | J Qian | N Chen | J Albert | Y Yan | S Ramirez Peking Univ First Hosp, Beijing, China | Univ Michigan, Ann Arbor, Michigan, USA | Arbor Res Collaborative for Health, Ann Arbor, Michigan, USA| First Affiliated Hosp Sun Yat-Sen Univ, Guangzhou, China | Dept Medicine, Renji Hosp | Shanghai Ruijin Hosp, Shanghai, China FP625 PREGNANCY: INTENSIFIED HEMODIALYSIS YES OR NO? Amelia Bernasconi | Rosa Waisman | Marina Beresan | Alicia Lapidus | Marcela Canteli | Ricardo Heguilen Hosp J.A. Fernandez FP626 CLINICIAN BELIEFS AND ATTITUDES ABOUT HOME HAEMODIALYSIS: QUALITATIVE INTERVIEW STUDY Allison Tong | Suetonia Palmer | Braden Manns | Jonathan Craig | Marinella Ruospo | Letizia Gargano | Giovanni Strippoli Univ Sydney | Univ Otago Christchurch, New Zealand | Univ Calgary, Calgary, Alberta | Diaverum Medical Scientific Office | Diaverum | Cochrane Renal Group, Sydney, Australia 190 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP628 A STAFF SURVEY ON END OF LIFE CARE IN ADVANCED KIDNEY DISEASE Muhammad Khan | Khaled Abdulnabi | Pearl Pai Royal Liverpool and Broadgreen Hosp NHS Trust FP629 PREVALENCE OF ORAL LESIONS IN HEMODIALYSIS PATIENTS: A PROSPECTIVE MULTINATIONAL COHORT STUDY Marinella Ruospo | Massimo Petruzzi | Michele De Benedittis | Michela Sciancalepore | Letizia Gargano | Mariacristina Vecchio | Valeria Saglimbene | Patrizia Natale | Fabio Pellegrini | Giorgio Gentile | Paul Stroumza | Luc Frantzen| Miguel Leal | Marietta Torok | Anna Bednarek | Jan Dulawa | Eduardo Celia| Ruben Gelfman | Jorgen Hegbrant | Charlotta Wollheim | Suetonia Palmer | David W Johnson | Pauline J Ford | Jonathan C Craig | Giovanni FM Strippoli Diaverum Medical Scientific Office, Sweden | Univ Bari, School Dentistry and Surgery, Italy | Diaverum Italy | Consorzio Mario Negri Sud, Italy | Univ Perugia, Italy | Diaverum France | Diaverum Portugal | Diaverum Hungary | Diaverum Poland | Diaverum Argentina | Diaverum Medical Scientific Office, Sweden | Univ Otago Christchurch, New Zealand | Univ Queensland, Princess Alexandra Hosp, Australia | Univ Queensland, School Dentistry, Australia | School Public Health, Univ Sydney, Australia FP630 PREVALENCE OF CHRONIC KIDNEY DISEASE (CKD) AND IDENTIFICATION OF ASSOCIATED RISK FACTORS IN A RURAL AREA BY MASS SCREENING Md. Abdul Muqueet | Mahmud Javed Hasan | M. Abul Kashem | Pradip Kumar Dutta Nephrology Dept MMC | Nephrology Dept CBMCB | Nephrology Dept CMC FP631 PERITONEAL DIALYSIS VS. IN-CENTER HEMODIALYSIS: A SYSTEMATIC REVIEW OF THE ECONOMIC LITERATURE Frank Xiaoqing Liu | Les Noe | Tiffany Quock | Nancy Neil | Gary Inglese Baxter Healthcare Corporation, McGaw Park, USA | ICON/Oxford Outcomes, Eugene, USA | ICON/Oxford Outcomes, San Francisco, USA | Decision Res, Eugene, USA FP632 PRACTICE PATTERNS FOR VASCULAR ACCESS AND ANEMIA MANAGEMENT: FINDINGS FROM THE CHINA DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS) POPULATION J Qian | M Guidinger | B Bieber | N Chen | Y Yan | RL Pisoni | M Wang | L Zuo | X Yu | X Yang | M Wang | J Albert | S Ramirez Shanghai Society Internal Medicine, Shanghai, China | Univ Michigan, Ann Arbor, Michigan, USA | Arbor Res Collaborative for Health, Ann Arbor, Michigan, USA | Shanghai Ruijin Hosp, Shanghai, China | Renji Hosp, Shanghai, China | Peking Univ First Hosp, Beijing, China | First Affiliated Hosp Sun Yat-Sen Univ, Guangzhou, China FP633 EFFECTIVENESS OF COGNITIVE- EXISTENTIAL GROUP THERAPY ON INCREASING HOPE IN WOMEN UNDER MAINTENANCE HEMODIALYSIS Shahrzad Ossareh | Maryam Motamed Najjar | Bahman Bahmani | Abdolah Shafiabadi Dept Medicine, Nephrology Section, Hasheminejad Clinical Res Development Center, Tehran Univ Medical Sciences, Tehran, Iran | Univ Social Welfare and Rehabilitation Sciences, Tehran, Iran | Allameh Tabatabayi Univ, Tehran, Iran w w w. e r a e d t a 2 01 2 . o r g 191 FRIDAY, MAY 25 FP627 AEROBIC EXERCISE IMPROVES SIGNS OF RESTLESS LEG SYNDROME IN END STAGE RENAL DISEASE PATIENTS SUFFERING CHRONIC HEMODIALYSIS Mojgan Mortazavi | Babak Vahdatpour | Shahrzad Shahidi | Aida Ghasempour| Diana Taheri | Shahaboddin Dolatkhah | Afsoon Emami Naieni | Maryam Ghassami Isfahan, Iran 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FP634 BIOCHEMICAL VARIABLES AND SURVIVAL IN PATIENTS WITH TYPE 1 DIABETES ON RENAL REPLACEMENT THERAPY Jaakko Helve | Mikko Haapio | Per-Henrik Groop | Carola Grönhagen-Riska| Patrik Finne Helsinki Univ Hosp, Dept Medicine, Helsinki, Finland | Helsinki Univ Central Hosp, Div Nephrology, Helsinki, Finland | Finnish Registry for Kidney Diseases, Helsinki, Finland FP635 PREDIALYTIC MEDICATION AND SURVIVAL IN PATIENTS WITH TYPE 1 DIABETES ON RENAL REPLACEMENT THERAPY Jaakko Helve | Mikko Haapio | Reijo Sund | Per-Henrik Groop | Carola Grönhagen-Riska | Patrik Finne Helsinki Univ Hosp, Dept Medicine, Helsinki, Finland | Helsinki Univ Central Hosp, Div Nephrology, Helsinki, Finland | National Inst Health and Welfare (THL), Serv Systems Res, Helsinki, Finland | Finnish Registry Kidney Diseases, Helsinki, Finland FP636 PSYCHOLOGICAL AND EXERCISE INTERVENTION IN DIALYSIS STUDY Michael Cai | Sanjeev Baweja | Amy Clements | Annette Kent | Rachel Reilly | Nicholas Taylor | Stephen Holt | Lawrence McMahon Eastern Health, Melbourne, Australia | Northern Hosp | Monash Univ | Eastern Health FP637 HIGHER INTERDIALYTIC WEIGHT GAIN BUT ALSO ITS DECLINES ARE ASSOCIATED WITH POORER OUTCOMES IN INCIDENT HEMODIALYSIS PATIENTS Len A Usvyat | Mary Carter | Frank M. van der Sande | Jeroen Kooman | Jochen Raimann | Nathan W Levin | Peter Kotanko Renal Res Inst, New York, USA | Sustainable Kidney Care Foundation, New York, USA | Maastricht Univ Hosp FP638 INCREASES IN NEUTROPHIL-TO-LYMPHOCYTE RATIO ARE ASSOCIATED WITH POORER OUTCOMES IN INCIDENT HEMODIALYSIS PATIENTS Len A Usvyat | Rakesh Malhotra | Georges Ouellet | E. Lars Penne | Jochen Raimann | Stephan Thijssen | Nathan W Levin | Peter Kotanko Renal Res Inst, New York, USA | Renal Res Inst, Beth Israel Medical Center | Hosp Maisonneuve-Rosemont | VU Medical Center FP639 PREDICTORS OF HEMODIALYSIS PATIENT OUTCOMES IN THE FIRST YEAR: RESULTS FROM AN INTERNATIONAL STUDY Michael Etter | Adam Tashman | Adrian Guinsburg | Aileen Grassmann | claudia barth | Cristina Marelli | Daniele Marcelli | Frank M. van der Sande | Gero von Gersdorff | Inga Bayh | Jeroen Kooman | Laura Scatizzi | Maggie Lam | Mathias Schaller | Stephan Thijssen | Ted Toffelmire | Yuedong Wang | Penny Sheppard | Len A Usvyat | Nathan W Levin | Peter Kotanko Fresenius Medical Care Asia Pacific | Renal Res Inst, New York, New York, USA| Fresenius Medical Care Latin America | Fresenius Medical Care Europe | Curatorium Dialysis and Kidney Transpl (KfH) | Maastricht Univ Hosp | Univ Hosp Cologne, Cologne, Germany | Fresenius Medical Care Canada | Univ California Santa Barbara FP640 INEQUALITIES IN TRANSPL WAITING LIST ACTIVATION FOR PATIENTS ON DIALYSIS IN THE MIGLIORDIALISI STUDY SAMPLE Luca Neri | Victor A. Andreucci | Lisa A. Rocca-Rey | Silvio V. Bertoli | Diego Brancaccio Dept Occupational and Environmental Health, Univ Milan | Fond Italiana Rene, onlus | Multimedica Hosp, Castellanza (VA) FP641 THE IMPACT OF A HOME NOCTURNAL HAEMODIALYSIS PROGRAM ON THE GROWTH OF FACILITY HAEMODIALYSIS: A RETROSPECTIVE RE- 192 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP642 ESSENTIAL POLYUNSATURATED FATTY ACIDS, INFLAMMATION AND MORTALITY IN DIALYSIS PATIENTS Xiaoyan Huang | Peter Stenvinkel | Abdul Rashid Qureshi | Ulf Riserus | Tommy Cederholm | Peter Barany | Olof Heimburger | Bengt Lindholm | Juan Jesus Carrero Karolinska Inst | Uppsala Univ | Div Renal Medicine and Baxter Novum, Dept Clinical Science, Intervention and Technology, Karolinska Inst, Stockholm, Sweden | Renal Medicine and Baxter Novum, Karolinska Inst FP643 SEXUAL DYSFUNCTION IN WOMEN WITH END-STAGE KIDNEY DISEASE REQUIRING HEMODIALYSIS: A MULTINATIONAL CROSS-SECTIONAL STUDY Mariacristina Vecchio | Suetonia Palmer | Giorgia De Berardis | Jonathan Craig| Giuseppe Lucisano | David Johnson | Fabio Pellegrini | Antonio Nicolucci | Michela Sciancalepore | Valeria Saglimbene | Letizia Gargano | Carmen Bonifati | Marinella Ruospo | Sankar D Navaneethan | Vincenzo Montinaro| Paul Stroumza | Marianna Zsom | Marietta Torok | Eduardo Celia | Ruben Gelfman| Anna Bednarek-Skublewska | Jan Dulawa | Giusi Graziano | Giorgio Gentile| Juan Nin Ferrari | Antonio Santoro | Annalisa Zucchelli | Giorgio Triolo | Stefano Maffei | Jörgen Hegbrant | Charlotta Wollheim | Salvatore De Cosmo | Valeria M Manfreda | Giovanni FM Strippoli Consorzio Mario Negri Sud, Italy | Dept Medicine, Univ Otago, Christchurch, New Zealand | Dept Clinical Pharmacology and Epidemiology, Mario Negri Sud Consortium | School Public Health, Univ Sydney, Australia | Dept Nephrology, Univ Queensland Princess Alexandra Hosp, Brisbane, Australia | Diaverum Medical-Scientific Office, Sweden | Dept Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH, USA | Dept Emergency and Organ Transpl, Univ Bari, Italy | Univ Perugia, Italy | Dept Nephrology, Dialysis, Hypertension, Policlinico S. Orsola-Malpighi, Bologna, Italy | SCDO Nefrology and Dialysis, Azienda Osp CTO/CRF/M. Adelaide, Torino | Unit Endocrinology, Scientific Inst Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy | Osp A Perrino, Brindisi, Italy FP644 EVOLUTION OF THE MANAGEMENT OF CHRONIC KIDNEY DISEASE IN FRANCE BETWEEN 1998 AND 2009: THE ORACLE STUDY Nicolas Janus | Vincent Launay-Vacher | Laurent Juillard | Adrien Rousset | François Butel | Sandrine Girardot-Seguin | Gilbert Deray | Thierry Hannedouche | Myriam Isnard | Yvon Berland | Philippe Vanhille | Jean-Paul Ortiz| Gérard Janin | Nicoud | Malik Touam | Elfie Bruce | Laurence Rouillon | Maurice Laville Serv ICAR, Nephrology Dept, Pitie-Salpetriere Hosp, Paris, France | Nephrology Dept, Edouard Herriot Hosp, Lyon, France | Roche Pharma, Boulogne-Billancourt, France | Nephrology Dept, Pitie-Salpetriere Hosp, Paris, France | Nephrology Dept, Hop Univ Strasbourg, Strasbourg, France | Nephrology Dept, AURA Auvergne, Chamalieres, France | Nephrology Dept, Conception Hosp, Marseille, France | Nephrology Dept, Valenciennes Hosp, Valenciennes, France| Nephrology Dept, Saint-Roch Private Hosp, Cabestany, France | Nephrology Dept, Chanaux Hosp, Mâcon, France | Nephrology Dept, Pays du Mont-Blanc Hosp, Chamonix, France | Nephrology, AURA Paris, Paris, France FP645 THE COURSE OF RENAL DISEASE IN DIABETIC PATIENTS IN FRANCE THE ORACLE STUDY Nicolas Janus | Laurent Juillard | Adrien Rousset | François Butel | Sandrine Girardot-Seguin | Gilbert Deray | Thierry Hannedouche | Myriam Isnard| Yvon Berland | Philippe Vanhille | Jean-Paul Ortiz | Gérard Janin | Philippe Nicoud | Malik Touam | Bruce | Laurence Rouillon | Maurice Laville Pitié-Salpêtrière Hosp, Paris, France | Nephrology Dept, Edouard Herriot Hosp, Lyon, France | Roche Pharma, Boulogne-Billancourt, France | Serv ICAR, Nephrology Dept, Pitie-Salpetriere Hosp, Paris, France | Nephrology Dept, Hôp Univ Strasbourg, Strasbourg, France | Nephrology Dept, AURA-Auvergne, Chamalières, France | Nephrology Dept, Conception Hosp, Marseille, France | w w w. e r a e d t a 2 01 2 . o r g 193 FRIDAY, MAY 25 VIEW (JANUARY 2000 – DECEMBER 2011) Alwie Tjipto | Rosemary Simmonds | John Agar Geelong Hosp, Barwon Health 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 Nephrology Dept, Valenciennes Hosp, Valenciennes, France | Nephrology Dept, Saint-Roch Pivate Hosp, Cabestany, France | Nephrology Dept, Chanaux Hosp, Macon, France | Nephrology Dept, Pays du Mont-Blanc Hosp, Chamonix, France| Nephrology Dept, AURA-Paris, Paris, France FP646 THE COURSE OF CHRONIC KIDNEY DISEASE IN FRANCE RESULTS OF THE ORACLE STUDY Nicolas Janus | Vincent Launay-Vacher | Laurent Juillard | Adrien Rousset | François Butel | Sandrine Girardot-Seguin | Gilbert Deray | Thierry Hannedouche | Myriam Isnard | Yvon Berland | Philippe Vanhille | Jean-Paul Ortiz | Gérard Janin | Philippe Nicoud | Malik Touam | Elfie Bruce | Laurence Rouillon| Maurice Laville Serv ICAR, Nephrology Dept, Pitie-Salpetriere Hosp, Paris, France | Nephrology Dept, Edouard Herriot Hosp, Lyon, France | Roche Pharma, Boulogne-Billancourt, France | Nephrology Dept, Hôp Univ Strasbourg, Strasbourg, France| Nephrology Dept, AURA-Auvergne, Chamalières, France | Nephrology Dept, Conception Hosp, Marseille, France | Nephrology Dept, Valenciennes Hosp, Valenciennes, France | Nephrology Dept, Saint-Roch Private Hosp, Cabestany| Nephrology Dept, Chanaux Hosp, Mâcon, France | Nephrology Dept, Pays du Mont-Blanc Hosp, Chamonix, France | Nephrology Dept, AURA-Paris, Paris, France FP647 DIALYSIS MODALITY AND SOCIO-ECONOMIC STATUS IN AUSTRALIA Blair Grace | Philip Clayton | Alan Cass | Stephen McDonald ANZDATA Registry, Adelaide, Australia | Australia and New Zealand Dialysis and Transpl Registry | George Inst Global Health FP648 WHEN 'NO' DOESNT MEAN NO. PATIENTS WHO OPT FOR CONSERVATIVE MANAGEMENT AND THEN CHANGE THEIR MIND REGARDING DIALYSIS TREATMENT- EXPERIENCE OF A SINGLE UK CENTRE Jyoti Baharani Birmingham Heartlands Hosp FP649 DIALYSIS SPECIALISTS ACHIEVED HIGHER GUIDELINE ADHERENCE RATE COMPARED WITH NON-SPECIALISTS Yoshiyuki Furumatsu | Tetsuya Kitamura | Naohiko Fujii | Satoshi Ogata | Hidetomo Nakamoto | Kunitoshi Iseki | Yoshiharu Tsubakihara Fujiidera Keijinkai Clinic | Hyogo Prefectural Nishinomiya Hosp | Hiroshima International Univ | Saitama Medical School | Univ Hosp Ryukyus | Depts Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan FP650 OUTCOMES OF DEMENTIA AMONG DIALYSIS PATIENTS: A NATIONWIDE POPULATION-BASED STUDY IN TAIWAN Chih-Chiang Chien | Jhi-Joung Wang | Jyh-Chang Hwang | Hsien-Yi Wang | Wei-Chih Kan Depts Nephrology, Chi-Mei Medical Center FP651 DOES HIGH SENSITIVITY TROPONIN T MODIFY LONG TERM RISK STRATIFICATION IN DIALYSIS PATIENTS? Nils Kuster | Laure Patrier | Anne-Sophie Bargnoux | Marion Morena | AnneMarie Dupuy | Stéphanie Badiou | Bernard Canaud | Jean-Paul Cristol Lab Biochimie, CHRU Montpellier | Serv Néphrologie-Hémodialyse et Soins Intensifs, CHRU Montpellier FP652 PERCEPTIVE OBSTACLES TO PERITONEAL DIALYSIS IMPLEMENTATION: AN OPINION POLL AMONG THE FRENCH-SPEAKING BELGIAN NEPHROLOGISTS Jean-Marc Desmet | Vasco Fernandes | Frédéric Collart | Nathalie Spinogatti | Jean-Michel Pochet | Max Dratwa | Eric Goffin | Joëlle Nortier Vésale Hosp, Montigny-le-Tilleul | Curry Cabral Hosp | Brugmann Hosp, Brussels | Centre Hosp Charleroi, Charleroi | Clinique St Elisabeth, Namur | Cliniques Univ St Luc, Brussels | Erasme Hosp, Brussels, Belgium 194 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP654 IMPACT OF A NEW DIALYSIS UNIT DEVELOPMENT ON PATIENTS REFERRING TO HOSPITAL HEMODIALYSIS IN FRANCE Sens Florence | Schott Anne-Marie | Labeeuw Michel | Colin Cyrille | Villar Emmanuel Hospices Civils Lyon, Centre Hosp Lyon-Sud, Dept Nephrology and Renal Transpl, Pierre Benite, France | Hospices Civils Lyon, Pole IMER, EAM 4128, Lyon, France FP655 RENAL REPLACEMENT TERAPY IN ALBANIA Ariana Strakosha | Nevi Pasko | Sulejman Kodra | Nestor Thereska Univ Hosp Center Mother Tereza | Univ Hosp Center Mother Tereza Dept Clinical Biology FP656 CROSS SECTIONAL OBSERVATIONAL STUDY OF SYMPTOM BURDEN AND HEALTH-RELATED QUALITY OF LIFE IN PREVALENT HAEMODIALYSIS PATIENTS IN IRELAND Aoife Lowney | Eanna Lowney | Rosie Grant | Marie Murphy | Liam Casserly| Tony O' Brien | William D Plant Cork Univ Hosp | Kerry General Hosp | Marymount Univ Hospice | Midwestern Regional Hosp FP657 RELATIONSHIP BETWEEN INFLAMMATION AND COGNITIVE PSYCHOMOTOR FUNCTION IN DIALYSIS PATIENTS Josipa Radic | Dragan Ljutic | Vedran Kovacic | Mislav Radic | Katarina DodigCurkovic | Milenka Sain | Ivo Jelicic Univ Hosp Split, Split, Croatia | Univ Hosp Osijek, Osijek, Croatia FP658 BONE TURNOVER MARKERS ASSOCIATE MORE STRONGLY WITH CARDIOVASCULAR MORTALITY THAN ALL-CAUSE DEATH IN MAINTENANCE HEMODIALYSIS PATIENTS Naohiko Fujii | Takayuki Hamano | Chikako Nakano | Sayoko Yonemoto | Ayako Okuno | Masaya Katayama | Yoshitaka Isaka Hyogo Prefectural Nishinomiya Hosp | Center Clinical Epidemiology and Biostatistics, Univ Pennsylvania Perelman School Medicine, Pennsylvania, USA | Dept Geriatric Medicine and Nephrology, Osaka Univ Grad School Medicine, Osaka, Japan | Rokushima Second Clinic, Hyogo, Japan FP659 OUTCOME PREDICTION OF DIFFERENT DIALYSIS MODALITIES IN ITALY: APPLICATION OF A MULTISTATE MODEL Maurizio Nordio | Aurelio Limido | Maurizio Postorino | Michele Nichelatti P. Cosma Hosp, Camposampiero, Italy | Nephrology and Dialysis Unit, Azienda Osp Fatebenefratelli e Oftalmico | CNR-IBIM | Serv Biostatistics, Niguarda Ca’ Granda Hosp – Milan, Italy FP660 STUDY OF VIRAL LOAD DYNAMICS IN CKD 5D PATIENTS WITH HEPATITIS C VIRUS Miroslava Khil | Irina Dudar | Vladimir Khil | Irina Shifris Inst Epidemiology and Infectious Diseases AMS of Ukraine, Kyiv, Ukraine | Inst Nephrology AMS of Ukraine, Kyiv, Ukraine | Main Military Hosp Ukraine, Kyiv, Ukraine FP661 EVALUATION OF AN ISOLATION PROGRAM OF HEPATITIS C VIRUS IN- w w w. e r a e d t a 2 01 2 . o r g 195 FRIDAY, MAY 25 FP653 NEPHROLOGY REFERRAL AND DIALYSIS INITIATION – STILL ROOM FOR IMPROVEMENT Diana Silvia Zilisteanu | Mihai Voiculescu | Elena Rusu | Camelia Achim | Raluca Bobeica | Sonia Balanica | Teodora Atasie Fundeni Center Internal Medicine and Nephrology, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania 49th ERA-EDTA CONGRESS P O S T E R S FECTED HEMODIALYSIS PATIENTS IN SOME HEMODIALYSIS CENTERS IN EGYPT Mohamed Momtaz | Amin Roshdy Soliman | Mona I El lawindi Cairo Univ, Cairo, Egypt FRIDAY, MAY 25 FP662 DECREASING PREVALENCE OF HEPATITIS C VIRUS INFECTION IN HEMODIALYSIS PATIENTS: FOLLOWING KDIGO GUIDALINES Pavlina Dzekova-Vidimliski | Svetlana Pavleska-Kuzmanovska | Lada Trajceska | Igor Nikolov | Gjulsen Selim | Saso Gelev | Vili Amitov | Aleksandar Sikole Univ Clinic Nephrology, Skopje, FYR Macedonia FP663 DECREASED SERUM ADRENAL ANDROGEN DEHYDROEPIANDROSTERONE SULFATE AS AN INDEPENDENT PREDICTOR OF MORTALITY IN HEMODIALYSIS PATIENTS Tetsuo Shoji | Ryusuke Kakiya | Tomoshige Hayashi | Naoko Tatsumi-Shimomura | Yoshihiro Tsujimoto | Tsutomu Tabata | Hideaki Shima | Katsuhito Mori | Shinya Fukumoto | Hideki Tahara | Hidenori Koyama | Masanori Emoto | Eiji Ishimura | Yoshiki Nishizawa | Osaka City Univ Grad School Medicine, Osaka, Japan | Inoue Hosp 196 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France NUTRITION, INFLAMMATION AND OXIDATIVE STRESS - CKD 5D FP665 A RISE IN MARKERS OF INFLAMMATION PRECEEDS THE END OF LIFE IN DIALYSIS PATIENTS: A GLOBAL PERSPECTIVE Gero von Gersdorff | Mathias Schaller | Inga Bayh | Michael Etter | Aileen Grassmann | Adrian Guinsburg | Jeroen Kooman | Maggie Lam | Daniele Marcelli | Cristina Marelli | Laura Scatizzi | Adam Tashman | Stephan Thijssen| Ted Toffelmire | Len Usvyat | Frank van der Sande | Yuedong Wang | Nathan W. Levin | Claudia Barth | Peter Kotanko Univ Hosp Cologne, Cologne, Germany | Fresenius Medical Care, Bad Homburg, Germany | Fresenius Medical Care, Hong Kong | Fresenius Medical Care, Argentina | Univ Maastricht, Netherlands | Univ California, Santa Barbara, USA| Renal Res Inst, New York, USA | Fresenius Medical Care, Canada | KfH Curatorium for Dialysis and Kidney Transpl, Germany FP666 SPECIFIC OXIDATIVE DNA DAMAGE IN MAINTENANCE HAEMODIALYSIS PATIENTS TA Moffitt | F Hariton | M Devlin | PJ Garrett | MP Hannon-Fletcher Western Renal Serv, Derry/Londonderry, Northern Ireland | Univ Ulster, Coleraine, Northern Ireland FP667 SELENIUM SUPPLEMENTATION IMPROVES NUTRITIONAL STATUS IN HEMODIALYSIS PATIENTS: A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL Maryam Ekramzadeh | Zahra Sohrabi | Moosa Salehi | Mohammad Kazem Fallahzadeh | Maryam Ayatollahi | Bita Geramizadeh | Jafar Hassanzadeh | Mohammad Mahdi Sagheb Shiraz Univ Medical Sciences, Shiraz, Iran FP668 LOW SERUM OBESTATIN PREDICTS MORTALITY IN PREVALENT HEMODIALYSIS PATIENTS Ilia Beberashvili | Inna Sinuani | Ada Azar | Hadas Kadoshi | Gregory Shapiro| Leonid Feldman | Zhan Averbukh | Joshua Weissgarten Nephrology Dept, Assaf Harofeh Medical Center, Zerifin, Israel | Nutrition Dept, Assaf Harofeh Medical Center, Zerifin, Israel FP669 N-TERMINAL PROBRAIN NATRIURETIC PEPTIDE - MARKER OF OVERHYDRATION, MALNUTRITION, INFLAMMATION OR ADIPONECTIN IN HEMODIALYSIS PATIENTS? Yasuhiro Abe | Maho Watanabe | Kenji Ito | Yoshie Sasatomi | Satoru Ogahara| Hitoshi Nakashima | Takao Saito Div Nephrology and Rheumatology, Dept Internal Medicine, Fukuoka Univ, Fukuoka, Japan FP670 KEY PARAMETERS DISCRIMINATING DIABETIC FROM NON-DIABETIC HEMODIALYSIS PATIENTS Sabine Witt | Hans Jürgen Guth | Horst Skarabis | Rudolf Kunze | Joerg Vienken Biometc GmbH | Praxis für Nieren- und Hochdruckkrankheiten | Statistical Consultant | Biomed Office Berlin Campus MDC | Fresenius Medical Care, Bad Homburg, Germany w w w. e r a e d t a 2 01 2 . o r g 197 FRIDAY, MAY 25 FP664 INCREASES IN SERUM CREATININE LEVELS ARE ASSOCIATED WITH IMPROVED PATIENT OUTCOMES IN CHRONIC HEMODIALYSIS PATIENTS WITH NO RESIDUAL RENAL FUNCTION Len A Usvyat | Jochen Raimann | Stephan Thijssen | Frank M. van der Sande | Jeroen Kooman | Nathan W Levin | Peter Kotanko Renal Res Inst, New York, USA | Maastricht Univ Hosp 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FP671 LOSS OF PLANT POLYPHENOLS AND THEIR METABOLITES PRESENT IN BLOOD, DURING SINGLE HAEMODIALYSIS SESSION IN PATIENTS WITH END-STAGE CHRONIC KIDNEY DISEASE Piotr Nowak | Radoslaw Wilk | Beata Mamelka | Anna Prymont-Przyminska| Anna Zwolinska | Agata Sarniak | Anna Wlodarczyk | Jacek Rysz | Dariusz Nowak Dept Nephrology, Hypertension and Family Medicine, Medical Univ Lodz, Lodz, Poland | Dept Lab Diagnostics and Clinical Biochemistry, Medical Univ Lodz, Lodz, Poland| Dept Clinical Physiology, Medical Univ Lodz, Lodz, Poland| WAM Univ Hosp FP672 NUTRITION IN RELATION TO ADVANCED GLYCATION END PRODUCTS IN DIALYSIS PATIENTS Lada Trajceska | Pavlina Dzekova-Vidimliski | Saso Gelev | Stefan Arsov | Aleksandar Sikole Univ Clinic Nephrology-Skopje, Macedonia FP673 ROLE OF DIALYSIS MODALITY AND MEMBRANES ON SELENIUM STATUS IN CHRONIC HEMODIALYSIS Makrouhi Sonikian | Artemisia Dona | Iakovos Skarakis | Polyxeni Metaxaki| Christos Chiotis | Ioannis Papoutsis | Aphroditi Karaitianou | Chara Spiliopoulou A. Fleming General Hosp | Forensic Medicine and Toxicology, Medical School, Kapodistriakon Univ, Athens, Greece | Chemistry School, Kapodistriakon Univ, Athens, Greece | 101 Renal Unit, Medical Center, Athens, Greece | Biochemistry Dept, A. Fleming General Hosp, Athens, Greece FP674 DECLINE IN ALBUMIN LEVELS IN HEMODIALYSIS PATIENTS IS ASSOCIATED WITH POOR OUTCOMES: A GLOBAL PERSPECTIVE Daniele Marcelli | Adam Tashman | Adrian Guinsburg | Aileen Grassmann| Claudia Barth | Cristina Marelli | Frank M. van der Sande | Gero von Gersdorff| Inga Bayh | Jeroen Kooman | Laura Scatizzi | Maggie Lam | Mathias Schaller | Michael Etter | Stephan Thijssen | Ted Toffelmire | Yuedong Wang | Len A Usvyat | Peter Kotanko | Nathan W Levin Fresenius Medical Care Europe | Renal Res Inst, New York, New York, USA | Fresenius Medical Care Latin America | Curatorium Dialysis and Kidney Transpl (KfH) | Maastricht Univ Hosp | Univ Hosp Cologne, Cologne, Germany | Fresenius Medical Care Asia Pacific | Fresenius Medical Care Canada | Univ California Santa Barbara FP675 PIOGLITAZONE IMPROVES INSULIN SENSITIVITY, REDUCES VISCERAL FAT AND INFLAMMATION, AND STIMULATES LIPOLYSIS IN NON DIABETIC DIALYZED PATIENTS Daniel Teta | Luc Tappy | Nicolas Theumann | Georges Halabi | Thierry Gauthier | Claudine Mathieu | Sylvie Tremblay | Pauline Coti | Michel Burnier | Anne Zanchi Serv Nephrology, Univ Hosp (CHUV), Lausanne, Switzerland | Dept Physiology, Univ Lausanne, Switzerland | Dept Radiology, Univ Hosp (CHUV), Lausanne, Switzerland | Dept Endocrinology and Metabolism, Univ Hosp (CHUV), Lausanne, Switzerland FP676 IS OXIDATIVE STRESS RELATED TO WHITE MATTER LESIONS IN CHRONIC HAEMODIALYSIS PATIENTS? Alberto Martinez Vea | Carmen Cabre | Diasol Villa | Monica Muñoz | Joan Pere Vives | Mercedes Arruche | Jordi Soler | Maria Teresa Compte | Josep Aguilera | Marta Romeu | Montse Giralt Hosp Univ Tarragona Joan XXIII, Tarragona, Spain | Pharmacology Unit, Dept Basic Sciences, Univ Rovira i Virgili, Tarragona, Spain | Reus Medical, Reus, Tarragona, Spain | Hosp Jesus, Tortosa, Tarragona, Spain | Centre Dialisi, Hosp Llevant, Tarragona, Spain 198 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP678 RELATIONSHIP OF NEUTROPHIL-TO-LYMPHOCYTE RATIO AND SERUM ALBUMIN LEVELS WITH C-REACTIVE PROTEIN IN HEMODIALYSIS PATIENTS: RESULTS FROM AN INTERNATIONAL STUDY Rakesh Malhotra | Len Usvyat | Samer R. Abbas | Stephan Thjissen | Mary Carter | Micahel Etter | Adam Tashman | Adrian Guinsburg | Aileen Grassmann| Claudia Barth | Cristina Marelli | Frank Van der Sande | Gero von Gersdorff| Inga Bayh | Jeroen Kooman | Laura Scatizzi | Maggie Lam | Mathias Schaller| Ted Toffelmire | Yuedong Wang | Daniele Marcelli | Nathan Levin | Peter Kotanko Renal Res Inst, Beth Israel Medical Center, New York, NY, USA | FMC Asia Pacific, Hong Kong, Hong Kong | FMC Latin America, Buenos Aires, Argentina| KfH Dialysis Centre Koeln-Lindenthal, Bad Homburg, Germany | Maastricht Univ Medical Center, Maastricht, Netherlands | Univ Cologne Medical Center, Cologne, Germany | FMC North America, Waltham, MA | Univ California-Santa Barbara, Santa Barbara, USA | FMC Europe, Bad Homburg, Germany FP679 EFFECT OF LOW- AND HIGH-FLUX MEMBRANE HEMODIALYSIS ON THE VITAMIN A TRANSPORT COMPLEX IN PLASMA OF PATIENTS WITH ENDSTAGE RENAL FAILURE Raila Jens | Martin Tepel | Espe Katharina | Henze Andrea | Frey Simone | Schweigert Florian Inst Nutritional Science Potsdam Germany FP680 ORAL HEALTH IN HAEMODIALYSIS PATIENTS AND IN NORMAL SUBJECTS – IS THERE A DIFFERENCE? Oana Slusanschi | Liliana Garneata | Ruxandra Moraru | Elena Preoteasa | Carmen Barbulescu | Caterina Santimbrean | Christian Klein | Diana Dragomir | Gabriel Mircescu Fac Dental Medicine, Dept Preventive Dentistry, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania | Carol Davila Univ Medicine, Dept Nephrology and Internal Medicine, Bucharest, Romania | Queen Mary Univ London, Barts& London School Medicine and Dentistry, Inst Dentistry | Fac Dental Medicine, Dept Mobile Prosthetics, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania | Dr Carol Davila Fresenius NephroCare Dialysis Center, Bucharest, Romania | Dr Carol Davila Teaching Hosp Nephrology, Bucharest, Romania | Fac Medicine, Dept Nephrology and Internal Medicine, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania FP681 GASTROINTESTINAL-MEDIATED GLUCOSE DISPOSAL, INCRETIN EFFECT AND GLUCAGON RESPONSES IN PATIENTS WITH END-STAGE RENAL DISEASE Thomas Idorn | Filip Knop | Jens Juul Holst | Mads Hornum | Bo Feldt-Rasmussen Dept Nephrology, Copenhagen Univ Hosp, RigsHosp, Copenhagen, Denmark| Gentofte Hosp, Hellerup, Denmark | Dept Biomedical Sciences, Panum Inst, Univ Copenhagen FP682 VASCULAR CALCIFICATION ON PLAIN RADIOGRAPHS IS ASSOCIATED WITH CAROTID INTIMA MEDIA THICKNESS, MALNUTRITION AND CARDIOVASCULAR EVENTS IN DIALYSIS PATIENTS w w w. e r a e d t a 2 01 2 . o r g 199 FRIDAY, MAY 25 FP677 SPANISH MULTICENTRIC STUDY ABOUT NUTRITION-INFLAMATION WITH MID DILUTION (ENIMID STUDY): PRELIMINARY RESULTS Guillermina Barril | S Anaya | C Vozmediano | AO Celayeta | R Novillo | V Bernal | I Beiret | E Huarte | J Martin | H Santana | G Torres | F Sousa | R Sanchez | A Lopez-Montes | F Tornero | J Uson | M Pousa | M Giorgi | B Rdez Cubillo Hosp U. Princesa | H. Ciudad Real | Hosp Donostia, San Sebastian | H. San Pedro Alcantara, Caceres | H. San Millan, Logroño | Hosp Sonsoles, Avila | H. Virgen del Camino, Zamora | H. General Yague, Burgos | H. Rio Carrión, Palencia | Hosp Segovia | C.H.U. Albacete | Hosp Sureste, Arganda del Rey | Hosp Virgen de la Luz, Cuenca | Hosp Costa, Burela, Lugo | Hosp Clinico, Madrid 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 Young Ki Son | Won Suk An | Seong Eun Kim | Ki Hyun Kim Dong-A Univ, Busan FP683 ORAL HEALTH, INFLAMMATION AND MALNUTRITION IN HAEMODIALYSIS PATIENTS – IS THERE A LINK? Liliana Garneata | Oana Slusanschi | Elena Preoteasa | Carmen Barbulescu | Caterina Santimbrean | Christian Klein | Gabriel Mircescu Carol Davila Univ Medicine, Dept Nephrology and Internal Medicine, Bucharest, Romania | Fac Dental Medicine, Dept Preventive Dentistry, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania | Fac Dental Medicine, Dept Mobile Prosthetics, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania| Dr Carol Davila Fresenius NephroCare Dialysis Center, Bucharest, Romania FP684 EFFECT OF HEMODIAFILTRATION WITH ENDOGENOUS REINFUSION (HFR) ON CHRONIC INFLAMMATION AND UNDER-NUTRITION IN MAINTENANCE HEMODIALYSIS (HD) PATIENTS: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY Silvio Borrelli | Roberto Minutolo | Luca De Nicola | Giuseppe Conte | Walter De Simone | Bruno Zito | Pasquale Guastaferro | Filippo Nigro | Antonio Bassi| Luigi Leone | Olga Credendino | Raffaele Genualdo | Maria Capuano | Giuseppe Iulianiello | Maria Rita Auricchio Second Univ Naples, Naples, Italy | G.Moscati Hosp Avellino Italy | G. Criscuoli Hosp, S. Angelo dei Lombardi (AV) Italy | County Hosp, Nocera Inferiore (SA) Italy | A. Cardarelli Hosp, Naples Italy | Trinità dei Pellegrini Hosp, Naples Italy | Melorio Hosp, S. Felice a Cancello (CE) Italy | Osp Riuniti Area Stabiese Hosp, Castellammare di Stabia (NA) Italy FP685 LONG TERM CLINICAL AND NUTRITIONAL INFLUENCE OF ORAL NUTRITIONAL SUPPLEMENTATION IN MAINTENANCE HEMODIALYSIS PATIENTS Siren Sezer | Zeynep Bal | Emre Tutal | Mehtap Erkmen Uyar | F. Nurhan Ozdemir Acar Dept Nephrology, Baskent Univ, Ankara, Turkey FP686 PON1 ACTIVITY IN HEMODIALYSIS PATIENTS: GENETIC AND NON-GENETIC FACTORS Sandra Ribeiro | M. Sameiro Faria | F. Melo | J. Sereno | I. Freitas | M. Mendonça | H. Nascimento | J. Fernandes | P. Rocha-Pereira | V. Miranda | D. Mendonça | A. Quintanilha | L. Belo | E. Costa | F. Reis | A. Santos-Silva Fac Farmácia, Univ Porto; Inst Biologia Molecular e Celular (IBMC)| FMC, Dinefro – Diálises e Nefrologia, SA; Inst Ciências Biomédicas Abel Salazar (ICBAS), Univ Porto | Lab Farmacologia e Terapêutica Experimental, IBILI, Fac Medicina, Univ Coimbra | Unidade Investigação, Hosp Central Funchal; Lab Genética Humana, Campus Univ Penteada, Madeira | Centro Investigação Ciências Saúde, Univ Beira Interior, Covilhã | Inst Biologia Molecular e Celular (IBMC), Univ do Porto; Inst Ciências Saúde Univ Católica Portuguesa, Porto FP687 SCALING BODY COMPOSITION TO HEIGHT AND WEIGHT: DIFFERENCES BETWEEN BODY MASS INDEX (BMI) AND BODY SURFACE AREA (BSA) IN HEMODIALYSIS (HD) PATIENTS Rodolfo Valtuille | Maria Elisa Casos | Elmer Andres Fernandez FMC Burzaco | Univ Catolica Cordoba 200 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP688 A RANDOMIZED OPEN-LABEL CLINICAL TRIAL EXAMINING THE EFFECT OF DENOSUMAB ON THE PREVENTION OF 1ST-YEAR BONE MINERAL DENSITY LOSS AFTER RENAL TRANSPLANTATION (POSTOP study; NCT01377467) Marco Bonani | Jens Brockmann | Clemens David Cohen | Thomas Fehr | Antonio Nocito | Marc Schiesser | Andreas L. Serra | Markus Blum | Marian Struker| Diana F. Frey | Rudolf P. Wüthrich Div Visceral and Transpl Surgery, Univ Hosp Zurich, Switzerland | Div Nephrology, Univ Hosp Zurich, Switzerland | Dept Rheumatology, Univ Hosp Zurich, Switzerland FP689 ASSOCIATIONS BETWEEN MMP-2 GENE POLYMORPHISMS AND POSTTRANSPLANTATIONAL DIABETES MELLITUS IN KOREAN RENAL ALLOGRAFT RECIPIENTS Yang Wook Kim | Seok Ju Park | Tae Hee Kim | Yeong-Hoon Kim | Sun Woo Kang Inje Univ, Busan, Korea FP690 PRIMARY RENAL DISEASE AND SURVIVAL AFTER TRANSPLANT FAILURE – IS THERE A RELATIONSHIP? AN ANALYSIS OF UK RENAL REGISTRY DATA Lynsey Webb | Anna Casula | Charlie Tomson | Yoav Ben-Shlomo UK Renal Registry, Bristol, UK | Southmead Hosp, Bristol, UK | School Social and Community Medicine, Bristol Univ, UK FP691 THE CLINICAL CHARACTERISTICS OF PATIENTS STARTING DIALYSIS AFTER RENAL TRANSPLANT FAILURE IN THE UK 2000-2008: A UK RENAL REGISTRY ANALYSIS Lynsey Webb | Anna Casula | Yoav Ben-Shlomo | Charlie Tomson UK Renal Registry, Bristol, UK | School Social and Community Medicine, Bristol Univ, UK | Southmead Hosp, Bristol, UK FP692 POST-TRANSPLANT GLOMERULONEPHRITIS IN LIVE-DONOR RENAL TRANSPLANT RECIPIENTS: CLINICAL COURSE AND RISK FACTORS Hany Mansour | Ahmed Akl | Ehab Wafa | Mohamed El Shahawy Hamed Al Essa OTC, Kuwait | Urology and Nephrology Center, Mansoura, Egypt | Benha Fac Medicine, Benha, Egypt FP693 PRE-TRANSPLANT HEPATITIS B SURFACE ANTIBODY (HBsAb) IS ASSOCIATED WITH PREVALENT AND INCIDENT HLA ANTIBODIES, HUMORAL REJECTION AND GRAFT LOSS Ramiro Palma | Suda Swaminathan | Ashley Bruce Irish San Cecilio Clinical Hosp, Granada, Spain| Royal Perth Hosp, Perth, Australia FP694 THE NEPHRON UNDERDOSING AS A RISK FACTOR FOR AN IMPAIRED EARLY FUNCTION AND AN INCREASED GRAFT LOSS IN THE LONGTERM FOLLOW-UP PERIOD Aureliusz Kolonko | Jerzy Chudek | Andrzej Więcek Dept Patophisiology, Dept Nephrology, Endocrinology and Metabolic Diseases, Medical Univ Silesia, Katowice, Poland FP695 RECIPIENT’S SMOKING HABITS AND DEATH-CENSORED RENAL ALLOGRAFT SURVIVAL Yves Vanrenterghem | Dirk Kuypers | De Vusser Katrien | Pieter Evenepoel | Kathleen Claes | Bert Bammens | Björn Meijers | Maarten Naesens Univ Hosp, Leuven, Belgium | Univ Hosp Gasthuisberg, Leuven | KULeuven, Nephrology w w w. e r a e d t a 2 01 2 . o r g 201 FRIDAY, MAY 25 TRANSPLANTATION - CLINICAL I 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 FP696 LONG-TERM GRAFT FUNCTION AND SURVIVAL IN KIDNEY TRANSPLANT RECIPIENTS DEPEND ON THE CONTINUITY OF DOPPLER SPECTRUM MEASURED IN THE EARLY PERIOD AFTER TRANSPLANTATION Aureliusz Kolonko | Jerzy Chudek | Andrzej Więcek Dept Patophisiology, Dept Nephrology, Endocrinology and Metabolic Diseases, Medical Univ Silesia, Katowice, Poland FP697 RISK FACTORS FOR DEATH WITH A FUNCTIONING GRAFT IN RENAL TRANSPLANT PATIENTS FROM HONG KONG RENAL REGISTRY DATA Stanley Lo | Ching-kit Chan | David Yong | Ping-nam Wong | Tze-hoi Kwan| Yuk-lun Cheng | Ka-shun Fung | Bo-ying Choy | Ka-foon Chau | Chi-bong Leung | James Ebben | Jiannong Liu | Shu-cheng Chen | Allan Collins | YiuWing Ho Dept Medicine, Pamela Youde Nethersole Eastern Hosp | UCH, Hong Kong | CMC, Hong Kong | KWH, Hong Kong | TMH, Hong Kong | AHNH, Hong Kong | PMH, Hong Kong | QMH, Hong Kong | QEH, Hong Kong | PWH, Hong Kong | USRDS, USA FP698 NON-HEART-BEATING DONATION AFTER 20-MINUTE NO-TOUCH PERIOD RESULTS WITH FASTER RECOVERY USING MACHINE-PERFUSED KIDNEY GRAFTS Massimo Abelli | Elena Ticozzelli | Benedetta Maiga | Antonjacopo Ferrario di Torvajana | Alessandro Patané | Paolo Albrizio | Marilena Gregorini | Carmelo Libetta | Teresa Rampino | Paolo Albrizio | Paolo Geraci | Antonio Dal Canton Fond IRCCS Policlinico San Matteo | Univ Pavia FP699 DUAL KIDNEY TRANSPLANTATION WITHOUT PREIMPLANTATION BIOPSY: A SINGLE CENTER EXPERIENCE Marie-Therese Rotter | Johannes Jacobi | Katharina Pressmar | Kerstin Amann| Kai-Uwe Eckardt | Alexander Weidemann Medical Clinic 4 - Nephrology and Hypertension, Erlangen, Germany | Inst Nephropathology, Erlangen, Germany FP700 MEASUREMENT OF INTERFERON-GAMMA INDUCED PROTEIN 10 IN SERUM: A RISK ASSESSMENT APPROACH FOR BKV-ASSOCIATED NEPHROPATHY Karin Müller | Maik Stein | Claudia Diezemann | Anett Sefrin | Nina Babel | Petra Reinke | Thomas Schachtner Charité Univ Medicine Berlin, Campus Virchow Clinic, Berlin, Germany FP701 POLYOMAVIRUS BK DETECTION AND SIGNIFICANCE IN RENAL TRANSPLANT PATIENTS WITH LUPUS NEPHRITIS AS UNDERLYING DISEASE Cristina Costa | Giovanni Antonio Touscoz | Francesca Sidoti | Franca Sinesi| Samantha Mantovani | Salvatore Simeone | Cinzia Balloco | Elsa Piasentin Alessio | Maria Messina | Giuseppe Segoloni | Rossana Cavallo Univ Hosp San Giovanni Battista, Turin, Italy FP702 FUNCTIONAL ASSESSMENT OF RENAL ALLOGRAFT BY DIFFUSION WEIGHTED MR IMAGING R.K Sharma | R.K. Gupta | Amit Gupta | Narayan Prasad | Dharmendra Bhadhuria |K.J. Suresh Sanjay Gandhi Post Grad Inst Medical Sciences FP703 CHOLECALCIFEROL OPTIMAL TREATMENT DURING THE FIRST YEAR AFTER RENAL TRANSPLANTATION DETERMINED BY A POPULATION PHARMACOKINETIC MODEL Sihem Benaboud | Dominqiue Prié | Eric Thervet | Saik Urien | Christophe Legendre | Jean-Claude Souberbielle | Déborah Hirt | Gérard Friedlander | Jean-Marc Tréluyer | Marie Courbebaisse Univ Paris Desacrtes Sorbonne Paris Cité EA3620 | Serv Explorations Fonction- 202 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP704 PREVALENCE AND FACTORS ASSOCIATED WITH EARLY-ONSET ANAEMIA AFTER KIDNEY TRANSPLANTATION IN SPAIN: A MULTICENTER, OBSERVATIONAL AND RETROSPECTIVE STUDY Manuel Arias | Josep Campistol | Julio Pascual | Josep Mª Grinyó | Domingo Hernández | José Mª Morales | Luis Miguel Pallardó | Daniel Serón Hosp Univ Marqués Valdecilla, Santander, Spain | Hosp Clínic i Provincial, Barcelona, Spain | Hosp Mar, Barcelona, Spain | Ciutat Sanitaria i Univ de Bellvitge, L´Hosp de Llobregat (Barcelona), Spain | Hosp Regional Univ Carlos Haya, Málaga, Spain | Hosp 12 de Octubre, Madrid, Spain | Hosp Univ Dr. Peset, Valencia, Spain | Hosp General Vall d'Hebron, Barcelona, Spain FP705 IMPACT OF DONOR ACUTE RENAL FAILURE ON KIDNEY FUNCTION ONE YEAR AFTER CADAVERIC RENAL TRANSPLANTATION Lynne Senécal | Raymond Dandavino | Anne Boucher | Suzon Colette | Michel Vallée | Jean-Philippe Lafrance Hôp Maisonneuve-Rosemont FP706 THE EXPRESSION OF NITROTYROSINE IS ASSOCIATED WITH INTERSTITIAL FIBROSIS/TUBULAR ATROPHY (IF/TA) IN CHRONIC ALLOGRAFT NEPHROPATHY: A QUANTITATIVE STUDY BY IMMUNOHISTOCHEMISTRY (IHC) ANALYSIS Yu Tung-Min | Wu Min-Ju | Chen Cheng-Hsu | Cheng Chi-Hung | Shu KuoHsiung | Wen Mei-Chin Taichung Veterans General Hosp FP707 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY FOR TRANSPLANT RENAL ARTERY STENOSIS USING SINGLE OR MULTIPLE PROCEDURES: CLINICAL OUTCOMES FROM ONE CENTRE Shamindra Direkze | Maryam Khorsavi | Sam Stuart | Antony Goode | Gareth Jones Royal Free Hosp, London, UK FP708 NO EFFECT OF BILATERAL NEPHRECTOMY PRIOR TO KIDNEY TRANSPLANT ON THE RESISTIVE INDICES MEASURED IN THE KIDNEY GRAFT Jerzy Chudek | Aureliusz Kolonko | Andrzej Więcek Dept Patophisiology, Dept Nephrology, Endocrinology and Metabolic Diseases, Medical Univ Silesia, Katowice, Poland FP709 FOLATE SUPPLEMENTATION DOES NOT REDUCE INCREASE OF CAROTID INTIMA-MEDIA THICKNESS IN RENAL TRANSPLANT RECIPIENTS Carlo Massimetti | Ilaria Napoletano | Gea Imperato | Maria Teresa Muratore | Sara Fazio | Gloria Pessina | Franco Brescia | Sandro Feriozzi Nefrologia-Dialisi, Osp Belcolle | Lab Analisi, Osp Belcolle | Lab Diagnostica Molecolare delle Emopatie, Osp Belcolle | Radiologia, Osp Belcolle FP710 SERUM URIC ACID IS AN INDEPENDENT PREDICTOR OF NEW-ONSET DIABETES AFTER TRANSPLANTATION (NODAT) IN LIVING-DONOR KIDNEY TRANSPLANTATION Kentaro Tanaka | Ken Sakai | Aki Futaki | Youji Hyoudo | Masaki Muramatsu| Takeshi Kawamura | Seiichiro Shishido | Shigeko Hara | Akifumi Kushiyama| Atsushi Aikawa Dept Nephrology, Toho Univ School Medicine | Div Diabetes and Metabolism, Inst Adult Diseases, Asahi Life Foundation FP711 PREVALENCE OF THE CORONARY HEART DISEASE RISK FACTORS AND w w w. e r a e d t a 2 01 2 . o r g 203 FRIDAY, MAY 25 nelles, Hôp Necker Enfants Malades, AP-HP, Univ Paris Descartes, Paris, France| Serv Transpl Rénale, Hôp Necker Enfants Malades, Univ Paris Descartes, Paris, France| Univ Paris Descartes Sorbonne Paris Cité, EA3620, Unité Recherche Clinque Hôp Tarnier; Paris, France 49th ERA-EDTA CONGRESS P O S T E R S FRIDAY, MAY 25 10-YEAR RISK OF CARDIOVASCULAR MORTALITY BASED ON THE HEARTSCORE IN PEOPLE QUALIFIED FOR KIDNEY DONATION Krzysztof Jankowski | Jolanta Gozdowska | Dorota Lewandowska | Artur Kwiatkowski | Magdalena Durlik | Piotr Pruszczyk Dept Internal Medicine and Cardiology, Medical Univ Warsaw, Poland | Dept Transpl Medicine and Nephrology, Medical Univ Warsaw | Dept General and Transpl Surgery, Medical Univ Warsaw FP712 THE IMPACT OF ONCE-DAILY DOSING ON ADHERENCE TO IMMUNOSUPPRESSIVE MEDICATION IN KIDNEY TRANSPLANT RECIPIENTS Yoshitsugu Obi | Naotsugu Ichimaru | Taigo Kato | Masayoshi Okumi | Junya Kaimori | Koji Yazawa | Norio Nonomura | Yoshitaka Isaka | Shiro Takahara Dept Geriatric Medicine & Nephrology, Osaka Univ Grad School Medicine, Osaka, Japan | Deparment of Urology, Osaka Central Hosp, Osaka, Japan | Dept Specific Organ Regulation (Urology), Osaka Univ Grad School Medicine, Osaka, Japan | Dept Advanced Technology Transpl, Osaka Univ Grad School Medicine, Osaka, Japan FP713 A CASE OF MALIGNANT VZV VASCULOPATHY IN A RENAL TRANSPLANT RECIPIENT Meftah Aimele | Ridel Christophe | d'Ythurbide Géraldine | Rondeau Eric | Hertig Alexandre APHP, Hôp Tenon | APHP, Paris, France | Inserm U702 « FP714 PERFORMANCE, LIMITATIONS AND UTILITY OF CYSTATIN C AS AN ENDOGENOUS GFR MARKER IN RENAL TRANSPLANTATION Ingrid Masson | Maillard Nicolas | Tack Ivan | Jaafar Acil | Thibaudin Lise | Hadj-Aissa Aoumeur | Dubourg Laurence | Delanaye Pierre | Cavalier Etienne| Rostaing Lionel | Kamar Nassim | Morelon Emmanuel | Alamartine Eric| Mariat Christophe Serv Nephrologie Dialyse Transpl Rénale CHU Saint Etienne, Saint-Etienne, France | Serv Explorations Fonctionnelles Physiologiques CHU Toulouse Rangeuil, Toulouse, France | Serv Dialyse CHU Sart-Tilman, Liège, Belgique | Serv Biochimie CHU Sart Tilman, Liège, Belgique | Serv Nephrologie Dialyse Transpl d'Organes CHU Toulouse Rangueil, Toulouse, France | Serv Nephrologie Dialyse Transpl Rénale CHU Edouard Herriot, Lyon, France « FP715 SURVIVAL AFTER RENAL TRANSPLANT FAILURE: A UK RENAL REGISTRY ANALYSIS Lynsey Webb | Anna Casula | Charlie Tomson | Yoav Ben-Shlomo UK Renal Registry, Bristol, UK | Southmead Hosp, Bristol, UK | School Social and Community Medicine, Bristol Univ, UK FP716 STRUCTURAL AND MECHANICAL PROPERTIES OF LARGE ARTERIES AFTER KIDNEY TRANSPLANTATION: MAJOR IMPACT OF DONOR SOURCE Karras Alexandre | Boutouyrie Pierre | Haymann Jean-Philippe | Prie Dominique | Legendre Christophe | Girschovitz Alexei | Delahousse Michel Hôp Européen Georges Pompidou, Paris | Hôp Tenon, Paris | Hôp Necker, Paris | Hop Foch FP717 OUTCOME OF DESENSITIZATION PROTOCOL FOR SENSITIZED RENAL TRANSPLANT PATIENTS Pankaj Shah | Vivek Balkrishna Kute | Aruna Vanikar | Manoj Gumber | Pranjal Modi | Hargovind Trivedi IKDRC-ITS, Ahmedabad, India « FP718 URINARY TRACT INFECTIONS DURING FIRST YEAR AFTER RENAL TRANSPLANTATION Justyna Gołębiewska | Alicja Dębska-Ślizień | Boleslaw Rutkowski Dept Nephrology, Transpl and Internal Medicine, Medical Univ Gdańsk 204 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France FP720 PHARMACOLOGICAL EVALUATION OF A REDUCED DOSING STRATEGY OF MYCOPHENOLATE MOFETIL IN TACROLIMUS-TREATED RENAL TRANSPLANT PATIENTS Chabroux Seffert Aline | Thierry Basset | Xavier Delavenne | Eric Alamartine| Christophe Mariat CHU Saint Etienne France FP721 LACK OF ASSOCIATION OF THE CTLA4, ICAM1 AND VCAM1 GENES POLYMORPHISMS WITH CHRONIC ALLOGRAFT NEPHROPATHY DEVELOPMENT Karolina Kloda | Leszek Domanski | Andrzej Pawlik | Katarzyna Bobrek-Lesiakowska | Magda Wisniewska | Maciej Romanowski | Krzysztof Safranow| Mateusz Kurzawski | Jacek Rozanski | Marek Myslak | Kazimierz Ciechanowski Dept Nephrology, Transpl and Internal Medicine, PMU | Dept Therapeutic Drug Monitoring, PMU | Dept General and Transpl Surgery, PMU | Dept Biochemistry and Medical Chemistry, PMU | Dept Pharmacology, PMU FP722 SERUM PHOSPHATE IS AN INDEPENDENT RISK FACTOR FOR LATE GRAFT FAILURE AFTER KIDNEY TRANSPLANTATION Martin De Borst | Leandro Baia | Gerjan Navis | Stephan Bakker Dept Nephrology, Univ Medical Center Groningen FP723 A NEWLY IDENTIFIED MUTATION IN THE COMPLEMENT FACTOR I GENE NOT ASSOCIATED WITH POST-TRANSPLANT RECURRENCE OF aHUS Andrea Ranghino | Giuliana Tognarelli | Elisa Basso | Maria Messina | Ana Maria Manzione | Germana Daidola | Giuseppe Paolo Segoloni Dept Internal Medicine, Nephrology, Dialysis and Transpl Unit, Univ Torino, Italy | Nephrology, Dialysis and Transpl Unit, San Giovanni Battista Hosp, Torino, Italy FP724 OUTCOME OF RENAL TRANSPLANTATION IN PATIENTS WITH LONGTERM (MORE THAN 10 YEARS) DIALYSIS THERAPY Takaaki Kimura | Takashi Yagisawa | Nobuo Ishikawa | Yasunaru Sakuma | Takehito Hujiwara | Akinori Nukui | Masahiro Yashi Jichi Medical Univ | Jichi Medical Univ Hosp FP725 MALIGNANCY INCIDENCE AFTER RENAL TRANSPLANTATION: A 20YEAR SINGLE-CENTER EXPERIENCE Ji Hyun Kim | Sung-Soo Kim | Duck Jong Han | Su-Kil Park Asan Medical Center FP726 EQUITY IN ORGAN DONATION AND TRANSPLANTATION: FACT OR FALLACY? Gurch Randhawa Univ Bedfordshire, Luton, England FP727 TRANSPLANTATION WITH KIDNEY PAIRED DONATION TO INCREASE THE DONOR POOL: A SINGLE-CENTER EXPERIENCE w w w. e r a e d t a 2 01 2 . o r g 205 FRIDAY, MAY 25 FP719 ARE THE OXIDOREDUCTASES (ENDOTHELIAL NO SYNTHASE, CATALASE, GLUTATHIONE PEROXIDASE, SUPEROXIDE DISMUTASES) GENES POLYMORPHISMS IMPLICATED IN THE EARLY PHASE AFTER KIDNEY TRANSPLANTATION? Leszek Domanski | Grazyna Dutkiewicz | Karolina Kloda | Andrzej Pawlik | Andrzej Ciechanowicz | Agnieszka Binczak-Kuleta | Jacek Rozanski | Marek Myslak | Krzysztof Safranow | Kazimierz Ciechanowski Dept Nephrology, Transpl and Internal Medicine, PMU | Dept Therapeutic Drug Monitoring, PMU | Dept Lab Diagnostics and Molecular Medicine, PMU | Dept Biochemistry, Pomeranian Medical Univ 49th ERA-EDTA CONGRESS P O S T E R S Manoj Gumber | Vivek Balkrishna Kute | Pankaj Shah | Himanshu Patel | Aruna Vanikar | Pranjal Modi | Hargovind Trivedi IKDRC-ITS, Ahmedabad, India FRIDAY, MAY 25 FP728 POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS IN PAEDIATRIC RECIPIENTS OF KIDNEY ALLOGRAFT Saeed Taheri Dr. Taheri Medical Res Group, Tehran, Iran FP729 EFFECT AND TOLERABILITY OF AGALSIDASE ALFA WERE ASSESSED IN PATIENTS WITH FABRY DISEASE WHO WERE TREATMENT-NAÏVE (NAÏVE) OR PREVIOUSLY TREATED WITH AGALSIDASE BETA (SWITCH PATIENTS) Ozlem Goker-Alpan | Khan Nedd | Suma Shankar | Howard Lein | Bruce Barshop | Ellen Boyd | Myrl Holida | Richard Hillman | Jennifer Ibrahim | Rebecca Mardach | Neil Wienreb | Barbara Rever | Richard Forte | Alpana Desai | Anna Wijatyk | Peter Chang | Rick Martin Lysosomal Disorders Res & Treatment Unit, Springfield, VA | Infusion Associates, Grand Rapids, MI | Emory Univ, Atlanta, GA | AKDHC, Tucson, AZ| UCSD, San Diego, CA | Fullerton Genetics Center, Asheville, NC | U Iowa Health Care, Iowa City, IA | U Missouri, Columbia, MO | St Joseph’s Children’s Hosp, Paterson, NJ | Kaiser Permanente, Los Angeles, CA | Univ Res Foundation for Lysosomal Storage Disorders, Coral Springs, FL | Central Coast Nephrology, Salinas, CA | North Shore Univ Hosp, Manhasset, NY | Stuart Oncology Associates, Stuart, FL | Shire HGT, Lexington, MA 206 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E DAY AT A GLANCE page 208 209 210 211 212 213 215 217 09:30 - 10:45 Poster session 249 10:45 - 11:30 Plenary Lecture R. Johnson Fructose, metabolic syndrome and kidney disease 219 SATURDAY, MAY 26 08:00 - 09:30 Symposia Salt and volume management in dialysis patients Highlights of the 2011 ESOT congress Pathophysiology of AKI Markers of renal progression Tubular function Free Communications + Mini Lectures EU and glomerular diseases Diabetes basic research Bone and mineral diseases - 1 11:45 - 13:15 Symposia Atherosclerotic and cardiac disease in CKD220 Ciliopathies and PKD 221 Renal sympathetic denervation, baroreflex stimulation 222 Minimal change diseases/FSGS 223 Free Communications + Mini Lectures Transplantation basic 224 Peritoneal dialysis 226 Renal fibrosis 228 13:15 - 15:15 Industry Symposia 15:15 - 16:45 Symposia Progression of CKD and associated cardiovascular complications Membranous nephropathy Elderly patient with CKD or on dialysis Genetic diseases of the glomerular barrier Outcomes after transplantation Free Communications + Mini Lectures Genetic diseases Dialysis techniques and adequacy Mineral homeostasis and nephrolithiasis 373 230 231 232 233 234 235 237 239 17:00 - 18:30 Symposia Management issues in patients with CKD 240 Vasculitis and lupus 241 Glomerular permeability and permeability- inducing factors 242 Tolerance and predictors of tx outcome 243 Literature Update CKD and dialysis 244 Free Communications + Mini Lectures Bone and mineral diseases - 2 245 Diabetes clinical studies 247 w w w. e r a e d t a 2 01 2 . o r g 207 49th ERA-EDTA CONGRESS S C I E N T I F I C GRAND AMPHITHEATRE P R O G R A M M E 08:00 - 09:30 Symposium 19 Salt and volume management in dialysis patients Chair:Michel Jadoul, Brussels, Belgium Eberhard Ritz, Heidelberg, Germany SATURDAY, MAY 26 Improving survival in dialysis patients: salt and volume management is more important than higher uremic toxin removal Adrian Covic, Iasi, Romania Improving survival in dialysis patients: higher uremic toxin removal is more important than salt and volume management! Raymond Vanholder, Ghent, Belgium Bioimpedance measurements in the assessment of volume status Martin K. Kuhlmann, Berlin, Germany Lung ultrasound to assess volume status in dialysis patients Carmine Zoccali, Reggio Calabria, Italy 208 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 1 08:00 - 09:30 Symposium 20 Highlights of the 2011 ESOT congress (in cooperation with European Society for Organ Transplantation) Chair:Alan G. Jardine, Glasgow, UK Marian Klinger, Wroclaw, Poland Basic and translational science highlights from ESOT 2011 Martin J. Hoogduijn, Rotterdam, Netherlands SATURDAY, MAY 26 Clinical highlights from ESOT 2011 Keith Rigg, Nottingham, UK Changes to clinical practice suggested by ESOT 2011 Josep M. Campistol, Barcelona, Spain w w w. e r a e d t a 2 01 2 . o r g 209 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE BLEU P R O G R A M M E 08:00 - 09:30 Symposium 21 New advances in the pathophysology of AKI Chair:Andreas Kribben, Essen, Germany Claudio Ronco, Vicenza, Italy Protection of mitochondria: new target to prevent nephrotoxicity Dmitry B. Zorov, Moscow, Russia SATURDAY, MAY 26 NGAL: more than a marker of AKI Jonathan Barasch, New York, USA The role of complement in the pathogenesis of ischemiareperfusion damage Giuseppe Grandaliano, Foggia, Italy FREE COMMUNICATIONS SAO001 NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN PREDICTS THE NEED FOR RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Dinna Cruz | Hilde R de Geus | Claudio Ronco | A B Johan Groeneveld San Bortolo Hosp Vicenza | Erasmus Univ Medical Center, Rotterdam, Netherlands SAO002 RENAL DENDRITIC CELLS RELEASE INTERLEUKIN-22 WHICH PROMOTES REGENERATION OF TUBULAR EPITHELIAL CELLS AFTER ACUTE KIDNEY INJURY Onkar P. Kulkarni | Jan H. Hagemann | Shrikant R. Mulay | Dana Thomasova | Mi Ryu | Hans-Joachim Anders Nephrological Center, Medical Policlinic, Univ Munich, Germany | Medizinische Poliklinik Innenstadt der LMU, Munich, Germany 210 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E AMPHITHEATRE BORDEAUX 08:00 - 09:30 Symposium 22 Markers of renal progression - New approaches and studies Chair:Matthias Kretzler, Ann Arbor, USA Carmine Zoccali, Reggio Calabria, Italy Systems biology: building a useful model from multiple markers and profiles Gert Mayer, Innsbruck, Austria SATURDAY, MAY 26 Genome-wide association studies in CKD Murielle Bochud, Epalinges, Switzerland The French CKD-REIN cohort study Bénédicte Stengel, Villejuif, France The BIND-NL cohort: a strategic initiative in CKD Gerjan Navis, Groningen, Netherlands w w w. e r a e d t a 2 01 2 . o r g 211 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE HAVANE P R O G R A M M E 08:00 - 09:30 Symposium 23 Advances in understanding tubular function Chair:Heini Murer, Zurich, Switzerland Pierre Verroust, Paris, France Molecular pathophysiology of renal magnesium handling Joost G.J. Hoenderop, Nijmegen, Netherlands SATURDAY, MAY 26 Cubilin and tubular function Erik Ilsø Christensen, Aarhus, Denmark Renal TRPathies Thomas Gudermann, Munich, Germany Role of parvalbumin in the distal tubule Olivier Devuyst, Zurich, Switzerland 212 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM 352AB 08:00 - 09:30 Free Communication Session 13 + Mini Lecture The EU and glomerular diseases Chair:Manuel Praga, Madrid, Spain Rolf A.K. Stahl, Hamburg, Germany FREE COMMUNICATIONS SAO003 NOVEL CONCEPTS IN NEPHROTIC SYNDROME: ANGIOPOIETIN-LIKE 4 INDUCED HYPERTRIGLYCERIDEMIA RESULTS FROM A MULTISYSTEM EFFORT TO REDUCE PROTEINURIA Camille Mace | Sumant Chugh | Lionel Clement Univ Alabama Birmingham, Birmingham, Alabama, USA « SAO004 mTORC1 CONTRIBUTES TO THE PATHOGENESIS OF FSGS Stefan Zschiedrich | Markus Gödel | Björn Hartleben | Kristina Eulenbruch | Stefan Munder | Nadja Herbach | Maria-Pia Rastaldi | Clemens D. Cohen | Michael N. Hall | Markus A. Rüegg | Gerd Walz | Tobias B. Huber Renal Div, Univ Hosp Freiburg, Germany | Inst Veterinary Pathology, Ludwig-Maximilians-Univ, Munich, Germany | Renal Research Lab, Milan, Italy | Renal Div and Inst Physiology, Univ Hosp and Univ Zürich, Switzerland | Biozentrum, Univ Basel, Switzerland SAO005 PLA2R ANTIGEN IN GLOMERULAR DEPOSITS IS A SENSITIVE DIAGNOSTIC MARKER FOR MEMBRANOUS NEPHROPATHY Svobodova Barbora | Honsova Eva | Ronco Pierre | Tesar Vladimir | Debiec Hanna Dept Nephrology, First Fac Medicine and General Univ Hosp, Prague, Czech Republic | INSERM U702, Dept Nephrology Tenon Hosp, Paris, France SAO006 MONOCLONAL IGG3 KAPPA ANTIBODIES TO THE PHOSPHOLIPASE A2 RECEPTOR AND RECURRENT MEMBRANOUS NEPHROPATHY Debiec Hanna | Hanoy Mélanie | Francois Arnaud | Guerrot w w w. e r a e d t a 2 01 2 . o r g 213 SATURDAY, MAY 26 Mini Lecture Presentation of EU-funded consortia in nephrology Carsten Wagner, Zurich, Switzerland 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E Dominique | Ferlicot Sophie | Johanet Catherine | Aucouturier Pierre | Godin Michel | Ronco Pierre Inserm U702 | Dept Nephrology Univ Hosp | Dept Pathology Univ Hosp | Kremlin-Bicêtre Hosp | Dept Immunology SaintAntoine Hosp, Paris, France SATURDAY, MAY 26 SAO007 RENAL INTERSTITIAL CELLULAR INFILTRATION IS PREDICTIVE OF POOR RENAL PROGNOSIS IN HIV-INFECTED PATIENTS Florence Aulagnon | Laure Champion | Francine Walker | Jerome Verine | Laurent Arnaud | Denis Glotz | François Vrtovsnik | Eric Daugas Nephrology Dpt Bichat Hosp AP-HP, Paris, France | Pathology Dpt Bichat Hosp AP-HP, Paris, France | Pathology Dpt SaintLouis Hosp AP-HP, Paris, France | Internal Medicine Dpt Pitie Salpetriere APHP, Paris, France | Nephrology Dpt Saint-Louis Hosp AP-HP, Paris, France 214 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM 342AB 08:00 - 09:30 Free Communication Session 14 Diabetes basic research Chair:Peter Mertens, Magdeburg, Germany Fabiola Terzi, Paris, France SAO008 5/6 NEPHRECTOMIZED MICE EXHIBITED EARLY FAT MASS LOSS ASSOCIATED WITH ECTOPIC LIPID REDEPOSITION AND INSULIN RESISTANCE: PUTATIVE ROLE OF LIPOTOXICITY Koppe Laetitia | Pelletier Caroline | Vella Roxane | Fouque Denis | Guebre-Egziahbher Fitsum | Soulage Christophe HCL, Hôp E. Herriot Lyon France | Univ Lyon, CarMeN, INSERM U1060, INSA Lyon, Univ Lyon-1, Villeurbanne, France SAO009 INVOLVEMENT OF INFLAMMATION-RELATED MICRORNAS: MIR-155 AND MIR-146-A IN DIABETIC NEPHROPATHY: IMPLICATION IN INFLAMMATION-MEDIATED ENDOTHELIAL INJURY Fang Liu | Youqun Huang | Ping Fu West China Hosp Sichuan Univ, Chengdu, China SAO010 PROTECTIVE ROLE OF MAFB IN DIABETIC NEPHROPATHY Naoki Morito | Keigyou Yoh | Akiko Fujita | Satoru Takahashi | Kunihiro Yamagata Dept Nephrology, Div Clinical Medicine, Fac Medicine, Univ Tsukuba, Tsukuba, Ibaraki, Japan | Dept Anatomy and Embryology, Life System Medical Sciences, Univ Tsukuba, Tsukuba, Ibaraki, Japan « SAO011 THE SOLUBLE GUANYLATE CYCLASE ACTIVATOR CINACIGUAT ATTENUATES NEPHROPATHY IN DIABETIC RATS Lilla Fang | Tamas Radovits | Bela Merkely | Miklos Mozes M.| Laszlo Rosivall | Gabor Kokeny Semmelweis Univ, Budapest, Hungary SAO012 INSULIN TREATMENT RESTORES HYPERFILTRATION AND AMELIORATES ARTERIAL HYPERTENSION IN NOD/ ShiLtJ DIABETIC MICE Marta Riera | Eva Marquez | Javier Gimeno | Heleia Roca | w w w. e r a e d t a 2 01 2 . o r g 215 SATURDAY, MAY 26 FREE COMMUNICATIONS 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E Sergi Clotet | Nuria Juanpere | Josep Lloreta | Julio Pascual | MªJose Soler Kidney Disease Research Group, Nephrology Dept, Hosp del Mar-IMIM Barcelona, Spain | Pathology Dept, Hosp del Mar Barcelona, Spain SATURDAY, MAY 26 SAO013 THE BENEFITS OF ASOCIATING IFN GAMMA WITH MINERALCORTICOIDS RECEPTOR BLOCKERS IN DELAYING DIABETIC NEPHROPATHY IN RODENTS WITH TYPE II DIABETES AND OBESITY Ionel-Alexandru Checherita | Andrei Niculae | Alexandru Ciocalteu Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania | St. John Emergency Clinical Hosp, Bucharest, Romania 216 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 2 08:00 - 09:30 Free Communication Session 15 Bone and mineral diseases - 1 Chair:Jorge B. Cannata-Andía, Oviedo, Spain Patrick D’Haese, Antwerp, Belgium SAO014 KAI-4169, A NOVEL PEPTIDE AGONIST OF THE CALCIUM SENSING RECEPTOR, ATTENUATES PTH AND SOFT TISSUE CALCIFICATION AND RESTORES PARATHYROID GLAND VDR LEVELS IN UREMIC RATS Sarah Walter | Jin Dong | Shawn Alexander | Tom Hunter | Kevin Yin | Derek Maclean | Jim Tomlinson | Felix Karim | Randy Johnson KAI Pharmaceuticals Inc., South San Francisco, US « SAO015 EFFECTS OF PHOSPHATE ON VASCULATURE CAN BE CORRECTED WITH A PHOSPHODIESTERASE 5 INHIBITOR Kathryn Stevens | Rajan Patel | Marc Clancy | Delyth Graham| Christian Delles | Alan Jardine Univ Glasgow, Glasgow, UK SAO016 SCLEROSTIN AND DKK-1 LEVELS IN PRE-DIALYISIS CKD PATIENTS Geert Behets | Liesbeth Viaene | Björn Meijers | Patrick D’Haese | Pieter Evenepoel Univ Antwerp, Antwerp, Belgium | KULeuven, Nephrology, Leuven | Univ Hosp, Leuven, Belgium SAO017 ELEVATED FGF-23 LEVELS IN CKD PATIENTS ON LOOP DIURETIC TREATMENT Sarah Seiler | Esther Herath | Franziska Flügge | Anja Weihrauch | Danilo Fliser | Gunnar Henrik Heine Dept Internal Medicine IV, Saarland Univ Hosp, Homburg, Germany SAO018 THE GERMAN CALCIPHYLAXIS REGISTRY Vincent Brandenburg | Thilo Krüger | Rabea Wagstaff | Jürgen Floege | Paula Specht | Markus Ketteler Univ Hosp Aachen | Nephrology, Univ Hosp Aachen | CTC-A, Univ Hosp Aachen | RWTH Aachen Univ | Cardiology, Univ Hosp Aachen | Klinikum Coburg, Coburg Germany w w w. e r a e d t a 2 01 2 . o r g 217 SATURDAY, MAY 26 FREE COMMUNICATIONS 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E SATURDAY, MAY 26 SAO019 EPC NUMBER AND FUNCTION IS IMPROVED BY VDRA TREATMENT IN HEMODIALYSIS PATIENTS Maria Laura Angelini | Giuseppe Cianciolo | Gaetano La Manna | Maria Laura Cappuccilli | Elena Della Bella | Iolanda Rum | Diletta Conte | Vania Cuna | Ada Dormi | Paola Todeschini | Gabriele Donati | Roberta Costa | Gian Paolo Bagnara| Sergio Stefoni Inst Nephrology, Dialysis and Renal Transpl, Dept Medicine and Public Health, Dept Histology, Embryology and Applied Biology, Univ Bologna, Bologna, Italy 218 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E GRAND AMPHITHEATRE 10:45 - 11:30 Plenary Lecture 2 Chair:Jürgen Floege, Aachen, Germany Vladimir Tesar, Prague, Czech Republic Fructose, metabolic syndrome and kidney disease SATURDAY, MAY 26 Richard Johnson, Denver, USA w w w. e r a e d t a 2 01 2 . o r g 219 49th ERA-EDTA CONGRESS S C I E N T I F I C GRAND AMPHITHEATRE P R O G R A M M E 11:45 - 13:15 Symposium 24 Atherosclerotic and cardiac disease in CKD Chair:Adrian Covic, Iasi, Romania Peter Stenvinkel, Stockholm, Sweden Features of cardiovascular disease in CKD Ziad A. Massy, Amiens, France SATURDAY, MAY 26 Vascular hemodynamic changes in CKD Gérard M. London, Fleury-Mérogis, France Cardiovascular complications in CKD: role of oxidative stress Kostas Siamopoulos, Ioannina, Greece Reducing the risk of stroke in dialysis patients Christiane Drechsler, Würzburg, Germany 220 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 1 11:45 - 13:15 Symposium 25 Ciliopathies and polycystic kidney disease (basic and translational) Chair:Nine Knoers, Utrecht, Netherlands Gerd Walz, Freiburg, Germany HNF1beta, cystic kidneys and morphogenesis Marco Pontoglio, Paris, France Ciliopathies / BBS Nicholas Katsanis, Durham, USA Are animal models suitable for testing therapies applicable to humans? Dorien Peters, Leiden, Netherlands w w w. e r a e d t a 2 01 2 . o r g 221 SATURDAY, MAY 26 Regulation of mTOR signalling by cilia and flow Wolfgang Kuehn, Freiburg, Germany 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE BLEU P R O G R A M M E 11:45 - 13:15 Symposium 26 Novel invasive strategies in antihypertensive treatment - Renal sympathetic denervation, baroreflex stimulation Chair:Michel Azizi, Paris, France Peter J. Blankestijn, Utrecht, Netherlands SATURDAY, MAY 26 Renal denervation as antihypertensive treatment - How does it work? Gerald F. DiBona, Iowa City, USA Sympathetic denervation as antihypertensive treatment - critical appraisal of first results Johannes Mann, Munich, Germany Resistant hypertension – baroreflex stimulation as a new tool Jan Menne, Hanover, Germany FREE COMMUNICATIONS SAO020 OVERVIEW OF PATIENTS SCREENEND FOR RENAL SYMPATHETIC DENERVATION AT THE UMC UTRECHT Eva Vink | Verloop Willemien | Voskuil Michiel | Spiering Wilko | Vonken Evert-Jan | PJ Blankestijn UMC Utrecht, Utrecht, Netherlands SAO021 CHRONIC BILATERAL RENAL DENERVATION ATTENUATES FIBROTIC MARKER EXPRESSION AND ALBUMINURIA IN EXPERIMENTAL DIABETIC NEPHROPATHY Yimin Yao | Joanne Harrison | Gerard Davis | Ivan Sammut Univ Otago School of Medical Sciences, Dunedin, New Zealand 222 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E AMPHITHEATRE BORDEAUX 11:45 - 13:15 Symposium 27 Minimal Change Disease / FSGS Chair:Alain Meyrier, Paris, France Jack F.M. Wetzels, Nijmegen, Netherlands Minimal change nephropathy: the search for molecular mediators Sumant Singh Chugh, Birmingham, USA When to start a genetic study in a patient with FSGS? Roser Torra, Barcelona, Spain Which treatment for steroid dependent nephrotic syndrome in children? Patrick Niaudet, Paris, France w w w. e r a e d t a 2 01 2 . o r g 223 SATURDAY, MAY 26 FSGS: the search for permeability factors Jochen Reiser, Miami, USA 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE HAVANE P R O G R A M M E 11:45 - 13:15 Free Communication Session 16 Transplantation basic Chair:Josep M. Campistol, Barcelona, Spain Olivier Thaunat, Lyon, France SATURDAY, MAY 26 FREE COMMUNICATIONS SAO022 MICROVESICLES DERIVED FROM ENDOTHELIAL PROGENITOR CELLS PROTECT FROM ANTIBODY- AND COMPLEMENT-MEDIATED ENDOTHELIAL INJURY THROUGH TRANSFER OF SPECIFIC mRNAs AND microRNAs: POTENTIAL ROLE IN GRAFT ACCOMODATION Vincenzo Cantaluppi | Michela De Lena | Federico Figliolini | Silvia Beltramo | Davide Medica | Giuliana Tognarelli | Luigi Biancone | Ciro Tetta | Giuseppe Paolo Segoloni | Giovanni Camussi Univ Turin, Italy | Fresenius Medical Care, Bad Homburg, Germany « SAO023 THROMBIN MODULATE T CELLS RESPONSE INDUCED BY DENDRITIC CELLS (DC) IN KIDNEY TRANSPLANT RECIPIENTS WITH DELAYED GRAFT FUNCTION (DGF) Paola Pontrelli | Marica Cariello | Raffaella Verrienti | Tiziana Tataranni | Margherita Gigante | Antonia Loverre | Giovanni Stallone | Francesco Paolo Schena | Elena Ranieri | Loreto Gesualdo | G Grandaliano DETO, Univ Bari, Italy | Dept Nephrology | Dept Biomedical Sciences, Univ Foggia, Foggia, Italy SAO024 PROFILING AND FUNCTIONAL CHARACTERIZATION OF POST-TRANSPLANT CIRCULATING ANTIBODIES IN KIDNEY TRANSPLANTATION USING DONOR ENDOTHELIAL CELLS Stephanie Coupel | Emmanuel Canet | Nathalie Gerard | Beatrice Charreau Inserm U643-ITERT-CHU Hotel-Dieu, Nantes, France « SAO025 A SPECIFIC B-CELL SUBSET AND FUNCTIONAL PROFILE IN THE CHRONIC HUMORAL REJECTION! Isabelle Segalen | Nouel Alexandre | Anne Grall | Pers Jacques-Olivier | Sophie Hillion | Yannick Le Meur Transplant unit, CHRU Brest, FRANCE | Immunology, Unity 2216, Brest, France | Transplant unit, CHRU Cavale Blanche Brest, France 224 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E SAO027 THREE-YEAR OUTCOME OF ISOLATED GLOMERULITIS ON 3-MONTH PROTOCOL BIOPSIES OF DONOR HLA ANTIBODY NEGATIVE PATIENTS David Buob | Philippe Grimbert | François Glowacki | Myriam Labalette | Françoise Dufossé | Dominique Nochy | Marie-Christine Copin | Emmanuel Boleslawski | Christian Noël | Marc Hazzan Serv Anatomie Pathologique, Centre Biologie Pathologie, CHRU Lille | Serv Néphrologie et Transpl Rénale, Hôp Henri Mondor, APHP et Univ Paris XII, Créteil, France | Serv Néphrologie, Hôp Huriez, CHU Lille, France | Serv Immunologie, Centre Biologie-Pathologie, CHU de Lille, Lille, France | Lab Anatomie Pathologique, Hôp Européen Georges Pompidou, APHP, Paris, France | Inst Pathologie, Centre Biologie-Pathologie, CHU Lille, Lille, France | Serv Chirurgie Digestive et Transpl, Hôp Huriez, CHU Lille, Lille, France w w w. e r a e d t a 2 01 2 . o r g 225 SATURDAY, MAY 26 SAO026 THE PHENOTYPE OF TUBULAR EPITHELIAL CELLS IS PREDICTIVE OF LONG TERM GRAFT FUNCTION Hertig Alexandre | Anglicheau Dany | Delahousse Michel| Glotz Denis | Legendre Christophe | Ouali Nacéra | Brochériou Isabelle | Rondeau Eric | Dubois Xu Yi Chun Inserm U702 | APHP, Hôp Necker | Hop Foch | APHP, Hop Saint Louis | APHP, Hôp Tenon, Paris, France 49th ERA-EDTA CONGRESS S C I E N T I F I C ROOM 352AB P R O G R A M M E 11:45 - 13:15 Free Communication Session 17 Peritoneal dialysis Chair:Nada Dimkovic, Belgrade, Serbia Cengiz Utas, Kayseri, Turkey SATURDAY, MAY 26 FREE COMMUNICATIONS t SAO028 NFAT5 CONTRIBUTES TO OSMOLALITY-INDUCED MCP-1 EXPRESSION IN MESOTHELIAL CELLS Franz-Xaver Beck | Christoph Küper | Wolfgang Neuhofer Univ Munich, Munich, Germany t SAO029 INTERLEUKIN L-17A: A NOVEL PLAYER IN PERITONEAL INJURY BY DIALYSIS Raquel Rodrigues-Díez | Luiz Guilherme Stark Aroeira | Jose A. Jimenez | Raul Rodrigues-Diez | Sandra Rayego-Mateos | Auxiliadora Bajo Rubio | Alberto Ortiz | Jesus Egido | Manuel Lopez-Cabrera | Rafael Selgas | Marta Ruiz-Ortega Cellular Biology Renal Diseases Lab Univ Autónoma Madrid, Spain | IDIPAZ, Madrid, Spain | Hosp Univ Puerta de Hierro, Madrid, Spain | Dialysis Unit, Fund Jiménez Díaz, Madrid, Spain | IIS-FJD, Madrid, Spain | Unidad Biología Molecular, Hosp Univ de la Princesa, Madrid, Spain « SAO030 REFUTING A TABOO: OVERHYDRATION PREVALENCE DOES NOT INCREASE IN PERITONEAL DIALYSIS PATIENTS - A PROSPECTIVE LONGITUDINAL STUDY Aguiar Pedro Ventura | Santos Olivia | Laetitia Teixeira | Vidinha Joana | Ferrer Francisco | Carvalho Maria João | Cabrita António | Anabela Soares Rodrigues Centro Hosp Porto - Hosp Santo António, Porto, Portugal | PDMA, ICBAS-UP, Porto, Portugal | Hosp São Teotónio, Viseu, Portugal | Centro Hosp Coimbra, Coimbra, Portugal « SAO031 PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS IN AUSTRIA: EPIDEMIOLOGY, RISK FACTORS, AND THE ROLE OF ORAL ACTIVE VITAMIN D Andreas Vychytil | Julia Kerschbaum | Karl Lhotta | Friedrich Prischl | Martin Wiesholzer | Gertrude Kopriva-Altfahrt | Veronika Machold-Fabrizii | Christoph Schwarz | Peter Balcke | Rainer Oberbauer | Reinhard Kramar | Paul König | Michael Rudnicki Medical Univ Vienna, Dept Nephrology and Dialysis | Academic Teaching Hosp Feldkirch | Dept Medicine III, Clinical 226 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E Div Nephrology and Dialysis, Krankenhaus der Barmherzigen Schwestern vom Hl. Kreuz, Wels | First Dept Medicine, Div Nephrology and Dialysis A.ö. Krankenhaus St. Pölten | Dept Medicine VI, Div Nephrology and Dialysis, Wilhelminenspital, Vienna|Dept Nephrology, Krankenhaus der Elisabethinen, Linz | Austrian Dialysis and Transplant Registry, Linz, Austria| Dept Internal Medicine IV, Nephrology and Hypertension, Medical Univ Innsbruck | Medical Univ, Innsbruck, Austria « SAO033 ENCAPSULATING PERITONEAL SCLEROSIS IN PEDIATRIC PERITONEAL DIALYSIS PATIENTS: THE EXPERIENCE OF THE ITALIAN REGISTRY OF PEDIATRIC CHRONIC DIALYSIS Enrico Vidal | Alberto Edefonti | Roberto Chimenz | Bruno Gianoglio | Giovanna Leozappa | Silvio Maringhini | Francesca Mencarelli | Carmine Pecoraro | Flora Puteo | Sara Testa | Rossella Cannavò | Enrico Verrina Dept Pediatrics, Univ Padova, Italy | Pediatric Nephrology and Dialysis Unit, Clinica Pediatrica De Marchi, Milano, Italy | Dept Pediatrics, Nephrology Unit, Univ School Medicine, Messina, Italy | Nephrology, Dialysis and Transpl Unit, Regina Margherita Children’s Hosp, Torino, Italy | Nephrology and Urology Dept, Bambino Gesù Children’s Hosp, Roma, Italy | Pediatric Nephrology Unit, Children’s Hosp G. Di Cristina, Palermo, Italy | Nephrology and Dialysis Unit, Dept Pediatrics, Azienda Osp Univ Sant’Orsola-Malpighi, Bologna, Italy | Nephrology and Dialysis Unit, Santobono Children’s Hosp, Napoli, Italy | Nephrology Div, Giovanni XXIII Children’s Hosp, Bari, Italy | Nephrology and Dialysis Div, Giannina Gaslini Inst, Genova, Italy w w w. e r a e d t a 2 01 2 . o r g 227 SATURDAY, MAY 26 « SAO032 A DUTCH GUIDELINE FOR THE MANAGEMENT OF ENCAPSULATING PERITONEAL SCLEROSIS Meelad Habib | Michiel Betjes | Mario Korte Erasmus MC, Univ Medical Center, Rotterdam, Netherlands | Albert Schweizer Hosp, Dordrecht, Netherlands 49th ERA-EDTA CONGRESS S C I E N T I F I C ROOM CONCORDE 2 P R O G R A M M E 11:45 - 13:15 Free Communication Session 18 + Mini Lecture Renal fibrosis Chair:Jonathan Fox, Glasgow, UK Hans-Peter Marti, Solothurn, Switzerland SATURDAY, MAY 26 FREE COMMUNICATIONS SAO034 FIBROCYTE DEVELOPMENT: ROLE OF CCR2+GR-1+ MONOCYTES Barbara Reich | Fabian Hermann | Yvonne Talke | Manuel Rodriguez Gomez | Kathrin Schmidbauer | Nicole Göbel | Isabel Ketelsen | Matthias Mack Univ Hosp Regensburg, Dept Internal Medicine II, Regensburg, Germany SAO035 A SUBSET OF METZINCINS AND RELATED GENES CONSTITUTES A MARKER OF SOLID ORGAN FIBROSIS ACROSS SPECIES Aikaterini Anagnostopoulou | Rob Walker | Aaron Jeffs | Andreas Scherer | Jennifer Bedford | John Leader | Ged Davis | Hans-Peter Marti Inst Anatomy, Univ Bern, Bern, Switzerland | Dept Medicine, Univ Otago, Dunedin, New Zealand | Pathology, Univ Otago, Dunedin, New Zealand | Australian Genome Research Facility Ltd., Walter and Eliza Hall Inst, Parkville, Australia | Dept Medicine, Bürgerspital, Solothurn, Switzerland SAO036 PERIOSTIN NULL MICE ARE PROTECTED AGAINST THE DEVELOPMENT OF URETERAL OBSTRUCTION- INDUCED RENAL DISEASE Mouna Mael-ainin | Simon J Conway | Jean-Claude Dussaule| Christos Chatziantoniou INSERM UMR S 702, Paris, France|Indiana Univ School Medicine, Indianapolis, USA SAO037 SILENCING DISCOIDIN DOMAIN RECEPTOR 1: A NOVEL APPROACH TO REVERSE THE PROGRESSION OF GLOMERULONEPHRITIS Carlo Alfieri | Monique Kerroch | Aude Dorison | Laurent Mesnard | Jean-Claude Dussaule | Christos Chatziantoniou Inserm UMR 702, Paris, France 228 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E SAO038 CORRELATION STUDY OF RENAL EXPRESSION OF COLLAGEN IV Α-CHAINS IN FEMALE X-LINKED ALPORT SYNDROME PATIENT Yu Yuan-Ting | Xiaodan Yao | Huang Gao-Yuan | Chen Xin| Xu Shu-Tian | Wang Qing-Wen | Chen Hui-Ping | Hu WeiXin | Tang Zhen | Liu Zhi-Hong Research Inst Nephrology, Jinling Hosp, Nanjing Univ School Medicine, Nanjing, China SATURDAY, MAY 26 Mini Lecture Balkan nephropathy - new insights Bojan Jelakovic, Zagreb, Croatia w w w. e r a e d t a 2 01 2 . o r g 229 49th ERA-EDTA CONGRESS S C I E N T I F I C GRAND AMPHITHEATRE P R O G R A M M E 15:15 - 16:45 Symposium 28 Progression of CKD and associated cardiovascular complications Chair:Ariela Benigni, Bergamo, Italy Andrzej Wiecek, Katowice, Poland Endothelin antagonists and renal progression David J. Webb, Edinburgh, UK SATURDAY, MAY 26 Effects of endothelin antagonists in CKD René R. Wenzel, Zell am See, Austria The role of renalase in cardiovascular risk/pathology in CKD Manuel Pestana, Porto, Portugal Vascular effects of aldosterone: role in CKD? Ernesto L. Schiffrin, Montréal, Canada 230 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 1 15:15 - 16:45 Symposium 29 Membranous nephropathy Chair:Paul Brenchley, Manchester, UK Richard Glassock, Los Angeles, USA PLA2-Receptor antibodies and their role in the monitoring of treatment of membranous nephropathy Rolf A.K. Stahl, Hamburg, Germany Spontaneous remission of nephrotic syndrome in membranous nephropathy Manuel Praga, Madrid, Spain KDIGO Guidelines: Treatment of membranous nephropathy Jack F.M. Wetzels, Nijmegen, Netherlands w w w. e r a e d t a 2 01 2 . o r g 231 SATURDAY, MAY 26 Recent advances in the pathogenesis of membranous nephropathy Hanna Debiec, Paris, France 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE BLEU P R O G R A M M E 15:15 - 16:45 Symposium 30 The elderly patient with CKD or on dialysis Chair:Denis Fouque, Lyon, France Francesco Locatelli, Lecco, Italy Haemodialysis in the elderly Antonio Santoro, Bologna, Italy SATURDAY, MAY 26 Treatment of frail CKD patients: maximum conservative management vs timely initiation of dialysis Pedro Ponce, Cascais, Portugal Protein-energy wasting in elderly dialysis patients Peter Barany, Stockholm, Sweden Kidney transplantation in the elderly Maria Alicja Dębska-Slizien, Gdansk, Poland 232 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E AMPHITHEATRE BORDEAUX 15:15 - 16:45 Symposium 31 Genetic diseases of the glomerular barrier Chair:Tobias Huber, Freiburg, Germany Marie Claire Gubler, Paris, France The cytoskeleton and FSGS Marina Noris, Bergamo, Italy SATURDAY, MAY 26 A new protein mutated in glomerular disease and neuropathy Corinne Antignac, Paris, France COL4A1 related disorders in mice and men Emmanuelle Plaisier, Paris, France Molecular genetics of familial hematuric diseases Constantinos Deltas, Nicosia, Cyprus w w w. e r a e d t a 2 01 2 . o r g 233 49th ERA-EDTA CONGRESS S C I E N T I F I C ROOM CONCORDE 2 P R O G R A M M E 15:15 - 16:45 Symposium 32 Outcomes after transplantation Chair:Josep M. Grinyó, Barcelona, Spain Claudio Ponticelli, Milan, Italy Kidney preservation and outcome after transplantation Sarah A. Hosgood, Leicester, UK SATURDAY, MAY 26 Impact of CKD in the outcome after non-renal transplants Gültekin Süleymanlar, Antalya, Turkey Renal transplantation with expanded criteria donors (the ERBP guideline) Uwe Heemann, Munich, Germany Scandiatransplant 2011 Søren Schwarz Sørensen, Copenhagen, Denmark 234 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E AMPHITHEATRE HAVANE 15:15 - 16:45 Free Communication Session 19 + Mini Lecture Genetic diseases Chair:Laurence Heidet, Paris, France Dorien Peters, Leiden, Netherlands SAO039 CHARACTERIZATION OF MOLECULAR PARTNERS OF THE PKD SUSCEPTIBILITY GENE SAMCYSTIN (ANKS6) Delestré Laure | Rude Estelle | Bakey Zeineb | Lelongt Brigitte| Bihoreau Marie-Thérèse | Gauguier Dominique INSERM UMRS872, Centre Recherche Cordeliers, Paris, France| INSERM UMRS702, Hôp Tenon, Paris, France | Centre National Génotypage, Evry, France SAO040 HYPERTENSION REQUIRES RENAL CYST FORMATION AND IS ASSOCIATED WITH INCREASED INTRARENAL EXPRESSION OF RENIN-ANGIOTENSIN SYSTEM COMPONENTS IN Pkd1-DEFICIENT MICE Jonathan M. Fonseca | Ana P. Bastos | Andressa G. Amaral| Mauri F. Sousa | Leandro E. Souza | Denise M. Malheiros | Klaus Piontek | Maria C. Irigoyen | Terry J. Watnick | Luiz F. Onuchic Div Nephrology and Molecular Medicine, Univ São Paulo, São Paulo, Brazil | Dept Medicine, Federal Univ Goiás | Heart Inst, Univ São Paulo | Dept Pathology, Univ São Paulo | Dept Oncology, Johns Hopkins Univ | Div Nephrology, Johns Hopkins Univ, Baltimore, USA SAO041 RAPAMYCIN FOR TREATMENT OF TYPE I AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) STUDY: A RANDOMIZED, CONTROLLED STUDY G Stallone | B Infante | F Bruno | C Bristogiannis | G Grandaliano | L Macarini | D Mezzopane | E Montemurno | Schirinzi A | M Sabatini | A Pisani | T Tataranni | FP Schena | L Gesualdo Nephrology, Dialysis and Transpl Unit, Dept Biomedical Sciences, Univ Foggia |Dept Surgical Sciences, Diagnostic Imaging Unit, Univ Foggia |Dept Systematic Pathology, Nephrology Unit, Federico II Univ, Naples | Dept Emergency and Organ Transpl, Nephrology, Dialysis and Transpl Unit, A. Moro Univ, Bari, Italy w w w. e r a e d t a 2 01 2 . o r g 235 SATURDAY, MAY 26 FREE COMMUNICATIONS 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E SATURDAY, MAY 26 « SAO042 PKD1 MUTATION INFLUENCES RENAL OUTCOME IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: RESULTS FROM THE GENKYST REGISTRY Emilie Cornec Le Gall | Audrezet Marie-Pierre | Treguer Laetitia | Hourmant Maryvonne | Morin Marie-Pascale | Wehbe Bassem | Charasse Christophe | Perrichot Regine | Renaudineau Eric | Jousset Phillipe | Ferec Claude | Le Meur Yannick CHRU BREST | Molecular Genetic, CHRU Brest, France | Nephrology, CHRU Brest, France | Nephrology, CHU Rennes, France | Nephrology, CHU Nantes, France | Nephrology, CH Quimper, France | Nephrology, CH Saint-Brieuc, France | Nephrology, CH Vannes, France | Nephrology, CH Saint-Malo, France | Nephrology, CH Pontivy, France | Molecular Genetic, CHRU Brest, France | Nephrology, CHRU Brest, France SAO043 DEVELOPMENT AND VALIDATION OF A PREDICTION SCORE FOR GENETIC TESTING IN HNF1B-RELATED DISEASE Stanislas Faguer | Nicolas Chassaing | Flavio Bandin | Cathie Prouheze | Patrick Calvas | Stéphane Decramer | Dominique Chauveau Serv Néphrologie et Immunologie clinique, CHU Rangueil, Toulouse | Serv Génétique Médicale, CHU Purpan, Toulouse, France | Serv Néphrologie - Médecine Interne - Transpl, Hôp des Enfants, Toulouse, France | Serv Génétique Médicale, CHU Purpan, Toulouse, France Mini Lecture The Medullary Sponge Kidney: a still misunderstood nephropathy Giovanni Gambaro, Rome, Italy 236 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM 352AB 15:15 - 16:45 Free Communication Session 20 + Mini Lecture Dialysis techniques and adequacy Chair:Farid Haddoum, Algiers, Algeria Martin Kuhlmann, Berlin, Germany « SAO044 A LOOK BEYOND BLOOD IN THE UREMIC SYNDROME: COMPARATIVE ANALYSIS OF INTERSTITIAL FLUID AND PLASMA IN KIDNEY DISEASE Leonard Ebah | Eystein Oveland | Ian Read | Angela Summers| Milind Nikam | Andrew Sayce | Christopher Chaloner| Warwick Dunn | Helge Wiig | Paul Brenchley | Sandip Mitra Manchester Royal Infirmary, Manchester, UK | Univ Bergen| Univ Manchester, UK SAO045 VARIATION IN FLUID STATUS IN HAEMODIALYSIS PATIENTS: INFLUENCE OF DAILY FLUID GAINS AND BMI ON PRESCRIBED TARGET WEIGHT Elizabeth Lindley | David Keane | Boyce Charlie | Hardy Jill | Jones Linda | Oldroyd Jayne | Garthwaite Elizabeth Leeds Teaching Hosp NHS Trust, UK SAO046 EFFECT OF BODY COMPOSITION ON CARDIOVASCULAR MORBIDITY AND MORTALITY IN HAEMODIALYSIS PATIENTS Ana Pérez de José | Soraya Abad Esttebanez | Úrsula Verdalles Guzmán | Almudena Vega Martinez | Laura Bucalo Mana | Abraham Rincón Bello | Daniel Barraca | Claudia Yuste Lozano | Juan Manuel López-Gómez Hosp Gregorio Marañón, Madrid, Spain Mini Lecture What have we learnt from the CONTRAST study (on convective removal in dialysis) Peter J. Blankestijn, Utrecht, Netherlands w w w. e r a e d t a 2 01 2 . o r g 237 SATURDAY, MAY 26 FREE COMMUNICATIONS 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E FREE COMMUNICATIONS SATURDAY, MAY 26 SAO047 THE OXYGEN SATURATION ITALIAN STUDY GROUP: FINAL RESULTS Elena Mancini | Piergiorgio Bolasco | Stefano Severi | Luca Corazza | Antonio Santoro Nephrology, Dialysis and Hypertension dpt, S. Orsola-Malpighi Hosp, Bologna, Italy | Territorial Nephrology and Dialysis dpt., Civil Hosp, Cagliari, Italy | Fac Bioengineering, DEIS dpt, Alma Mater Studiorum Univ Bologna, Bologna, Italy |Bellco srl, Mirandola, Italy on behalf of all the SOGLIA study investigators SAO048 DETERMINANTS OF PHOSPHORUS KINETIC PARAMETERS DURING HAEMODIALYSIS: RESULTS FROM THE HEMO STUDY Baris Agar | Ken Leypoldt | Alp Akonur | Audrey Hutchcraft| Bruce Culleton Baxter Healthcare Corporation, McGaw Park, USA 238 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM 342AB 15:15 - 16:45 Free Communication Session 21 + Mini Lecture Mineral homeostasis and nephrolithiasis Chair:Joost G.J. Hoenderop, Nijmegen, Netherlands Dominique Prié, Paris, France SAO049 IS TRPC3 A NOVEL MEDIATOR IN CALCIUM HOMEOSTASIS? Emmanuel Letavernier | Anita Rodenas | Dominique Guerrot| Jean-Philippe Haymann Univ Pierre et Marie Curie, Paris, France | AP-HP SAO050 CALCIUM SENSING RECEPTOR GENE MUTATIONS AND POLYMORPHISMS ARE FOUND IN MORE THAN 50% OF PATIENTS WITH HYPOCALCIURIC HYPERCALCEMIA: A SINGLE-CENTER STUDY Marco Quaglia | Guido Merlotti | Roberta Fenoglio | Alberto Menegotto | Cristina Izzo | Andrea Airoldi | Vito Guarnieri| Piero Stratta Amedeo Avogadro Univ, Novara, Italy |Maggiore della Carità Hosp, Novara, Italy| Casa Sollievo Sofferenza Hosp, San Giovanni Rotondo (FG), Italy SAO051 RENAL HISTOPATHOLOGICAL FINDINGS IN PATIENTS WITH 2,8-DIHYDROXYADENINURIA Vidar Edvardsson | Sverrir Harðarson | Runolfur Palsson Landspitali - National Univ Hosp Iceland, Reykjavik, Iceland ¯ t SAO052 GLUT9-MEDIATED RENAL URIC ACID HANDLING Bernard Thorens | Auberson Muriel | Bonny Olivier Dept Physiology and Center Integrative Genomics, Lausanne, Switzerland « SAO053 ENTERIC HYPEROXALURIA PREDISPOSING TO NEPHROLITHIASIS IS A COMPLICATION OF BARIATRIC SURGERY Leila Froeder | Alessandra Calábria Baxmann | Ita Pfeferman Heilberg Univ Federal São Paulo, São Paulo, Brazil Mini Lecture Genetic animal models for primary hyperoxaluria Eduardo Salido, La Laguna, Spain w w w. e r a e d t a 2 01 2 . o r g 239 SATURDAY, MAY 26 FREE COMMUNICATIONS 49th ERA-EDTA CONGRESS S C I E N T I F I C GRAND AMPHITHEATRE P R O G R A M M E 17:00 - 18:30 Symposium 33 Management issues in patients with CKD Chair:Pieter Evenepoel, Leuven, Belgium Kostas Siamopoulos, Ioannina, Greece New uraemic toxins Griet Glorieux, Ghent, Belgium SATURDAY, MAY 26 Obesity and renoprotection Francesca Mallamaci, Reggio Calabria, Italy Contrast-induced AKI in CKD patients: how much contrast agent is “safe”? Patrick Murray, Dublin, Ireland Are all iron preparations equal? Walter H. Hörl, Vienna, Austria 240 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 1 17:00 - 18:30 Symposium 34 Vasculitis and lupus Chair:Ricard Cervera, Barcelona, Spain Wladimir M. Szpirt, Copenhagen, Denmark Lupus nephritis: the role of extracellular matrix and chemokines Liliana Schaefer, Frankfurt am Main, Germany Recent advances in the treatment of ANCA-positive vasculitis Wladimir M. Szpirt, Copenhagen, Denmark Recent advances in the treatment of lupus nephritis Vladimir Tesar, Prague, Czech Republic w w w. e r a e d t a 2 01 2 . o r g 241 SATURDAY, MAY 26 Unravelling ANCA vasculitis mechanisms using animal models Ralph Kettritz, Berlin, Germany 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE BORDEAUX P R O G R A M M E 17:00 - 18:30 Symposium 35 Glomerular permeability and permeability-inducing factors Chair:Erik Ilsø Christensen, Aarhus, Denmark Jochen Reiser, Miami, USA SATURDAY, MAY 26 Electrical effects across the glomerular filtration barrier Marcus J. Moeller, Aachen, Germany Podocytes, the filtration barrier and glomerular permeability Tobias Huber, Freiburg, Germany c-mip and idiopathic nephrotic syndrome Dil Sahali, Créteil, France The role of the glomerular endothelial barrier Börje Haraldsson, Gothenburg, Sweden 242 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 2 17:00 - 18:30 Symposium 36 Tolerance and predictors of transplant outcome Chair:Ulrich Kunzendorf, Kiel, Germany Manuel Pascual, Lausanne, Switzerland Biomarkers of transplantation tolerance Maria Hernandez-Fuentes, London, UK Can genotypes predict renal graft outcomes? Lidia Ghisdal, Brussels, Belgium Clinical and histological predictors of long-term kidney graft survival Eric Rondeau, Paris, France w w w. e r a e d t a 2 01 2 . o r g 243 SATURDAY, MAY 26 New clinical and biological correlates of kidney operational tolerance in humans Jean-Paul Soulillou, Nantes, France 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE BLEU P R O G R A M M E 17:00 - 18:30 Literature Update 3 CKD & Dialysis Chair:Walter Hörl, Vienna, Austria Ercan Ok, Izmir, Turkey Tilman Drueke, Amiens, France SATURDAY, MAY 26 Carmine Zoccali, Reggio Calabria, Italy 244 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E AMPHITHEATRE HAVANE 17:00 - 18:30 Free Communication Session 22 Bone and mineral diseases - 2 Chair:Teresa Adragão, Cascais, Portugal David Goldsmith, London, UK SAO054 KAI-4169, A NOVEL CALCIUM SENSING RECEPTOR AGONIST, DECREASES SERUM IPTH, FGF-23 AND IMPROVES SERUM BONE MARKERS IN A PHASE 2 STUDY IN HEMODIALYSIS SUBJECTS WITH CHRONIC KIDNEY DISEASEMINERAL AND BONE DISORDER Geoffrey Block | Gregory Bell| Karen Pickthorn | Saling Huang | Kevin Martin Denver Nephrology, Denver, US | KAI Pharmaceuticals, Inc., South San Francisco, US | Div Nephrology, Saint Louis Univ School Medicine, St Louis, USA ¯ SAO055 PARATHYROID HORMONE (PTH) LEVELS ROSE OVER TIME IN HEMODIALYSIS (HD) PATIENTS: RESULTS FROM THE DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS) F Tentori | B Bieber | H Morgenstern | SH Jacobson | V Andreucci | M Fukagawa | DA Mendelssohn | RL Pisoni | BM Robinson Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA | Univ Michigan, Ann Arbor, Michigan, USA | Danderyd Hosp, Stockholm, Sweden | Italian Kidney Foundation, Italy | Tokai Univ School Medicine, Kanagawa, Japan | Humber River Regional Hosp, Toronto, Canada « SAO056 EFFECTIVENESS OF A MG-BASED PHOSPHATE BINDER ON THE DEVELOPMENT OF VASCULAR CALCIFICATIONS IN UREMIC RATS Tineke De Schutter | Ellen Neven | Geert Behets | Mirjam Peter | Sonja Steppan | Jutta Passlick-Deetjen | Patrick D’Haese Univ Antwerpen, Antwerpen, Belgium | Fresenius Medical Care Deutschland GmbH | Fresenius Medical Care, Bad Homburg, Germany | Univ Dusseldorf, Dusseldorf, Germany SAO057 A MULTI-CENTRE, OPEN-LABEL, FLEXIBLE DOSE, LONGTERM SAFETY STUDY OF COLESTILAN IN CHRONIC KIDNEY DISEASE STAGE V SUBJECTS ON DIALYSIS WITH HYPERPHOSPHATAEMIA w w w. e r a e d t a 2 01 2 . o r g 245 SATURDAY, MAY 26 FREE COMMUNICATIONS 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E Fred Senatore | Allan Manning | Shigekazu Nakajima | Yoshiteru Ushirogawa | Kikumi Tsuda | Hiroaki Egawa Mitsubishi Tanabe Pharma Development America Inc, Warren, NJ, USA | Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan | Mitsubishi Pharma Europe, London, UK SATURDAY, MAY 26 SAO058 RELATIONSHIP BETWEEN FIBROBLAST GROWTH FACTOR 23 AND WEEKLY SERUM PHOSPHATE SERIAL MEASUREMENTS IN A PROSPECTIVE COHORT OF PATIENTS UNDERGOING CHRONIC INTERMITTENT HEMODIALYSIS TREATMENT Gaetano Lucisano | Sarah Seiler | Philipp Ege | Fiita Romero de Vorsmann | Matthias Klingele | Anne-Kathrin Lerner-Gräber | Danilo Fliser | Gunnar Henrik Heine Dept Internal Medicine IV - Nephrology and Hypertension, Saarland Univ Hosp, Homburg, Germany | Universitätsklinikum des Saarlandes, Homburg, Germany « SAO059 SEVELAMER ATTENUATES CV MORTALITY IN INCIDENT HEMODIALYSIS PATIENTS: OPEN LABEL, RANDOMIZED CLINICAL TRIAL OF EFFICACY AND SAFETY (INDEPENDENT STUDY) Donald Molony | Antonio Bellasi | Vincenzo Bellizzi | Domenico Russo | Biagio Di Iorio 2. Div Renal Dis & Hypertension, Dept Medicine, Univ Texas Houston Medical School, Houston, Texas, USA | UOC Nefrologia, AO Ruggi d’Aragona, Salerno, Italy | Univ Federico II Napoli | Osp Landolfi, Solofra, Avellino, Italia 246 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM 352AB 17:00 - 18:30 Free Communication Session 23 Diabetes clinical studies Chair:Zhihong Liu, Nanjing, China Carl Erik Mogensen, Aarhus, Denmark SAO060 SYSTEMIC TRANSCRIPTOME ANALYSIS FOR EXTRACTION OF SPECIFIC GENE CLUSTERS IN DIABETIC NEPHROPATHY-REDUCED EXPRESSION OF INSULIN REGULATED AMINOPEPTIDASE ANGIOTENSIN IV RECEPTOR (AT4/IRAP) IN DIABETIC RENAL TISSUE Tadashi Konoshita | Mai Ichikawa | Tomoko Kimura | Satsuki Sato | Miki Fujii | Yasukazu Makino | Shigeyuki Wakahara| Isamu Miyamori Fukui Univ, Eiheiji, Fukui, Japan SAO061 ALBUMINURIA AND RENAL FUNCTION AS RISK FACTORS FOR CARDIOVASCULAR EVENTS AND MORTALITY Maria Svensson | Jan Cederholm | Björn Eliasson | Bjorn Zethelius | Soffia Gudbjörnsdottir Dept Nephrology, Sahlgrenska Univ Hosp, Gothenburg, Sweden | Dept Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology, Uppsala Univ, Uppsala | Dept Medicine, Sahlgrenska Academy Univ Gothenburg, Gothenburg, Sweden | Dept Public Health and Caring Sciences/Geriatrics, Uppsala Univ, Uppsala, Sweden ¯ t SAO062 10-YEAR CARDIOVASCULAR RISK IN TYPE 2 DIABETES IS PREDICTED BY MEASURABLE URINARY ALBUMIN EVEN IN THE NORMOALBUMINURIC RANGE Esteban Porrini | Piero Ruggenenti | Nicola Motterlini | Annalisa Perna | Aneliya Parvanova Ilieva | Ilian Petrov Iliev| Alessandro Roberto Dodesini | Antonio Bossi | Giuseppe Sampietro | Enrica Capitoni | Flavio Gaspari | Nadia Rubis | Giulia Gherardi | Bogdan Ene-Iordache | Giuseppe Remuzzi Hosp Univ Canarias, Tenerife, Spain | Clinical Research Center for Rare Diseases Aldo & Cele Daccò, Mario Negri Inst Pharmacological Research | Units Diabetology Azienda Osp Riuniti Bergamo | Unit Diabetology, Treviglio Hosp | Epidemiological Observatory, Azienda Sanitaria Locale Provincia Bergamo | Research Foundation, Azienda Osp Riuniti Bergamo, Italy SAO063 EFFECT OF GLYCEMIC CONTROL ON GLOMERULAR HEw w w. e r a e d t a 2 01 2 . o r g 247 SATURDAY, MAY 26 FREE COMMUNICATIONS 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E MODYNAMIC MEASURED BY INULIN AND PARA-AMINOHYPURIC ACID CLEARANCE IN HUMAN—POOR GLYCEMIC CONTROL INDUCES INCREASED RESISTANCE OF EFFERENT ARTERIOLE Akihiro Tsuda | Eiji Ishimura | Yoshiteru Ohno | Mitsuru Ichii| Shinya Nakatani | Katsuhito Mori | Masaaki Inaba Osaka City Univ Graduate School of Medicine, Osaka, Japan SATURDAY, MAY 26 SAO064 TREATMENT OF DIABETIC NEPHROPATHY WITH TRIPTERYGIUM WILFORDII HOOK F: A PROSPECTIVE RANDOMIZED CONTROLLED CLINICAL TRIAL Yongchun Ge | Honglang Xie | Shijun Li | Bo Jin | Jinhua Hou| Haitao Zhang | Mingjun Shi | Zhihong Liu Reasch Inst Nephrology, Jinling Hosp, Nanjing Univ School Medicine, Nanjing China SAO065 DIABETES MELLITUS (DM) REDUCES SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA (RCC): ROLE OF OGG1 AND TUBERIN Simona Simone | Marica Cariello | Antonio Vavallo | Antonia Loverre | Elena Ranieri | Michele Battaglia | Pasquale Ditonno| Loreto Gesualdo | G Grandaliano | Giovanni Pertosa Nephrology, Dialysis and Transpl Unit, DETO, Univ Bari, Italy| Urology Unit, DETO, Univ Bari, Italy | Univ Bari, Bari, Italy | Dialysis and Transpl Unit, Dept Biomedical Sciences, Univ Foggia, Italy 248 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France POSTER SESSION Poster Area 09:30 - 10:45 SAP001-SAP011 Genetic diseases SAP012-SAP045 Hormones SAP046-SAP051 AKI - Experimental SAP052-SAP100 AKI - Clinical SAP101-SAP181bis Clinical Nephrology - Epidemiology II SAP182-SAP246 Clinical studies in CKD 1-5 SAP247-SAP260 Nutrition, inflammation and oxidative stress - CKD 1-5 SAP261-SAP285 Primary and secondary glomerulonephritis II SAP286-SAP329 Experimental pathology SAP330-SAP407 Renal histopathology SAP408-SAP427 Peritoneal dialysis SAP428-SAP509 Renal anaemia - CKD 5D SAP510-SAP537 Mineral and bone disease - CKD 5D SAP538-SAP595 Pathophysiology CKD 5D SAP596-SAP613 Transplantation - Basic SAP614-SAP642 Transplantation - Clinical II SAP643-SAP680 Paediatric nephrology SAP681-SAP724 w w w. e r a e d t a 2 01 2 . o r g 249 SATURDAY, MAY 26 Renal development / Cystic diseases 49th ERA-EDTA CONGRESS P O S T E R S RENAL DEVELOPMENT / CYSTIC DISEASES SAP001 MAS RECEPTOR INHIBITS URETERIC BUD (UB) BRANCHING MORPHOGENESIS VIA DOWNREGULATION OF THE GDNF/RET/WNT11 PATHWAY Ihor Yosypiv | Renfang Song | Graeme Preston Tulane Univ School Medicine SATURDAY, MAY 26 SAP002 DELETIONS OF SIX1 AND UPK3A MAY CONTRIBUTE TO A RENAL PHENOTYPE IN SYNDROMAL PATIENTS Albertien M. van Eerde | Ellen van Binsbergen | Yvette Konijnenberg | Merel C. Maiburg | Klaske Lichtenbelt | Peter G.J. Nikkels | Jasper vd Smagt | Kirsten Y. Renkema | Jacques C. Giltay | Tom P.V.M. de Jong | Marc R. Lilien | Nine V.A.M. Knoers UMC Utrecht, Dept Medical Genetics, Netherlands | UMC Utrecht, Paediatric Renal Center, Netherlands | UMC Utrecht, Dept Pathology, Netherlands SAP003 POLYCYSTIC KIDNEY DISEASE IN TRANSGENIC MICE EXPRESSING A MUTANT KI-RAS GENE Charlotte Gueydan | Germano Serena | Grouls Stephan | Robert Koesters Inserm U702, Paris, France | Dept Nephrology, Univ Heidelberg, Heidelberg, Germany | Univ Pierre et Marie Curie, Paris, France SAP004 CHARACTERISATION OF A NEW MOUSE MODEL OF POLYCYSTIC KIDNEY DISEASE INDUCED BY ENU MUTAGENESIS OF ANKS6 Bakey Zeineb | Delestré Laure | Arnould Catherine | Bihoreau Marie-Thérèse | Dominique Gauguier | Brigitte Lelongt INSERM UMR_S702 | INSERM UMRS872, Centre Recherche Cordeliers, Paris, France | Centre National Génotypage SAP005 DIAGNOSIS OF CYST INFECTION BY 18F-FDG LABELED WBC PET/CT SCAN IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A PROSPECTIVE STUDY Seung Hwan Moon | Hayne Cho Park | Ho-Young Lee | Jin Ho Hwang | Jong Cheol Jeong | Jae-Yoon Park | Seong Woo Lee | Young-Hwan Hwang | Keon Wook Kang | Curie Ahn Dept Nuclear Medicine, Seoul National Univ College Medicine, Seoul, Korea | Dept Internal Medicine, Seoul National Univ College Medicine, Seoul, Korea | Dept Internal Medicine, Eulji General Hosp, Seoul, Korea SAP006 RAPAMYCIN INHIBITS COMPENSATORY HYPERTROPHY ASSOCIATED ENLARGEMENT IN RODENT NEPHRONOPHTHISIS Vincent Gattone | Alexander Carr | Robin Crosler-Roberts Indiana Univ School of Medicine, Indianapolis, IN, USA SAP007 A NOVEL PPAR GAMMA AGONIST DJ5 RETARDS CYST GROWTH AND PRESERVES KIDNEY FUNCTION IN A RAT POLYCYSTIC KIDNEY DISEASE MODEL Xueqi Wang | Yang Liu | Jianhua Shen | Rudolf Wuthrich | Andreas Serra | Changlin Mei Univ Hosp Zurich, Zurich, Switzerland | Inst Physiology, Univ Zürich, Div Nephrology, Univ Hosp Zürich, Zurich, Switzerland | Shanghai Inst Materia Medica, Chinese Academy of Sciences, Shanghai, China| Kidney Inst PLA, Dept Nephrology, Shanghai Changzheng Hosp, Second Military Medical Univ, Shanghai, China SAP008 DO SYMPTOMATIC RENAL CYSTS EVEN REALLY NEED THERAPEUTIC INTERVENTION? Liliana Tuta | Florin Botea Ovidius Univ, Fac Medicine, Constanta, Romania 250 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP010 HNF1-β DELETION AND NEUROLOGICAL DISORDERS: A NON FORTUITUS ASSOCATION Fanny Laffargue | Brigitte Llanas | Véronique Baudouin | Annie Lahoche | Jean-Bernard Palcoux | Denis Morin | Loïc De Parscau | Claire Bahans | MarieAnge Delrue | Emilie Dizier | Elisabeth Taupiac | Nicolas Rodier | Cecile Laroche | Bertrand Lacombe | Sylvie Bourthoumieu | Vincent Guigonis CHU Limoges, France | CHU, Bordeaux, France | Hop Robert Debré, Paris, France | CHU Lille, France | CHU Clermont-Ferrand, France | CHU Montpelier, France | CHU Brest, France SAP011 PREMATURE DELIVERY TRIGGERS TERMINATION OF NEPHROGENESIS PROGRAM WHICH LEADS TO REDUCED NEPHRON NUMBER AND HYPERTENSION Ashraf El-Meanawy | Victoriya Rufanova | Cary Stelloh Medical College Wisconsin and Milwaukee VA Medical Center, Milwaukee, Wisconsin, USA w w w. e r a e d t a 2 01 2 . o r g 251 SATURDAY, MAY 26 SAP009 HNF1-β PATIENTS COHORT: PRELIMINARY ANALYSIS OF THE FIRSTS 121 PATIENTS Vincent Guigonis | Nicolas Rodier | Claire Bahans | Stephane Decramer | Aurelia Bertholet-Thomas | Laurence Heidet | Philippe Eckart | Marie-Pierre Lavocat | Isabelle Vrillon | Sylvie Cloarec | Annie Lahoche | Lucie Bessenay | Ferielle Louillet | Gwenaelle Roussey | Caroline Rousset-Rivière | Olivier Dunand | Véronique Baudouin | François Nobili | Christine Pietrement | Loïc De Parscau | Vincent Gajdos | Denis Morin CHU Limoges, Limoges, France | CHU Toulouse, France | CHU Lyon, France | Hop Necker, Paris, France | CHU Caen, France | CHU Saint Etienne, France | CHU Nancy, France | CHU Tours, France | CHU Lille, France | CHU ClermontFerrand, France | CHU Rouen, France | CHU Nantes, France | CHU Marseille, France | CHU La Réunion, France | Hop Robert Debré, Paris, France | CHU Besançon, France | CHU Reims, France | CHU Brest, France | Hôp Béclère, Clamart, France | CHU Montpelier, France 49th ERA-EDTA CONGRESS P O S T E R S GENETIC DISEASES SAP012 MUTATIONAL ANALYSIS OF THE URATE TRANSPORTER 1 GENE IN JAPANESE PATIENTS WITH RENAL HYPOURICEMIA Tetsuya Inazu | Tetsuya Kawahara | Hitoshi Endou | Naohiko Anzai Ritsumeikan Univ, Kusatsu, Japan | Niigata Rosai Hosp | Kyorin Univ School Medicine, Tokyo, Japan SATURDAY, MAY 26 SAP013 NEPHROLITHIASIS CAUSED BY HEREDITARY RENAL HYPOURICEMIA Ivan Sebesta | Blanka Stiburkova | Kimiyoshi Ichida | Makoto Hosoyamada Inst Clinical Biochemistry and Lab Diagnostics, First Fac Medicine, Charles Univ, Prague, Czech Republic | Inst Inherited Metabolic Disorders | Dept Pathophysiology, Tokyo Univ Pharmacy and Life Sciences, Tokyo, Japan | Div Pharmacotherapeutics, Fac Pharmacy, Keio Univ, Tokyo, Japan SAP014 SLC2A9 POLYMORPHISM, THE MAJOR GENETIC DETERMINANT OF SERUM URIC ACID LEVEL, PREDICTS PROGRESSION TO KIDNEY FAILURE IN CKD PATIENTS Alessandra Testa | Daniela Leonardis | Filippo Catalano | Anna Pisano | Angela Mafrica | Belinda Spoto | Maria Cristina Sanguedolce | Rosa Maria Parlongo| Giovanni Tripepi | Maurizio Postorino | Giuseppe Enia | Carmine Zoccali | Francesca Mallamaci | MAURO Working Group* CNR-IBIM, Reggio Calabria | MAURO Working Group SAP015 SEVERE MANIFESTATION OF BARTTER SYNDROME TYPE IV CAUSED BY A NOVEL INSERTION MUTATION IN THE BSND GENE Augusto Luque de Pablos | Victor Garcia-Nieto | Jesús C. López-Menchero | Elena Ramos-Trujillo | Hilaria González-Acosta | Felix Claverie-Martin Hosp General Gregorio Marañón, Madrid, Spain | Hosp N. S. de Candelaria, Santa Cruz de Tenerife, Spain | Hosp General Ciudad Real, Ciudad Real, Spain SAP016 THE CLINICAL RELEVANCE OF FAMILIAL MICROSCOPIC HEMATURIA. PATHOPHYSIOLOGY AND NATURAL PROGRESSION. THE GREAT DIAGNOSTIC SIGNIFICANCE OF MOLECULAR GENETICS Maria Arsali | Panayiota Demosthenous | Louiza Papazachariou | Yiannis Athanasiou | Konstantinos Voskarides | Constantinos Deltas | Alkis Pierides Dept Nephrology, Nicosia General Hosp, Nicosia, Cyprus | Molecular Medicine Res Center and Lab Molecular and Medical Genetics, Univ Cyprus, Nicosia, Cyprus | Hippokrateon Hosp, Nicosia, Cyprus SAP017 SIGNIFICANT ASSOCIATION BETWEEN TOLL-LIKE RECEPTORS GENE POLYMORPHISM AND POST-TRANSPLAL DIABETES MELLITUS Sulra Lee | Kyung Hwan Jeong | ChunGyoo Ihm | Tae Won Lee | Sang Ho Lee| Ju Young Moon | Jeong Gook Wi | Hong Joo Lee | Eun Young Kim Kyung Hee Univ Medical Center SAP018 PLASMA LEVELS OF THE EPIGENETIC REGULATION FACTOR S-ADENOSYLHOMOCYSTEINE ARE ASSOCIATED WITH SUBCLINICAL ATHEROSCLEROSIS AND EGFR AMONG APPARENTLY HEALTHY SUBJECTS Kyrill Rogacev | Annika Friedrich | Björn Hummel | Judith Berg | Adam Zawada | Danilo Fliser | Jürgen Geisel | Gunnar Henrik Heine Dept Internal Medicine IV, Saarland Univ Medical Center, Homburg, Germany | Clinical Chemistry and Lab Medicine/Central Lab, Saarland Univ Medical Center, Homburg, Germany SAP019 STUDY OF TRANSCRIPTOME OF NODULAR AND DIFFUSE PARATHYROID GLANDS IN DIALYSIS AND KIDNEY TRANSPL PATIENTS Irena Brabcova | Sylvie Dusilova-Sulkova | Zdenek Krejcik | Viktor Stranecky | Kvetoslav Lipar | Tomas Marada | Jitka Stepankova | Ondrej Viklicky 252 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Inst Clinical and Experimental Medicine, Prague | Inst Hematology and Blood Transfusion, Prague | Center Applied Genomics, Prague SAP020 STRONG ASSOCIATION OF MATRIX METALLOPROTEINASE-9 GENE POLYMORPHISM WITH CARDIOVASCULAR DISEASE IN END-STAGE RENAL DISEASE PATIENTS Monika Buraczynska | Pawel Zukowski | Wojciech Zaluska | Agata Kuczmaszewska | Andrzej Ksiazek Medical Univ, Lublin, Poland SAP022 FABRY DISEASE 9 YEAR FOLLOW UP Ricardo Heguilén | Lautaro Albarracin | Juan Politei | Amador Andrés Liste | Amelia Bernasconi Hosp J.A.Fernandez SAP023 PREVALENCE OF FABRY DISEASE IN DIALYSIS PATIENTS IN JAPAN Eiji Kusano Jichi Medical Univ SAP024 EFFECTS OF SWITCH THERAPY WITH AGALSIDASE-ALFA IN PATIENTS WITH ANDERSON-FABRY DISEASE (AFD) PREVIOUSLY TREATED WITH AGALSIDASE-BETA: A PROSPECTIVE CARDIAC MAGNETIC RESONANCE IMAGING STUDY Roberta Russo | Antonio Pisani | Giancarlo Messalli | Massimo Imbriaco Chair Nephrology Federico II Naples | Chair Radiology FedericoII Naples SAP025 WHETHER NPHS1 GENE POLYMORPHISM c.349G>A CONTRIBUTES TO EFFICASY OF IMMUNOSUPPRESSIVE TREATMENT OF STEROID-RESISTANT NEPHROTIC SYNDROME IN CHILDREN? Larisa Prikhodina | Oxana Ryzhkova | Vladimir Polyakov Res Inst Pediatrics & Children Surgery | Res Center for Medical Genetics, Moscow; Russia « SAP026 THE JaK/STAT SIGNALING PATHWAY MODIFICATIONS BY GLUCOCORTICOSTEROIDS IN THE LEUKOCYTES OF CHILDREN WITH NEPHROTIC SYNDROME Katarzyna Lipkowska | Danuta Ostalska-Nowicka | Magdalena Smiech | Małgorzata Jaroniec | Katarzyna Zaorska | Witold Szaflarski | Michal Nowicki| Jacek Zachwieja Dept Pediatric Cardiology and Nephrology, Poznan Univ Medical Science, Poznan, Poland SAP027 A COMMONLY CARRIED ALLELE OF THE FAT-MASS AND OBESITY-RELATED GENE (FTO) IS A PREDICTOR OF ALL-CAUSE MORTALITY IN KIDNEY FAILURE Belinda Spoto | Alessandra Testa | Maria Cristina Sanguedolce | Graziella D'Arrigo | Rosa Maria Parlongo | Anna Pisano | Giovanni Tripepi | Carmine Zoccali| Francesca Mallamaci CNR-IBIM, Reggio Calabria | CNR IBIM and Osp Riuniti, Reggio Calabria w w w. e r a e d t a 2 01 2 . o r g 253 SATURDAY, MAY 26 SAP021 PREDICTORS OF URINARY GLOBOTRIAOSYLCERAMIDE (GB3) EXCRETION IN PATIENTS WITH CHRONIC KIDNEY DISEASE Martina Gaggl | Stefanie Weidner | Marlene Hofer | Julia Kleinert | Günter Fauler | Manfred Wallner | Peter Kotanko | Gere Sunder-Plassmann | Eduard Paschke Medical Univ Vienna, Dept Medicine III, Div Nephrology & Dialysis, Vienna, Austria | Medical Univ Graz, Clinical Inst Medical and Chemical Lab Diagnostics, Graz, Austria | Dept Internal Medicine IV, Section Nephrology, Klinikum Wels-Grieskirchen, Wels, Austria | Renal Res Inst, New York USA | Medical Univ Graz, Dept Pediatrics, Graz, Austria 49th ERA-EDTA CONGRESS P O S T E R S SAP028 UROMODULIN GENOTYPES PREDICT AGE AT ONSET OF GOUT AND ESRD IN PATIENTS WITH AN UROMODULIN-ASSOCIATED KIDNEY DISEASE: RESULTS FROM AN INTERNATIONAL DATA REVIEW Jonathan Moskowitz | Sian Piret | Adam Tashman | Erin Velez | Karl Lhotta | Rajesh Thakker | Peter Kotanko Renal Res Inst, New York, New York, USA | Academic Endocrine Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Churchill Hosp, Univ Oxford, Headington, Oxford, UK | Academic Teaching Hosp Feldkirch SATURDAY, MAY 26 SAP029 THE NATURAL HISTORY OF RENAL ANGIOMYOLIPOMATA (AMLS) IN TUBEROUS SCLEROSIS COMPLEX (TSC) Jane Cox | John Kingswood | Jana Mbundi | Ginny Attard | Uday Patel | Anand Saggar | Frances Elmslie | Tim Doyle Brighton & Sussex Univ Hosp Trust | South West Thames Regional Genetics Serv | Radiology, St Georges Hosp SAP030 EFFECT OF EVEROLIMUS THERAPY ON RENAL ANGIOMYOLIPOMA RESPONSE IN PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX BEING TREATED FOR SUBEPENDYMAL GIANT CELL ASTROCYTOMA: EXPLORATORY RESULTS FROM EXIST-1 Anna Jansen | Sergiusz Jozwiak | Elena Belousova | Michael Frost | Rachel Kuperman | Martina Bebin | Bruce Korf | Robert Flamini | Michael Kohrman | Steven Sparagana | Joyce Wu | James Ford | Gaurav Shah | David Franz Pediatric Neurology Dept, UZ Brussel Campus Jette, Brussels, Belgium | Dept Child Neurology, Children's Memorial Health Inst Warsaw, Poland | Moscow Res Inst Pediatrics & Pediatric Surgery, Moscow, Russia | Minnesota Epilepsy Group, St. Paul, MN, USA | Dept Neurology, Children's Hosp and Res Center Oakland, Oakland, CA | Dept Neurology, Univ Alabama School of Medicine, Birmingham, AL, USA | Dept Genetics, Univ Alabama at Birmingham, Birmingham, AL, USA | Children’s Healthcare of Atlanta, Atlanta, GA, USA | Univ Chicago and Comer Children’s Hosp, Chicago, IL, USA | Texas Scottish Rite Hosp for Children, Dallas, TX, USA | Div Pediatric Neurology, Mattel Children’s Hosp at UCLA, Los Angeles, CA, USA | Novartis Pharmaceuticals Corporation, Florham Park, NJ, USA | Dept Pediatrics and Neurology, Cincinnati Children's Hosp Medical Center, Cincinnati, OH, USA SAP031 PHARMACOKINETICS/PHARMACODYNAMICS OF EVEROLIMUS IN PATIENTS WITH RENAL ANGIOMYOLIPOMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX OR SPORADIC LYMPHANGIOLEIOMYOMATOSIS Bernard Zonnenberg | Wing Cheung | Shweta Urva | Jixian Wang | Michael Frost | Chris Kingswood | Klemens Budde Univ Medical Center Utrect, Utrecht, Netherlands | Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA | Minnesota Epilepsy Group, St. Paul, MN, USA | Royal Sussex County Hosp, Brighton, UK | Charite-Univsmedizin Berlin, Berlin, Germany SAP032 COLLAPSING GLOMERULOPATHY ASSOCIATED LUPUS IN A BLACK FEMALE WITH HOMOZYGOUS APOL1 MUTATION Tomek Kofman | Celine Narjoz | Quentin Raimbourg | Melanie Roland | Marie-Anne Loriot | Alexandre Karras | Gary, S. Hill | Christian Jacquot | Dominique Nochy | Eric Thervet APHP, Paris, France | Univ Paris Descartes, INSERM UMR-S 775, Paris, France| Assist Publ Hôp Paris, Hôp Européen Georges Pompidou, Serv Néphrologie, Paris | Néphrologie, HEGP, Paris, France | Assistance Publique Hôpitaux de Paris, Hôp Européen Georges Pompidou, Serv Anatomopathologie, Paris, France SAP033 GENETIC FACTOR IN THE DEVELOPMENT OF PRIMARY CHRONIC GLOMERULONEPHRITIS Paweł Jagodziński | Magdalena Mostowska | Andrzej Oko Dept Biochemistry and Molecular Biology, Poznań Univ Medical Sciences | Dept Nephrology, Transpl and Internal Medicine, Poznan Univ Medical Sciences, Poznan, Poland 254 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP035 RENAL CONSEQUENCES OF MEGALIN DEFICIENCY IN HUMANS Tina Storm | Rikke Nielsen | Erik Christensen | Carina Frykholm | Lisbeth Tranebjaerg | Henrik Birn | Pierre Verroust | Tryggve Neveus | Birgitta Sundelin | Jens Michael Hertz | Gerd Holmström | Katharina Ericson Inst Biomedicine, Aarhus Univ, Aarhus, Denmark | Dept Biomedicine, Aarhus Univ, Aarhus, Denmark | Dept Immunology, Genetics and Pathology, Uppsala Univ, Uppsala, Sweden | Dept Audiology, Bispebjerg Hosp and Wilhelm Johannsen Centre Functional Genomics, Inst Cellular and Molecular Medicine, Univ Copenhagen, Panum Inst, Copenhagen, Denmark | Dept Women's and Children's Health, Uppsala Univ, Uppsala, Sweden | Pathology Unit, Karolinska Univ Hosp, Karolinska Inst, Stockholm, Sweden | Dept Clinical Genetics, Odense Univ Hosp, Odense, Denmark | Dept Neuroscience, Uppsala Univ, Uppsala, Sweden SAP036 PREGNANCY IN ALPORT SYNDROME: TWO CASE REPORTS WITH DIFFERENT EVOLUTION Alberta Fabris | Daniela Cremasco | Alessandra Zambon | Eva Muraro | Marianna Alessi | Angela D'Angelo | Franca Anglani | Dorella Del Prete Obstetric Unit, Univ Padua | Div Nephrology Dept Medicine Univ Padova SAP037 PROMOTER POLYMORPHISM OF THE IL-6 (C-174G) GENE AND THE ESTIMATION OF METABOLIC SYNDROME OCCURRENCE AMONG A COHORT OF PATIENTS WITH HYPERTENSION Andrei Alkmim Teixeira | Beata Marie Quinto | Cassio Jose Rodrigues | Artur Beltrame Ribeiro | Marcelo Batista UNIFESP - EPM / Sao Paulo / Brasil | Univ Federal São Paulo, São Paulo, Brazil SAP038 NPHS2 p.V290M MUTATION IN ADULT-ONSET STEROID-RESISTANT NEPHROTIC SYNDROME – SHOULD IT BE SCREENED FOR? Andrea Kerti | Rózsa Csohány | Attila Szabó | Ottó Árkossy | Péter Sallai | Vincent Moriniére | Virginia Vega-Warner | Orsolya Lakatos | Tamás Szabó | George Reusz | Kálmán Tory First Dept Pediatrics, Semmelweis Univ, Budapest, Hungary | Szent János Hosp, Budapest, Hungary | INSERM U983, Hôp Necker, Paris, France | Dept Pediatrics and Human Genetics, Univ Michigan, Ann Arbor, Michigan, USA | Univ Pécs, Hungary | Univ Debrecen, Hungary SAP039 ATYPICAL DENT’S DISEASE PHENOTYPES: THE POSSIBLE ROLE OF DIGENIC INHERITANCE Maria Addis | Enrica Tosetto | Franca Anglani | Cristina Meloni | Monica Ceol| Rosalba Cristofaro | Maria Antonietta Melis | Paolo Vercelloni | Angela D'Angelo | Giuseppina Marra Dept Biomedical and Biotecnology Sciences, Univ Cagliari, Italy | Div Nephrology, Dept Medicine, Univ Padova, Italy | Nefrology Unit, IRCCS Ca’ Grande Univ Milano, Italy SAP040 GITELMAN SYNDROME DUE TO TWO NOVEL MUTATIONS IN SLC12A3 GENE Sonia Kaniuka | Mato Nagel | Wojciech Wołyniec | Łukasz Obołończyk | Renata Świątkowska-Stodulska | Krzysztof Sworczak | Boleslaw Rutkowski w w w. e r a e d t a 2 01 2 . o r g 255 SATURDAY, MAY 26 SAP034 IDENTIFICATION AND CHARACTERIZATION OF A RARE GENE VARIANT IN CONGENITAL INTERSTITIAL LUNG FIBROSIS AND NEPHROTIC SYNDROME Nayia Nicolaou | SH Kevelam | MR Lilien | MJ Oosterveld | Roel Goldschmeding | Albertien van Eerde | R Pfundt | Arnoud Sonnenberg | P ter Hal | Nine Knoers | Kirsten Renkema Univ Medical Centre Utrecht, Netherlands | Dept Medical Genetics UMC Utrecht, Netherlands | Dept Pediatric Nephrology, UMC Utrecht | Dept Pathology, UMC Utrecht, Netherlands | Dept Human Genetics, Radboud Univ Nijmegen Medical Centre | Div Cell Biology, Netherlands Cancer Inst, Amsterdam 49th ERA-EDTA CONGRESS P O S T E R S Dept Endocrinology and Internal Medicine, Medical Univ Gdansk, Poland | Center Nephrology and Metabolic Disorders, Weisswasser, Germany | Dept Nephrology, Transpl and Internal Medicine, Gdansk, Poland SAP041 SIX NOVEL SLC12A3 MUTATIONS IN CHINESE PATIENTS WITH GITELMAN SYNDROME Chen Chen | Lanping Jiang | Limeng Chen PUMCH SAP042 STRAIN DEPENDENT PROGRESSION OF MYOCARDIAL FIBROSIS IN MOUSE MODEL OF TGF-ß INDUCED RENAL FIBROSIS Lilla Fang | Miklos Mozes M. | Martina Boosi | Laszlo Rosivall | Gabor Kokeny Semmelweis Univ, Budapest, Hungary SATURDAY, MAY 26 SAP043 ANTIFIBROTIC, NEPHROPROTECTIVE EFFECTS OF PARICALCITOL VS. CALCITRIOL ON TOP OF ACE-INHIBITOR THERAPY IN THE COL4A3KNOCKOUT MOUSE-MODEL FOR PROGRESSIVE RENAL FIBROSIS Rubel Diana | Oliver Gross | Temme Johanna | Girgert Rainer | Ciner Ayse | Hiller Henrik | Müller Gerhard-Anton Univ Medicine Goettingen, Goettingen, Germany SAP044 KCNJ11 E23K MISSENSE MUTATION INFLUENCE DIABETIC NEPHROPATHY AND HYPERGLYCEMIA CONTROL IN TYPE 2 DIABETES PATIENTS Mtiraoui Nabil | Ezzidi Intissar Hematology Lab Fac Pharmacy Monastir Tunisia SAP045 HDR SYNDROME: UNDER-RECOGNISED, YET GENETICALLY IDENTIFIABLE Hendrica Belge | Julie Bloch | Karin Dahan | Yves Pirson | Philippe Vanhille | Nathalie Demoulin Serv Néphrologie, Cliniques Univ St Luc, Bruxelles | Serv Néphrologie, Centre Hosp Valenciennes | Serv Génétique, Cliniques Univ St Luc, Bruxelles 256 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France HORMONES SAP046 RENAL AND INTESTINAL GUANYLIN PEPTIDES SYSTEM IN A MOUSE MODEL OF DIET-INDUCED OBESITY Liliana Simões-Silva | Mónica Moreira-Rodrigues | Janete Quelhas-Santos | Cátia Fernandes-Cerqueira | Manuel Pestana | Isabel Soares-Silva | Benedita Sampaio-Maia Unit Res and Development Nephrology, Fac Medicine, Univ Porto | Inst Pharmacology and Therapeutics, Fac Medicine, Univ Porto, Porto, Portugal SAP048 SEX HORMONE LEVELS AND CORONARY CALCIFICATION IN POSTMENOPAUSAL WOMEN WITH CHRONIC KIDNEY DISEASE STAGE 3-5 Ilona Kurnatowska | Piotr Grzelak | Magdalena Kaczmarska | Anna MasajtisZagajewska | Ludomir Stefańczyk | Michał Nowicki Dept Nephrology, Hypertension and Kidney Transpl Łódź, Poland | Dept Radiology and Diagnostic Imaging, Medical Univ Łódź, Poland SAP049 THE CONCENTRATION OF TESTOSTERONE MORE THAN AGE INFLUENCES THE CONVERSION OF THYROID HORMONES IN PATIENTS WITH CRF Stanislaw Niemczyk | Longin Niemczyk | Katarzyna Szamotulska | Zbigniew Bartoszewicz | Ivanna Dubchak | Urszula Syta | Joanna MatuszkiewiczRowińska Dept Nephrology, Military Inst Medicine, Warsaw, Poland | Dept Nephrology and Internal Diseases, Medical Univ Warsaw, Warsaw, Poland | National Res Inst Mother and Child, Warsaw, Poland | Dept Internal Diseases and Endocrynology, Medical Univ Warsaw, Warsaw, Poland SAP050 DETERMINING THE ENZYMATIC ACTIVITIES OF IODOTHYRONINE 5’ DEIODINASES IN RENAL MEDULLA AND CORTEX Stanislaw Niemczyk | Marta Dudek | Zbigniew Bartoszewicz | Katarzyna Szamotulska | Dorota Brodowska | Łukasz Woźniacki | Longin Niemczyk | Małgorzata Gomółka | Urszula Syta | Aleksandra Rymarz Dept Nephrology, Military Inst Medicine, Warsaw, Poland | Medical Univ, Warsaw, Poland | Mother and Child Inst, Warsaw, Poland SAP051 A NEW MARKER IN NEPHROLOGY: THE APELIN Antonio Lacquaniti | Valentina Donato | Maria Rosaria Fazio | Silvia Lucisano| Valeria Cernaro | Rosaria Lupica | Michele Buemi Univ Messina, Messina, Italy w w w. e r a e d t a 2 01 2 . o r g 257 SATURDAY, MAY 26 SAP047 INFLUENCE OF SMOKING ON PLASMA VASOPRESSIN AND URINE CONCENTRATION IN A FRENCH MIDDLE-AGED POPULATION (THE D.E.S.I.R. COHORT) Lise Bankir | Fezeu Leopold | Bouby Nadine | Ronan Roussel | Beverley Balkau| Marre Michel | Bichet Daniel INSERM U872-E2, Centre Recherche Cordeliers, Paris, France | INSERM U1018, Centre Recherche Epidémiologie et Santé Publique, Villejuif, France | Univ Paris–Diderot; AP-HP, Hôp Bichat, Diabétologie, Paris, France | Dépt Néphrologie, Univ Montréal, Hôp Sacré-Coeur, Montréal, Canada 49th ERA-EDTA CONGRESS P O S T E R S AKI - EXPERIMENTAL SAP052 IS THERE ANY WAY TO PROTECT FROM TACROLIMUS-INDUCED RENAL AND PANCREAS INJURY? Kubra Kaynar | Safak Ersoz | Rezzan Aliyazioglu | Aysegul Uzun | Sukru Ulusoy | Sait Al | Gulsum Ozkan | Muammer Cansız Dept Nephrology, Dept Pathology, School Medicine, Karadeniz Technical Univ | Dept Basic Science, School Pharmacy, Karadeniz Technical Univ | Dept Biochemistry; Dept Surgery Res Center SATURDAY, MAY 26 « SAP053 IS VASCULAR SMOOTH MUSCLE CELLS MINERALOCORTICOID RECEPTOR INVOLVED IN CYCLOSPORINE A NEPHROTOXICITY? Jean-Philippe Bertocchio | Jenny Lançon | Soumaya El Moghrabi | Guillaume Galmiche | Jean-Paul Duong Van Huyen | Philippe Rieu | Frédéric Jaisser INSERM UMRS872 Team 1, Paris, France | Hôp Européen Georges Pompidou, Paris, France | CHU Hôp Maison Blanche, Reims, France SAP054 RESVERATROL INHIBITS THE INTRACELLULAR CALCIUM INCREASE AND RAS/ENDOTHELIN SYSTEMS ACTIVATION INDUCED BY SOLUBLE URIC ACID IN MESANGIAL CELLS Guilherme Albertoni | Sheila Andrade | Jose Augusto Barreto | Fernanda Borges | Nestor Schor Federal Univ São Paulo (UNIFESP) SAP055 HEME OXYGENASE-1 ENHANCES RENAL TUBULAR CELLS REGENERATION IN ISCHEMIA-REPERFUSION INJURY THROUGH ACTIVATION OF ERK1/2 IN MICE Wen-Yu Ho | Shin-Hung Chen | Ching-Jiunn Tseng Div General Internal Medicine, Dept Internal Medicine, Kaohsiung Medical Univ Hosp, Kaohsiung, Taiwan | Dept Medical Education and Res, Kaohsiung Veterans General Hosp, Kaohsiung, Taiwan SAP056 PRODUCTION OF REACTIVE OXYGEN SPECIES IN MITOCHONDRIA OF PROXIMAL TUBULES SECONDARY TO HYPOXIA/REOXYGENATION Anja Bienholz | Thorsten Feldkamp | Joel M Weinberg Div Nephrology, Dept Internal Medicine, Univ Hosp Essen, Essen, Germany | Div Nephrology, Dept Internal Medicine, Univ Michigan, Ann Arbor, USA SAP057 CONDITIONED MEDIUM FROM MESENCHYMAL STEM CELLS (MSCs) PROTECTS HUMAN PROXIMAL TUBULAR CELLS (HK2) FROM GENTAMICIN (GENTA) AND LPS TOXICITIES Jéssica Suller Garcia | Marcelo Naves | Fernanda Borges | Nestor Schor Federal Univ São Paulo (UNIFESP), São Paulo, Brazil SAP058 GENTAMICIN (G) NEPHROTOXICITY: PREVENTION AND REPAIR BY BONE MARROW-DERIVED MESENQUIMAL STEM CELLS (BMSCS) TRANSPL (TX) Fernanda Borges | Luciana Aparecida Reis | Manuel de Jesus Simões | Nestor Schor Federal Univ São Paulo (UNIFESP) | Morphology Dept SAP059 EVALUATION OF REPARATIVE POTENTIAL OF CELL THERAPY WITH MESENCHYMAL STEM CELLS (MSCS) IN THE RENAL DAMAGE INDUCED BY IONIZING RADIATION (IR) IN AN ANIMAL MODEL Waldemar S Almeida | Vitória Moreau Longo | Helena Regina Comodo Segreto| Nestor Schor Escola Paulista Medicina/UNIFESP | Radioterapy Dept | Federal Univ São Paulo (UNIFESP) 258 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP060 THE EFFECT OF BONE MARROW MESENCHYMAL STEM CELLS IN RATS WITH SEPSIS INDUCED ACUTE KIDNEY INJURY Ahmed Ghoneim | Ahmed Elkholy | Tarek Medhat Abbas | Mona El Hadeedy| Fatma Elhusseini | Basem Elessawey | Eman Eltanaihy| Ahmed Lotfy | Sara Eldesoky | Hussein Sheashaa | Mohamed Sobh Mansoura Experimental Res Center Nephrology Dept, Urology & Nephology Center, Mansoura Univ, Mansoura, Egypt | Nephrology Dept, Urology & Nephology Center Univ Mansoura, Mansoura, Egypt | Microbiology Dept, Mansoura Univ, Mansoura, Egypt | Pathology Dept, Mansoura Univ, Mansour, Egypt SAP062 THE EFFECT OF CONDITIONED MEDIUM (CM) OF MESENQUIMAL STEM CELLS DERIVED FROM BONE MARROW (BMSC) IN ACUTE KIDNEY INJURY (AKI) INDUCED BY GENTAMICIN (G) IN RATS Fernanda Borges | Luciana Aparecida Reis | Manuel de Jesus Simões | Nestor Schor Federal Univ São Paulo (UNIFESP) | Morphology Dept SAP063 EFFECT OF THE APPLIANCE OF BONE MARROW MESENCHYMAL STEM CELLS (MSC) IN RATS WITH ACUTE KIDNEY INJURY (AKI) DUE TO SEPSIS Joelma Santina Christo | Clévia dos Santos Passos | Luciana Aparecida Reis | Douglas Rene de Alencar | Jéssica Suller Garcia | Nestor Schor Univ Federal São Paulo SAP064 NATURAL TRIGGERING OF p21 PROTEIN UPREGULATION IS INHIBITED IN VITAMIN D-DEPLETED RATS WITH ISCHEMIC ACUTE KIDNEY INJURY Ana Carolina de Braganca | Daniele Canale | Janaina Garcia Gonçalves | Thais Prevital Bastos Brandão | Maria Heloisa Massola Shimizu | Rildo Aparecido Volpini | Antonio Carlos Seguro | Lucia Andrade Hosp Clínicas Fac Medicina Univ São Paulo | Fac Medicina Univ São Paulo | HCFMUSP SAP065 TENOFOVIR-INDUCED NEPHROTOXICITY IN VITAMIN D-DEFICIENT RATS: THE ROLE OF OXIDATIVE STRESS Daniele Canale | Ana Carolina de Braganca | Janaina Garcia Gonçalves | Thais Prevital Bastos Brandão | Maria Heloisa Massola Shimizu | Rildo Aparecido Volpini | Lucia Andrade | Antonio Carlos Seguro Fac Medicina Univ São Paulo | Hosp Clínicas Fac Medicina Univ São Paulo | HCFMUSP SAP066 PARICALCITOL SUPPRESSES THE RENAL INFLAMMATION DURING ISCHEMIA/REPERFUSION-INDUCED ACUTE KIDNEY INJURY Jae-Won Lee | Hyung Kyu Kim | Won Yong Cho | Sang-Kyung Jo | Eunjung Cho Korea Univ Anam Hosp, Seoul, Korea SAP067 EXPERIMENTAL SEPSIS DIFFERENTIALLY REGULATES RENAL Ca2+ TRANSPORT PROTEINS IN MICE Klaus Höcherl | Christoph Schmidt Univ Regensburg | Martin-Luther-Univ Halle-Wittenberg « SAP068 CALCIUM-OXALATE CRYSTALS INDUCE RENAL INFLAMMATION AND ACUTE KIDNEY INJURY BY ACTIVATING NLRP3 INFLAMMASOME-MEw w w. e r a e d t a 2 01 2 . o r g 259 SATURDAY, MAY 26 SAP061 MESENCHYMAL STEM CELLS EFFECTIVELY TREAT ACUTE KIDNEY INJURY (AKI) WHEN ADMINISTERED 24 OR 48 HOURS AFTER INJURY IN THE RAT ISCHEMIA-REPERFUSION AKI MODEL Dena M. Minning | David Warnock | Ali S. Mohamed | John B. Wirthlin | Subba R. Chintalacharuvu | Laura Boone | Robert M. Brenner AlloCure, Inc., Burlington, MA, USA | Univ Alabama Birmingham, Birmingham, AL USA | Covance Laboratories, Inc., Greenfield, IN, USA 49th ERA-EDTA CONGRESS P O S T E R S DIATED INTERLEUKIN-1Β SECRETION IN RENAL DENDRITIC CELLS Shrikant R. Mulay | Onkar P. Kulkarni | Khader Valli Rupanagudi | Adriana Migliorini | Helen Liapis | Hans-Joachim Anders Nephrological Center, Medical Policlinic, Univ Munich, Germany | Dept Pathology, Washington Univ, School Medicine, St Louis, MO, USA SAP069 MECHANISMS OF DELETERIOUS EFFECTS OF MYOGLOBIN UNDER RHABDOMYOLISIS Irina Pevzner | Anastasia Chupyrkina | Egor Plotnikov | Dmitry Zorov Mitoengineering Res Inst, Lomonosov Moscow State Univ, Moscow, Russia | A.N.Belosersky Inst Physico-Chemical Biology, Moscow State Univ, Moscow, Russia SATURDAY, MAY 26 SAP070 ROLE OF RENAL ENDOGLIN DURING RENAL ISCHEMIA-REPERFUSION INJURY Jose-Miguel Lopez-Novoa | Fernando Perez-Barriocanal | Miguel Arevalo | Neil Docherty Univ, Salamanca, Spain | Conway Inst Biomolecular and Biomedical Sciences, Univ College, Dublin, Ireland SAP071 COMPLEMENT (C) ACTIVATION IN RENAL ISCHEMIA/REPERFUSION (I/R) INJURY IS MEDIATED BY PENTRAXIN 3 (PTX3): A SPECIES-SPECIFIC DIFFERENCE Giuseppe Castellano | Chiara Divella | Antonia Loverre | Alessandra Stasi | Claudia Curci | Michele Rossini | Pasquale Ditonno | Michele Battaglia | Mohamed R. Daha | Cees Van Kooten | Loreto Gesualdo | Francesco Paolo Schena| Giuseppe Grandaliano Dept Emergency and Organ Transpl, Univ Bari, Bari, Italy, | Urology and Transpl Unit, Univ Bari, Bari, Italy | Dept Nephrology, Univ Medical Center, Leiden, Netherlands | Nephrology Unit, Dept Biomedical Sciences, Univ Foggia, Italy SAP072 NOVEL XANTHINE OXIDOREDUCTASE INHIBITOR, FEBUXOSTAT, ATTENUATES RENAL ISCHEMIA-REPERFUSION INJURY IN RATS Hidetoshi Tsuda | Noritaka Kawada | Hirotsugu Iwatani | Toshiki Moriyama| Shiro Takahara | Hiromi Rakugi | Yoshitaka Isaka Osaka Univ « SAP073 HYPOXIC RESPONSE IN MACROPHAGES IN RENAL ISCHEMIA REPERFUSION INJURY Gunnar Schley | Joanna Kalucka | Bernd Klanke | Jonathan Jantsch | Susanne Olbrich | Jasmin Baumgärtl | Kerstin Amann | Kai-Uwe Eckardt | Alexander Weidemann Medical Clinic 4 - Nephrology and Hypertension, Univ Erlangen-Nuremberg, Erlangen, Germany | Inst Microbiology, Univ Erlangen-Nuremberg, Erlangen, Germany | Inst Nephropathology, Univ Erlangen-Nuremberg, Erlangen, Germany SAP074 CORRECTION OF ENDOTHELIAL DISFUNCTION AFTER RENAL ISCHEMIA-REPERFUSION INJURY IN RATS Anna Dolgolikova | Valery Pilotovich | G Ivanchik | I. Shved Belarusian Medical Academy of Post-Grad Education Minsk, Belarus SAP075 DEHYDROEPIANDROSTERONE (DHEA) AND CASTRATION IMPROVES KIDNEY FUNCTION FOLLOWING ISCHEMIA/REPERFUSION (IR) INJURY: ROLE OF SIGMA-1 RECEPTOR (SIGMA-1R) – AKT - NA/K ATPASE (NKA) PATHWAY Nora F Banki | Zsuzsanna Antal | Adam Hosszu | Sandor Koszegi | Adam Vannay | Laszlo Wagner | Agnes Prokai | Vera Muller | Attila J Szabo | Andrea Fekete Semmelweis Univ 1st Dept Pediatrics, Hungary | Dept Pulmonology, Semmelweis Univ 260 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP076 TLR-4: “TROJAN HORSE” IN AKI INDUCED ENCEPHALOPATHY Sally Farrag | Sarah Abulasrar | Mohamed Salama | Maha Amin | Azza Ali | Hussein Sheashaa | Mohamed Sobh Mansoura Medical Experimental Res Center SAP077 INHIBITION OF eIF5A HYPUSINATION: A NEW PHARMACOLOGICAL TARGET APPLIED TO THE PROTECTION OF THE ISCHEMIC INDUCED RENAL DYSFUNCTION Isabelle Rubera | Christophe Duranton | Marc Cougnon | Nicolas Melis | Michel Tauc LP2M CNRS FRE 3472 SAP079 ERK PHOSPHORYLATION PLAYS A KEY ROLE IN HYPOTHERMIC RENAL PROTECTION Young Tai Shin | Seong Suk Kim | Yoon Kyung Chang | Dae Eun Choi | KiRyang Na | Kang Wook Lee Renal Div, Chungnam National Univ Hosp, Daejeon, Korea | Internal Medicine, Sun Hosp, Daejeon| Internal Medicine, Daejeon Saint Mary Hosp, Daejeon, Korea | Renal Div, Dept Internal Medicine, Chungnam National Univ Hosp, Daejeon, Korea SAP080 EXPRESSION OF CALCINEURIN AND REGULATOR OF CALCINEURIN 1 (RCAN1) IN THE RAT KIDNEY FOLLOWING LIPOPOLYSACCHARIDE ADMINISTRATION Jae-Youn Choi | Dong-Chan Jin | Jung-Ho Cha Dept Anatomy, Dept Internal Medicine, College of Medicine, Catholic Univ Korea, Seoul, Korea SAP081 EVIDENCE FOR THE INVOLVEMENT OF OAT1/3 IN RENAL OUTCOME AFTER ISCHEMIC ACUTE KIDNEY INJURY Reinhard Schneider | Boris Betz | Marcus Meusel | Christopher Held | Christoph Wanner | Michael Gekle | Christoph Sauvant Univklinikum Würzburg | Julius-Bernstein-Inst Physiologie | Univklinikum Halle SAP082 RECOMBINANT HUMAN MANGANESE SUPEROXIDE DISMUTASE PROTECTS AGAINST POSTISCHEMIC RENAL INJURY Antonio Pisani | Aldo Mancini | Roberta Rossano Chair of Nephrology FedericoII Naples | Molecular Biology & Viral Oncogenesis Dept National Cancer SAP083 ENDOTHELIAL CELL-DERIVED ENDOTHELIN-1 KNOCK-OUT PRESERVES CORTEX ARCHITECTURE AFTER ISCHEMIC-REPERFUSION EPISODE IN MICE Nur Arfian | Keiko Yagi | Kazuhiko Nakayama | Hirowati Ali | Dyah S. Mayasari | Eko Purnomo | Noriaki Emoto Cardiovascular Div Internal Dept, Grad School of Medicine Kobe Univ | Clinical Pharmacy Dept, Kobe Pharmaceutical Univ SAP084 PREVENTION OF HYPERGLYCEMIA-INDUCED AKI DEVELOPMENT Shai Efrati | Sylvia Berman | Ramzia Abu Hamad | Joshua Weissgarten Assaf Harofeh Medical Center w w w. e r a e d t a 2 01 2 . o r g 261 SATURDAY, MAY 26 SAP078 PROTECTION OF MITOCHONDRIA: NEW TARGET TO PREVENT NEPHROTOXICITY Egor Plotnikov | Dmitry Zorov | Anastasia Chupyrkina | Stanislovas Jankauskas | Maria Morosanova | Irina Pevzner | Natalia Pulkina | Ljubava Zorova Belozersky Inst, Lomonosov Moscow State Univ, Moscow, Russia 49th ERA-EDTA CONGRESS P O S T E R S SAP085 EXTRACELLULAR HISTONES AGGRAVATE ACUTE KIDNEY INJURY BY CAUSING MICROVASCULAR DAMAGE AND TOLL-LIKE RECEPTOR-2/4 ACTIVATION Christina Rebecca Scherbaum | Ramanjaneyulu Allam | Julia Lichtnekert | Murthy Narayana Darisipudi | Holger Hägele | Shrikant R Mulay | Khader Valli Rupanagudi | Bernd Hohenstein | Christian Hugo | Liliana Schaefer | Hans-Joachim Anders Dept Nephrology, Medizinische Poliklinik, Klinikum Univ München, Campus Innenstadt, München, Germany | Div Nephrology, Univ Dresden, Dresden, Germany | Inst Allgemeine Pharmakologie und Toxikologie, Klinikum GoetheUniv, Frankfurt am Main, Germany SATURDAY, MAY 26 SAP086 A RABBIT MODEL OF UREMIA-INDUCED CARDIOMYOPATHY Cristiana Corsi | Emiliana Ferramosca | Eleonora Grandi | Luciano Pisoni | Ilaria Rivolta | Boris Dalpozzo | Eriselda Hoxha | Stefano Severi | Antonio Santoro DEIS, Univ Bologna, Italy | Veterinary Medicine, Univ Bologna, Italy | Experimental Medicine, Bicocca Univ Milano, Italy | Nephrology, Dialysis and Hypertension, S.Orsola-Malpighi Univ Hosp, Bologna, Italy SAP087 GENETIC BACKGROUND INFLUENCES VEGFR PATHWAYS AND GLOMERULAR THROMBOTIC LESIONS IN NEPHROTOXIC NEPHRITIS Mesnard Laurent | Rafat Cedric | Cathelin Dominique | Vandermeersch Sophie| Dominique Nochy | Garcon Loic | Callard Patrice | Jouanneau Chantal | Verpont Marie-Christine | Hertig Alexandre | Rondeau Eric INSERM U702, Paris, France | APHP, Paris, France | Assist Publ Hôp Paris, Hôp Européen Georges Pompidou, Serv Anatomopathologie, Paris, France SAP088 PERFLUOROCARBON PROTECTS KIDNEY TUBULAR EPITHELIAL CELLS BY SEPTIC PLASMA-INDUCED APOPTOSIS AND PROMOTES CD133+ RENAL PROGENITOR CELL DIFFERENTIATION Vincenzo Cantaluppi | Davide Medica | Alessandro Domenico Quercia | Federico Figliolini | Sergio Dellepiane | Olga Randone | Giuseppe Paolo Segoloni | Giovanni Camussi Univ Turin, Turin, Italy SAP089 A NOVEL MITOCHONDRIA TARGET ANTIOXIDANT AMELIORATES CISPLATIN NEPHROTOXICITY Young Tai Shin | Dae Eun Choi | Ki-Ryang Na | Yoon Kyung Chang | Seong Suk Kim | Bong-Hyun Ahn | Soon Ha Kim | Kang Wook Lee Renal Div, Dept Internal Medicine, Chungnam National Univ Hosp, Daejeon, Korea | Internal Medicine, Daejeon Saint Mary Hosp, Catholic Univ, Korea | LG Life Sciences Ltd., R&D Park, Daejeon, Korea SAP090 PHYSICAL EXERCISE MINIMIZES CISPLATIN-INDUCED ACUTE RENAL INJURY WITH DOWN-MODULATION OF TNF Mariana Yasue Saito Miyagi | Niels Camara | Marilia Cerqueira Leite Seelaender | Lucas Maceratesi Enjiu | Patrícia Estler Rocha Guilherme | Marcus Pisciottano | Meire Hiyane | Caroline Yuri Hayashida | Vinícius de Andrade Oliveira| Niels Olsen Saraiva Camara | Mariane Tami Amano Inst Biomedical Sciences USP, São Paulo, Brazil SAP091 IDENTIFICATION OF EXOSOMAL BIOMARKERS OF CISPLATIN CYTOTOXICITY IN RENAL TUBULAR CELLS: POTENTIAL DIAGNOSTIC APPLICATIONS IN ACUTE KIDNEY INJURY Sandra M. Sancho-Martinez | Fernando Sanchez-Juanes | Laura Vicente | Jose Manuel Gonzalez-Buitrago | Ana Isabel Morales | Jose M. Lopez-Novoa | Francisco J. Lopez-Hernandez Univ Salamanca | Hosp Univ Salamanca | Unidad Toxicología and Unidad Fisiopatología Renal y Cardiovascular, Univ Salamanca, Spain | Inst Estudios Ciencias Salud Castilla y León (IECSCYL) 262 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP092 USING A HEAT INJURY ENDOTHELIAL CELL MODEL TO STUDY THE RELATIONSHIP AMONG AMILORID, PLASMINOGEN, UROKINASE, UROKINASE RECEPTOR, AND ALPHA-ENOLASE Jin-Shuen Chen | Li-Chien Chang | Chun-Chi Chen Tri-Serv General Hosp, National Defense Medical Center, Taipei, Taiwan | School Pharmacy, National Defense Medical Center, Taipei, Taiwan SAP093 THE ANTI-INFLAMMATORY EFFECTS OF STATIN IN 5/6 NEPHRECTOMIZED RAT Moo Young Park | Soo Jung Choi | Jin Gook Kim | Seung Duk Hwang Dept Internal Medicine, Soon Chun Hyang Univ Hosp, Korea SAP095 CHRONIC PREDISPOSITION TO ACQUIRE ACUTE KIDNEY INJURE CAN BE DETECTED BY URINARY TRANSFERRIN IN RATS Laura Vicente-Vicente | Laura Ferreira | Jose Manuel González-Buitrago | Francisco J. López-Novoa | Jose Miguel López-Novoa | Ana Isabel Morales Unidad Toxicología and Unidad Fisiopatología Renal y Cardiovascular, Univ Salamanca, Spain | Unidad Investigación, Hosp Univ Salamanca, Salamanca, Spain SAP096 SEPSIS-RELATED DOWNREGULATION OF MEDULLARY SOLUTE AND WATER TRANSPORTERS IS MEDIATED BY NO-INDUCED INACTIVATION OF TONEBP/NFAT5 Küper Christoph | Fraek Maria-Luisa | Beck Franz-Xaver | Wolfgang Neuhofer Dept Physiology, Dept Nephrology, Univ Munich, Munich, Germany SAP097 TIME COURSE mRNA EXPRESSION OF DNA METHYLTRANSFERASE 1, 3a, 3b and 3L DURING DEVELOPMENT OF RENAL FIBROSIS Benjamin Vervaet | Nathalie Le Clef | Anja Verhulst | Patrick D'Haese Univ Antwerpen, Antwerpen, Belgium SAP098 CCAAT/ENHANCER-BINDING PROTEIN DELTA (CEBPD) AS A NOVEL REGULATOR OF HYPOXIA-INDUCIBLE FACTOR-1 (HIF-1) IN KIDNEY DISEASE Tetsuhiro Tanaka | Junna Yamaguchi | Nobuaki Eto | Ichiro Kojima | Toshiro Fujita | Masaomi Nangaku Univ Tokyo, Tokyo, Japan | Div Nephrol & Endocrinol, Univ Tokyo Sch Med SAP099 EFFECT OF METFORMIN GIVEN BEFORE OR DURING RENAL ISCHEMIA ON ACUTE KIDNEY INJURY IN RATS Antoni Wystrychowski | Grzegorz Wystrychowski | Ewa Obuchowicz | Władysław Grzeszczak | Andrzej Więcek Dept Nephrology, Endocrinology and Metabolic Diseases, Medical Univ Silesia, Katowice, Poland | Dept Internal Medicine, Diabetology and Nephrology, Medical Univ Silesia, Zabrze, Poland | Dept Pharmacology, Medical Univ Silesia, Katowice, Poland « SAP100 EFFECT OF ERYTHROPOIETIN ON SHORT TERM I/R REPERFUSION INJURY IN RATS Ciro Esposito | Massimo Torreggiani | Francesca Castoldi | Clara Migotto | Nicoletta Serpieri | Fabrizio Grosjean | Alessandra Manini | Enrico Pertile | Antonio Dal Canton Unit Nephrology and Hemodialysis, IRCCS Fond Salvatore Maugeri, Univ Pavia, Pavia, Italy | Unit Nephrology, Dialysis and Transpl, Fond IRCCS Policlinico San Matteo, Univ Pavia, Pavia, Italy w w w. e r a e d t a 2 01 2 . o r g 263 SATURDAY, MAY 26 SAP094 TRANSFERRIN, A POTENTIAL TOOL FOR THE DIAGNOSIS OF THE ACUTE PREDISPOSITION TO CISPLATIN-INDUCED ACUTE KIDNEY INJURY Laura Vicente-Vicente | Laura Ferreira | Marta Prieto | Omar García-Sánchez | María A. Sevilla | Francisco J. López-Hernández | Jose Miguel López-Novoa | Ana Isabel Morales Unidad Toxicología and Unidad Fisiología Renal y Cardiovascular, Univ Salamanca, Spain | Unidad Investigación, Hosp Univ Salamanca, Spain 49th ERA-EDTA CONGRESS P O S T E R S AKI - CLINICAL SAP101 IS THE CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING OR MAGNETIC FIELD SAFE FOR THE PATIENTS WITH HIGH-RISK FOR ACUTE KIDNEY INJURY? Ebru Gok Oguz | Refik Olmaz | Kenan Turgutalp | Necati Muşlu | Mehmet Ali Sungur | Ahmet Kiykim Div Nephrology Sanliurfa Hosp, Sanliurfa Turkey | Dept Internal Medicine, Div Nephrology, Shool Medicine, Mersin Univ, Mersin | Dept Biochemistry, Shool Medicine, Mersin Univ, Mersin, Turkey | Dept Bioistatistic, Shool Medicine, Mersin Univ, Mersin, Turkey SATURDAY, MAY 26 SAP102 NEURAL NETWORKS FOR THE DIAGNOSIS OF ACUTE KIDNEY INJURY Wim Van Biesen | Jill Vanmassenhove | Griet Glorieux | Raymond Vanholder Ghent Univ Hosp, Nephrology, Gent, Belgium | Ghent Univ Hosp, Ghent, Belgium SAP103 ASSOCIATION OF ACE D ALLELE WITH ACUTE KIDNEY INJURY IN NONCHINESE PATIENTS AFTER CARDIAC SURGERY IN A MULTI-ETHNIC SOUTH ASIAN POPULATION Sophia Chew Singapore General Hosp, Singapore SAP104 PREOPERATIVE SERUM URIC ACID IS THE MOST PREDICTIVE MARKER FOR THE INCIDENCE OF ACUTE KIDNEY INJURY FOLLOWING CARDIAC SURGERY Katharina Förster | Tim Kaufeld | Jan Kielstein | Tobias Schilling | Axel Haverich | Hermann Haller | Bernhard Schmidt Hannover Medical School, Hannover, Germany | Dept Nephrology & Hypertension, Medical School of Hannover, Germany SAP105 DEVELOPMENT AND VALIDATION OF A SEVERE A ACUTE KIDNEY INJURY RISK INDEX FOR CHINESE ELDERLY PATIENTS WITH CARDIAC SURGERY Penghua Hu | Xinling Liang | Yuanhan Chen | Ruizhao Li | Fen Jiang | Zhilian Li | Wei Shi Div Nephrology, Guangdong General Hosp, Guangdong Academy of Medical Sciences Guangzhou, Guangdong, China SAP106 LONG TERM RENAL OUTCOMES IN PATIENTS WITH ACUTE KIDNEY INJURY REQUIRING RENAL REPLACEMENT THERAPY AFTER CORONARY ARTERY BYPASS GRAFT SURGERY Cynthia C.W. Lim | Cynthia M.L. Chia | Ann Kheng Tan | Chieh Suai Tan Singapore General Hosp, Dept Renal Medicine | Singapore General Hosp, Dept Cardiothoracic Surgery SAP107 EARLY POSTOPERATIVE ANGIOTENSIN COVERTING ENZYME INHIBITORS/ANGIOTENSIN RECEPTOR INHIBITORS OR DIURETICS USE IS ASSOCIATED WITH A LOWER INCIDENCE OF ACUTE KIDNEY INJURY AFTER CARDIAC SURGERY IN ELDERLY PATIENTS Penghua Hu | Xinling Liang | Yuanhan Chen | Ruizhao Li | Fen Jiang | Zhilian Li | Wei Shi Div Nephrology, Guangdong General Hosp, Guangdong Academy of Medical Sciences Guangzhou, Guangdong, China SAP108 ASSOCIATION BETWEEN THE LOWEST HEMATOCRIT DURING CARDIOPULMONARY BYPASS AND ACUTE KIDNEY INJURY Roderica Ng | Sudhakar Subramani | Sophia Chew NUS, Singapore | SGH, Singapore 264 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP109 ANAEMIA PREVIOUS CARDIAC SURGERY PREDICTS ACUTE KIDNEY INJURY Ana Pérez de José | Carmen Bernis Carro | Rosario Madero Jarabo | Juan Bustamante | Jose Antonio Sánchez Tomero Spain, Madrid, Hosp Gregorio Marañón | Hosp la Princesa, Madrid, Spain | Hosp la Paz, Madrid, Spain SAP110 RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BLOCKADE EXACERBATES CONTRAST-INDUCED NEPHROPATHY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY: PROPENSITY-MATCHED COMPARISON Wookyung Chung | Han Ro | Jae Hyun Chang | Hyun Hee Lee | Ji Yong Jung Gachon Univ Medicine and Science SAP112 RENAL RECOVERY OF ACUTE KIDNEY INJURY (AKI) AFTER CARDIAC SURGERY Loredana Fazzari | Anna Giuliani | Jacopo Scrivano | Laura Pettorini | Umberto Benedetto | Remo Luciani | Antonino Roscitano | Antonello Napoletano | Daniela Coclite | Emanuela Cordova | Giorgio Punzo | Riccardo Sinatra | Paolo Menè | Nicola Pirozzi Dept Clinical and Molecular Medicine, Univ Rome Sapienza, UOC Nephrology and Dialysis, AO Sant’Andrea, Italy | Dept Cardiac Surgery, Univ Rome Sapienza, AO Sant’ Andrea, Italy | UOC Nefrologia, AO G.Rummo, Benevento, Italy | Ist Superiore Sanità, Rome, Italy SAP113 URINARY NGAL (NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN) FOR EARLY DETECTION OF ACUTE KIDNEY INJURY (AKI) IN GERIATRIC PATIENTS WITH URINARY TRACT INFECTION (UTI) TREATED BY COLISTIN Linda Shavit | Rackhel Manilov | Nurit Algur | Yonit Wiener-Well | Itzchak Slotki Shaare Zedek Medical Center, Jerusalem, Israel SAP114 THE COMBINATION OF URINE NGAL AND SERUM CREATININE IS A GOOD PREDICTOR FOR DIALYSIS REQUIREMENT IN ICU POPULATION Chrysoula Pipili | Charikleia S. Vrettou | Kyparissia Avrami | Foteini Economidou | Kostas Glynos | Sophia Ioannidou | Vasiliki Markaki | Evaggelia Douka| Serafeim Nanas Dept Nephrology, Aretaieion Univ Hosp, Athens, Greece | First Critical Care Dept National and Kapodistrian Univ Athens,Greece | Dept Biochemistry, Evangelismos Hosp, Athens, Greece SAP115 ACUTE KIDNEY INJURY AFTER CARDIAC SURGERY: ROLE OF CYSTATIN C AND NGAL Antonio De Pascalis | Piero Cofano | Stefania Proia | AnnaRita Valletta | Ottavia Vitale | Franco Russo | Erasmo Buongiorno Nephrology, Dialysis, Transpl Unit, V. Fazzi Hosp, Lecce, Italy | Central Lab, V. Fazzi Hosp, Lecce, Italy SAP116 PLASMA NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AS AN EARLY PREDICTIVE MARKER OF CONTRAST-INDUCED NEPHROPATHY IN HOSPITALIZED LOW-RISK PATIENTS UNDERGOING COMPUTED TOMOGRAPHY (CT) Vassilis Filiopoulos | Dimitra Biblaki | Dimitrios Lazarou | Dimitios Chrysis | Mavra Fatourou | Sofia Lafoyianni | Dimosthenis Vlassopoulos w w w. e r a e d t a 2 01 2 . o r g 265 SATURDAY, MAY 26 SAP111 URINARY NGAL AT ADMISSION DOES NOT PROVIDE ADDITIONAL INFORMATION THAN SERUM CREATININE, URINE OUTPUT AND FIRST 24H FLUID BALANCE, FOR PREDICTION OF AKI IN SEPTIC PATIENTS AT ICU Jill Vanmassenhove | Wim Van Biesen | Griet Glorieux | Raymond Vanholder Ghent Univ Hosp, Ghent, Belgium | Ghent Univ Hosp, Nephrology, Gent, Belgium 49th ERA-EDTA CONGRESS P O S T E R S Nephrology Dept, 1st Dept Internal Medicine, 2nd Dept Internal Medicine, Amalia Fleming General Hosp, Athens, Greece | Amalia Fleming General Hosp, Athens, Greece SAP117 EVALUATION OF NOVEL BIOMARKERS IN PATIENTS WITH ACUTE KIDNEY INJURY Oskar Zakiyanov | Vítězslav Kříha | Jan Vachek | Jana Švarcová | Tomáš Zima| Vladimír Tesař | Marta Kalousová Dept Nephrology, First Fac Medicine, Charles Univ Prague and General Univ Hosp Prague, Prague, Czech Republic | Dept Physics, Fac Electrical Engineering, Czech Technical Univ in Prague, Prague | Inst Medical Biochemistry and Lab Diagnostics, First Fac Medicine, Charles Univ Prague and General Univ Hosp Prague SATURDAY, MAY 26 SAP118 NOVEL BIOMARKERS FOR PREDICTION OF RENAL REPLACEMENT THERAPY IN ACUTE KIDNEY INJURY: A SYSTEMATIC REVIEW Manish Kaushik | Claudio Ronco | Dinna Cruz San Bortolo Hosp, Vicenza, Italy SAP119 EXPRESSION OF NESTIN IDENTIFIED BY PROTEOMICS: AS A URINARY BIOMARKER OF ACUTE KIDNEY INJURY Lu Zhang | Wen Zhang | Nan Chen Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School of Medicine SAP120 COMPARISON OF SERUM URIC ACID AND BIOMARKERS TO PREDICT ACUTE KIDNEY INJURY A Ahsan Ejaz | Ganesh Kambhampati | Noel Ejaz | Bhagwan Dass | Vijay Lapsia | Amir A. Arif | Abdo Asmar | Michiko Shimada | Mourad Alsabbagh | Ravi Aiyer | Richard Johnson Univ Florida | College Univ Chicago | Mount Sinai School of Medicine | Univ Central Florida | Hirosaki Univ | Univ Colorado Health Sciences Center SAP121 ACUTE KIDNEY INJURY BIOMARKERS FOR PATIENTS IN A CORONARY CARE UNIT: A PROSPECTIVE COHORT STUDY Tien-Hsing Chen | Chih-Hsiang Chang | Ming-Yang Chang | Ya-Chung Tian| Cheng-Chieh Hung | Ji-Tseng Fang | Chih-Wei Yang | Yung-Chang Chen Second Sect Cardiology | Dept Nephrology | Div Critical Care Nephrology, Chang Gung Memorial Hosp SAP122 RETROSPECTIVE 10-YEAR ANALYSIS OF SEPSIS-ASSOCIATED ACUTE KIDNEY INJURY: INCIDENCE, IMPACT ON OUTCOME, IDENTIFICATION OF PLASMA MICROVESICLES AS POTENTIAL MEDIATORS AND BIOMARKERS OF DISEASE Vincenzo Cantaluppi | Alessandro Domenico Quercia | Federico Figliolini | Sylvia Giacalone | Alfonso Pacitti | Massimo Gai | Cesare Guarena | Gianluca Leonardi | Luigi Biancone | Giovanni Camussi | Giuseppe Paolo Segoloni Univ Turin, Turin, Italy | Nephrology and Dialysis, Cuneo, Italy SAP123 THE ROLE OF PLASMA BIOMARKERS IN THE CHARACTERIZATION OF ICU PATIENTS WITH SEPSIS AND WITH AKI Massimo de Cal | Paolo Lentini | Anna Clementi | Grazia M Virzì | Elisa Scalzotto | Claudio Ronco Div Nephrology, Univ Padua, Padua, Italy | San Bassiano Hosp | San Bortolo Hosp | Dept Nephrology, Dialysis and Transpl, St Bortolo Hosp, IRRIV-International Renal Resarch Inst Vicenza, Vicenza, Italy SAP124 CONTRAST MEDIA, NEPHROTOXICITY AND NEUTROPHIL-GELATINASE ASSOCIATED LIPOCALIN: BETWEEN DOUBTS AND CERTAINTIES Antonio Lacquaniti | Valentina Donato | Maria Rosaria Fazio | Silvia Lucisano| Valeria Cernaro | Rosaria Lupica | Michele Buemi Univ Messina, Messina, Italy 266 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP125 COMMUNITY ACQUIRED ACUTE KIDNEY INJURY IN THE ELDERLY AND VERY ELDERLY PATIENTS: A SINGLE CENTER EXPERIENCE Kenan Turgutalp | Ilter Helvacı | Ekrem Anık | Ahmet Kiykim Mersin Univ Dept Internal Medicine Mersin, Turkey | Dept Biostatistic School Medicine, Mersin Univ | Dept Internal Medicine, Div Nephrology, School Medicine, Mersin Univ, Mersin, Turkey SAP126 CLINICAL PRESENTATION, COURSE AND OUTCOME OF ACUTE KIDNEY INJURY DUE TO VITAMIN D INTOXICATION Muzafar Wani | Imtiaz Wani | Mohd Ashraf Bhat | Khurshid Banday | Mohd Saleem Najar | Abdul Rashid Reshi | Nazir Ahmed Palla SKIMS, Soura, Srinagar, India SAP128 THYROID FUNCTION TESTS IN ACUTE KIDNEY INJURY Pedro Iglesias | Teresa Olea | Cristina Vega-Cabrera | Manuel Heras | M.Auxiliadora Bajo | Gloria del Peso | M.J. Arias | Rafael Selgas | Juan Jose Diez Hosp Ramón y Cajal | Hosp Univ La Paz | Hosp General Segovia SAP129 THE KIDNEY-LUNG CROSSTALK AND MORTALITY IN A COHORT OF PATIENTS WITH SEVERE LEPTOSPIROSIS (WEIL SYNDROME) IN BRAZIL Elizabeth Daher | Pedro Lucas Costa | Eduardo N.S. Pereira | Renata D.P. Santos | Krasnalhia Livia Abreu | Geraldo Silva Junior | Eanes D.B. Pereira School Medicine, Federal Univ Ceara, Fortaleza, Brazil | School Medicine, Univ Fortaleza, Fortaleza, Brazil SAP130 REDUCED SYSTEMIC OXYGEN DELIVERY AND LOW BLOOD PRESSURE ON DAY OF EARLY AKI INCREASE THE RISK OF PROGRESSION TO SEVERE AKI IN CRITICALLY ILL PATIENTS Mário Raimundo | Siobhan Crichton | Yadullah Syed | Jonny Martin | Craig Whiteley | David Bennett | Marlies Ostermann Hosp Santa Maria, Lisbon, Portugal | King’s College London, London, UK | Guy’s & St Thomas Hosp, Dept Critical Care, London, UK SAP131 ACUTE KIDNEY INJURY ACCORDING TO RIFLE CLASSIFICATION IN THE INTENSIVE CARE UNIT: OCURRENCE, RISK FACTORS, OUTCOME AND PREDICTIVE FACTORS Albana Gjyzari | Nestor Thereska | Alketa Koroshi | Myftar Barbullushi | Sulejman Kodra | Alma Idrizi | Arjana Strakosha | Elizana Petrela Nephrology, Epidemiology, Univ Hosp Center Nënë Tereza SAP132 REDUCED BLOOD PRESSURE AND FLUID ACCUMULATION IN CRITICALLY ILL PATIENTS WITH EARLY AKI ARE ASSOCIATED WITH INCREASED MORTALITY Mário Raimundo | Siobhan Crichton | Yadullah Syed | Jonny Martin | Joanna Lemmich Smith | David Bennett | Marlies Ostermann Hosp Santa Maria, Lisbon, Portugal | King’s College London, London, UK | Guy’s & St Thomas Hosp, Dept Critical Care, London, UK SAP133 ACUTE KIDNEY INJURY IN PATENTS HOSPITALIZED WITH ACUTE DECOMPENSATED HEART FAILURE DEPENDING ON HYDRATION STATUS Anna Klimenko | Evgeny Tuykhmenev | Svetlana Villevalde | Zhanna Kobalava Peoples’ Friendship Univ Russia, Moscow, Russia w w w. e r a e d t a 2 01 2 . o r g 267 SATURDAY, MAY 26 SAP127 RENAL ARTERY STENOSIS: THE COMPARISON OF THE DOPPLER USG, CONTRAST-ENHANCED MAGNETIC RESONANCE ANGIOGRAPHY AND SELECTIVE RENAL ARTERIOGRAPHY Kenan Turgutalp | Ahmet Kiykim | Ilter Helvacı Mersin Univ Dept Internal Medicine Mersin, Turkey | Div Nephrology, Dept Internal Medicine, School Medicine, Mersin Univ, Mersin, Turkey | Dept Biostatistic School Medicine, Mersin Univ 49th ERA-EDTA CONGRESS P O S T E R S SAP134 ACUTE KIDNEY INJURY IN PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME Svetlana Avdoshina | Svetlana Villevalde | Evgeny Tyukhmenev | Marina Efremovtseva | Zhanna Kobalava Peoples' Frendship Univ Russia, Moscow SATURDAY, MAY 26 SAP135 DISTANT EFFECTS OF AKI ON LUNG INJURIES BY SOLUBLE MEDIATORS IN BRONCHO-ALVEOLAR LAVAGE FLUID IN PATIENTS WITH ACUTE LUNG INJURY / ACUTE RESPIRATORY DISTRESS SYNDROME Hiroki Hayashi | Sachiyo Suzuki | Kensuke Kataoka | Yasuhiro Kondoh | Hiroyuki Taniguchi | Daisuke Sugiyama | Kunihiro Nishimura | Waichi Sato | Shoichi Maruyama | Seiichi Matsuo | Yukio Yuzawa Nephrology, Fujita Health Univ School Medicine, Toyoake, Aichi, Japan | Nephrology, Nagoya Univ Grad School Medicine, Nagoya, Aichi, Japan | Respiratory and Allergic Medicine, Tosei General Hosp, Seto, Aichi, Japan | Clinical Pathology and Immunology, Kobe Univ Grad School Medicine, Kobe, Hyogo, Japan SAP136 COMPARED ANALYSIS OF THE MORTALITY IN PATIENTS WITH ACUTE RENAL FAILURE VS MULTI-ORGAN FAILURE IN FRENCH ICU d'Ythurbide Géraldine | Fartoukh Muriel | Hertig Alexandre | Rondeau Eric APHP, Hôp Tenon | Inserm U702 SAP137 HEMOPERFUSION PLUS CONTINUOUS VENO-VENOUS HEMOFILTRATION ON PATIENTS WITH MULTIPLE ORGAN DYSFUNCTION SYNDROME Ping Fu | Ling Zhang West China Hosp Sichuan Univ, Chengdu, China SAP138 A NEW CITRATE ANTICOAGULATION PROTOCOL IN EXTRACORPOREAL TREATMENT FOR SEPTIC SHOCK PATIENTS WITH COUPLED PLASMA FILTRATION ADSORPTION (CPFA) Marco Pozzato | Fiorenza Ferrari | Pasqualina Cecere | Paola Mesiano | Antonella Vallero | Sergio Livigni | Francesco Quarello ASLTO2, Nephrology and Dialysis Dept, San Giovanni Bosco Hosp, Turin, Italy| ASLTO2, ICU Dept, San Giovanni Bosco Hosp, Turin, Italy SAP139 IMPACT OF INTENSIVE DAILY HAEODIALYSIS ON RENAL RECOVERY OF CAST NEPHROPATHIES: A RETROSPECTIVE STUDY Laurent Hudier | Olivier Decaux | Atman Haddj-Elmrabet | Lise Mandart | Marie Lino-Daniel | Franck Bridoux | Eric Renaudineau | Théophile Sawadogo| Patrick Le Pogamp | Cécile Vigneau Médecine Interne, CHU Rennes | Néphrologie, CHU RENNES | Néphrologie, Centre Hosp Bretagne Atlantique, Vannes | Néphrologie, CHU Nantes | Néphrologie, CHU Poitiers | Néphrologie, Centre Hosp Broussais, Saint-Malo | Néphrologie, Centre Hosp Bretagne Sud, Lorient SAP140 URINE OUTPUT AS A FACTOR IN INITIATING CONTINUOUS RENAL REPLACEMENT THERAPY FOR ACUTE KIDNEY INJURY Doh Famee | Hyang Mo Koo | Hyung Jung Oh | Seung Hyeok Han | Kyu Hun Choi | Shin-Wook Kang Dept Internal Medicine, College of Medicine, Yonsei Univ, Seoul, Korea SAP141 ECONOMIC IMPACT OF TWO MODALITIES OF CVVHDF ON NURSES WORKING LOAD Manolie Mehdi | Maillard Nicolas | Christophe Mariat CHU Saint Etienne, France SAP142 OUTCOME AND PROGNOSTIC FACTORS OF MALARIA-ASSOCIATED ACUTE KIDNEY INJURY Pankaj Shah | Vivek Balkrishna Kute | Aruna Vanikar | Manoj Gumber | Hi- 268 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France manshu Patel | Hargovind Trivedi IKDRC-ITS, Ahmedabad, India SAP143 MICROCIRCULATION CORRELATES WITH RIFLE SCORE ON ADMISSION AND PRIOR TO CRRT INITIATION Chrysoula Pipili | Christos Manetos | Charikleia S. Vrettou | Stefania Poulaki| Elli-Sophia Tripodaki | Adroula Papastylianou | Christina Routsi | Serafeim Nanas Dept Nephrology, Aretaieion Univ Hosp, Athens, Greece | First Critical Care Dept National and Kapodistrian Univ Athens, Greece SAP145 THE THROMBOTIC MICROANGIOPATHIES IN THE ERA OF HIV - AN AFRICAN PERSPECTIVE Gaji Chita | Malcolm Davies | Yusuf Veriawa | Saraladevi Naicker Univ Witwatersrand, Johannesburg, South Africa SAP146 SURROGATE PREDICTORS OF SNAKEBITE MEDIATED ACUTE KIDNEY INJURY AND CARBONYL STRESS – A PROSPECTIVE STUDY Pinaki Mukhopadhyay | Debarati Mukherjee | Raghwendra Mishra | Monoj Kar NRS Medical College & Hosp, Kolkata, India SAP147 ACUTE TUBULOINTERSTITIAL NEPHRITIS CAUSED BY ABACAVIR AND LAMIVUDINE (KIVEXA ®) Daniel Zickler | Hans Wesselmann | Ralf Schindler Charité Nephrology and Intensive Care | Dept Infectious Diseases and Pulmonary Medicine, Charité-Univ Berlin | Charité-Virchow Klinik SAP148 PATHOGENIC MECHANISMS INFLUENCING THE RECOVERY OF RENAL FUNCTION AFTER MACROHEMATURIA-INDUCED ACUTE KIDNEY INJURY (AKI) IN IGA NEPHROPATHY Eduardo Gutierrez | Jesús Egido | Alfonso Rubio-Navarro | Irene Buendía | Luis Miguel Blanco-Colío | Oscar Toldos | Félix Manzarbeitia | Alberto De Lorenzo | Rosa Sánchez | Manuel Praga | Juan Antonio Moreno Hosp Univ 12 de Octubre, Madrid, Spain | IIS-Fund Jiménez Díaz, Autonoma Univ, FRIAT; Madrid, Spain | Complejo Hosp Segovia, Segovia, Spain SAP149 HIGHER INFUSION RATE OF MANNITOL INCREASES THE RISK OF ACUTE KIDNEY INJURY IN PATIENTS WITH INTRACRANIAL HEMORRHAGE Min Young Kim | Na Ree Kang | Hye Ryoun Jang | Jung Eun Lee | Wooseong Huh | Yoon-Goo Kim | Dae Joong Kim | Seung-Chyul Hong | Jong-Soo Kim| Ha Young Oh Seoul Medical Center, Seoul, Korea | Samsung Medical Center, Seoul, Korea SAP150 GADOLINIUM-CONTRAST NEPHROTOXICITY IN MAGNETIC RESONANCE IMAGING Tomoko Okamoto | Kouju Kamata | Shokichi Naito | Hiromi Tazaki | Shinichi Kan Kitasato Univ, Sagamihara, Japan SAP151 EARLY INITIATION OF CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY IS ASSOCIATED WITH A BETTER RENAL RECOVERY - A PROSPECTIVE OBSERVATIO- w w w. e r a e d t a 2 01 2 . o r g 269 SATURDAY, MAY 26 SAP144 DOES ACUTE KIDNEY INJURY LEADS TO OR WORSEN CHRONIC KIDNEY DISEASE? RISK FACTORS FOR CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY Kensuke Uchida | Kunihiro Yamagata | Chie Saitou | Masashi Okada Mito-Saiseikai General Hosp, Mito city, Japan | Tsukuba Univ Hosp, Tsukuba city, Japan 49th ERA-EDTA CONGRESS P O S T E R S NAL TRIAL Lerner-Gräber Anne-Kathrin | Timo Speer | Link Andreas | Groesdonk Heinrich | Volk Thomas | Aaron Poppleton | Fliser Danilo | Klingele Matthias Saarland Univ Hosp, Dept Internal Medicine 4, Homburg/Saar, Germany | Saarland Univ Hosp, Dept Internal Medicine 3, Homburg/Saar, Germany | Saarland Univ Hosp, Dept Cardiothoracic Surgery, Homburg/Saar, Germany | Saarland Univ Hosp, Dept Anesthesiology, Homburg/Saar, German SAP152 IN-HOSP MORTALITY AND LONG-TERM OUTCOMES OF NON-DIALYSIS REQUIRING ACUTE KIDNEY INJURY IN CRITICALLY-ILL PATIENTS Chun-Fu Lai | Vin-Cent Wu | Chih-Chung Shiao | Tao-Min Huang | KwanDun Wu National Taiwan Univ Hosp, Taipei, Taiwan | Saint Mary’s Hosp, Luodong, Taiwan | National Taiwan Univ Hosp Yun-Lin Branch, Douliou, Taiwan SATURDAY, MAY 26 SAP153 ACUTE KIDNEY INJURY (AKI): AN ACCEPTABLE RISK OF TREATMENT WITH ACE INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS? Michael Bedford | Christopher Farmer | Jean Irving | Paul Stevens East Kent Hosp Univ NHS Found Trust SAP154 CHANGES IN THE INCIDENCE OF ACUTE KIDNEY INJURY REQUIRING DIALYSIS (AKI-D): A FIVE YEARS SINGLE-CENTER REGISTER Francesco Patera | Francesca Mattozzi | Sara Battistoni | Riccardo Maria Fagugli Nephrology - Azienda Osp Perugia, Perugia, Italy SAP155 THE URINARY CYSTATIN C LEVEL AS A PROGNOSTIC BIOMARKER OF MORTALITY IN PATIENTS WITH ACUTE KIDNEY INJURY Moo Young Park | Soo Jung Choi | Jin Gook Kim | Seung Duk Hwang Dept Internal Medicine, Soon Chun Hyang Univ Hosp, Korea SAP156 CLINDAMYCIN RELATED ACUTE KIDNEY INJURY IN 22 CASES Honglang Xie | Huiping Chen | Shutian Xu | Qunpeng He | Jin Liu | Weixin Hu | Zhihong Liu Res Inst Nephrology, Jinling Hosp, Nanjing, China SAP157 CYSTATIN C PREDICT MORTALITY BUT NOT AKI OCCURRENCE AMONG ELDERLY CRITICALLY ILL PATIENTS Maria Dalboni | Rosangela Blaya | Beata Marie Quinto | Roberto Narciso | Moacir Oliveira | Julio Monte | Marcelino Durão | Miguel Cendoroglo | Marcelo Batista Univ Federal São Paulo/UNIFESP, São Paulo, Brazil | Hosp Israelita Albert Einstein SAP158 RENAL EXPRESSION OF MONOCYTE CHEMOTACTIC PROTEIN-1 IN PATIENTS WITH SCHISTOSOMIASIS MANSONI IN AN AREA OF LOW ENDEMICITY IN NORTHEAST BRAZIL Ana Lucia Hanemann | Alexandre Liborio | Elizabeth Daher | Alice Martins | Maria Christiany C. Pinheiro | Geraldo Silva Junior | Gdayllon Meneses | Ramon de Paula Pessoa | Mariana Sousa | Fernando Schemelzer M. Bezerra Dept Pathology and Legal Medicine, Federal Univ Ceara, Fortaleza, Brazil | School Medicine, Univ Fortaleza, Fortaleza, Brazil | School Medicine, Federal Univ Ceara, Fortaleza, Brazil | Dept Clinical Analysis and Toxicology, Federal Univ Ceara, Fortaleza, Brazil | Dept Physiology and Pharmacology, Federal Univ Ceara, Fortaleza, Brazil SAP159 SNAKEBITES-INDUCED ACUTE KIDNEY INJURY IN NORTHEAST BRAZIL Polianna L.M.M. Albuquerque | Juliana B. Lima | Caroline B. Lima | Maria do Socorro B. Veras | Geraldo Silva Junior | Elizabeth Daher School of Medicine, Federal Univ Ceara, Fortaleza, Brazil | Hosp Geral Waldemar Alcântara, Fortaleza, Brazil | Center Toxicological Assistance, Inst Dr. José Frota, Fortaleza, Brazil | School of Medicine, Univ Fortaleza, Fortaleza, Brazil 270 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP160 AKIN (ACUTE KIDNEY INJURY NETWORK) SCORE DID NOT PREDICT SURVIVAL AFTER ORTHOTOPIC LIVER TRANSPL (OLT) Thais Nemoto Matsui | Claudia Totoli | Maria Claudia Cruz Andreoli | Maria Paula Vilela Coelho | Nadia Karina Guimaraes de Souza | Adriano Luiz Ammirati | Fellype de Carvalho Barreto | Ben-Hur Ferraz Neto | Bento Fortunato Cardoso dos Santos Albert Einstein Jewish Hosp, Sao Paulo, Brazil | Federal Univ Sao Paulo SAP161 SNAKE BITES, OBSTETRIC COMPLICATIONS AND INDIGENOUS MEDICINES ACCOUNT FOR HALF THE CASES OF BIOPSIED ACUTE KIDNEY INJURY IN SOUTHERN INDIA Anila Abraham | Georgi Abraham | Milly Mathew Madras Medical Mission, Chennai, India SAP163 PREDICTIVE FACTORS FOR AKI DEVELOPMENT IN OLDER PATIENTS Henrique Palomba | Isac Castro | Sirlei Regina Sousa | Andressa Nascimento Jesus | Thiago Romano | Emannuel Burdmann | Luis Yu State Univ São Paulo | Hosp Sancta Maggiore SAP164 OUTCOME OF HOSP-ACQUIRED ACUTE KIDNEY INJURY ACCORDING TO AKIN CRITERIA: LONG-TERM FOLLOW UP Soon Hyo Kwon | Jin Young You | Yu Kyung Hyun | Sung Ae Woo | Jin Seok Jeon | Hyun Jin Noh | Dong Cheol Han Dept Internal Medicine, Soon Chun Hyang Univ Hosp, Seoul, Korea SAP165 THE VALIDITY OF THE URINE OUTPUT AND SERUM CREATININE AS CRITERIA OF RIFLE CLASSIFICATION IN OUTCOME OF AKI Liljana Tozija | Zvezdana Petronievic | Gjulsen Selim | Igor Nikolov | Olivera Stojceva-Taneva | Koco Cakalaroski Univ Clinic Nephrology, Univ Sts. Cyril and Methodius Skopje, R. Macedonia SAP166 CIRCULATING ANGIOPOIETIN-2 AS A MARKER OF A COMPLICATED COURSE OF E.COLI 0104:H4 INDUCED HEMOLYTIC UREMIC SYNDROME IN ADULT PATIENTS Alexander Lukasz | Jan Beneke | Bernhard Schmidt | Jan Kielstein | Hermann Haller | Jan Menne | Mario Schiffer Dept Nephrology & Hypertension, Hannover Medical School SAP167 FIBRATE-INDUCED ACUTE KIDNEY INJURY: A COMMON AND OCCASIONALLY IRREVERSIBLE COMPLICATION Natalia Polanco | Eduardo Hernandez | Eduardo Gutierrez | Victor Gutierrez Millet | Esther Gonzalez Monte | Enrique Morales | Manuel Praga 12 de Octubre Univ Hosp SAP168 A PROSPECTIVE OBSERVATIONAL BIOELECTRICAL IMPEDANCE STUDY: PROGNOSIS IN ACUTE KIDNEY INJURY Lavilla Francisco Javier | Garcia-Fernandez Nuria | Mora-Gutierrez Jose Maria| Maira Bes Rastrollo Clinica Univ Navarra, Pamplona, Spain w w w. e r a e d t a 2 01 2 . o r g 271 SATURDAY, MAY 26 SAP162 ACUTE KIDNEY INJURY AFTER AUTOLOGOUS BONE MARROW TRANSPL IN PACIENTS USING LOWER DOSAGE OF DIMETHYL SULFOXIDE Pastora M.A. Duarte | Fernando B. Duarte | Emanuelle M. Barros | Farnando Q.S. Castro | Geraldo Silva Junior | Elizabeth Daher School Medicine, Federal Univ Ceara, Fortaleza, Brazil | School Medicine, Univ Fortaleza, Fortaleza, Brazil 49th ERA-EDTA CONGRESS P O S T E R S SAP169 METFORMIN-ASSOCIATED LACTIC ACIDOSIS (MALA): A SINGLE CENTRE EXPERIENCE ON 14 PATIENTS Andrea Angioi | Maura Conti | Riccardo Cao | Alice Atzeni | Gianfranco Pili| Valeria Matta | Efisio Murgia | Patrizia Melis | Valentina Binda | Antonello Pani Div Nephrology and Dialysis, Azienda Osp G.Brotzu, Cagliari, Italy SAP170 PHARMACOKINETICS OF MEROPENEM WITH 3-HOUR INFUSION REGIMEN IN CRITICALLY ILL PATIENTS ON CONTINUOUS RENAL REPLACEMENT THERAPY Fernando Thomé | Fabiane Leusin | Elvino Barros | Cássia Morsch | Antônio Balbinotto | Carmen Pilla Hosp Clínicas Porto Alegre, Brazil SATURDAY, MAY 26 SAP171 ACUTE MYOGLOBINURIC RENAL FAILURE IN THE INTENSIVE CARE PATIENTS Vladimir Premru | Jadranka Buturović-Ponikvar | Rafael Ponikvar | Andreja Marn-Pernat | Bojan Knap | Janko Kovač | Jakob Gubenšek | Boštjan Kersnič | Ljuba Krnjak | Marija Prezelj Univ Medical Center Ljubljana, Slovenia SAP172 CLINICAL SIGNIFICANCE OF HIGH URINARY ALPHA-1-MICROGLOBULINE - PROMISING MARKER OF ACUTE KIDNEY INJURY? Jana Granatova | Martin Havrda | Zdenka Hruskova | Karolina Kratka | Ondrej Remes | Magdalena Mokrejsova | Milada Bolkova | Vera Lanska | Ivan Rychlik Thomayer Hosp, Prague, Dept Biochemistry | Charles Univ, 3rd Medical Fac, Prague, Czech Republic | Charles Univ, 1st Medical Fac, Prague, Czech Republic| Inst Clinical and Experimental Medicine, Prague, Czech Republic SAP173 DOES THE CAUSE OF ‘PRE-RENAL’ AKI IN A GENERAL HOSPITAL SETTING MAKE A DIFFERENCE TO OUTCOMES? Mark D. Uniacke | Robert J. Lewis | Scott Harris | Paul Roderick Wessex Renal and Transpl Serv, Portsmouth, UK | Univ Southampton, Southampton, UK SAP174 IMPROVEMENT IN OUTCOMES OVER TIME ARE BIASED BY ACUTE KIDNEY INJURY PATIENTS WHO DO NOT BENEFIT FROM RENAL REPLACEMENT THERAPY Fernando Thomé | Antônio Balbinotto | Elvino Barros | Cássia Morsch Hosp Clínicas Porto Alegre, Brazil SAP175 MAIN PAPER SHIGA-TOXIN INDUCED HUS Nitschke Martin | Kunzendorf Ulrich | Beneke Jan | Bramstedt Jörn | Brunkhorst Reinhard | Kielstein Jan | Haller Hermann | Meyer Tobias F. | Ramazan Leyla | Schmidt Bernhard M.W. | Schoecklmann Harald | Steinhoff Jürgen | Kuehbacher Tanja | Jan Menne | Schiffer Mario Univ Hosp Schleswig-Holstein | Medical School Hannover | Bremerhaven Hosp Reinkenheide | Hosp Hannover Oststadt | Asklepios Hosp Hamburg Barmbek| Dept Nephrology & Hypertension, Medical School Hannover, Germany SAP176 SYMPTOMS IN SHIGA-TOXIN INDUCED HUS PATIENTS Beneke Jan | Emden Sang Hi | Ramazan Leyla | Michael Claus | Vetter Frank| Sartison Aleksej | Samiri Sengül | Kielstein Jan | Bramstedt Jörn | Brunkhorst Reinhard | Meyer Tobias F. | Schmidt Bernhard M.W. | Schiffer Mario | Nitschke Martin | Kunzendorf Ulrich | Stingele Robert | Weissenborn Karin | Kuehbacher Tanja | Haller Hermann | Jan Menne Medical School Hannover | Hosp Reinkenheide | Hosp Hannover Oststadt | Asklepios Hosp Hamburg Barmbek | Univ Hosp Schleswig-Holstein | Dept Nephrology & Hypertension, Medical School Hannover, Germany 272 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP177 WOMEN ARE PRONE TO DEVELOP A MORE SEVERE COURSE OF SHIGATOXIN MEDIATED HUS Ramazan Leyla | Kielstein Jan | Beneke Jan | Brunkhorst Reinhard | Gueler Feikah | Haller Hermann | Kuehbacher Tanja | Kunzendorf Ulrich | Menne Tobias F. | Michael Claus | Nitschke Martin | Schiffer Mario | Schmidt Bernhard M.W.| Schoecklmann Harald | Steinhoff Jürgen | Jan Menne Medical School Hannover | Hosp Hannover Oststadt | Univ Hosp SchleswigHolstein | Freeman Hosp | Dept Nephrology & Hypertension, Medical School Hannover, Germany ¯ SAP179 BEST SUPPORTIVE CARE AND THERAPEUTIC PLASMA EXCHANGE Jan Kielstein | Gernot Beutel | Susanne Fleig | Jürgen Steinhoff | Tobias Meyer | Carsten Hafer | Joern Bramstedt | Veit Busch | Martin Vischedyk | Uwe Kuhlmann | Wolfgang Ries | Steffen Mitzner | Stefan Mees | Sylvia Stracke| Jens Nürnberger | Peter Gerke | Monika Wiesner | Bernd Sucke | Miriam AbuTair | Andreas Kribben | Norbert Klause | Ralf Schindler | Frank Merkel | Sabine Schnatter | Eiske Dorresteijn | Ola Samuelsson | Reinhard Brunkhorst | German STEC-HUS Registry Medical School Hannover | Univ Hosp Lübeck | Asklepios Klinik Hamburg | Klinikum Bremerhaven | Univ Hosp Münster | St. Vinzenz Krankenhaus Paderborn| Klinikum Bremen Mitte | Diakonissenkrankenhaus Flensburg | Center Extracorporeal Organ Support Univ Rostock | Walddoerfer Dialyse | Nephrology | Helios Klinikum Schwerin | Nierenzentrum am Sana Klinikum | Klinikum Oldenburg | Klinikum Darmstadt | Evangelisches Krankenhaus Gilead | Dept Nephrology, Univ Hosp Essen, Univ Duisburg-Essen, Essen, Germany | Nephrologisches Zentrum Rendsburg-Eckernfoerde | Charité-Virchow Klinik | Klinikum Merheim| Klinikum Ernst v. Bergmann | Erasmus Medical Center, Rotterdam, Netherlands | Dept Kidney Diseases, Sahlgrenska Univ Hosp, Gothenburg, Sweden | President German Society of Nephrology | German STEC-HUS Registry SAP180 CAMPYLOBACTER INFECTION PRESENTING WITH BLOODY DIARRHEA: SONOGRAPHIC DIFFERENTIATION FROM EHEC/STEC INFECTION DURING A LARGE OUTBREAK IN GERMANY Ansgar Reising | Carsten Hafer | Jan Kielstein | Bernhard Schmidt | FranzChristoph Bange | Marcus Hiss Dept Nephrology and Hypertension, Medical School Hannover, Germany | Medical School Hannover | Dept Microbiology, Medical School Hannover SAP181 MARKED AND PROLONGED DECREASE IN THE NO PRODUCTION CAPACITY IN PATIENTS WITH STEC-HUS INDICATED BY A LOW L-ARGININE/ ADMA RATIO Frank Vetter | Jan Beneke | Stefanie M Bode-Böger | Jens Martens-Lobenhoffer| Mario Schiffer | Bernhard M. W. Schmidt | Herrmann Haller | Jan Menne | Jan T Kielstein Dept Nephrology and Hypertension Medical School Hannover, Hannover, Germany | Inst Clinical Pharmacology, Otto-von-Guericke Univ, Magdeburg, Germany SAP181bis OUTCOMES OF ACUTE KIDNEY INJURY PATIENTS WITH AND WITHOUT CANCER Ho Sik Shin | Yeon Soon Jung | Hark Rim Kosin Univ College Medicine, Busan, Korea w w w. e r a e d t a 2 01 2 . o r g 273 SATURDAY, MAY 26 SAP178 PREDICTIVE PARAMETERS FOR PATIENTS WITH SHIGA-TOXIN INDUCED HUS Michael Claus | Kielstein Jan | Beneke Jan | Brunkhorst Reinhard | Gueler Feikah | Haller Hermann | Kunzendorf Ulrich | Menne Tobias F. | Meyer Tobias N.| Nitschke Martin | Ramazan Leyla | Schmidt Bernhard M.W. | Schoecklmann Harald | Steinhoff Jürgen | Kuehbacher Tanja | Schiffer Mario | Jan Menne Medical School Hannover | Hosp Hannover Oststadt | Universital Hosp Schleswig-Holstein | Freeman Hosp | Asklepios Hosp Hamburg Barmbek | Dept Nephrology & Hypertension, Medical School Hannover, Germany 49th ERA-EDTA CONGRESS P O S T E R S CLINICAL NEPHROLOGY EPIDEMIOLOGY II SAP182 THE BIRMINGHAM VASCULITIS ACTIVITY SCORE (BVAS) PREDICTS ALL CAUSE MORTALITY IN PATIENTS WITH ANCA ASSOCIATED VASCULITIS Haris Agnes | Polner Kalman | Aranyi Jozsef | Braunitzer Henrik | Istvan Mucsi Nephrology Dept, St. Margit Hosp, Budapest, Hungary | McGill Univ Health Centre, Montreal, Quebec, Canada SATURDAY, MAY 26 SAP183 CLINICAL CHARACTERISTICS OF PRIMARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME (APS) WITH CHRONIC KIDNEY DISEASE (CKD) Kouju Kamata | Takashi Sano | Shokichi Naito | Tomoko Okamoto | Chikako Okina | Mariko Kamata | Junya Murano | Kei Kobayashi | Mamiko Uchida | Togo Aoyama | Yasuo Takeuchi | Yasushi Nagaba | Hisato Sakamoto Kitasato Univ School Medicine | Kitasato Univ, Sagamihara, Japan | Kitasato Univ Hosp, Kanagawa, Japan « SAP184 LUNG CONGESTION BY ULTRASOUND PREDICTS DEATH AND CARDIOVASCULAR COMPLICATIONS IN HEMODIALYSIS (HD) PATIENTS: A MULTICENTRE COHORT STUDY Claudia Torino | Vincenzo Panuccio | Anna Clementi | Maurizio Garozzo | Graziella Bonanno | Rosalia Boito | Giuseppe Natale | Teresa Cicchetti | Antonio Chippari | Domenico Logozzo | Giovanni Alati | Simonetta Cassani | Arcangelo Sellaro | Graziella D’Arrigo | Giovanni Tripepi | Aliotta Roberta | Maurizio Postorino | Francesca Mallamaci | Carmine Zoccali CNR-IBIM, Reggio Calabria | Lung Comets Cohort (LCC) Working Group | CNR IBIM and Osp Riuniti, Reggio Calabria SAP185 CARDIOVASCULAR EVENTS AND INCEPTION OF DIALYSIS IN DIABETIC AND NON-DIABETIC CKD PATIENTS WITH CORONARY ARTERY CALCIFICATION. FOLLOW-UP STUDY Elisa Buonanno | Stefania Brancaccio | Vanessa Fimiani | Paola Napolitano | Rosanna Spadola | Luigi Morrone | Biagio Di Iorio | Domenico Russo Univ Naples Federico II, Naples, Italy | Osp Rummo, Benevento, Italy | Osp Landolfi, Solofra, Avellino, Italy SAP186 EARLY DETECTION OF ATHEROMATOUS DISEASE AT ALL STAGES OF CHRONIC KIDNEY DISEASE IMPROVES WITH SIMULTANEOUS FEMORAL AND CAROTID ULTRASOUND Angels Betriu | Montserrat Martinez-Alonso | Teresa Vidal | Jose Valdivielso| Elvira Fernandez IRBLleida, Lleida, Spain | Hosp Arnau Vilanova, Lleida, Spain SAP187 A PROSPECTIVE STUDY IN VERY ELDERLY (>80 YEARS) PATIENTS WITH CKD STAGE 4-5 NEWLY REFERRED FOR NEPHROLOGY CARE Faller Bernadette | Beuscart Jean-Baptiste | Luc Frimat Serv Néphrologie, Hôp Pasteur | Serv Néphrologie, CHU Lille | Nephrology Dept, Nancy Univ SAP188 CKD AND CVD RISK FACTORS IN THE POORLY-RESOURCED NORTHERN KWAZULU-NATAL, SOUTH AFRICA N.D. Madale | G.P. Thusi | N. Sibisi | B.G. Mazubuki | A.G.H. Assounga Univ Kwazulu-Natal, Durban, South Africa SAP189 DIURETICS TREATMENT AND RELATED SERUM SODIUM IMBALANCE ARE ASSOCIATED WITH WORSE CLINICAL OUTCOME IN CHRONIC KIDNEY DISEASE PATIENTS Ni-Chin Tsai | Hsiao-Han Wang | Yun-Chen Chen | Chi-Chih Hung | ShangJyh Hwang | Hung-Chen Chen Kaohsiung Medical Univ Hosp 274 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP190 HEART RATE VARIABILITY IN CKD PATIENTS Patricia Branco | Teresa Adragao | Rita Birne | Ana Rita Martins | Ricardo Vizinho | Augusta Gaspar | Maria José Grilo | Jose Diogo Barata | Daniel Bonhorst | Pedro Adragão Hosp Santa Cruz, Lisbon, Portugal | Inst Português Ritmo Cardíaco, Oeiras, Portugal SAP191 THE E/E' RATIO CAN PREDICT MORTALITY AND CARDIOVASCULAR EVENTS IN CKD PATIENTS WITH DIASTOLIC DYSFUNCTION Jae Seok Kim | Min Keun Kim | Seung Ok Choi | Byoung Geun Han Yonsei Univ Wonju College of Medicine, Wonju, Korea SAP193 IMPORTANCE OF BLOOD PRESSURE CONTROL IN THE HIGH RISK POPULATION OF CHRONIC KIDNEY DISEASE: FROM THE RESULTS OF THE KIDNEY EARLY EVALUATION PROGRAM IN JAPAN Mitsuru Yanai | Kazuyoshi Okada | Kazuhisa Takeuchi | Kosaku Nitta | Susumu Takahashi Div General Medicine, Dept Internal Medicine, Nihon Univ School Medicine | International Kidney Evaluation Association Japan, Tokyo, Japan SAP194 MODERATE AND SEVERE CORONARY CALCIFICATIONS IN NON DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS. WHICH BIOMARKERS? FIBROBLAST GROWTH FACTOR-23 AND/OR OSTEOPROTEGERIN? Marion Morena | Isabelle Jaussent | Aurore Halkovich | Anne-Marie Dupuy | Anne-Sophie Bargnoux | Leila Chenine | Hélène Leray-Moragues | Kada Klouche | Hélène Vernhet | Bernard Canaud | Jean-Paul Cristol IRFD, CHRU, Montpellier, France | INSERM U1061, Montpellier, France | CHRU, Montpellier, France | Lab Biochimie, CHRU Montpellier | CHRU, Serv Néphrologie, Hémodialyse et Soins Intensifs, Montpellier, France | CHRU, Serv Réanimation Métabolique, Montpellier, France | CHRU, Serv Radiologie, Montpellier, France | Univ Montpellier, Hôp Lapeyronie, Dept Nephrology, Montpellier, France SAP195 THE LOW GLOMERULAR FILTRATION RATE IN PATIENTS WITH CHRONIC HEART FAILURE IS ASSOCIATED WITH HIGH INCIDENCE OF ARTERIAL HYPOTENSION Alexander Shutov | Valery Serov | Julia Kuznetsova | Maxim Menzorov | Diana Serova Ulyanovsk State Univ, Ulyanovsk, Russian Federation SAP196 VASCULAR CALCIFICATION, ARTERIAL STIFFNESS AND HYPERHYDRATION: PREVALENCE, DETERMINANTS AND CORRELATIONS IN NONDIALYSED CKD PATIENTS Ligia Petrescu | Adrian Zugravu | Cristina Capusa | Simona Stancu | Simona Cinca | Cristina Anghel | Delia Timofte | Lacramioara Medrihan | Dorin Ionescu | Gabriel Mircescu Nephrology, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania| Dr Carol Davila Teaching Hosp Nephrology, Bucharest, Romania | Dialmed Dialysis Centers S.R.L., Bucharest, Romania | Univ Emergency Hosp, Bucharest, Romania SAP197 SEVERITY OF CORONARY ARTERY DISEASE AND SUBSEQUENT RENAL w w w. e r a e d t a 2 01 2 . o r g 275 SATURDAY, MAY 26 SAP192 ESTIMATED GLOMERULAR FILTRATION RATE DOES NOT ASSOCIATE WITH THE CONCENTRATION OF LOW MOLECULAR WEIGHT PROTEINS IN CHRONIC KIDNEY DISEASE Neirynck Nathalie | Eloot Sunny | Griet Glorieux | Barreto Daniela | Barreto Fellype | Liabeuf Sophie | Lemke Horst D | Massy Ziad | Vanholder Raymond Ghent Univ Hosp, Gent, Belgium | INSERM ERI-12 (EA4292), Amiens, France | EXcorLab GmbH, Obernburg, Germany | Amiens Univ Hosp, Amiens, France 49th ERA-EDTA CONGRESS P O S T E R S FUNCTION DECLINE IN NON-DIABETIC PATIENTS Ta-Wei Hsu | Ko-Lin Kuo | Szu-Chun Hung | Der-Cherng Tarng National Yang-Ming Univ Hosp, Yilan, Taiwan | Div Nephrology, Buddhist Tzu Chi Hosp Taipei Branch | Div Nephrology, Dept Medicine, Taipei Veterans General Hosp, and Inst Physiology and Clinical Medicine, National Yang-Ming Univ, Taipei, Taiwan SAP198 DECREASED RENAL FUNCTION IS INDEPENDENTLY ASSOCIATED WITH THE SEVERITY OF CORONARY ARTERY DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE Soobong Lee | Ilyoung Kim | Dongwon Lee | Harin Rhee | Sangheon Song | Eunyoung Seong | Ihmsoo Kwak Pusan National Univ School Medicine, Busan, Korea SATURDAY, MAY 26 SAP199 RENAL DYSFUNCTION AND RISK OF FIRST HOSPITALIZATION FOR HEART FAILURE FOLLOWING CORONARY ARTERY BYPASS GRAFTING Martin Holzmann | Carl Gardell | Anders Jeppsson | Ulrik Sartipy Karolinska Inst | Göteborgs Univ SAP200 MALNUTRITION, INFLAMMATION, AND ATHEROSCLEROSIS SYNDROME COMPONENTS PREDICTS POOR CARDIOVASCULAR OUTCOMES IN PATIENTS WITH STAGE 3-5 CHRONIC KIDNEY DISEASE Yalcin Solak | Mahmut Ilker Yilmaz | Kayser Caglar | Mutlu Saglam | Halil Yaman | Alper Sonmez | Hilmi Umut Unal | Mahmut Gok | Abduzhappar Gaipov | Mehmet Kayrak | Tayfun Eyileten | Suleyman Turk | Abdulgaffar Vural Konya Univ Meram School Medicine, Konya, Turkey | Gulhane School Medicine, Ankara, Turkey SAP201 ECHOCARDIOGRAPHY, RIGHT VENTRICULAR FUNCTION AND CHRONIC KIDNEY DISEASE Luca Di Lullo | Fulvio Floccari | Rodolfo Rivera | Antonio Granata | Alessandro D'Amelio | Franco Logias | Giovanni Otranto | Moreno Malaguti | Alberto Santoboni | Fulvio Fiorini Dept Nephrology and Dialysis, L. Parodi Delfino Hosp, Colleferro (Roma), Italy| Dept Nephrology and Dialysis, S. Paolo Hosp, Civitavecchia (Roma), Italy | Dept Nephrology S. Gerardo Hosp, Monza, Italy | Dept Nephrology and Dialysis, S. Giovanni di Dio Hosp, Agrigento, Italy | Dept Nephrology, Dialysis and Transpl Vito Fazzi Hosp, Lecce, Italy | Dept Nephrology and Dialysis Sorgono Hosp, Sorgono (Nuoro), Italy |Dept Nephrology and Dialysis S. Maria della Misericordia Hosp, Rovigo, Italy SAP202 HIGH INCIDENCE OF END-STAGE RENAL DISEASE IN THE TURKISHCYPRIOT POPULATION OF NORTHERN CYPRUS: A POPULATION BASED STUDY Thomas Connor | Deren Oygar | Dorothea Nitsch | Danniel Gale | Retha Steenkamp | Guy H. Neild | Patrick Maxwell Univ College London | Nicosia State Hosp | London School Hygiene and Tropical Medicine | UK Renal Registry SAP203 ESTIMATION OF KIDNEY FUNCTION IN CANCER PATIENTS WITH RISK FACTORS OF CHRONIC KIDNEY DISEASE Ida Louise Høgsbro | Belén Redal-Baigorri Roskilde Univ Hosp, Roskilde, Denmark SAP204 EXISTENCE OF AN INTERNATIONAL NETWORK OF WORKING GROUPS ON OUTCOMES MEASURES IS ASSOCIATED WITH BETTER REPORTING AND GREATER HOMOGENEITY IN OUTCOME MEASUREMENT IN RANDOMISED TRIALS: RHEUMATOLOGY VERSUS NEPHROLOGY Benedicte Sautenet | Jean Michel Halimi | Agnes Caille | Philippe Goupille | Bruno Giraudeau Hop Bretonneau, Tours, France | CHU Bretonneau, Tours, France 276 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP205 RED CELL DISTRIBUTION WIDTH INDEPENDENTLY PREDICTS CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE Yalcin Solak | Mahmut Ilker Yilmaz | Kayser Caglar | Mutlu Saglam | Halil Yaman | Hilmi Umut Unal | Mahmut Gok | Yusuf Oguz | Abduzhappar Gaipov | Mujdat Yenicesu | Hakki Cetinkaya | Tayfun Eyileten | Suleyman Turk| Abdulgaffar Vural Konya Univ Meram School Medicine, Konya, Turkey | Gülhane School Medicine, Ankara, Turkey SAP207 OUTCOMES IN HEPATOCELLULAR CARCINOMA AND RENAL FUNCTION Yu Ishimoto | Takamasa Ohki | Mai Sugahara | Takafumi Kanemitsu | Masafumi Kobayashi | Lisa Uchida | Nagaaki Kotera | Shinji Tanaka | Tokuichiro Sugimoto | Naobumi Mise Mitsui Memorial Hosp, Tokyo, Japan SAP208 TRADITIONAL THERMAL THERAPY WITH INDIRECT-MOXIBUSTION REDUCES THE RESISTIVE INDEX OF RENAL SEGMENTAL ARTERIES IN PATIENTS WITH CHRONIC KIDNEY DISEASE Nagisa Miyazaki | Jun Matsumoto | Ichijiro Murata | Gakuro Yoshida | Kentaro Morishita | Hiroaki ushikoshi | Kazuhiko Nishigaki | Shinji Ogura | Shinya Minatoguchi Dept Cardiology, Respirology & Nephrology, Gifu Univ Grad School Medicine, Gifu, Japan | Advanced Critical Care Centre, Gifu Univ Hosp, Gifu, Japan SAP209 PATIENT-CENTERED, COLLABORATIVE, COMMUNITY RENAL CLINIC Rebecca Harvey | Azhar Ala | Debasish Banerjee St Georges, Univ London | Lambeth Primary Healthcare Trust | St Georges Healthcare NHS Trust, London UK SAP210 CLINICAL DECISION SUPPORT IN PRIMARY CARE LEADS TO REDUCED LATE REFERRAL FOR RENAL REPLACEMENT THERAPY Christopher Farmer | Jean Irving | Helen Hobbs | Toby Wheeler | Bernhard Klebe | Paul Stevens East Kent Univ Hosp NHS Found Trust SAP211 EARLY NEPHROLOGY REFERRAL AND LATE INITIATION OF DIALYSIS PREDICTS SURVIVAL IN HEMODALYSIS PATIENTS: 5 YEAR FOLLOW-UP ANALYSIS Gjulsen Selim | Olivera Stojceva-Taneva | Liljana Tozija | Nikola Stojcev | Saso Gelev | Pavlina Dzekova-Vidimliski | Svetlana Pavleska | Aleksandar Sikole Univ Clinic Nephrology, Univ Sts. Cyril and Methodius Skopje, R. Macedonia SAP212 INCREASE IN RENAL REPLACEMENT THERAPY INCIDENCE HAS COME TO AN END IN SWEDEN Abdul Rashid Qureshi | Marie Evans | Maria Stendahl | Karl Göran Prütz | Carl Gustaf Elinder Karolinska Inst | Div Renal Medicine, CLINTEC Karolinska Inst, Stockholm, Sweden| Dept Internal Medicine, Ryhov Hosp, Jönköping, Sweden | Dept Internal Medicine, Helsingborg Hosp, Helsingborg, Sweden SAP213 LEFT VENTRICULAR GEOMETRIC PATTERNS IN THE PROGRESSION OF w w w. e r a e d t a 2 01 2 . o r g 277 SATURDAY, MAY 26 SAP206 SIMILARITY AND DIFFERENCE IN CLINICAL OUTCOMES BETWEEN PATIENTS WITH DIABETIC NEPHROPATHY AND CHRONIC GLOMERULONEPHROPATHY IN A PROPENSITY SCORE MATCHED COHORT OF CHRONIC KIDNEY DISEASE Yun-Chen Chen | Hsiao-Han Wang | Ni-Chin Tsai | Chi-Chih Hung | ShangJyh Hwang | Hung-Chen Chen Kaohsiung Medical Univ Hosp 49th ERA-EDTA CONGRESS P O S T E R S CHRONIC KIDNEY DISEASE Keiichi Tamagaki | Hiroshi Kado | Mayumi Nakata | Takashi Kitani | Noriyoshi Ota | Ryo Ishida | Eiko Matsuoka | Yayoi Shiotsu | Mami Ishida | Yasukiyo Mori Kyoto, Japan SAP214 IMPACT OF THE MANAGEMENT OF CKD PATIENTS IN A CARE NETWORK ON EARLY CARDIOVASCULAR MORBIDITY AND PREMATURE MORTALITY IN INCIDENT DIALYSIS PATIENTS Maurice Christelle | Nicolas Rognant | Decullier Evelyne | Fave Sophie | Juillard Laurent | Laville Maurice Hospices Civils Lyon, Lyon, France | Réseau TIRCEL, Lyon, France | Hôp Edouard Herriot, Lyon, France SATURDAY, MAY 26 SAP215 CHILDHOOD BODY MASS INDEX TRAJECTORY AND CHRONIC KIDNEY DISEASE AT AGE 60-4 YEARS Richard Silverwood | Mary Pierce | Diana Kuh | Caroline Savage | Charles Ferro | Dorothea Nitsch London School Hygiene and Tropical Medicine, London, UK | MRC Unit Lifelong Health and Ageing, Univ College London, London | Univ Birmingham, Birmingham | Queen Elizabeth Hosp, Birmingham SAP216 COURSE OF UREMIC SYMPTOMS AND QUALITY OF LIFE DURING PREDIALYSIS CARE de Goeij Moniek | Halbesma Nynke | Ocak Gurbey | Rotmans Joris | Dekker Friedo Leiden Univ Medical Center, Dept Clinical Epidemiology, Leiden, Netherlands | Leiden Univ Medical Center, Dept Nephrology, Leiden, Netherlands SAP217 SOCIO-ECONOMIC STATUS AND INCIDENCE OF RENAL REPLACEMENT THERAPY IN AUSTRALIA Philip Clayton | Blair Grace | Alan Cass | Stephen McDonald Australia and New Zealand Dialysis and Transpl Registry | George Inst Global Health SAP218 SERUM PHOSPHATE QUALIFIES AS AN ATHEROSCLEROTIC RISK FACTOR PARTICULARLY IN THE SETTING OF YOUNGER CKD PATIENTS Victor Lorenzo | Marisa Martin Conde | Angels Betriu | Adriana Dusso | Jose M Valdivielso | Elvira Fernandez Hosp Univ La Laguna, Tenerife | IRBLleida, Lleida, Spain | Nefrologia Experimental IRB Lleida | Hosp Arnau Vilanova, Lleida SAP219 SHPT PARAMETERS AND THERAPEUTIC COSTS IN PATIENTS NEW TO HAEMODIALYSIS: A SUB POPULATION ANALYSIS OF THE FARO2 STUDY Daniela Paola Roggeri | Giuseppe Cannella | Mario Cozzolino | Sandro Mazzaferro | PierGiorgio Messa | Diego Brancaccio Health Economist, Bergamo, Italy | Nefrologia, Osp S Martino, Genova, Italy | DMCO, UO Nefrologia e Dialisi AO San Paolo, Univ Milano, Italy | Sapienza, Univ Roma, Italy | Nefrologia, Osp Policlinico, Milano, Italy | UO Emodialisi Simone Martini, Milano, Italy SAP220 THE PULMONARY FUNCTION AND PHYSICAL CAPACITY BEHIND THE KIDNEY: AN EVALUATION OF PATIENTS WITH PRE-DIALYTIC CHRONIC KIDNEY DISEASE Ruiter de Souza Faria | Natalia Fernandes | Julio Lovisi | Murilo Moura Marta | Maycon Reboredo | Bruno do Vale Pinheiro | Marcus Bastos Interdisciplinary Program Studies, Res, and Treatment in Nephrology, Federal Univ Juiz de Fora, Juiz de Fora – MG, Brazil SAP221 PRECAPILLARY PULMONARY HYPERTENSION IN PATIENTS WITH 278 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France CHRONIC KIDNEY DISEASE ON DIALYSIS AND WITHOUT DIALYSIS: RESULTS OF THE PEPPER-STUDY Felix Hundt | Stefan Pabst | Christoph Hammerstingl | Thomas Gerhardt | Dirk Skowasch | Rainer Woitas Univ Hosp Bonn, Clinic Internal Medicine I, Bonn | Univ Hosp Bonn, Clinic for Internal Medicine II, Bonn | Praxis für Nieren und Hochdruckkrankheiten, Bonn, Germany SAP223 EFFECT MODIFICATION BY ARGININE OF ADMA-RELATED LONG-TERM CLINICAL OUTCOMES IN AN ELDERLY GENERAL POPULATION Francesco Pizzarelli | Pietro Dattolo | Giovanni Tripepi | Stefano Michelassi | Cristina Rossi | Stefania Bandinelli | Maren Mieth | Renke Mass | Luigi Ferrucci| Carmine Zoccali S M Annunziata Hosp, Florence, Italy | CNR-IBIM and Nephrology-Transpl Unit, Osp Riuniti, Reggio Calabria, Italy | Geriatric Unit and InCHIANTI Study, Florence, Italy | Clinical Pharmacology, Univ Erlangen-Nuremberg, Nuremberg, Germany | National Inst Aging, Baltimore, USA SAP224 MULTIPLE GESTATION IN CKD PATIENTS: AN EXPLOSIVE MIX Silvia Parisi | Silvana Arduino | Rossella Attini | Federica Fassio | Marilisa Biolcati | Arianna Pagano | Carlotta Bossotti | Martina Ferraresi | Piero Gaglioti| Tullia Todros | Giorgina Barbara Piccoli Materno-Foetal Unit, Dept Obstetrics, ASOU OIRM S Anna, Univ Torino, Italy | SS Nefrologia Dept Clinical and Biological Sciences, ASOU San Luigi Gonzaga, Univ Torino, Italy SAP225 DISCORDANCES IN THE CLASSIFICATION OF RENAL IMPAIRMENT IN SUMMARIES OF PRODUCT CHARACTERISTICS Teresa M. Salgado | Blanca Arguello | Shalom I. Benrimoj | Fernando Fernandez-Llimos Res Inst Medicines and Pharmaceutical Sciences (iMed.UL), Fac Pharmacy, Univ Lisbon, Lisbon, Portugal | Grad School Pharmacy, Univ Technology Sydney, Sydney, Australia | Res Inst Medicines and Pharmaceutical Sciences (iMed.UL), Dept Social Pharmacy, Fac Pharmacy, Univ Lisbon, Portugal SAP226 COMPARING METHODS OF ESTIMATING RENAL FUNCTION IN AN INDIAN POPULATION: ASSOCIATION WITH DXA MEASURED MUSCLE MASS Pippa Bailey | Charlie Tomson | Yoav Ben-Shlomo Southmead Hosp, Bristol, UK | School Social and Community Medicine, Bristol Univ, UK SAP227 THE CLASSIFICATION TREE METHODOLOGY: A NEW WAY TO ESTIMATE THE RISK AND THE PREDICTORS OF PROGRESSION OF CHRONIC KIDNEY DISEASE Antonio Santoro | Paola Rucci | Marcora Mandreoli | Francesco Caruso | Mattia Corradini | Marta Flachi | Dino Gibertoni | Angelo Rigotti | Giorgia Russo| Mariapia Fantini Malpighi Hosp, Bologna, Italy | Dept Medicine and Public Health, Univ Bologna| Unità Operativa Nefrologia, Dialisi e Ipertensione, Azienda S.Orsola - Malpighi, Bologna, Italy | Osp Ramazzini, Carpi- Italy | Nephrology and Dialysis Unit Arcisp Santa Maria Nuova, Reggio Emilia , Italy | Dept Nephrology and Dialysis, Osp Bufalini; Cesena | Osp Infermi, Rimini-Italy | Arcisp S. Anna, Ferrara -Italy w w w. e r a e d t a 2 01 2 . o r g 279 SATURDAY, MAY 26 SAP222 ASSOCIATIONS OF HANDGRIP STRENGTH WITH MORTALITY RISK AND HEALTH-RELATED QUALITY OF LIFE IN MAINTENANCE HAEMODIALYSIS PATIENTS: A 6-YEAR COHORT STUDY Antonio Alberto Lopes | Luciana Ferreira Silva | Cácia Mendes Matos | Márcia Silva Martins | Fernanda Albuquerque Silva | Gildete Barreto Lopes Fac Medicina Bahia, Univ Federal Bahia, Salvador, Brazil | Univ Estado Bahia, Salvador, Brazil | Inst Nefrologia e Diálise, Salvador, Brazil | Clinica Rim e Hipertensão, Salvador, Brazil | Clínica NEPHRON, Salvador, Brazil | Federal Univ Bahia, Salvador, Brazil 49th ERA-EDTA CONGRESS P O S T E R S SAP228 SCREENING FOR DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE (CKD) AMONG HIGH RISK CENTRAL GOVERNMENT EMPLOYEES IN DELHI, INDIA: A WHO SPONSORED PILOT STUDY Himansu Sekhar Mahapatra | Shamsunder Choudhury | Gurdeep Buxi | Neera Sharma | Yadunanda Gupta | Venkentsan Sekhar PGIMER, Dr. RML Hosp New Delhi, India | ICFAI Business School, Gurgaon, Hariyana, India SATURDAY, MAY 26 SAP229 DEVELOPMENT OF A QUESTIONNAIRE TO CLASSIFY POPULATION IN TO HIGH RISK (HR) AND NO RISK (NR) GROUPS FOR CHRONIC KIDNEY DISEASE (CKD) SCREENING AMONG CENTRAL GOVERNMENT EMPLOYEES IN DELHI, INDIA Himansu Sekhar Mahapatra | Shamsunder Choudhury | Gurdeep Buxi | Neera Sharma | Yadunanda Gupta | Venkentsan Sekhar PGIMER, Dr. RML Hosp New Delhi, India | ICFAI Business School, Gurgaon, Hariyana, India SAP230 RISK CATEGORY SYSTEM COMBINED GLOMERULAR FUNCTION WITH ALBUMINURIA HAS BETTER ABILITY TO PREDICT ADVERSE OUTCOMES IN HIV-INFECTED MEN Naoki Yanagisawa | Minoru Ando | Atsushi Ajisawa | Ken Tsuchiya | Kosaku Nitta Dept Infectious Diseases and Nephrology, Tokyo Metropolitan Komagome Hosp, Tokyo, Japan | Dept IV Internal Medicine, Tokyo Women's Medical Univ, Tokyo, Japan SAP231 PSYCHOLOGICAL ASPECTS OF THE QUALITY OF LIFE (QoL)IN DIALYSED PATIENTS. PART II: CORRELATION BETWEEN THE QoL AND THE PERSONALITY TYPE OF DIALYSED PERSONS Ostrowski Janusz | Majkowicz Mikołaj | Manitius Jacek | Rutkowski Bolesław Dept Nephrology, Wloclawek, Poland | Dept Psychiatric Diseases and Neurotic Disorders, Medical Univ, Gdańsk, Poland | Dept Nephrology and Internal Medicine, Medical Univ, Bydgoszcz, Poland | Dept Nephrology, Transpl and Internal Medicine, Medical Univ, Gdańsk, Poland « SAP232 GEOGRAPHIC DISTRIBUTION OF SERVS MAY BE A BARRIER TO HOME DIALYSIS IN THE USA Suma Prakash | Rick Coffin | Jesse Schold | Douglas Einstadter | Susan Stark | Darlene Rodgers | Matthew Howard | Ashwini Sehgal Case Western Reserve Univ, Cleveland Ohio, USA | Renal Netowrk, Indianapolis, USA | Cleveland Clinic Foundation | MetroHealth Medical Center | The Intermountain ESRD Network SAP233 IDENTIFICATION OF CHRONIC KIDNEY DISEASE IN PRIMARY CARE AND THE INFLUENCE OF COMPUTERISED CLINICAL DECISION SUPPORT Paul Stevens | Jean Irving | Toby Wheeler | Bernhard Klebe | Christopher Farmer East Kent Univ Hosp NHS Found Trust SAP234 SYSTEMATIC REVIEW: HOME VERSUS IN-CENTER HEMODIALYSIS FOR PEOPLE WITH END-STAGE KIDNEY DISEASE Suetonia Palmer | Allison Tong | Braden Manns | Jonathan Craig | Marinella Ruospo | Letizia Gargano | Giovanni Strippoli Univ Otago Christchurch, New Zealand | Univ Sydney | Univ Calgary, Calgary, Alberta | Diaverum Medical Scientific Office | Cochrane Renal Group, Sydney, Australia SAP235 ORAL DISEASE IN PEOPLE WITH CHRONIC KIDNEY DISEASE: METAANALYSIS OF PREVALENCE AND ASSOCIATION WITH CLINICAL OUTCOMES Marinella Ruospo | Suetonia Palmer | Mariacristina Vecchio | Letizia Gargano| 280 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Massimo Petruzzi | M De Benedictis | Fabio Pellegrini | Giovanni Strippoli Diaverum Medical Scientific Office | Univ Otago Christchurch, New Zealand| Consorzio Mario Negri Sud, Italy | Univ Bari, Italy | Cochrane Renal Group, Sydney, Australia SAP236 PREVALENCE OF AND FACTORS ASSOCIATED WITH CHRONIC KIDNEY DISEASE IN JAPANESE SUBJECTS, WHO HAVE NO KNOWN CHRONIC DISEASE, UNDERGOING AN ANNUAL HEALTH CHECKUP Yoshiteru Ohno | Eiji Ishimura | Toshihide Naganuma | Kyoko Kondo | Wakaba Fukushima | Kayo Mui | Masaaki Inaba | Yoshio Hirota Osaka City Univ Grad School Medicine SAP238 DETECTING RISK FACTORS FOR KIDNEY DISEASE IN THE GENERAL POPULATION – EXPERIENCE OF NEPHROLOGY CAMPAIGNS IN A LARGE URBAN CENTER IN BRAZIL Elizabeth Daher | Geraldo Silva Junior | Camilla N. Jacinto | Rodrigo S. Pimentel | Graziela B.R. Aguiar | Caroline B. Lima | Renata C. Borges | Livia P.C. Mota | João Victor L. Melo | Saulo A. Melo | Vanessa T. Canamary | Marilia Alves | Sônia M.H.A. Araújo School Medicine, Federal Univ Ceara, Fortaleza, Brazil | School Medicine, Univ Fortaleza, Fortaleza, Brazil SAP239 WHY ELDER CHRONIC KIDNEY DISEASE PATIENTS HAVE LESS DIALYSIS THAN DEATH, BESIDES THE EFFECT OF COMPETING RISK OF DEATH? Yun-Chen Chen | Yen Kai Huang | Ni-Chin Tsai | Hsiao-Han Wang | Chi-Chih Hung | Shang-Jyh Hwang | Hung-Chen Chen Kaohsiung Medical Univ Hosp, Kaohsiung City, Taiwan SAP240 CD14++CD16+ MONOCYTES ARE PREDICTORS OF CARDIOVASCULAR OUTCOME Kyrill Rogacev | Bodo Cremers | Adam Zawada | Sarah Seiler | Nadine Binder| Philipp Ege | Gunnar Große-Dunker | Isabel Heisel | Florian Hornof | Jana Jeken | Niko Rebling | Christof Ulrich | Bruno Scheller | Michael Böhm | Danilo Fliser | Gunnar Henrik Heine Dept Internal Medicine IV, Dept Internal Medicine III, Saarland Univ Medical Center | Inst Medical Biometry and Medical Informatics, Univ Medical Center, Freiburg SAP241 INTERNATIONAL VARIATION IN INFLUENZA VACCINATION PRACTICES AND COVERAGE RATES AMONG HEMODIALYSIS PATIENTS: AN OPPORTUNITY TO IMPROVE CARE BM Robinson | Mia Wang | Brian Bieber | Richard Fluck | Peter G. Kerr | Björn Wikström | Mahesh Krishnan | Allen Nissenson | Ronald L. Pisoni Arbor Res Collaborative for Health, Ann Arbor, Michigan, USA | Derby City General Hosp, UK | Monash Univ, Australia | Akademiska Hosp,Uppsala, Sweden | DaVita, Washington, USA | DaVita, El Segundo, USA SAP242 BELIEFS ABOUT MEDICINES IN DIALYSIS PATIENTS DIFFER FROM THE GENERAL POPULATION Solveig Mykleset | Tone Brit Østhus | Bård Waldum | Ingrid Os Oslo Univ Hosp Ullevål, Oslo w w w. e r a e d t a 2 01 2 . o r g 281 SATURDAY, MAY 26 SAP237 AGE-RELATED CHANGES IN KIDNEY FUNCTION, ITS INFLUENCING FACTORS, AND ASSOCIATION WITH ASYMPTOMATIC CAROTID ATHEROSCLEROSIS IN HEALTHY INDIVIDUALS. A 5-YEAR FOLLOW-UP STUDY Xuefeng Sun | Shimin Jiang | Hongxia Gu | Yunshuang Chen | Chunsheng Xi| Xi Qiao | Xiangmei Chen Dept Nephrology, Chinese PLA General Hosp, State Key Lab Kidney Disease, Beijing, China 49th ERA-EDTA CONGRESS P O S T E R S SAP243 IMPROVEMENT IN KIDNEY FUNCTION AFTER CARDIAC RESYNCHRONIZATION THERAPY Jesmar Buttigieg | Andrew Cassar | Joseph Farrugia Agius Mater Dei Hosp Nephrology Dept Malta | Mater Dei Hosp Cardiology Dept Malta SAP244 IDENTIFICATION OF PATIENTS WITH GLOMERULAR HYPERFILTRATION Belén Redal-Baigorri Roskilde Univ Hosp, Roskilde, Denmark SATURDAY, MAY 26 SAP245 PRESENCE OF PROTEINURIA HAS A SIGNIFICANT IMPACT ON SHORTTERM MORTALITY OF PATIENTS WITH NON-HODGKIN LYMPHOMA Masaki Hara | Minoru Ando | Ken Tsuchiya | Kosaku Nitta Tokyo Metropolitan Komagome Hosp, Tokyo, Japan | Tokyo Women's Medical Univ, Tokyo, Japan SAP246 A PILOT STUDY OF ANTI-BETA1-ADRENERGIC RECEPTOR ANTIBODIES IN CKD PATIENTS Masaya Yamato | Keiko Yasuda | Koichi Sasaki Rinku General Medical Center 282 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France CLINICAL STUDIES IN CKD 1-5 SAP247 PLASMA ADIPONECTIN CONCENTRATION AND ESTIMATED GLOMERULAR FILTRATION RATE (eGFR) IN ELDERLY SUBJECTS. THE POLISH POPULATION STUDY - POLSENIOR Magdalena Szotowska | Jerzy Chudek | Andrzej Więcek | Marcin Adamczak Nephrology, Endocrinology and Metabolic Clinic, Medical Univ Silesia | Dept Patophisiology, Dept Nephrology, Endocrinology and Metabolic Diseases, Medical Univ Silesia, Katowice, Poland SAP249 LATENT TUBERCULOSIS INFECTION IN END STAGE RENAL DISEASE PATIENTS ON DIALYSIS IN POPULATION WITH MODERATE PREVALENCE RATE OF TUBERCULOSIS Anna Steć | Maria Kozioł-Montewka | Andrzej Książek Nephrology Dept, Medical Univ Lublin, Poland | Dept Medical Microbiology, Medical Univ Lublin, Poland SAP250 OBSERVATIONAL DATA TO STUDY SODIUM BICARBONATE IN CKD: THE FEASIBILITY OF MARGINAL STRUCTURAL MODELLING Kate Birnie | Fergus Caskey | Aisha Iqbal Geeson Bristol Univ, Bristol, UK | NHS North Bristol Trust, Bristol, UK SAP251 CLINICAL DOSE SELECTION OF THE C5A RECEPTOR ANTAGONIST CCX168 FOR THE PHASE 2 ANCA-ASSOCIATED RENAL VASCULITIS CLINICAL TRIAL (THE CLEAR TRIAL) Daniel Dairaghi | Daniel Johnson | Manmohan Leleti | Shichang Miao | Hong Xiao | J. Charles Jennette | Jay P. Powers | Lisa Seitz | Yu Wang | Juan C. Jaen| Thomas J. Schall | Pirow Bekker ChemoCentryx, Mountain View, CA, USA | Univ North Carolina, Chapel Hill, NC, USA SAP252 SEQUENTIAL CLINICAL AND PATHOLOGICAL EVALUATION OF IGG4RELATED RENAL DISEASE PATIENTS Haruna Arai | Hiroki Hayashi | Kazuhiro Sugiyama | Kouichirou Yamamoto| Shigehisa Koide | Kazutaka Murakami | Makoto Tomita | Midori Hasegawa | Yukio Yuzawa Dept Nephrology, Fujita Health Univ School of Medicine, Aichi SAP253 COGNITIVE DYSFUNCTION IN CKD AND HYPERTENSIVE PATIENTS WITHOUT CLINICAL DEMENTIA. PREVALENCE AND ASSOCIATED FACTORS Despina Karasavvidou | Rigas Kalaitzidis | George Spanos | Kosmas Pappas | Athina Tatsioni | Kostas Siamopoulos Dept Nephrology, Univ Hosp Ioannina SAP254 SIGNIFICANCE OF MAST CELL RENAL INFILTRATION IN PATIENTS WITH ANTI-GLOMERULAR BASEMENT MEMBRANE NEPHRITIS Yi-Yan Zhang | Zheng Tang | Dong-Mei Chen | Ming-Chao Zhang | Zhi-Hong Liu Res Inst Nephrology, Jinling Hosp, Nanjing Univ School of Medicine SAP255 THE CLINICAL SIGNIFICANCE OF MORPHOGENETIC PROTEIN-FGF-23 w w w. e r a e d t a 2 01 2 . o r g 283 SATURDAY, MAY 26 SAP248 TIME OF RECOVERY AFTER HEMODIALYSIS IS RELATED TO THE NUMBER OF FATIGUE QUALITIES Maurizio Bossola | Enrico Di Stasio | Manuela Antocicco | Patrizia Silvestri | Luigi Tazza Catholic Univ 49th ERA-EDTA CONGRESS P O S T E R S AND KLOTHO SERUM DETERMINING IN CKD PATIENTS Yuriy Milovanov | Ludmila Milovanova | Lidia Kozlovskaya I.M. Sechenov First Moscow State Medical Univ, Ministry Health and Social Development Russia SAP256 EXPOSURE-RESPONSE ANALYSES OF BARDOXOLONE METHYL SAFETY AND EFFICACY AND CLINICAL TRIAL SIMULATIONS TO INFORM PHASE III DOSE SELECTION Cheri Klein | Peter Noertersheuser | Sven Mensing | Nathan Teuscher | Colin Meyer | Emily Dumas | Walid Awni Abbott Laboratories | Abbott GmBH & Co | Reata Pharmaceuticals SATURDAY, MAY 26 SAP257 VITAMIN D3 SUPPLEMENTATION DOES NOT AFFECT SERUM LIPIDS IN NON-DIABETIC PATIENTS WITH MODERATE IMPAIRMENT OF RENAL FUNCTION Hamid Dezfoolian | Ola Samuelsson | Maria Svensson Dept Nephrology, Sahlgrenska Academy, Gothenburg Univ, Gothenburg, Sweden | Dept Kidney Diseases, Sahlgrenska Univ Hosp, Gothenburg, Sweden | Dept Nephrology, Sahlgrenska Univ Hosp, Gothenburg, Sweden SAP258 PITAVASTATIN AMELIORATES RENAL FUNCTION IN PATIENTS WITH CKD (P-STAR-CKD) Yoshinari Yasuda | Sawako Kato | Naotake Tsuboi | Waichi Sato | Shoichi Maruyama | Enyu Imai | Yukio Yuzawa | Seiichi Matsuo Nagoya Univ Grad School Medicine, Nagoya, Japan | Fujita Health Univ, Toyoake, Japan SAP259 PREVALENCE AND DETERMINANTS OF HYPERKALEMIA IN PRE-DIALYSIS PATIENTS FOLLOWED IN A LOW-CLEARANCE CLINIC ENVIRONMENT Pantelis Sarafidis | Rochelle Blacklock | Eleri Wood | Adam Rumjon | Shanique immonds | Jessica Fletcher-Rogers | Rob Elias | Beatriz Tucker | Dawn Baynes| Claire Sharpe | Katie Vinen Academic Dept Renal Medicine, King’s College Hosp SAP260 BARDOXOLONE METHYL IMPROVES MARKERS OF RENAL FUNCTION IN PATIENTS WITH STAGE 4 CKD AND TYPE 2 DIABETES Sudarshan Hebbar | Angie Goldsberry, MS | Melanie Chin | Colin Meyer | Paul Audhya Reata Pharmaceuticals, Irving TX, USA 284 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France NUTRITION, INFLAMMATION AND OXIDATIVE STRESS - CKD 1-5 SAP261 OXIDATIVE STRESS AND SYSTEMIC INFLAMMATION AS IMPORTANT COMPONENTS OF CARDIAC VALVE CALCIFICATION IN PREDIALYSIS PATIENTS Oleksandr Susla Ternopil Univ Hosp, Ternopil, Ukraine SAP263 CARBAMYLATED LOW DENSITY LIPOPROTEIN (LDL) INDUCES ENDOTHELIAL DYSFUNCTION Timo Speer | Frederick O. Owala | Marjan Razawi | Eric Holy | Bahlmann Ferdinand | Fliser Danilo | Thomas F. Lüscher | Felix C. Tanner Univ Hosp Zurich, Cardiovascular Center, Zurich, Switzerland | Saarland Univ Hosp, Dept Internal Medicine IV, Homburg/Saar, Germany SAP264 THE ROLE OF LEPTIN IN NUTRITIONAL STATUS AND SURVIVAL IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS Anastasia Markaki | Ioannis Petrakis | Vasiliki Mavroeidi | Kostas Perakis | George A Fragkiadakis | Maria Venyhaki | Michael Tzanakakis | Eleftheria Vardaki | Kyriaki Maraki | Theodoros Doskas | Eugene Daphnis Dept Nutrition and Dietetics, Technological Educational Inst Crete, Crete, Greece | Dept Nephrology, Univ Hosp Heraklion, Heraklion, Crete, Greece | Dept Clinical Chemistry, School Medicine, Univ Crete, Greece | Dept Nephrology, General Hosp Chios, Chios, Greece SAP265 CENTRAL ADIPOSITY AND INFLAMMATION IN CHRONIC KIDNEY DISEASE PATIENTS Rachel Bregman | Barbara Vale | Carla Lemos | Laura Kawakami | Maria Ines Silva State Univ Rio de Janeiro SAP266 ESTIMATION OF TOTAL ADIPOSE TISSUE IN HEMODIALYSIS PATIENTS USING BIOIMPEDANCE TECHNIQUES Fansan Zhu | George Kaysen | Peter Kotanko | Samer R. Abbas | Yanna Dou | Steven Heymsfield | Nathan W Levin Renal Res Inst, New York USA | Univ California Davis, Davis CA USA | Renal Res Inst; Beth Israel Medical Cener, New York, USA | St. Lukes Hosp, New York, USA SAP267 PERI-AORTIC FAT TISSUE AND MALNUTRITION-INFLAMMATION-ATHEROSCLEROSIS/CALCIFICATION SYNDROME IN END-STAGE RENAL DISEASE PATIENTS Kultigin Turkmen | Hatice Kayikcioglu | Ibrahim Guney | Lutfullah Altintepe| Orhan Ozbek | Halil Zeki Tonbul Konya Univ, Meram School Medicine, Konya, Turkey | Konya Univ, Konya, Turkey | Meram Training and Reseach Hosp SAP268 HIGH DENSITY LIPOPROTEIN VARIABILITY AND LOW TRIGLYCERIDE LEVELS PREDICT MORTALITY IN INCIDENT HEMODIALYSIS PATIENTS BY VIRTUE OF THEIR ASSOCIATION WITH INFLAMMATION George A Kaysen | Len A Usvyat | Stephan Thijssen | Nathan W Levin | Peter Kotanko Dept Medicine Div Nephrology UC Davis | Renal Res Inst, New York, USA w w w. e r a e d t a 2 01 2 . o r g 285 SATURDAY, MAY 26 SAP262 GERIATRIC NUTRITIONAL RISK INDEX MAY BE A SIGNIFICANT PREDICTOR OF MORTALITY IN KOREAN HEMODIALYSIS PATIENTS: A SINGLE CENTER STUDY Ho Sik Shin | Yeon Soon Jung | Hark Rim Kosin Univ College Medicine 49th ERA-EDTA CONGRESS P O S T E R S SAP269 SERUM FETUIN-A IS ASSOCIATED WITH THE COMPONENTS OF MIAC (MALNUTRITION, INFLAMMATION, ATHEROSCLEROSIS, CALCIFICATION) SYNDROME IN DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE Ruya Mutluay | Ceyla Konca Degertekin | Ülver Derici | Mahmut Ilker Yılmaz| Ferda Akkıyal | Serap Gültekin | Sevim Gönen | Serpil Müge Değer | Turgay Arınsoy | Şükrü Sindel Gazi Univ Fac Medicine, Dept Nephrology, Ankara, Turkey | Gazi Univ Fac Medicine, Dept Endocrinology, Ankara, Turkey | Dept Radiology, Gazi Univ Fac Medicine, Ankara, Turkey SATURDAY, MAY 26 SAP270 ACTIVATION OF NUCLEAR FACTOR-K B IN THE AORTA OF PATIENTS IS ASSOCIATED WITH THE SEVERITY OF ATHEROSCLEROSIS BUT NOT WITH CHRONIC KIDNEY DISEASE Miguel Hueso | Joan Torras | Marta Carrera | August Vidal | Estanis Navarro | Israel Rivas | Ines Rama | Nuria Bolaños | Cristian Varela | Alberto MartinezCastelao | Josep M. Grinyo Hosp Bellvitge-IDIBELL | Lab Oncologia Molecular-IDIBELL SAP271 THE EFFECT OF N-3 POLYUNSATURATED FATTY ACIDS ON ADIPONECTIN LEVELS IN PATIENTS WITH END STAGE RENAL DISEASE Frederik Harving | My Svensson | Erik Berg Schmidt | Kaj Anker Jørgensen | Jeppe Hagstrup Christensen Dept Nephrology Aalborg Hosp, Aalborg, Denmark | Dept Cardiology, Center Cardiovascular Res, Aalborg Hosp, Aalborg, Denmark | Dept Renal Medicine C, Skejby Hosp, Aarhus Univ Hosp, Aarhus, Denmark SAP272 PROCALCITONIN IS NOT SUPERIOR TO C-REACTIVE PROTEIN AS A MARKER OF INFECTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE Ji Hyeon Park | Eun Hee Koo | Hyun Kyung Kim | Min Su Kim | A Jin Cho | Jung Eun Lee | Hye Ryoun Jang | Wooseong Huh | Dae Joong Kim | Yoon-Goo Kim | Ha Young Oh Samsung Medical Center, Seoul, Korea SAP273 EFFECT OF ORAL FRUCTOSE LOAD ON SERUM URIC ACID, LIPIDS AND BLOOD PRESSURE IN RENAL TRANSPL RECIPIENTS AND NON-TRANSPLED CHRONIC KIDNEY DISEASE PATIENTS Anna Zawiasa | Dariusz Nowak | Michał Nowicki Dept Nephrology, Hypertension and Kidney Transpl, Medical Univ Łódź | Chair Clinical and Experimental Physiology, Medical Univ Łódź, Poland SAP274 DO CYTOKINES AT CURRENTLY OBSERVED CONCENTRATIONS IN CHRONIC KIDNEY DISEASE INDUCE LEUKOCYTE ACTIVITY? Neirynck Nathalie | Glorieux Griet | Schepers Eva | Vanholder Raymond Ghent Univ Hosp, Gent, Belgium SAP275 USE OF ALLOPURINOL IS ASSOCIATED WITH REDUCED ARTERIAL STIFFNESS IN PROGRESSIVE CHRONIC KIDNEY DISEASE (CKD) Khai Ping Ng | Stephanie Stringer | Mark Jesky | Mary Dutton | Charles Ferro| Paul Cockwell Univ Hosp Birmingham, Birmingham, UK | Univ Bimingham, UK | Queen Elizabeth Hosp Birmingham, UK SAP276 INSULIN GROWTH FACTOR-1 (IGF-1) AS A PREDICTOR OF NUTRITIONAL STATUS AND MORTALITY IN CHRONIC KIDNEY DISEASE (CKD) STAGE 5 PATIENTS Ting Jia | Thiane Gama Axelsson | Bengt Lindholm | Olof Heimburger | Peter Barany | Peter Stenvinkel | Abdul Rashid Qureshi Div Renal Medicine and Baxter Novum, Dept Clinical Science, Intervention and Technology, Karolinska Inst, Stockholm,Sweden | Baxter Novum and Renal Medicine, Karolinska Inst | Karolinska Inst 286 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP277 INFLUENCE OF INTRA-INDIVIDUAL INTERLEUKIN-6 VARIATIONS ON THE CARDIOVASCULAR PROGNOSIS OF PATIENTS WITH CHRONIC RENAL DISEASE (NOT ON DIALYSIS) Borja Quiroga | Marian Goicoechea | Soledad García de Vinuesa | Úrsula Verdalles | Javier Reque | Nayara Panizo | David Arroyo | Alba Santos | Nicolás Macías | José Luño Hosp Gregorio Marañón SAP279 INCREASED ARTERIAL STIFFNESS IN NEPHROTIC SYNDROME PATIENTS Ozkan Gungor | Meltem Sezis Demirci | Fatih Kircelli | Erhan Tatar | Ender Hur | Sait Sen | Huseyin Toz | Ali Basci | Ercan Ok Ege Univ School of Medicine, Div Nephrology | Ege Univ School Medicine, Div Pathology SAP280 PBMC MICRO RNA-155 IS UP-REGULATED IN CHRONIC HEMODIALYSIS PATIENTS Vincenzo Sepe | Paolo Albrizio | Massimiliano Gnecchi | Elisabetta Cervio | Pasquale Esposito | Teresa Rampino | Carmelo Libetta | Antonio Dal Canton Fond IRCCS Policlinico San Matteo, Pavia, Italy | Univ Pavia SAP281 OXIDIZED-LDL AND LIPOPROTEIN (A) LEVELS IN CHRONIC KIDNEY DISEASE PATIENTS UNDER HEMODIALYSIS: INFLUENCE OF ADIPONECTIN AND OF A POLYMORPHISM IN THE APOLIPOPROTEIN (A) GENE M. Sameiro Faria | Sandra Ribeiro | G. Silva | H. Nascimento | P. Rocha-Pereira| V. Miranda | E. Vieira | R. Santos | D. Mendonça | A. Quintanilha | E. Costa| L. Belo | A. Santos-Silva FMC, Dinefro – Diálises e Nefrologia, SA; Inst Ciências Biomédicas Abel Salazar, Univ Porto | Fac Farmácia, Univ Porto; Inst Biologia Molecular e Celular (IBMC)| Inst Biologia Molecular e Celular (IBMC), Univ Porto; Centro Investigação Ciências Saúde, Univ Beira Interior, Covilhã | Unidade Genética Molecular, Centro Genética Médica Dr. Jacinto Magalhães (INSARJ) | Inst Ciências Biomédicas Abel Salazar, Univ Porto; Inst Saúde Pública da Univ Porto (ISPUP) SAP282 EFFECT OF DARK CHOCOLATE INTAKE ON RENAL TISSUE OXYGENATION AS MEASURED BY BOLD-MRI Menno Pruijm | Lucie Hofmann | Elise Heuvelin | Valentina Forni | Andrew Coristine | Matthias Stuber | Bruno Vogt | Michel Burnier Univ Lausanne, Lausanne | Univ Hosp Lausanne, Lausanne SAP283 AN ORIGINAL MODEL FOR DIAGNOSIS AND FOLLOW-UP OF MALNUTRITION IN CHRONIC KIDNEY DISEASE PATIENTS Maria Grazia Chiappini | Thomas Ammann | Lina Muzzi | Alessandra Grosso Nefrology and Dialysis Unit, FBF Hosp | Nephrology and Dialysis Unit AfaR CRCCS FBF Hosp, Rome, Italy SAP284 TREATMENT OF CHRONIC HCV WITH PEGYLATED IFN ALPHA 2-A IN HEMODIALYSIS PATIENTS; SINGLE SAUDI CENTER EXPERIENCE Alaa Sabry Mansoura Urology and Nephrology Center w w w. e r a e d t a 2 01 2 . o r g 287 SATURDAY, MAY 26 SAP278 OXIDIZED HIGH-DENSITY LIPOPROTEIN AND ITS SUBFRACTION ARE INCREASED ACCORDING TO CKD STAGE SEVERITY Hirokazu Honda | Tsutomu Hirano | Masashi Ueda | Shiho Kojima | Shinichi Mashiba | Yasuyuki Hayase | Tetsuo Michihata | Tadao Akizawa Div Nephrology, Diabetes, Metabolism, and Endocrinology, Dept Medicine, Showa Univ School Medicine, Tokyo, Japan | Ikagaku Co. Ltd., Kyoto, Japan | Ebara Clinic, Tokyo, Japan 49th ERA-EDTA CONGRESS P O S T E R S SATURDAY, MAY 26 SAP285 INCREASED LEVELS OF SERUM AMYLOID A IN END STAGE RENAL DISEASE PATIENTS IS ASSOCIATED WITH THE PRESENCE OF A UNIQUE BIOMARKER IDENTIFIED BY PROTEIN CHIP ARRAY ANALYSIS Vinod Bansal | Debra Hoppensteadt | Walter Jeske | Jawed Fareed Loyola Univ Medical Center 288 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France PRIMARY AND SECONDARY GLOMERULONEPHRITIS II SAP286 PERUVIAN AMAZONIC RACE AS A FACTOR OF WORSE PROGNOSIS ON RENAL FUNCTION IN PROLIFERATIVE LUPUS NEPHRITIS Renzo P. Valdivia Vega | Jessica Perez Carlos Hosp Nacional Edgardo Rebagliati Martins, Lima, Peru | EsSalud SAP288 ORAL MIZORIBINE PULSE THERAPY FOR NEPHROTIC SYNDROME AND LUPUS NEPHRITIS Noriaki Yorioka | Toshiki Doi | Shuma Hirashio | Michiko Arita | Akira Hirabayashi Hiroshima Kidney Organization, Hiroshima | East Clinic, Hiroshima | Hiroshima Univ Hosp, Hiroshima | Hiroshima Bay Clinic, Hiroshima SAP289 ANTIPHOSPHOLIPID SYNDROM, ANTIPHOSHPHOLIPID ANTIBODIES AND RENAL INVOLVEMENT - CLINICOPATHOLOGIC FEATURES, TREATMENT AND OUTCOME Eduard Tilkiyan | Emilia Chonova | Yovko Ronchev | Emil Kumchev MHAT Kaspela Plovdiv Bulgaria Nephrology Ward SAP290 COMPARISON OF TWO DIFFERENT THERAPEUTIC REGIMENS FOR THE TREATMENT OF PURE MEMBRANOUS LUPUS NEPHRITIS Panagiotis Giamalis | Michalis Spartalis | Maria Stangou | Ioannis Tsouchnikas| Dimitrios Moysiades | Despina Dimopoulou | Alexandros Garyfalos | George Efstratiadis | Dimitrios Memmos Nephrology Clinic, Hippokration General Hosp, Thessaloniki, Greece | 4th Clinic Internal Medicine, Hippokration General Hosp, Thessaloniki, Greece SAP291 MEMBRANOUS GLOMERULONEPHRITIS AND ANTI-PHOSPHOLIPASE A2RECEPTOR ANTIBODY TESTING: USEFUL TOOL IN IN ROUTINE CLINICAL PRACTICE Ulf Schönermarck | Peter Eichhorn | Thomas Sitter | Thorsten Wendler | Volker Vielhauer | Stephan Lederer | Kai Fechner | Michael Fischereder Nephrology Div, Medical Clinic IV, Inst Clinical Chemistry, Univ Hosp Munich, Ludwig-Maximilians Univ, Munich, Germany | KfH Nierenzentrum Laim, Munich, Germany | Inst Experimental Immunology, Euroimmun AG, Luebeck, Germany SAP292 INFLUENCE OF A FUNCTIONAL POLYMORPHISM OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) GENE ON MEMBRANOUS NEPHROPATHY Christos Bantis | Peter Heering | Nicoletta-Maria Kouri | Maria Stangou | Christina Schwandt | Nicola Kuhr | Katrin Ivens | Lars-Christian Rump Dept Nephrology, Papanikolaou General Hosp, Thessaloniki, Greece | Dept Nephrology, Heinrich-Heine Univ Düsseldorf, Germany SAP293 LONG TERM (MORE THAN 20 YEARS) CLINICAL OUTCOME OF 114 IMN PATIENTS: A SINGLE CENTRE EXPERIENCE Valeria Matta | Patrizia Melis | Maura Conti | Riccardo Cao | Valentina Binda| Paolo Altieri | Anna Maria Asunis | Walter Catani | Matteo Floris | Andrea Angioi | Mauro Congia | Francesco Cucca | Luigi Minerba | Marcella Peri | Antonello Pani Nephrology, Pathology, Brotzu Hosp, Cagliari | Univ Cagliari | Univ Sassari w w w. e r a e d t a 2 01 2 . o r g 289 SATURDAY, MAY 26 SAP287 FUNCTIONAL MR IMAGING OF KIDNEYS IN PATIENTS WITH LUPUS NEPHRITIS: INITIAL STUDY Xiao Li | Xueqin Xu | Wen Zhang | Hong Ren | Nan Chen Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School Medicine | Ruijin Hosp, Shanghai Jiaotong Univ 49th ERA-EDTA CONGRESS P O S T E R S SAP294 TREATMENT OF MEMBRANOUS NEPHROPATHY WITH ADRENOCORTICOTROPIC HORMONE (ACTH) GEL: CORRELATION OF ANTI-PLA2R AND DISEASE ACTIVITY Laurence H. Beck | Fernando C. Fervenza | Andrew S. Bomback | Rivka Ayalon| Maria V. Irazabal | Alfonso Eirin | Daniel C. Cattran | Gerald B. Appel | David J. Salant Boston Univ | Mayo Clinic | Columbia Univ | Toronto General Hosp SATURDAY, MAY 26 SAP295 UNEXPECTED EFFECT OF ANTI-TNF THERAPY IN MEMBRANOUS GLOMERULONEPHRITIS Domenico Santoro | Adele Postorino | Giuseppe Costantino | Guido Bellinghieri | Vincenzo Savica Unit Nephrology and Dialysis, Univ Messina SAP296 ANCA-ASSOCIATED VASCULITIS IN THE ELDERLY – A PRELIMINARY REPORT Maria Weiner | Suh Mein Goh | Aladdin Mohammad | Per Eriksson | Kerstin Westman | Daina Selga | Alan Salama | Mårten Segelmark Linköping Univ, Linköping, Sweden | Royal Free Hosp | Lund Univ | Dept Rheumatology, County Council Östergötland, Linköping, Sweden | Lund Univ, Malmö, Sweden | Lund Univ, Lund, Sweden SAP297 MARKERS OF T CELL ACTIVATION INCREASE AFTER RITUXIMAB ADMINISTRATION IN ANCA-ASSOCIATED VASCULITIS Zdenka Chocova | Zdenka Hruskova | Helena Mareckova | Barbora Svobodova| Eva Jancova | Vladimira Bednarova | Romana Rysava | Vladimir Tesar Dept Nephrology, Inst Immunology and Microbiology, First Fac Medicine and General Teaching Hosp, Charles Univ, Prague, Czech Republic SAP298 CLINICAL FEATURES AND OUTCOMES OF cANCA vs. pANCA-ASSOCIATED RENAL VASCULITIS Zdenka Hruskova | Eva Jancova | Vladimir Hanzal | Kamil Zamboch | Monika Grussmannova | Jan Svojanovsky | Jan Klaboch | Michaela Kubisova | Jakub Sevcik | Renata Olsanska | Marta Sobotkova | Radim Becvar | Petr Nemec | Michal Kodeda | Dalibor Jilek | Zdenka Chocova | Vladimir Tesar Dept Nephrology, General Univ Hosp and First Fac Medicine, Charles Univ, Prague, Czech Republic | Dept Nephrology, Inst Clinical and Experimental Medicine, Prague, Czech Republic | Third Dept Medicine, Teaching Hosp and Fac Medicine, Olomouc, Czech Republic | First Dept Internal Medicine, Third Fac Medicine, Charles Univ, Prague, Czech Republic | Second Dept Medicine, St Ann’s Hosp, Brno, Czech Republic | First Dept Medicine, Teaching Hosp and Fac Medicine, Plzen, Czech Republic | Dept Gerontology and Metabolism, Univ Hosp and Fac Medicine, Hradec Kralove | Third Dept Medicine, Brno-Bohunice Teaching Hosp, Brno, Czech Republic | Dept Medicine, Teaching Hosp and Fac Medicine, Ostrava, Czech Republic | Dept Immunology, Univ Hosp Motol, Prague, Czech Republic | Inst Rheumatology and First Fac Medicine, Charles Univ Prague, Prague, Czech Republic | Second Dept Medicine, Teaching Hosp and Fac Medicine, Hradec Kralove, Czech Republic | Dept Clinical Immunology and Allergology, Health Inst, Usti n. Labem, Czech Republic SAP299 FACTORS PREDICTING INFECTIVE COMPLICATIONS OF CYCLOPHOSPHAMIDE THERAPY IN ANCA ASSOCIATED VASCULITIS Memuna Hussain | Ajay Dhaygude Royal Preston Hosp | Royal Preston Hosp SAP300 PAUCI-IMMUNE RENAL VASCULITIS: COMPARISON BETWEEN TWO GROUPS OF ELDERLY AND VERY ELDERLY PATIENTS Claire Cartery | Antoine Huart | Emmanuelle Plaisier | Vanina Bongard | François Montastruc | Pierre Ronco | Jacques Pourrat | Dominique Chauveau Tenon Hosp, Paris France | Rangueil Hosp, Toulouse France | Purpan Hosp, Toulouse France 290 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP301 ANCA-NEGATIVE PAUCI-IMMUNE CRESCENTIC GLOMERULONEPHRITIS: CLINICAL CHARACTERISTICS AND OUTCOMES Narayan Prasad | Desraj Gurjar | Dharmender Bhadauria | Raj Kumar Sharma| Amit Gupta | Anupama Kaul | Manoj Jain Sanjay Gandhi PostGrad Inst Medical Sciences,Lucknow, India SAP302 PREVENTION OF TREATMENT RELATED MORBIDITY IN ANCA- ASSOCIATED VASCULITIS: THE PATIENT'S PERSPECTIVE Michael Venning | Nina Brown | Ian Bruce Manchester Royal Infirmary, Manchester, UK | Univ Manchester, Manchester, UK SAP304 ORAL C5A RECEPTOR ANTAGONIST CCX168 IN A PHASE 2 CLINICAL TRIAL IN ANCA-ASSOCIATED RENAL VASCULITIS Pirow Bekker | Antonia Potarca | Daniel Dairaghi | Shichang Miao | Jay P. Powers | Juan C. Jaen | Thomas J. Schall ChemoCentryx, Inc. | ChemoCentryx Inc, Mountain View (CA), USA SAP305 TH-CYTOKINES IN THE URINE OF PATIENTS WITH PRIMARY GLOMERULONEPHRITIS IN REMISSION AND THEIR POTENTIAL ROLE AS MARKERS OF DISEASE ACTIVITY Dimitra Kalavrizioti | Miltiadis Gerolymos | Dimitrios Komninakis | Maria Rodi | Athanasia Mouzaki | Pantelitsa Kalliakmani | Dimitrios Goumenos Univ Hosp, Patras, Greece | Div Hematology, Dept Internal Medicine, Fac Medicine, Patras, Greece SAP306 CLINICAL CHARACTERISTICS AND TREATMENT OF HEPATITIS B ASSOCIATED IgA NEPHROPATHY Bum Soon Choi | Cheol Whee Park | Yong-Soo Kim | Chul Woo Yang | In O Sun Catholic Univ Korea, Seoul, Korea | Dept Internal Medicine, Seoul Saint Mary’s Hosp, Catholic Univ Korea SAP307 MYCOPHENOLIC ACID REVERSE IgA1 ABERRANT GLYCOSYLATION THROUGH UP-REGULATING COSMC EXPRESSION IN IgA NEPHROPATHY Wei Qin | Linshen Xie | Chunyu Tan Div Nephrology, Div Rheumatology and Immunology, West China Hosp, Sichuan Univ SAP308 DOWN-REGULATED PERIPHERAL LYMPHOCYTE MICORRNA-155 IS RELATED TO IGA NEPHROPATHY Wei Qin | Wei Mian | Ping Fu | Chunyu Tan Div Nephrology, West China Hosp, Sichuan Univ | West China Hosp Sichuan Univ, Chengdu, China | Div Rheumatology and Immunology, West China Hosp, Sichuan Univ SAP309 URINARY C-REACTIVE PROTEIN CONCENTRATION IN PATIENTS WITH PRIMARY GLOMERULONEPHRITIS AND EFFECT ON IT OF QUERCETIN Vitaliy Kaminskyy Ivano-Frankivsk National Medical Univ, Ivano-Frankivsk, Ukraine SAP310 INFLUENCE OF G-1082A POLYMORPHISM OF INTERLEUKIN-10 GENE ON FOCAL SEGMENTAL GLOMERULONEPHRITIS: A CLINICOPATHOLOGIC STUDY Christos Bantis | Peter Heering | Nicoletta-Maria Kouri | Nicola Kuhr | Christi- w w w. e r a e d t a 2 01 2 . o r g 291 SATURDAY, MAY 26 SAP303 INCREASED INCIDENCE OF VENOUS THROMBOEMBOLISM IN ANCA ASSOCIATED VASCULITIS Sehrash Noor | Ajay Dhaygude Royal Preston Hosp 49th ERA-EDTA CONGRESS P O S T E R S na Schwandt | Katrin Ivens | Lars-Christian Rump Dept Nephrology, Papanikolaou General Hosp, Thessaloniki, Greece | Dept Nephrology, Heinrich-Heine Univ Düsseldorf, Germany SAP311 UNIQUE METABOLIC PROFILE OF HUMAN FOCAL SEGMENTAL GLOMERULOSCLEROSIS Xu Hao | Hong Ren | Weiming Wang | Nan Chen Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School of Medicine SATURDAY, MAY 26 SAP312 SUBCLINICAL CARDIOVASCULAR DISEASE IN CHILDREN WITH IDIOPATHIC STEROID RESISTANT NEPHROTIC SYNDROME Candan Cengiz | Canpolat Nur | Yildiz Nurdan | Gokalp Selman | Turhan Pınar | Tasdemir Mehmet | Sever Lale | Salim Caliskan Medeniyet Univ | Cerrahpasa Medical Fac | Marmara Medical Fac SAP313 METHYLPREDNISOLONE PULSE THERAPY ACCELERATED COMPLETE REMISSION OF PROTEINURIA IN ADULT-ONSET MINIMAL CHANGE NEPHROTIC SYNDROME PATIENTS Maki Shinzawa | Ryohei Yamamoto | Yasuyuki Nagasawa | Susumu Oseto | Daisuke Mori | Kakuya Niihata | Megumu Fukunaga | Atsushi Yamauchi | Yoshiharu Tsubakihara | Hiromi Rakugi | Yoshitaka Isaka Dept Geriatric Medicine & Nephrology, Osaka Univ Grad School of Medicine, Suita, Japan | Dept Internal Medicine, Toyonaka Municipal Hosp, Toyonaka, Japan | Dept Nephrology, Osaka Rosai Hosp, Sakai, Japan | Dept Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan SAP314 ROLE OF SERUM LEVEL OF SOLUBLE UROKINASE RECEPTOR IN VARIOUS BIOPSY-PROVEN KIDNEY DISEASES Jin-Shuen Chen | Yuh-Feng Lin | Wei-Ya Lin | Kuo-Hsiung Shu | Han-Hsiang Chen | Chih-Jen Wu | Chwei-Shiun Yang | Tzu-Ling Tseng Tri-Serv General Hosp, National Defense Medical Center, Taipei, Taiwan | Shuang Ho Hosp, Taipei Medical Univ, Taipei, Taiwan | Biomedical Engineering Res Labs, Industrial Technology Res Inst, Hsinchu, Taiwan | Taichung Veterans General Hosp, Taipei, Taiwan | Mackay Memorial Hosp, Taipei, Taiwan | Cathay General Hosp, Taipei, Taiwan SAP315 INCIDENCE OF PRIMARY GLOMERULONEPHRITIS IN A LARGE NORTHEASTERN ITALIAN AREA: A 13-YEAR RENAL BIOPSY STUDY Gianluigi Zaza | Patrizia Bernich | Antonio Lupo Renal and Dialysis Unit Hosp, Univ Verona, Italy « SAP316 DECREASING INCIDENCE IN RENAL AMYLOIDOSIS. DATA FROM LARGE REGISTRY OF KIDNEY BIOPSIES Nayara Panizo | Francisco Rivera | Juan Manuela Lopez Gomez | Spanish Registry of Glomerulonephrities REGN Hosp General Univ Gregorio Marañón, Madrid, Spain | Hosp General Univ Ciudad Real, Ciudad Real, Spain | SEN SAP317 ASSOCIATION BETWEEN AUTOIMMUNE THYROIDITIS AND IDIOPATHIC RETROPERITONEAL FIBROSIS: A CASE-CONTROL STUDY Graziano Ceresini | Maria Letizia Urban | Domenico Corradi | Elisa Usberti | Alessandra Palmisano | Carlo Buzio | Augusto Vaglio Geriatrics and Endocrinology, Nephrology Unit, Pathology, Univ Parma, Italy SAP318 RENAL BIOPSY DURING PREGANCY: RETROSPECTIVE STUDY ABOUT 9 CASES Houmaid Zineb |Benyounes Ramdani Univ Hosp Centre, Casablanca, Morocco 292 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP319 CONSEQUENCES OF GLOMEROPATHY-PREGNANCY INTERACTION Luiz Paulo José Marques | Lilimar da Silveira Rioja | Regina Rocco | Ana Cassia Falcão Nery | Benedita Calheiros Novaes Federal Univ Rio de Janeiro State SAP321 IMPACT OF BORTEZOMIB IN THE SURVIVAL OF PATIENTS WITH REFRACTORY OR RELAPSED MULTIPLE MYELOMA WITH RENAL FAILURE. EXPERIENCE OF A SINGLE CENTRE Carreño Parrilla Agustin | Hernandez Ruiz M Belen | Calle Primo Carmen | Olazo Eliana | Pereira Elisa | Piccone Luis | Martinez-Calero Alberto | Nieto Javier | Ferreras Isabel Hosp General Univ Ciudad Real SAP322 CLINICAL PRESENTATION AND OUTCOME OF PATIENTS AFFECTED BY SYSTEMIC AMYLOIDOSIS WITH PREDOMINANT RENAL INVOLVEMENT: A 10 YEAR, SINGLE CENTRE EXPERIENCE Riccardo Cao | Maura Conti | Alice Atzeni | Antioco Fois | Doloretta Piras | Stefania Maxia | Andrea Angioi | Valentina Binda | Patrizia Melis | Giovanna Sau | Gianfranco Pili | Matteo Floris | Anna Maria Asunis | Maurizio Porcu | Daniele Derudas | Emanuele Angelucci | Antonio Ledda | Giorgio La Nasa | Antonello Pani Nephrology, Pathology, Cardiology, Brotzu Hosp, Cagliari | Haematology, Businco Hosp, Cagliari | Haematology, Binaghi Hosp, Cagliari SAP323 CLINICO-PATHOLGIC FINDINGS IN IRANIAN ELDERLY KIDNEY PATIENTS - A CASE SERIES STUDY Shahrzad Ossareh | Mojgan Asgari | Shokoufeh Savaj | Yousef Ataipour | Ezatollah Abdi | Tahereh Malakoutian Dept Medicine, Nephrology Section, Hasheminejad Clinical Res Development Center, Tehran Univ Medical Sciences, Tehran, Iran | Dept Medicine, Nephrology Unit, Firoozgar Hosp, Tehran Univ Medical Sciences, Tehran, Iran SAP324 EVOLUTIVE PROFILE OF ACUTE POST INFECTIOUS GLOMERULONEPHRITIS WITH EXTRACAPILLARY PROLIFERATION: EXPERIENCE IN 14 CASES Rifai Rajaa | Fatima Zahra Berkchi | Laila Haffane | Zoubair Squalli | Lamiae Rouass | Zaitouna Al Hamany | Fatima Ezzaitouni | Loubna Benamar | Rabia Bayahya | Naima Ouzeddoun Serv Néphrologie Dialyse Transpl Rénale CHU Ibn Sina Rabat Morocco | Serv Antomie Pathologique Hop Enfants Rabat Morocco SAP325 PILOT OBSERVATION OF LIPID PROFILE CHANGES IN LIPOPROTEIN CAST NEPHROPATHY TREATED WITH FENOFIBRATE OR STATIN Huang Gao-Yuan | Xiaodan Yao | Chen Xin | Cheng Zhen | Guo Yong-Chun| Wang Qing-Wen | Chen Hui-Ping | Ji Da-Xi | Gong De-Hua | Hu Wei-Xin | Liu Zhi-Hong Res Inst Nephrology, Jinling Hosp, Nanjing Univ School Medicine, Nanjing, China w w w. e r a e d t a 2 01 2 . o r g 293 SATURDAY, MAY 26 SAP320 NON-PROTEINURIC LCDD NEPHROPATHY: A RETROSPECTIVE STUDY OF 14 PATIENTS Frank Bridoux | Antoine Sicard | Delphine Labatut | Guy Touchard | Clémetine Sarkozy | Philippe Vanhille | Patrice Callard | Marie Essig | François Provot| Alain Nony | Pierre Ronco | Alexandre Karras Néphrologie, CHU, Poitiers, France | Néphrologie, Valenciennes, France | Renal Pathology, CHU, Poitiers, France | Hématologie, Hôp A. Mignot, Versailles, France | Néphrologie, Valenciennes, France | Renal Pathology, Hôp Tenon, Paris, France | Néphrologie, CHU, Limoges, France | Néphrologie, CHU, Lille, France | Néphrologie, CH, Bourges, France | Néphrologie, Hôp Tenon, Paris, France | Néphrologie, HEGP, Paris, France 49th ERA-EDTA CONGRESS P O S T E R S SAP326 CLINICAL AND EVOLUTIVE PROFILE OF THE ACUTE POST INFECTIOUS GLOMERULONEPHRITIS: EXPERIENCE IN 30 CASES Rifai Rajaa | Fatima Zahra Berkchi | Laila Haffane | Zoubair Squalli | Lamiae Rouass | Zaitouna Al Hamany | Fatima Ezzaitouni | Loubna Benamar | Rabia Bayahya | Naima Ouzeddoun Serv Néphrologie Dialyse Transpl Rénale CHU Ibn Sina Rabat Morocco | Serv Antomie Pathologique Hop Enfants Rabat Morocco SAP327 IS THERE ANY LINK BETWEEN THE DETECTION OF ANTI-C1Q ANTIBODIES IN THE SERUM AND CLINICAL MANIFESTATION OF GLOMERULAR INJURY IN PRIMARY AND SECONDARY GLOMERULONEPHRITIDES Katarzyna Smykal-Jankowiak | Zofia Niemir | Magdalena Polcyn-Adamczak | Beata Szramka-Pawlak | Ryszard Zaba Dept Nephrology, Dept Dermatology, Univ Medical Sciences, Poznan, Poland SATURDAY, MAY 26 SAP328 CLINICAL ANALYSIS OF THE PATIENTS WITH PRIMARY DISTAL RENAL TUBULAR ACIDOSIS Chunli Zhang | Hong Ren | Yuhua Ma | Weiming Wang | Wen Zhang | Pingyan Shen | Nan Chen Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School Medicine SAP329 CHARACTERISTICS OF CLINICAL MANIFESTATIONS IN CHINESE FABRY PATIENTS Yan Ouyang | Xiaoxia Pan | Zhaohui Wang | Xiaobei Feng | Pingyan Shen | Hong Ren | Liyan Ni | Wen Zhang | Nan Chen Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School Medicine 294 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France EXPERIMENTAL PATHOLOGY SAP330 THE TUBULAR EXPRESSION OF MESENCHYMAL MARKERS INCLUDES EXTRACELLULAR MATRIX PROTEINS Dubois Xu Yi Chun | Hertig Alexandre | Baugey Edith | Ouali Nacéra | Peltier Julie | Jouanneau Chantal | Rondeau Eric APHP, Hôp Tenon | Inserm U702 SAP332 RENAL TUBULAR FLUID SHEAR STRESS FACILITATES MONOCYTE ACTIVATION TOWARDS INFLAMMATORY MACROPHAGES Mathieu Miravete | Romain Dissard | Julie Klein | Julien Gonzalez | Cécile Caubet | Christiane Pecher | Bernard Pipy | Jean-Loup Bascands | Muriel Mercier-Bonin | Joost Schanstra | Bénédicte Buffin-Meyer Inserm U1048 | UMR-MD3 EA2405 | INSA, UPS, INPT, LISBP SAP333 CD154 INDUCES MATRIX METALLOPROTEASE-9 SECRETION IN HUMAN PODOCYTES Rigothier Claire | Daculsi Richard | Lepreux Sébastien | Saleem Moin | Bourget Chantal | Combe Christian | Ripoche Jean INSERM U1026, Univ Bordeaux 2, Bordeaux, France | Serv Anatomie Pathologique, CHU Bordeaux, France | Children's Renal Unit and Academic Renal Unit, Univ Bristol, Bristol, UK SAP334 BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MEDIATES THE ANTIPROTEINURIC EFFECT OF FLUOXETIN THROUGH PRESERVATION OF PODOCYTE INTEGRITY Massimiliano Migliori | Vincenzo Cantaluppi | Claudio Mannari | Davide Medica | Luca Giovannini | Vincenzo Panichi Nephrology and Dialysis Unit, Versilia Hosp | Nephrology, Dialysis, Renal Transpl Unit and Centre Experimental Medical Res (CeRMS), Univ Turin | Dept Neuroscience, Univ Pisa SAP335 IMPAIRMENT OF PODOCYTE FUNCTION BY DIPHTERIA TOXIN - A NEW REVERSIBLE PROTEINURIA MODEL IN MICE Andreas Goldwich | Steinkasserer Alexander | Gessner André | Kerstin Amann Univ Hosp | Univ Hosp Erlangen | Univ Regensburg | Nephropathology SAP336 IFN-alpha AND IFN-beta SPECIFICALLY AFFECT RENAL PROGENITORS AND PODOCYTES IN-VITRO AND IN-VIVO Adriana Migliorini | Costanza Sagrinati | Maria Lucia Angelotti | Shrikant R. Mulay | Elisa Ronconi | Anna Peired | Paola Romagnani | Hans-Joachim Anders Nephrological Center, Medical Policlinic, Univ Munich, Germany | Excellence Center Res, Transfer and High Education Denothe, Univ Florence, Italy | Univ Florence SAP337 ANGIOPOIETINS MODULATES ENDOTHELIAL ADAPTATION, GLOMERULAR AND PODOCYTE HYPERTROPHY AFTER UNINEPHRECTOMY Wen Chih Chiang | Chun Fu Lai | Wei-Hao Peng | Ching Fang Wu | Fan-Chi Chang | Yi-Ting Chen | Shuei-Liong Lin | Yung Ming Chen | Kwan Dun Wu | Kuo-Shyan Lu | Tun Jun Tsai National Taiwan Univ Hosp, Taipei, Taiwan | College Medicine, National Taiwan Univ, Taipei, Taiwan | National Taiwan Univ Hosp ChuDong Branch, Yunlin County, Taiwan | E-Da Hosp, Kaohsiung City, Taiwan w w w. e r a e d t a 2 01 2 . o r g 295 SATURDAY, MAY 26 SAP331 1,25-DIHYDROXYVITAMIN D3 SUPPRESSES HIGH GLUCOSE ACTIVATED MACROPHAGE DROVED TUBULAR EPITHELIAL TO MESENCHYMAL TRANSITION IN PROXIMAL TUBULAR EPITHELIAL CELLS Xiaoliang Zhang | Yansheng Jin Zhong Da Hosp, School Medicine, Southeast Univ, Nanjing, China 49th ERA-EDTA CONGRESS P O S T E R S SAP338 C-MIP DOWNREGULATES NF-κB ACTIVITY AND PROMOTES APOPTOSIS IN PODOCYTES OF PATIENTS WITH IDIOPATHIC NEPHROTIC SYNDROME Ory Virgine | Fan Qing Feng | Shao-Yu Zhang | Desvaux Dominique | Audard Vincent | Candelier Marina | Lang Philippe | Guellaen Georges | Andre Pawlak | Djillali Sahali INSERM U955 Group 21, Créteil, France | Dept Nephrology, Henri Mondor Hosp, Créteil, France SATURDAY, MAY 26 SAP339 PHARMACOLOGICAL SUPPRESSION OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) AMELIORATES THE INJURY OF GLOMERULAR PODOCYTE IN THE EXPERIMENTAL GLOMERULONEPHRITIS Sachiko Matsumoto | Atsuhiro Ichimura | Takashi Dan | Takashi Nakamichi | Tadashi Tsujita | Koji Akahori | Sadayoshi Ito | Tosho Miyata Tohoku Univ Grad School Medicine, Sendai, Japan | Dept Molecular Medicine and Therapy, United Centers Advanced Res and Translational Medicine (ART), Tohoku Univ Grad School Medicine | Div Nephrology, Dept Endocrinology and Vascular Medicine, Tohoku Univ Grad School of Medicine | Tohoku Univ, Sendai, Japan SAP340 PHARMACEUTICAL INHIBITION OF PODOCYTE UPAR EXPRESSION REDUCES PROTEINURIA IN NTX RATS AND LPS MICE Shaoting Xie | Bin Zhang | Wei Shi | Yun Yang Guangdong General Hosp, Guangzhou, China SAP341 KLOTHO PROTEIN REDUCES MOUSE RENAL FIBROSIS AFTER UNILATERAL URETERAL OBSTRUCTION THROUGH INHIBITION OF WNT SIGNALING Hajime Nagasu | Minoru Satoh | Kengo Kidokoro | Yuko Nishi | Chieko Ihoriya | Hiroyuki Kadoya | Tamaki Sasaki | Naoki Kashihara Kawasaki Medical School, Kurashiki, Japan SAP342 TRANSFORMING GROWTH FACTOR Β STIMULATES PROFIBROTIC EPITHELIAL SIGNALING TO ACTIVATE PERICYTE-MYOFIBROBLAST TRANSITION IN OBSTRUCTIVE KIDNEY FIBROSIS Ching-Fang Wu | Fan-Chi Chang | Yi-Ting Chen | Yu-Hsiang Chou | Jeremy Duffield | Shuei-Liong Lin National Taiwan Univ Hosp | Univ Washington | National Taiwan Univ SAP343 MESENCHYMAL STROMAL CELLS AND LISINOPRIL COMBINATION THERAPY INDUCE RENAL REPAIR MODULATING SCATTER FACTORS IN UNILATERAL URETERAL OBSTRUCTION EXPERIMENTAL MODEL Chiara Rocca | Marilena Gregorini | Valeria Corradetti | Teresa Valsania | Giulia Bedino | Francesca Bosio | Eleonora Francesca Pattonieri | Pasquale Esposito| Vincenzo Sepe | Carmelo Libetta | Teresa Rampino | Antonio Dal Canton Unit Nefrology, Dialysis and Transpl, Univ and Fond IRCCS Policlinico San Matteo SAP344 COMBINATION THERAPY WITH MESENCHYMAL STROMAL CELLS AND LISINOPRIL REDUCES RENAL FIBROSIS IN A RAT EXPERIMENTAL MODEL OF UNILATERAL URETERAL OBSTRUCTION INHIBITING RENIN ANGIOTENSIN SYSTEM Giulia Bedino | Marilena Gregorini | Valeria Corradetti | Chiara Rocca | Eleonora Francesca Pattonieri | Teresa Valsania | Francesca Bosio | Pasquale Esposito | Vincenzo Sepe | Carmelo Libetta | Teresa Rampino | Antonio Dal Canton Dip Nefrologia, Dialisi e Trapianto, Univ e Policlinico San Matteo, Pavia SAP345 USE OF XANTHINE OXIDASE INHIBITOR FEBUXOSTAT INHIBITS RENAL INTERSTITIAL INFLAMMATION AND FIBROSIS IN UNILATERAL URETERAL OBSTRUCTIVE NEPHROPATHY Hiroki Omori | Noritaka Kawada | Kazunori Inoue | Yoshiyasu Ueda | Ryohei Yamamoto | Isao Matsui | Jyunya Kaimori | Yoshitsugu Takabatake | Toshiki 296 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Moriyama | Yoshitaka Isaka | Hiromi Rakugi Dept Geriatric Medicine and Nephrology, Osaka Univ Grad School Medicine SAP346 KIM-1 AND NGAL: NEW MARKERS OF OBSTRUCTIVE NEPHROPATHY Anna Wasilewska | Katarzyna Taranta-Janusz | Wojciech Dębek | Elżbieta Kuroczycka-Saniutycz Dept Pediatrics and Nephrology SAP348 DELETION OF ENDOTHELIN-1 FROM ENDOTHELIAL CELL IN-VIVO AND ETAR BLOCKING IN-VITRO ATTENUATE KIDNEY FIBROSIS AND MYOFIBROBLAST FORMATION Nur Arfian | Noriaki Emoto | Keiko Yagi | Kazuhiko Nakayama | Anggoro Budi Hartopo | Dwi Aris Nugrahaningsih | Masashi Yanagisawa | Ken-ichi Hirata Cardiovascular Div Internal Dept, Grad School Medicine Kobe Univ | Clinical Pharmacy Dept, Kobe Pharmaceutical Univ | Howard Hughes Medical Inst, Univ Texas Southwestern Medical Center, Dallas SAP349 ALK1 HETEROZYGOUS DISRUPTION INCREASES RENAL FIBROSIS FOLLOWING URETERAL OBSTRUCTION José Manuel Muñoz-Félix | Jose M. Lopez-Novoa | Carlos Martinez-Salgado Unidad Fisiopatología Renal y Cardiovascular, Inst Reina Sofía Investigación Nefrológica, Salamanca, Spain | Univ Salamanca, Salamanca, Spain, | Inst Estudios Ciencias Salud Castilla y León (IECSCYL), Unidad Investigacion, Hosp Univ Salamanca, Spain SAP350 L-ENDOGLIN OVEREXPRESSION INCREASES RENAL FIBROSIS AFTER UNILATERAL URETERAL OBSTRUCTION Barbara Oujo | José Manuel Muñoz-Félix | Miguel Arevalo | Carmelo Bernabeu| Fernando Perez-Barriocanal | Jose M. Lopez-Novoa Univ Salamanca, Salamanca, Spain | Unidad Fisiopatología Renal y Cardiovascular, Inst Reina Sofía Investigación Nefrológica, Salamanca, Spain | Centro Investigaciones Biologicas, CSIC, Madrid, Spain SAP351 IMPACT OF TWO IMMUNOSUPPRESSIVE DRUGS (CYCLOSPORINE AND EVEROLIMUS) ON IRI-INDUCED FIBROSIS Kers Jesper | Vittoz Nathalie | Galichon Pierre | Dubois Xu Yi Chun | Hertig Alexandre | Rondeau Eric Dept Pathology | APHP, Hôp Tenon | Inserm U702 SAP352 THERAPEUTIC EFFECTS OF MESENCHYMAL STEM CELLS IN WISTARKYOTO RATS WITH ANTI-GLOMERULAR BASEMENT MEMBRANE GLOMERULONEPHRITIS Masayuki Iyoda | Takanori Shibata | Kei Matsumoto | Yuki Shindo-Hirai | Yoshihiro Kuno | Yukihiro Wada | Tadao Akizawa Div Nephrology, Dept Medicine, Showa Univ School Medicine SAP353 ATTENUATED GLOMERULAR ARGININE TRANSPORT PREVENTS HYPERFILTRATION AND INDUCES HIF-1Α IN THE PREGNANT UREMIC RAT Idit Schwartz | Doron Schwartz Tel Aviv Sourasky Medical Center SAP354 INTERACTION BETWEEN IgA AND PROXIMAL TUBULAR CELLS DURING GLOMERULAR DISEASES Caroline Prot Bertoye | Sara Terryn | Julien Claver | Walid Beghdadi Beghdadi| Renato Monteiro | Uli Blank | Olivier Devuyst | Eric Daugas w w w. e r a e d t a 2 01 2 . o r g 297 SATURDAY, MAY 26 SAP347 URETERAL ANGIOGENESIS AND LYMPHANGIOGENESIS AFTER URETERAL OBSTRUCION IN MICE Ae Sin Lee | Jung Eun Lee | Yu Jin Jung | Kyung Pyo Kang | Sik Lee | Won Kim Dept Internal Medicine and Inst Medical Sciences, Chonbuk National Univ Medical School, Jeonju, Korea 49th ERA-EDTA CONGRESS P O S T E R S INSERM U699, Paris France | Div Nephrology- NEFR Unit- Univ Catholique Louvain Medical School, Brussels, Belgium | Nephrology Dpt Bichat Hosp APHP, Paris, France SAP355 COMPARATIVE STUDY OF VALPROIC ACID AND TRICHOSTATIN A IN AN EXPERIMENTAL MODEL OF FSGS Katrien Van Beneden | Caroline Geers | Marina Pauwels | Inge Mannaerts | Christiane Van den Branden | Leo A. van Grunsven Vrije Univ Brussel, Brussels, Belgium | Univ Ziekenhuis Brussel, Brussels, Belgium SATURDAY, MAY 26 SAP356 TRANSPORT IN PODOCYTES OF ACUTE PUROMYCIN AMINONUCLEOSIDE NEPHROSIS (PAN) Ismail Seckin | Meltem Pekpak | Mumin Uzunalan | Bulent Uruluer | Sibel Köktürk | Zeynep Öztürk | Hüseyin Sönmez | Elif Yaprak Istanbul Univ, Cerrahpasa Medical Fac, Dept Histology and Embryology | Lab Memorial Hosp | Istanbul Univ, Cerrahpasa Med Fac, Biochemistry SAP357 NOVEL VASCULOPROTECTIVE ROLE OF NITRIC OXIDE SYNTHASE (NOS) SYSTEM IN MICE: INVOLVEMENT OF NOS SYSTEM IN BONE MARROWDERIVED VASCULAR PROGENITOR CELLS Yumi Furuno | Masato Tsutsui | Tsuyoshi Morishita | Hiroaki Shimokawa | Yutaka Otsuji | Nobuyuki Yanagihara | Narutoshi Kabashima | Serino Ryota| Kaori Kanegae | Tetsu Miyamoto | Junichi Nakamata | Nana Ishimatsu | Masahito Tamura Second Dept Internal Medicine, Univ Occupational and Environmental Health| Dept Pharmacology, Grad School Medicine, Univ Ryukyus | Dept Cardiovascular Medicine, Tohoku Univ Grad School Medicine | Kidney Center, Univ Occupational and Environmental Health SAP358 PLATELET-DERIVED GROWTH FACTOR RECEPTOR BETA SIGNAL COULD CONTRIBUTE TO VULNERABILITY AND REPAIRABILITY OF GLOMERULAR CAPILLARY STRUCTURE Taizo Nakagawa | Kumi Ichikawa | Mayumi Miyamoto | Daisuke Takabayashi| Hidenori Yamazaki | Kouta Kakeshita | Tsutomu Koike | Satoshi Kagitani | Fumihiro Tomoda | Takeru Hamashima | Yoko Ishii | Hiroshi Inoue| Masakiyo Sasahara Second Dept Internal Medicine, Dept Pathology, Univ Toyama, Toyama, Japan SAP359 SILENCING THE EXPRESSION OF NOTCH3 RECEPTOR PREVENTS THE DEVELOPMENT OF GLOMERULONEPHRITIS Fala El Machhour | Monique Kerroch | Laurent Mesnard | Christos Chatziantoniou | Jean-Claude Dussaule INSERM UMR S 702, Paris, France SAP360 CALPONIN-H2 SUPPRESSES THE DEVELOPMENT OF INTERSTITIAL FIBROSIS OF BOTH KIDNEYS AND HEART IN OLD MICE Kiyoko Inui | Fumihiko Sasai | Yuichi Maruta | Hiroki Nishiwaki | Eri Kawashima | Yoshihiko Inoue | Ashio Yoshimura Showa Univ Fujigaoka Hosp Yokohama Japan SAP361 RECOMBINANT HUMAN SOLUBLE THROMBOMODULIN ATTENUATES ANTI-GLOMERULAR BASEMENT MEMBRANE GLOMERULONEPHRITIS IN WISTAR-KYOTO RATS Kei Matsumoto | Masayuki Iyoda | Takanori Shibata | Yukihiro Wada | Yuki Shindo-Hirai | Yoshihiro Kuno | Tadao Akizawa Div Nephrology, Dept Medicine, Showa Univ School Medicine, Tokyo, Japan SAP362 PROTECTIVE EFFECT OF N-3 FATTY ACIDS AGAINST CYCLOSPORIN AASSOCIATED CYTOTOXICITY IN CULTURED HUMAN MESANGIAL CELLS 298 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Estella Musacchio | Giovanna Priante | Chiara Valvason | Leonardo Sartori | Bruno Baggio Clinica Medica I, Dept Medicine, Univ Padova | Nephrology Unit, Dept Medicine, Univ Padova SAP363 INFLUENCE OF CYCLOSPORINE A ON GLOMERULAR GROWTH AND PROTECTIVE EFFECT OF MIZORIBINE AND LOSARTAN ON CYCLOSPORINE A NEPHROTOXICITY IN RAT Ji Hong Kim Ganagnam Severance Hosp, Yonsei Univ College Medicine, Seoul, Korea SAP365 REGULATION OF THE MOUSE GLOMERULAR FILTRATION BY THE INTEGRIN LINKED KINASE (ILK). ROLE OF THE VASODILATORY cGMP PATHWAY Jose Luis Cano | Mercedes Griera | Gemma Olmos | Paloma Martin | Maria Alicia Cortes | Susana Lopez-Ongil | Diego Rodriguez-Puyol | Sergio De Frutos Alcala Univ, Alcala de Henares, Spain | Physiology Dept, Alcala Univ, Alcala de Henares, Madrid, Spain | Univ Alcala, Fac Medicina, Alcala de Henares, Madrid, Spain | Fund Investigacion Biomedica Hosp Principe Asturias, Alcala de Henares, Madrid, Spain | Nephrology Section and Res Unit, Hosp Príncipe Asturias, Alcalá de Henares and IRSIN, Alcala De Henares, Madrid SAP366 HSP70 INCREASE THE PRODUCTION OF EXTRACELLULAR MATRIX BY VASCULAR SMOOTH MUSCLE CELLS THROUGH TGFΒ1 UP-REGULATION Marta Gonzalez | Sergio De Frutos | Jose Luis Cano | Alicia Luengo | Paloma Martin | Manuel Rodriguez-Puyol | Laura Calleros Alcala Univ, Alcala de Henares, Spain | Univ Alcala, Fac Medicina, Alcala de Henares, Madrid, Spain SAP367 PROTEINURIC EFFECTS OF TANSCRANIAL MAGNETIC STIMULATIONS Rosaria Lupica | Antonio Lacquaniti | Valentina Donato | Rossella Maggio | Claudia Mastroeni | Silvia Lucisano | Valeria Cernaro | Maria Rosaria Fazio | Angelo Quartarone | Michele Buemi Policlinico Univ G. Martino, Messina, Italy SAP368 REGULATION OF RENAL FIBROBLAST FUNCTION BY POTASSIUM CHANNELS Michael Kacik | Sybell Goedicke | Holger Eggert | Joachim Dirk Hoyer Philipps-Univ, Dept Nephrology, Marburg, Germany | Dept Nephrology, Marburg, Germany SAP369 CCR7 DEFICIENCY CAUSES A RENAL PHENOTYPE Simone Wurm | Andreas Steege | Miriam Banas | Armin Kurtz | Bernhard Banas Univ Medical Center Regensburg | Univ Regensburg SAP370 EFFECTS OF GSK3 INHIBITION ON THE REGENERATIVE CAPACITY OF RENAL PROGENITOR CELLS Laura Lasagni | Elena Lazzeri | Anna Peired | Maria Lucia Angelotti | Elisa Ronconi | Simone Romoli | Paola Romagnani Univ Florence, Florence, Italy w w w. e r a e d t a 2 01 2 . o r g 299 SATURDAY, MAY 26 SAP364 EVALUATION OF EARLY DIAGNOSTIC MARKERS FOR ALPORT SYNDROME BEFORE THE ONSET OF MICROALBUMINURIA IN THE COL4A3-KNOCKOUT ANIMAL MODEL OF CHRONIC PROGRESSIVE RENAL FIBROSIS Oliver Gross | Rubel Diana | Dihazi Gry H. | Bibi Asimal | Temme Johanna | Schmidt-Eylers Imke | Weimer Lydia | Müller Gerhard-Anton | Dihazi Hassan Univ Medicine Goettingen, Goettingen, Germany 49th ERA-EDTA CONGRESS P O S T E R S SAP371 TYROSINE PHOSPHORYLATION SITES Y4/8/10 OF CD2AP DETERMINE BINDING TO NEPHRIN Irini Schaefer | Beina Teng | Kirstin Worthmann | Hermann Haller | Mario Schiffer Medical School Hannover, Nephrology | Medical School Hannover, Germany SATURDAY, MAY 26 SAP372 PROTEOMIC PROFILE OF CD24+ CD133+ RENAL MULTIPOTENT PROGENITORS (RMP) Clelia Prattichizzo | Giuseppe Stefano Netti | Maria Teresa Rocchetti | Luigi Cormio | Giuseppe Carrieri | Giovanni Stallone | Giuseppe Grandaliano | Elena Ranieri | Loreto Gesualdo Nephrology, Dialysis and Transpl Unit, Clinical Pathology Unit, Dept Biomedical Sciences, Univ Foggia | Univ Foggia, Foggia, Italy | Urology Unit, Dept Surgical Sciences, Univ Foggia | Nephrology, Dialysis and Transpl Unit, DETO, Univ Bari SAP373 THE INFLUENCE OF HIGH PROTEIN SOY BEAN DIET ON BLOOD SERUM NIITRATE LEVEL IN SPONTANEOUSLY HYPERTENSIVE RATS WITH EXPERIMENTAL RENAL FAILURE Anatoliy Kucher | Alexey Smirnov | Marina Parastayeva | Olga Beresneva | Ivan Kayukov | Irina Zubina | Galina Ivanova Saint-Petersburg State Medical Univ named after I.P. Pavlov | Pavlov Inst Physiology, Saint-Petersburg, Russia SAP374 IMPLICATION OF Cx37 IN EXPERIMENTAL NEPHROPATHY Ahmed Abed | Ludwig Schlekenbach | Bernard Foglia | Christos Chatziantoniou | Brenda Kwak | Christos Chadjichristos INSERM U702 | Cardiology Dpt, Geneva Univ Hosp SAP375 INCREASED ANGIOTENSIN II AND ALDOSTERONE LEVELS INDUCE OXIDATIVE STRESS AND DNA DAMAGE IN THE KIDNEY INDEPENDENT OF THEIR HEMODYNAMIC EFFECTS Nina Queisser | Nicole Schupp | Susanne Brand Univ Würzburg, Würzburg, Germany SAP376 ROLE OF IL-17 IN THE PATHOMECHANISM OF RENAL FIBROSIS Leonóra Himer | Beáta Szebeni | Erna Sziksz | Shinobu Saijo | Éva Kis | Ágnes Prókai | Nóra F. Bánki | Andrea Fekete | Tivadar Tulassay | Ádám Vannay Res Lab Paediatrics and Nephrology, Hungarian Academy of Sciences, Budapest, Hungary | Center Experimental Medicine, Inst Medical Science, Univ Tokyo, Japan | First Dept Paediatrics, Semmelweis Univ, Budapest, Hungary SAP377 SELECTIVE INDUCTION AND MODULATION OF mTORC1 AND mTORC2 SIGNALING DURING OSTEOBLASTIC DIFFERENTIATION AND CALCIFICATION OF MESENCHYMAL STEM CELLS Björn Hegner | Theres Schaub | Claudia Lange | Duska Dragun Dept Nephrology and Intensive Care Medicine | Charite, Berlin Germany | Clinic Stem Cell Transpl SAP378 CKD IMPAIRS FUNCTIONALITY OF MESENCHYMAL STEM CELLS (MSC) IN VITRO AND IN VIVO Barbara Mara Klinkhammer | Kramann Rafael | Mallau Monika | Makowska Anna | Claudia van Roeyen | Peter Boor | Buecher Eva Bettina | Otten Simon | Stuettgen Esther | Jürgen Floege | Uta Kunter Univ Hosp RWTH Aachen, Nephrology and Clinical Immunology, Aachen, Germany | RWTH Aachen Univ SAP379 PRO-CALCIFYING CELL FUNCTIONS OF MESENCHYMAL STEM CELLS IS DIFFERENTIALLY MODULATED BY UREMIC RETENTION SOLUTES – A SYSTEMATIC ANALYSIS 300 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Björn Hegner | Daniel Janke | Theres Schaub | Claudia Lange | Joachim Jankowski | Duska Dragun Dept Nephrology and Intensive Care Medicine | Charite, Berlin Germany | Clinic for Stem Cell Transpl | Dept Nephrology SAP380 LIPOPOLYSACCHARIDE INCREASES CALCIFICATION IN VASCULAR SMOOTH MUSCLE CELLS BY HIGH INORGANIC PHOSPHATE AND HIGH CALCIUM CONCENTRATION MEDIA Matsuhiko Hayashi | Ichiro Takamatsu | Chihiro Horimai | Tadashi Yoshida Apheresis and Dialysis Center, Keio Univ, School Medicine, Tokyo, Japan SAP382 ANTIOXIDATIVE STRATEGY TO PROTECT THE KIDNEY FROM EXPERIMENTAL PYELONEPHRITIS IN VITRO AND IN VIVO Egor Plotnikov | Maria Morosanova | Irina Pevzner | Ljubava Zorova | Natalya Pulkova | Dmitry Zorov Belozersky Inst Physico-Chemical Biology, Moscow State Univ | Fac Bioengineering and Bioinformatics, Mitoengineering Res Inst, Lomonosov Moscow State Univ, Moscow, Russia | Mitoengineering Res Inst, Lomonosov Moscow State Univ, Moscow, Russia SAP383 RESPONSE OF VEGF TO ACTIVATION OF VIRAL RECEPTORS AND TNFα IN IMMUNE MEDIATED GLOMERULONEPHRITIS Markus Wörnle | Andrea Ribeiro | Franziska Belling | Monika Merkle Medical Policlinic, Univ Munich, Germany SAP384 ABNORMAL CONFORMATION AND IMPAIRED DEGRADATION OF NEUTROPHIL EXTRACELLULAR TRAPS INDUCED BY PROPYLTHIOURACIL ARE IMPLICATED IN THE PATHOGENESIS OF MPO-ANCA-ASSOCIATED VASCULITIS Daigo Nakazawa | Saori Nishio | Sekiya Shibasaki | Utano Tomaru | Ishizu Akihiro Hokkaido Univ Hosp, Internal Medicine II | Hokkaido Univ, Internal Medicine II | Hokkaido Univ, Dept Pathology | Hokkaido Univ, Fac Health Sciences SAP385 AMELIORATED DUAL ABNORMALITIES OF MEGALIN AND NAPI-IIC EXPRESSIONS IN PROXIMAL RENAL TUBULES BY ORAL PREDNISOLONE THERAPY IN A CASE OF ANTI-MITOCHONDRIAL ANTIBODIES-M2 POSITIVE TUBULOINTERSTITIAL NEPHRITIS WITH FANCONI SYNDROME Ikue Kobayashi | Yasuo Imanishi | Masafumi Kurajoh | Yuki Nagata | Masayo Yamagata | Masanori Emoto | Toshimi Michigami | Eiji Ishimura | Masaaki Inaba Osaka City Univ Grad School Medicine, Osaka, Japan | Res Inst, Osaka Medical Center Maternal and Child Health, Osaka, Japan SAP386 RALOXIFENE AMELIORATES PROTEINURIA-INDUCED INFLAMMASOME ACTIVATION AND TUBULAR INJURY Yuko Nishi | Minoru Satoh | Tamaki Sasaki | Naoki Kashihara Kawasaki Medical School, Kurashiki, Japan SAP387 RESVERATROL ENHANCES ENDOGENOUS HEME OXYGENASE-1 AND ANTI-COMPLEMENTARY ACTIVITY TO AMELIORATE EXPERIMENTAL MURINE MEMBRANOUS NEPHROPATHY Chia-Chao Wu | Kuo-Cheng Lu | Jin-Shuen Chen | Pauling Chu | Yuh-Feng Lin Div Nephrology, Dept Medicine, Tri-Serv General Hosp, National Defense Me- w w w. e r a e d t a 2 01 2 . o r g 301 SATURDAY, MAY 26 SAP381 HYPERPHOSPHATEMIA DIRECTLY AFFECTS ENDOTHELIAL FUNCTION BY DOWN-REGULATING ANNEXIN II Giovanna Seno Di Marco | Maximilian Koenig | Christian Stock | Stephanie Reiermann | Susanne Amler | Gabriele Koehler | Manfred Fobker | Friedrich Buck | Hermann Pavenstaedt | Detlef Lang | Marcus Brand Univ Muenster 49th ERA-EDTA CONGRESS P O S T E R S dical Center, Taipei, Taiwan | Dept Medicine, Cardinal Tien Hosp, School Medicine, Fu Jen Catholic Univ, New Taipei city, Taiwan | Div Nephrology, Dept Medicine, Shuang-Ho Hosp, Taipei Medical Univ, Taipei, Taiwan SAP388 LIPOCALIN-2 IS AN ENDOGENOUS INHIBITOR OF INFLAMMATION IN MURINE NEPHROTOXIC SERUM NEPHRITIS Kathrin Eller | Andrea Schroll | Miriam Banas | Alexander Kirsch | Julia Huber| Günter Weiss | Igor Theurl | Alexander R. Rosenkranz Medical Univ Graz, Graz, Austria | Medical Univ Innsbruck, Innsbruck, Austria| Medical Univ Regensburg, Regensburg, Germany SATURDAY, MAY 26 SAP389 DEVELOPMENTAL RELATIONSHIP OF HUMAN MONOCYTE SUBSETS AND THE IMPACT OF IMMUNOSUPPRESSANTS ON MONOCYTE SUBPOPULATIONS Adam Zawada | Kyrill Rogacev | Marina Achenbach | Danilo Fliser | Gerhard Held | Gunnar Henrik Heine Dept Internal Medicine IV, Dept Internal Medicine I, Saarland Univ Medical Center, Homburg, Germany SAP390 A UREMIC TOXIN, 3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONATE ACCUMULATES IN PROXIMAL TUBULAR CELLS AND INDUCES CELL DAMAGE THROUGH INCREASING OXIDATIVE STRESS Yohei Miyamoto | Yasunori Iwao | Hiroshi Watanabe | Daisuke Kadowaki | Yu Ishima | Victor Tuan Giam Chuang | Keizo Sato | Masaki Otagiri | Toru Maruyama Dept Biopharmaceutics, Grad School Pharmaceutical Sciences, Kumamoto Univ, Kumamoto, Japan | School Pharmaceutical Sciences, Univ Shizuoka, Shizuoka, Japan | School Pharmacy, Fac Health Sciences, Curtin Health Innovation Res Inst, Curtin Univ, Western Australia, Australia | School Pharmacy, Kyushu Univ Health and Welfare, Nobeoka, Japan | Fac Pharmaceutical Sciences, Sojo Univ, Kumamoto, Japan SAP391 THE EFFECT OF INDOXYL SULFATE ON INTESTINAL IMMUNOLOGY IN CHRONIC KIDNEY DISEASE Yoshiyasu Ueda | Hirotsugu Iwatani | Yoshitaka Isaka Osaka Univ, Suita, Japan SAP392 p-CRESYL SULFATE CAUSES RENAL TUBULAR CELL DAMAGE BY INDUCING OXIDATIVE STRESS THROUGH THE ACTIVATION OF NADPH OXIDASE Hiroshi Watanabe | Daisuke Honda | Yohei Miyamoto | Tsuyoshi Noguchi | Daisuke Kadowaki | Yu Ishima | Motoko Tanaka | Hisae Tanaka | Masafumi Fukagawa | Masaki Otagiri | Toru Maruyama Dept Biopharmaceutics, Grad School Pharmaceutical Sciences, Kumamoto Univ, Kumamoto, Japan | Dept Nephrology, Akebono Clinic, Kumamoto, Japan | Div Nephrology, Endocrinology and Metabolism, Tokai Univ School Medicine, Kanagawa, Japan | Fac Pharmaceutical Sciences, Sojo Univ, Kumamoto, Japan SAP393 IMMUNOMODULATORY EFFECTS OF TUMOR NECROSIS FACTOR ALPHA AND TNF RECEPTOR SYSTEM: IMPLICATIONS FOR IMMUNE MEDIATED GLOMERULAR AND VASCULAR DISORDERS AND THEIR THERAPY WITH BIOLOGICAL AGENTS Markus Wörnle | Andrea Ribeiro | Joachim Pircher | Simone Köppel | Hanna Mannell | Florian Krötz | Monika Merkle Medical Policlinic, Univ Munich, Germany | Walter-Brendel-Centre Experimental Medicine, Univ Munich, Germany SAP394 EFFECT OF CARDIORENAL SYNDROME TYPE 1 PLASMA ON MONOCYTES APOPTOSIS: A PILOT STUDY Grazia Maria Virzì | Chiara Bolin | Dinna Cruz | Elisa Scalzotto | Massimo de Cal | Giorgio Vescovo | Claudio Ronco 302 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Dept Nephrology, Dialysis and Transpl, St Bortolo Hosp, IRRIV-International Renal Resarch Inst Vicenza, Italy | Internal Medicine, St Bortolo Hosp , Vicenza, Italy | San Bortolo Hosp Vicenza | Div Nephrology, Univ Padua, Padua, Italy SAP395 TYPICAL PLASMA PROFILE IN CARDIORENAL SYNDROME TYPE 1 PATIENTS Grazia Maria Virzì | Chiara Bolin | Dinna Cruz | Elisa Scalzotto | Massimo de Cal | Giorgio Vescovo | Claudio Ronco Dept Nephrology, Dialysis and Transpl, St Bortolo Hosp, IRRIV-International Renal Resarch Inst Vicenza, Italy | Internal Medicine, St Bortolo Hosp , Vicenza, Italy | San Bortolo Hosp Vicenza | Div Nephrology, Univ Padua, Padua, Italy SAP397 VITAMIN D RECEPTOR ACTIVATORS INHIBIT VASCULAR SMOOTH MUSCLE CELL MINERALIZATION INDUCED BY PHOSPHATE AND TNF-α Yumie Aoshima | Masahide Mizobuchi | Hiroaki Ogata | Chiaki Kumata | Ai Nakazawa | Fumiko Kondo | Naoko Ono | Fumihiko Koiwa | Eriko Kinugasa| Tadao Akizawa Dept Nephrology, Showa Univ School of Medicine, Tokyo, Japan SAP398 RENAL AFFERENT NEURONS EXHIBIT AN ALTERED FIRING PATTERN IN AN IN VITRO MODEL OF KIDNEY INFLAMMATION Wolfgang Freisinger | Nena Lale | Angelika Lampert | Tilmann Ditting | Sonja Heinlein | Roland E. Schmieder | Roland Veelken Med Clinic 4, Inst Physiology and Pathophysiology, Univ Erlangen-Nürnberg, Germany SAP399 EFFECT OF CHRONIC ADMA INFUSION IN RATS ON WHITE BLOOD CELL COUNT, LEUKOCYTE SUBSETS AND TISSUE NK CELLS Heike Nave | Ronny Perthel | Mayuren Suntharalingam | Stefanie Bode-Böger| Gernot Beutel | Jan Kielstein Martin Luther Univ Halle-Wittenberg | Medical School Hannover | Otto-vonGuericke Universtiy SAP400 CONNECTIVE TISSUE GROWTH FACTOR INDUCES A SUSTAINED INFLAMMATORY RESPONSE IN THE KIDNEY AND VESSELS VIA LOCAL INTERLEUKIN 17A PRODUCTION Raquel Rodrigues-Díez | Raul Rodrigues-Diez | Sandra Rayego-Mateos | Carolina Lavoz | Luiz Guilherme Stark Aroeira | Macarena Orejudo | Matilde Alique| Alberto Ortiz | Jesus Egido | Marta Ruiz-Ortega Cellular Biology Renal Diseases Lab Univ Autónoma Madrid, Spain | IDIPAZ, Madrid, Spain | Dialysis Unit, Fund Jiménez Díaz, Madrid, Spain| IIS-FJD, Madrid, Spain SAP401 NON-HLA ANTIBODIES TARGETING G-PROTEIN COUPLED RECEPTORS INDUCE mTORC1 AND mTORC2 SIGNALLING IN HUMAN MICROVASCULAR ENDOTHELIUM Wischnewski Oskar | Catar Rusan | Theres Schaub | Björn Hegner | Duska Dragun Charité-Univsmedizin Berlin, Germany | Dept Nephrology and Intensive Care Medicine w w w. e r a e d t a 2 01 2 . o r g 303 SATURDAY, MAY 26 SAP396 INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE M PREVENTS CHRONIC AFTER ACUTE KIDNEY INJURY THROUGH SUPPRESSION OF RENAL INFLAMMATION Regina Gröbmayr | Maciej Lech | Mi Ryu | Hans-Joachim Anders Medizinische Klinik und Poliklinik IV, Univ Munich, Munich, Germany | Renal Div, Medizinische Klinik und Poliklinik IV, Univ Munich, Munich, Germany | LMU, Munich, Germany | Nephrological Center, Medical Policlinic, Univ Munich, Germany 49th ERA-EDTA CONGRESS P O S T E R S SAP402 ENDOTHELIAL GLYCOCALYX DAMAGE IN CHRONIC KIDNEY DISEASE COINCIDENCES WITH ENDOTHELIAL DYSFUNCTION Jan-Sören Padberg | Anne Wiesinger | Marcus Brand | Giovanna Seno Di Marco| Stefan Reuter | Alexander Grabner | Dominik Kentrup | Alexander Lukasz| Hans Oberleithner | Hermann Pavenstädt | Philipp Kümpers Dept Medicine D, Div Internal Medicine, Nephrology, and Rheumatology, Univ Hosp Münster, Münster, Germany | Dept Nephrology & Hypertension, Hannover Medical School | Inst Physiology II, Univ Muenster SATURDAY, MAY 26 SAP403 COMPLEMENT REGULATION BY HUMAN FACTOR H-RELATED PROTEIN 2 (CFHR2) IS LINKED TO MPGN I Hannes U Eberhardt | Christine Skerka | Qian Chen | Teresia Hallstroem | Andrea Hartmann | Markus J Kemper | Peter F Zipfel Leibniz Inst Natural Product Res and Infection Biology, Jena, Germany | Univ Hosp Eppendorf, Hamburg, Germany SAP404 C-MIP IS A NEGATIVE REGULATOR OF T-LYMPHOCYTE ACTIVATION AND REPRODUCES IN VIVO SOME T LYMPHOCYTE DISORDERS OBSERVED IN ACTIVE MCNS Kélhia N'Gomé-Sendeyo | Qing-Feng Fan | Shao-Yu Zhang | André Pawlak | Djillali Sahali INSERM U955 équipe 21, Créteil, France SAP405 ROLE OF RECEPTORS OF THE INNATE IMMUNE SYSTEM IN GLOMERULAR FIBRIN DEPOSTIION AND FIBROSIS Markus Wörnle | Andrea Ribeiro | Monika Merkle Medical Policlinic, Univ Munich, Germany SAP406 IRON DEFICIENCY ANAEMIA INCREASES RENAL OXIDATIVE STRESS AND INFLAMMATION IN SPONTANEOUSLY HYPERTENSIVE STROKE PRONE RATS TREATED WITH DOXORUBICIN Jorge Toblli | Gabriel Cao | Jorge Fernando Giani | Fernando Pablo Dominici Lab Experimental Medicine, Hosp Alemán | School Pharmacy Univ Buenos Aires, Argentina SAP407 THE BLOCKING OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM CAN DECLINE BOTH EPO AND EPO RECEPTOR IN CKD RAT Jae Seok Kim | Jae Won Yang | Min Keun Kim | Byoung Geun Han | Seung Ok Choi Yonsei Univ Wonju College Medicine, Wonju, Korea 304 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France RENAL HISTOPATHOLOGY SAP408 COMPLEMENT PATHWAYS ACTIVATION IN PAUCI-IMMUNE NECROTIZING GLOMERULONEPHRITIS WITH ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODY Figuères Marie-Lucile | Noel Laure-Hélène | Chaabouni Yosr | Moreau Anne| Fakhouri Fadi Serv Anatomopathologie, Hôp Necker, Paris, France | Serv Néphrologie, Tunis, Tunisie | Serv Anatomopathologie, CHU Nantes, France | Serv Néphrologie, CHU Nantes, France SAP410 THE EUROPEAN MPGN REGISTRY: NOVEL GENETIC- AND AUTOIMMUNE- FACTORS ALLOW A DIFFERENTIATION BETWEEN MPGN SUBTYPE I AND SUBTYPE II Qian Chen | Barbara Uzonyi | Susann Lindner | Christoph Licht | Bernd Hoppe| Magdalena Riedl | Michael Kirschfink | Sandra Habbich | Gunter Wolf | Lisa Strain | Timothy HJ Goodship | Peter F Zipfel Leibniz Inst Natural Product Res and Infection Biology, Jena Germany | Hosp Sick Children, Toronto, Canada | Univ Children's Hosp, Cologne, Germany | Univ Innsbruck, Austria | Univ Heidelberg, Germany | Imoversoty Cjildren's Hosp Cologne, Germany | Univ Hosp Jena, Germany | Newcastle upon Tyne Hosp, Newcastle upon Tyne, UK SAP411 VALIDITY OF OXFORD CLASSIFICATION OF IgA NEPHROPATHY IN ARABS Hala Kfoury | Abdulkareem Alsuwaida | Khaled Alsaad | Fayez Alhejaili | Mohammed Alghonaim | Jamal Alwakeel | Sufia Husain | Noura AlOudah King Saud Univ, Riyadh, Saudi Arabia | King Abdulaziz Medical City, College Medicine, King Saud bin Abdulaziz Univ Health Sciences, Riyadh, Saudi Arabia| King Saud Univ, King Khalid Univ Hosp, Dept Medicine, Riyadh, Saudi Arabia | King Saud Univ, King Khalid Univ Hosp, Dept Pathology, Riyadh, Saudi Arabia SAP412 LAPAROASSISTED RETROPERITONEAL KIDNEY BIOPSY (LKB) IN PATIENTS WITH CONTRAINDICATIONS TO PERCUTANEOUS KIDNEY BIOPSY (PKB) Luca Besso | Michela Tamagnone | Germana Daidola | Manuel Burdese | Lorenzo Repetto | Giovanni Pasquale | Loredana Colla | Luigi Biancone | Piero Stratta | Giuseppe Paolo Segoloni Nephrology, Molinette Hosp, Turin, Italy | Dept Internal Medicine, Nephrology, Univ Turin,Turin, Italy | Urology, Molinette Hosp, Turin, Italy | Nephrology, Piemonte Orientale Univ, Novara, Italy SAP413 RENAL BIOPSY DATABASE FROM THE DEPT PATHOLOGY DUBRAVA UNIV HOSP ZAGREB Jasna Bacalja | Ana Marija Bauer Šegvić | Stela Bulimbašić | Arijana Pačić| Mladen Knotek | Mirjana Sabljar Matovinović | Krešimir Galešić | Danica Galešić Ljubanović Univ Hosp Dubrava Zagreb, Zagreb, Croatia | Dubrava Univ Hosp, Zagreb, Croatia | Merkur Univ Hosp, Zagreb, Croatia SAP414 MORPHOLOGICAL CHARACTERISTICS OF KIDNEY INVOLVEMENT IN NON-HODGKIN LYMPHOMA/LEUKEMIA, LYMPHOPLASMACYTIC LYM- w w w. e r a e d t a 2 01 2 . o r g 305 SATURDAY, MAY 26 SAP409 COMPUTERIZED INSTERSITIAL FIBROSIS IS THE MOST POWERFUL HISTOLOGICAL PREDICTOR OF RENAL OUTCOME IN ANCA-ASSOCIATED VASCULITIS Charlene Levi| Vannary Meas-Yedid | Cristina Daniliuc | Alexandre Karras | Jean Christophe Olivo-Marin | Luc Mouthon | Elsa Guiard | Melanie Roland | Loic Guillevin | Christian Jacquot | Dominique Nochy | Eric Thervet Hop Europeen Georges Pompidou | Lab Analyse Images Quantitative, Inst Pasteur | Hop Cochin 49th ERA-EDTA CONGRESS P O S T E R S PHOMA AND ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA – ONE CENTER EXPERIENCE Elena Zakharova | Ekaterina Stolyarevich | Olga Vorobjova City Hosp n.a. S.P. Botkin, Moscow, Russian Federation | Moscow City Nephrology Center | Leningrad Regional Patology Bureau SATURDAY, MAY 26 SAP415 ACTIVATION OF MAPK/ERK SIGNALING PATHWAY IN MESANGIAL CELLS IS ASSOCIATED WITH GLOMERULAR DAMAGE IN IGA NEPHROPATHY Houda Tamouza | Jonathan Maurice Chemouny | Martin Flamant | Leona Raskova Kafkova | Marie Demion | Mesnard Laurent | Francine Walker | Bruce A Julian | Emilie Tissandié | Meetu Kaushik Tiwari | Jan Novak | Niels Olsen Camara | Marc Benhamou | Francois Vrtovsnik | Renato C Monteiro | Ivan Cruz Moura INSERM U699, Paris, France | APHP, Paris, France | Dept Microbiology, Univ Alabama Birmingham, Birmingham, AL, USA | INSERM U702, Paris, France | Dept Pathology, Hôp Bichat-Claude Bernard, Paris, France | Transpl Immunobiology Lab, São Paulo, Brazil | Hôp Bichat, AP-HP SAP416 CORRELATION OF INFLAMMATORY CELL INFILTRATION AND HISTOLOGIC AND CLINICAL MANIFESTATIONS OF LUPUS NEPHRITIS Shiva Samavat | Pedram Ahmadpoor | Peyman Torbati | Ramin Ghaderi | Fatemeh Poorrezagholi | Fariba Samadian | Mohsen Nafar Labbafinejad Hosp, Tehran, Iran SAP417 GLOMERULAR CAPILLARY INJURY IN THE ENDOCAPILLARY PROLIFERATIVE LESIONS OF VARIOUS GLOMERULONEPHRITIS Akiko Mii | Akira Shimizu | Tomohiro Kaneko | Fumihiko Yasuda | Megumi Fukui | Yukinari Masuda | Yasuhiko Iino | Yasuo Katayama Nippon Medical School, Tokyo, Japan SAP418 NCAM POSITIVE INTERSTITIAL CELLS INCREASE IN INTERSTITIAL FIBROSIS IN DIFFERENT RENAL DISEASES Claudia Müller | Jasmina Marković-Lipkovski | Sanja Simić-Ogrizović | Radomir Naumović | Sanja Ćirović | Dragan Mitrović | Gerhard Müller Univ Tübingen, ZMF – Zentrum Med Forschung, Tübingen, Germany | Univ Belgrade, Fac Medicine, Nephrology Clinic, Belgrade, Serbia | Univ Belgrade Fac Medicine, Inst Pathology, Belgrade, Serbia | Univsmedizin Göttingen, Zentrum Innere Medizin, Göttingen, Germany SAP419 PROGNOSTIC MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL FACTORS IN PATIENTS WITH SCHOENLEIN-HENOCH NEPHROPATHY Aldona Wozniak | Małgorzata Janicka-Jedyńska | Jakub Żurawski | Elżbieta Kaczmarek | Jacek Zachwieja Dept Clinical Pathology, Dept Clinical Pathomorphology, Dept Childhood Cardiology and Nephrology, Univ Medical Sciences, Poznań, Poland SAP420 THE CLINICAL PRESENTATION AND COURSE OF IDIOPATHIC RENAL THROMBOTIC MICROANGIOPATHY (RTMA) S Khilji | T Dorman | P O'Kelly | L Lampty | KCP Leung | A Shadivan | C Varghese | JJ Walshe Beaumont Hosp, Dublin, Ireland SAP421 IMMUNOHISTOCHEMICAL CHARACTERISTICS OF IGG4-RELATED KIDNEY DISEASE (IGG4RKD) Takao Saito | Mitsuhiro Kawano | Takako Saeki | Ichiro Mizushima | Yutaka Yamaguchi | Naofumi Imai | Hitoshi Nakashima | Hisanori Umehara Fukuoka Univ School Medicine, Fukuoka, Japan | Kanazawa Univ Hosp, Kanazawa, Japan | Nagaoka Red Cross Hosp, Nagaoka, Japan | Yamaguchi's Pathology Lab, Matsudo, Japan | Niigata Univ Grad School Medicine, Hiigata, Japan | Kanazawa Medical Univ, Ishikawa, Japan 306 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP422 PAX-2 PROTEIN AS A MARKER OF DEDIFFERENTIATION OF PODOCYTES IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS (CGN): ASSOCIATION WITH CLINICAL AND MORPHOLOGICAL MARKERS OF GLOMERULAR DEMAGE AND NEPHROSCLEROSIS Mikhail Shvetsov | Olga Popova | Natalia Chebotareva | Aleksey Ivanov | Irina Bobkova I.M. Sechenov First Moscow State Medical Univ, Moscow, Russia SAP424 NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IN GLOMERULONEPHRITIDES: AN IMMUNOHYSTOCHEMICAL EXPRESSION ANALYSIS Giuseppe Coppolino | Nicola Comi | Davide Bolignano | Valentina Piraina | Roberta Talarico | Alessandro Colombo | Gaetano Lucisano | Giorgio Fuiano Azienda Osp-Univ Magna Graecia, Catanzaro, Italy SAP425 NEPHROTIC SYNDROME IN THE ADULT: DISTRIBUTION OF HISTOLOGICAL TYPES, REFERRING TO RENAL BIOPSIES PERFORMED IN NORTHERNEASTERN ITALY FROM 1998 TO 2008 Patrizia Bernich | Antonio Lupo | Triveneto Registry of Renal Biopsies Dept Nephrology, Verona, Italy SAP426 INFLAMMATORY INDICES AND PARENCHYMAL CALCIFICATIONS IN KIDNEY TRANSPL BIOPSIES Maria Pia Rastaldi | Piergiorgio Messa | Diana Alexandru | Laurentiu Mogoanta | Ofelia Claudia Jercan IRCCS Fond Ca' Granda Osp Policlinico, Milan, Italy | Univ Medicine and Pharmacy Craiova, Romania SAP427 MORPHOLOGIC MARKERS OF INTRARENAL BLOOD FLOW AND ANGIOGENESIS DISORDERS IN CHRONIC GLOMERULONEPHRITIS: ASSOCIATION WITH SYSTEMIC ARTERIAL HYPERTENSION AND DISEASE ACTIVITY Mikhail Shvetsov | Aleksey Ivanov | Veronica Uribe Villegas | Olga Popova I.M. Sechenov First Moscow State Medical Univ, Moscow, Russia w w w. e r a e d t a 2 01 2 . o r g 307 SATURDAY, MAY 26 SAP423 CLC-5 AND PROTEINURIC NEPHROPATHY: WHICH HYPOTHESIS SUGGEST THE STUDY OF TUBULAR AND GLOMERULAR PROTEIN? Daniela Cremasco | Monica Ceol | Licia Peruzzi | Gianna Mazzucco | Marra Giuseppina | Giuseppe Vezzoli | Rosalba Cristofaro | Angela D'Angelo | Franca Anglani | Dorella Del Prete Div Nephrology, Dept Medicine Univ Padova | Nephr Dial Traspl, Regina Margherita Children’s Hosp Torino | Patol Anat Unit, Univ Torino | Nephr Dial IRCCS Ca’ Grande Milano | Nephr Dial, U, IRCCS Hosp S Raf Milano | Lab Histomorphology and Molecular Biology Kidney, Div Nephrology, Dept Medicine, Univ Padua, Italy 49th ERA-EDTA CONGRESS P O S T E R S PERITONEAL DIALYSIS SAP428 THE EFFECT AND MECHANISM OF FLUVASTATIN ON THE EXPRESSION OF FIBRONECTIN IN HUMAN PERITONEAL MESOTHELIAL CELLS INDUCED BY HIGH-GLUCOSE PERITONEAL DIALYSATE Jia Liu | Yanchun Liu | Yaguang Xu | Xiufen Zhao | Jun Qian | Bin Sun | Changying Xing First Affiliated Hosp Nanjing Medical Univ, Nanjing, China SATURDAY, MAY 26 « SAP429 EFFECTS OF TRANSPLED MESOTHELIAL CELLS DURING PERITONEAL REPAIR USING TEMPERATURE-SENSITIVE SV40 LARGE T ANTIGEN GENE TRANSGENIC RAT MESOTHELIAL CELLS Reo Kanda | Chieko Hamada | Takanori Nakano | Keiichi Wakabayashi | Hiroaki Io | Satoshi Horikoshi | Yasuhiko Tomino Div Nephrology, Dept Internal Medicine, Juntendo Univ Fac Medicine, Tokyo, Japan SAP430 PENTRAXIN 3 EXPRESSION IN A RAT MODEL OF CONTINUOUS PERITONEAL DIALYSIS Nana Ishimatsu | Tetsu Miyamoto | Hiroyuki Morimoto | Junichi Nakamata | Ryoko Baba | Kaori Kanegae | Ryota Serino | Narutoshi Kabashima | Yutaka Otsuji | Yoshiaki Doi | Masahito Tamura Second Dept Internal Medicine, Dept Anatomy, Kidney Center, Univ Occupational and Environmental Health, Kitakyusyu, Japan SAP431 HIGH GLUCOSE PERITONEAL DIALYSATE INDUCES APOPTOSIS THROUGH ENDOPLASMIC RETICULUM STRESS IN PERITONEAL MESOTHELIAL CELLS Junichi Nakamata | Hiroyuki Morimoto | Ryoko Baba | Nana Ishimatsu | Tetsu Miyamoto | Kaori Kanegae | Ryota Serino | Narutoshi Kabashima | Yutaka Otsuji | Yoshiaki Doi | Masahito Tamura Second Dept Internal Medicine, Dept Anatomy, Kidney Center, Univ Occupational and Environmental Health, Kitakyushu, Japan SAP432 ADMINISTRATION OF PIGMENT EPITHELIUM-DERIVED FACTOR AMELIORATES CG-INDUCED PERITONEAL INJURY AND FIBROSIS IN MICE Takuo Kusumoto | Kei Fukami | Sho-ichi Yamagishi | Seiji Ueda | Yusuke Kaida | Takuma Hazama | Yosuke Nakayama | Ryotaro Ando | Nana Obara | Seiya Okuda Div Nephrology, Dept Medicine, Dept Pathophysiology and Therapeutics Diabetic Vascular Complications, Kurume Univ School Medicine SAP433 PROTECTIVE EFFECTS OF ICODEXTRIN ON INTER-CELLULAR ADHESION MOLECULE-1 EXPRESSION VIA PROTEIN KINASE C IN HUMAN ENDOTHELIAL CELLS Masahito Tamura | Mika Matsumoto | Tetsu Miyamoto | Kaori Kanegae | Yumi Furuno | Ryota Serino | Narutoshi Kabashima | Yutaka Otsuji Univ Occupational and Environmental Health, Kitakyushu, Japan SAP434 CALCITRIOL AMELIORATES CHLORHEXIDE DIGLUCONATE-INDUCED LIVER PERITONEAL FIBROSIS IN RATS Hsu Bang-Gee Tzu Chi General Hosp, Hualien, Taiwan SAP435 PULSE PRESSURE IN PD PATIENTS Luisa Mazzotta | Alberto Rosati | Antonio Carlini Dept Nephrology, Lucca Hosp 308 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP436 THE TIME HAS AN EFFECT ON THE DECLINE IN SERUM ALBUMIN CONCENTRATIONS IN PATIENTS ON PERITONEAL DIALYSIS INCIDENTS Viviana Teixeira Henriques | Edson Zangiacomi Martinez | José Carolino Divino-Filho | Roberto Pecoits-Filho | José Abrão Cardeal da Costa Univ São Paulo, Ribeirão Preto, Brazil | Baxter Health Care and Social Medicine| Pontificia Univ Catolica Parana, Curitiba SAP437 ESTIMATES OF FOOD INTAKE AND ABSORPTION OF CARBOHYDRATES IN PERITONEAL DIALYSIS (PD) AND LIPID PROFILE Viviana Teixeira Henriques Univ São Paulo SAP439 MALNUTRITION AND INFLAMMATION AFFECT THE VIABILITY OF PERITONEAL MESOTHELIAL CELLS IN PERITONEAL DIALYSIS PATIENTS Masanobu Akazawa | Tomomi Uno | Eiichiro Kanda | Yoshitaka Maeda Tokyo Koysai Hosp | JA Toride Mecial Center SAP440 RESIDUAL RENAL FUNCTION PREDICTS NUTRITIONAL STATE IN PERITONEAL DIALYSIS (PD) PATIENTS Maria Aktsiali | Sofia Antonopoulou | Konstantina Tsiolaki | Neratzoula Bakirtzi | Alexandra Patrinou | Maria Georgopoulou | Paraskevi Liaveri | Nikolaos Afentakis | George Tsirpanlis Dept Nephrology, General Hosp Athens, G. Gennimatas, Athens, Greece SAP441 LOWER BASELINE PERITONEAL MEMBRANE TRANSPORT STATUS WITH STRICT PROTEIN RESTRICTION DIET DURING PREDIALYTIC PERIOD IS ASSOCIATED WITH CONSEQUENT BETTER OUTCOMES AMONG PERITONEAL DIALYSIS PATIENTS Takeshi Hasegawa | Hiroki Nishiwaki | Makoto Hirose | Daisuke Komukai | Hironori Tayama | Fumihiko Koiwa | Ashio Yoshimura Showa Univ Fujigaoka Hosp SAP442 EFFECT OF BIOCOMPATIBLE PERITONEAL DIALYSIS FLUIDS ON DAILY URINE VOLUME, SERUM ADIPONECTIN LEVELS, SMALL SOLUTE PERMEABILITY AND MESOTHELIAL CELL INTEGRITY SIX MONTHS AFTER CONVERSION BACK TO CONVENTIONAL PERITONEAL DIALYSIS FLUIDS Sing Leung Lui | Susan Yung | Colin Tang | Flora Ng | Wai Kei Lo | Tak Mao Chan Tung Wah Hosp, Hong Kong SAR, China | Univ Hong Kong, Hong Kong SAR, China SAP443 LOW CIRCULATING ADIPONECTIN LEVELS ARE ASSOCIATED WITH INSULIN RESISTANCE IN NON-OBESE PERITONEAL DIALYSIS PATIENTS Hyang Mo Koo | Fa Mee Doh | Dong Eun Yoo | Hyung Jung Oh | Tae-Hyun Yoo | Kyu Hun Choi | Shin-Wook Kang | Dae Suk Han | Seung Hyeok Han College Medicine, Yonsei Univ, Seoul, Korea SAP444 SURVIVAL OF INCIDENT PERITONEAL DIALYSIS PATIENTS IN BRAZIL (BRAZPD): IS OVERWEIGHT/OBESITY AN ADVANTAGE? Natalia Fernandes | Marcus Gomes Bastos | Márcia Regina Gianotti Franco | Alfredo Chaoubah | Maria da Glória Lima | Roberto Pecoits-Filho | José Carolino Divino-Filho | Abdul Rashid Qureshi w w w. e r a e d t a 2 01 2 . o r g 309 SATURDAY, MAY 26 SAP438 ASSOCIATION BETWEEN PHYSICAL ACTIVITY MEASURED BY ACCELEROMETRY AND INFLAMMATION, CO-MORBIDITY, AND NUTRITIONAL STATUS IN PERITONEAL DIALYSIS PATIENTS Thiane Gama Axelsson | Bengt Lindholm | Juan Jesus Carrero | Olof Heimburger | Peter Stenvinkel | Abdul Rashid Qureshi Baxter Novum and Renal Medicine, Karolinska Inst 49th ERA-EDTA CONGRESS P O S T E R S Interdisciplinary Program Studies, Res, and Treatment Nephrology – Federal Univ Juiz Fora, Juiz de Fora – MG, Brazil | Clinica GAMEN – Rio de Janeiro | Dept Statistics – Federal Univ Juiz Fora, Juiz de Fora | Center Health and Biological Sciences, Pontifícia Univ Católica Paraná, Curitiba | Div Renal Medicine, CLINTEC, Karolinska Inst | Karolinska Inst SAP445 GERIATRIC NUTRITIONAL RISK INDEX AS A RISK FACTOR FOR MORTALITY IN PERITONEAL DIALYSIS PATIENTS Seokhui Kang | Junyoung Do | Kyuhyang Cho | Jongwon Park | Kyungwoo Yoon Yeungnam Univ Hosp, Daegu, Korea SATURDAY, MAY 26 SAP446 RELATIONSHIP BETWEEN KT/V UREA VALUES, NUTRITIONAL STATUS, COMORBIDITY INDEX AND COMPONENTS OF QUALITY OF LIFE IN INCIDENT PERITONEAL DIALYSIS PATIENTS Jin-Bor Chen | Ben-Chung Cheng | Te-Chuan Chen | Yu-Jen Su | Chien-Hsing Wu Kaohsiung Chang Gung Memorial Hosp and Chang Gung Univ College Medicine, Kaohsiung, Taiwan SAP447 CLINICAL STATUS OF PATIENTS TREATED FOR MORE 10 YEARS WITH CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) Yongki Park | Jimin Jeon Dongrae BongSaeng Hosp SAP448 UREMIC PRURITUS: PREVALENCE, CLINICAL CHARACTERISTICS AND IMPACT ON QUALITY OF LIFE IN PATIENTS ON MAINTENANCE PERITONEAL DIALYSIS Maria Tsikeloudi | Panagiotis Pateinakis | Katerina Patsatsi | Eleni Manou | Dimitrios Sotiriadis | Dimitrios Tsakiris Dept Nephrology, Papageorgiou General Hosp, Thessaloniki, Greece | Second Dept Dermatology, Medical School, Aristotle Univ Thessaloniki, Papageorgiou General Hosp, Thessaloniki, Greece SAP449 TIME-DEPENDENT COVARIATES: A PROBLEMATIC IN SURVIVAL ANALYSIS TAKING COMPETING RISKS INTO ACCOUNT. AN EXAMPLE IN PERITONEAL DIALYSIS Laetitia Teixeira | Anabela Rodrigues | M.J. Carvalho | António Cabrita | Denisa Mendonça PDMA, ICBAS-UP, Porto, Portugal | Nephrology Unit, CHP – Hosp Santo António, Porto, Portugal | Populations Studies Dept, ICBAS, Univ Porto, Porto, Portugal SAP450 IS THE LOW-GDP SOLUTION RELATED TO CHANGE IN PERITONEAL MEMBRANE CHARACTERISTICS IN LONG-TERM PERITONEAL DIALYSIS PATIENTS? Seokhui Kang | Junyoung Do | Jongwon Park | Kyuhyang Cho | Kyungwoo Yoon Yeungnam Univ Hosp, Daegu, Korea SAP451 THE HIDDEN MESSAGE OF PERITONEAL DIALYSIS EFFLUENT IN PAEDIATRIC PATIENTS Maurizio Bruschi | Giovanni Candiano | Laura Santucci | Salvatore Luzio | Rossella Cannavò | Gian Marco Ghiggeri | Enrico Verrina G. Gaslini SAP452 ULTRASOUND GUIDED RECTUS SHEATH AND TRANSVERSUS ABDOMINIS PLANE BLOCK (TAP) FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) CATHETERIZATION - OUR EXPERIENCE Yogesh Varadarajan | Balasubramaniyam Raju K.G Hosp and PG Medical Inst, Coimbatore, Tamilnadu, India 310 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP453 CATHETER REVISION FOR THE TREATMENT OF INTRACTABLE EXIT SITE INFECTION/TUNNEL INFECTION IN PERITONEAL DIALYSIS PATIENTS: A SINGLE CENTER EXPERIENCE Kyu-Hyang Cho | Junyoung Do | Seokhui Kang | Jong-Won Park | Kyung-Woo Yoon | Tae-Woo Kim Dept Internal Medicine, Yeungnam Univ Hosp, Daegu, Korea | Yeungnam Univ Hosp, Daegu, Korea | Dept Internal Medicine, Soonchunhyang Univ Gumi Hosp, Gumi, Korea SAP455 32-YEARS EXPERIENCE IN PERITONEAL DIALYSIS-RELATED PERITONITIS IN ONE ACADEMIC CENTRE: CHANGES IN PERITONITIS RATES, CAUSATIVE ORGANISMS AND OUTCOME, RELATED TO THE IMPLEMENTATION OF THE DOUBLE-BAG Y-SET DEVICE AND DAILY MUPIROCIN ON THE EXIT-SITE Dirk Struijk | Sadie van Esch | Raymond T. Krediet AMC, Amsterdam, Netherlands SAP456 THE RELEVANCE OF ANCESTRALLY ADMIXED POPULATION ON SURVIVAL IN INCIDENT PERITONEAL DIALYSIS PATIENTS IN BRAZIL Natalia Fernandes | Tessa van den Beukel | Tiny Hoekstra | Luciana Tirapani| Kleyton de Andrade Bastos | Roberto Pecoits-Filho | Abdul Rashid Qureshi | Marcus Bastos | Friedo Dekker | José Carolino Divino-Filho Interdisciplinary Program Studies, Res, and Treatment Nephrology – Federal Univ Juiz Fora, Juiz de Fora – MG, Brazil | Leiden Univ Medical Central | Federal Univ Sergipe | Pontific Univ Paraná | Karolinska Inst | Div Renal Medicine, CLINTEC, Karolinska Inst, Stockholm, Sweden SAP457 HYPONATREMIA IN PD PATIENTS; INFLUENCE OF FUROSEMIDE AND EFFECT OF VASOPRESSIN RECEPTOR ANTAGONIST Tamura Yasuhisa | Hidetoshi Kanai | Kenji Harada | Yasuhiro Kawai Kokura Memorial Hosp SAP458 PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY OF ADEQUATE DIALYSIS IN JAPANESE PATIENTS UNDERGOING PERITONEAL DIALYSIS: PERITONEAL DIALYSIS REGISTRY AND COHORT STUDY (PDR-CS) Hitoshi Sugiyama | Yasuhiko Ito | Kazuhiko Tsuruya | Hisako Yoshida | Hiroki Maruyama | Shin Goto | Masaaki Nakayama | Hidetomo Nakamoto | Hiroshi Morinaga | Seiichi Matsuo | Hirofumi Makino Okayama Univ Grad School | Nagoya Univ Grad School | Grad School Medical Sciences, Kyushu Univ | Niigata Univ Grad School | Fukushima Medical Univ| Saitama Medical School SAP459 CHANGES IN BODY COMPOSITION USING BIOELECTRICAL IMPEDANCE IN PATIENTS ON PERITONEAL DIALYSIS (PD) PREVALENT María Cristina Di Gioia | Paloma Gallar | Nuria Laso | Isabel Rodriguez | Gabriela Cobo | Aniana Oliet | Julie Hynostroza | Juan Carlos Herrero | Carmen Mon | Milagros Ortiz | Ana Vigil Hosp Severo Ochoa, Leganes, Madrid, Spain SAP460 WATER SOLUBLE VITAMIN E (TMG) PREVENTS GDPS INDUCED PERITONEAL DAMAGE Tadashi Tomo Oita Univ w w w. e r a e d t a 2 01 2 . o r g 311 SATURDAY, MAY 26 SAP454 CHANGING PICTURE IN THE MICROBIOLOGY OF PERITONEAL DIALYSIS ASSOCIATED PERITONITIS - REPORT OVER ALMOST THREE DECADES Martin Kimmel | Niko Braun | Jörg Latus | Mark Dominik Alscher Robert-Bosch Hosp, Stuttgart, Germany 49th ERA-EDTA CONGRESS P O S T E R S SAP461 POLYCYSTIC KIDNEY DISEASE SHOULD NOT BE CONSIDERED AS A FORMAL CONTRAINDICATION FOR PERITONEAL DIALYSIS Jose Portolés | Simona Uta | Ana M Tato | Paula Lopez-Sanchez | Maite Rivera| Rosely Rodriguez-Pena | Gloria del Peso | Mayra Ortega | Carmen Felipe Hosp Univ Puerta de Hierro, Majadahonda, Spain | Hosp Univ Fund Alcorcon, Alcorcon, Spain | Hosp Univ Ramon y Cajal, Madrid, Spain | Hosp Univ La Paz, Madrid, Spain | Hosp Infanta Leonor, Madrid, Spain | Hosp Nuestra S. de Sonsoles, Avila, Spain SAP462 EFFECT OF PERITONEAL DIALYSIS ON LIFE QUALITY IN PATIENTS WITH REFRACTORY END STAGE CONGESTIVE HEART FAILURE Eirini Tsampikaki | Georgios Aperis | Aristeides Kaikis | Christos Paliouras | Nikolaos Karvouniaris | Maria Maragaki | Polichronis Alivanis General Hosp Rhodes, Greece SATURDAY, MAY 26 SAP463 PERITONEAL DIALYSIS IN A PATIENT WITH SEVERE RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA Birgit Kortus-Götze | Thomas Höferhüsch | Joachim Hoyer Dept Internal Medicine, Div Nephrology, Univ Medical Center, Philipps-Univ Marburg, Germany SAP464 THE VARIABILITY OF HYDRATATION STATUS AFFECTS RESIDUAL RENAL FUNCTION IN PERITONEAL DIALYSIS PATIENTS Francesca Martino | Manish Kaushik | Maria Pia Rodighiero | Carlo Crepaldi| Claudio Ronco San Bortolo Hosp, Vicenza, Italy SAP465 NGAL IN PERITONEAL DIALYSIS REFLECTS THE STATUS OF THE PERITONEUM Antonio Lacquaniti | Valentina Donato | Maria Rosaria Fazio | Silvia Lucisano | Valeria Cernaro | Rosaria Lupica | Michele Buemi | Carmela Aloisi Univ Messina, Messina, Italy SAP466 CELL POPULATION IN PERITONEAL DIALYSIS EFFLUENT REFLECTS PERITONEAL MEMBRANE DAMAGE Tomomi Uno | Masanobu Akazawa | Eiichiro Kanda | Yoshitaka Maeda JA Toride Mecial Center | Tokyo Koysai Hosp SAP467 QT INTERVAL DISPERSION AMONG CHRONIC AMBULATORY PERITONEAL DIALYSIS PATIENTS AND ASSOCIATION WITH IRON STORES Nuket Bavbek Ruzgaresen | Sema Secilmis | Hakki Yilmaz | Ali Akcay | Murat Duranay Fatih Univ Medical School, Dept Nephrology, Ankara, Turkey | Ankara Education and Res Hosp, Dept Internal Medicine, Ankara, Turkey SAP468 RELATIONSHIP BETWEEN FIBROBLAST GROWTH FACTOR-23 AND FETUIN-A WITH METASTATIC CALCIFICATION AND ATHEROSCLEROSIS IN PERITONEAL DIALYSIS PATIENTS Nilgül Akalın | Mehmet Rıza Altıparmak | Sinan Trabulus | Ayşe Serap Yalın | Rezzan Ataman | Kamil Serdengeçti Istanbul Univ Cerrahpasa Medical Fac Dept Internal Medicine, Istanbul, Turkey SAP469 DIALYSIS DOSE ADJUSTED TO RESIDUAL RENAL FUNCTION Karoly Schneider | Balintné Bator B.BRAUN Avitum Hungary Zrt. Dialysis Centre No. 11, Győr, Hungary SAP470 HISTOLOGICAL CRITERIA FOR ENCAPSULATING PERITONEAL SCLEROSIS – A STANDARDIZED APPROACH 312 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Braun Niko | Fritz Peter | Christoph Ulmer | Latus Joerg | Kimmel Martin | Biegger Dagmar | Ott German | Reimold Fabian | Dippon Juergen | Segerer Stephan | Alscher Dominik Robert-Bosch Hosp, Stuttgart | Margarete Fischer–Bosch Inst Clinical Pharmacology | Beth Israel Deaconess Medical Center, Boston, USA | Dept Mathematics, Univ Stuttgart, Germany | Div Nephrology, Univ Hosp, Zurich, Switzerland SAP472 ENCAPSULATING PERITONEAL SCLEROSIS MAY EVOLVE WITHOUT SYSTEMIC INFLAMMATION AND ABSENCE OF RADIOLOGICAL ABNORMALITIES Meelad Habib | Mario Korte | Martijn Hagen | Frank Dor | Michiel Betjes Erasmus MC, Univ Medical Center, Rotterdam, Netherlands | Albert Schweizer Hosp, Dordrecht, Netherlands SAP473 LOCALIZED ENCAPSULATING PERITONEAL SCLEROSIS (EPS) CONSTRICTING THE TERMINAL ILEUM; AN UNUSUAL APPEARANCE REQUIRING SURGICAL INTERVENTION Meelad Habib | Martijn Hagen | Mario Korte | Robert Zietse | Frank Dor | Michiel Betjes Erasmus MC, Univ Medical Center, Rotterdam,Netherlands | Albert Schweizer Hosp, Dordrecht, Netherlands SAP474 ENCAPSULATING PERITONEAL SCLEROSIS- CLINICAL, RADIOLOGICAL AND HISTOLOGICAL DATA AND OUTCOME OF 49 PATIENTS Joerg Latus | Christoph Ulmer | Peter Fritz | Bianka Rettenmaier | Dagmar Biegger | Thomas Lang | German Ott | Christoph Scharpf | Martin Kimmel | Mark Dominik Alscher | Niko Braun Robert-Bosch Hosp, Stuttgart, Germany | Margarete-Fischer–Bosch Inst Clinical Pharmacology, Stuttgart, Germany SAP475 CLINICAL FEATURES OF POST-TRANSPL ENCAPSULATING PERITONEAL SCLEROSIS (EPS); LESS INFLAMMATION, LOWER MORTALITY, AND A DIFFERENT SECOND HIT COMPARED TO CLASSICAL EPS Meelad Habib | Mario Korte | Robert Zietse | Michiel Betjes Erasmus MC, Univ Medical Center, Rotterdam, Netherlands | Albert Schweizer Hosp, Dordrecht, Netherlands « SAP476 THE EFFECT OF HMG-COA REDUCTASE INHIBITOR ON INSULIN RESISTANCE IN PATIENTS UNDERGOING PERITONEAL DIALYSIS Tae Ik Chang | Dong Ho Shin | Hyung Jung Oh | Shin-Wook Kang | Dae-Suk Han | Tae-Hyun Yoo | Seung Hyeok Han Dept Internal Medicine, National Health Insurance Corporation Ilsan Hosp, Koyang, Korea, | Dept Internal Medicine, College Medicine, Yonsei Univ, Seoul, Korea SAP477 LONG TERM EFFECT OF CONTINUOUS AMBULATORY PERITONEAL DIALYSIS FLUIDS WITH NEUTRAL PH AND LOW GLUCOSE DEGRADATION PRODUCT CONCENTRATION; A 5-YEAR RETROSPECTIVE STUDY Hun Young Choi | Yong Kyu Lee | Beom Suk Kim | Seung Hyeok Han | Tae Hyun Yoo | Hyeong Cheon Park | Ho Yung Lee Kangnam Severance Hosp, Seoul, Korea | Severance Hosp, Seoul, Korea w w w. e r a e d t a 2 01 2 . o r g 313 SATURDAY, MAY 26 SAP471 DIFFERENT PHENOTYPES OF ENCAPSULATING PERITONEAL SCLEROSIS – MACROSCOPICAL APPEARANCE, HISTOLOGICAL FINDINGS AND OUTCOME Joerg Latus | Christoph Ulmer | Peter Fritz | Bianka Rettenmaier | Sandra Hirschburger | Stephan Segerer | Dagmar Biegger | Thomas Lang | German Ott | Martin Kimmel | Mark Dominik Alscher | Niko Braun Robert-Bosch Hosp, Stuttgart, Germany | Margarete-Fischer–Bosch Inst Clinical Pharmacology, Stuttgart, Germany | Univ Hosp, Zurich, Switzerland 49th ERA-EDTA CONGRESS P O S T E R S SAP478 THE SELECTION OF PERITONEAL MESOTHELIAL CELLS IS IMPORTANT FOR CELL THERAPY TO AMELIORATE PERITONEAL FIBROSIS Naoya Horimoto | Kenji Tuji | Shinji Kitamura | Hitoshi Sugiyama | Hirohumi Makino Dept Medicine and Clinical Science, Okayama Univ Grad School Medicine, Dentistry and Pharmaceutical Sciences | Center Chronic Kidney Disease and Peritoneal Dialysis, Okayama Univ Hosp SAP479 MILD COGNITIVE IMPAIRMENT (MCI) IS MORE PREVALENT IN PERITONEAL DIALYSIS PATIENTS: NEUROIMAGING BY BRAIN SPECT Rei Isshiki | Masao Iwagami | Daimu Tsutsumi | Yasuhiro Mochida | Kunihiro Ishioka | Machiko Oka | Kyoko Maesato | Hidekazu Moriya | Takayasu Ohtake| Sumi Hidaka | Shuzo Kobayashi Shonan Kamakura General Hosp, Kamakura, Japan SATURDAY, MAY 26 SAP480 AQUAPORIN-1 AND ANGIOGENESIS IN CAPD PERITONEUM Chieko Higuchi | Yoko Tanihata | Madoka Ishii | Himiko Sugimoto | Naoyo Sato | Ai Kyono | Tetsuya Ogawa | Hideki Nishimura | Kuniaki Otsuka Tokyo Women's Medical Univ Medical Center East, Tokyo, Japan SAP481 THE EFFECT OF LOW GDP SOLUTION ON PERITONEAL SOLUTE TRANSPORT IN CAPD PATIENTS Kyu-Hyang Cho | Jun-Young Do | Seokhui Kang | Jong-Won Park | KyungWoo Yoon | Tae-Woo Kim Dept Internal Medicine, Yeungnam Univ Hosp, Daegu, Korea | Dept Internal Medicine, Soonchunhyang Univ Gumi Hosp, Gumi, Korea SAP482 MEDICAL AND NON MEDICAL FACTORS LIMITATING THE DEVELOPMENT OF PD: ANALYSIS OF A PREDIALYSIS INFORMATION PROGRAM Caroline du Halgouët | Azeroual Latifa | Verhoeven Anne Sophie | Dupuis Emmanuel | Randoux Christine | Vrtovsnik François Hop Bichat, Paris, France SAP483 MEMBRANE EFFECT OF PREDNISOLONE - STUDY IN VITRO Teresa Grzelak | Lucja Czyzewska-Majchrzak | Marta Kramkowska | Henryk Witmanowski | Krystyna Czyzewska Poznan Univ Medical Science, Poznan, Poland SAP484 D/P CREATININE AS AN INDEPENDENT RISK FACTOR FOR TOTAL MORTALITY AND CARDIOVASCULAR MORTALITY IN A POPULATION OF PERITONEAL DIALYSIS PATIENTS Katarzyna Janda | Marcin Krzanowski | Paulina Dumnicka | Władysław Sułowicz Chair and Dept Nephrology, Jagiellonian Univ Collegium Medicum, Cracow, Poland | Dept Medical Diagnostics, Jagiellonian Univ Collegium Medicum, Cracow SAP485 IS SERUM ALKALINE PHOSPHATASE A PREDICTOR OF CARDIOVASCULAR CALCIFICATIONS IN PERITONEAL DIALYSIS PATIENTS? Merita Rroji (Molla) | Saimir Seferi | Myftar Barbullushi | Erjola Likaj | Elizana Petrela | Nestor Thereska UHC Mother Teresa, Dept Nephrology-Dialysis-Transpl, Tirana, Albania | UHC Mother Teresa, Dept Statistic, Tirana, Albania SAP486 PERITONEAL DIALYSIS IN THE LONG TERM: ELEVEN YEARS’ EXPERIENCE IN A SINGLE SARDINIAN CENTER Gianfranca Cabiddu | Elena Dessi | Augusta Arceri | Pisano Laura | Eleonora Manca | Maura Conti | Riccardo Cao | Antonello Pani Azienda Osp Brotzu Cagliari | Nephrology, Brotzu Hosp 314 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP487 IMMUNOPHENOTYPING OF PERITONEAL MACROPHAGES AND THEIR SURFACE MARKERS IN PERITONEAL DIALYSIS PATIENTS Chia-Te Liao Cardiff Univ, Cardiff, UK SAP488 PROGNOSTIC HOSPITALIZATIONS AND SURVIVAL FACTORS IN ELDERLY PATIENTS ON RENAL REPLACEMENT THERAPY IN MEXICO Olynka Vega Vega | Angeles Mendoza de la Garza | Ricardo Correa-Rotter National Inst Nutrition, Mexico, Mexico SAP490 CONTRIBUTION OF FLUID STATUS TO PERITONEAL SOLUTE TRANSPORT IN PERITONEAL DIALYSIS PATIENTS Akihiko Matsuda | Yousuke Tayama | Tomonari Ogawa | Mizuki Iwanaga | Chie Noiri | Minoru Hatano | Tota Kiba | Koichi Kanozawa | Hitoshi Katou | Hajime Hasegawa | Tetsuya Mitarai Dept Nephrology and Blood Purification, Saitama Medical Center, Saitama Medical Univ, Kawagoe, Japan SAP491 INFLUENCE OF RESIDUAL DIURESIS (RD) AND FRACTIONAL SODIUM EXCRETION (FENa) AND BLOOD PRESSURE IN PERITONEAL DIALYSIS (PD) PATIENTS Silvia Ros-Ruiz | Laura Fuentes-Sanchez | Cristina Jironda-Gallegos | Elena Gutierrez-Vilches | Patricia Garcia-Frias | Domingo Hernandez-Marrero Carlos Haya Hosp SAP492 RAPID DECLINE OF RESIDUAL RENAL FUNCTION IS ASSOCIATED WITH PARADOXICAL IMPROVEMENT OF NUTRITIONAL STATUS IN PERITONEAL DIALYSIS PATIENTS WITH HEAVY PROTEINURIA Seokhui Kang | Seunghyun Lee | Kyuhyang Cho | Jongwon Park | Kyungwoo Yoon | Junyoung Do Yeungnam Univ Hosp, Daegu, Korea | Yeungnam Univ Yeongcheon Hosp, Yeongcheon, Korea SAP493 HIGH SCORE IN EPWORTH SLEEPINESS SCALE PREDICT ALL CAUSE MORTALITY AND CARDIOVASCULAR EVENTS IN PERITONEAL DIALYSIS PATIENTS Xueli Lai | Wei Chen | Zhiyong Guo Dept Nephrology, Changhai Hosp SAP494 THE PHARMACOLOGICAL EFFECT OF SODIUM CITRATE IN PD FLUID Magnus Braide Univ Gothenburg, Gothenburg, Sweden SAP495 GLUCOSE VARIABILITY MONITORING WITH CGMS IN UREMIC PERITONEAL DIALYSIS PATIENTS WITH TYPE 2 DIABETES MELLITUS Vaduva Cristina | Simona Georgiana Popa | Mota Maria | Mota Eugen Haemodialysis Center, Emergency Hosp Craiova, Romania | Clinical Centre Diabetes, Nutrition, Metabolic Diseases, Nephrology Dept, Univ Medicine and Pharmacy Craiova, Romania w w w. e r a e d t a 2 01 2 . o r g 315 SATURDAY, MAY 26 SAP489 COMBINATION THERAPY WITH PERITONEAL DIALYSIS AND HEMODIALYSIS FROM THE INITIATION OF RENAL REPLACEMENT THERAPY PRESERVE THE RESIDUAL RENAL FUNCTION AND IMPROVE THE PATIENTS’ PROGNOSIS - RETROSPECTIVE COHORT STUDY FOR 24 MONTHS Atsushi Ueda | Kei Nagai | Madoka Morimoto | Aki Hirayama | Shigeru Owada | Yukio Tonozuka | Chie Saito | Chie Saito | Kunihiro Yamagata Namegata District General Hosp | Tsukuba Univ Technology | Asao Clinic | Baxter Limited 49th ERA-EDTA CONGRESS P O S T E R S SAP496 BONE DENSITY AND VASCULAR CALCIFICATION IN PERITONEAL DIALYSIS PATIENTS Francesca Martino | Pierluigi Di Loreto | Claudio Ronco San Bortolo Hosp, Vicenza, Italy SAP497 IS RESIDUAL RENAL FUNCTION AN IMPORTANT FACTOR IN CONTROL OF PHOSPHORUS LEVELS IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS PATIENTS Merita Rroji (Molla) | Saimir Seferi | Myftar Barbullushi | Elizana Petrela | Nereida Spahia | Erjola Likaj | Nestor Thereska UHC Mother Teresa, Dept Nephrology-Dialysis-Transpl, Tirana, Albania | Dept Statistic, Tirana, Albania SATURDAY, MAY 26 SAP498 PERINATAL OUTCOMES OF WOMEN WITH ADVANCE CHRONIC KIDNEY DISEASE THAT INITIATIED PERITONEAL DIALYSIS DURING PREGNANCY Lucio O. Sánchez Macías | Karla I. Lares Castellanos | J. Antonio Hernandez Pacheco | Olynka Vega Vega | Ricardo Correa Rotter National Medical Science and Nutrition Inst Salvador Zubirán | National Inst Perinatology Isidro Espinosa de los Reyes | National Inst Nutrition, Mexico, Mexico SAP499 ANURIC PATIENTS ARE NOT MORE OVERHYDRATED UNDER ADEQUATE PD PRESCRIPTION: CLINICAL RELEVANCE OF MULTIFREQUENCY BIOIMPEDANCE ANALYSIS Aguiar Pedro Ventura | Santos Olivia | Laetitia Teixeira | Vidinha Joana | Ferrer Francisco | Carvalho Maria João | Cabrita António | Anabela Soares Rodrigues Centro Hosp Porto, Hosp Santo Antonio, Porto, Portugal | PDMA, ICBAS-UP, Porto, Portugal | Hosp São Teotónio, Viseu, Portugal | Centro Hosp Coimbra, Coimbra, Portugal SAP500 COMPARISON OF DIURNAL BLOOD PRESSURE PATTERN, RESIDUAL RENAL FUNCTION AND LEFT VENTRICULAR HYPERTROPHY IN PERITONEAL DIALYSIS PATIENTS ON DIFFERENT REGIMENS Nuh Ataş | Yasemin Erten | Kürşad Öneç | Salih Inal | Salih Topal | Ahmet Akyel | Bülent Çelik | Gülay Ulusal Okyay | Yusuf Tavil Gazi Univ Medical School, Dept Internal Medicine, Ankara, Turkey | Gazi Univ Medical School, Dept Nephrology, Ankara, Turkey | Gazi Univ Medical School, Dept Cardiology, Ankara, Turkey | Gazi Univ Fac Health Sciencel, Dept Statistics, Ankara, Turkey SAP501 MEAN PLATELET VOLUME IS RELATED TO D/P CREATININE IN PERITONEAL DIALYSIS Matthias Zeiler | Tania Monteburini | Rosa Maria Agostinelli | Rita Marinelli| Stefano Santarelli Dept Nephrology, Osp Carlo Urbani, Jesi, Italy SAP502 ASSOCIATION BETWEEN BIOIMPEDANCE ANALYSIS PARAMETERS AND LEFT VENTRICULAR HYPERTROPHY IN PERITONEAL DIALYSIS PATIENTS Yasemin Erten | Salih Inal | Kürşad Öneç | Nuh Ataş | Gülay Ulusal Okyay | Çağrı Yaylacı | Gülşah Şahin | Yusuf Tavil | Galip Güz | Şükrü Sindel Gazi Univ, Medical School, Dept Nephrology, Ankara, Turkey | Gazi Univ, Medical School, Dept Internal Medicine, Ankara, Turkey | Gazi Univ, Medical School, Dept Cardiology, Ankara, Turkey | Gazi Univ Fac Health Sciences, Dept Nutrition and Dietetics, Ankara, Turkey SAP503 MORTALITY AND PERITONITIS RISK STRATIFICATION IN PERITONEAL DIALYSIS PATIENTS: THE RELEVANCE OF C-REACTIVE PROTEIN Ana Pinho | Ana Cabrita | Anabela Malho Guedes | André Fragoso | Helena Carreira | Isabel Pinto | Idalecio Bernardo | Pedro Leao Nephrology Dept Faro Hosp, Faro, Portugal | Inst Public Health Univ Porto 316 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP504 TRANSFORMING GROWTH FACTOR BETA (TGF-β) AS A RISK FACTOR FOR CARDIOVASCULAR DISEASE IN A POPULATION OF PERITONEAL DIALYSIS PATIENTS Katarzyna Janda | Marcin Krzanowski | Beata Kuśnierz-Cabala | Paulina Dumnicka | Andrzej Kraśniak | Eve Chowaniec | Barbara Tabor-Ciepiela | Władysław Sułowicz Chair and Dept Nephrology, Dept Medical Diagnostics, Jagiellonian Univ Collegium Medicum, Cracow, Poland SAP505 PERI-AORTIC FAT TISSUE THICKNESS IN PERITONEAL DIALYSIS PATIENTS Kultigin Turkmen | Orhan Ozbek | Mehmet Kayrak | Cigdem Samur | Ibrahim Guler | Halil Zeki Tonbul Konya Univ, Meram School Medicine, Konya, Turkey SAP507 APD MAKES HIGH DEMANDS ON CATHETER FUNCTION – NEW SURGICAL PROCEDURE FOR IMPLANTATION OF TENCKHOFF CATHETERS Clemens-Magnus Meier | Danilo Fliser | Martin K. Schilling | Matthias Klingele Univsklinikum des Saarlandes, Homburg, Germany SAP508 THE PREVENTION TECHNIQUE FOR PD CATHETER MALPOSITION Mizuya Fukasawa | Masayuki Takeda | Manabu Kamiyama Yamanashi Univ SAP509 LEFT VENTRICULAR DIASTOLIC DYSFUNCTION AS A PREDICTOR OF RAPID DECLINE OF RESIDUAL RENAL FUNCTION IN PATIENTS WITH PERITONEAL DIALYSIS Young Rim Song | Hyung Jik Kim | Sung Gyun Kim | Jwa-Kyung Kim | Jung Woo Noh | Young Ki Lee | Jong Woo Yoon | Ja-Ryong Koo Dept Internal Medicine, Hallym Univ Sacred Heart Hosp | Dept Internal Medicine, Kangnam Sacred Heart Hosp | Dept Internal Medicine, Chuncheon Sacred Heart Hosp w w w. e r a e d t a 2 01 2 . o r g 317 SATURDAY, MAY 26 SAP506 GSK-3BETA INHIBITION: A NOVEL TREATMENT OPTION TO DECREASE MESOTHELIAL INJURY IN EXPERIMENTAL PERITONEAL DIALYSIS Krisztina Rusai | Rebecca Herzog | Klaus Kratochwill | Lilian Kuster | Christoph Aufricht Medical Univ Vienna 49th ERA-EDTA CONGRESS P O S T E R S RENAL ANAEMIA - CKD 5D SAP510 UP-REGULATION OF HEPCIDIN-25 BY EPOETIN-BETA AND METHOXY POLYETHYLENE GLYCOL-EPOETIN-BETA IS DEPENDENT ON SERUM FERRTIN LEVEL IN HEMODIALYSIS PATIENTS Kazuya Takasawa | Chikako Takaeda | Masato Higuchi | Teiryo Maeda | Naohisa Tomosugi | Norishi Ueda Pubulic Central Hosp Matto-Ishikawa, Hakusan, Japan | Medical Care Proteomics Biotechnology Co., Ltd. | Biomarker Society | Div Advanced Medicine, Medical Res Inst, Kanazawa Medical Univ SATURDAY, MAY 26 SAP511 HEPCIDIN-20 AS PREDICTIVE BIOMARKER FOR HEMOGLOBIN IN HEMODIALYSIS PATIENTS Yusuke Sasaki | Masaya Ikezoe | Masahiro Hagiwara | Shunichi Furuhata | Minoru Murakami | Yasushi Shimonaka | Satoshi Yamazaki Chugai Pharmaceutical Co., Ltd. | Saku Central Hosp SAP512 LOW HEPCIDIN LEVEL IS ASSOCIATED WITH INCREASED ERYTHROPOIESIS IN MAINTENANCE HEMODIALYSIS (MHD) PATIENTS WITH LESS IRON STORAGE Sayuri Hamahata | Mai Oue | Takahiro Kuragano | Minoru Furuta | Mana Yahiro | Aritoshi Kida | Yoshinaga Otaki | Yukiko Hasuike | Hiroshi Nonoguchi| Takeshi Nakanishi Hyogo College Medicine SAP513 THE RELATIONSHIP BETWEEN OBESITY AND HEPCIDIN LEVELS IN HAEMODIALYSIS PATIENTS Pantelis Sarafidis | Adam Rumjon | Daniel Ackland | Helen MacLaughlin | Sukhvinder S. Bansal | Iain C. Macdougall King's College Hosp NHS Found Trust, London, UK | Inst Pharmaceutical Sciences, King's College London, London, UK | Renal Unit, King's College Hosp SAP514 ON-LINE HEMODIAFILTRATION AND ERYTHROPOIETIN RESISTANCE IN HEMODIALYTIC PATIENTS: ROLE OF HEPCIDIN. PRELIMINARY RESULTS FROM REDERT STUDY Vincenzo Panichi | Alberto Rosati | Erasmo Malagnino | Riccardo Giusti | Aldo Casani | Giancarlo Betti | Paolo Conti | Giada Bernabini | Giada Bernabini | Claudio Gabrielli | David Caiani | Alessia Scatena | Massimiliano Migliori | Francesco Pizzarelli Versilia's Hosp | Nephrology and Dialysis Unit, Hosp Lucca | Nephrology and Dialysis Unit, Hosp Massa | Nephrology and Dialysis Unit, Hosp Grosseto | Nephrology and Dialysis Unit, S.Maria Annunziata Hosp, Firenze | Nephrology and Dialysis Unit, Versilia Hosp SAP515 FACTORS PREDICTING THE INCREASE OF RETICULOCYTE HAEMOGLOBIN CONTENT (CHr) FOLLOWING INTRAVENOUS IRON ADMINISTRATION IN HAEMODIALYSIS PATIENTS Efstathios Mitsopoulos | Maria Tsiatsiou | Ilias Minasidis | Varvara Kousoula | Eleni Intzevidou | Ploumis Passadakis | Vasilis Vargemezis | Dimitrios Tsakiris Papageorgiou General Hosp, Thessaloniki, Greece | Democritus Univ Thrace, Alexandroupolis, Greece SAP516 AN OPEN, RANDOMIZED, PARALLEL GROUP, MULTI-CENTER STUDY ON THE PROGNOSIS OF HEMODIALYSIS PATIENTS IN ANEMIA TREATMENT BY COMBINATION THERAPY WITH IRON AND VITAMIN C AND ERYTHROPOIETIN (ACTIVE STUDY) Mana Yahiro | Aritoshi Kida | Yoshinaga Otaki | Yukiko Hasuike | Hiroshi Nonoguchi | Takeshi Nakanishi | Takahiro Kuragano Hyogo College Medicine 318 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP517 A 12 MONTH RANDOMISED CONTROLLED TRIAL EXAMINING THE ESASPARING EFFECTS OF A VITAMIN E BONDED DIALYSIS MEMBRANE Simon W Lines | Angela M Carter | Emma J Dunn | Mark J Wright St James's Univ Hosp, Leeds, UK | Univ Leeds, Leeds, UK SAP518 INTRODUCTION OF ANEMIA TREATMENT ALGORITHM USING IRON AND ESA IMPROVED HB LEVELS WITHIN THE TARGET RANGE IN HEMODIALYSIS PATIENTS Ryuzi Aoyagi | Takayoshi Miura Tachikawa General Hosp SAP520 IRON RESTRICTION WTIH ESA (ERYTHROPOIESIS STIMULATING AGENT) FOR ESA-HYPORESPONSIVENESS Yukiko Hasuike | Hiromi Fukumoto | Shoji Kaibe | Masanori Tokuyama | Aritoshi Kida | Yoshinaga Otaki | Takahiro Kuragano | Hiroshi Nonoguchi| Mana Hiwasa | Takashi Miyamoto | Haruki Ohue | Akihide Matsumoto | Kazuhiro Toyoda | Takeshi Nakanishi Hyogo College Medicine | Hiwasa Clinic, Nishinomiy, Japan | Miyamoto Clinic| Ohue Clinic | Seiyu Clinic | Meiwa Hosp SAP521 MANAGEMENT OF ANEMIA IN HEMODIALYSIS PATIENTS: A RETROSPECTIVE STUDY ON THE PRACTICES IN FRENCH CENTERS Jacques Rottembourg | Corinne Emery | Antoine Lafuma | Jorge Wernli | Lorraine Zakin | Lamine Mahi Dialysis Unit Diaverum, Paris, France | Cemka/Eval | Vifor Pharma SAP522 ANEMIA MANAGEMENT IN CHILDREN ON CHRONIC PD: A STUDY OF THE INTERNATIONAL PEDIATRIC PERITONEAL DIALYSIS NETWORK (IPPN) Dagmara Borzych-Duzalka | Yelda Bilginer | Lars Pape | Il So Ha | Mustafa Bak | Annabelle Chua | Lesley Rees | S Pesle | Francisco Cano | Agnieszka Urzykowska | Sevinc Emre | J Russcasso | V Ramela | Nikoleta Printza | Colin White | Dafina Kuzmanovska | Vogel Andrea | Dirk Müller-Wiefel | Bradley Warady | Franz Schaefer Medical Univ Gdansk, Poland | Dept Pediatric Nephrology, Hacettebe Univ, Turkey | Medizinische Hochschule, Hannover | National Univ Children’s Hosp, Seoul, South Korea | Dr Behcet Uz Children Res and Education Hosp, Izmir, Turkey | Texas Children’s Hosp, Houston, USA | Great Ormond Street Hosp Children NHS Trust, London | Hosp Pediatrico Humberto Notti, Mendoza, Argentina | Hosp Luis Calvo Mackenna, Santiago, Chile | Children’s Memorial Hosp, Warsaw, Poland | Istambul Univ, Istambul, Turkey | Serv Nefrología Hosp Niños Sor María Ludovica, La Plata, Argentina | SENNIAD, Montevideo, Uruguay | Aristoteles Univ, Thessaloniki, Greece | BC Children’s Hosp, Vancuver, Canada | Pediatric Clinic, Nephrology Unit, Skopje, Macedonia | Pontificia Univ Católica Chile, Santiago, Chile | KfH Center Children and Adolescents, Hamburg, Germany | Children’s Mercy Hosp, Kansas City, USA | Univ Heidelberg, Heidelberg, Germany SAP523 THE EFFECT OF INTRAVENOUS ASCORBIC ACID IN CONTINUOUS HEMODIALYSIS PATIENTS WITH ANEMIA Jong Hoon Chung | Mi Kyung Park | Hyun Lee Kim | Bung Chul Shin Dept Internal Medicine, Chosun Univ Medical School, GwangJu, Korea | Dept Nursing, Nambu Univ, GwangJu, South Korea w w w. e r a e d t a 2 01 2 . o r g 319 SATURDAY, MAY 26 SAP519 PREDICTIVE POWER OF ESAs RESPONSIVENESS OF RETICULOCYTIES AND THEIR SUBTYPES IN NORMORESISTANT HEMODIALYSIS PATIENTS: A TIME-DEPENDENT COX MODELS APPROACH Luciano De Paola | Gianmarco Lombardi | Giuseppe Coppolino | Luigi Lombardi SOC Nefrogy and Dialysis, AO Pugliese-Ciaccio Catanzaro | Azienda Osp-Univ Magna Graecia, Catanzaro, Italy 49th ERA-EDTA CONGRESS P O S T E R S SAP524 RESIDUAL STANDARD DEVIATION OF HEMATOCRIT AND THE RELATED FACTORS IN HEMODIALYSIS PATIENTS Tetsuya Fujikawa | Tadashi Kuji | Midori Kakimoto | Kazuhiko Shibata | Hidehisa Satta | Masahiro Nishihara | Seiichi Kawata | Naoaki Koguchi | Yoshiyuki Toya | Satoshi Umemura Yokohama City Univ, Yokohama, Japan | Yokohama Minami Clinic | Toshin Clinic | Yokodai Central Clinic, Yokohama, Japan SATURDAY, MAY 26 SAP525 MANAGEMENT OF ANEMIA WITH CERA IN ROUTINE CLINICAL PRACTICE: RESULTS AT 12 MONTHS OF THE HORTENSIA STUDY IN HEMODIALYSIS Verhelst David | Godin Michel | Hoffmann Maxime | Landais Paul | Kone Sebastien | Vrtovsnik Francois Dept Nephrology, Centre Hosp Avignon | CHU Rouen | Polyclinique La Louviere | Hosp Necker | Roche Lab | Hosp Bichat SAP526 RELATIONSHIP BETWEEN ERYPTOSIS AND RED BLOOD CELL LIFESPAN IN HEMODIALYSIS PATIENTS Viktoriya Kuntsevich | Yanna Dou | Stephan Thijssen | Nathan W Levin | Peter Kotanko Beth Israel Medical Center, New York, USA | Renal Res Inst; Beth Israel Medical Cener, New york, USA SAP527 IL-6 IS AN INDEPENDENT RISK FACTOR FOR RESISTANCE TO ERYTHROPOIESIS-STIMULATING AGENTS IN HEMODIALYSIS PATIENTS WITHOUT IRON DEFICIENCY Byung Soo Kim | Won Do Park | Ho Cheol Song | Hyun Gyung Kim | YoungOk Kim Catholic Univ Korea | Sanggye Paik Hosp, Inje Univ | Uijeongbu St. Mary's Hosp, Catholic Univ Korea SAP528 BONE MARROW TARGETING CONTRIBUTES TO ERYTHROPOIETIC EQUIVALENCE FOLLOWING INTRAVENOUS (IV) AND SUBCUTANEOUS (SC) PEGINESATIDE ADMINISTRATION IN RATS Kathryn Woodburn | Kei-Lai Fong | Yuu Moriya | Yoshihiko Tagawa Affymax Inc, Palo Alto, USA | Accellient Partners LLC, Waltham, USA | Takeda Pharmaceutical Company Ltd., Osaka, Japan SAP529 APPROPRIATE FERRITIN LEVELS IN TREATMENT OF RENAL ANEMIA Teiryo Maeda | Fumiyoshi Kanda | Natumi Morita | Naohisa Tomosugi Biomarker Society.Co., Ltd. | Keio Univ Fac Nursing and Medical Care | Dept Advanced Medicine, Medical Res Inst, Kanazawa Medical Univ SAP530 CHARACTERISTICS OF PATIENTS ENROLLED IN THE EUROPEAN MONITOR-CKD5 PHARMACOEPIDEMIOLOGICAL STUDY OF ANAEMIA MANAGEMENT WITH BIOSIMILAR EPOETIN ALFA Gerard London | Philippe Zaoui | Adrian Covic | Frank Dellanna | David Goldsmith | Loreto Gesualdo | Johannes Mann | Christian Combe | Matthew Turner | Michael Meunzberg | Karen MacDonald | Ivo Abraham Centre Hosp FH Manhes, Fleury-Merogis, France | Centre Hosp Univ Grenoble| GI Pop Univ Hosp Medicine and Pharmacy | Dialysezentrum | Guy's and St Thomas' NHS Found Hosp | Univ Studi Bari, Bari, Italy | Schwabing Klinikum and Friedrich Alexander Univ Erlangen-Nurnburg | Centre Hop Bordeaux | Sandoz Biopharmaceuticals | Matrix45, LLC SAP531 RISK-BASED INDIVIDUALISATION OF TARGET HB IN HAEMODIALYSIS PATIENTS WITH RENAL ANAEMIA IN THE POST-TREAT ERA: PHYSICIANREPORTED PRINCIPLES VERSUS SPECIFIED TARGET HB LEVELS (MONITOR-CKD5 STUDY) Loreto Gesualdo | Christian Combe | Adrian Covic | Frank Dellanna | David 320 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France Goldsmith | Gerard London | Johannes Mann | Philippe Zaoui | Matthew Turner | Michael Meunzberg | Karen MacDonald | Ivo Abraham Dept Emergency and Organ Transpl, Univ Bari, Italy | Centre Hop Bordeaux| GI Pop Univ Hosp Medicine and Pharmacy | Dialysezentrum | Guy's and St Thomas' NHS Found Hosp | Centre Hosp FH Manhes, Fleury-Merogis, France | Schwabing Klinikum and Friedrich Alexander Univ Erlangen-Nurnburg | Centre Hosp Univ Grenoble | Sandoz Biopharmaceuticals | Matrix 45, LLC SAP532 IMPROVEMENT OF ANEMIA MANAGEMENT IN HEMODIALYSIS PATIENTS BY SIMULTANEOUS, ONCE EVERY TWO WEEKS ADMINISTRATIONS OF DARBEPOETIN ALFA AND IRON: ANEMIA DAY CONCEPT Jacques Rottembourg | Alain Guerin | Mirela Diaconita Dialysis Unit Diaverum, Paris, France SAP534 A META-ANALYSIS OF FERRIC CITRATE FOR HYPERPHOSPHATEMIA: THE EFFECTS OF AN ORAL IRON-CONTAINING PHOSPHATE BINDER ON SERUM FERRITIN AND SATURATED TRANSFERRIN IN HEMODIALYSIS PATIENTS Christopher Bond | Donna Jensen | Steven Wang | Elizabeth Pham | Jaime Rubin | Mohammed Sika | Robert Niecestro DaVita Inc, Denver, CO, USA | Vanderbilt Univ | Keryx Biopharmaceuticals SAP535 ERYTHROPOIETIC ACTIVITY, ABSORPTION, DISTRIBUTION, METABOLISM AND EXCRETION (ADME) OF PEGINESATIDE, AN ERYTHROPOIESIS STIMULATING AGENT, IN THE MONKEY Kathryn Woodburn | Kei-Lai Fong | Steven Sloneker | Paul Strzemienski | Eric Solon | Yuu Moriya | Yohihiko Tagawa Affymax Inc, Palo Alto, USA | Accellient Partners LLC, Waltham, USA | Calvert Laboratories Inc., Olyphant, USA | QPS, Newark, USA | Takeda Pharmaceutical Company Ltd., Osaka, Japan SAP536 UREMIA, ANAEMIA AND MORPHOLOGICAL ABNORMALITIES OF THE RED BLOOD CELLS IN HAEMODIALYSIS: AN INVESTIGATION WITH THE ATOMIC FORCE AND SCANNING ELECTRON MICROSCOPES Dimosthenis Stamopoulos | Nerantzoula Mpakirtzi | Eirini Grapsa | Basiliki Gogola | Efthymios Manios | Nikolaos Afentakis Inst Materials Science, National Center Scientific Res Demokritos, Athens, Greece| Dept Nephrology, National Hosp Athens G. Gennimatas | Dept Nephrology, General Hosp Athens Aretaieion, Athens, Greece | Dept Nephrology, General Hosp Athens G. Gennimatas, Athens, Greece SAP537 A RECENT RESURGENCE OF ANTIBODY-MEDIATED PRCA CASES IN THE UK James Ewer | Iain C. Macdougall Kings College Hosp, London, UK | Renal Unit, King's College Hosp w w w. e r a e d t a 2 01 2 . o r g 321 SATURDAY, MAY 26 SAP533 RED BLOOD CELL LIFE SPAN VARIABILITY – A NOVEL INDICATOR AND ITS CLINICAL CORRELATES IN CHRONIC HEMODIALYSIS Rebecca Apruzzese | Yanna Dou | Stephan Thijssen | Anja Kruse | Georges Ouellet | Nathan W. Levin | Peter Kotanko Renal Res Inst, New York, USA 49th ERA-EDTA CONGRESS P O S T E R S MINERAL AND BONE DISEASE - CKD 5D SAP538 CLINICAL EVALUATION OF NOVEL PTH(1-84) BIOINTACT ASSAYS IN HEMODIALYSIS PATIENTS Manfred Hecking | Alexander Kainz | Bernhard Bielesz | Max Plischke | Georg Beilhack | Walter H. Hoerl | Gere Sunder-Plassmann | Christian Bieglmayer Medical Univ Vienna | Dept Medicine III, Div Nephrology and Dialysis, Medical Univ Vienna, Vienna, Austria SAP539 EVALUATION OF INTACT PTH IN HEAMODIALYZED PATIENTS WITH A THIRD GENERATION KIT Sydney Benchetrit | Janice Green | Jacques Bernheim | Eliezer Golan Dpt Nephrology and Hypertension, Meir Medical Center | Renal Physiology Lab, Dept Nephrology and Hypertension, Meir Medical Center SATURDAY, MAY 26 SAP540 PLASMA FATTY ACID COMPOSITION IS ASSOCIATED WITH BONE MINERAL DENSITY IN HAEMODIALYSIS PATIENTS Nobuyuki Oyake | Keiko Suzuki | Saki Itoh | Kazuaki Tanabe Otsuka Clinic | Shimane Univ Fac Medicine SAP541 ASSOCIATION OF SERUM PENTOSIDINE LEVEL WITH THE PREVALENCE OF FRACTURES IN HEMODIALYSIS PATIENTS Akira Fujimori | Shioko Okada | Kiyoko Yamamoto | Makoto Sakai | Nozomu Kamiura Konan Hosp, Kobe, Japan SAP542 STRONG RELATIONSHIP BETWEEN BONE MICROARCHITECTURE AND ADIPONECTIN IN MAINTENANCE HEMODIALYSIS Pelletier Solenne | Fitsum Guebre-Egziabher | Justine Bacchetta | Jocelyne Drai| Michel Richard | Roland Chapurlat | Denis Fouque Hop Edouard Herriot | Hop Femme Mere Enfant | Hop Lyon Sud SAP543 BONE TOURNOVER ABNORMALITIES IN DIALYSED PATIENTS Zbigniew Nowak | Kade Grzegorz | Konieczna Maria | Wańkowicz Zofia Military Inst Medicine, Warsaw, Poland SAP544 BONE HISTOMORPHOMETRY IN PATIENTS UNDERGOING DIALYSIS WITH SERIOUS CALCIFICATIONS Kamil Zamboch | Jana Zahalkova | Zdenka Kosatikova | Petra Skypalova | Josef Skarda Dept Internal Medicine III, Univ Hosp and Palacky Univ Olomouc, Czech Republic | Šternberk Hosp, Dept Hemodialysis, Czech Republic | Dept Pathology, Univ Hosp and Palacky Univ Olomouc, Czech Republic SAP545 EFFECT OF HIGH GLUCOSE CONCENTRATION ON THE OSTEOBLAST FUNCTION Juliana Cunha | Mirian Boim | Vanessa Ferreira | Marcelo Naves Federal Univ São Paulo, São Paulo, Brazil SAP546 A NOVEL AND SIMPLE METHOD FOR EVALUATING THE AMOUNT OF INTRADIALYTIC PHOSPHATE REMOVAL Hiroshi Kikuchi | Hisaki Shimada | Yasumi Takimoto | Ryo Karasawa | Masaaki Shimotori | Kozo Ikarashi | Noriko Saito | Shigeru Miyazaki | Shinji Sakai| Masashi Suzuki Toyosaka Hosp, Kita-ku, Niigata city, Niigata pref, Japan | Kidney Center Shinraku-en Hosp, Niigata, Japan 322 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP547 EFFECT OF CINACALCET HYDROCHLORIDE (CH) ON BONE MINERAL DENSITY IN HEMODIALYSIS (HD) PATIENTS WITH SECONDARY HYPERPARATHYROIDISM (SHPT) Hiroaki Ogata | Akiko Takeshima | Masahiro Yamamoto | Kei Asakura | Tadashi Kato | Kanji Shishido | Fumihiko Koiwa | Masahide Mizobuchi | Eriko Kinugasa | Tadao Akizawa Dept Internal Medicine, Showa Univ Northern Yokohama Hosp Yokohama, Japan | Internal Medicine, Kawasaki Clinic, Kawasaki, Japan | Dept Internal Medicine, Showa Univ Fujigaoka Hosp, Yokohama, Japan | Dept Nephrology, Showa Univ School Medicine, Tokyo, Japan SAP549 LANTHANUM CARBONATE (LC) INTERFERES IN MEASUREMENR OF LUMBAR BONE MINERAL DENSITY (BMD) WITH DUAL ENERGY X-RAY ABSORPTIOMETRY (DEXA) IN PATIENTS ON HEMODIALYSIS (HD) Hiroaki Ogata | Yui Takeshige | Masahide Mizobuchi | Kantaro Matsuzaka | Masahiro Yamamoto | Kanji Shishido | Tadao Akizawa | Eriko Kinugasa Dept Internal Medicine, Showa Univ Northern Yokohama Hosp Yokohama, Japan | Showa Univ Northern Yokohama Hosp, Yokohama, Japan | Dept Nephrology, Showa Univ School Medicine, Tokyo, Japan | Internal Medicine, Kawasaki Clinic, Kawasaki, Japan SAP550 LANTHANUM PREVENTS HIGH PHOSPHATE-INDUCED VSMCs OSTEOBLASTIC DIFFERENTATION Paola Ciceri | Elisa Volpi | Irene Brenna | Francesca Elli | Elisa Borghi | Diego Brancaccio | Mario Cozzolino Lab Experimental Nephrology, DMCO, Univ Milan | Lab Microbiology, DMCO, Univ Milan | DMCO, Univ Milan, Renal Div, San Paolo Hosp, Milan, Italy SAP551 ANALYSIS OF SERUM PHOSPHATE CONTROL AND PHOSPHATE BINDER UTILIZATION IN PATIENTS NEW TO HAEMODIALYSIS Kimberley Farrand | J. Brian Copley | Jamie Heise | Moshe Fridman | Michael Keith | Arthur Silverberg Shire Pharmaceuticals, Wayne, PA, USA | AMF Consulting, Los Angeles, CA, USA SAP552 LOWER SERUM PHOSPHORUS CAN BE ATTAINED BY INCREASING THE DOSE OF LANTHANUM CARBONATE Rosamund Wilson | J. Brian Copley | Lynne Poole Spica Consultants, Marlborough, UK | Shire Pharmaceuticals, Wayne, PA, USA| Shire Pharmaceuticals, Basingstoke, UK SAP553 INCREASED LEVELS OF SERUM PARATHYROID HORMONE AND FIBROBLAST GROWTH FACTOR-23 ARE THE MAIN FACTORS ASSOCIATED WITH THE PROGRESSION OF VASCULAR CALCIFICATION IN LONGHOUR HEMODIALYSIS PATIENTS Guillaume Jean | Eric Bresson | Charles Chazot Nephrocare Tassin-Charcot France | Clinique Protestante Caluire France SAP554 BIOLOGICAL IMPACT OF TARGETED DIALYSATE CALCIUM CHANGES IN HEMODIALYSIS PATIENTS: THE KEY ROLE OF PARATHYROID HORMONE Guillaume Jean | Charles Chazot Nephrocare Tassin-Charcot France w w w. e r a e d t a 2 01 2 . o r g 323 SATURDAY, MAY 26 SAP548 LANTHANUM CARBONATE: A POSTMARKETING OBSERVATIONAL STUDY OF EFFICACY AND SAFETY Francesco Londrino | Valentina Corbani | Michela Ardini | Valeria Falqui | Tito Zattera | Giuseppe Rombola' Osp S. Andrea La Spezia Italy 49th ERA-EDTA CONGRESS P O S T E R S SAP555 DIALYSATE CALCIUM INDIVIDUALIZATION ADJUSTED BY INTRADIALYTIC CALCIUM BALANCE Francisco Maduell | Marta Arias | Alexis Sentis | Nestor Rodriguez | Sonia Jimenez | Belen Alemany | Nuria Perez | Manel Vera | Nestor Fontsere | Montserrat Carrera | Aleix Cases Hosp Clinic, Barcelona, Spain | Hosp Dr Peset, Valencia, Spain SATURDAY, MAY 26 SAP556 INTRADIALYTIC CALCIUM BALANCE IN HEMODIALYSIS PATIENTS TREATED WITH CALCIMIMETICS AND SEVELAMER HYDROCHLORIDE Makrouhi Sonikian | Theodora Miha | Iakovos Skarakis | Ioannis Karatzas | Aphroditi Karaitianou Nephrology Dept, A. Fleming General Hosp, Athens, Greece| Chemistry School, Kapodistriakon Univ, Athens, Greece | Biochemistry Dept, A. Fleming General Hosp, Athens, Greece SAP557 LOW VS STANDARD CALCIUM DIALYSATE IN TREATMENT OF HAEMODIALYSIS PATIENTS WITH DIFFERENT SERUM PARATHYROID HORMONE LEVELS Vasilije Tomanoski | Dobrila Petkovic | Ivan Curic | Rajko Hrvacevic Special Hosp Haemodialysis Fresenius Medical Care, Novi Sad, Serbia | Fresenius Medical Care Srbija d.o.o., Belgrade, Serbia SAP558 CINACALCET VS. PARICALCITOL IN HEMODIALYSIS PATIENTS Nickos Kaperonis | Christine Kourvelou | Aris Sgantzos | Dimitra Nastou|George Ntatsis | Stavroula Ziakka | Filippos Karakakis | Vasileios Nikolopoulos | Dimitra Zoubaniotou | Alexandra Koutsovasili |Antonis Zagorianakos | Vasileios Kolovos | Nikos Papagalanis Red Cross Hosp, Athens, Greece SAP559 AN INTEGRATED CARE APPROACH USING ELECTRONIC PILLBOX MONITORING OF CINACALCET TO REACH iPTH TARGETS IN HEMODIALYSIS PATIENTS: A MULTICENTER, RANDOMIZED TRIAL Valentina Forni | Menno Pruijm | Eric Tousset | Carole Zweiacker | Isabel Menetrey | Lorenzo Berwert | Roberto Bullani | Anne Cherpillod | Luca Gabutti | Thierry Gauthier | Georges Halabi | Claudine Mathieu | Pascal Meier | Olivier Phan | Silvio Pianca | Carlo Schoenholzer | Daniel Teta | Beat von Albertini | Bernard Vrijens | Michel Burnier Univ Hosp Lausanne, Lausanne SAP560 CONSISTENT USE OF CINACALCET IMPROVES CLINICAL OUTCOMES IN JAPANESE HAEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM: MARGINAL STRUCTURAL ANALYSES FROM THE MINERAL AND BONE DISORDER OUTCOMES STUDY FOR JAPANESE CKD STAGE 5D PATIENTS (MBD-5D) Tadao Akizawa | Noriaki Kurita | Masahide Mizobuchi | Masafumi Fukagawa| Yoshihiro Onishi | Takuhiro Yamaguchi | Takeshi Hasegawa | Shingo Fukuma | Kiyoshi Kurokawa | Shunichi Fukuhara Dept Nephrology, Showa Univ School Medicine, Tokyo, Japan | Kyoto Univ, Kyoto, Japan | Div Nephrology, Endocrinology and Metabolism, Tokai Univ School Medicine, Isehara, Japan | Inst Health Outcomes and Process Evaluation Res | Tohoku Univ, Sendai, Japan | Showa Univ Fujigaoka Hosp | National Grad Inst Policy Studies SAP561 IMPROVED CONTROL OF SECONDARY HYPERPARATHYROIDISM (SHPT) USING CINACALCET WITH LOW DOSES OF VITAMIN D (IF PRESCRIBED) IN INCIDENT HAEMODIALYSIS SUBJECTS NOT RECEIVING VITAMIN D AT ENROLMENT P Urena | I Bridges | C Christiano | S Cournoyer | K Cooper | M Farouk | N Kopyt | M Rodriguez | D Zehnder | A Covic Clinique Landy, France | Amgen Ltd, UK | East Carolina Univ, USA | Hôp Charles LeMoyne, Canada | Amgen Inc., USA | Amgen (Europe) GmbH, Swit- 324 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France zerland | Lehigh Valley Hosp, USA | Hosp Univ Reina Sofia, IMIBIC, Spain | Warwick Medical School, UK | Parhon Univ Hosp, Gr.T. Popa Univ Medicine and Pharmacy, Romania SAP562 CINACALCET HCL INDUCES DIFFICULTY OF PARATHYROIDECTOMY FOR PATIENTS WITH SECONDARY HYPERPARATHYROIDISM Yoshihiro Tominaga | Takahisa Hiramitsu | Takayuki Yamamoto | Kouji Nanmoku | Yoshiko Matsuda | Toyonori Tsuzuki Nagoya Second Red Cross Hosp, Nagoya Japan SAP564 TWO YEARS AFTER THE PUBLICATION OF THE K/DIGO CKD-MBD GUIDELINES: WHAT DID CHANGE IN OUR TREATMENT STRATEGIES? Christos Bantis | Nicoletta-Maria Kouri | Ellada Tsandekidou | Stylianos Frangidis | Apostolos Tsiandoulas | Eleni Liakou | Gerasimos Bamichas | Maria Stangou | Aikaterini Papagianni | Georgios Efstratiadis | Taisir Natse | Dimitrios Memmos Dept Nephrology, Papanikolaou General Hosp, Thessaloniki, Greece | Dept Nephrology, Aristotle Univ Thessaloniki, Hippokration Hosp, Thessaloniki, Greece SAP565 ACHIEVEMENT OF THE NKF/K-DOQI RECOMMENDED TARGET VALUES FOR BONE AND MINERAL METABOLISM IN INCIDENT HAEMODIALYSIS PATIENTS: RESULTS OF THE FARO-2 COHORT Mario Cozzolino | Piergiorgio Messa | Diego Brancaccio | Giuseppe Cannella| Sandro Mazzaferro DMCO, Univ Milan, Renal Div, San Paolo Hosp, Milan, Italy | CROFF, Milan, Italy | Univ Milan | H S Martino, Genova | Univ La Sapienza, Rome SAP566 MINERAL AND BONE DISORDER AMONG PARTICIPANTS IN THE CHINA DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS): SERUM BIOMARKERS X Yu | M Guidinger | B Bieber | X Yang | F Tentori | RL Pisoni | J Qian | N Chen | Y Yan | M Wang | L Zuo | H Wang | M Wang | J Albert | S Ramirez First Affiliated Hosp Sun Yat-Sen Univ, Guangzhou, China | Univ Michigan, Ann Arbor, Michigan, USA | Arbor Res Collaborative for Health, Ann Arbor, Michigan, USA | Dept Medicine, Renji Hosp, Shanghai, China | Shanghai Ruijin Hosp, Shanghai, China | Peking Univ First Hosp, Beijing, China SAP567 MINERAL METABOLISM IN HEMODIALYSIS PATIENTS BETWEEN GUIDELINES AND CLINICAL PRACTICE: A 3 YEARS RETROSPECTIVE OBSERVATIONAL STUDY Francesco Caccetta | Maurizio Caroppo | Fernando Musio | Anna Mudoni | Antonella Accogli | Maria Dolores Zacheo | Vitale Nuzzo Card. G. Panico Hosp, Tricase - Italy SAP568 SERUM iPTH, CALCIUM AND PHOSPHATE, AND ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN HEMODYALISIS PATIENTS: A SINGLE CENTER 5 YEAR FOLLOW-UP ANALYSIS Gjulsen Selim | Olivera Stojceva-Taneva | Liljana Tozija | Saso Gelev | Vlatko Pusevski | Pavlina Dzekova-Vidimliski | Irena Rambabova-Busletic | Aleksandar Sikole Univ Clinic Nephrology, Univ Sts. Cyril and Methodius Skopje, R. Macedonia w w w. e r a e d t a 2 01 2 . o r g 325 SATURDAY, MAY 26 « SAP563 ACTIVATED VITAMIN D ALTERS THE T CELL DIFFERENTIATION IN CHRONIC HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM Cheng-Lin Lang | Kuo-Cheng Lu | Min-Hui Wang | Shin-Yun Liu | Jenq-Wen Huang | Chih-Kang Chiang | Kuan-Yu Hung Cardinal Tien Hosp, YongHe Br | Dept Internal Medicine, Cardinal Tien Hosp | Dept Internal Medicine, National Taiwan Univ Hosp 49th ERA-EDTA CONGRESS P O S T E R S SAP569 OBSTACLES TO MINERAL METABOLISM CONTROL IN HEMODIALYSIS PATIENTS: FIRST RESULTS FROM THE ITALIAN NATIONAL AUDIT Pasquale Esposito | Rosanna Coppo | Fabio Malberti | Antonio Dal Canton Nephrology, Dialysis, Transpl; Fond IRCCS Policlinico San Matteo; Pavia, Italy| Nephrology, Dialysis, Transpl, Regina Margherita Univ Hosp, Turin, Italy | Dept Nephrology, Ist Osp, Cremona- Italy SAP570 COST-EFFECTIVENESS OF 99mTc-MIBI SCINTIGRAPHY FOR HAEMODIALYSIS PATIENTS WITH PERSISTENT OR RECURRENT HYPERPARATHYROIDISM IN JAPAN Kensuke Moriwaki | Hirotaka Komaba | Takatoshi Kakuta | Masafumi Fukagawa Dept Health Informatics, Niigata Univ Health and Welfare, Niigata, Japan | Div Nephrology, Endocrinology and Metabolism, Tokai Univ School Medicine, Isehara, Japan SATURDAY, MAY 26 SAP571 POTENTIAL ROLE OF RELAXIN IN RENAL OSTEODYSTROPHY Valeria Cernaro | Rosaria Lupica | Valentina Donato | Antonio Lacquaniti | Maria Rosaria Fazio | Silvia Lucisano | Michele Buemi Polyclinic Messina, Dept Internal Medicine, Div Nephrology SAP572 SIGNIFICANT POSITIVE RELATIONSHIP BETWEEN SERUN UNDERCARBOXYLATED OSTEOCALCIN AND GLYCEMIC CONTROL IN MAINTENANCE HEMODIALYSIS PATIENTS Senji Okuno | Eiji Ishimura | Naoki Tsuboniwa | Kyoko Norimine | Kenjiro Yamakawa | Tomoyuki Yamakawa | Shigeichi Shoji | Katsuhito Mori | Yoshiki Nishizawa | Masaaki Inaba Shigasagi Hosp, Osaka, Japan | Osaka City Univ Grad School Medicine, Osaka, Japan SAP573 IS VITAMIN D A CONCERN IN BLACK AFRICAN HEMODIALYSIS PATIENTS? Mohamed Dahaba | Sidy Seck | Moustapha Cisse Polyclinic ABC, Dakar, Senegal SAP574 THE CONTROL OF CORRECTED CALCIUM, PHOSPHORUS AND INTACTPTH WITHOUT SEVELAMER HCL FOLLOWING THE 2011 DISASTER IN JAPAN Yukinori Jotoku | Yuzuyu Sato Matsuyama, Ehime SAP575 A MULTI-CENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, MULTIPLE FIXED-DOSE STUDY OF COLESTILAN (MCI-196) VERSUS PLACEBO IN CHRONIC KIDNEY DISEASE STAGE 5 SUBJECTS ON DIALYSIS (CKD 5D) WITH HYPERPHOSPHATAEMIA AND DYSLIPIDAEMIA (DL): SAFETY RESULTS Nada Dimkovic Clinical Dept Renal Diseases, Zvezdara Univ Medical Center, Belgrade SAP576 FGF-23 LEVELS ARE ASSOCIATED WITH VASCULAR CALCIFICATION IN PERITONEAL DIALYSIS PATIENTS Ebru Asicioglu | Arzu Kahveci | Hakki Arikan | Mehmet Koc | Serhan Tuglular| Cetin Ozener Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Istanbul, Turkey SAP577 CONSISTENT MANAGEMENT OF MINERAL-AND-BONE DISORDER: A CASE-COHORT STUDY OF CAUSES OF DEATH IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM Masafumi Fukagawa | Ryo Kido | Hirotaka Komaba | Yoshihiro Onishi | Ta- 326 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France kuhiro Yamaguch | Takeshi Hasegawa | Noriaki Kurita | Tadao Akizawa | Kiyoshi Kurokawa | Shunichi Fukuhara Div Nephrology, Endocrinology and Metabolism, Tokai Univ School Medicine| Inst Health Outcomes and Process Evaluation Res (iHope International)| Div Biostatistics Tohoku Univ Grad School Medicine | Div Nephrology, Dept Internal Medicine, Showa Univ Fujigaoka Hosp | Dept Epidemiology and Healthcare Res, Grad School Medicine and Public Health, Kyoto Univ | Div Nephrology, Dept Medicine, Showa Univ School Medicine | National Grad Inst Policy Studies| Dept Epidemiology and Healthcare Res, School of Public Health, Univ Kyoto SAP579 EFFICACY OF THE COMBINATION OF FLEXIBLE DOSES OF PARICALCITOL AND CINACALCET IN THE TREATMENT OF MODERATE TO SEVERE SECONDARY HYPERPARATHYROIDISM IN HEMODIALYSIS PATIENTS German Perez-Suarez | Eduardo Baamonde | Elvira Bosch | Jose Ignacio Ramirez | Bilal El Hayek | Maria del Mar Lago | Cesar Garcia | Maria Dolores Checa Avericum Hemodialysis Center, Las Palmas, Spain | Hosp Univ Insular Gran Canaria, Las Palmas, Spain SAP580 CLINICO-HISTOLOGIC EVALUATION OF PATIENTS WITH UREMIC TUMORAL CALCINOSIS RECEIVING HEMODIALYSIS Rikako Hiramatsu | Yoshifumi Ubara Toranomon Hosp, Tokyo, Japan SAP581 EFFICACY, TOLERABILITY, SAFETY PROFILE AND SATISFACTION DEGREE WITH CALCIUM ACETATE AND MAGNESIUM CARBONATE TREATMENT IN HEMODIALYSIS Karla Salas | Esteve Simo Vicent | Juan Carlos Gonzalez Oliva | Miquel Fulquet | Veronica Duarte | Monica Pou | Anna Saurina | Javier Macías | Manel Ramírez de Arellano Serv Nefrologia, Hosp Terrassa, Consorci Sanitari Terrassa (CST)| Serv Nefrologia, Hosp Mollet (Barcelona) SAP582 CALCIUM ACETATE/ MAGNESIUM CARBONATE THERAPY IS ASSOCIATED WITH LOWER PROGRESSION OF LEFT VENTRICULAR MASS INDEX AND VALVULAR CALCIFICATIONS IN HAEMODIALYSIS PATIENTS Patricia Matias | Cristina Jorge | Marco Mendes | Tiago Amaral | Carina Ferreira | Inês Aires | Célia Gil | Aníbal Ferreira Nephrocare - Vila Franca de Xira, Portugal SAP583 CALCIUM ACETATE AND MAGNESIUM CARBONATE ASSOCIATION: A GOOD ALTERNATIVE OF CALCIUM-BASED PHOSPHATE BINDERS Francesc Maduell | Nuria Perez | Marta Arias | Nestor Fontsere | Manel Vera| Montserrat Carrera | Alexis Sentis | Nestor Rodriguez | Carola Arcal | Josep Maria Campistol Hosp Clinic, Barcelona, Spain SAP584 IS THERE ANY CORRELATION BETWEEN CARDIAC VALVE CALCIFICATION AND ABDOMINAL AORTIC CALCIFICATION IN HEMODIALYSIS PATIENTS? Saimir Seferi | Merita Rroji | Eriola Likaj | Elizana Petrela | Myftar Barbullushi| Nereida Zeneli | Suela Mumajesi | Nestor Thereska Univ Hosp Center Mother Teresa, Dept Nephrology- Dialysis-Transpl, Tirana, Albania | Univ Hosp Center Mother Teresa, Dept Statistic, Tirana, Albania w w w. e r a e d t a 2 01 2 . o r g 327 SATURDAY, MAY 26 SAP578 BOTH VASCULAR AND VALVULAR CALCIFICATION ARE STRONG PREDICTORS OF 6-YEARS MORTALITY IN NON-DIABETIC PATIENTS ON MAINTENANCE HEMODIALYSIS Andrzej Krasniak | Maciej Drozdz | Grzegorz Chmiel | Piotr Podolec | Mieczyslaw Pasowicz | Martyna Kowalczyk-Michalek | Wladyslaw Sulowicz Chair and Dept Nephrology, Jagiellonian Univ, Krakow, Poland | Inst Cardiology, Krakow, Poland 49th ERA-EDTA CONGRESS P O S T E R S SAP585 HISTOLOGY AMD IMMUNOCHEMISTRY OF PARATHYROID GLANDS IN HEMODIALYSIS PATIENTS REFRACTORY TO CONVENTIONAL OR CINCALCET THERAPY Carlo Vulpio | Maurizio Bossola | Egidio Stigliano | Guido Fadda Catholic Univ Rome SAP586 INFLUENCE OF PARATHYROIDECTOMY ON MORTALITY IN HEMODIALYSIS PATIENTS Ana Paula Santana Gueiros | Joaquim Oliveira Borba Junior | Andrea Bezerra de Melo da Silveira Lordsllen | José Edevanilson de Barros Gueiros UFPE, Recife, Brazil SATURDAY, MAY 26 SAP587 ARE THE PARATHYROID HORMONE LEVELS IN JAPANESE HEMODIALYSIS PATIENTS UNDERESTIMATED? - SPECULATION FROM A SINGLE CENTER EXPERIENCE Noritomo Itami | Kazushi Tuneyama | Susumu Uemura | Hiromi Hamada | Jouji Takada | Kunihiko Takahashi Kidney Center, Nikko Memorial Hosp-Higasimuroran Satellite Clinic SAP588 IMPACT OF RENAL TRANSPLANT ON CORONARY ARTERY CALCIFICATION IN HEMODIALYSIS PATIENTS Konstantinos Adamidis | Christos Pleros | Theodora Oikonomaki | Eirini Kyratzi | Dimitrios Exarchos | Georgios Metaxatos | Spyros Dracopoulos | Nikoletta Nikolopoulou | Theophanis Apostolou Nephrology Dept, Radiology Dept, Renal Transpl unit, Evangelismos General Hosp, Athens, Greece SAP589 OBSERVATIONAL PROSPECTIVE STUDY ON INCIDENT HAEMODIALYSIS PATIENTS: VDRA USE AND IMPACT ON SURVIVAL: RESULTS OF THE FARO-2 COHORT Piergiorgio Messa | Mario Cozzolino | Sandro Mazzaferro | Diego Brancaccio| Giuseppe Cannella Fond IRCCS Ca' Granda Policlinico Milan Italy | Osp S. Paolo Milan Italy | Univ La Sapienza Roma Italy | Osp S. Martino Genova Italy SAP590 COMPLIANCE OF THE HEMODIALYSIS PATIENT TO THE NATIVE VITAMIN D THERAPY Pierre Delanaye | Bernard Dubois | Jean-Marie Krzesinski | Etienne Cavalier Univ Liège SAP591 REPERCUSSION OF CHOLECALCIFEROL SUPPLEMENTATION ON THE TREATMENT OF MINERAL METABOLISM IN HEMODIALYSIS PATIENTS Vanesa de la Fuente | Maria Teresa Gil | Patricia Gutierrez | Pablo Delgado | Jorge Ribero | Lola Arenas Hosp Perpetuo Socorro, Alicante, Spain SAP592 RELATIONSHIP BETWEEN VITAMIN D ANALOGS AND LEFT VENTRICULAR MASS INDEX IN MAINTANENCE HEMODIALYSIS PATIENTS Siren Sezer | Emre Tutal | Zeynep Bal | Mehtap Erkmen Uyar | F. Nurhan Ozdemir Acar Dept Nephrology, Baskent Univ, Ankara, Turkey | Dept Nephrology, Baskent Univ, Adana, Turkey | Dept Nephrology, Baskent Univ, Istanbul, Turkey SAP593 CHRONIC KIDNEY DISEASE - MINERAL BONE DISORDER EVALUATION IN PERITONEAL DIALYSIS PATIENTS Rodrigo Azevedo de Oliveira | Fellype Carvalho Barreto | Monique Mendes | Luciene Dos Reis | Juliana Cunha Ferreira | Zita Maria Leme Britto | Rosa Maria Moysés | Vanda Jorgetti Univ São Paulo, São Paulo, Brasil | CETENE 328 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP594 TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN MAINTANENCE HEMODIALYSIS PATIENTS: A RANDOMISED CLINICAL TRIAL COMPARING PARICALCITOL, CALCITRIOL AND SINACALCET Siren Sezer | Emre Tutal | Zeynep Bal | Ruya Ozelsancak | Bahar Gurlek Demirci | Dilek Torun | F. Nurhan Ozdemir Acar Dept Nephrology, Baskent Univ, Ankara, Turkey | Dept Nephrology, Baskent Univ, Adana, Turkey | Dept Nephrology, Baskent Univ, Adana, Turkey | Dept Nephrology, Baskent Univ, Istanbul, Turkey SATURDAY, MAY 26 SAP595 FIXED DOSES OF PARICALCITOL AND CINACALCET IN THE THERAPY OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON MAINTENANCE DIALYSIS – OUR INITIAL EXPERIENCE Ljubisa Veljancic | Milorad Radojevic | Zoran Paunic | Neven Vavic | Katarina Obrencevic | Zoran Kovacevic | Janko Pejovic Clinic Nephrology MMA | Inst Medical Biochemistry MMA w w w. e r a e d t a 2 01 2 . o r g 329 49th ERA-EDTA CONGRESS P O S T E R S PATHOPHYSIOLOGY CKD 5D SAP596 HIGH PREVALENCE OF DEPRESSION IN HAEMODIALYSED PATIENTS Marcin Adamczak | Andrzej Więcek | Łukasz Nowak Dept Nephrology, Endocrinology and Metabolic Diseases, Medical Univ Silesia SATURDAY, MAY 26 SAP597 INFLUENCE OF LOW-FAT DIET AND PHYSICAL ACTIVITY ON SERUM SALUSIN-ALPHA CONCENTRATION IN HEMODIALYSIS PATIENTS Alicja E. Grzegorzewska | Leszek Niepolski | Dominik Pajzderski Univ Medical Sciences, Poznań, Poland | B.Braun Avitum Dialysis Centre, Nowy Tomyśl, Poland | Dept Nephrology, Transpl and Internal Diseases, Univ Medical Sciences, Poznań, Poland SAP598 SODIUM THIOSULFATE (STS): A NEW OPTION FOR HEMODIALYSIS PATIENTS WITH UREMIC PRURITUS Walid Ahmed Abdel Atty Mohamed | Farouk Mohame Khamis Zaki | Wessam Harby Mohamed Bekhit | Ibrahim Sobhy Sherif Alexandria Univ Student Hosp, Elshatby, Alexandria, Egypt | Qabbary Specialized Hosp, Qabbary, Alexandria, Egypt | Abu Keer General Hosp, Abu Keer, Alexandria, Egypt | Elshefaa Hosp, Sidi Gaber, Alexandria, Egypt SAP599 SERUM FETUIN A AND ITS RELATIONSHIP WITH HEPATIC STEATOSIS AND SERUM CHEMERIN LEVEL IN MAINTENANCE HEMODIALYSIS PATIENTS Chien-Chu Lin | Hung-Yuan Chen | Yen-Lin Chiu | Shih-Ping Hsu | Mei-Fen Pai | Ju-Yeh Yang | Yu-Sen Peng | Tun-Jun Tsai | Kwan-Dun Wu Div Gastroenterology and Hepatology, Dept Internal Medicine, Far Eastern Memorial Hosp, New Taipei City, Taiwan | Div Nephrology, Dept Internal Medicine, Far Eastern Memorial Hosp, New Taipei City, Taiwan | Div Nephrology, Dept Internal Medicine, National Taiwan Univ Hosp and National Taiwan Univ College Medicine, Taipei, Taiwan SAP600 CAN PAST HISTORY OF VARICELLA INFECTION PREDICT SEROPOSITIVITY FOR VARICELLA ZOSTER VIRUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE? Soroush Shojai | Uday Udayaraj | Parastoo Shojai Southmead Hosp, Bristol, UK | Southmead Hosp, North Bristol NHS Trust, Bristol, UK SAP601 IS THE FEELING OF THIRST A PRIMARY CAUSE OF EXCESSIVE WEIGHT GAIN IN PATIENTS ON MAINTAINING HEMODIALYSIS? Rafał Zwiech | Agnieszka Bruzda-Zwiech Dept Kidney Transpl, Dept Paediatric Dentistry, Medical Univ Lodz, Poland SAP602 HSP27 AS A NEW MARKER OF APOPTOSIS IN CHILDREN ON CHRONIC DIALYSIS Kinga Musial | Danuta Zwolinska Dept Pediatric Nephrology, Wroclaw Medical Univ, Wroclaw, Poland SAP603 ASSOCIATION OF IL12 POLYMORPHIC VARIANTS WITH DEVELOPMENT OF ANTIBODIES TO SURFACE ANTIGEN OF HEPATITIS B VIRUS IN HEMODIALYSIS PATIENTS IN RESPONSE TO HEPATITIS B VIRUS VACCINATION OR INFECTION Alicja E. Grzegorzewska | Wobszal Piotr M. | Adrianna Mostowska | Paweł P. Jagodziński Dept Nephrology, Transpl and Internal Diseases, Dept Biochemistry and Molecular Biology, Univ Medical Sciences, Poznań 330 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP604 IMMUNOGENICITY AND SEROCONVERSION AFTER HEPATITIS B VACCINATION IN HAEMODIALYSIS PATIENTS: RESULTS OF TWO DIFFERENT VACCINATION SCHEDULES Vittorio Ortalda | Paola Tomei | Tewolde Yabarek | Olga Tobaldini | Concetta Gangemi | Michele Giuseppe Messa | Antonio Lupo Div Nephrology A.U.O.I Verona, Italy | Nephrology, ULSS 22, Villafranca Verona, Italy SAP605 PRESSURE-VOLUME RELATIONSHIPS IN THE INTERSTITIAL COMPARTMENT OF PATIENTS WITH RENAL DYSFUNCTION AND OEDEMA; CLINICAL CORRELATES AND IMPLICATIONS FOR VOLUME ASSESSMENT Leonard Ebah | Milind Nikam | Angela Summers | Idalia Dawidowska | Anuradha Jayanti | Helge Wiig | Paul Brenchley | Sandip Mitra Manchester Royal Infirmary, Manchester, UK | Univ Bergen SAP607 CLINICAL EFECTIVNESS OF VACCINATION AGAINST INFLUENZA IN DIALYSIS PATIENTS Pavlina Dzekova-Vidimliski | Aleksandar Sikole | Saso Gelev | Gjulsen Selim| Lada Trajceska Univ Clinic Nephrology, Skopje, FYR Macedonia SAP608 LOW LEVELS OF EICOSAPENTAENOIC ACID (EPA)/ARACHIDONIC ACID (AA) RATIO IN JAPANESE HEMODIALYSIS PATIENTS Shouichi Fujimoto | Hiroko Inagaki | Keiichi Fukudome | Fumitaka Ebihara | Naoto Yokota | Yuji Sato Univ Miyazaki Hosp | Chiyoda Hosp | Yokota Clinic SAP609 CHARACTERISTICS OF PATIENTS RECEIVING EXTREMELY LONG TERM HEMODIALYSIS THERAPY Takashi Akiba | Shigeru Otsubo | Kosau Nitta Dept Blood Purification, Dept Medicine, Kidney Center, Tokyo Women’s Medical Univ, Tokyo, Japan SAP610 HEPARIN-FREE (EVODIAL) DIALYSIS DOES NOT ACTIVATE ACTIVIN A Alicja Rydzewska-Rosolowska | Joanna Gozdzikiewicz | Jacek Borawski | Tomasz Hryszko | Ewa Koc-Zorawska | Michal Mysliwiec Dept Nephrology and Transpl, Medical Univ Bialystok, Bialystok, Poland SAP611 OPTIMIZATION OF 2D-DIGE ANALYSIS IN PLASMA AND ULTRAFILTRATE FOR IDENTIFICATION OF NEW UREMIC TOXINS Marta Arias | Elisenda Bañon-Maneus | Amanda Sole | Natalia Hierro-Garcia| Jordi Rovira | Maria Jose Ramírez-Bajo | Luis Fernado Quintana | Fritz Diekmann | Daniel Moya-Rull | Francisco Maduell | Josep Maria Campistol Hosp Clinic, Barcelona, Spain SAP612 FACTORS INFLUENCING HYPERVISCOSITY IN MAINTENANCE HEMODIALYSIS PATIENTS Mehtap Erkmen Uyar | Selami Kocak Toprak | Hatice Saglam | Emre Tutal | Meltem Bay | Osman Ilhan | Siren Sezer Başkent Univ Hosp, Dept Nephrology, Ankara, Turkey | Dept Hematology, Baskent Univ, Ankara, Turkey | Dept Internal Medicine, Baskent Univ, Ankara, Turkey | Dept Hematology, Ankara Univ, Ankara, Turkey w w w. e r a e d t a 2 01 2 . o r g 331 SATURDAY, MAY 26 SAP606 INTRODUCTION OF VILDAGLIPTIN IN HEMODIALYSIS PATIENTS Satoshi Mikami | Takayuki Hamano | Osamu Iba | Mitsunobu Toki | Hiroshi Mikami | Yoshihiro Takamitsu | Masamitsu Fujii Higashikohri Hosp | Clinical Epidemiology Unit, Center Clinical Epidemiology and Biostatistics, Univ Pennsylvania School Medicine 49th ERA-EDTA CONGRESS P O S T E R S SATURDAY, MAY 26 SAP613 RENALASE, STROKE AND HYPERTENSION IN HEMODIALYZED PATIENTS Jolanta Malyszko | Jacek Malyszko | Piotr Kozminski | Ewa Koc-Zorawska | Edyta Zbroch | Michal Mysliwiec Nephrology Dept | Nephrol Dept, Med Univ, Bialystok, Poland | Dialysis Unit, Mlawa, Poland 332 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France TRANSPLANTATION - BASIC SAP614 EFFECT OF CYCLOSPORINE A ADMINISTRATION IN PREGNANT RATS ON BLOOD PRESSURE AND GLOMERULI NUMBER IN THEIR OFFSPRING Marcin Adamczak | Nadezda Koleganova | Jens Randel Nyengaard | Eberhard Ritz | Andrzej Więcek | Natalia Słabiak Błaż Dept Nephrology, Endocrinology and Metabolic Diseases, Medical Univ Silesia| Dept Pathology, Univ Heidelberg, Heidelberg, Germany | Stereology and Electron Microscopy Res Lab, Inst Clinical Medicine, Aarhus Univ, Aarhus, Denmark| Dept Internal Medicine, Univ Heidelberg, Germany SAP616 IMPACT OF EVEROLIMUS AND SIROLIMUS ON PODOCYTES: A DIRECT COMPARISON Sandra Müller-Krebs | Lena Weber | Julia Tsobaneli | Jochen Reiser | Martin Zeier | Vedat Schwenger Dept Nephrology, Univ Heidelberg, Heidelberg, Germany | Div Nephrology and Hypertension, Leonard Miller School Medicine, Univ Miami, Miami, FL, USA SAP617 EFFECTS OF IMMUNOSUPPRESSIVE DRUGS ON TH17 CELLS DIFFERENTIATION Claire Tinel | Maxime Samson | Bernard Bonnotte | Christiane Mousson Dept Nephrology, Univ Hosp, Dijon, France | Inserm U866, Fac Medicine, Dijon, France SAP618 EFFECTS OF CYCLOSPORINE A AND RAPAMYCIN ON DENDRITIC CELLS MATURATION IN VITRO Maja Machcińska | Katarzyna Bocian | Marcin Wyzgał | Grażyna KorczakKowalska Dept Immunology, Fac Biology, Univ Warsaw, Poland | Transpl Inst, Medical Univ Warsaw, Poland SAP619 MIZORIBINE VERSUS MYCOPHENOLATE MOFETIL IN COMBINATION WITH TACROLIMUS FOR PRIMARY KIDNEY TRANSPLANTATION: EFFICACY AND SAFETY EVALUATION Man Ki Ju | Kyu Ha Huh | Kwan Tae Park | Sung Joo KIm | Baik Hwan Cho | Chan Duck Kim | Byung Jun So | Samuel Leee | Chong Myung Kang | Dong Jin Joo | Yu Seun Kim Gangnam Severance Hosp, YUMC, Seoul, Korea | Dept Transpl Surgery, Severance Hosp, Yonsei Univ Health System, Seoul | Dept Surgery, Korea Univ College Medicine, Seoul | Dept Surgery, Samsung Medical Center, Seoul | Dept Surgery, Chonbuk Univ College Medicine, Jeonju | Dept Internal Medicine, Kyungpook National Univ College Medicine, Daegu | Dept Surgery, Wonkwang Univ College Medicine, Iksan | Dept Surgery, Hallym Univ College Medicine, Seoul | Dept Internal Medicine, Hanyang Univ College Medicine, Seoul SAP620 IMMUNOSUPPRESSIVE AGENTS IMPAIR ANTIGEN UPTAKE OF DENDRITIC-LIKE CELLS Katarzyna Bocian | Michał Zarzycki | Anna Sobich | Grażyna Korczak-Kowalska Dept Immunology, Fac Biology Univ Warsaw w w w. e r a e d t a 2 01 2 . o r g 333 SATURDAY, MAY 26 SAP615 THE PHENOTYPE OF TUBULAR EPITHELIAL CELLS DOES NOT RECOVER AFTER A CONVERSION FROM CYCLOSPORINE A TO SIROLIUMUS Dubois Xu Yi Chun | Hertig Alexandre | Girardot-Seguin Sandrine | Toupance Olivier | Etienne Isabelle | Legendre Christophe | Touchard Guy | Westeel Pierre François | Rérolle Jean-Philippe | Lebanchu Yvon | Rondeau Eric APHP, Hôp Tenon | Inserm U702 | Roche | CHU Reims | CHU Rouen | APHP, Hôp Necker | CHU Poitiers | CHU Amiens | CHU Limoges | Univ Tours | APHP, Hôp Tenon 49th ERA-EDTA CONGRESS P O S T E R S « SAP621 “PROPE TOLERANCE” THE POSSIBILITY OF DONOR INTERLEUKIN-10TRANSDUCTED FOETAL LIVER STEM CELLS IN MICE HEART ALLOGRAFT Masahide Matsuyama | Taro Hase | Rikio Yoshimura | Katsuhiro Koshino | Kazuki Sakai | Tomoyuki Suzuki | Syuuji Nobori | Hidetaka Ushigome | Leila Brikci-Nigassa | Jamel Chargui | Jean-Louis Touraine | Norio Yoshimura Dept Transpl and Regenerative Surgery, Grad School Medical Science, Kyoto Prefectural Univ Medicine, Kyoto, Japan | Dept Urology, Osaka City Univ Grad School Medicine, Osaka, Japan | Dept Transpl and Clinical Immunology, Claude Bernard Univ Lyon and Lyon Hosp, Lyon, France SATURDAY, MAY 26 SAP622 MACROPHAGE STIMULATING PROTEIN (MSP) PROMOTES TUBULAR REGENERATION AND CD133+ RENAL PROGENITOR DIFFERENTIATION AFTER KIDNEY ISCHEMIA-REPERFUSION INJURY: POTENTIAL PROTECTIVE ROLE IN DELAYED KIDNEY GRAFT FUNCTION Vincenzo Cantaluppi | Davide Medica | Federico Figliolini | Massimilano Migliori | Claudio Mannari | Sergio Dellepiane | Alessandro Domenico Quercia | Olga Randone | Michela Tamagnone | Maria Messina | Ana Maria Manzione| Andrea Ranghino | Luigi Biancone | Giuseppe Paolo Segoloni | Giovanni Camussi Univ Turin, Turin, Italy | Nephrology and Dialysis Unit, Osp Versilia, Camaiore (LU), Italy | Dept Neuroscience, Univ Pisa, Italy SAP623 IMPROVED KIDNEY ISOGRAFT SURVIVAL WITH A NEW HISTIDINETRYPTOPHANE-KETOGLUTARATE (HTK)-BASED COLD PRESERVATION SOLUTION Tobias R. Türk | Xunfeng Zou | Ursula Rauen | Herbert de Groot | Kerstin Amann | Andreas Kribben | Kai-Uwe Eckardt | Wanja M. Bernhardt | Oliver Witzke Dept Nephrology and Hypertension, Univ Hosp Erlangen, Friedrich-Alexander Univ, Erlangen-Nuremberg, Germany | Dept Nephrology, Univ Hosp Essen, Univ Duisburg-Essen, Essen, Germany | Inst Physiological Chemistry, Univ Hosp Essen, Univ Duisburg-Essen, Germany | Nephropathology SAP624 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES 13 LOCI ASSOCIATED WITH ACUTE T-CELL REJECTION IN CAUCASIAN RENAL TRANSPLANT PATIENTS Ghisdal Lidia | Coppieters Wouter | Lebranchu Yvon | Alamartine Eric | Le Meur Yann | Touchard Guy | Noël Christian | Essig Marie | Merville Pierre| Ajarchouh Zineb | Dinic Miriana | Massart Annick | Abramowicz Marc | Abramowicz Daniel Hôp Erasme-ULB | GIGA, Univ Liège, Liège, Belgium | CHU Tours, Tours, France | CHU Saint-Etienne | CHU Brest, Brest, France | CHU Poitiers | CHRU Lille | CHU Limoges | CHU Bordeaux « SAP625 IMMUNOMODULATORY EFFECTS OF TNFα / TNF RECEPTOR SYSTEM DEPENDENT ON ACTIVATION OF VIRAL RECEPTORS OF THE INNATE IMMUNE SYSTEM IN POLYOMAVIRUS BK ASSOCIATED NEPHROPATHY Markus Wörnle | Andrea Ribeiro | Nasim Motamedi | Hermann Josef Gröne | Clemens D. Cohen | Detlef Schlöndorff | Holger Schmid Medical Policlinic, Univ Munich, Germany | Dept Virology, Max v. PettenkoferInst, Munich, Germany | Dept Cellular and Molecular Pathology, German Cancer Res Center, Heidelberg, Germany | Div Nephrology and Inst Physiology, Univ Zurich, Zurich, Switzerland | Dept Medicine, Mount Sinai School Medicine, New York, NY USA SAP626 EARLY PHYSICAL EXERCISE DECREASES ASYMMETRIC DIMETHYLARGINE AFTER RENAL TRANSPLANTATION Vladimir Teplan Inst Clin Exp Medicine, Prague, Czech Republic SAP627 BRAIN DEATH CHANGES CHEMOKINE AND FUNCTIONAL TOLL-LIKE 334 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France RECEPTOR EXPRESSION IN KIDNEYS AND OTHER SOLID ORGANS Miriam Banas | Bernhard Banas | Andreas Steege | Tobias Bergler | Bernd Krüger | Peter Schnülle | Benito Yard | Bernhard K Krämer | Simone Höger Klinik und Poliklinik Innere Medizin II, Uniklinikum Regensburg, Germany | V. Medizinische Klinik, Univsklinikum Mannheim, Germany SAP628 GITR/TNFRSF18 IS SIGNIFICANTLY UP-REGULATED IN FINE-NEEDLE ASPIRATION BIOPSY SAMPLES FROM STABLE AS COMPARED WITH ACUTE REJECTION KIDNEY TRANSPLANTS Maria Paula Xavier | Susana Sampaio-Norton | Sérgio Gaião | Helena Alves | Gerardo Oliveira Centro Histocompatibilidade Norte, Porto, Portugal | Serv Nefrologia, Hosp S. João, Porto, Portugal | CINTESIS, Fac Medicina Porto, Portugal SAP630 ICOS IS SIGNIFICANTLY UP-REGULATED IN FINE-NEEDLE ASPIRATION BIOPSY SAMPLES FROM ACUTE REJECTION KIDNEY TRANSPLANTS Maria Paula Xavier | Susana Sampaio-Norton | Sérgio Gaião | Helena Alves | Gerardo Oliveira Centro Histocompatibilidade Norte, Porto, Portugal | Serv Nefrologia, Hosp S. João, Porto, Portugal | GCCT, Hosp S. João, Porto, Portugal SAP631 IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS Gianluigi Zaza | Federica Rascio | Paola Pontrelli | Simona Granata | Carlo Rugiu | Giuseppe Grandaliano | Antonio Lupo Univ Verona | Renal Unit, Univ Bari, Italy | Renal Unit, Univ Bari, Italy | Renal Unit Hosp/Univ Verona, Italy « SAP632 MOLECULAR PREDICTORS OF DELAYED GRAFT FUNCTION OF KIDNEY ALLOGRAFT Mariana Wohlfahrtova | Irena Brabcova | Peter Balaz | Libor Janousek | Alena Lodererova | Eva Honsova | Peter Wohlfahrt | Ondrej Viklicky Inst Clinical and Experimental Medicine SAP633 POSITRON EMISSION TOMOGRAPHY WITH EX VIVO 18F-FDG LABELED HUMAN T-LYMPHOCYTES FOR DIAGNOSIS OF ACUTE REJECTION AFTER RENAL TRANSPLANTATION IN THE RAT Alexander Grabner | Dominik Kentrup | Bayram Edemir | Yasemin Sirin | Hermann Pavenstädt | Otmar Schober | Eberhard Schlatter | Michael Schäfers | Uta Schnöckel | Stefan Reuter Dept Internal Medicine D, Experimental Nephrology, Univ Hosp Münster, Münster, Germany | Dept Nuclear Medicine, Münster, Germany | European Inst Molecular Imaging, Univ Münster, Münster, Germany SAP634 CHARACTERIZATION OF THE TRANSCRIPTOMIC PROFILE OF PERIPHERAL LYMPHOMONOCYTES IN RENAL CHRONIC ANTIBODY-MEDIATED REJECTION (CAMR) Federica Rascio | Paola Pontrelli | Matteo Accetturo | Margherita Gigante | Maddalena Gigante | Tiziana Tataranni | Anna Zito | Antonio Schena | Francesco Paolo Schena | Giovanni Stallone | Loreto Gesualdo | G Grandaliano Dept Emergency and Organ Transpl, Univ Bari, Italy | DETO, Univ Bari, Italy| Dept Biomedical Sciences, Univ Foggia, Foggia, Italy | Univ Foggia, Italy | Nephrology Dialysis and Transpl Unit, Dept Emergency and Organ Transpl w w w. e r a e d t a 2 01 2 . o r g 335 SATURDAY, MAY 26 SAP629 PD-L2 IS SIGNIFICANTLY UP-REGULATED IN FINE-NEEDLE ASPIRATION BIOPSY SAMPLES FROM STABLE AS COMPARED WITH ACUTE REJECTION KIDNEY TRANSPLANTS Maria Paula Xavier | Susana Sampaio-Norton | Sérgio Gaião | Helena Alves | Gerardo Oliveira Centro Histocompatibilidade Norte, Porto, Portugal | Serv Nefrologia, Hosp S. João, Porto, Portugal | GCCT, Hosp S. João, Porto, Portugal 49th ERA-EDTA CONGRESS P O S T E R S (D.E.T.O.), Univ Bari, Italy | Dept Biomedical Sciences, Univ Foggia, Italy | Nephrology, Dialysis and Transpl Unit, Dept Biomedical Sciences, Univ Foggia SAP635 REMOVING ANTI-HLA ANTIBODIES: WHAT IS THE BEST TECHNIQUE? Nicolas Maillard | Ingrid Masson | Absi Lena | Mehdi Manolie | Alamartine Eric | Mariat Christophe Serv Néphrologie, Dialyse, Transpl Rénale, Saint Etienne, France | Etablissement Français Sang Auvergne Loire, France SATURDAY, MAY 26 SAP636 METABOLITES FROM THE SUPERFICIAL RENAL GRAFT CORTEX AS MESSENGERS OF ORGAN QUALITY – A MICRODIALYSIS STUDY Casper Kierulf Lassen | Anna Krarup Keller | Ulla Møldrup | Bo Martin Bibby| Bente Jespersen Dept Nephrology, Aarhus Univ Hosp, Skejby, Denmark | Inst Clinical Medicine, Aarhus Univ, Denmark | Dept Urology, Aarhus Univ Hosp, Skejby, Denmark | Dept Biostatistics, Aarhus Univ, Denmark SAP637 THE LEVEL OF ARGININE METABOLIC PRODUCTS IN KIDNEY TRANSPLANT PATIENTS Tatjana Cvetkovic | Radmila Velickovic Radovanovic | Radmila Pavlovic | Vidojko Djordjevic | Predrag Vlahovic | Nikola Stefanovic | Nikola Sladojevic | Aleksandra Ignjatovic Clinic Nephrology, Clinical Centre, Nis, Serbia | Inst Chemistry, Medical Fac Nis, Serbia | Cathedra Statistic and Informatics, Medical Fac, Nis, Serbia SAP638 ARGINASE INHIBITION IMPROVES ACUTE KIDNEY INJURY AFTER ISCHEMIA REPERFUSION INJURY AND RENAL TRANSPLANTATION IN MICE Song Rong | Jan Menne | Hermann Haller | Peter Suszdak | Peter Tomczuk | Faikah Gueler | Shushakova Nelli Hannover Medical School, Hannover, Germany | Dept Nephrology & Hypertension, Medical School Hannover, Germany | Corridor Inc. SAP639 THE PERIOPERATIVE MANAGEMENT OF DONOR IN KIDNEY TRANSPLANTATION Dehayni Sara | El Khyat Salma | Mtioui Naoufal | Madad Tarik | Zamd Mohamed | Medkouri Guislaine | Benghanem Mohamed Gharbi | Ramdani Benyounes Dept Nephrology Uh Ibn Rochd Casablanca SAP640 INHIBITION OF CLASSICAL PKC-alpha/beta ATTENUATE HYPOXIA INDUCED PROGRESSIVE INTERSTITIAL FIBROSIS AND TUBULAR ATROPHY BY TGF-beta INHIBITION Xia Lu | Song Rong | Nelli Shushakova | Jan Menne | Torsten Kirsch | Hermann Haller | Faikah Gueler Inst Organ Transpl, Tongji Hosp, Wuhan, China | Hannover Medical School, Hannover, Germany | Dept Nephrology, Hannover Medical School, Hannover, Germany « SAP641 SYSTEMATIC HISTOLOGICAL ANALYSIS OF THROMBOTIC MICROANGIOPATHY IN A PORCINE XENO-KIDNEY-TRANSPLANT-MODEL Clemens L. Bockmeyer | Wolf Ramackers | Juliane Wittig | Putri A. Agustian| Johannes Klose | Maximilian E. Dämmrich | Hans Kreipe | Verena Bröcker | Michael Winkler | Jan U. Becker Medical School Hannover, Inst Pathology, Hannover, Germany | Medical School Hannover, Clinic General, Visceral and Transpl Surgery, Hannover, Germany SAP642 microRNA EXPRESSION PROFILES IN TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY Putri A. Agustian | Juliane Wittig | Jan U. Becker | Clemens L. Bockmeyer Medical School Hannover, Inst Pathology, Hannover, Germany 336 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France TRANSPLANTATION - CLINICAL II SAP643 EFFECT OF CONVERSION FROM CYCLOSPORINE A TO TACROLIMUS ON ENDOTHELIAL PROGENITOR CELLS IN STABLE LONG-TERM KIDNEY TRANSPLANT RECIPIENTS. A RANDOMIZED CONTROLLED TRIAL Markus Riegersperger | Max Plischke | Sabine Steiner-Böker | Daniela Seidinger | Wolfgang Winkelmayer | Gere Sunder-Plassmann Medical Univ Vienna, Dept Medicine III, Div Nephrology & Dialysis, Austria | Medical Univ Vienna, Dept Medicine II, Div Angiology, Austria | Stanford Univ, Palo Alto, USA SAP645 EFFECTS OF TWICE-DAILY VS. ONCE-DAILY SLOW RELEASE TACROLIMUS ON THE INSULIN RESISTANCE INDEXES IN KIDNEY TRANSPLANT PATIENTS Valeria Cademartori | Fabio Massarino | Emanuele Luigi Parodi | Rodolfo Russo | Antonella Sofia | Iris Fontana | Giorgio L. Viviani | Giacomo Garibotto Dept Internal Medicine, Nephrology Section, Genoa Univ, Genoa, Italy | Transpl Section, Genoa Univ and AOU San Martino, Genoa, Italy SAP646 IMMUNOSUPPRESSION WITH RAPID STEROID TAPER IN KIDNEY TRANSPLANT USING DONATION AFTER CARDIAC DEATH (DCD) DONORS Martin Mai | William Mai | Burcin Taner | Hani Wadei | Mary Prendergast | Thomas Gonwa Mayo Clinic, Jacksonville, USA | Univ William and Mary, Williamsburg, USA SAP647 EARLY CONVERSION FROM TWICE DAILY TACROLIMUS TO THE ONCE DAILY EXTENDED FORMULATION IN RENAL TRANSPLANT PATIENTS BEFORE HOSPITAL DISCHARGE Jannot Martin | Sury Aurore | Chabroux Seffert Aline | Maillard Nicolas | Medhi Manolie | Sauron Catherine | Alamartine Eric | Mariat Christophe CHU Saint-Etienne SAP648 EFFECT OF IMMUNOSUPPRESSIVE REGIMEN ON DONOR-SPECIFIC HLAANTIBODY FORMATION AFTER KIDNEY TRANSPLANTATION Susanne Brakemeier | Lutz Liefeldt | Petra Glander | Johannes Waiser | Nils Lachmann | Constanze Schönemann | Bianca Zukunft | Patrick Illigens | Danilo Schmidt | Kaiyin Wu | Birgit Rudolph | Hans-H. Neumayer | Klemens Budde Charité, Nephrology, Berlin, Germany | Charité, HLA-Lab, Berlin, Germany | Charité, Pathology, Berlin, Germany SAP649 PRETRANSPLANT DONOR-SPECIFIC HLA ANTIBODIES DETECTED BY SINGLE-ANTIGEN BEAD FLOW CYTOMETRY: RISK FACTORS AND OUTCOME AFTER KIDNEY TRANSPLANTATION Luis Pallardo Mateu | Asuncion Sancho Calabuig | Josep Crespo Albiach | Sandra Beltran Catalan | Eva Gavela Martinez | Julia Kanter Berga Hosp Dr Peset Valencia, Spain SAP650 ABO INCOMPATIBLE KIDNEY TRANSPLANTATION IN THE ELDERLY Takaaki Kimura | Takashi Yagisawa | Nobuo Ishikawa | Yasunaru Sakuma | Takehito Hujiwara | Akinori Nukui | Masahiro Yashi Jichi Medical Univ | Jichi Medical Univ Hosp w w w. e r a e d t a 2 01 2 . o r g 337 SATURDAY, MAY 26 SAP644 THE EFFECT OF DIFFERENT CALCINEURIN INHIBITORS ON OXIDATIVE STRESS PARAMETERS IN RENAL TRANSPLANT RECIPIENTS Predrag Vlahović | Tatjana Cvetković | Vidojko Djordjević | Radmila VeličkovićRadovanović | Nikola Stefanović | Aleksandra Ignjatović | Nikola Sladojević Center Medical Biochemistry, Clinical Center, Niš, Serbia | Clinic Nephrology and Hemodialysis, Clinical Center, Niš, Serbia | Center Statistics and Informatics, Medical Fac, Niš, Serbia 49th ERA-EDTA CONGRESS P O S T E R S SAP651 EFFECT OF DONOR GENDER IN KIDNEY GRAFT SURVIVAL IN THE AGEMARGINAL DONOR POOL Jose Duraes | Jorge Malheiro | Isabel Fonseca | Ana Rocha | La Salete Martins| Manuela Almeida | Leonideo Dias | Antonio Castro-Henriques | António Cabrita Hosp Santo António | Nephrology Unit, Centro Hosp Porto, Porto, Portugal SAP652 SUBCLINICAL REJECTION ADVERSELY AFFECTS KIDNEY GRAFT SURVIVAL AND FUNCTION Martin Mai | William Mai | Hani Wadei | Mary Prendergast | Thomas Gonwa Mayo Clinic, Jacksonville, USA | Univ William and Mary, Williamsburg, USA SATURDAY, MAY 26 SAP653 TRANSURETHRAL RESECTION THE PROSTATE FOR BLADDER OUTLET OBSTRUCTION DUE TO BENIGN PROSTATIC HYPERPLASIA IN KIDNEY TRANSPLANT RECIPIENTS: LONG-TERM UROLOGICAL AND RENAL FUNCTIONAL OUTCOMES IN A PROSPECTIVE STUDY Alessandro Volpe | Marco Quaglia | Alberto Menegotto | Roberta Fenoglio | Cristina Izzo | Andrea Airoldi | Carlo Terrone | Piero Stratta Amedeo Avogadro Univ, Maggiore della Carità Hosp, Novara, Italy SAP654 A CASE-CONTROL STUDY OF THE IMPACT OF TICLOPIDINE AND CLOPIDOGREL ON SURGICAL RISK IN RENAL TRANSPLANTATION Benahmed Ahmed | Kianda Mireille | Broeders Nilufer | Massart Annick | Wissing Karl Martin | Hoang Anh-Dung | Mikhalski Dimitri | Madhoun Philippe | Racapé Judith | Abramowicz Daniel Hop Erasme | UZ Brussel SAP655 DETERMINANTS OF OUTCOME AFTER KTX IN ELDERLY PATIENTS Lutz Liefeldt | Petra Glander | Yang Lan | Danilo Schmidt | Christoph Heine | Klemens Budde | Hans-H. Neumayer Charité, Nephrology, Berlin, Germany SAP656 DETERMINANTS AND DURATION OF HOSPITALISATIONS AFTER KTX IN ELDERLY PATIENTS Danilo Schmidt | Petra Glander | Klemens Budde | Hans-H. Neumayer | Lutz Liefeldt Charité, Nephrology, Berlin, Germany SAP657 ADULT MALE DONOR INTO FEMALE RECIPIENT INCREASES THE RISK OF KIDNEY GRAFT LOSS ONLY IN YOUNG-FOR-YOUNG RENAL TRANSPLANT Marco Quaglia | Valentina Capone | Cristina Izzo | Alberto Menegotto | Roberta Fenoglio | Andrea Airoldi | Piero Stratta Amedeo Avogadro Univ, Novara, Italy. | Maggiore della Carità Hosp SAP658 TRANSPLANTATION RATES FOR LIVE-DONOR, BUT NOT DECEASEDDONOR KIDNEYS VARY WITH SOCIO-ECONOMIC STATUS IN AUSTRALIA Blair Grace | Philip Clayton | Alan Cass | Stephen McDonald ANZDATA Registry, Adelaide, Australia | Australia and New Zealand Dialysis and Transpl Registry | George Inst Global Health SAP659 LONGITUDINAL OBSERVATION OF RENAL FUNCTIONS FOLLOWING LIVE KIDNEY TRANSPLANTATION: FEASIBILITY AND LIMITATION TO USE ELDERLY KIDNEY Takashi Yagisawa | Masahiro Yashi | Takaaki Kimura | Akinori Nukui | Takehito Fujiwara | Yasunaru Sakuma | Nobuo Ishikawa | Toshihisa Iwabuchi| Osamu Muraishi Jichi Medical Univ Hosp | St. Luke’s International Hosp 338 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP660 ROLE OF FGF23 IN KIDNEY TRANSPLANT: IS THERE ANY DIFFERENCE BETWEEN RECIPIENTS OF PREEMPTIVE TRANSPLANTS AND PATIENTS WHO HAD BEEN ON DIALYSIS? Vicente Torregrosa | Xoana Barros | Mª Jesús Martinez de Osaba | Raphael Paschoalin | Josep María Campistol Hosp Clinic, Barcelona, Spain SAP661 KIDNEY TRANSPLANTATION AND ITS IMPACT ON FEMALE SEXUAL FUNCTION Rashad Hassan | Ahmed El-Hefnawy | Shady Soliman | Ahmed Shokeir Urology and Nephrology Center, Mansoura, Egypt SAP663 THE TREATMENT OF ACUTE HUMORAL REJECTION (AHR): A TASK STILL FAR AT HAND Silvio Sandrini | Gisella Setti | Francesca Valerio | Stefano Possenti | Irene Torrisi A.O. Spedali Civili, Brescia, Italy SAP664 BK VIRUS NEPHROPATHY TREATED WITH mTOR INHIBITORS-BASED IMMUNOSUPPRESSION Natalia Polanco | Laura Garcia-Puente | Esther Gonzalez Monte | Enrique Morales | Eduardo Gutierrez | Ignacio Bengoa | Ana Hernandez | Jorge Caballero| Jose Maria Morales | Amado Andres 12 de Octubre Univ Hosp SAP665 PROSPECTIVE STUDY ON THE CLINICAL AND PROGNOSTIC SIGNIFICANCE OF POLYOMAVIRUS JC INFECTION IN KIDNEY TRANSPLANT Veronica Sgarlato | Giorgia Comai | Gaetano La Manna | Ilaria Moretti | Valeria Grandinetti | Davide Martelli | Maria Piera Scolari | Sergio Stefoni Inst Nephrology, Dialysis and Renal Transpl, Univ Bologna, Bologna, Italy | S. Orsola Hosp SAP666 EFFICACY AND APPROPRIATENESS OF HISTOLOGICAL SCORE IN PREDICTION OF THE 3-YEAR OUTCOME OF KIDNEY TRANSPLANTATION Chiara Valentini | Elisa Persici | Gaetano La Manna | Maria Laura Cappuccilli| Veronica Sgarlato | Giovanni Liviano D'Arcangelo | Benedetta Fabbrizio | Elisa Carretta | Giovanni Mosconi | Maria Piera Scolari | Giorgio Feliciangeli | Franco Walter Grigioni | Sergio Stefoni Inst Nephrology, Dialysis and Renal Transpl, Univ Bologna, Bologna, Italy | F. Addarii Inst Oncologic and Transpl Molecular Pathology, Univ Bologna, Bologna, Italy | Dept Medicine and Public Health, Univ Bologna, Bologna, Italy « SAP667 SHORT-TERM EFFECTS OF AN ω-3 (n-3) RICH DIET ON METABOLIC AND INFLAMMATORY MARKERS IN RENAL TRANSPLANT RECIPIENTS Luca Apicella | Brunella Guida | Sossio Vitale | Gianluca Garofalo | Luigi Russo | Imma Maresca | Roberta Rossano | Bruno Memoli | Rosa Carrano | Stefano Federico | Massimo Sabbatini Univ Napoli Federico II, Napoli, Italy | Dept Neuroscience, Physiology Nutrition Unit, Nephrology and Renal Transpl, Dept Systematic Pathology, Univ Naples Federico II, Naples, Italy w w w. e r a e d t a 2 01 2 . o r g 339 SATURDAY, MAY 26 SAP662 DETERMINANTS OF CAROTID ATHEROSCLEROSIS CHANGES IN RENAL TRANSPLANT PATIENTS: THE ROLE OF ASYMMETRIC DIMETHYLARGININE Aysegul Cobanoglu Kudu | Ozkan Gungor | Fatih Kircelli | Ekrem Altınel | Gulay Asci | Suha Sureyya Ozbek | Huseyin Toz | Ercan Ok Ege Univ School Medicine, Div Nephrology, Izmir, Turkey | Ege Univ School Medicine, Div Radiology, Izmir, Turkey 49th ERA-EDTA CONGRESS P O S T E R S SAP668 PRE TRANSPLANT BIOPSY AND 1 YEAR GRAFT OUTCOMES IN MARGINAL KIDNEY. A MONOCENTRIC STUDY Paolo Carta | Maria Zanazzi | Lorenzo Di Maria | Leonardo Caroti | Anduela Miejshtri | Aris Tsalouchos | Elisabetta Bertoni Nephrology Unit, Careggi Univ Hosp, Florence, Italy SAP669 DETERMINANTS OF LEFT VENTRICULAR MASS INDEX IN RENAL ALLOGRAFT RECIPIENTS Siren Sezer | Mehtap Erkmen Uyar | Turan Colak | Zeynep Bal | Emre Tutal | Gaye Kalacı | F. Nurhan Ozdemir Acar Dept Nephrology, Baskent Univ, Ankara, Turkey| Dept Internal Medicine, Baskent Univ, Ankara, Turkey | Dept Nephrology, Baskent Univ, Istanbul, Turkey SATURDAY, MAY 26 SAP670 MEDICAL FACTORS ASSOCIATED TO THE REGISTRATION ON THE KIDNEY WAITING LIST IN FRANCE Christian Jacquelinet | Sahar Bayat Agence Biomedecine | EHESP SAP671 LYMPHOCYTE RECONSTITUTION AFTER INDUCTION WITH THYMOGLOBULIN IN RENAL TRANSPLANTATION: IMPACT OF THE MODE OF ADMINISTRATION (DAILY VS INTERMITTENT TREATMENT BASED ON T LYMPHOCYTE MONITORING) Vincent Pernin | Pierre Portales | Ilan Szwarc | Valerie Garrigue | Fernando Vetromile | Sylvie Delmas | Jean Francois Eliaou | Georges Mourad CHU Lapeyronie Montpellier | CHU St Eloi Montpellier SAP672 POSTTRANSPLANT HYPOPHOSPHATEMIA IS FREQUENT AND ASSOCIATED WITH BETTER OUTCOMES Lu Huber | Torsten Slowinski | Marcel Naik | Petra Glander | Lutz Liefeldt | Danilo Schmidt | Hans-Hellmut Neumayer | Klemens Budde Charité – Univsmedizin Berlin SAP673 HYPERPARATHYROIDISM IN KIDNEY TRANSPLANT PATIENTS DISCONTINUING CINACALCET AFTER LONG-TERM HEMODIALYSIS Kentaro Nakai | Hideki Fujii | Keiji Kono | Shunsuke Goto | Takeshi Ishimura| Masashi Takeda | Masato Fujisawa | Shinichi Nishi Div Nephrology and Kidney Center, Div Urology, Kobe Univ Grad School Medicine, Kobe, Japan SAP674 KIDNEY TRANSPLANT PATIENTS ON CINACALCET BEFORE SURGERY SHOW LESS GRAFT CALCIFICATION DURING THE FIRST YEAR AFTER TRANSPLANTATION THAN THE ONES THAT HAVE NEVER RECEIVED IT Raphael Pereira Paschoalin | Jose Vicente Torregrosa | Xoana Barros Freiria | Carlos Edoardo Durán Rebolledo | Ana Sanchez Escuredo | Manel Solé | Josep Maria Campistol Hosp Clinic - Barcelona, Spain « SAP675 ANALYSIS OF CHARACTERISTICS AND OUTCOMES OF A SINGLE CENTRE CLUSTER OF PNEUMOCYSTIS JIROVECII PNEUMONIA IN THE UK Sajeda Youssouf | Fozia Tabbasm | Ricky Bell | Reem Al-Jayyousi | Graham Warwick Univ Hosp Leicester SAP676 THE NEW SPECTRUM OF PNEUMOCYSTIS JIROVECII PNEUMONIA: A MULTICENTER STUDY Anne Grall | Laeticia Treguer | Marie Essig | Caroline Lecaque | Natacha Noël| Matthias Büchler | Dominique Bertrand | Joseph Rivalan | Laura Braun | Florence Villemain | Bruno Hurault de Ligny | Anne Totet | Nathalie Pestourie | Dominique Toubas | Gilles Nevez | Yannick Le Meur 340 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France CHU, Brest France | CHU, Limoges France | CHU, Amiens France | CHU, Reims France | CHU, Tours France | CHU, Rouen France | CHU, Rennes France| CHU, Strasbourg France | CHU, Angers France | CHU, Caen France SAP677 ORGAN DONATION: OPINION OF DOCTORS Bassit Nour El Houda | Habiblah Mustapha | Fadili Wafaa | Laouad Inass CHU Mohammed VI Marrakech SAP678 USE OF EXPANDED CRITERIA LIVING DONORS: POSSIBLE SOLUTION OF SEVERE ORGAN SHORTAGE IN THE BALKANS Irena Rambabova Bushljetikj | Jelka Masin-Spasovska | Goce Spasovski | Zivko Popov | Aleksandar Sikole | Ninoslav Ivanovski Univ Clinic Nephrology and Urology , Skopje, R. Macedonia SAP680 RESULTS OF LIVER AND COMBINED LIVER-KIDNEY TRASPLANT WITH MELD SCORE: WHAT CHANGED AFTER THE INCLUSION OF RENAL FUNCTION AS A DETERMINANT OF LIVER ALLOCATION? Daniela Loredo | Mariana Cleres | Gabriel Gondolesi | Luis Maria Gutierrez | R. Marcela Fortunato | Valeria Descalzi | Pablo Raffaele Univ Hosp, Favaloro Fond, Buenos Aires, Argentina w w w. e r a e d t a 2 01 2 . o r g 341 SATURDAY, MAY 26 SAP679 INTERMEDIATE EARLY GRAFT FUNCTION IS A RISK FACTOR FOR GRAFT LOSS AND WORSE LONG-TERM GRAFT FUNCTION IN KIDNEY TRANSPLANT PATIENTS Mário Raimundo | José Guerra | Catarina Teixeira | Alice Santana | Sónia Silva| Clara Mil Homens | António Gomes da Costa Hosp Santa Maria, Dept Nephrology & Renal Transpl, Lisbon, Portugal 49th ERA-EDTA CONGRESS P O S T E R S PAEDIATRIC NEPHROLOGY SAP681 URINARY HEME OXYGENASE-1 IS A NEW INDICATOR IN HUMAN CONGENITAL HYDRONEPHROSIS Hufeng Shi | Jianguo Wen | Zhenzhen Li First Affiliated Hosp Zhengzhou Univ, Zhengzhou, China SAP682 ULTRASOUND IN NEONATAL AND CHILDHOOD HYDRONEPHROSIS: IS IT A RELIABLE TOOL TO GUIDE THE MANAGEMENT? Maged Elsayed | Khaled Kamal Erfan Hosp Sitteen Street Jeddah | Ain Shams Univ Cairo SATURDAY, MAY 26 SAP683 URINARY MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR MATRIX METALLOPROTEINASE-1 IN CHILDREN WITH URETEROPELVIC JUNCTION OBSTRUCTION Zhenzhen Li | Jianguo Wen | Hufeng Shi First Affiliated Hosp Zhengzhou Univ, Zhengzhou, China SAP684 MDR-1 GENE POLYMORPHISMS AND CLINICAL COURSE OF NEPHROTIC SYNDROME IN EGYPTIAN CHILDREN Amal El Shal | Doaa Youssef Zagazig Univ, Zagazig, Egypt SAP685 LC-MS/MS AND ANTIBODY-ARRAY BASED URINARY PROTEOME ANALYSIS OF OBSTRUCTIVE NEPHROPATHY Cécile Caubet | Chrystelle Lacroix | Breuil Benjamin | Flavio Bandin | JeanLoup Bascands | Bernard Monsarrat | Stéphane Decramer | Joost Schanstra Inserm U1048 | CNRS, IPBS (Inst Pharmacologie et Biologie Structurale) | CHU Toulouse, Hôp Enfants, Serv Néphrologie | Inst National Santé et Recherche Médicale (INSERM), U1048, Inst Cardiovascular and Metabolic Disease SAP686 DOES RITUXIMAB INDUCE HYPOGAMMAGLOBULINEMIA IN CHILDREN WITH STEROID DEPENDENT IDIOPATHIC NEPHROTIC SYNDROME? Delbe-Bertin Laetitia | Tim Ulinski | Bilal Aoun Armand Trousseau Hosp, APHP, France SAP687 THE ROLE OF TREG CELLS IN PEDIATRIC PATIENTS WITH IDIOPATHIC NEPHROTIC SYNDROME Kadriye Ozdemir | Nida Dincel | Betul Sozeri | Sevgi Mir Ege Univ Fac Medicine SAP688 THE RELATIONSHIP BETWEEN GLOMERULOSCLEROSIS AND mRNA EXPRESSION OF GENES ENCODING PODOCTYE PROTEINS IN CHILDREN WITH STEROID RESISTANT NEPHROTIC SYNDROME Nida Dincel | Afig Berdeli | Sevgi Mir | Fatma Akyiğit Ege Univ Fac Medicine SAP689 EFFICACY OF COMBINED THERAPY WITH CYCLOSPORINE A AND MYCOPHENOLATE MOPHETIL IN CHILDREN WITH IDIOPATHIC NEPHROTIC SYNDROME Malgorzata Mizerska-Wasiak | Malgorzata Panczyk-Tomaszewska | Hanna Szymanik-Grzelak | Maria Roszkowska-Blaim Dept Pediatrics and Nephrology, Medical Univ Warsaw SAP690 RITUXIMAB RESTORES EXPRESSION OF TOLL-LIKE RECEPTORS AND NFΚB PATHWAY IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF CHILDREN SUFFERING FROM STEROID SENSITIVE IDIOPATHIC NEPHROTIC 342 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SYNDROME Agnes Jamin | Laurene Dehoux | Renato C Monteiro | Georges Deschenes INSERM U699, Paris, France | Serv Néphrologie Pédiatique, Hôp Robert Debré, Paris, France SAP692 RENAL MANIFESTATIONS AND GROWTH IN CHILDREN AND ADOLESCENTS WITH FABRY DISEASE INCLUDED IN THE FABRY OUTCOME SURVEY (FOS) Guillem Pintos-Morell | Uma Ramaswami | Rossella Parini | Marianne Rohrbach | Gisela Kalkum | Michael Beck Univ Hosp Germans Trias i Pujol, Badalona, Spain | Addenbrooke’s Hosp, Cambridge, UK | San Gerardo Hosp, Monza, Italy | Univ. Children's Hosp Zurich, Switzerland | Univ. Children’s Hosp, Mainz, Germany | Johannes-GutenbergUniv Mainz SAP693 A HEALTHCARE MODEL TO LESSEN THE GLOBAL EPIDEMIC OF NONCOMMUNICABLE DISEASES (NCD) IN LOW AND MIDDLE INCOME COUNTRIES (LMIC): PERITONEAL DIALYSIS (PD) FOR ACUTE KIDNEY INJURY (AKI) Mary Carter | Sampson Antwi | John Callegari | Peter Kotanko | Nathan W Levin Sustainable Kidney Care Foundation, New York, USA | Kwamw Nkrumah Univ Science & Technology/Komfo Anokye Teaching Hosp, Kumasi, Ghana | Renal Res Inst, New York USA SAP694 HEPCIDIN-25 AND MARKERS OF MINERAL METABOLISM IN CHILDREN WITH PRE-DIALYSIS CKD STAGES 3-5 Adam Rumjon | Iain C. Macdougall | Charles Turner | Caroline J. Booth | David Goldsmith | Manish D. Sinha King's College Hosp NHS Found Trust, London, UK | Renal Unit, King's College Hosp | WellChild Lab, Evelina Children's Hosp, Guy's and St. Thomas' Hosps NHS Found Trust, London, UK | Dept Paediatric Nephrology, Evelina Children's Hosp, Guy's and St. Thomas' Hosp NHS Found Trust, London, UK | Guy's and St Thomas' NHS Found Hosp SAP695 ACTIVATION OF INNATE IMMUNITY IN CHILDREN WITH HENOCH– SHOENLEIN PURPURA: TOLL-LIKE RECEPTORS IN CIRCULATING MONONUCLEAR CELLS Roberta Camilla | Elisa Loiacono | Maria Elena Donadio | Margherita Conrieri| Manuela Bianciotto | Francesca M. Bosetti | Licia Peruzzi | Giovanni Conti | Alessandra Bitto | Alessandro Amore | Rosannna Coppo Nephrology, Dialysis and Transpl - R. Margherita Hosp, Turin | Pediatric Emergency Dept - R. Margherita Hosp, Turin | Pediatric Nephrology - Martino Hosp, Messina SAP696 EFFICACY OF TREATMENT HENOCH-SCHÖNLEIN NEPHRITIS BASED ON CLINICAL AND HISTOLOGICAL MANIFESTATIONS Malgorzata Mizerska-Wasiak | Maria Roszkowska-Blaim | Jadwiga Maldyk Dept Pediatrics and Nephrology, Dept Pathology, Medical Univ Warsaw SAP697 MYCOPHENOLIC ACID TREATMENT IN PAEDIATRIC ONSET LUPUS NEPHRITIS Hsin-Hsu Chou | Yuan-Yow Chiou w w w. e r a e d t a 2 01 2 . o r g 343 SATURDAY, MAY 26 SAP691 PREVENTION OF STEROID INDUCED BONE DISEASE IN CHILDREN WITH NEPHROTIC SYNDROME: A SYSTEMATIC REVIEW Antonia Bouts | Jean-Claude Davin | Eiske Dorresteijn | Michiel Schreuder | Marc Lilien | Michiel Oosterveld | Sharon Kramer | Mariken Gruppen Emma Children's Hosp, Academic Medical Center, Amsterdam, Netherlands | Erasmus Medical Center, Rotterdam, Netherlands | Radboud Univ, Nijmegen, Netherlands | Wilhelmina Children's Hosp, Utrecht, Netherlands | Cochrane Collaboration Center, Academic Medical Center, Amsterdam, Netherlands 49th ERA-EDTA CONGRESS P O S T E R S Ditmanson Medical Foundation Chia-Yi Christian Hosp, Chiayi, Taiwan | National Cheng Kung Univ Medical Center SAP698 METABOLIC PROFILE OF NEPHROLITHIASIS IN CHILDREN AGED 0-2 YEARS- SINGLE CENTER EXPERIENCE Violetta Bochniewska | Katarzyna Jobs | Anna Jung Wojskowy Inst Medyczny, Warsaw, Poland SATURDAY, MAY 26 SAP699 UROLITHIASIS IN INFANTS Mohammad Hossein Fallahzadeh Abarghooei | Javad Zare | Vahid Sedighi Goorabi | Ali Derakhshan | Mitra Basiratnia | Mohammad Amin Fallahzadeh Abarghooei | Ghamar Hosseini Al-Hashemi | Fatemeh Fallahzadeh Abarghooei Shiraz Nephro-Urology Res Center, Shiraz Univ Medical Sciences, Shiraz, Iran SAP700 NONDIPPING STATUS AS AN EARLY RISK FACTOR FOR THE DIABETIC COMPLICATIONS IN NORMOTENSIVE PATIENTS WITH T1DM Agnieszka Kluska-Jozwiak | Jolanta Soltysiak | Katarzyna Lipkowska | Magdalena Silska | Piotr Fichna | Bogda Skowronska | Witold Stankiewicz | Danuta Ostalska-Nowicka | Jacek Zachwieja Dept Pediatric Cardiology and Nephrology, Dept Pediatric Diabetes and Obesity, Poznan Univ Medical Science, Poznan, Poland SAP701 KIDNEY DAMAGE IN PRIMARY HYPERTENSION IN CHILDHOOD İlknur Girişgen | Ferah Sönmez | Çiğdem Yenisey Pediatric Nephrology Dept, Biochemistry Dept, Adnan Menderes Univ, Aydın, Turkey SAP702 MEASUREMENT OF PULSE WAVE VELOCITY IN HEALTHY YOUNGSTERS – REFERENCE VALUES AND COMPARISON OF THREE DEVICES Eva Kis | Orsolya Cseprekal | Andrea Kerti | Attila Szabo | Paolo Salvi | Athanase Benetos | Tivadar Tulassay | George Reusz SE, 1st Dept Pediatrics, Budapest, Hungary | Dept Internal Medicine and Geriatrics, INSERM U961, Univ Nancy, France SAP703 SKIN AUTOFLUORESCENCE (sAF) AS A NEW NONINVASIVE MARKER OF CARDIOVASCULAR DAMAGE IN CHILDREN WITH CHRONIC KIDNEY DISEASE (CKD) Irena Makulska | Maria Szczepańska | Dorota Drożdż | Danuta Zwolńska Dept Pediatric Nephrology Wrocław Medical Univ | Dialysis Unit, Silesian Medical Univ, Zabrze, Poland | Children’s Hosp, Jagiellonian Univ, Cracow, Poland SAP704 IN THE FAMILIAL MEDITERRENEAN FEVER PATIENTS, CARDIOVASCULAR RISK ASSESSMENT GENETIC MARKERS AND BIOMARKERS: LIPOPROTEIN A AND SERUM AMYLOID A Betul Sozeri | Afig Berdeli | Sevgi Mir Ege Univ Fac Medicine SAP705 PLATELETS VITAL COMPUTER MORPHOMETRY IN CHILDREN WITH HEMOLYTIC UREMIC SYNDROME Evgeniya Tolstova Mocscow State Medical Dentist Univ, Moscow, Russian Federation SAP706 E. COLI VIRULENCE PATERN IN URINARY TRACT INFECTION (UTI) WITH OR WITHOUT URINARY TRACT ANOMALIES – MAY IT HELP TO FURTHER REDUCE VOIDING CYSTOGRAPHIES IN CHILDREN? Larakeb Anis | Tim Ulinski | Bensman Alber | Bingen Edouard Armand Trousseau Hosp, APHP 344 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP707 PREVALENCE OF ALBUMINURIA IN CHILDREN FOLLOWED FOR HIV INFECTION IN THE PEDIATRIC UNIVERSITY HOSPITAL (CHUP-CDG) OF OUAGADOUGOU Coulibaly Gérard | Kouanda Seni | Tountian/Ouedraogo Dunia Julienne Hadiza | Sapo Christian | Tiendrébéogo Benoît | Babinet François | Lengani Adama Serv Nephrologie et Hemodialyse, CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso | Inst Recherche Sciences Santé, Ouagadougou | Echo Pôle Sante, Le Mans, France SAP709 EFFECT OF HEMODIALYSIS (HD) SESSION ON VENTRICULAR ACTIVATION TIME IN CHILDREN WITH END-STAGE RENAL FAILURE (ESRF) Dorota Polak-Jonkisz | Krystyna Laszki-Szczachor | Danuta Zwolinska | Anna Janocha | Leslaw Rusiecki | Malgorzata Sobieszczanska Wroclaw Medical Univ « SAP710 CARPEDIEM: CARDIO-RENAL PEDIATRIC DIALYSIS EMERGENCY MACHINE. A NEW HOPE FOR INFANTS Francesco Garzotto | Zaccaria Ricci | Anna Clementi | Roberto Cena | Jeong Chul Kim | Monica Zanella | Claudio Ronco Nephrology Dept, St. Bortolo Hosp, Vicenza, Italy | Dept Cardiology and Cardiac Surgery, Pediatric Cardiac Intensive Care Unit, Bambino Gesù Children’s Hosp, Rome, Italy | San Bortolo Hosp | Product Specialist, Bellco, Italy SAP711 INCREASED CASPASE -3 ACTIVITY IN RED BLOOD CELLS (RBCS) IN CHILDREN WITH CHRONIC KIDNEY DISEASE (CKD) TREATED CONSERVATIVELY Dorota Polak-Jonkisz | Leszek Purzyc | Danuta Zwolinska | Irena Makulska | Maria Szczepanska Wroclaw Medical Univ | Medical Univ Silesia SAP712 RENAL FUNCTIONAL RESERVE IN CHILDREN WITH SOLITARY KIDNEY AND CHRONIC RENAL FAILURE Amira Peco-Antic | Jelena Kotur-Stevuljević | Dušan Paripović | Gordana Šćekić | Gordana Miloševski-Lomić | Dragana Bogićević | Brankica SpasojevićDimitrijeva Medical Fac, Fac Pharmacy, Univ Belgrade, Belgrade, Serbia | Dept Nephrology, Univ Children's Hosp, Belgrade, Serbia | Children Hosp Zemun, Zemun, Serbia| Dept Neurology, Univ Children's Hosp, Belgrade, Serbia SAP713 EFFECT OF GENDER ON HEALTH-RELATED QUALITY OF LIFE IN PEDIATRIC LIVE-DONOR KIDNEY TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE Rashad Hassan | Amr El-Husseini | Mohamed Sobh | Mohamed Ghoneim Urology and Nephrology Center, Mansoura, Egypt | Univ South Florida SAP714 ADULT HEIGHT AFTER CHILDHOOD ONSET RENAL REPLACEMENT THERAPY IN EUROPE: AN ESPN/ERA-EDTA REGISTRY STUDY Jerome Harambat | Marjolein Bonthuis | Karlijn J. van Stralen | Gema Ariceta | Nina Battelino | Timo Jahnukainen | Ana R. Sandes | Christian Combe | Kitty J. Jager | Enrico Verrina | Franz Schaefer ESPN/ERA-EDTA Registry, Academic Medical Center, Amsterdam, Netherlands | Univ Children's Hosp Cruces, Barracaldo, Spain | Univ Children's Hosp, w w w. e r a e d t a 2 01 2 . o r g 345 SATURDAY, MAY 26 SAP708 NEPHRITIS IN NEWLY DIAGNOSED S.L.E. CHILDREN IN AUSTRALIA Andrew Rosenberg | Jane Munro | Kevin Murray | Brynn Wainstein | John Ziegler | Davinder Singh-Grewal | Christina Boros | Navid Adib | Elizabeth Elliot | Rose Fahy | Fiona Mackie | Gad Kainer Sydney Children's Hosp | Royal Children's Hosp Melbourne | Princess Margaret Hosp Children | Children's Hosp, Westmead | Univ Adelaide | Children's Hosp, Brisbane | Australian Paediatric Surveillance Unit | Alice Springs Hosp 49th ERA-EDTA CONGRESS P O S T E R S Ljubljana, Slovenia | Univ Children’s Hosp, Helsinki, Finland | Univ Children's Hosp Santa Maria, Lisbon, Portugal | Nephrology Dept, Univ Hosp, Bordeaux, France | Gaslini Children's Hosp, Genoa, Italy | Univ Children's Hosp, Heidelberg, Germany SATURDAY, MAY 26 SAP715 VESICO-URETERAL REFLUX AS A RISK FACTOR FOR ACUTE PYELONEPHRITIS AND RENAL DAMAGE IN CHILDREN WITH UTI: SYSTEMATIC REVIEW AND META-ANALYSIS Reynaldo Espindola | Justine Bacchetta | Pierre Cochat | Constantinos Stefanis| Sandrine Leroy Inst Pasteur | Hôp Femme Mère Enfant & Univ Lyon | P. and A. Kyriakou’ Children’s Hosp SAP716 PROCALCITONIN PREDICTS WELL ACUTE PYELONEPHRITIS AND RENAL SCARS IN CHILDREN WITH URINARY TRACT INFECTION Sandrine Leroy | Anna Fernandez-Lopez | Roya Nikfar | Carla Romanello | François Bouissou | Alain Gervaix | Metin Gurgoze | Silvia Bressan | Vladislav Smolkin | David Tuerlinkx | Constantinos Stefanidis | Georgios Vaos | Pierre Leblond | Firat Gungor | Dominique Gendrel | Martin Chalumeau Inst Pasteur | Joan de Deu Hosp | Abuzar Children Medical Center Hosp | Univ Udine | Children's Hosp, Paul Sabathier Univ, CHU Purpan | Univ Hosp Geneva | Fırat Univ Medicine Fac | Univ Padova | Medical Center | Cliniques Univ Mont-Godinne, Univ Catholique Louvain | P. and A. Kyriakou Children’s Hosp| Democritus Univ Thrace and Univ General Hosp Alexandroupolis | Jeanne de Flandre Hosp | Akdeniz Univ, School Medicine | Necker Hosp SAP717 DOES HEPCIDIN-25 CORRELATE WITH LV MASS IN PAEDIATRIC CKD PATIENTS? Adam Rumjon | Iain C. Macdougall | Charles Turner | Debbie Rawlins | Caroline J. Booth | John M. Simpson | Manish D. Sinha King's College Hosp NHS Found Trust, London, UK | Renal Unit, King's College Hosp | WellChild Lab, Dept Congenital Heart Disease | Dept Paediatric Nephrology, Evelina Children's Hosp, Guy's and St. Thomas' Hosp NHS Found Trust, London, UK SAP718 SUCCESSFUL TREATMENT OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS TYPE I WITH MONOCLONAL ANTI C5 ANTIBODY (ECULIZUMAB) Garnier Arnaud | Modesto Anne | Tellier Stéphanie | Bandin Flavio | Fremeaux Bacchi Veronique | Decramer Stéphane Hôp Enfants | Hôp Rangueil | Hôp Européen Georges Pompidou ¯ t SAP719 UK PAEDIATRIC RENAL TRANSPLANTATION: A REVIEW OF CHANGING PRACTICE AND IMPROVED OUTCOMES OVER 20 YEARS Lisa Mumford | Stephen Marks | Niaz Ahmad | Heather Maxwell | Jane Tizard NHS Blood and Transpl, Bristol, UK | Great Ormond Street Hosp, London, UK | Leeds General Infirmary, Leeds, UK | Royal Hosp Sick Children, Glasgow, UK | Bristol Royal Hosp Children, Bristol, UK SAP720 NEAR-INFRARED SPECTROSCOPY AS A CONTINUOUS REAL-TIME MONITORING FOR KIDNEY GRAFT PERFUSION Enrico Vidal | Angela Amigoni | Mariacristina Varagnolo | Elisa Benetti | Giulia Ghirardo | Valentina Brugnolaro | Luisa Murer Dept Pediatrics, Univ Padova, Italy | Lab Medicine, Padova Hosp, Italy | Paediatric Nephrology, Dialysis and Transpl Unit, Dept Paediatrics, Univ Padova, Padova, Italy SAP721 SUCCESSFUL LIVER-KIDNEY TRANSPLANTATION IN A PATIENT WITH ESRD DUE TO HOMOZYGOUS FACTOR H MUTATION Bilal Aoun | Grapin Christine | Bensman Alber | Tim Ulinski Armand Trousseau Hosp, APHP, France 346 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 P O S T E R S PARIS, France SAP722 PROTOCOL BIOPSIES IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS ON CYCLOSPORINE VERSUS TACROLIMUS Bilal Aoun | Stéphane Decramer | Flavio Bandin | Tim Ulinski Armand Trousseau Hosp, APHP, France | Pediatrics, CHU Toulouse SAP723 AMBULATORY ARTERIAL STIFFNESS INDEX IN RENAL TRANSPLANT CHILDREN – CROSS SECTIONAL STUDY Arianna Dégi | Andrea Kerti | Éva Kis | Orsolya Cseprekál | Attila J. Szabó | György S. Reusz First Dept Pediatrics, Semmelweis Univ, Budapest, Hungary SATURDAY, MAY 26 SAP724 TRANSPLANT RENAL ARTERY STENOSIS IN PEDIATRIC KIDNEY TRANSPLANTATION: INCIDENCE, RISK FACTORS, EFFICACY AND SAFETY OF ENDOSCOPIC TREATMENT Giulia Ghirardo | Alessandro Vidoni | Enrico Vidal | Elisa Benetti | Gaetano Ramondo | Diego Miotto | Luisa Murer Paediatric Nephrology, Dialysis and Transpl Unit, Dept Paediatrics, Univ Padova, Padova, Italy | Dept Medical Diagnostic Sciences and Special Therapies, Univ Padova, Italy | Dept Pediatrics, Univ Padova, Italy w w w. e r a e d t a 2 01 2 . o r g 347 49th ERA-EDTA CONGRESS S C I E N T I F I C 348 P R O G R A M M E w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E DAY AT A GLANCE page 08:00 - 09:30 Symposia Diabetic nephropathy 350 Anaemia management 351 Complications after transplantation 352 Hyponatremia 353 Albuminuria and other biomarkers 354 Free Communications + Mini Lectures Cardiovascular complications in CKD 5D 355 Autoimmune systemic diseases 357 Clinical studies in CKD 359 09:45 - 10:30 Plenary Lecture R. Bindels 361 10.30 - 11.30 ERA-EDTA General Assembly (for ERA-EDTA members only) 362 w w w. e r a e d t a 2 01 2 . o r g 363 364 365 366 367 368 370 SUNDAY, MAY 27 11:30 - 13:00 Symposia IgA nephropathy Reappraisal of European Guidelines Renal cancer and the kidney in cancer Stem cells Prevention of AKI and delayed graft function Free Communications + Mini Lectures Transplantation clinical CKD 5D epidemiology and outcomes 349 49th ERA-EDTA CONGRESS S C I E N T I F I C GRAND AMPHITHEATRE P R O G R A M M E 08:00 - 09:30 Symposium 37 Diabetic nephropathy Chair:Hermann Haller, Hanover, Germany Detlef Schlöndorff, New York, USA New insights into the pathogenesis of diabetic nephropathy Katalin Susztak, New York, USA Models of diabetic nephropathy: in search of the holy grail Charles Alpers, Seattle, USA Paradigm shifts and optimal treatment of diabetic nephropathy Carl Erik Mogensen, Aarhus, Denmark SUNDAY, MAY 27 Therapeutic approaches to diabetic nephropathy beyond the RAS (including SOCS; suppressors of cytokines) Jesus Egido, Madrid, Spain 350 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 1 08:00 - 09:30 Symposium 38 Anaemia management Chair:Kai-Uwe Eckardt, Erlangen, Germany Pierre-Yves Martin, Geneva, Switzerland How important is transfusion avoidance in 2012 Iain C. Macdougall, London, UK Can we predict the risk for adverse events? Andrzej Wiecek, Katowice, Poland Anaemia management: the KDIGO recommendations Patrick S. Parfrey, St. John’s, Canada SUNDAY, MAY 27 Anaemia management: how and why does ERBP differ from KDIGO Francesco Locatelli, Lecco, Italy w w w. e r a e d t a 2 01 2 . o r g 351 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE BLEU P R O G R A M M E 08:00 - 09:30 Symposium 39 Complications after transplantation Chair:Claudio Ponticelli, Milan, Italy Lionel Rostaing, Toulouse, France Prevention of renal progression in renal transplantation Anke Schwarz, Hanover, Germany Posttransplant recurrence of primary glomerulonephritis Claudio Ponticelli, Milan, Italy Metabolic syndrome, insulin resistance, and chronic allograft dysfunction Esteban Porrini, La Laguna, Spain SUNDAY, MAY 27 Risk factors for NODAT. Influence of immunosuppressive therapy Marian Klinger, Wroclaw, Poland 352 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E AMPHITHEATRE BORDEAUX 08:00 - 09:30 Symposium 40 Hyponatremia Chair:Gabriel Choukroun, Amiens, France Robert Unwin, London, UK The pathophysiology and symptoms of hyponatremia Peter Gross, Dresden, Germany Diagnostic approach to hyponatremia: the ERBP point of view Robert Zietse*, Rotterdam, Netherlands Treatment of hyponatremia Michael Joannidis*, Innsbruck, Austria SUNDAY, MAY 27 * ERBP Workgroup on Hyponatremia Guidelines w w w. e r a e d t a 2 01 2 . o r g 353 49th ERA-EDTA CONGRESS S C I E N T I F I C ROOM CONCORDE 2 P R O G R A M M E 08:00 - 09:30 Symposium 41 Albuminuria and other biomarkers Chair:Ron T. Gansevoort, Groningen, Netherlands Gert Mayer, Innsbruck, Austria Albuminuria as predictor of poor renal and CV outcome Paul de Jong, Groningen, Netherlands Albuminuria - a limb of the new KDIGO CKD tripod Christopher G. Winearls, Oxford, UK Finding protein biomarkers in urinary exosomes: application of principles from systems biology Mark A. Knepper, Bethesda, USA SUNDAY, MAY 27 Transcriptional networks in glomerular failure Matthias Kretzler, Ann Arbor, USA 354 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E AMPHITHEATRE HAVANE 08:00 - 09:30 Free Communication Session 24 Cardiovascular complications in CKD 5D Chair:Bengt Fellström, Uppsala, Sweden Fatih Kircelli, Yozgat, Turkey FREE COMMUNICATIONS SUO002 DYSFUNCTIONAL HIGH DENSITY LIPOPROTEIN (HDL) FROM PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) INCREASES ARTERIAL BLOOD PRESSURE: ROLE OF ENDOTHELIAL NITRIC OXIDE (NO) SYNTHASE Timo Speer | Lucia Rohrer | Nicolle Kränkel | Kira Kuschnerus | Zewinger Stephen | Alexander Akhmedov | Yi Shi | Andreas Jung | Gabriel Wernicke | Arnold von Eckardstein | Thomas F. Lüscher | Danilo Fliser | Ulf Landmesser | Ferdinand Bahlmann Univ Hosp Zurich, Dept Clinical Chemistry, Zurich, Switzerland | Univ Hosp Zurich, Cardiovascular Center, Zurich, Switzerland | Saarland Univ Hosp, Dept Internal Medicine IV, Homburg/Saar, Germany SUO003 PREDIALYSIS BLOOD PRESSURE AND CARDIOVASCULAR OUTCOMES AMONG HEMODIALYSIS PATIENTS: RESULTS FROM THE DOPPS Bruce Robinson | Angelo Karaboyas | Christian Combe | Martin Gallagher | Patricia De Sequera | Hiroyasu Yamamoto| Hal Morgenstern | Douglas Schaubel | David Goodkin | Nathan Levin | Rajiv Saran | Friedrich Port Arbor Research Collaborative for Health, Ann Arbor, USA | Centre Hosp Univ Bordeaux, France | Renal Unit, Concord Repatriation & General Hosp, Sydney, Australia | Seccion Nefrologia, Hosp Infanta Leonor, Madrid, Spain | Div Kidney and Hypertension, Jikei Univ School Medicine, Tokyo, Japan | Univ Michigan, Ann Arbor, USA | Renal Research Inst, New York, USA w w w. e r a e d t a 2 01 2 . o r g 355 SUNDAY, MAY 27 SUO001 SERUM SALUSIN-ALPHA AND CD36 ARE POSITIVELY CORRELATED IN HEMODIALYSIS PATIENTS Alicja E. Grzegorzewska | Leszek Niepolski | Jan Sikora | Paweł P. Jagodziński | Dominik Pajzderski Univ Medical Sciences, Poznań, Poland | B.Braun Avitum Dialysis Centre, Nowy Tomyśl | Dept Clinical Immunology, Univ Medical Sciences, Poznań | Dept Biochemistry and Molecular Biology, Univ Medical Sciences, Poznań | Dept Nephrology, Transplantology and Internal Diseases, Univ Medical Sciences, Poznań, Poland 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E SUO004 PREDICTING ACUTE SUDDEN CARDIAC DEATH Benjamin Goldstein | Wolfgang Winkelmayer | Themistocles Assimes Stanford Univ, Palo Alto, USA SUO005 ALDOSTERONE AND CORTISOL AFFECT THE RISK OF SUDDEN CARDIAC DEATH IN HAEMODIALYSIS PATIENTS Christiane Drechsler | Eberhard Ritz | Andreas Tomaschitz| Stefan Pilz | Stephan Schönfeld | Katja Blouin | Martin Bidlingmaier | Fabian Hammer | Vera Krane | Winfried März | Bruno Allolio | Martin Fassnacht | Christoph Wanner Univ Würzburg, Germany | Univ Heidelberg, Germany | Univ Graz, Austria | LMU Munich, Germany| Synlab Lab, Heidelberg, Germany SUNDAY, MAY 27 SUO006 RISK STRATIFICATION OF CARDIAC DEATH IN HEMODIALYSIS PATIENTS WITHOUT CORONARY ARTERY DISEASE BY MYOCARDIAL FATTY ACID IMAGING Masato Nishimura | Yu Okamoto | Toshiko Tokoro | Masashi Nishida | Nodoka Sato | Tetsuya Hashimoto | Noriyuki Iwamoto | Toshihiko Ono Toujinkai Hosp, Kyoto, Japan 356 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM 352AB 08:00 - 09:30 Free Communication Session 25 + Mini Lecture Autoimmune systemic diseases Chair:Mohamed Daha, Leiden, Netherlands Ralph Kettritz, Berlin, Germany Mini Lecture Modulators of positive and negative costimulation Bernard Vanhove, Nantes, France SUO007 COSTIMULATION BLOCKADE WITH SYSTEMIC siRNA ANTI CD40 AMELIORATES EXPERIMENTAL LUPUS NEPHRITIS IN A DOSE DEPENDENT MANNER Elia Ripoll | Montse Goma | Nuria Bolaños | Immaculada Herrero | Oriol Bestard | Josep M Cruzado | Josep M Grinyó| Juan Torras HUB-IDIBELL, Barcelona, Spain SUO008 ANTIPHOSPHOLIPID SYNDROME NEPHROPATHY IN LUPUS EXPOSES TO MORE ANTIPHOSPHOLIPID ANTIBODY SYNDROME – RELATED EVENTS BUT NOT TO WORSE RENAL FUNCTION DURING LONG TERM FOLLOW-UP Marion Venot | Dominique Nochy | Valérie Caudwell | Christian Jacquot | Gary Hill | Jean-Charles Piette | Eric Daugas Nephrology Dpt Bichat Hosp APHP, Paris, France | Pathology Dpt HEGP APHP, Paris France | Nephrology Dpt Hôp Sud Francilien, Evry, France | Nephrology Dpt HEGP APHP, Paris France | Internal Medicine Dpt GH Pitié Salpêtrière APHP, Paris, France SUO009 IL-10 PRODUCING REGULATORY B-CELLS ARE DIMINISHED IN ANCA-ASSOCIATED VASCULITIS Benjamin Wilde | Marielle Thewissen | Pieter van Paassen | Marc Hilhorst | Jan Damoiseaux | Oliver Witzke | Jan Willem Cohen Tervaert Maastricht Univ, Dept Internal Medicine, Div Clinical and Experimental Immunology, Maastricht, Netherlands | Univ Duisburg-Essen, Dept Nephrology, Essen, Germany SUO010 A RANDOMIZED CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL VERSUS CYCLOPHOSPHAMIDE FOR w w w. e r a e d t a 2 01 2 . o r g 357 SUNDAY, MAY 27 FREE COMMUNICATIONS 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E INDUCTION THERAPY IN ANCA ASSOCIATED SYSTEMIC VASCULITIS WITH RENAL INVOLVEMENT Nan Chen | Xin Li | Wen Zhang | Pingyan Shen | Haijing Yu| Yongxi Chen | Hong Ren | Liyan Ni Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School of Medicine, Shanghai. China SUNDAY, MAY 27 SUO011 SCLERODERMA RENAL CRISIS: A RETROSPECTIVE MULTICENTRE STUDY ON 91 PATIENTS AND 427 CONTROLS Céline Lebas | Loïc Guillevin | Alice Bérezné | Raphaèle Seror| Luis Teixeira | Jacques Pourrat | Alfred Mahr | Eric Hachulla | Christian Agard | Jean Cabane | Philippe Vanhille| Jean-Robert Harle | Isabelle Deleveaux | Luc Mouthon Dept Nephrology and Internal Medicine, Centre Hosp, Valenciennes, France | Dept Internal Medicine, Hôp Cochin, Paris, France | Dept Nephrology and Clinical Immunology, Hôp Rangueil, Toulouse, France | Dept Internal Medicine, Hôp Huriez, Lille, France | Dept Internal Medicine, Hôtel Dieu, Nantes, France | Dept Internal Medicine, Hôp Saint Antoine, Paris, France | Dept Internal Medicine, Hôp Conception, Marseille, France | Dept Internal Medicine, Hôp Gabriel-Montpied, Clermont-Ferrand, France 358 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM 342AB 08:00 - 09:30 Free Communication Session 26 + Mini Lecture Clinical studies in CKD Chair:Peter Barany, Stockholm, Sweden Adeera Levin, Vancouver, Canada SUO012 CANADIAN STUDY OF PREDICTION OF DEATH, DIALYSIS AND INTERIM CARDIOVASCULAR EVENTS: CANPREDDICT: BIOMARKERS IMPROVE PREDICTION OF ONE YEAR OUTCOMES IN CHRONIC KIDNEY COHORT Adeera Levin | Claudio Rigatto | Brendan Barrett | François Madore | Norman Muirhead | Daniel Holmes | Catherine Clase | Mila Tang | Ognjenka Djurdjev | on behalf of the CANPREDDICT investigators Univ British Columbia | Univ Manitoba | Memorial Univ Newfoundland | Univ Montréal | London Health Science Center | St. Paul’s Hosp | McMaster Univ | BC Renal Agency, Vancouver, Canada SUO013 SERUM METABOLITES ASSOCIATE WITH KIDNEY FUNCTION DECLINE AND INCIDENT CHRONIC KIDNEY DISEASE IN THE GENERAL POPULATION Oemer-Necmi Goek | Angela Döring | Christian Gieger | Margit Heier | Wolfgang Koenig | Cornelia Prehn | Werner Römisch-Margl | Rui Wang-Sattler | Thomas Illig | Karsten Suhre | Peggy Sekula | Jerzy Adamski | Anna Köttgen | Christa Meisinger Div Nephrology, Univ Medical Center Freiburg, Freiburg, Germany | Inst Epidemiology I, Inst Genetic Epidemiology, Helmholtz Zentrum München, German Research Center Environmental Health, Neuherberg, Germany|Dept Internal Medicine II - Cardiology, Univ Ulm Medical Center, Ulm, Germany | Inst Experimental Genetics, Genome Analysis Center, Inst Bioinformatics and Systems Biology, Research Unit Molecular Epidemiology, Inst Bioinformatics and Systems Biology, Helmholtz Zentrum München, German Research Center Environmental Health, Neuherberg, Germany | Inst Medical Biometry and Medical Informatics, Univ Medical Center Freiburg, Freiburg, Germany SUO014 FETUINURIA PREDICTS ADVERSE OUTCOME IN CKD 3&4 Edward Smith | Martin Ford | Laurie Tomlinson | Lawrence McMahon | Chakravarthi Rajkumar | Stephen Holt Monash Univ | Brighton and Sussex Medical School | Dept Clinical Pharmacology, Addenbrooke’s Hosp, Cambridge, UK w w w. e r a e d t a 2 01 2 . o r g 359 SUNDAY, MAY 27 FREE COMMUNICATIONS 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E SUO015 EFFECTS OF N-3 FATTY ACIDS ON DECLINE OF KIDNEY FUNCTION AFTER MYOCARDIAL INFARCTION: ALPHA OMEGA TRIAL Ellen Hoogeveen | Eugenie Gemen | Marianne Geleijnse | Ron Kusters | Daan Kromhout | Erik Giltay Jeroen Bosch Hosp, Den Bosch, Netherlands | Wageningen Univ, Wageningen, Netherlands | Leiden Univ Medical Center, Leiden, Netherlands Mini Lecture Is AKI a risk factor for CKD and ESRD? Norbert Lameire, Ghent, Belgium SUNDAY, MAY 27 FREE COMMUNICATION SUO016 A MULTIFACTORIAL INTERVENTION WITH THE AID OF NURSE PRACTITIONERS IMPROVES RENAL OUTCOME IN PATIENTS WITH CHRONIC KIDNEY DISEASE: RESULTS OF THE MASTERPLAN STUDY MJ Peeters | AD van Zuilen | AJG van den Brand | ML Bots | PJ Blankestijn | JFM Wetzels Radboud University Nijmegen Medical Center | University Medical Center Utrecht, Netherlands 360 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E GRAND AMPHITHEATRE 09:45 - 10:30 Plenary Lecture 3 Chair:Markus Ketteler, Coburg, Germany Cengiz Utas, Kayseri, Turkey Novel insights into the renal handling of calcium and magnesium SUNDAY, MAY 27 René Bindels, Nijmegen, Netherlands w w w. e r a e d t a 2 01 2 . o r g 361 49th ERA-EDTA CONGRESS S C I E N T I F I C P R O G R A M M E Registered Charity No. 1060134 ERA-EDTA GENERAL ASSEMBLY SUNDAY, MAY 27 AMPHITHEATRE HAVANE 10:30 - 11:30 The admission to the General Assembly is strictly reserved to ERA-EDTA Members only. Members should have their ERA-EDTA membership cards to show in order to enter the room for the General Assembly. All ERA-EDTA Members (Full and Associate) can participate with voice during the meeting, however vote is only possible for Full Members. 362 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E GRAND AMPHITHEATRE 11:30 - 13:00 Symposium 42 IgA Nephropathy Chair:Nan Chen, Shanghai, China Renato Monteiro, Paris, France Pathogenesis of IgA Nephropathy: new insights John Feehally, Leicester, UK VALIGA: the largest clinical and pathological database for IgA nephropathy in Europe Rosanna Coppo, Turin, Italy IgAN - a mucosal immune disease? Bengt Fellström, Uppsala, Sweden SUNDAY, MAY 27 KDIGO Guidelines: Indications for immunosuppressive therapy in IgA Nephropathy Jürgen Floege, Aachen, Germany w w w. e r a e d t a 2 01 2 . o r g 363 49th ERA-EDTA CONGRESS S C I E N T I F I C ROOM CONCORDE 1 P R O G R A M M E 11:30 - 13:00 Symposium 43 Reappraisal of European Guidelines Chair:Ali Basci, Izmir, Turkey Wim Van Biesen, Ghent, Belgium How to assess target organ damage – blood vessels vs. kidney? Sadayoshi Ito, Sendai, Japan Blood pressue control in CKD 4-5 patients with diabetes: the ERBP guideline Hermann Haller, Hanover, Germany Antihypertensive treatment in dialysis patients Rajiv Agarwal, Indianapolis, USA SUNDAY, MAY 27 Novel antihypertensive agents Mustafa Arici, Ankara, Turkey 364 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E AMPHITHEATRE BLEU 11:30 - 13:00 Symposium 44 Renal cancer and the kidney in cancer Chair:Jean-Pierre Grünfeld, Paris, France Martin Zeier, Heidelberg, Germany The role of miRNA in RCC Elena Ranieri, Foggia, Italy VHL tumor suppressor protein and longevity Roman-Ulrich Müller, Cologne, Germany The dilemma of early treatment of angiomyolipomas John Bissler, Cincinnati, USA ¯ SUO017 ANGIOMYOLIPOMA RESPONSE TO EVEROLIMUS TREATMENT IN PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX OR SPORADIC LYMPHANGIOLEIOMYOMATOSIS: RESULTS FROM EXIST-2 Bernard Zonnenberg|Klemens Budde | Chris Kingswood| Michael Frost | Elena Belousova | Elzbieta Radzikowska | Matthias Sauter| Norio Nonomura | Susanne Brakemeier | Petrus de Vries | Judith Klimovsky | Gaurav Shah | Sara Miao| Jeremie Lincy | John Bissler Univ Medical Center Utrect, Utrecht, Netherlands|ChariteUniversitätsmedizin Berlin, Berlin, Germany|Royal Sussex County Hosp, Brighton, UK|Minnesota Epilepsy Group, St. Paul, MN, USA|Moscow Research Inst Pediatrics & Pediatric Surgery, Moscow, Russia|National Tuberculosis and Lung Diseases Research Inst, Warsaw, Poland|Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximilians Univ, Munich, Germany|Osaka Univ Hosp, Suita, Osaka, Japan| Charite-Universitätsmedizin Berlin, Berlin, Germany|Div Child & Adolescent Psychiatry, Univ Cape Town, South Africa| Novartis Pharmaceuticals Corporation, Florham Park, NJ, USA| Novartis Pharma AG, Basel, Switzerland|Div Nephrology, Cincinnati Children’s Hosp Medical Center, Cincinnati, OH, USA SUO018 SOLID RENAL TUMORS OF COLLECTING DUCT ORIGIN IN PATIENTS WITH CHRONIC LITHIUM NEPHROPATHY Boer Walther | Goldschmeding Roel | Rookmaaker Maarten Dept Nephrology, Dept Pathology, Univ Medical Center, Utrecht, Netherlands w w w. e r a e d t a 2 01 2 . o r g 365 SUNDAY, MAY 27 FREE COMMUNICATIONS 49th ERA-EDTA CONGRESS S C I E N T I F I C AMPHITHEATRE BORDEAUX P R O G R A M M E 11:30 - 13:00 Symposium 45 Stem cells Chair:Duska Dragun, Berlin, Germany Shoichi Maruyama, Nagoya, Japan Stem cells and renal repair Ariela Benigni, Bergamo, Italy Endogenous stem cells of the kidney Paola Romagnani, Florence, Italy Stem cell function in the uremic milieu Uta Kunter, Aachen, Germany SUNDAY, MAY 27 FREE COMMUNICATION SUO019 ADULT RENAL STEM/PROGENITOR CELLS REPAIR ACUTE RENAL TUBULAR CELL INJURY BY MEANS OF SPECIFIC TLR2-DRIVEN PARACRINE FACTORS Fabio Sallustio | Vincenzo Costantino | Sharon Natasha Cox | Antonia Loverre | Marco Rizzi | Francesco Paolo Schena Dept Emergency and Organ Transpl, Univ Bari, Bari, Italy | Nephrology Dialysis and Transpl Unit, Bari, Italy 366 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E ROOM CONCORDE 2 11:30 - 13:00 Symposium 46 Prevention of AKI and delayed graft function Chair:Giuseppe Grandaliano, Foggia, Italy Patrick Maxwell, London, UK Abnormal oxygen metabolism in uremia Masaomi Nangaku, Tokyo, Japan Prevention of renal injury through upregulation of HIF Kai-Uwe Eckardt, Erlangen, Germany Ischemic preconditioning Mohammad Magdi Yaqoob, London, UK SUNDAY, MAY 27 Machine-perfusion of kidney allografts Rutger J. Ploeg, Oxford, UK w w w. e r a e d t a 2 01 2 . o r g 367 49th ERA-EDTA CONGRESS S C I E N T I F I C ROOM 352AB P R O G R A M M E 11:30 - 13:00 Free Communication Session 27 + Mini Lecture Transplantation clinical Chair:Marian Klinger, Wroclaw, Poland Bruno Watschinger, Vienna, Austria FREE COMMUNICATIONS SUNDAY, MAY 27 SUO020 CIRCULATING PRO-INFLAMMATORY CD4+CD28NULL T CELLS INCREASE THE RISK FOR A CARDIOVASCULAR EVENT SHORTLY AFTER KIDNEY TRANSPLANTATION Michiel Betjes | Willem Weimar | Nicolle Litjens Erasmus MC, Univ Medical Center, Rotterdam, Netherlands SUO021 HCMV-SPECIFIC CELLULAR IMMUNE RESPONSE IN KIDNEY TRANSPLANT RECIPIENTS Cristina Costa | Alda Saldan | Franca Sinesi | Francesca Sidoti| Samantha Mantovani | Salvatore Simeone | Cinzia Balloco| Elsa Piasentin Alessio | Andrea Piceghello | Alessia Di Nauta| Andrea Ranghino | Giuseppe Segoloni | Rossana Cavallo Univ Hosp San Giovanni Battista Torino, Turin, Italy SUO022 LONG-TERM IMPACT OF EARLY CYTOMEGALOVIRUS INFECTION AFTER KIDNEY TRANSPLANTATION Yuliya V Smedbraaten | Anders Hartmann | Halvor Rollag | Torbjoern Leivestad | Aksel Foss | Haavard Viko | Ingrid Os| Solbjørg Sagedal Dept Nephrology, Oslo Univ Hosp Ullevaal, Oslo, Norway | Sect Nephrology, Div Specialised Medicine and Surgery, Inst Medical Microbiology, Oslo Univ Hosp RiksHosp and Univ Oslo, Oslo, Norway t SUO023 ECULIZUMAB FOR AHUS RECURRENCE IN RENAL TRANSPLANTATION Julien Zuber | Krid Saoussen | Le Quintrec Moglie | Noel Laure-Hélène | Gueutin victor | Chatelet Valérie | Salomon Rémi| Lahoche Annie | Deschênes Georges | Hourmant Maryvonne | Frémeaux-Bacchi Véronique | Niaudet Patrick | Rondeau Eric| Legendre Christophe | Loirat Chantal Univ Paris Descartes, Paris, France | Necker Néphrologie pédiatrique, Paris, France | Hôp Foch, Paris, France | Hôp Pitié-Salpétrière, Paris, France | CHU Caen | CHU Lille | Hôp Robert Debré, Paris, France | CHU Nantes | HEGP | Hôp Tenon, Paris, France 368 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E « SUO024 UK STUDY OF LIVING KIDNEY DONOR-RECIPIENT RELATIONSHIPS: GENDER AND ETHNIC VARIATIONS Rishi Pruthi | Rommel Ravanan | Anna Casula | Paul Roderick UK Renal Registry, Bristol, England | Southmead Hosp, Bristol, UK | Univ Southampton, Southampton, UK SUNDAY, MAY 27 Mini Lecture Weight changes before and after kidney transplantation - is it relevant? Magdalena Durlik, Warsaw, Poland w w w. e r a e d t a 2 01 2 . o r g 369 49th ERA-EDTA CONGRESS S C I E N T I F I C ROOM 342AB P R O G R A M M E 11:30 - 13:00 Free Communication Session 28 CKD 5D epidemiology and outcomes Chair:Friedo Dekker, Leiden, Netherlands Patrick S. Parfrey, St. John’s, Canada FREE COMMUNICATIONS SUNDAY, MAY 27 « SUO025 EVIDENCE FOR A CAUSAL RELATIONSHIP BETWEEN NERVE DYSFUNCTION AND HYPERKALAEMIA IN ENDSTAGE KIDNEY DISEASE Ria Arnold | Bruce A. Pussell | Virginija Grinius | Matthew C. Kiernan | Cindy S-Y. Lin | Arun V. Krishnan School Medical Sciences, Univ New South Wales, Sydney, Australia | Dept Nephrology, Prince Wales Hosp Randwick, Sydney, Australia | Neuroscience Research Australia, Sydney, Australia SUO026 PATIENTS IN CHRONIC HEMODIALYSIS PRESENT INCREASED INDOLEAMINE 2,3-DIOXYGENASE (IDO) ACTIVITY: A CLUE FOR UREMIC IMMUNODEFICIENCY Davide Defedele | Elisa Loiacono | M. Paola Puccinelli | Licia Peruzzi | Stefano Maffei | Roberta Camilla | Rachele Gallo | Giorgio Triolo | Daniela Bergamo | Elena Palazzo | Luca Vergano | Federica Campolo | Alessandro Amore | Rosannna Coppo Diagnostics Dept, Nephrology, Dialysis, Transpl - Regina Margherita Hosp, Turin | Nephrology and Dialysis, CTO - M. Adelaide Hosp, Turin, Italy | Diagnostic Serv, Diagnostic Dept, R. Margherita Hosp, Turin, Italy « SUO027 PREDICTING ERYTHROPOIETIN RESISTANCE IN HEMODIALYSIS PATIENTS: POST HOC ANALYSES FROM THE 4D STUDY Andreas Schneider | Markus P. Schneider | Alan G. Jardine | Christoph Wanner | Christiane Drechsler Univ Hosp Wuerzburg, Wuerzburg, Germany | Univ Hosp Erlangen, Erlangen, Germany | Univ Glasgow, Glasgow, UK SUO028 DIALYSATE SODIUM PRESCRIPTION, BLOOD PRESSURE, AND OUTCOMES IN HEMODIALYSIS PATIENTS Manfred Hecking | Angelo Karaboyas | Hugh Rayner | Rajiv Saran | Ananda Sen | Masaaki Inaba | Jurgen Bommer | Walter Horl | Ronald Pisoni | Bruce Robinson | Gere SunderPlassmann | Friedrich Port 370 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France S C I E N T I F I C P R O G R A M M E Medical Univ Vienna, Austria | Arbor Research Collaborative for Health, Ann Arbor, USA | Birmingham Heartlands Hosp, UK | Univ Michigan, Ann Arbor, USA | Osaka City Univ Graduate School Medicine, Japan | Univ Heidelberg, Germany « SUO029 PATTERNS OF SYSTOLIC BLOOD PRESSURE, ALBUMIN, AND INTERDIALYTIC WEIGHT GAIN IN CHRONIC HEMODIALYSIS PATIENTS BEFORE HOSP ADMISSION Len A Usvyat | Stephan Thijssen | Peter Kotanko | Nathan W Levin Renal Research Inst, New York, USA SUNDAY, MAY 27 « SUO030 RENAL CENTRE CHARACTERISTICS AND PRACTICE PATTERNS ASSOCIATED WITH RRT INCIDENCE IN THE UK Clare Castledine | Julie Gilg | Chris Rogers | Yoav Ben-Shlomo | Fergus Caskey UK Renal Registry, Bristol, UK | UK Renal Registry | Univ Bristol | School Social and Community Medicine, Bristol Univ, UK| NHS North Bristol, Bristol, UK w w w. e r a e d t a 2 01 2 . o r g 371 49th ERA-EDTA CONGRESS P R O G R A M M E SUNDAY, MAY 27 S C I E N T I F I C 372 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France I N D U S T R Y S P O N S O R E D S Y M P O S I A INDUSTRY SPONSORED SYMPOSIA Friday, May 25 13:15 – 15:15 page Grand Amphitheatre Room Concorde 1 Amphitheatre Bleu Amphitheatre Bordeaux Room Concorde 2 Room 252 AB Amphitheatre Havane Room 352 AB Roche Gambro Fresenius Medical Care Sanofi Otsuka Pharmaceutical Europe Alexion Pharma International Takeda Pharmaceuticals Europe B.Braun Saturday, May 26 13:15 – 15:15 Abbott Amgen Shire Pharmaceuticals Baxter Healthcare Vifor Pharma and Fresenius Medical Care DV Care Nipro Europe Toray page 382 383 384 385 386 387 388 389 INDUSTRY SPONSORED SYMPOSIA Room Concorde 1 Amphitheatre Bleu Amphitheatre Bordeaux Room Concorde 2 Room 252 AB Amphitheatre Havane Room 342 AB Room 352 AB 374 375 376 377 378 379 380 381 w w w. e r a e d t a 2 01 2 . o r g 373 49th ERA-EDTA CONGRESS I N D U S T R Y S P O N S O R E D Friday, May 25 Grand Amphitheatre S Y M P O S I A 13:15 - 15:15 Offering stability in the fluctuating world of renal anaemia Chair: Philippe Lang, Paris, France Welcome & Introduction Philippe Lang, Paris, France New targets, new standards: The key messages from KDIGO Kai-Uwe Eckardt, Erlangen, Germany New vs. old world: Implications of an individualised treatment approach to renal anaemia Angel Luis Martín de Francisco, Santander, Spain Case in point: The potential effect of KDIGO on European chronic renal anaemia care Sean Fenwick, Sunderland, UK Discussion Summary & Conclusions INDUSTRY SPONSORED SYMPOSIA organised by ROCHE 374 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France I N D U S T R Y S P O N S O R E D Friday, May 25 Room Concorde 1 S Y M P O S I A 13:15 - 15:15 Reflections and experience from 30 years in the files of dialysis Chair: Claudio Ronco, Vicenza, Italy Introduction Ingrid Ledebo, Lund, Sweden Panel discussion with the participation of Anders Christensson, Malmö, Sweeden Ingrid Ledebo, Lund, Sweden Raymond Vanholder, Ghent, Belgium Richard Ward, Louisville, USA - - - - - How physiological is contemporary dialysis? Which components of a dialysis treatment can still be considered unphysiological? Can and should we strive to make dialysis therapy more physiological? If so, which are the most important steps to take? What impact could this have on outcome? INDUSTRY SPONSORED SYMPOSIA organised by GAMBRO w w w. e r a e d t a 2 01 2 . o r g 375 49th ERA-EDTA CONGRESS I N D U S T R Y Friday, May 25 Amphitheatre Bleu S P O N S O R E D S Y M P O S I A 13:15 - 15:15 Meeting cardiovascular challenges in haemodialysis Chair: David Wheeler, London, UK High-volume online HDF: maximizing convection for better outcomes Bernard Canaud, Montpellier, France Potassium control in CKD: can we do better? James Heaf, Herlev, Denmark Modern phosphate binding therapy involving magnesium Markus Ketteler, Coburg, Germany INDUSTRY SPONSORED SYMPOSIA organised by FRESENIUS MEDICAL CARE 376 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France I N D U S T R Y S P O N S O R E D Friday, May 25 Amphitheatre Bordeaux S Y M P O S I A 13:15 - 15:15 New insights in markers of CKD-MBD; how can we improve patient outcomes? Chair: Tilman Drueke, Amiens, France The rise of FGF23 from mendelian obscurity to mainstream cardiovascular notoriety Myles Wolf, Miami, USA The reappraisal of calcium balance in chronic kidney disease David Spiegel, Denver, USA Prevention of cardiovascular calcification in CKD patients, should this be key priority? Chris McIntyre, Derby, UK INDUSTRY SPONSORED SYMPOSIA organised by SANOFI w w w. e r a e d t a 2 01 2 . o r g 377 49th ERA-EDTA CONGRESS I N D U S T R Y S P O N S O R E D Friday, May 25 Room Concorde 2 S Y M P O S I A 13:15 - 15:15 Taking a closer look at hyponatraemia Chair: Maurice Laville, Lyon, France Welcome and introduction: The hyponatraemia mind-set and environment Maurice Laville, Lyon, France Under the microscope: Hyponatraemia from a fluid balance perspective Søren Nielsen, Aarhus, Denmark Robert W. Schrier, Denver, USA Investigating the optimal treatment of hyponatraemia: Practical case studies Volker Burst, Köln, Germany Questions and answers Chair close INDUSTRY SPONSORED SYMPOSIA organised by OTSUKA PHARMACEUTICAL EUROPE 378 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France I N D U S T R Y S P O N S O R E D Friday, May 25 Room 252 AB S Y M P O S I A 13:15 - 15:15 aHUS: A complement-Mediated Thrombotic Microangiopathy Chair: Christophe Legendre, Paris, France The role of complement in complement mediated diseases Peter Zipfel, Jena, Germany aHUS disease and diagnosis: key learnings Franz Schaefer, Heidelberg, Germany Improving patient outcomes in aHUS Chantal Loirat, Paris, France INDUSTRY SPONSORED SYMPOSIA organised by ALEXION PHARMA INTERNATIONAL w w w. e r a e d t a 2 01 2 . o r g 379 49th ERA-EDTA CONGRESS I N D U S T R Y S P O N S O R E D Friday, May 25 Amphitheatre Havane S Y M P O S I A 13:15 - 15:15 Chemin de fer: following the right track in anaemia management Chair: Iain Macdougall, London, UK Chairman’s introduction Iain Macdougall, London, UK Planning the route ahead: Meeting the challenges of disease progression in renal anaemia Simon Roger, Gosford, Australia Future therapeutic options: Following the right track in anaemia management in CKD Francesco Locatelli, Lecco, Italy Signalling change: Hepcidin as a novel biomarker for CKD Tomas Ganz, Los Angeles, USA All aboard! Open forum discussion Iain Macdougall, London, UK INDUSTRY SPONSORED SYMPOSIA organised by TAKEDA PHARMACEUTICALS EUROPE 380 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France I N D U S T R Y S P O N S O R E D Friday, May 25 Room 352 AB S Y M P O S I A 13:15 - 15:15 Ensuring good dialysis quality in times of cost pressure Chairs: Ziad A. Massy, Amiens, France Philippe Nicoud, Sallanches, France What counts? Efficiency and efficacy of interventions to ensure good dialysis quality John Moran, Los Angeles, USA High flux dialysis changing medical practice - an update James Tattersall, Leeds, UK Water quality and needs for good dialysis: the impact of dialysate flow rate on delivered Kt/V Nicholas Hoenich, Newcastle, UK INDUSTRY SPONSORED SYMPOSIA organised by B. BRAUN AVITUM w w w. e r a e d t a 2 01 2 . o r g 381 49th ERA-EDTA CONGRESS I N D U S T R Y Saturday, May 26 Room Concorde 1 S P O N S O R E D S Y M P O S I A 13:15 - 15:15 Mitigation of declining kidney function: how pathophysiological mechanisms inform new treatment options Chair: Dick de Zeeuw, Groningen, Netherlands Introduction and opening remarks Dick de Zeeuw, Groningen, Netherlands Progression of kidney disease: processes and variability Adeera Levin, Vancouver, Canada How do oxidative stress and inflammation contribute to declining kidney function? Ziad Massy, Amiens, France KEAP1-Nrf2 as a therapeutic target Christoph Wanner, Würzburg, Germany Panel discussion INDUSTRY SPONSORED SYMPOSIA organised by ABBOTT 382 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France I N D U S T R Y S P O N S O R E D Saturday, May 26 Amphitheatre Bleu S Y M P O S I A 13:15 - 15:15 Evolving our understanding of CKD management through outcome trials Chair: Eberhard Ritz, Heidelberg, Germany Chair’s welcome and introduction: the role of evidence based medicine in clinical decision taking Eberhard Ritz, Heidelberg, Germany Improving outcomes in CKD-MBD patients with calcimimetics: the potential of EVOLVE David Wheeler, London, UK Management of anaemia in chronic kidney disease: Recent learnings Robert Toto, Dallas, USA INDUSTRY SPONSORED SYMPOSIA organised by AMGEN w w w. e r a e d t a 2 01 2 . o r g 383 49th ERA-EDTA CONGRESS I N D U S T R Y S P O N S O R E D Saturday, May 26 Amphitheatre Bordeaux S Y M P O S I A 13:15 - 15:15 Clinical challenges in balancing nutritional intake and phosphate metabolism in dialysis patients Chair: Denis Fouque, Lyon, France Chair’s Introduction Denis Fouque, Lyon, France Protein intake and phosphate control Kamyar Kalantar-Zadeh, Los Angeles, USA Enabling adequate protein intake: the critical role of phosphate binders Mario Cozzolino, Milan, Italy The challenge of non-adherence Rob Horne, London, UK Questions to the panel Meeting close INDUSTRY SPONSORED SYMPOSIA organised by SHIRE PHARMACEUTICALS 384 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France I N D U S T R Y S P O N S O R E D Saturday, May 26 Room Concorde 2 S Y M P O S I A 13:15 - 15:15 Delivering high dose haemodialysis in the home: physician and patient perspectives Chair: Gérard M. London, Fleury-Mérogis, France Providing patients an option for high dose haemodialysis - balancing patient benefits, risks and lifestyle Deborah Zimmerman, Ottawa, Canada Hurdles to establish and maintain a successful home haemodialysis programme Eero Honkanen, Helsinki, Finland Leaving the centre behind - a patient’s perspective Ian Hazel, Chesterfield, UK Q & A Session Summary and Conclusions INDUSTRY SPONSORED SYMPOSIA organised by BAXTER HEALTHCARE w w w. e r a e d t a 2 01 2 . o r g 385 49th ERA-EDTA CONGRESS I N D U S T R Y Saturday, May 26 Room 252 AB S P O N S O R E D S Y M P O S I A 13:15 - 15:15 The new KDIGO Anaemia Guidelines – Targeting better patient outcomes Chair: Walter Hörl, Vienna, Austria Introduction Walter Hörl, Vienna, Austria The new KDIGO Anaemia Guidelines on the use of iron in clinical practice: What do we know and what do we not know? Patrick Parfrey, St. John’s, Canada Achieving a balance in anaemia management: What is the role of IV iron? Gilbert Deray, Paris, France IV iron therapy: How do we maximize benefit and minimize risk? Iain Macdougall, London, United Kingdom Panel discussion INDUSTRY SPONSORED SYMPOSIA organised by VIFOR PHARMA and FRESENIUS MEDICAL CARE 386 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France I N D U S T R Y S P O N S O R E D Saturday, May 26 Amphitheatre Havane S Y M P O S I A 13:15 - 15:15 Bringing quality to life for dialysis patients: how can we improve the patient experience? Chairs: David Van Wyck, Denver, USA Kai-Uwe Eckardt, Erlangen, Germany Treatment around the world: how are we doing? David Van Wyck, Denver, USA Kai-Uwe Eckardt, Erlangen, Germany Patient-based medicine in dialysis: what is the spectrum of alternatives? Claudio Ronco, Vicenza, Italy Population-based medicine in dialysis: is it applicable in all patients? Wim Van Biesen, Ghent, Belgium Continuous improvement in patient management: how can we apply the learning healthcare paradigm to dialysis? Mahesh Krishnan, Minneapolis, USA INDUSTRY SPONSORED SYMPOSIA organised by DV CARE w w w. e r a e d t a 2 01 2 . o r g 387 49th ERA-EDTA CONGRESS I N D U S T R Y Saturday, May 26 Room 342 AB S P O N S O R E D S Y M P O S I A 13:15 - 15:15 Health & safety in dialysis Chair: Lucile Mercadal, Paris, France Bisphenol A (BPA) exposure from dialysis equipment: implications for adverse health effects in patients with impaired kidney function Frederick Vom Saal, Columbia, USA Buttonhole needling of hemodialysis arterio-venous fistulae results in less complications and interventions compared to the rope-ladder technique Madga van Loon, Maastricht, Netherlands INDUSTRY SPONSORED SYMPOSIA organised by NIPRO EUROPE 388 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France I N D U S T R Y S P O N S O R E D Saturday, May 26 Room 352 AB S Y M P O S I A 13:15 - 15:15 Clinical potentials of adsorptive dialysis membrane Chair: Thierry Hannedouche, Strasbourg, France Immune deficiency in ESRD patients; the role of the dialysis membrane Marie-Noëlle Peraldi, Paris, France Removal of albumin-bound uremic toxins by hemodialysis Toshimitsu Niwa, Nagoya, Japan Clinical experience with enhanced adsorption dialysis for FLCs removal in patients with multiple myeloma Antonio Santoro, Bologna, Italy INDUSTRY SPONSORED SYMPOSIA organised by TORAY w w w. e r a e d t a 2 01 2 . o r g 389 49th ERA-EDTA CONGRESS EXHIBITORS E X H I B I T O R S 390 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S INDUSTRY EXHIBITION THURSDAY, MAY 24, 2012 17:00-21:00 Exhibition Open 19:30-21:00 Welcome Reception in the Exhibition FRIDAY, MAY 25, 2012 09:00-17:30 Exhibition Open 09:30-10:45 Poster Viewing and Exhibition Visit 11:30-11:45 Coffee Break and Exhibition Visit 16:45-17:00 Coffee Break and Exhibition Visit SATURDAY, MAY 26, 2012 09:00-17:30 Exhibition Open 09:30-10:45 Poster Viewing and Exhibition Visit 11:30-11:45 Coffee Break and Exhibition Visit 16:45-17:00 Coffee Break and Exhibition Visit SUNDAY, MAY 27, 2012 Exhibition Open 09:30-09:45 Coffee Break and Exhibition Visit EXHIBITORS 09:00-12:00 w w w. e r a e d t a 2 01 2 . o r g 391 49th ERA-EDTA CONGRESS E X H I B I T O R S EXHIBITORS LIST A-Z EXHIBITORS COMPANY..............................................................Booth No. Abbott............................................................. 2.03+2.90+2.88 Actual Way Medical Devices - Via Actual................... 2.21 Alam Medical................................................................ 1.64A Alere International........................................................... 1.93 Alexion Pharma International.............................1.26+1.116 Allmed Medical................................................................ 2.27 Amgen Europe................................................................. 2.48 ARBOR Research............................................................. 1.G7 Asahi Kasei Medical Europe.................................1.42+1.47 Atcor Medical................................................................ 1.G23 Atlantic Biomedical.......................................................... 2.04 Awak Technologies......................................................... 1.68 B.Braun Avitum................................................................ 2.12 Bain Medical Equipment................................................. 1.22 Baxter Healthcare............................................................. 2.39 Bellco....................................................................Hall Maillot Binding Site (the).............................................................. 1.05 Bionic Medizintechnik................................................... 1.103 BioPorto Diagnostics.................................................... 1.G21 Bodystat............................................................................ 1.G6 Culligan............................................................................. 1.94 Covidien............................................................................ 1.16 Cybernius Medical........................................................... 1.37 Debiotech........................................................................... 1.91 Diaverum........................................................................... 2.19 Dirinco............................................................................... 1.32 Dustri Verlag....................................................................1.P1 DV Care............................................................................. 1.29 DWA.................................................................................. 2.81 E.D.P. La Traccia........................................................... 1.G22 EffeEmme.......................................................................... 2.44 EG Medical Systems........................................................ 1.62 Elsevier Masson................................................................1.P4 Emodial.............................................................................. 2.42 ERA-EDTA 2013 Congress Istanbul........................... 1.G14 Etropal............................................................................... 1.11 Euroclinic.......................................................................... 1.G5 FedAirg............................................................................. 1.G9 French Society of Dialysis............................................ 1.G11 French Society of Nephrology....................................... 1.G8 Fresenius Kabi.................................................................. 2.68 Fresenius Medical Care................................................... 2.68 Gambro.............................................................................. 2.46 Gardhen Bilance............................................................ 1.98C HemoSapiens................................................................. 1.G24 Herco Wassertechnik....................................................... 2.64 Hospira UK....................................................................... 2.83 IFKF - International Federation of Kidney Foundation.................................................... 1.G4 Immundiagnostik.......................................................... 1.G19 Infomed............................................................................. 1.45 Innovative Blood Purification........................................ 1.50 Intermedt Medizin & Technik........................................ 1.97 ISN International Society of Nephrology.................... 1.G3 392 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S Janssen............................................................................... 2.37 JiHua Medical Apparatus and Instruments.............. 1.G17 Joline.................................................................................. 1.34 Karger................................................................................1.P6 Kawasumi......................................................................... 2.05 Kimal.................................................................................. 1.01 Labor Limbach............................................................... 1.G20 Lauer.................................................................................. 2.12 Likamed............................................................................. 2.66 Medcomp.......................................................................... 1.71 Medica Italia................................................................... 1.100 Medikit.............................................................................. 1.35 Meditechlab & Suisse Med Technologies..................... 1.92 MediTheque Bookshop...................................................1.P5 Medvision........................................................................ 1.115 MedXL............................................................................ 1.G10 Membrana......................................................................... 2.20 Miltenyi Biotec.................................................................. 2.40 Mitsubishi Pharma Europe............................................. 1.10 Nature PG.........................................................................1.P2 NDT-ERBP-NDT-Educational...................................... 1.102 Nephrokit.......................................................................... 1.28 Nikkiso Europe................................................................ 2.75 Ningbo Tianyi Medical Appliance............................. 1.G15 Nipro Europe.................................................................... 2.14 NKF USA........................................................................... 2.26 Novartis Pharmaceuticals - Oncology.......................... 1.31 NxStage Medical.............................................................. 1.02 Otsuka Pharmaceuticals Europe.................................... 1.60 OUP Oxford University Press........................................ 1.72 PakuMed........................................................................... 1.36 Pharmacosmos.................................................................. 2.13 Physidia............................................................................. 1.65 PosterSessionOnLine - Poster Virtual Gallery............. 1.24 Pronefro............................................................................. 1.96 Roche.................................................................................. 2.52 Sandoz............................................................................... 2.73 Sanofi Aventis Groupe.................................................... 2.79 Savient Pharmaceuticals................................................. 1.14 Serumwerk Bernburg...................................................... 1.61 Shire Pharmaceuticals..................................................... 2.01 Sined................................................................................... 1.57 Soludia Maghreb.............................................................. 2.65 Takeda Pharmaceuticals Europe...........................P01+P02 TauroPharm...................................................................... 1.43 Terumo BCT....................................................................1.98B Thermo Fisher Scientific................................................ 1.113 Tianjin Denny Tech Co..................................................1.63B Toray.................................................................................. 1.49 Turkish Society of Nephrology................................... 1.G12 Vifor Fresenius Medical Care Renal Pharma......2.22+2.23 Wichtig Editore..................................................................1P3 Wisepress....................................................................... 1.G18 WS Far Ir Medical......................................................... 1.63A w w w. e r a e d t a 2 01 2 . o r g 393 EXHIBITORS COMPANY...............................................................Booth No 49th ERA-EDTA CONGRESS E X H I B I T O R S LIST OF EXHIBITORS IN ALPHABETICAL ORDER Companies are totally responsible for the description below Abbott..............................................Booth 2.03+2.90+2.88 Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. Our commitment to kidney care and kidney patients stretches back more than two decades and extends across our pharmaceutical, nutritional, diagnostic and vascular divisions. We produce and market a wide range of products that benefit kidney disease patients in more than 130 countries around the world today, and have an industry-leading pipeline focused on brining continued innovation to patients tomorrow. Abbott information is available on the company’s websites at www.abbott.com EXHIBITORS Actual Way Medical Devices Via Actual......................................................... Booth 2.21 We are ActualWay®, a Portuguese manufacturer of care treatment medical equipment such as Therapy, Sampling/Blood Donation, Gynaecological, Multifunctional Chairs, Couches and many accessories. We have been increasing our distribution all over the world thanks to big efforts in promoting our products. Our sales strategy is based on building a long term relationship with all our partners providing quality and service. The best way to take care is to get our partners´ and patients´ satisfaction meeting their needs. We produce reliable, strong and comfortable products because we do care. Come and join us so that we can expand business together! www.actualway.pt 394 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S Alam Medical................................................ Booth 1.64A Alam Medical, a French company, develops, manufactures and markets high-tech medical products with particular focus on cardiovascular diagnosis with the Compliorr device. Complior AnalyseR measures aortic stiffness with the reference methodology: simultaneous carotid-femoral pulse wave velocity (PWV). Compliorr is the device used in most epidemiological studies which made PWV a recognized measurement of organ damage in the ESH guidelines. The latest distance methodology and the international PWV reference values are included in Compliorr Analyse for a rapid and easy interpretation of the results. With the Compliorr Analyse, it is possible to assess central pressure from a carotidogram. The measurement is handsfree and done during the PWV measurement with no additional time. With Compliorr Analyse, you have the reference gold standard PWV and carotid central pressure analysis in a single acquisition. www.complior.com Alere International.......................................... Booth 1.93 By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere Inc. (formerly Inverness Medical Innovations, Inc.) enables individuals to take charge of improving their health and quality of life. Alere’s global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women’s health. For more information about Alere, please visit at www.alere.com w w w. e r a e d t a 2 01 2 . o r g EXHIBITORS Alexion Pharma International......... Booths 1.26+1.116 Alexion Pharmaceuticals is a global biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Alexion is the global leader in complement inhibition, and has developed and markets Soliris® (eculizumab) as a treatment for patients with PNH and aHUS. Alexion is evaluating other potential indications for Soliris and is developing four other highly innovative biotechnology product candidates. www.alxn.com 395 49th ERA-EDTA CONGRESS E X H PI O B IS TT O E R S Allmed Medical . ............................................ Booth 2.27 Allmed Medical GmbH is a vertically integrated manufacturer, providing the latest world-class standards in dialysis products. Allmed’s leading dialyzer brand, Polypurer incorporates a new proprietary Polysulfone membrane, with outstanding performances in both efficiency and biocompatibility aspects. The membrane is unique for its unprecedented Micro-Undulation Technology. Allmed and its partners are committed to offer customised solutions to professionals and patients in Hemodialysis. Capitalizing on its long experience in the field of hemodialysis, Allmed is able to give personalised service and assistance to its customers. www.allmedgrp.com Amgen Europe................................................... Booth 2.48 Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980 and the originator of recombinant ESAs, Amgen was one of the first companies to realize the new science’s promise by bringing novel medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses. With a broad and deep pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives. June 2011 marks 10 years since the launch of Aranesp® (darbepoetin alfa) and 5 years since the introduction of the world’s firstgen. calcimimetic, Mimpara®. We invite you to come and celebrate with us on booth 2.02, level 2. www.amgen.com EXHIBITORS Arbor Research............................................... Booth 1.G7 Arbor Research is a not-for-profit research organization based in Ann Arbor, Michigan, USA, conducting large studies in epidemiology and public health. With particular expertise in biostatistical analysis, clinical practice, the management and integration of large data sets, economics, and public policy, Arbor Research engages in health outcomes research on chronic disease and end-stage organ failure, currently including the international Dialysis Outcomes and Practice Patterns Study. www.dopps.org 396 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S Asahi Kasei Medical Europe.............. Booths 1.42+1.47 Asahi Kasei Medical is a world leader in research, development, and production of devices and systems for blood treatment and purification based on advanced membrane separation and adsorption technologies. It serves the global market with haemodialysis, therapeutic apheresis, and blood transfusion products. Information about Asahi’s membranes, adsorbents and full range of products can be found on our website at: www.asahikasei-medical.com Atcor Medical................................................ Booth 1.G23 AtCor Medical’s SphygmoCor® systems, featured in over 2000 published studies, are the global gold standard for noninvasive central blood pressure/arterial stiffness assessment. Major studies have found: -- Elevated central pressure is a superior independent predictor of CV risk -- 70% of patients with high normal blood pressure had central pressures equivalent with those of patients with Stage 1 Hypertension --Patients with central pulse pressure ≥ 50mmHg are at significantly higher risk for cardiovascular events. Visit us for a complementary central pressures assessment. www.atcormedical.com w w w. e r a e d t a 2 01 2 . o r g EXHIBITORS Atlantic Biomedical........................................ Booth 2.04 Atlantic Biomedical P. Ltd. is an overriding organization incorporated in the year 2008 by the joint efforts of Mr. Ravi Vazirani & Mr. Sunil Vazirani in the domain of dialysis related products and services. Atlantic Biomedical P. Ltd. is engaged in the manufacturing of medical equipments whereas Atlantic Pharmaceuticals (incorporated in the year 1987) is engaged in the manufacturing and marketing of licensed drug products. Ours is an ISO 13485-2003 certified company and have distinction of being the first manufactures of Dialyzer Reprocessing Machine RENACLEAN®, Cold Sterilant RENACLEAN®, Hot Disinfectant RENASTERIL®, Acid Concentrate CITRACON®, Calcium Acetate LOW-PHOS® tablets in India. Apart from what we are one of the leading Dialysis Fluid Manufacturers in the country like Bicarbonate, Acetic, Na, K, Calcium Free & Citric Acid Concentrate. 397 49th ERA-EDTA CONGRESS E X H I B I T O R S Awak Technologies........................................ Booth 1.68 Awak is developing the world’s first wearable dialysis machine targeting ESRD patients. Our Vision is to create a new paradigm in renal dialysis. It is different from current dialysis machines in the market, as it provides patients with freedom during their treatment. With Awak weighing only 1kg and the ability to regenerate spent dialysate, it now substitutes the major functions of a kidney by constantly removing toxins and waste materials, and excessive fluid from the patient’s body. This new technology not only have and sustain ESRD patients, but also enhances their lives, bringing them comfort and convenience. www.awak.com B.Braun Avitum............................................... Booth 2.12 Always with Passion. B. Braun Avitum is a leading provider of dialysis care products. The B. Braun Avitum product range includes dialysis machines and dialysis consumables for chronic and acute dialysis as well as a comprehensive product portfolio for special blood cleansing processes to treat conditions such as lipid metabolic disorders. B. Braun Avitum manufactures top quality dialysis machines, dialyzers (e.g. xevonta) and disposables. www.bbraun.com EXHIBITORS Bain Medical Equipment . ............................ Booth 1.22 Bain Medical Equipment (Guangzhou) Co., Ltd. was established in 2003 specialized in researching, developing, manufacturing and distributing of medical equipment and medical macromolecule products. We have strong technical strength, comprising an experienced team with expertise and high technologies from Europe and Japan. Having introduced advanced manufacturing and inspecting facilities, we are able to perform dynamic monitoring covering full process of materials purchase, production and finished products. Presently Bain specializes in manufacturing and distributing hemodialyzer, tubing sets for hemodialysis, disposable AV fistula needle sets, and tubing disposables for hemodialysis, all with leading technologies in the industry. ISO9001, ISO13485, CE and CCC certification passed. www.bainmedical.com 398 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S Baxter Healthcare............................................ Booth 2.39 Baxter International Inc’s Renal franchise is a leader in renal home therapies through its products for Peritoneal Dialysis (PD), providing PD solutions including Low Glucose, devices, related supplies and services to help end-stage kidney disease patients perform dialysis treatment in the home. Baxter also distributes products and provides support services for Continuous Renal Replacement Therapy (CRRT), an acute, hospital-based therapy, and distributes products for In-Center Hemodialysis (HD). Baxter, in partnership with DEKA Research and Development Corporation, is developing innovative technologies aimed at employing a compact design and convenient use for patients, such as a new automated PD cycler and High Dose HD technology platform. www.baxter.com EXHIBITORS Bellco..............................................................Hall Maillot Bellco, with over 40 years’ experience, operates worldwide offering therapies and systems for blood purification in Dialysis, Intensive Care and Cardiology, with increased focus on personalized treatments for critical patients. Bellco stands out for the Collaborative Research in the treatment of renal failure, multiple organ failure, sepsis and congestive heart failure, with the goal of sharing know-how and innovation with the scientific and medical communities. Upon these premises, Bellco provides its contribution to the Collaborative Research Club. Biocompatibility, cardiovascular stability, nutritional state and clearance efficiency are the leading challenges for Bellco’s Therapeutic Dialysis: constant research and innovation for personalised solutions. Complex clinical conditions, such as those of patients in Intensive Care, undergoing surgery, with multiple traumas, sepsis, multi-organ failure, cardiopathy, affected by immune pathologies and intoxication, require integrated therapeutic approaches capable of assuring versatility, functionality and effectiveness. The Bellco’s all-embracing offer for all these pathologies provides a completely new outlook on Acute patients. www.bellco.net w w w. e r a e d t a 2 01 2 . o r g 399 49th ERA-EDTA CONGRESS E X H I B I T O R S Binding Site...................................................... Booth 1.05 Visit stand 1.05 to learn more about polyclonal Freelite® serum free light chain (FLC) measurement in Acute Kidney Injury: “Clonal serum FLC can be measured with high sensitivity and specificity and used to rapidly screen for cast nephropathy. A sustained decrease in serum FLC levels within 3 weeks of starting treatment is associated with renal recovery”- Cockwell 2010. Collect your copy of this paper and the Kidney in plasma cell dyscrasias book International Myeloma Working Group and NCCN® guidelines recommend use of serum free light chain assays in the initial diagnostic workup of Multiple Myeloma and related disorders. www.bindingsite.co.uk Bionic Medizintechnik................................ Booth 1.103 Bionic Medizintechnik with HQ in Friedrichsdorf near Frankfurt, Germany, is a specialised manufacturer of products for dialysis since 30 years. Our product range includes a large selection of dialysis fistula needles, dialysis catheters, therapy chairs and beds. Bionic dialysis fistula needles are leading in Europe and are setting new standards in quality and puncture characteristics. Bionic therapy chairs and beds are leading in performance and ergonomics. www.bionic-jms.com EXHIBITORS BioPorto Diagnostics................................... Booth 1.G21 The ability to diagnose acute kidney injury (AKI) at an early time point is essential for improving the management and outcome of patients at risk of AKI. The novel biomarker NGAL has been shown to outperform current kidney status markers such as serum creatinine and cystatin C because it responds much earlier and shows a proportionate response to injury. With The NGAL Test™ your hospital lab can measure NGAL in both plasma and urine samples on fully automated analyzers. www.bioporto.com 400 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S Bodystat........................................................... Booth 1.G6 BODYSTAT are established as one of the global leaders in body composition analysis using Bioelectrical Impedance Analysis (BIA) technology. Complex changes occur in body composition and fluid status during illness, renal failure and haemodialysis. Bodystat’s Multi-Frequency BIA technology can be used to assist in achieving Dry Weight, quickly, conveniently, without significant training or education. See validation paper: Calf Bioimpedance Ratio Improves Dry Weight Assessment and Blood Pressure Control in Hemodialysis Patients. (Yi-Lun Zhou et al) Am J Nephrol 2010;32:109-116. www.bodystat.com Covidien............................................................ Booth 1.37 Covidien Vascular Therapies delivers a broad range of innovative non-invasive and endovascular devices for the treatment of vascular disease worldwide. Covidien currently offers clinically proven solutions for the prevention and treatment of deep vein thrombosis (DVT), chronic venous insufficiency, dialysis access, peripheral vascular disease, and neurovascular disease. Covidien develops new technologies, products and programs focused on improved patient outcomes and safer, more efficient healthcare practices throughout the continuum of care, across the globe. www.covidien.com w w w. e r a e d t a 2 01 2 . o r g EXHIBITORS Cybernius Medical.......................................... Booth 1.16 Cybernius Medical Ltd. is committed to the effective utilization of proven leading edge technology in the Health Care Industry. CML focuses its resources on the development, sale, deployment and support of the cyberREN® Renal Patient Care Management System for Nephrology. cyberREN® is a comprehensive Electronic Medical Record (EMR), Clinical Data Analysis, and Reporting System for Nephrology. cyberREN® is marketed and serviced by a team of dedicated clinicians and information technologists. Also Available: cyberREN OFFICE, (Nephrologist Private Practice System) and cyberFUNDS (Billing for Nephrology) To contact a representative in your area call: 1.800.276.8128 or visit our website at www.cyberren.com - email: info@cyberren.com 401 49th ERA-EDTA CONGRESS E X H I B I T O R S Culligan............................................................. Booth 1.94 Culligan International is one of the longest-established, best-known companies in the water treatment sector, founded in Chicago in 1936. Culligan is a worldwide organization whose mission is water quality improvement. We have an extensive licensee distribution system in over 100 countries. Culligan manufactures a complete line of systems for drinking water, as well as for many demanding industrial applications: ultrafiltration, electro-deionisation, pharmaceutical industry, haemodialysis, food and beverage industry, electronics industry, which requires the highest purity water possible. www.culligan.it Debiotech.......................................................... Booth 1.91 Debiotech is a Swiss, independent, high-tech medical device development company founded in 1989. Its core competence lies in the identification of breakthrough technologies and their development to market approval. These devices are then licensed to major international pharmaceutical and medical device companies. DialEaseTM is the lightest and smallest APD Cycler ever conceived for Homecare Peritoneal Dialysis, with an innovative approach to offer more Quality and Safety for Patients, with full remote control by Nephrologists, while simplifying daily use and transportation. www.debiotech.com EXHIBITORS Diaverum.......................................................... Booth 2.19 At Diaverum, our mission is to improve the quality of life for renal patients by revitalising them both physically and emotionally. Being one of the world’s leading renal care providers, Diaverum offers a holistic approach, from preventive and early stage renal care to all renal replacement therapies. As a product independent provider – the largest in Europe - we are able to focus soley on caring for the individual needs of our patients. Our experience in renal care dates back 20 years, when the first dialysis clinic was established, previously under our former name Gambro Healthcare. Today, 6,800 employees care for more than 20,000 patients in 17 countries in Europe, Latin America, Middle East and Australia. The corporate office of Diaverum is located in Munich, Germany, the head office is in Lund, Sweden. For more information visit www.diaverum.com. 402 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S Dirinco............................................................... Booth 1.32 The Dirinco Group is a Dutch and Swiss based company, with innovations mainly in the field of vascular access, hemotology, oncology and nephrology. CitraLock™ - catheter lock solution, anti-clotting and antimicrobial is one of the innovations from Dirinco. The products are in a vial or prefilled syringe and is based on tri-sodium citrate and can be safely used in all catheters! Please find the different catheter lock solutions like Citra-lock and CitraFlow by Dirinco on www.citra-lock.com Dustri Verlag.................................................... Booth 1.P1 Clinical Nephrology – Dustri Verlag For almost 40 years, Clinical Nephrology, a DustriVerlag publication, has been one of the leading journals in its field. Under the editorship of H.H. Malluche (Lexington, KT, USA) – supported by 18 Section Editors – the editorial quality has improved significantly due to a remarkable increase of manuscript submissions. Also ask for our special fellowship program. The book program of Dustri-Verlag was extended by “Seyffart’s Directory of Drug Dosage in Kidney Disease” in 2011 www.clinnephrol.com - www.dustri.com w w w. e r a e d t a 2 01 2 . o r g EXHIBITORS DV Care............................................................. Booth 1.29 DV Care., a wholly owned subsidiary of a United States based FORTUNE 500® company that is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of December 31, 2011, the organization operated or provided administrative services at 1,809 dialysis facilities in the United States, serving approximately 142,000 patients. The company also operated 11 outpatient dialysis centers located in three countries outside the United States. In line with the overall corporate mission, DV Care strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. The organization also supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For inquiries dial +310 536 2478 or 403 49th ERA-EDTA CONGRESS E X H I B I T O R S send an email to global@davita.com. DWA.................................................................. Booth 2.81 DWA - The Dialysis Water Specialists DWA has specialised in innovative solutions for the supply of high purity water to dialysis centres - worldwide. DWA develops systems for production of ultrapure permeate and its distribution right to the dialysis machine. Our expertise in water treatment covers all aspects from the pre-treatment stages, through reverse osmosis, ultrafiltration and hot cleaning systems, right up to the supply connection through to the dialysis machine. In addition, DWA offers systems for production and distribution of acid and bicarbonate concentrates. DWA is partner for dialysis centres - worldwide! www.dwa-online.com EXHIBITORS E.D.P. La Traccia........................................... Booth 1.G22 Cooperativa Edp La Traccia is: - a Research Laboratory for the ICT and Robotic sectors; - certified ISO 9001:2000 for the design, development, maintenance, assistance and sale of software and hardware products; designing and implementation of professional training projects; - certified ISO 27001 for specialized consultancy and expert technical assistance of software and hardware products, management of LAN networks and internal infrastructures; - a recognized Training Centre by the Basilicata Region. La Traccia, thanks to state-of-the-art technology and the large number of solutions in place with customers distributed all over Italy, is the Italian market leader for the supply of: - software applications for Nephrology and Dialysis hospital wards (installed in over 210 Italian hospitals); - software products for the Management of Organ Transplant Waiting Lists (installed in 9 Italian Regions); - software application to manage the Regional Dialysis and Organ Transplant Register (installed in 8 Italian Regions); - software application for the management of “Register of Medical and Dental Surgeons (installed in 20 Italian Provincial Orders); 404 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S The company has furthermore: - maturated significant experience in the computerization of Hospital Patient Records, with vertical integration for the various specializations; - carried out research projects: the most important of which was relative to Theme 7 of the National Research Project of Telemedicine funded by the M.I.U.R. (Monitoring of Dialysis and Perinatal Outpatients). www.latraccia.it EffeEmme......................................................... Booth 2.44 We have been producing bloodlines and accessories for haemodialysis treatments for 30 years. Our company structure, always evolving, allows us to promptly react to the increasing requirements of the market. Our customers have confidence in us as a reliable partner with a track record of long lasting cooperation. On time delivery and service are our standard. www.effeemme.it EG Medical Systems....................................... Booth 1.62 EG-Medical Systems manufactures and supplies regionally a rich span of medical disposables and devices including Medical, Surgical & Dialysis disposables e.g. Blood Lines & Fistula Needles, Urine & Drainage bags, Infusion & Transfusion sets, CVP, at top quality level since year 2000. The company has been merited ISO 9001, ISO 13485, CE 0120 www.eggroup-eg.com w w w. e r a e d t a 2 01 2 . o r g EXHIBITORS Elsevier Masson............................................... Booth 1.P4 Elsevier Masson is the first French speaking medical and paramedical publisher. Its three mains activities are the publishing of books for initial or continuing education, of EMC treaties, and the publication of medical and paramedical journals. The university books, written by the best teachers, form all the profession of health for two centuries. The books of continuous medical education, written by the best experts hospitalo-university and intended for the professionals of health, the general practitioner, the specialists, the pharmacists, the dental surgeons, the veterinarians and in the all paramedical, insure the permanent update of their practical knowledge. www.elsevier.com 405 49th ERA-EDTA CONGRESS E X H I B I T O R S Emodial............................................................. Booth 2.42 Emodial Srl was established in 1982 in Ferrara, Italy, and since that time has been operating in the field of haemodialysis providing a complete range of products for dressings and becoming one the leading companies in the field. Our products have been designed on the basis of the suggestions and co-operation offered by various Dialysis Centres of relevant Care Units, which felt the need for new products suitable for the medications and absorption of wound exudates, to be used as an alternative to the traditional cotton or non-woven pads. Our main products can be referable to the following typologies: -pads, plasters and bandages for fistula; -start-stop kits for haemodialysis, catheterism and peritoneal dialysis -devices for the disposal of used fistula needles; We have also recently developed a new range of patented products based on silver which helps to control the risk of infections of the vascular access. www.emodial.it EXHIBITORS ERA-EDTA 2013 Congress Istanbul......... Booth 1.G14 The ERA-EDTA congress that will be held in Istanbul in 2013 (May 18-21) will be the 50th annual congress of this association. In order to mark this important anniversary the scientific programme will be richer than usual, with more pathways and more courses. The venue for this event will be the recently built Istanbul Congress Center, completed in September 2009 and situated in Harbiye, on a hilltop overlooking the Bosphorus. Information will be available at the booth and in the website www.era-edta2013.org 406 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S Etropal............................................................... Booth 1.11 Etropal is a company with over thirty years of experience in research, development and manufacturing of medical devices for single use, meeting all the requirements of a contemporary medicine in this field. The company offers an extensive product line that spans medical devices for haemodialysis-dialysers, blood lines, fistula needles and other medical devices. The company operates a fully integrated ‘quality assurance system’ according to ISO 9001 and ISO 13485. www.etropal.eu M E D I C A L E Q U I P M E N T Euroclinic......................................................... Booth 1.G5 Euroclinic SpA is a leading manufacturing company specialized in the production of high-tech Medical Equipments presently distributed and appreciated in more than 27 foreign countries mainly for the elegant design and the technical reliability. The continuous Research and Development activity is focused on state-of-art lines of Units and Chairs for ENT, Podiatry, Gynaecology, Diagnostic & Imaging fields. A new product for Dialysis/Oncology has been developed in the last year thanks to a highly experienced team of engineers. www.euroclinic.it w w w. e r a e d t a 2 01 2 . o r g EXHIBITORS FedAirg............................................................. Booth 1.G9 Federg is an initiative aimed at establishing a European federation of patients with renal genetic diseases (RGD). Federg will gather European associations devoted to RGD, thus providing enough voice and room to the smallest ones and given them more empowerment within the European community: better inform, help and advocate, support research, better represent patients and foster the development of national associations. AIRG-France, a French association, focussing on Renal Genetic Diseases (RGD), has taken the initiative of FEDERG and was promptly joined by other AIRGs in Europe (Belgium, Switzerland and Spain) and other RGD associations. It has received the support of ERA-EDTA, ESPN and Eurordis. The project will be developed in 2012, information can be found on the following sites: www.federg2012.wordpress.com - www.airg-france.fr 407 49th ERA-EDTA CONGRESS E X H I B I T O R S French Society of Dialysis.......................... Booth 1.G11 The Société de Francophone de Dialyse (SFD) is a French speaking association of nephrologists founded in 1993, currently having about 800 members throughout the French speaking countries. The French speaking Society of Dialysis aims to improve formation and collaborative work in dialysis through an annual Joint Meeting with the Société de Néphrologie, and by organizing annually two or more specific CME courses in collaboration with the Moroccan Society of Nephrology and the Tunisian Society of Nephrology. SFD contributes further to research on dialysis and end stage renal disease by funding clinical and fundamental research programmes. Publication media are the journal «Néphrologie & Thérapeutique», the e-learning website www.rein-eform.org and the society own website www.sfdial.org. Please visit the booth to learn more on SFD and join us. French Society of Nephrology..................... Booth 1.G8 The Société de Néphrologie (SN) is a French speaking association of nephrologists founded in 1961, currently having about 1500 members. Its publication is Néphrologie & Thérapeutique. SN contributes to the dissemination of knowledge by its annual Joint Meeting with the Société Francophone de Dialyse, and by organizing annually a specific CME course. SN contributes to research in nephrology directly by funding research projects both for laboratories and individual researchers as post-doctoral trainings. Visit the booth to learn about the next annual Joint Meeting: Geneva, October 2-5, 2012. More information at: www.soc-nephrologie.org EXHIBITORS Fresenius Kabi................................................. Booth 2.68 Fresenius Kabi is dedicated to the therapy and care of critically and chronically ill patients inside and outside the hospital by providing intravenously administered drugs, infusion therapies, clinical nutrition and related medical devices. The company applies its long-standing expertise in pharmaceuticals and medical devices to support clinical staff and care professionals in the best therapy of patients. For more information about Fresenius Kabi, visit the company’s Web site at www.fresenius-kabi.com. 408 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S Fresenius Medical Care.................................. Booth 2.68 Fresenius Medical Care is the world’s largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2.1 million individuals worldwide. Through its network of more than 2,890 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to more than 233,100 patients around the globe. Fresenius Medical Care is also the world’s leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. With the new business unit Renal Pharma Fresenius Medical Care is now complementing its leading dialysis technologies, products and services with renal pharmaceuticals. We will continuously build up and provide a comprehensive range of drugs and drive their integration into innovative treatment platforms to achieve improved therapeutic outcomes in dialysis patients. www.fmc-ag.de Gambro............................................................. Booth 2.46 Gambro has been pioneering solutions for patients in Chronic and Acute Therapies for more than 47 years. With you and your patients as our inspiration, we are constantly seeking ways to advance the science of dialysis. The result is innovative products & therapies that will support your success. Gambro - Your home of INNOVATION - You inspire, We innovate. www.gambro.com w w w. e r a e d t a 2 01 2 . o r g EXHIBITORS Gardhen Bilance............................................Booth 1.98C Gardhen bilance is a company presents in most parts of the world thanks to its exclusive distributors and to high quality of the products. The beds and chairs with or without scales are presents in all privates dialysis centers and dialysis hospital departments. Gardhen bilance manufactures medical devices and weighing systems in conformity to ISO 9001:2008, ISO 13485:2003, 93/42/CEE. Design, comfort, robust construction is our mission www.gardhenbilance.it 409 49th ERA-EDTA CONGRESS E X H I B I T O R S HemoSapiens................................................ Booth 1.G24 Hemo Sapiens® Inc is a high-tech medical company specialized in the development of non-invasive medical devices designed for the real-time assessment, monitoring and management of complete hemodynamics. Hemo Sapiens® ® flagship product is Hotman® - a PC-based system for automatic, noninvasive and hands-free acquisition of a patient’s blood flow and left-ventricular parameters using Company’s proprietary very-low current TEB (Thoracic Electrical Bioimpedance) providing the unique Integrated Hemodynamic Management solution. www.hemosapiens.net Herco Wassertechnik...................................... Booth 2.64 Herco developed and offers complete water treatment solutions for dialysis applications. Products are: Water softeners, filters, reverse osmosis, ring main, bed head media panels, central concentrate distribution. Reverse osmosis units for haemodialysis purposes according to MDD, TÜV approved. www.herco-wt.de EXHIBITORS Hospira UK....................................................... Booth 2.83 Hospira is a global speciality pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As a world expert in speciality generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Illinois, United States and has more than 14,000 employees. The head office for Hospira in Europe, Middle East and Africa is in Royal Leamington Spa, UK. Learn more about Hospira at www.hospira.com. 410 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S EXHIBITORS IFKF - International Federation of Kidney Foundation................................... Booth 1.G4 Improving Kidney Health Worldwide Our Long Term Commitment: Improvement in prevention, quality of life and health for all people with or at risk of kidney disease, regardless of race, color, creed, gender, sexual orientation or social class. Our Mission: To foster creation, growth, and international collaboration between local kidney foundations and to enable and help empower member organizations to attain our goals. To represent at the international level the needs of people with, or at risk of kidney disease. Our worldwide community of kidney foundations constitutes a unique and potent force to bring a global instrument for the prevention, detection and treatment of kidney disease. Our Tools: Annual meeting, regional meetings, Kidney Foundations Partnership Program KFPP, educational programs and seminars for health care workers on nutrition and other topics. SeeKD® program for detection and prevention of CKD. Joel D Kopple Award for outstanding performance, IFKF Innovation Challenge for innovative ideas for compliance with medicine use. World Kidney Day, in cooperation with ISN. www.ikfk.net w w w. e r a e d t a 2 01 2 . o r g 411 49th ERA-EDTA CONGRESS E X H I B I T O R S Immundiagnostik........................................ Booth 1.G19 Closing the Gaps in Laboratory Diagnostics Immundiagnostik AG, founded in 1986, is a globally operating diagnostics company represented in over 30 countries. We focus on the development and production of innovative immunoassays (ELISA, EIA) and other analytical detection methods (e.g. HPLC, LCMS/MS and PCR) for medical routine and research. Our mission is to provide effective tools for prevention, differential diagnosis and therapy monitoring in the areas of gastroenterology, cardiovascular diseases, disorders of the skeletal system and oxidative stress. The product portfolio is completed by a broad range of antibodies and antigens. Our business relations include contract analyses for diagnostic laboratories and academic research institutions, esp. in context with clinical trials. Multiple cooperations with the pharmaceutical industry and a tight network with scientific organisations are the basis for a successful product development. Securing progress: Our comprehensive range of products is continuously refuelled by a rich pipeline of proprietary developments. With a headcount of more than 60 employees, Immundiagnostik’s headquarter is located in Bensheim, south-western Germany. www.immundiagnostik.com EXHIBITORS Infomed............................................................. Booth 1.45 With 20 years of experiences around the world, Infomed has comforted its leadership as a provider of extracorporeal blood purification devices offering complete solutions with many advanced medical treatments such as: Continuous hemofiltration and hemodiafiltration, plasma exchange, cascade filtration, double filtration plasmapheresis (DFPP), blood and plasma perfusion and CPFA (Coupled Plasma Filtration Adsorption). Infomed provides a complete range of machines and all associated disposables such as pre-assembled kits, filters and adsorption cartridges. www.infomed.biz 412 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S Innovative Blood Purification...................... Booth 1.50 We are an integrated provider of hemodialysis medical disposables products, such as Dialyzers, Bloodline Sets & AV Fistula Needle Sets and Dialysate Solution, for individuals undergoing dialysis due to chronic kidney failure. We manufacture and distribute our hemodialysis medical disposables to dialysis clinics all over Eastern Europe, Middle East and Asia Pacific. Through our jointly-owned German subsidiary, International Dialysers Technologies GmbH (“IDT”) that own and manage a dialyzer assembly plant in Germany, we were able to develop our Dialyzer under our own brand name “Innovative”, we also manufactured our products via our OEM Partners. All our products are certified with CE and ISO 13485. www.innovative-bp.com Intermedt Medizin & Technik..................... Booth 1.97 Intermedt was founded in 1997 and is a specialist for dialysis concentrate production systems. The fully automatic dry concentrate system ECOMix in combination with ECOCart allows the production of concentrate in your own dialysis center. We don’t transport any Water only the dry salts in large cartridges. The “ECOCart” is a reusable cartridge and contains all raw materials in dry form for the production of 750l acid concentrate. www.intermedt.de w w w. e r a e d t a 2 01 2 . o r g EXHIBITORS ISN International Society of Nephrology.Booth 1.G3 The International Society of Nephrology (ISN) is a global not-for-profit society dedicated to its philanthropic mission of advancing the diagnosis, treatment, and prevention of kidney diseases in the developing and developed world. Since its foundation in 1960, ISN has pursued the worldwide advancement of education, science and patient care in nephrology. The Society represents a wide international network and provides an efficient platform for timely scientific exchange, debate and dissemination between healthcare professionals around the world. ISN has over 9,000 professional members from more than 126 countries. In addition, ISN closely collaborates with over 70 national and regional nephrology societies around the world, representing about 20,000 professionals. www.theisn.org 413 49th ERA-EDTA CONGRESS E X H I B I T O R S Janssen............................................................... Booth 2.37 Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology (e.g. multiple myeloma and prostate cancer), immunology (e.g. psoriasis), neuroscience (e.g. schizophrenia, dementia and pain), infectious disease (e.g. HIV/AIDS, Hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g. diabetes). Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency. More information can be found at www.janssen-emea.com JiHua Medical Apparatus and Instruments..Booth 1.G17 Jihua Medical Apparatus and Instruments Co.,LTD GuangZhou (Jihua Company), established in 2000. We are specialized to research, produce and sell hemodialysis equipment and some relative blood purification devices such as electric dialysis chair, RO water unit, dialyzer reprocessing machine, hemoperfusion machine, blood pump, dialysate powder stirring machine ect. Our dialysis equipments have gained the CE mark and company are certified with ISO 9001&ISO 13485 in 2007. So far, Jihua products are selling in the whole provinces in china and successfully exported to more than 60 countries in Asia, South America, Europe and Africa countries. Our vision is to contribute to the growth of international blood purification career and to be the leadership on nephrology with the most professional and sustainable development ability and outstanding corporate culture. www.ji-hua.com EXHIBITORS Joline.................................................................. Booth 1.34 Joline GmbH & Co. KG is an internationally operating company in southern Germany with a strong focus on quality standards and innovative, medical technologies. Since our foundation in 1999 it has been our intent to develop and produce high-quality products in the field of Vascular Access. All our FlowFamilyProducts are CE marked and exclusively “Made in Germany”. www.joline.net 414 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S Karger................................................................ Booth 1.P6 S. Karger Medical Publishers is a publishing house whose publications in the field of nephrology include 6 scientific journals, e.g. ‘Nephron’, and the renowned book series ‘Contributions to Nephrology’. New releases presented include the titles Hepatitis C in Renal Disease, Hemodialysis and Transplantation’, ‘On-Line Hemodiafiltration: The Journey and the Vision’ and ‘Controversies in Acute Kidney Injury’. Publications are accessible online, with full-text search of articles, pay-per-view options and many other services. Founded 122 years ago, this Swiss-based family-owned publishing house combines highly sophisticated production technology with customized services for its authors, editors and readers. www.karger.com/nephrology Kawasumi......................................................... Booth 2.05 Since 1957, Kawasumi Laboratories has been providing nephrologists worldwide dialyzers, blood tubing lines, and AV fistula sets. We are renowned for our consistently high quality. Kawasumi is a leading supplier of advanced dialyzers. The RENAK PS dialyzer will delight you with its high performance. Blood tubing lines and AV fistula sets are among the best known and most trusted in the world. Kawasumi also provides a wide variety of therapeutic plasmapheresis products. Visit the Kawasumi booth and see how we can help you provide excellent therapy! www.kawasumi.jp EXHIBITORS Kimal................................................................. Booth 1.01 w w w. e r a e d t a 2 01 2 . o r g 415 49th ERA-EDTA CONGRESS E X H I B I T O R S Labor Limbach.............................................. Booth 1.G20 Limbach Laboratory is the market leader in medical laboratory testing in Germany as well as the largest provider of diagnostic services to nephrology departments, dialysis units and nephrologists in private practices. It was founded 1979 in Heidelberg by Dr.med. Hans-Jakob Limbach. A central focus of its activity was the determination of parathyroid hormone and other special hormone testing. Today, Limbach Laboratories Group covers all diagnostic fields of laboratory medicine within 29 affiliated laboratories countrywide. Furthermore, it has built up a network of laboratory services throughout Europe. Last but not least, Limbach Laboratory has an active R&D program in the field of test development, particularly for markers of bone metabolism. www.labor-limbach.de Lauer.................................................................. Booth 2.12 LMW/Aquaboss® stands for innovation, quality and cost efficiency. Since 1989 Lauer is developing, manufacturing and marketing RO systems, accessory equipment for dead space free supply of purified water and other liquid media used in dialysis. During the years Lauer has introduced several patented technologies inrenal market, e.g. impulse backwashing and secondary ring mains. www.aquaboss.com EXHIBITORS Likamed............................................................ Booth 2.66 We are an expert for therapy and treatment chairs and beds in the medical field and we are more than 30 years successful in the market. Our long lasting experience und strict quality check, guarantee that the label “Made by Likamed” stands always for highest quality. Our products and our company are certificated for DIN EN ISO 13485. www.likamed.de 416 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S Medcomp.......................................................... Booth 1.71 Medcomp, well known for its wide range of cuffed and uncuffed venous access catheters will be offering new information on: 1. Videos on new dialysis catheter implantation technique 2. Catheter Locking Solutions 3. Long Term Dialysis Catheters 4. Acute Access Blood Purification Catheters www.medcompnet.com Medica Italia.................................................. Booth 1.100 Mdica S.p.A. is located inside the biomedical district of Mirandola near Modena Italy. Medica was established in 1985, and since then it has been operating in the manufacturing and sales of medical devices specifically in the field of blood purification and recently also in water purification, providing an extensive range of products. Blood lines, Dialysers, Electro medical machines and associated disposables and Infusion disposables are at the core of Medica manufacturing. Since the early 90’s Medica continues to work on developing and manufacturing of hollow fiber membranes for both medical and water purification applications. The development and manufacturing of these technologies is primarily in house. www.medica.it EXHIBITORS Medikit.............................................................. Booth 1.35 Medikit is a leading manufacturer of vascular access medical devices based in Tokyo, Japan. Supercath brand hemodialysis fistula catheter, upgrade replacement of steel fistula needle, can reduce risk of damage with cannulation on AV fistulas and AV Grafts. Catheters with safety mechanism preventing accidental needle-stick injuries are also available. Come and visit us at stand 1.35. www.medikit.co.jp w w w. e r a e d t a 2 01 2 . o r g 417 49th ERA-EDTA CONGRESS E X H I B I T O R S Meditechlab & Suisse Med Technologies..... Booth 1.92 Suisse Med Technologies is a market leader in providing synthetic hollow fiber spinning lines and dialyser assembly lines. Our technology is designed to deliver optimal cost of goods while ensuring worldwide quality standards. We support our customers achieve their financial goals by offering a wide range of additional services such as go-to-market strategies, regulatory compliance, ISO-10993 compliant devices and qualified raw materials. Our subsidiary, Meditechlab, is a supplier of quality dialysis products that meet all international norms: ISO 9001 v-2000, ISO 13485 v-2003 and the European Medical Device Directive 93/42/ EEC (CE-mark). www.meditechlab.com www.SuisseMT.com MediTheque Bookshop................................. Booth 1.P5 Medvision....................................................... Booth 1.115 As an international developer of professional medical information systems, we are providing efficient and economical solutions for the treatment and care of sick people for over twenty years now. Our medical information systems are used in many doctor’s practices, outpatient clinics, hospitals, dialysis units, and medical care centres. Especially in the field of dialysis, we have made a name for ourselves with a market share of well over 60 % in Germany and a large number of customers in Europe and Asia. Our international OEM cooperation partners are the world leaders in dialysis. www.medvision.de EXHIBITORS MedXL............................................................ Booth 1.G10 MedXL designs and manufactures quality healthcare products since 1992 and is a leader in setting the standards for safe, secure and efficacious prefilled syringe products. Our prefilled CitraFlow™ syringes containing 4% sodium citrate are currently used in many countries as an alternative to heparin for locking catheters. CitraFlow™ is a natural way to safely and effectively lock indwelling catheters. www.medxl.com 418 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S Membrana........................................................ Booth 2.20 Membrana is the largest independent membrane producer worldwide. Membrana is part of Polypore International Inc., a global high technology company specializing in microporous membranes. Membrana offers a wide range of capillary and flat sheet membranes, particularly for haemodialysis, blood oxygenation and plasmapheresis. Products include the haemodialysis membrane families of DIAPES® and PUREMA®. Membrana also manufactures a variety of membranes used for filtration in various industries and applications and the Liqui-Cel® contactors for gas transfer as well as the Liqui-Flux® modules for membrane filtration. www.membrana.com Miltenyi Biotec................................................ Booth 2.40 Miltenyi Biotec, a diversified biotechnology and medical device company, offers the CliniMACS® Cell Selection System. Based on MACS® Technology, it can be used for clinical-scale magnetic enrichment of cells. Another exemplary clinical application represents TheraSorb™ Therapeutic Apheresis, which selectively removes pathogenic substances from the blood by immunoadsorption. www.miltenyibiotec.com EXHIBITORS Mitsubishi Pharma Europe........................... Booth 1.10 Mitsubishi Pharma Europe is the European Headquarters of one of Japan’s largest pharmaceutical companies, Mitsubishi Tanabe Pharma Corporation. Based in London, Mitsubishi Pharma Europe is engaged in the clinical development of new drugs for the European markets. Mitsubishi Pharma Europe is conducting trials in Europe in the following therapy areas; cardiovascular, diabetes, CNS and renal conditions. The staff include regulatory, QA, clinical, biostatistics, medical information, pharmacovigilance, pharmaceutical technology and marketing. www.mitsubishi-pharma.eu w w w. e r a e d t a 2 01 2 . o r g 419 49th ERA-EDTA CONGRESS E X H I B I T O R S Nature PG......................................................... Booth 1.P2 Nature Publishing Group (NPG) brings you leading scientific and medical research. Our portfolio combines the continued excellence of Nature, its associated research and review journals, and over 50 leading academic and society journals in the life, physical and clinical sciences. Open access options are offered through the academic and society journals. NPG also provides timely news content and, through Naturejobs, scientific career information. Visit the NPG stand P02 to pick up your free sample copies of Kidney International, Nature Reviews Nephrology and other NPG journals, subscribe at the conference rate, or find out about advertising opportunities in any NPG title. www.nature.pg NDT-ERBP-NDT-Educational.................... Booth 1.102 Visit the ERA-EDTA booth to find information about the current activities, especially with regard to educational initiatives and to the European Renal Best Practice. ERBP’s main purpose is to help increasing the implementation of European nephrology recommendations and guidance and to enhance the quality of European and worldwide nephrology practice. ERBP has also created a set of patient information documents, in the belief that joint decisions, made together by physicians and well-informed patients, are fundamental to obtain the best treatment for each individual renal patient. EXHIBITORS At the booth you can also collect a printed copy of this congress’s Book of Abstracts, if you wish to have a paper version of it in addition to the one on CD. www.eraedta.org 420 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S Nephrokit......................................................... Booth 1.28 Nephtrokit was founded on December 2007, by Dr Mokhtar Chawki, skilled French Nephrologist on dialysis vascular access field. Based on the west suburb of Paris. Nephrokit is an innovative start-up who detains 4 validated patents for improving techniques of securing dialysis needle and reducing post dialysis time to clot of vascular access puncture sites. Nephrokit creates a breakthrough with new compressive device named “IRIS”® for dialysis access puncture sites. Non exclusive agreement for IRIS distribution was signed with Bellco France and Belgium, Gambro France. The device is also sold in dialysis kits by Mölnylcke in Europe. Nephrokit is also seeking to introduce Iris® in the domain of blood transfusion and is looking for partners in this field. www.nephrokit.com Nikkiso Europe............................................... Booth 2.75 The Nikkiso group has been providing technologies and products in order to meet demands of our customer, the society and the times we live in for more than half a century. The Nikkiso Europe GmbH is our European entity based in Hanover/Germany and responsible for production and distribution of our excellent technologies to the EMEA (Europe, Middle East, Africa) region. Beyond production and distribution Nikkiso Europe is able to develop extracorporeal technologies in our Research and Development department. Overall the Nikkiso Europe GmbH is our clear commitment to Europe and our customers there. Nikkiso Europe GmbH – Our flexibility is your efficiency. www.nikkiso-europe.eu R TYH w w w. e r a e d t a 2 01 2 . o r g EXHIBITORS Ningbo Tianyi Medical Appliance........... Booth 1.G15 Established in 1998, Ningbo Tianyi Medical is specialized in producing hemodialysis blood line, blood tubing sets for Continuous Renal Replacement Treatment (CRRT), Arterial venous fistula (AVF) needle, infusion set, blood transfusion set ect. The company has achieved ISO 13485 certification. Products are under CE and CCC certificates. “Quality first, scientific management, sincere and creditable service, customeroriented” is our business concept. www.tianyinb.com 421 49th ERA-EDTA CONGRESS E X H I B I T O R S Nipro Europe................................................... Booth 2.14 Nipro Europe has built its reputation on consistent high levels of quality and service in Europe. With its 5 Business Units, we distribute products for hemodialysis (Renal Care), hospital consumables (Hospital Products), blood glucose diagnostics (Diabetes Care), oxygenators and accessories (Cardiopulmonary) and medical glass products (Pharmaceutical Solutions). Our priority is building long-term partnerships with each customer. This is accomplished by providing superior quality and value throughout the business in addition to listening to customer needs and translating those needs into specific products and services. We constantly thrive to create and offer safe, high-quality products ensuring a better quality of life. www.nipro-europe.com NKF USA.......................................................... Booth 2.26 NKF USA offers the nephrology community the latest science and practical tools through our clinical practice guidelines, our free kidney screening programs, and our professional memberships. Learn more about KDOQI (T), KEEP (T), and our scientific journals: AJKD, ACKD and JRN. Find out about the new KDIGO (R) Guidelines that are being published this year including AKI, GN, Hypertension and Anemia. www.kidney.org EXHIBITORS Novartis Pharmaceuticals - Oncology......... Booth 1.31 Novartis is a global leader in oncology through strong research and development efforts and a broad portfolio of marketed products. Novartis Oncology discovers and develops innovative therapies including Glivec® (imatinib), Tasigna® (nilotinib), Afinitor® (everolimus), Zometa® (zoledronic acid), Femara® (letrozole), Sandostatin® LAR® (octreotide acetate for injectable suspension) and Exjade® (deferasirox). Novartis Oncology has one of the broadest and most comprehensive pipelines in the industry, currently with more than 20 novel medicines in development that target many therapeutically important proteins to help address the unmet needs of patients. www.novartis.com 422 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S NxStage Medical............................................. Booth 1.02 NxStage is leading a movement to transform renal care. To make it simpler. To make it portable. To expand treatment options for clinicians by overcoming traditional barriers. NxStage is finding itself at the forefront of dramatically improved renal care, thanks to innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. For more information visit www.nxstage.com Otsuka Pharmaceuticals Europe.................. Booth 1.60 Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: ‘Otsuka-people creating new products for better health worldwide.’ The Otsuka Group is comprised of 151 companies and employs approximately 40,000 people in 23 countries and regions worldwide. Otsuka is committed to focusing its research and development on innovative products and medical devices that address unmet medical needs, particularly in our specialist areas of renal, endocrine, gastro-intestinal and central nervous system disorders. Come and visit Otsuka Europe at Stand 1.60 on Level 1 at the Palais des Congrès de Paris, to learn more about Otsuka’s commitment to innovation and education in nephrology. www.otsuka-europe.com EXHIBITORS OUP Oxford University Press....................... Booth 1.72 Oxford University Press publishes some of most respected medical books and journals in the world including the Oxford Clinical Nephrology Series, and on behalf of the ERA-EDTA we publish the leading European journal Nephrology Dialysis Transplantation as well as CKJ (Clinical Kidney Journal). Visit our stand to browse books and to pick up free copies of the journals. www.oxfordjournals.org and www.oup.com. w w w. e r a e d t a 2 01 2 . o r g 423 49th ERA-EDTA CONGRESS E X H I B I T O R S PakuMed........................................................... Booth 1.36 PakuMed medical products gmbh is a German company founded in 1990 specialized in the development, manufacture and worldwide distribution of special medical products. Highly qualified medical competence, flexibility and close cooperation with our customers as well as best service are our strong points. Our product quality meets highest international standard with reasonable prices. Besides port catheter systems and accessories, innovative products for Hemodialysis and Apheresis are designed to meet the needs of our clients and complete our product range. www.pakumed.de Pharmacosmos................................................. Booth 2.13 PHARMACOSMOS develops and markets medicines for the treatment of iron deficiency. An independent pharmaceutical company with an ongoing R&D programme, Pharmacosmos’ goal is to improve treatment options for healthcare professionals and patients, by offering innovative treatments - Pharmacosmos works with exclusive partners in more than 50 countries worldwide. Pharmacosmos holds the marketing authorisation for Monofer® (iron isomaltoside 1000), a treatment for iron deficiency anaemia that offers patients with various iron needs the convenience of high dose iron in one visit. Seventy million doses of its second parenteral iron preparation CosmoFer® (low molecular weight iron dextran) have already been administered worldwide. www.pharmacosmos.com EXHIBITORS Physidia............................................................. Booth 1.65 Physidia is a French start-up. Its mission is the development and marketing of a daily hemodialysis system suitable for home use. The project was initiated in Lyon. In 2002-2005, the first tests systems were developed, which passed clinical trials. The S³ system will be marketed in 2013 in France. Main features are: premix dialysate; disposable lines and pumps; simplified operations; truly portable; versatile modalities: SDHD and HDF, practice inspired by peritoneal dialysis. www.physidia.com 424 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S PosterSessionOnLine Poster Virtual Gallery.................................... Booth 1.24 PosterSessionOnline is the world’s largest free-access medical poster resource - browse posters from ERAEDTA and more than 50 other congresses online at your leisure. Log on to the exciting new ERA-EDTA ONLINE POSTER FORUM to ask questions to the presenters, exchange ideas and network with colleagues. PosterSessionOnline has also provided all poster presenters with the opportunity to have their posters printed and delivered free of charge to the congress venue, picking them up from the Takeda Hospitality Suite during the meeting. Log in and join the debate in the Era-Edta online poster forum! www.postersessiononline.com Pronefro............................................................ Booth 1.96 Pronefro, Produtos Nefrológicos, S.A. company was founded in 1983 and has its headquarters in Maia, located around 10km Porto in north of Portugal. We have a large experience has manufacture since we have been working with medical devices and more specifically on dialysis products for over 25 years. We have in our range of products, bloodlines, AV fistulas needles, dialysers, catheters, therapy chairs, tubes for esthetical use, diabetics shoes and others accessories. We work mostly with distributors, our product quality meets highest international standards; the company is certified according to EN ISO 9001 and EN ISO 13845. For more information please see our website www.pronefro.pt w w w. e r a e d t a 2 01 2 . o r g EXHIBITORS Roche................................................................. Booth 2.52 Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. For more information: www.roche.com 425 49th ERA-EDTA CONGRESS E X H I B I T O R S Sandoz............................................................... Booth 2.73 Sandoz is a Novartis company with a reputation for quality going back to the 19th century. Present in 130 countries, our broad portfolio of affordable, high-quality medicines is available to 90% of the world’s population. Sandoz Biopharmaceuticals, a specialized business within Sandoz and Novartis, develops, produces and markets biopharmaceutical medicines and active ingredients worldwide, and enjoys close synergies across the value chain with other parts of the Novartis Group. Our decades of experience and significant investments have helped to position us as the pioneer and global leader in biosimilars. Our vision is to dramatically increase patient access to essential highquality biopharmaceuticals, by consistently advancing this global leadership position. www.sandoz.com Sanofi Aventis Groupe................................... Booth 2.79 Sanofi a diversified global healthcare leader, focused on patients’ needs Sanofi has core strengths in the field of healthcare with growth platforms: emerging markets, human vaccines, consumer healthcare, diabetes, innovative products and animal health. Through the acquisition of Genzyme, Sanofi has reinforced its footprint in biotechnology and rare diseases. Sanofi’ strategy is based on three key principles in order to deliver long-term sustainable growth: increasing innovation in Research & Development, seizing external growth opportunities, adapt to future challenges and opportunities. Sanofi: - More than 110,000 employees in 100 countries - 2011 net sales: €33.4 billion For more information: http://en.sanofi.com/home.asp EXHIBITORS Savient Pharmaceuticals................................ Booth 1.23 Savient Pharma Ireland Limited, a wholly-owned subsidiary of Savient Pharmaceuticals, is a specialty biopharmaceutical company seeking regulatory approval for KRYSTEXXA® in the European Union for the treatment of refractory chronic gout. KRYSTEXXA is available in the European Union through a Named Patient Programme and is currently the only FDA approved product for this indication in the United States. www.savient.com 426 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S Serumwerk Bernburg..................................... Booth 1.61 The Serumwerk Bernburg Group is an internationally - renowned producer and supplier of medicinal products and medical devices for human and veterinary use, based in Germany. The dialysis division is successfully active since 1998 in Europe, Middle East, Asia and North Africa. It offers a wide range of medical disposables for hemodialysis, e.g. VitaPES dialyzers, DiaCart & DiaBox bicarbonate cartridges, bloodlines and IV solutions. The company is focused on offering “Made in Germany” products to their worldwide clients. www.serumwerk.de Shire Pharmaceuticals.................................... Booth 2.01 Shire shares the vision of nephrology practitioners to place the best interest of patients at the heart of everything we do. The commitment of Shire is to enable people with life-altering conditions to lead better lives. In the field of nephrology, Shire supports research which improves understanding of renal science, kidney health awareness and education in renal units Products include Fosrenol®, a non-calcium, non-resin phosphate binder for the management of hyperphosphataemia. www.shire.com w w w. e r a e d t a 2 01 2 . o r g EXHIBITORS Sined.................................................................. Booth 1.57 Sined is an international medical computer solutions specialist, focused exclusively on the design, manufacture, installation and maintenance of remote monitoring, clinical record and data collection systems. Sined not only offers leading expertise as a pioneer of IT in nephrology, but is uniquely customer focused, committed to multi-brand compatibility that protects existing investments while providing fully-customised, scalable solutions that meet all a customer’s needs cost-effectively. Renowned for close customer service, Sined works with medical, IT and administrative staff to increase efficiency and reduce risks, simultaneously improving stock and finance management to achieve substantial savings and reliable revenue. www.sined.it 427 49th ERA-EDTA CONGRESS E X H I B I T O R S Soludia Maghreb............................................. Booth 2.65 Based in Morocco since 1998, Soludia Maghreb pharmaceutical laboratory is the leading manufacturer specialized in producing haemodialysis solution and powder products with a French licence. We provide excellent service to our customers. Our company is certified ISO 9001, ISO 13485, CE 120 labelled products, ISO 17025 in progress Our range of products : - Bicarbonate liquid, Bicarbonate powder for Gambro generator, for Fresenius generator and for Bellco generator. - 5 liters acid bag, acetate free acid, acid central with 1000 liters Tank. - water analysis for haemodialysis We have the big part of the Moroccan market shares. We have been exporting our products to West Africa. We started exporting our products to Europe. For additional information on our company and products, please log on our website www.soludia.ma Takeda Pharmaceuticals Europe.......... Booth P01+P02 Takeda is a research-based global pharmaceutical company committed to striving towards better health for patients worldwide through leading innovations in medicine. Takeda is renowned for its expertise and is dedicated to building on its success as a leader and preferred partner in the pharmaceutical industry. Takeda’s vision is to embody worldwide pharmaceutical leadership through innovation, culture and growth, guided by an unwavering commitment to significantly improve the lives of patients. www.takeda.eu EXHIBITORS TauroPharm...................................................... Booth 1.43 TauroPharm GmbH is a life science company specialized in antimicrobial medical devices. One of the company’s core interests is to offer a safe and effective technology for locking central venous access devices (catheters and ports). TauroLock™, a non-antibiotic lock solution, which is capable of dramatically reducing catheter related blood stream infections (CRBSI) is free of side effects. TauroLock™ is highly effective in eradicating bacteria and fungi and has been successfully tested on more than five hundred organisms, including multiresistant forms such as MRSA and VRE. It is to be used in dialysis, oncology, intensive care and parenteral nutrition. To improve catheter patency Tau- 428 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S roLock™ products contain 4% citrate and/or heparin (TauroLock™, TauroLock™-Hep100, TauroLock™Hep500) and/or urokinase (TauroLock™-U25.000). www.tauropharm.de Terumo BCT...................................................Booth 1.98B CaridianBCT and Terumo Transfusion have united to become Terumo BCT, a global leader in blood component and cellular technologies. We believe in the potential of blood and cell therapies to do even more for the world than they do today. As we strive to make even safer, higher-quality transfusions available, we can help our customers bring even more treatment options to patients with advanced blood therapies and we can help researchers develop cell therapies that may fundamentally improve health care. www.terumobct.com BRAHMS GmbH, Part of Thermo Fisher Scientific................. Booth 1.113 Thermo Fisher Scientific specialises in innovative products that facilitate earlier diagnosis of diseases and better control of therapy, thus enabling doctors to provide more efficient and economic patient care. Major fields of activity are diagnosis of infectious and thyroid diseases, cardiology and pneumology as well as sepsis, tumors, and Down’s syndrome. www.thermoscientific.com/brahms w w w. e r a e d t a 2 01 2 . o r g EXHIBITORS Tianjin Denny Tech Co................................Booth 1.63B We are professional manufacturer of dialysis product, We hold 1000 m2 clean room and completed foundation complementation. We possess advanced injection machine, extruding machine, high frequency heat sealing machine, ETO sterilization equipment, semiproduct automatic assembling machine, large-scale central air conditioning system and cooling unit. The composition delivers the totally enclosed production process from raw material investment to the end product.The blood tubing and arterial venous fistula needle was sales in world wide and we have passed CE and ISO13485 quality certification. 429 49th ERA-EDTA CONGRESS E X H I B I T O R S Toray . ............................................................... Booth 1.49 Toray is a leading manufacturer of synthetic fibers and dedicated to the development of dialysis products under its corporate slogan, “Innovation by Chemistry”. Toray supports high quality and advanced medical care with our biocompatible polymethylmethacrylate dialyzer, FILTRYZER, high flux polysulfone dialyzer, TORAYSULFONE & TORAYLIGHT, and dialysis machine, TR-8000. www.toray-medical.com/en/index.html Turkish Society of Nephrology................. Booth 1.G12 When the Turkish Society of Nephrology (TSN) was founded in Istanbul forty one years ago in 1970, it coincided with that of many of the Western European Nephrology Societies. Currently, TSN has 411 active members and 11 working groups also 8 branches with their own separate memberships in Istanbul, Izmir, Kayseri, Antalya, Bursa, Konya, Adana and Ankara. Turkish membership has actually reached 273 in ISN & 294 in ERA-EDTA (6th largest membership). TSN has increased its patient awareness activities this year and on the Kidney Day, TSN Activities consisted of a large variety from Banners in Football Matches to Newspaper Advertisements, TV Ads, Stands in Shopping Malls, Press Briefings School Visits and handouts in Nephrology Centers. www.tsn.org.tr/en/ EXHIBITORS Vifor Fresenius Medical Care Renal Pharma.......................................... Booth 2.22+2.23 Vifor Fresenius Medical Care Renal Pharma Ltd. is a strategic partnership between Vifor Pharma and Fresenius Medical Care. The nephrology company develops and commercialises innovative and high-quality products to improve the lives of patients suffering from chronic kidney disease worldwide. The products include Venofer® and Ferinject® in the field of dialysis and pre-dialysis (CKD stage III – V) as well as PA21, a novel iron-based phosphate binder. www.viforpharma.com/en/About-Vifor/businesses. php 430 w w w. e r a e d t a 2 01 2 . o r g MAY 24-27, 2012 PARIS, France E X H I B I T O R S WICHTIG EDITORE MEDICAL PUBLISHER Wichtig Editore................................................. Booth 1P3 Wichtig Editore Medical publisher began its activity in 1977, dedicating passion and competence to the publication of widely appreciated scientific journals focusing on nephrology, dialysis and transplantation – mostly indexed in important bibliographic databases. The Editorial Board of these outstanding journals acknowledge well-known leading scientists and, it is also thanks to their contributions, that Wichtig Editore’s titles are increasingly appreciated worldwide. Also, to be up-to-date, Wichtig Editore Medical Publisher is working to make its publications available as e-pubs for tablets and smartphones Websites: www.artificial-organs.com www. jnephrol.com - www.vascular-access.info - www. wichtig-publisher.com/gin Wisepress....................................................... Booth 1.G18 Wisepress.com, Europe’s leading conference bookseller, has a complete range of relevant books and journals which can be purchased at the stand or, if you would rather not carry them, posted to you - Wisepress will deliver worldwide. We also have a comprehensive medical and scientific online bookshop with great offers. www.wisepress.com w w w. e r a e d t a 2 01 2 . o r g EXHIBITORS WS Far Ir Medical........................................ Booth 1.63A We are the pioneer in Far-Infrared medical equipment industry, and have been manufacturing the FIR Therapy Unit for 20 years; our product WS Far-Infrared Therapy Unit is an essential tool for vascular access care in the hemodialysis centers all across Taiwan. In March 2007, the clinical evidence, “Far Infrared Therapy: a Novel Treatment Improving Access Blood Flow and Unassisted Patency of Arteriovenous Fistula in Hemodialysis Patients” was published in the Journal of American Society of Nephrology shows that FarInfrared Therapy can effectively improve the access blood flow and unassisted patency of AV Fistula in hemodialysis patients. www.far-infrared.com.tw 431 Exhibition Level 1 and 2 PARIS 2012 tav sin.indd 1 19:30 - 21:00 Welcome Reception Room 253 The Soft-Skill Masterclass Immunonephrology Working Group Room Concorde 2 Transplantation End stage renal disease, dialysis 26-04-2012 6:38:03 Hypertension, diabetes, vascular disease CKD - epidemiology, prevention, progression, pathophysiology Hereditary disorders, development, pregnancy, paediatric nephrology Drug-induced renal injury: the quest for sensitive biomarkers (IMI) Room 352AB CME 2 Peritoneal Dialysis Acute kidney injury and intensive care nephrology Fluid and electrolytes, tubular transport, physiology EuDial Working Group Working Group on Inherited Kidney Disorders EURECA-m Working Group EUTox Working Group Room 351 Programme at a glance Glomerular diseases and general clinical nephrology CME 4 CME 3 Clinical questions for managing Nephrolithiasis Renal Pathology Grand Amphitheatre Room 252AB CME 1 Rheumatology for nephrologists 15:30 - 17:00 18:00 - 19:30 Opening Ceremony 15:00 - 17:00 13:45 - 15:15 13:00 - 17:00 10:15 - 11:45 12:00 - 13:30 08:30 - 12:30 Thursday, May 24th, 2012 MAY 24-27, 2012 PARIS, France 49th ERA-EDTA CONGRESS LEGENDA PARIS 2012 tav sin.indd 2 15:15 - 16:45 S 11 Thrombotic microangiopathies and complement disorders 16:45 - 17:00 17:00 - 18:30 S 16 DOPPS 13:15 - 15:15 Roche Amphitheatre Bleu Amphitheatre Bordeaux Amphitheatre Havane Room 352AB S 13 Calcium sensing and PTH secretion LU 1 Clinical nephrology S 17 Vascular calcifications in CKD S8 Polycystic kidney disease: clinical studies Fresenius Medical Care FC 7 Vascular damage and access in CKD Coffee break and exhibition visit LU 2 S 18 Transplantation Paraneoplastic GN, monoclonalIgG related disorders and amyloid S 14 Peritoneal dialysis Coffee break and exhibition visit S9 S 10 Bone and mineral metabolism Leukocytes and pro-inflammatory after transplantation mediators in renal injury Sanofi Takeda Pharmaceuticals Europe Room 342AB FC 2 Renal physiology FC 10 Genetic studies in renal diseases FC 8 Clinical epidemiology and CKD 1-5 FC 11 Hypertension Room 252 AB FC 12 Anaemia S 15 Renal fibrosis 26-04-2012 6:38:07 Otsuka Pharmaceutical Alexion Pharma Europe International FC 6 Paediatric nephrology FC 3 IgA Nephropathy and urinary proteomics Room Concorde 2 Programme at a glance FC 9 AKI clinical studies FC 4 FC 5 Mechanisms and targets of HUS and diabetic glomerular damage nephropathy B.Braun S3 S4 S5 FC 1 Current aspects of CKD- Diagnostic approaches Advances in understanding AKI and stem cells mineral bone disorders to the tranplant kidney the renin-angiotensin system Poster session, coffee break and exhibition visit S 12 The prehypertensive kidney S7 What is “good dialysis”? Gambro S2 ERA-EDTA Registry 08:00 - 09:30 S 1 Late breaking clinical trials 09:30 - 10:45 10:45 - 11:30 Plenary Lecture 1 G. Karsenty: The novel endocrinology of bone 11:30 - 11:45 11:45 - 13:15 S 6 Sepsis and AKI Room Concorde 1 Friday, May 25th, 2012 Grand Amphitheatre MAY 24-27, 2012 PARIS, France 49th ERA-EDTA CONGRESS PARIS 2012 tav sin.indd 3 15:15 - 16:45 S 28 Progression of CKD and associated cardiovascular complications 16:45 - 17:00 17:00 - 18:30 S 33 Management issues in patients with CKD 13:15 - 15:15 Grand Amphitheatre 08:00 - 09:30 S 19 Salt and volume management in dialysis patients 09:30 - 10:45 10:45 - 11:30 Plenary Lecture 2 R. Johnson: Fructose, metabolic syndrome and kidney disease 11:30 - 11:45 11:45 - 13:15 S 24 Atherosclerotic and cardiac disease in CKD Saturday, May 26th, 2012 S 34 Vasculitis and lupus S 29 Membranous nephropathy S 26 Novel invasive strategies in antihypertensive treatment - Renal sympathetic denervation, baroreflex stimulation Amgen S 25 Ciliopathies and polycystic kidney diseases (basic and translational) Abbott Coffee break and exhibition visit S 27 FC 16 Minimal change Transplantation basic diseases/FSGS FC 23 Diabetes clinical studies FC 20 FC 21 Dialysis techniques and Mineral homeostasis adequacy and nephrolithiasis S 36 Tolerance and predictors of transplant outcome 26-04-2012 6:38:11 Baxter Healthcare Vifor Pharma and Fresenius Medical Care S 32 Outcomes after transplantation Room 252 AB Toray Room Concorde 2 FC 15 Bone and mineral diseases 1 FC 18 Renal fibrosis Nipro Europe Room 342AB FC 14 Diabetes basic research Programme at a glance FC 17 Peritoneal dialysis Amphitheatre Bordeaux Amphitheatre Havane Room 352AB S 22 S 23 FC 13 Markers of renal Advances in The EU and glomerular progression - New understanding tubular diseases approaches and studies function Poster session, coffee break and exhibition visit Shire DV Care Pharmaceuticals S 30 S 31 FC 19 The elderly patient with CKD or Genetic diseases of the Genetic diseases on dialysis glomerular barrier Coffee break and exhibition visit LU 3 S 35 FC 22 CKD and dialysis Glomerular permeability and Bone and mineral permeability-inducing factors diseases 2 Amphitheatre Bleu S 21 New advances in the pathophysiology of AKI Room Concorde 1 S 20 Highlights of the 2011 ESOT congress MAY 24-27, 2012 PARIS, France 49th ERA-EDTA CONGRESS S 42 IgA nephropathy Plenary Lecture 3 R. Bindels: Novel insights into the renal handling of calcium and magnesium S37 Diabetic nephropathy PARIS 2012 tav sin.indd 4 11:30 - 13:00 10:30 - 11:30 09:45 - 10:30 09:30 - 09:45 08:00 - 09:30 Sunday, May 27th, 2012 Grand Amphitheatre S 43 Reappraisal of European Guidelines S 38 Anaemia management Room Concorde 1 S 44 Renal cancer and the kidney in cancer S 39 Complications after transplantation Amphitheatre Bleu MAY 24-27, 2012 PARIS, France 49th ERA-EDTA CONGRESS S 45 Stem cells FC 24 Cardiovascular complications in CKD 5D Amphitheatre Havane ERA-EDTA General Assembly Coffee break and exhibition visit Amphitheatre Bordeaux S 40 Hyponatremia FC 27 Transplantation clinical FC 25 Autoimmune systemic diseases Room 352AB FC 28 CKD 5D epidemiology and outcomes FC 26 Clinical studies in CKD Room 342AB 26-04-2012 6:38:16 S 46 Prevention of AKI and delayed graft function S 41 Albuminuria and other biomarkers Room Concorde 2 Programme at a glance An Otsuka SPONSORED INDUSTRY Satellite Symposium held during THE European Renal Association – European Dialysis and Transplant Association Congress, Paris 2012 Taking a closer look at hyponatraemia Friday 25th May 2012, 13:15 –14:30 Concorde 2, Level 4, Neuilly Side Le Palais des Congres de Paris, Paris 13:15Lunch 13:30 Welcome and introduction: The hyponatraemia mind-set and environment Maurice Laville (Chair) 13:35 Under the microscope: Hyponatraemia from a fluid balance perspective Robert Schrier and Søren Nielsen 14:00 Investigating the optimal treatment of hyponatraemia: Practical case studies Volker Burst 14:20 Questions and answers All 14:30 Chair close Maurice Laville For more information please visit stand 1.60 To find out more visit www.hyponatraemia.com Date of preparation: March 2012 OPEL/0212/SAM/1098 49th ERA-EDTA CONGRESS 4 MAY 24-27, 2012 PARIS, France M Level 0 PARIS 2012 piante x web.indd 1 27-04-2012 5:29:58 49th ERA-EDTA CONGRESS 4 MAY 24-27, 2012 PARIS, France M COMPANY .................. BOOTH NO. COMPANY .................. BOOTH NO. Takeda Pharmaceuticals Europe..................................P01+P02 Kimal ........................................... 1.01 NxStage Medical......................... 1.02 Binding Site (the) ....................... 1.05 Mitsubishi Pharma Europe......... 1.10 Etropal ........................................ 1.11 Bain Medical Equipment............ 1.22 Poster Session On Line Poster Virtual Gallery ................. 1.24 Alexion Pharma International ... 1.26 Nephrokit.................................... 1.28 DV Care ....................................... 1.29 Novartis Pharmaceuticals Oncology..................................... 1.31 Dirinco......................................... 1.32 Joline ........................................... 1.34 Medikit........................................ 1.35 PakuMed ..................................... 1.36 Covidien ...................................... 1.37 Asahi Kasei Medical Europe ...... 1.42 TauroPharm ................................ 1.43 Infomed ...................................... 1.45 Asahi Kasei Medical Europe ...... 1.47 Toray ........................................... 1.49 Innovative Blood Purification .... 1.50 Sined ........................................... 1.57 Otsuka Pharmaceuticals Europe 1.60 Serumwerk Bernburg ................. 1.61 EG Medical Systems .................... 1.62 WS Far Ir Medical .....................1.63A Tianjin Denny Tech Co..............1.63B Alam Medical............................1.64A Physidia ....................................... 1.65 Awak Technologies .................... 1.68 Medcomp .................................... 1.71 OUP Oxford University Press...... 1.72 Debiotech ................................... 1.91 Meditechlab & Suisse Med Technologies ............................... 1.92 Alere International..................... 1.93 Culligan ....................................... 1.94 Pronefro ...................................... 1.96 Intermedt Medizin & Technik .... 1.97 Terumo BCT ..............................1.98B Gardhen Bilance .......................1.98C Savient Pharmaceuticals ............ 1.14 Cybernius Medical ...................... 1.16 Thermo Fisher Scientific ........... 1.113 Medica Italia ............................. 1.100 NDT-ERBP-NDT-Educational ..... 1.102 Bionic Medizintechnik ............. 1.103 Medvision ................................. 1.115 Alexion Pharma International . 1.116 Sandoz - Novartis Group ............1.G1 ISN International Society of Nephrology ............................1.G3 IFKF - International Federation of Kidney Foundation ................1.G4 Euroclinic ....................................1.G5 Bodystat ......................................1.G6 ARBOR Research .........................1.G7 French Society of Nephrology ...1.G8 Fedairg ........................................1.G9 MedXL .......................................1.G10 French Society of Dialysis .........1.G11 Turkish Society of Nephrology 1.G12 ERA-EDTA 2013 Congress Istanbul .....................1.G14 Ningbo Tianyi Medical Appliance ..................................1.G15 JiHua Medical Apparatus and Instruments .......................1.G17 Wisepress ..................................1.G18 Immundiagnostik .....................1.G19 Labor Limbach ..........................1.G20 BioPorto Diagnostics ................1.G21 E.D.P. La Traccia ........................1.G22 Atcor Medical ...........................1.G23 HemoSapiens ............................1.G24 Dustri........................................... 1.P1 Nature PG ................................... 1.P2 Elsevier Masson .......................... 1.P4 MediTheque Bookshop .............. 1.P5 Karger ......................................... 1.P6 Wichtig Editore ........................... 1P3 Poster Help Desks ...........PD01+PD02 Gielissen Exhibition Service Desk ..............................1.64B Catering Areas ..................C11+C11D Sitting Areas ......C11abc+1.14+1.53+ 1.108+1.111 PARIS 2012 piante x web.indd 2 Level 1 27-04-2012 5:30:05 49th ERA-EDTA CONGRESS 4 MAY 24-27, 2012 PARIS, France M COMPANY ........................... BOOTH NO. Shire Pharmaceuticals .......................... 2.01 Abbott................................................... 2.03 Atlantic Biomedical .............................. 2.04 Kawasumi ............................................. 2.05 B.Braun Avitum .................................... 2.12 Lauer ..................................................... 2.12 Pharmacosmos ...................................... 2.13 Nipro Europe ........................................ 2.14 Diaverum .............................................. 2.19 Membrana ............................................ 2.20 Actual Way Medical Devices Via Actual ............................................. 2.21 Vifor Fresenius Medical Care Renal Pharma .............................. 2.22+2.23 NKF USA ................................................ 2.26 Allmed Medical .................................... 2.27 Janssen .................................................. 2.37 Baxter Healthcare................................. 2.39 Miltenyi Biotec ..................................... 2.40 Emodial ................................................. 2.42 EffeEmme ............................................. 2.44 Gambro ................................................. 2.46 Amgen Europe ..................................... 2.48 Roche .................................................... 2.52 Fresenius Medical Care Therapy Forum ....... 2.54+2.55+2.60+2.60A Herco Wassertechnik............................ 2.64 Soludia Maghreb .................................. 2.65 Likamed ................................................ 2.66 Fresenius Kabi....................................... 2.68 Fresenius Medical Care ........................ 2.68 Sandoz - Novartis Group ...................... 2.73 Nikkiso Europe ..................................... 2.75 Sanofi Aventis Groupe ......................... 2.79 DWA ...................................................... 2.81 Hospira UK ............................................ 2.83 Abbott.......................................... 2.90+2.88 Bellco.........................................Hall Maillot Catering Areas .............. C20+C21+C23+C24 Level 2 PARIS 2012 piante x web.indd 3 27-04-2012 5:30:11 49th ERA-EDTA CONGRESS 4 MAY 24-27, 2012 PARIS, France M Level 3 PARIS 2012 piante x web.indd 4 27-04-2012 5:30:18 49th ERA-EDTA CONGRESS 4 MAY 24-27, 2012 PARIS, France M Level 4 PARIS 2012 piante x web.indd 5 27-04-2012 5:30:24 ERA-EDTA is a medical association active in encouraging intercultural communication and knowledge What can ERA-EDTA do for you? ISSN 0931-0500 (Print) ISSN 1480-2385 (Online) Volume 1 Number 1 7 Jan 2012 ndt NEPHROLOGY DIALYSIS TRANSPLANTATION Basic and clinical renal science ISSN 0931-0500 (Print) ISSN 1480-2385 (Online) Volume 1 Number 1 7 Jan 2012 CKJ Stanley Shaldon, ERA-EDTA award, PRAGUE, 23 JUNE 2011 CLINICAL KIDNEY JOURNAL Official Publication of the European Renal Association -European Dialysis and Transplant Association an academic journal of the ERA-EDTA PARIS, France MAY 24-27, 2012 www.ndt.oxfordjournals.org eraedta2012.org EDTA 2012 Paris man70x100.indd 1 www. Official Publication of the European Renal Association European Dialysis and Transplant Association 49th ERA-EDTA CONGRESS www.ndt.oxfordjournals.org 31-03-2011 8:09:01 ERA-EDTA members are entitled to EXCLUSIVE benefits: Free subscription to NDT and CKJ and access to NDT archive Exclusive access to scientific and educational contents Very special low registration fee at the ERA-EDTA Congress Special access to the ERA-EDTA restricted libraries on the web-site Special Discounts to Oxford University Press Medical publications What can you do for ERA-EDTA? Become a member and start to network now! www.era-edta.org EDTA_AD 10,5x22,5 FP Paris.indd 1 19-04-2012 7:01:36 The new 5008 CorDiax Beyond your expectations Visit u at bo s oth 2.68 Level 2 Cardioprotective Haemodialysis SP T The new 5008 CorDiax Cardioprotective Haemodialysis with advanced safety for reduced cardiovascular complications and mortality: AutoSub plus maximising patients’ substitution volumes with minimum efforts for the full benefits of advanced ONLINE HDF Sophisticated safety features setting new benchmarks in venous access monitoring 5008 CorDiax – The essential element of the CorDiax product line. Fresenius Medical Care Deutschland GmbH 61346 Bad Homburg · Germany · www.fmc-ag.com AL_6198_120411_Anz_5008_NDT_105x225mm.indd 1 11.04.12 15:39
